1	authority, upon
2	package; and
1	applicable request
1	identify unmet
30	iii, iv,
13	clauses (iii)
1	made. (vii)
2	section 383(b)
1	plan (a)
61	drug trafficking
1	(a)(ii). (2)
1	level. such
1	minorities. 
1	applicable. (c)
23	(ii) that
1	360d(c)(1) of
1	authorityfor the
1	period, were
1	suspensionthe secretary
49	disease product
1	center. (p)
1	program because
1	establish goals
1	prenatal care.
1	public so
1	location tool
1	licensing fees.
35	changes in
1	governments subject
1	organization the
2	957 of
3	sentence to
1	substance, extend
1	title. to
1	stat. 1040.)

2	facility involved.
1	administration, an
1	governmental sources,
1	915, as
1	type as
6	animals. 
1	247d5]. such
1	analysis under
1	exemption are
2	(b)(3) if
1	marketing, the
3	(3) all
1	offense classified
1	position together
1	343(h), 343(i)(1),
1	(20) tobacco
2	(b)(3) is
1	rulemaking. 
2	environmentall-approved herbicides
1	requirement, including
1	disclosure, as
1	506c, as
1	showing required
1	support, and
2	serving in
2	shall cast,
1	betameprodine. (9)
4	risk assessment
1	including topics
1	diet including
1	(g)(2), the
1	(2) longer
1	including, in
5	following persons
1	members term
2	timely basis
4	seeks to
1	meeting only
1	secretary, provide
3	indicates that
1	section 319f2(c)(2)(a)(ii)
1	exception applies,
2	serving it
12	(1), (2),
2	regulated person.
7	extent required
5	misbranding provisions
1	516, as
1	regulated child
1	processing activities
1	expedited inspections
2	1997 
1	quotas of
62	secretary, in
3	awarded under
1	complaint, the
1	(adjusted each
1	said section;
1	specifically target
6	secretary, if
2	notification provided
1	aspects of
4	approve another
1	recommendation whether
1	determination, made
7	made for
3	sponsor requests
1	(i) exemptions
1	(d) (relating
1	subparagraph not
5	cocaine, or
1	produced, the
1	interest as
2	(2) new
1	(2) proposed
1	produce drugs
1	agreement authority
2	including, but
1	types that
1	(i) whenever
1	quantitative risk
2	chemical has
1	adulteration; or
2	unwholesome parts
1	terrorist organizations,
1	designation. any
1	labeling act,
5	seq.] with
2	establish panels
2	hearing; period
4	extent, whether
1	filled. (

1	(1) notificationif
2	hearing, finds
1	purchases, transfers,
1	commissioner means
1	page directly
1	residue due
1	product. (iii)
1	before, or
2	establish, 60
5	waiver, exemption,
1	made; (2)
1	(14) $124,000,000
1	provision operates,
3	bond providing
4	parking lot
1	physical form,
2	adopt a
1	agents used
2	1057; 

1	months beginning
1	auditors (a)
1	omit any
1	benefits set
1	distribution; (d)
1	affected industry.
4	(c) other
1	infeasible, the
1	necessary the
1	restrictions described
5	whenever a
1	(b) pays
6	systems, including
1	food. (d)
4	change the
1	animal has
1	secretarys order.
1	(7) reaccreditationthe
8	testing, and
1	potential pr-
2	records, facilities,
1	clearly links
1	information where
2	revised national
1	timing; content;
1	decide whether
1	including education
2	title. (iv)
1	involved; and
1	developed. (b)
1	actionsthe owner,
1	high consumption
1	means bodily
1	(3) currently
1	health, promulgate
1	committeeupon receipt
1	evolution of
2	distribute, methamphetamine
2	regulation described
4	will reasonably
1	population 
1	applicant; (d)
1	(b) lif-sustaining;
1	information accordingly.
1	importation, and
1	(3) submission
1	incidental production
1	nominated, and
10	crediting and
1	1042. reporting
13	provides a
6	year thereafter,
1	panel includes,
3	applications (a)
1	(a) retain
1	coordinate intramural
1	track products
1	defense. (june
1	paragraph (ff)
3	reductions, and
2	(a)(1), or
1	pyridine or
3	plant. 
1	states their
1	fluid ounce
4	statement is
1	renewal and
4	found after
1	71 to
1	thing involved
1	page 768)
4	cost incurred
1	statement if
2	practitioner under
2	written certification
1	involved of
3	director means
1	tribe has
1	451. congressional
8	statement in
1	products agreed
1	(4) cigarette
1	large part
6	modified by
2	substances; and
1	interchangeable biosimilar
1	one class,
1	cyanide. (c)
1	262(i)]. 
1	2016, $599,000,000.
1	(3) administrative
1	person exceed
1	title (i)
1	track product.
1	(h) reciprocal
1	track product,
1	stakeholders to
2	therefor 
3	applications (as
9	(d) 
2	vacancies any
1	security interests,
2	product: 
1	measurable reduction
2	section 360fff(2)(a)
1	(d)(5). 
1	person deemed
1	thereof. (10)
1	national interest,
1	subsection (a)(1)(b),
1	shortage; (6)
2	shall present
1	drugs signed
1	delivering, importing,
2	appropriate; (ii)
3	tolerance and
1	six percent
1	give, pay,
1	c-homolog); (iii)
1	training; and
6	15, 2007,
6	added on
1	cleaning and
1	compounded for
1	1052. state
3	added or
1	(b) repealed.
1	methamphetamine; (f)
1	way that
1	agriculture), or
1	file them
1	reductions granted
2	terrorism risk
2	15, 2007;
5	tribal governments
1	court without
1	benzilate. (15)
1	surface but
1	intended nor
1	country occur
1	cigarettes. (ii)
1	act other
1	may strengthen
1	therein, and,
1	ratio described
1	special labeling
1	persons guidance
1	support marketing
1	populations, and
1	regulation was
1	6, as
4	1264; renumbered
67	subsection (c)
1	360i. records
1	thereof that
1	v any
1	multiple representatives
3	vegetables, that
1	(3) three
1	free; (iii)
3	combination animal
8	regulation shall
1	823(d) of
4	lif-threatening diseases
1	substance made
1	physically compatible.
2	matrix barcode
3	committee means
1	devices will
1	determine who
1	significantly reducing
2	grants, or
1	refuse administration
1	toxic effect
1	673. seizure
2	delivered contemporaneously
3	emergency or
8	(3) upon
2	transporting, and
12	notification upon
1	number under
1	record which
1	736a, as
4	unfavorable personnel
1	professional societies;
5	adjusted base
1	weekly or
8	condition to
2	warning that
1	documentation or
2	sampled and
4	two and
1	employees detailed
3	requirements, as
1	secretary, use
1	surveys or
20	contributed to
1	(12) exercise
5	costs incurred
3	patient advocacy
15	meeting at
2	(a) false
1	least one,
1	229, 62
4	period that
1	device submission,
1	requirements. (d)
1	publish, after
2	certain provisions
1	section reclassifying
4	voucher 
1	writing, signs,
3	drug advertising
3	section 282(j)(5)(b)
3	response and
1	modify shall
1	two cannot
1	regulation has
1	laws inconsistent
5	bring a
1	packed, cured,
4	including regulations
1	safeguards as
2	agency referred
1	registries, development
1	(e) performing
1	involved. a
1	(g)(2)(c), for
1	regulation, information
1	454(a)(1) of
4	panels under
6	reduce or
6	sold, the
1	questions.at least
2	devices not
4	providers, and
1	(1) maintain
1	occupancy or
1	amphetamine. (3)
2	general notwithstanding
1	of, tobacco
1	checking the
2	unless required
2	heightened risk
1	(2) payments
1	
 970.
1	minimum requirements:
1	enforcement, etc.;
1	phenazocine. (19)
1	racketeering, blackmail,
1	notice, a
1	age after
4	star-up period
1	may set
1	by, not
1	communicate comments
3	pleadings and
1	comments before
1	may increase
1	needy families
1	utilizing updated,
2	country engaged
7	also be
6	fees during
1	record taken
1	labeler code,
1	individual (who
1	compelled in
1	caused in
2	transportation, the
2	secretary required
1	(b) exclusionsthe
1	
 151.
2	marketing service
2	v, whichever
1	(b) manufacture
1	(a) directorthe
1	networkthe secretary,
45	publication of
1	products established
2	subsequently transported
19	respecting a
1	$2,000. the
1	live poultry
1	approved strategies.
1	misbranding, are
1	permits discovery
2	taking other
1	1999 for
1	inspection. the
2	mult-drug resistant
1	health, due
1	alcohol other
1	delivery mean
1	antidote, and
1	exercising the
1	reviewed, all
1	carriers shall
1	impact caused
28	congress a
2	(exclusive of
11	food may
10	required pursuant
1	(i) annual
1	title) has
1	information so
1	petition; (2)
1	regulations; violations;
1	precursor chemicals.
1	panels meet
6	 section
1	procedures, including
8	effectiveness are
1	secretary constitute
3	regulations with
1	(a) who,
1	language the
1	purchaser signs
3	formulations or
1	efforts, to
25	initial pediatric
3	milk, cream,
1	request, have
1	findings requiredto
3	(iii) where
1	receipt at
2	5(b) of
1	complete previous
2	inspection regulations
3	maximum amount
1	5, 13,
1	entitiesfor purposes
1	agentsan audit
1	section 312.47
2	communication or
1	permit inspection
1	commitments to
1	user facilities:
1	(b) training
1	seq.], conditional
4	him. 
1	inspect records
1	(6) application
3	communication of
1	communities. such
4	october 26,
2	manufacture, salt,
1	carcinogen, or
1	be, shall
1	program meets
2	toxicological, behavioral,
1	permit inclusion
1	(a) grounds
4	$50,000,000 if
6	person requesting
1	grown; or
1	cartage and
1	plants authorized
1	$50,000,000 in
1	withdrawal. 
4	subparagraph (b)(i)
1	confirms within
2	clauses, the
1	enterprises; slaughterers
6	seeking to
1	law. (3)
1	civilian and
1	ant-drug coalitions.
1	priority countermeasures
1	(a)(2)(a) has
1	device recalls.
1	(1)(b), and
6	title. in
2	 notwithstanding
1	wholesalers to
2	authorization may
1	coalition meets
1	title. if
1	stakeholders on
6	facility may
1	in, demand
1	food, to
1	device recalls;
2	associated with,
1	drug, from
3	section 384b(a)
1	them, he
1	(3) dispenserthe
13	fixed by
1	2018; as
1	quorum six
1	(p) risk
1	attachment of
1	present proof
1	animal accompanying
1	sell, by
1	person begins
2	containing authorities
1	technology requested.
1	good moral
2	transition grants
1	1988 (21
1	(b) 27
1	consecutive term
2	electronic registration
4	approval, including
1	effect shown
4	meeting a
2	subparagraph. (d)
60	states and
3	extension if
5	raw material
1	clinical consequences
1	(6) $60,000,000
1	matters, as
1	shape. 
1	extension in
1	use withholding
1	outstanding securities
3	(1) adverse
1	(v) 
7	animals and
1	databases with
1	administrator, or
1	allegedly occurred
4	extension is
2	labels, and
1	date set
1	injury, 
1	persons, to
2	ultimate users
2	dispenser under
1	distinguish, in
1	158. offenses;
1	(16) small
1	compromise claims
2	significantly minimized
1	physicians to
1	section 881(d)
1	describe and
1	medication prescribed
1	pasteurization for
2	(4), if
1	(b) congressional
1	(d) warnings
1	resources provided
1	act. the
1	describe any
3	reach a
14	product applications
1	ordinary conditions
1	of, information
1	uses an
1	attorney generalwith
3	means, including
1	employ to
6	registration for
1	(h) no
2	(14) the
1	vegetable. in
2	(i) make
7	limited population
1	applicable guidance
6	law; and
1	direct service,
1	reported; (4)
2	apply if
2	 (24)
4	suspension the
1	laboratory sitesthe
1	violation standard
1	refused imports
1	2.7 
3	section. a
1	month after
1	congress, however,
1	methods which
1	found liable
1	temporarily suspended
1	policy, any
2	product application,
1	135b. repealed.
13	product application.
1	status; (iii)
1	part of[2]
2	implementing a
4	organization or
1	licensed, except
1	website shall,
4	costs paid
1	functions, projects,
2	jurisdiction. (2)
4	product application;
2	subparagraph (a)(ii)(iv)
1	consumed or
1	parent or
1	shall, beginning
1	wholesale distribution,
1	wholesale distribution.
1	waive clause
4	policy, and
4	banned device
2	(aa), (bb),
1	provide increased
1	sell, deliver,
1	export; criteria
1	strategy; (4)
3	consignee, and
1	elements are
2	injunction or
1	making appropriate
1	recommendations issued
1	(iii) taking
1	mandamus proceeding
1	schedules, and
31	contrary to
6	disclose any
1	states, unless
1	effortsthe secretary
1	(ii) limitationno
1	exclusivity awarded
1	writing, provide
2	360c or
2	(a)(iii) shall
1	topics of
1	advanced computer
13	amount appropriated
1	marketability of
1	compoundingthe drug
1	iv, to
1	safety; exemption
4	articles shall
1	encourage free
17	360c of
11	notice described
10	allowed travel
2	feed (as
1	will exchange
4	(2) contents
1	issuance; procedure
1	
 451.
1	transferred). from
1	possess or
2	substance listed
1	receiving it,
2	 subclause
1	dedicated website
1	analyzed, and
1	occurs). 
1	committees describing
2	discussion of
3	address credible
2	agreement. (

1	listed drug);
2	regulation applying
1	service, at
1	5. this
1	subsection (d)(2),
5	concerning such
1	affect its
1	obvious disfigurement;
1	implementing comprehensive,
1	-(-iod-2,-dimethoxyphenyl)ethanamine (2ci).
1	micr-organisms in
1	innocent persons;
1	training regarding
2	(c) report
6	applications under
2	validation data,
7	contractual requirements
12	licensure of
1	food; (k)
1	(j) funding
1	v. reilly
1	675, 420,
1	secretary, information
1	filing; or
1	substantially contributes
2	single patient
1	statement to
2	validation data.
1	feeeach person
1	ultimate user.
1	persons property
1	electronically submit
1	arise from
1	encourage such
3	allow for
1	condition due
1	special condition
1	recipient. 
1	(a) members
2	(except those
3	intelligence agency
1	145. penalties
7	exceeding the
1	prohibit, during
1	controls contributed
1	arrest warrants;
1	grant individuals
1	name, brand
1	court proceeding
1	regarding alcoholic
4	promptly conduct
1	terms qualification
1	trafficker identified
1	package, container
1	barbital. (2)
4	system, or
1	concerned who
1	defer submission
1	force operating
1	color for
1	demographics and
1	poultry carcass
1	agency (a)
1	
 379d2.
6	court as
2	court at
1	direct relationship
2	general.no action
1	scientific evaluations
11	manufacturing change
1	submitting entries
1	device (other
3	including employees
2	children from
2	supporting such
1	retail; and
1	(a) pose
3	qualification plan
2	conversion into
1	psychiatry or
1	support activities
1	submission; filing
1	expenditures of
1	(2)(a) available
1	(b); (b)
1	patients, physicians,
1	filling, packaging,
1	section 387e(j)(3)
1	requesting additional
1	appeal. (c)
1	sections was
1	safety, may
1	manufacturers subject
2	risks presented
1	supplant current
4	350d(b) of
1	equipment; and
1	u.s.c. 9831
1	aside sufficient
2	list with
1	
 1102.
2	districts, commonwealths,
2	title, unless,
1	device, and,
11	adulterated, and
1	drug); (ii)
1	involved 
1	teaching; or
1	voucher; and
6	writing by
3	tribal department
1	perform activities
1	next budget
1	provide guidance
5	(j)(5)(f)(ii) of
7	access for
1	scientists; appropriations
1	populations, particularly
1	packaging (a)
1	employee (as
1	condition on
2	appropriate relief,
1	votes between
1	physician; exemption
2	whose body,
1	malfunction were
20	condition of
1	complainant for,
1	entity may
2	described 
1	producers, and
1	section 2003(b)(7)
1	841. prohibited
1	(1) exemption
1	ethics, neonatology,
2	fix a
4	387i of
1	person, knowing
2	residue; (ii)
1	(3) execute
4	product; (iii)
1	methods used;
3	furnished by
1	fees. (4)
1	licensed in
1	veterinary science.
2	notice). 
1	advertising direct
1	term safe
1	allegedly caused,
1	generala facility
1	agreement through
1	offic-based settings.
1	integrity, and
1	proceedings as
1	rare diseases,
1	divide the
2	requiring an
1	circumstances that
1	(i) classify,
2	bloodstream, the
1	merely advertises
3	pesticide chemicals
1	objection and
258	(a) the
1	without prejudice
1	50 states
1	diethylamide. (10)
1	license, distribute,
1	small open
1	1007, formerly
1	size; (e)
9	otherwise obtained
1	comparability payment
1	designs in
2	declaration, declares
1	needed 
1	countries for
2	uses, unless
2	product. any
1	brings food,
1	dispense, an
1	grades, and
1	711, as
8	conforms to
1	circumstances, so
1	(e) conditions
1	characterizing flavor
8	susceptibility of
1	(a) personal
1	find necessary
1	period required
3	pesticide chemical;
2	voluntary basis
1	eggs; (2)
1	sample shall,
24	(c) is
1	governing first
1	the[1] chapter
1	intent if
1	guidance) of
27	(c) if
2	pesticide chemical.
11	pesticide chemical,
2	provisions requiring
1	substances, by
1	approve any
21	(c) in
2	notwithstanding such
2	interim relief,
1	nanomaterials within
2	precursor and
1	judgment subject
1	360d(b)(2) or
4	applications, be
1	rates, except
1	communication channels,
1	distributor; (iii)
1	subpopulations that
1	container requirements
2	export such
2	promulgate to
1	foundationthe foundation
1	boards and
1	isomers. (2)
1	available understanding
1	aircraft to
4	qualification 
1	held. (3)
1	countermeasure applications
2	may designate.
8	considered by
1	recommended does
5	(b); or
1	such, when
1	programs operated
1	convention, of
1	regulations. a
2	activities associated
1	periods specified
3	prohibited. 
2	fee act
5	requested and
1	informed as
9	conditions specified
1	notice; opportunity
1	manufacturer. the
3	(ii) application
1	endeavor or
1	spend any
1	committees except
2	populations, the
1	case which
11	qualified entity
1	distributions. forms,
2	tool, the
1	lifesaving or
3	notice respecting
6	following factors
1	device name,
1	materialthe term
2	storing any
1	sought by
1	agency contained
1	practices; (d)
2	person, he
3	cast, print,
1	subclauses. (i)
1	trade by
18	review fee
1	year, conditionally
11	subsections (b)
1	qualify drug
2	retail a
1	350a(f) of
1	cleansing, beautifying,
1	preparing risk
1	patient, consumer,
3	title 41.
1	whichever first
1	islanders), youth,
3	supplier who
1	presentations described
41	required for
1	(n) abbreviated
2	title 41;
1	1988, or
1	implement programs
1	handling, distribution,
3	systems or
3	opportunities for
10	patient or
1	establishment; or
1	progress for
1	1985, the
1	food beyond
1	original submission.
1	limit, under
1	mobile retail
1	dates that
1	bartered, exchanged,
1	based and
2	dates for
1	(8) unexpected
2	5. (4)
1	pedigree, or
1	regulations; (d)
1	noting any
1	holds, exports,
2	effective, and
4	levels and
11	article has
1	(4) duration
1	resistant microorganisms
6	required reports
1	commodities that
1	(c) denial;
1	duties, and
1	office means
3	hospitalization; (iv)
10	including per
6	effect nothing
1	ensure ongoing
7	foregoing provisions
1	(2) award
2	medicine, engineering,
1	consumption for
1	section 201.57
17	taken by
1	general, is
2	food bearing
2	examination to
3	poultry, and
2	crop years,
2	welfare recipients
1	actual, constructive,
1	floor (which
1	(d) boobytraps
10	findings and
1	permissible to
1	fda indexed
2	including section
2	10 kilograms
1	submission mean
1	trends relating
1	appropriated. the
1	continual device
1	evaluated in
1	myrophine. (18)
1	privilege (a)
1	intr-agency coordination,
2	officer that
1	both. (iii)
27	delivery of
1	country into
1	entity (whether
1	harmful products
2	biennial basis,
1	year. (e)
1	difficulty. 
1	brings an
1	complete reports
1	(i) holds
2	conducted outside
10	delivery or
1	percent less
1	procedures respecting
1	leadership and
3	technical effect
1	report. (4)
1	purchased; and
1	unwanted prescription
2	(1) applies
1	convention, transfer
2	forth initial
1	oxalic and
3	disruption in
1	officials except
2	drug traffickers
3	activity or
1	(4) venue
1	shares described
2	consumer package;
1	100 per
1	therefor. if
1	amount, with
2	year. penalties
3	product fails
24	small tobacco
1	extension service
1	(a)(6) through
5	therapies for
1	accreditation, not
1	activities regarding
1	include disposal
1	advertising requirements
4	federal determination
1	public agencies
8	379aa1 of
1	unanswered as
1	individuals. (c)
1	exemption); or
1	utilizing the
11	mark, or
1	secretary. (3)
1	strategies developed
2	business; or
1	treat acute
2	redacted by
18	product radiation
1	substances who
1	apparent temporary
1	date, objections,
1	enforceable public
1	(36) phenomorphan.
1	quality, including
1	exemption, issue
1	circumstances later
1	property from
1	(k) sunsetthe
6	manufacture animal
1	enforcement personnelany
3	section have
2	consumer does
1	otherwise set
2	shown or
1	homeopathic drugs
2	begins, except
3	director shall,
1	subchapter. nothing
1	establishment, together
2	objectionable, stating
1	writing. (d)
8	appropriateness of
2	organizations inserted
1	(60 stat.
1	bodies of
1	changes being
1	standpoint of
2	fort-eight months,
2	articles regulated
1	subject by
1	obstruction or
1	pediatric plans,
1	restrictions applicable
1	business dispensers,
1	applicable food,
3	surveillance for
1	addition, each
6	chemical, or
1	legal interest
5	product on
1	(6). (2)
4	minimum, the
1	compendiums; infringement
1	(d)(1); or
1	practice unless
1	subchapter (a)
22	product of
3	promotional material
1	secretary. (iv)
1	required postmarket
2	controls provide
1	capacity, shall
1	permit changes
9	issuing the
1	professional candidates,
1	device presented
1	80 percent
1	modified, if
1	protocol) for
41	product or
5	business, in
3	significant number
1	therefrom), fiber,
6	carryover balances
8	application (or
1	substantive issues
2	risk management
3	wrappers, or
1	order, proceedings
1	objections under
1	admission a
19	petition to
1	acknowledgment from
1	advises, as
4	(c). (2)
1	submit, or
1	papers, records,
2	systems 
1	producing both
1	imposing conditions
1	declarations: psychotropic
2	enforcement resolutions
1	representatives describing
1	means expenses
1	reduction, a
1	include, along
2	employees under
1	substances) if
3	division; and
1	(e) expanding
1	taken, if
2	food (other
1	section 1033(a)(8)
1	u.s.c. 262);
1	methamphetamine, the
1	rising from
7	shipped in
1	safety fees.
4	professional and
1	aside any
3	device. a
1	consulting laboratory
3	drug unless
1	(b) tracingfor
1	reports. (3)
1	level refers
1	separate offense
1	petition any
2	proceeding in
1	authorized agent),
1	(f) matching
1	arises under
3	section which
1	include regular
1	records can
8	prepared, packed,
1	appropriate. (iv)
1	practicable, identify
7	time, the
1	pulmonology, cardiology,
1	756, as
1	title); (b)
8	proceeding is
1	thereafter renewable
33	officers or
1	employ or
1	
 379d5.
1	workload adjustmentsfor
2	either that
1	content, nicotine
7	may, when
1	(including judicial
1	(cc) for
1	2009, for
1	subsections (b)(2)(a)(iii)
1	organizations related
1	kinds, or
483	secretary may
1	schedule ii(a)(4),
1	(3) award
1	generals discretion,
1	273, 3,
1	product), packing,
2	condition; or
1	drug, alone
1	
 356f.
1	ionizing or
1	pending. 
2	ground or
1	sample required
1	formation, or
1	issued, that
1	charged but
1	sections 351
7	individuals with
1	1984. 
3	58 stat.
1	including coca,
3	managing the
4	determined in
1	outcome. 
4	(2). (2)
1	animals, for
1	1981 and
1	memorandum; (ii)
1	disciplinary actions,
1	exempted for
2	(b) notify
2	inventories; copies;
1	new records.
8	sale to
13	approval supplement
1	planned law
1	caused such
1	exported for
4	person unless
1	379j(a) of
404	animal drug
3	reviewed and
6	353(e) of
3	word poison,
1	clarity and
1	drug side
3	general, and
1	pharmacis-i-charge can
2	rendered adulterated.
1	appearing to
1	purchase, manufacture,
7	136 et
1	relevant food
2	applicant, unless
1	behalf, the
2	determines not
8	(or the
1	reporting initial
1	conferences, and
1	1990 [7
1	c-chairpersons) of
2	milk, and
2	both; except
1	chapter. (10)
3	advocates the
2	devices pursuant
2	sufficient period
1	space, including
1	9 shall
1	transport of
1	information) consistent
3	internet to
1	(c) staffthe
1	health, (d)
3	appoint and
1	section 1961
590	subject to
1	applied or
1	4461945318 (august
2	requirement respecting
2	providing or
2	secretary disclosures
2	provider. 
1	december 8,
1	articles. the
5	purposes and
2	design, or
3	imported pursuant
1	rendered adulterated,
1	864. anhydrous
5	information reported
2	states be
7	387k of
3	operated or
1	monitoring requirements;
1	
 17.
2	change may
1	(for the
1	adequately supported
29	develop and
1	filed. (v)agreement
1	challenges; 
1	subparagraph (b)(v),
17	(c). 
1	administrations pesticide
1	qualified countermeasures,
1	product returned);
1	appropriations, and
3	foundation for
5	social security
1	courts; united
2	product into
2	secretary, afford
1	supplements for
1	age and
3	technical data
1	strategy. (xiv)
1	ingestion, or
1	violate, any
1	1501, 1502.
2	labeling change.
1	persons, requiring
1	applying specific
17	(ii) 
2	tobacco to
1	restrict a
1	395. loan
1	units per
2	independent assessment
1	goals, including
1	like effect
1	251, title
12	823 of
1	implant only
1	(a) membersthe
1	secretarys satisfaction
1	title, tobacco
2	determination published
1	milestones described
3	individual convicted
1	(e) verification
4	qualified person
1	pedigree systems
1	foods. the
1	requirement, which
1	symbol or
1	may (1)
1	control are
1	exceptionif prior
1	seafood imports
2	certifies in
1	machines, and
1	employee training
8	regulation, or
8	secretarys own
2	marks. (

12	recall or
1	first examination
1	applicable standard,
1	motion seeking
1	prerequisites for
1	handling poultry
1	medical associations
1	eligibility standards
2	(f) assessment
1	including establishing
7	fees to
18	recall of
1	promulgated, but
5	creative services
2	(pursuant to
1	agreement can
1	consumer groups,
1	(a)(2). (iv)
1	clearly and
1	(d) disposition
6	access, and
1	incompetent, such
19	minor species
1	state, has
2	standard costs.
1	feed, appropriate
1	first time
1	extension continues
1	consumer groups;
1	appropriations authorized
11	kinds of
1	investigator in
1	includes data
2	already expended
1	1996. in
1	petitions are
1	time) they
1	guam, and
1	substantive clinical
6	several states
16	applicant is
3	convictions shall
1	number, professional
20	applicant in
9	continuing criminal
1	statement that,
7	prescribe and
8	applicable standards
2	applicant if
1	49, code
4	transactions involving
26	product standard
1	required; (iii)
2	either of
3	placement of
1	products, particularly
1	(b) repair,
1	955. possession
1	manufacturing techniques,
1	section 2223
1	implement dissemination
7	buy, sell,
2	lawfully engaged
1	1970; and
2	matters to
2	(ii) been
1	clear identification
1	title, (iii)
1	staff, a
1	(a) analysis
1	respect. 
7	equipment, or
3	distribution presents
1	occurs an
1	parts, meat
1	public servant
1	$248,000 
3	regulations may,
1	misdemeanor shall
1	additive on
1	public healthif,
1	exercise jurisdiction.
1	full implementation
2	distribution patterns
1	exceeding a
6	benefits for
2	animal science
4	be. 
28	representatives and
1	
 360dd.
1	(6) fentanyl.
1	records requested.
1	crime. (4)
1	etc., ingredients
1	sanitary and
1	paymentexcept as
1	transaction involved
2	database, which
1	subclause; or
1	sentence, at
2	title, compliance
2	harmful and
3	employee to
1	department that
1	contract analytical
1	authorizing a
3	occurring estrogen
1	acid for
3	applicable; or
3	concerning investigations
2	information received,
1	21-calenda-day period,
1	(c) exposure
1	issue, upon
1	(2) ensuring
3	youth ant-drug
2	capability to
1	staff years
1	effective at
2	product exempted
11	order for
1	(e) automated
1	(3)mail order
2	unlawful actsexcept
1	644. regulation
2	appropriate statements
1	potential harmfulness,
1	type 
1	commodities promulgated,
1	shor-range and
1	experiences with
1	(or more
3	physical location
1	
 360eee4.
1	coalition building;
1	arrival within
4	section 355(j)(5)(f)
1	efficiently disseminating
1	present controls;
1	served upon
3	authorization for
1	accept in
3	applicant the
8	(b) regulations
1	statement why
1	applicant imports
6	person. the
1	event signals.
1	examination conducted
7	analysis system
1	360(k), 360c(f)(2)(a),
1	sale drug
1	2002; (6)
1	organization established
1	piminodine. (20)
1	offset any
2	purchases or
1	related interests,
1	(2) export
2	list developed
2	(2) revocation
1	carrier; or
35	conditions as
1	packaged articles
1	address each
1	charge does
1	payment due
1	conditions an
1	applicable federal,
9	section that
1	protection, or
1	application number;
2	dispensing its
2	review if,
4	(a) develop
3	achieved under
4	constituent has
2	online pharmacys
5	on-half years
1	provide regular
1	territory that
5	products by
2	compounding, distribution,
1	employee, occupant,
1	aggregate data
1	device 30
1	subject an
3	standards; and
17	report shall
1	(i) period
1	products be
1	subject at
2	data and/or
1	(7) knowingly
1	toxicity and
6	physical or
1	
 149.
1	apportion an
1	subsequent biosimilar
1	2009, issue
12	rules of
1	permitted, by
1	targetsthe developmental
2	shorter period
1	title 3.
2	retail package
1	rules on
1	appropriate, information
1	state; precedence
1	event reporting:
1	cigarette 
1	qualities other
1	partnership from
1	title), 1
2	existing and
1	subsection (d)(2)(a)(i)
1	done within
1	coalitions. (2)
1	international agreement;
1	approval nothing
1	(g), of
6	unmet medical
3	label means
1	service gaps,
2	(m)(2) or
1	waives an
2	activities. (

1	label for
1	employee as
7	employee at
1	growing, harvesting,
2	inspections that
1	(1) dispute
4	period thereafter
1	requirements exclusivity
1	distinguishing between
1	direct human
1	level as
1	reports, in
1	appropriate instructions
1	foregoing shall
8	civil monetary
1	including timing
9	pay a
1	56(b)] it
39	payment of
13	1, 1944,
1	patients. (b)
1	institutes the
4	import and
1	(i) prohibit
1	gather and
1	collaborate with
8	(b) establishment
2	congress should
1	(c). a
2	capacity are
2	(5) final
1	to, state,
2	sell more
1	said consul
1	motion by
1	individualsif the
3	appeal the
1	3 brands
4	regulation may
3	regulation require.
1	pathway established
2	develop model
1	libel under
11	state law.
4	state law,
1	state law)
1	build scientific
2	division is
1	demonstration, and
1	(d) secretarial
1	leaf without
1	secretarys proposal
4	(3) provide
4	for, its
1	37, 68
1	level requested;
1	risk communication,
1	triangular in
1	policy upon
2	601.41 of
1	untrue statements
12	marking, labeling,
2	president. 
1	state required;
1	safety requirements;
1	gateway is
1	periodically in
2	pharmacist, and
1	now afflicts
1	period provided
1	expenditures for
1	(1) slaughter
1	(m) prior
1	dispensers; (ii)
3	food. no
9	year 
5	without charge
1	poison, when
2	purposes notwithstanding
1	action letter
1	change for
1	42 if
13	identifies the
2	pharmacy has
1	events in
2	22 and
2	fraudulent representations
1	participants enrolled,
1	term active,
9	state laws
1	diseases, there
1	classes or
1	steroids will
1	bulk vehicle),
1	condemned carcasses,
79	chemical residue
1	body; (cc)
1	15, formerly
1	iii, an
1	governmentsparticularly those
17	paragraph and
1	voluntary nature
1	(4) basis
1	
 692.
1	intervals so
1	(3) scope
1	352(f)(1), 355,
1	wholesome, fit
1	duties. while
1	maximum fine
1	territorial exemption
1	budget recommendations
1	beverages. 
2	(b) advisory
1	(bb) signs
1	appropriate, adequate
1	administrator, within
1	understanding by
3	dispenser transfers
1	section can,
2	otherwise been
1	recipient state
1	revision the
1	section 679a
1	c-licensed partner
2	thereof, be
1	special registration;
1	secretaries, permit
1	codex alimenterius[2]
1	community based,
1	25, 1985,
2	sponsor the
1	(b) time
4	deputy directors
1	subsection[1] commence
13	subsection (a)(1),
1	5 u.s.c.
6	subsection (a)(1).
3	additive, the
1	proposed state
1	(b) relating
1	ethical, and
1	application, review,
1	subsection meets
1	action directed
5	360(j) of
1	(k)(3) will
2	404 of
1	analytical techniques,
2	reasonably expected
1	specific data
2	optical isomer
1	applies 
15	guidance under
3	emergency declaration
16	without the
1	databases. 
1	method the
1	safety, recommend
1	interagency relationships,
1	senate. (c)
1	communication strategies
2	single day
1	section 360eee(9)(a)
1	applicants knowledge
1	configuration) combined
1	authorized thir-party
1	purchaser to
1	name designated
1	(including creative
1	(q) reusable
1	analysis based
3	disease and
1	
 355b.
9	intelligence, and
1	misbranded 
16	medical evaluation
1	(b) shows
1	additional clinical
3	fee program
1	(d) definitionsas
1	appropriate validated
20	interested persons
7	member shall
1	
 1705.
1	court, regardless
1	members, acting
1	(38) piritramide.
1	31. (g)
2	plan will
2	approved, evaluated
4	forfeited property
1	invest, and
1	illegal importation,
1	$30,000,000 or
2	tangible things
1	supplement whose
13	study of
1	advertisements regarding
3	business to
1	without good
1	below.
 

1	methodology. 
1	service personnel.
2	(2)(a)(vii), the
1	programsthe provisions
1	(4) mission
1	evidence (obtained
1	drug tested;
1	(including children
1	chapter (and
3	exportation for
1	employees; (10)
1	shall remit
4	radiation was
1	view of
1	dispenser shall,
1	feasible or
1	final medical
1	following applies,
1	transfer funds
1	will only
7	programs to
1	purposes, on
1	intentionally modified
1	provide. 
1	dispense, conduct
1	(b)(1)(a)(ii) or
1	rules shall
5	laboratory accreditation
12	within 180
1	validates the
1	document that,
1	advertising under
6	information; and
3	register criteria
1	first. (b)
2	(ii) adequate
1	adulterated fooda
1	advisories issued
2	seeking premarket
2	last assessment
1	experience means
1	emergency pursuant
2	qualifying physician,
4	study described
20	bodily injury
11	available data
3	states desiring
2	(4) relation
3	weighted average
4	section 381(a)
1	certificate no
1	single application,
4	shall act
1	monograph; (c)
2	compliance office
1	dairy and
1	administrations communication
1	practice compliance
1	infrasonic, or
1	surveys of
3	establish in
1	new authorities,
1	container no
1	assistance; advisory
3	u.s.c. 262];
1	term institution
1	operation at
1	sales, transfers,
3	claimant may
3	said article
1	agent. such
2	compact under
1	oxide, analgesia.
1	(iii) nothing
1	request if,
2	illness outbreaks.
1	proposed different
1	listing. 
1	individuals. if
1	ruleevery person
1	law, furnish
1	trade, delivery,
1	(2) requirementsthe
2	drugs (including
2	heroin; (ii)
13	issue such
1	(b) types
1	foo-related hazards,
22	ingredients of
14	studies are
2	available a
2	extent appropriate,
2	illicit narcotics
14	date and
1	section 455
1	packer; marking
2	agencies responsible
2	appropriate members
1	(e), each
3	list established
1	residues (a)
16	ingredients or
2	full range
2	toward correcting
2	date any
2	one month
2	facilities the
1	store, the
3	refusing or
4	824(c) of
1	terminated, a
6	date as
1	
 321.
1	record with
1	contractual right
1	burden illicit
1	rating period,
1	administrator would
18	(c) provide
1	voucher awarded
1	proposed regulated
1	commissioner about
1	(a)(3) on
1	
 355f.
1	another grant
1	persons employed
1	(a)(3) of
1	(l) transitional
9	date an
3	beginning 3
1	360nn(f) of
1	u.s.c. 1333]
1	brief application
2	expenses to
1	produce dependence
1	notifications related
1	seq.] nonfat
1	schedule i(c)
1	beginning 1
21	increase the
1	sponsor, may,
1	(3) amateur
2	300.0 
1	include preclinical
1	schedule unless
1	average, as
2	competitive service
1	found adulterated,
1	refuse approval
2	term tropical
7	preservation of
1	379g of
1	(including production
1	crime associated
1	commissioner 
1	panel (referred
1	action. (june
1	(d) cosmetics
6	pediatric population
6	animal food
1	1043. rules
1	ancillary services.
1	outstanding facility
1	supplemental grants
1	compromise an
8	drug shortages
13	bears a
2	substances pursuant
2	eggs with
1	
 399f.
1	1048 of
1	675, 601,
1	person knowledgeable
1	hearing; withholding
2	product packed
1	without notice
1	effect paragraph
2	producers of
1	writing regarding
1	(3) person
1	educational agencies,
1	(iv) recruitment
1	paragraph (1)(g)(iv),
69	interstate commerce
1	amounts are
1	coverageno person
2	adjustment calculation
1	rent, use,
1	retarding, or
5	hydroxybutyric acid
2	exceed $15,000
1	notification pursuant
3	process any
1	device, but
2	collection during
1	subsection (c)(2)(a)(i))
1	facilities, traceability
2	care facilities
1	supply sold
1	$280,587,000 multiplied
1	interstate traffic
3	occur naturally,
1	lawfully used
2	summary under
1	report (and
2	trafficker publicly
1	indicates the
2	one species,
3	drug shortage.
29	products shall
1	determined de
2	least 180
1	feed, if
1	seafood facilities
1	particular matter
1	(p) estrogenic
2	drug shortage;
1	section. facilities
1	took actions
1	use; (d)
8	poultry inspection
2	delegated below
1	including differences
11	information available
2	inspect eggs
1	animals. (3)
1	neonatology expertise
1	2202 of
3	excluding allowable
1	indicate in
7	transported, or
1	list unless
1	forces coordinate
1	occurs. 
1	enforcement policy
2	3502(2) of
1	use review
6	within that
1	advertising. (g)
2	experts as
1	
 873.
1	dividing the
1	economic productivity.
1	subsection (c)(2)(b),
1	dihydrocodeine. (5)
1	(f) exemption
3	disposal is
9	certification that
2	because, with
1	spontaneous disintegration
5	use of,
1	360hh of
1	ballot initiative,
3	paragraph (8),
1	additional potential
14	transfer of
1	(e) consultation
1	drug/device, biologic/device,
11	drugs (a)
3	product or,
1	reasons; (j)
2	hard copy;
4	f.r. 2421,54
2	preceding sentences.
1	innovation act.
1	required; (ii)
1	person more
1	alimentarius commission.
1	listing have
1	warning statements
2	u.s.c. 2603];
1	subsection, which
3	360b(b) of
3	mortem inspection
3	written description
3	compromise the
2	1260; renumbered
1	modify elements
4	(2) contentsthe
2	body found
3	food, cosmetic,
1	benefit. (2)
1	warrants for
1	whose responsibilities
1	521, as
1	term standardized
1	administration; (ix)
1	giving a
19	shall set
1	area, submit
1	practitioners federal
1	(1) exemptiona
1	(xii) validation
1	214[1] of
18	whenever he
1	electing and
1	information both
1	
 203.
1	completed and,
6	effect pursuant
1	services administration);
1	litigation or
1	margarine unless
1	assistance. (5)
2	writing, and
2	sufficiency of
1	i, for
1	names for
1	privacy protections
1	keep confidential.
1	(vi) -[-(-morpholinyl)ethyl--(-naphthoyl)indole
1	license any
1	subsection (a)(2)(a).
1	standard review
3	subsection (a)(2)(a),
1	do. the
1	1357, 2,
1	narcotic or
1	drugs (as
1	communication materials
1	954, and
3	collective average
1	litigation on
1	authority. (b)
1	(16) shall
1	1, 70
1	product definedfor
1	information, other
2	memorandum shall
1	periodically revise
1	gases a
1	establishment hereinbefore
1	among all
5	advertisement to
1	employer, the
1	animal modeling
2	food; (8)
31	inspection under
1	certain therapeutic
1	property; (ii)
4	shall place
1	350d(a)(4)1 of
1	require, make
1	bar on
2	withdrawal, obtain
3	sale) the
1	entitled guidance
3	injury, including
1	transported on
3	businesses and
1	declining such
1	tracing recordkeeping
6	term adjustment
2	officers, agents,
2	ability and
9	bear the
1	formerly 359,
2	eggs of
1	substantially meets
20	amount not
1	poppy, and
1	pesticides used
1	establish categories
2	slaughtered separately
4	kilograms of
3	assistance act
1	seek a
1	transported or
6	notification from
2	purposes. the
1	fundsan eligible
1	(c) third
1	
 134
1	fee pursuant
1	electronic gateway
1	required data
1	2000; (4)
1	thereafter,,[1] the
1	retract or
1	thereto) to
1	sterilized seed
1	review, shall
1	processed when
1	(6)[1] of
12	designated new
1	scientist shall
1	individuals conviction
1	demonstrations, or
1	u.s.c. 351
1	qualified medical,
1	871. attorney
1	pay, awards,
1	charitable contributions
3	applicant required
1	(iii)(i); or
1	existing additive,
1	provisions; marking
1	agency personnel
1	potential elements
1	subchapter with
1	(11), there
2	act), and
30	purchase, or
2	prior calendar
1	days, commenced
9	shall refund
1	title, information
10	made, and
1	stakeholders. (b)
1	diverse working
12	drug administration;
1	accredits, or
1	patient engagement
1	(c)(2)(c) shall
3	served with
6	united states),
1	imaging; (b)
31	follows: 
69	drug administration,
1	authorities conferred
43	drug administration.
1	ris-benefit analysis;
4	valid marketing
1	30, 1977,
1	united states).
2	term antimicrobial
1	paper) shall
1	may disqualify
1	shall govern
1	applicable, that
1	(d) noncompliance
1	efficiency, and
2	year 1997,
1	administer prescription
1	360bb. designation
1	yolks, moldy
3	burden interstate
1	immediate supplier.
2	beginning 30
1	require nominees
1	901, as
1	facie evidence
2	person applying
1	panel that
1	territory any
1	municipality thereof
2	person charged
4	criminal case
10	drug administrations
5	complete the
1	misbranded. (l)
1	agencies, schools,
2	(2)(a)(iv) shall
1	region, or
2	periodic basis
1	including who
6	bearing any
1	association) if
1	involved. in
1	temporarily unavailable
2	specifications for
2	supplemental rules
1	360c, as
1	patients ability
1	
 200
1	recurrence of
16	state may
1	advertised drug
1	paragraphs (g)
3	fellowship, memorandum
2	level, the
1	sid-effects for
1	moreover, if
1	administration (such
1	drugs) on
1	(ii) measurable
1	short period
1	charitable distribution
2	notify such
1	membersthe secretary
2	secretary and,
2	transporting, distribution,
2	clause, an
1	animals caused
1	settingthe secretary
1	(c), an
5	certification and
1	date, whether
1	22, 2009
1	sections; (f)
1	extramural grants
4	subsection (c)(1).
7	felony violation
3	package. 
6	25 employees
2	afforded an
1	order theretofore
1	territory shall
3	chapter, specifically
1	requested, and
1	applicable, are
4	(c), as
1	educational purposes
1	pending human
2	states, districts,
1	(1) amount
1	carcasses to
1	
 1801
4	toxic substances
4	(c) are
2	patient. the
1	c (a)
1	fda. 
16	program agencies
1	(iu) 250.0
1	animal fat
1	marketing agreement
10	paragraph to
1	ongoing, and
1	(d) agency
1	assessmentsif a
2	ingredient which
2	applicant can
9	patients and
8	strategy and
1	correct and
1	centers; and
1	transparent decisionmaking;
1	may implead
1	(2) expressing
2	(through classroom
1	obstacles. (c)
1	expertise for
11	resources to
2	poison label
1	drug. an
1	foo-producing minor
1	outcome measures,
1	registered foreign
1	ris-based information
7	acts for
2	correct any
1	dispose of,
1	21, 1971;
1	separate violation.
1	(4) nothing
2	practitioner (as
2	transaction, transportation
1	353a. pharmacy
4	processing operations
1	also take
1	responsible use
2	investigations. 
1	(b) listing
1	
 353c.
1	commission pursuant
1	services into
1	carcasses (if
1	shortage 
1	postapproval requirement
1	355(j) when
1	training (through
42	adverse health
1	claimant files
2	responsibilities relating
1	(iii) necessitates
1	section 360i(g)
1	generala declaration
1	(ii) congress;
1	chemistry of
1	operations that
44	political subdivision
1	general. (6)
2	term inspection
1	(ii) where
1	pharmacy, hospital,
1	additive, to
1	perspectives of
1	involving combination
1	(10) although
1	authorizationthe secretary,
1	medical purpose.
1	traffickers in
2	title finds,
3	review upon
1	activities threaten
1	written verification
1	subclauses (i),
1	(2) cooperate
1	
 876.
1	350j(c) of
1	imports has
1	pcp, methamphetamine,
1	characteristics are
1	(g)(2); (b)
1	(8) even
1	mark, tag,
1	regarding pharmaceuticals
1	month. for
3	substantial importance
2	approved such
2	modification to
1	(d) assure
2	affected nothing
67	protection of
4	knowledge which
1	(1) conduct
2	dismiss in
1	registrant subject
21	shall prepare
2	failure or
2	possessed, used,
1	and, based
1	biomedical etiology
1	(d) exclusionssuch
1	20 (commonly
1	(a) provision
2	(3) inclusion
1	(c) contentsthe
2	hereinafter provided;
1	license which
1	draft guidance,
1	states. subpoenas
46	authority to
5	ii may
3	participation and
2	drug activities.
10	except the
1	extent necessary,
1	prescription; dextromethorphan;
2	effectuate its
2	coalitions that
1	ii pharmaceutical
1	safety ris-benefit
3	individual for
1	expedited clearance
3	year pursuant
1	division. 
1	substances signed
3	place under
8	applications 
1	communication systems
2	unrevoked license
1	august 2,
1	vanilla, coconut,
1	prosecution by
57	state and
1	barium, chromium,
5	(4) offset
1	radar imaging;
1	involved, (b)
2	reduction; and
2	similar effect
1	exhaust administrative
12	assessed a
1	division director),
4	decision in
1	activities could
1	381. imports
7	criteria specified
1	structuring the
1	concentration provides
1	director believes
1	generalin carrying
3	safety studies
7	year 2016,
1	agriculture, promptly
1	year 2016.
1	section 290aa(d)(16)
37	mixture or
4	drug. (f)
1	determining, from
1	applied 
1	(4) continue
1	due once
5	individuals in
1	(or appropriate
3	device contained
2	regulatory science
3	improvements in
1	attempted transfer
1	change, such
2	phenylpropanolamine each
1	issues; and
1	year makes
1	request, within
3	review each
3	priorities for
1	treasury in
2	inspect in
1	mandatory performance
1	consumer containing
1	(iii) facilitates
1	adopt other
7	access by
1	expedited procedure
1	675, 904,
1	person. (2)
1	isomers. (f)
4	31. 
1	corporation, whose
3	stat. 833.)

4	administered to
2	diverted, subpotent,
1	(d) which
2	matter as
4	12, eff.
1	specified. (g)
1	1984; and
2	tolerance to
2	pilot or
1	applies not
2	(or supplement)
1	(ii) criteria
2	article, of
1	eligible controlled
1	1.04, such
1	reasonable period,
10	vegetables that
2	sample to
1	teenage and
1	convention, control
1	evidence, taken
1	insert for
1	(iv) listing
1	take or
1	within his
2	becoming a
3	eggs which
1	except advertisements
1	2223[1] of
1	337a. extraterritorial
1	(iii) having
1	(iii) recognizing
1	form) that
1	criteria, and
23	forfeiture under
1	departments in
1	required; maximum
1	narcotics leadership
1	arrangements responsive
1	whether action
1	general state
2	prepare the
2	safety training,
1	register announcing
1	860. distribution
1	repackager notified
1	exemption were
1	360ccc. conditional
1	generalthe interdiction
1	hundred points
9	reflect the
9	due, such
1	successor regulation)),
39	(b) to
1	(2) generic
3	accuracy of
1	510, as
1	successor regulation));
1	(4) remote
2	verifying that
1	him, the
2	ingredients, additives,
2	mechanism of
11	approval, licensure,
2	state coordinators
1	apparatus intended
2	regarding product
1	analysis. those
1	dating 
1	otherwise altering
1	establishment upon
1	manufacturers product
1	section, funds
1	product cannot
5	regarding drug
2	committee; and
1	followin-described substances,
1	criminal and
1	terminated in
1	acquiring or
1	additional staff
1	unless before
1	holder that,
1	(4) harm
2	contact regarding
3	location consisting
1	base sold
2	eliminate illicit
1	reimbursement mechanism.
1	submission. (e)
1	shortages described
9	labeled for
19	otherwise be
3	subsection. any
1	year 2003;
1	requirements, for
8	higher than
1	(h). (iii)
8	time a
6	clinical investigation,
4	documents shall
1	immediately prohibit
2	protocol, (ii)
1	1, 1995,
1	laboratory the
1	360ccc2, 374,
6	may, for
1	mandatory conditions;
4	with, or
1	seizure (a)
1	applicants agreement
1	animal for
1	year. funds
1	distribute alcohol;
1	(ii) regularly
1	section 419(5)
1	affiliates of
3	testing (on
2	sponsor. (h)
2	designated; or
1	anticipated not
2	(a) report
2	2003 (excluding
2	exists, and
1	product (1)
4	supplements, or
2	law as
2	affiliate or
1	programs, especially
43	to, or
1	food borne
1	tint or
1	518d of
3	reasons therefor,
1	necessary data,
1	(15) $129,000,000
1	321(p)(2) of
1	manufacturing, storing,
1	both, and
16	september 24,
1	shall supply
1	applicable monograph
4	(2) before
1	bond shall
13	affiliate of
16	(b) with
1	dietary consumption
1	disease outbreaks
1	quantity, or
1	(i) 30
1	controls. (b)
1	(2)(a), but
1	848. continuing
1	measurable metrics
2	section until
4	shall verify
2	humans; (c)
1	subsection the
2	selling of
2	plant or
1	defendants. (b)
2	imposed and
3	information act),
6	diseases. 
1	importations or
4	items in
9	action, the
3	(including, for
1	prior judgment
1	thereof; waiver
6	potential benefits
4	22, 1954,
2	(b), such
1	district selected
1	be, has
2	exist with
3	disclosed under
1	said meat
1	6333(c) of
1	test applied
55	chapter or
1	defining such
3	(a) where
1	ch. 743,
1	(c)(4) or
1	identify weaknesses
1	coalition, or
4	chapter on
1	court; (d)
1	warehouse act
1	red ink.
2	u.s.c. 355)
1	distributed, held,
1	chapter of
1	housing, or
1	affirm, modify,
1	governing bodies
1	hair dyes
14	applications or
1	offender provides
8	campaign. 
1	(f) compensation
1	consul that
1	position in
1	transferee establishes
5	administration modernization
1	previous -month
1	tobacco product)
2	387e(h) of
33	tobacco product,
16	tobacco product.
3	applications of
1	personnel training
1	confirmation by
1	reasonably incurred,
30	 (j)
1	subject; or
1	electron), and
1	welfare, or
1	epidemiology, demographics,
4	causes the
3	projects, or
1	675, 565,
8	scientific data
4	test or
16	38 stat.
1	consignee in
6	bearing on
8	person against
1	knowingly failed
1	financial or
36	bearing or
1	restaurants; access
1	periodically publish
47	salts of
2	term state,
2	disclosed in
1	certification, including,
1	drug treatment,
1	require measurement
1	schedule. 
1	r-exportation, the
1	screens, hashish
1	business under
4	term human
1	stat. 1500.)

2	(i) identifying
134	tobacco products
1	(b) could
1	record so
1	subsection beginning
1	exceptionsit shall
2	disseminated or
1	abuse education,
2	protocols to
1	monograph exists
1	seas), and
26	federal and
1	conduct prohibited
1	advice. with
1	hair dye,
1	(b) rapid
1	zoonotic diseases;
1	bold type
2	regulations making
1	28, 1953,
2	files that
1	previous 1-month
54	chapter shall
1	necessary) the
6	labeling act
4	any) presented
1	app.) and
1	title regarding
1	diseases. (r)
2	disease means
2	declaration, or
1	cigars, including
5	substance 
2	articles. 
1	orphan asylums,
1	seizure pursuant
1	(25) hydroxypethidine.
2	contracted for
1	ignatia, lobelia,
1	c (ascorbic
1	(viii) 5
1	
 113.
1	sources; and
3	material used
1	(1), notice
3	order, on
1	equivalents engaged
6	issued after
2	paragraph in
2	related responsibilities
3	device solely
4	paragraph is
1	trial sponsors,
1	treat that
12	order, or
1	
 1134
1	(2) specify
1	application, during
1	
 1131
2	responsive to
1	nonconcurrence with
1	registration registration
1	1709. repealed.
2	applied nutrition
1	increase of
1	(b)(2)(a): 
1	3101 note)
1	if, 31
1	professional employees
2	reason unsound,
1	programs at
29	final regulation
1	be, until
9	assessed in
4	administration (a)
2	subpopulation for
1	556(d) of
2	devices, upon
1	assessed if
1	restrictions for
1	taken reasonable
1	1988. (ii)
1	(7) significant
1	implementing strategies
1	interest was
1	use generic
1	kind for
1	may participate
2	held liable
2	40 years
3	distributing of
1	persons eligible
1	import tolerances
2	term health
1	remains with
1	products (including
3	(2) duties
1	parental obligation
1	subsection. (6)
1	20 miles
1	additive, in
1	time, but
1	psychiatry, and
1	wildlife, or
1	part 601
3	additive, if
1	may 16,
1	1974. 
1	covered by,
7	holding, or
1	evidence the
1	(e) construction
42	year, the
1	chemical as
3	border protection,
2	(including through
1	psilocyn. (17)
1	additive, it
11	ingredient of
18	records and
1	detail or
1	store and,
13	(d) if
1	rural coalition
1	residue resulting
3	applicants or
9	(d) in
1	diseasesany person,
7	(d) is
6	antifungal drug
2	section 360(h)
3	scheduling the
1	explain or
2	state is
1	security, to
1	product, (b)
26	resources allocated
3	product, device,
2	day so
1	(c)(2), including
1	1605 or
3	dealing in
20	serious risk
1	process, grant
8	conditions whereby
1	link with
2	event is
1	management responsibility
1	formulary committee,
1	phenylacetic acid,
1	section,[1] any
3	encoded with
3	subchapter. the
4	1605 of
1	event in
1	individuals knowledge,
1	successes of
4	agreement regarding
1	regularly participate
3	334 of
3	claim for
1	(i). (x)
1	joint food
1	retail establishments,
1	section; (ii)
1	bacterial otitis
1	facility inspection
1	industry not
6	pediatric age
4	affording opportunity
3	causing such
1	$7,429,000 for
1	establish regional
1	pasteurizing, stabilizing,
1	appropriate, regarding
1	review could
3	registered in
10	maintained by
6	validity and
1	islands are
3	360e, or
2	1997 or
12	elements to
1	period it
2	establishing fee
1	quantitatively each
1	term regenerative
1	removed. 
1	coordinated drug
1	subparagraph (a)(i).
1	facility cannot
1	subparagraph (a)(i))
1	714b(h)); (c)
1	age, biological,
1	facilities applicable;
1	audit a
1	reason; (iv)
4	professionals who
3	given reasonable
3	declaration that
2	qualifications for
2	termination is
1	343(c) of
1	42, no
1	administration guidance
4	identifier the
1	securing funding
2	state if
1	(f) advisory
8	subchapter to
1	(a) suspend
31	adulterated under
1	(3) conduct
1	receive access
2	employee thereof,
1	parents would
1	identifier systems
1	initiates such
1	27, 2007),
1	contact intact
1	1, 2015
1	assessments completed
1	3561. accelerated
1	straw means
1	study commitments
1	product (but
1	approval entitled
1	interchangeable with
7	360f of
1	section 824(a)
1	disaster relief.
1	published regarding
13	submitted pursuant
1	violators, but
1	apply economic
1	testing during
4	identifier. 
7	promulgating the
7	investigations were
6	availability 
1	(b) transfer
1	meetings. (7)
1	program equal
1	comparator month
1	radiation intended
1	1-year period
11	exclusivity for
7	exchange, or
35	may request
1	purpose. (

1	rule 4(i)(1)
1	administration; (b)
1	governmental entity.
1	interior shall
2	(c) consideration
7	petitioner shall
1	471. safe
3	secretary, as
7	secretary, at
3	deemed and
1	carbon dioxide
3	subchapter, subchapter
1	structured ris-benefit
2	exception any
1	made (a)
1	(i) acceptance
3	violations under
7	sections 355a
1	2017, such
3	development, review,
1	experts (including
1	requirement; training
3	granted a
2	applied on
1	importation. 
1	enterprises (including
1	authorization are
6	prominently placed
1	$100,000,000 shall
1	practicing in
1	policies as
25	standards and
1	registered, deliver
1	379d. automation
2	records constitute
1	secretary last
1	(a) property
1	product.) 
3	recommendation, if
1	court so
1	upon thir-party
1	(including paper
1	nonenforcement; designation
5	(or in
1	person sells
1	467f. federal
5	base amount
1	information charging
3	not, under
1	committee) which
3	necessary, on
1	medical specialty;
1	including factories,
1	accomplices in
1	gift, devise,
2	obtained upon
1	originates from
12	extended by
1	dates subsection
2	paid all
5	(i) each
7	intentionally 
1	(ii) infected
1	term component
1	disease. (b)
1	comprehensive statement
1	fee obligationa
1	(3) schedule
2	consulted under
1	release material,
6	employment or
1	appropriate) deemed
1	eating places,
10	including information
1	staff resources
1	discloses the
4	employment of
1	proceedings) and
1	practitioner. this
1	grade a
1	6 fiscal
2	taking action
1	(3) maximum
4	help to
1	folic acid
2	magistrate judge,
1	program, such
2	predicted effect
2	necessary information
1	approval may,
5	material fact.
1	material fact,
1	advisory assistance,
1	manifest or
2	operation. the
1	employees, fellows,
5	material fact;
1	material fact:
1	covered entityin
1	1536. communit-based
8	device, drug,
1	youth, women,
1	review required
1	360bbb3a. emergency
1	biennial reportson
1	282(j) of
1	experts the
1	drug activity,
1	companion animal
1	seller for
1	(i) because
26	(a) may
1	program, system,
2	assisting the
1	include nutritional
1	actual adverse
3	devices solely
1	devices. (ii)
1	available technology
1	prescription; (c)
1	government, may
2	including allowing
1	sellers of
1	1296), and
1	find appropriate.
4	assist a
2	civilly or
1	public upon
7	subparagraph or
2	clinical protocols
2	market at
1	(a) help
13	dispose of
1	(c) include
1	large quantities
1	invalid, or
1	sections 2202
2	institution programs
3	(b) only
1	2012 
3	products produced
2	387i, or
3	material facts
1	subsequent transferee
1	subchapter; 
1	packages bearing
1	plus (ii)
2	information listed
2	victims of
1	protein (gm)
1	including marijuana.
1	requirements during
1	appropriations requested
1	forms, receipts,
4	required at
4	safety factors
1	receive data
1	1995, the
2	trial shall
1	(15) quarantine
1	drug; contents;
9	federal advisory
5	consultation not
2	may violate
1	provide, by
1	decreasing the
1	governmental authorities;
3	2003, had
1	section 360b(d)(1)
1	designated, the
6	investigation. (b)
1	complaint, information,
1	publication) making
1	done acted
1	chain. (d)
1	states (a)
1	packagethe secretary
1	employed, (d)
1	data is
2	least every
3	activities the
1	facilities) bearing
1	unfinished drugs,
1	new coalitions
3	prominence, the
3	data if
1	slaughtering; name
1	regulation amend
9	prohibited acts
1	(a) grants
1	fundamental sciences
7	data in
1	subchapter, whether
2	convictions to
1	adversely impacts
1	amend, in
1	provisions not
1	imports refused
3	population and
4	devices shall
13	issues of
1	(i) exceed
12	upon any
1	operate from
1	equivalence or
1	-buty--(-naphthoyl)indole (jwh073);
1	period subsequent
1	device substantially
1	flows through
1	members either
1	minimize litigation
1	confectionery by
3	grounds exist
4	personnel. 
2	(3), any
3	inspection frequency
4	requirements, in
1	(c) strike
2	outsourcing facilities.
14	including through
1	pathogens) or
3	(1) safety
1	areas 
1	(5) petition
1	section 802(54)(e)
1	location that
3	tolerance; or
1	materials that
1	provide directly,
1	evaluation with
2	conviction if
1	including farms
4	agencies or
1	education; and
1	conviction in
1	(jwh018 and
1	administrationbecause of
1	organizations specified
1	transaction, including
1	third request
1	enforcement agent.
2	plant where
12	another person
3	health, to
1	contacted. (4)
1	title1 or
3	education assistance
1	16(b) of
1	minimum it
1	has, within
1	(a) outreach,
3	print, lithograph,
1	international crime
1	foregoing, or
2	respecting safety
3	distributed 
1	secretary, selecting
2	container, or
3	387i, 387j,
1	extensions requested
1	used. the
1	hectares of
1	maximize the
1	safety, he
1	(8) label
3	affix or
1	leaf tobacco
1	paid, an
1	particular focus
1	paid, as
1	(1) new
1	compendium. (e)
1	states warehouse
1	(3) opium
1	title report
4	prescribe regulations
1	expedited, or
9	regulation. 
1	(3) after
1	acts occurred.
1	1, 1948,
3	45 degrees
6	states olympic
1	detecting at
1	manufacturing process.
1	shall intensify
1	
 822a.
1	section 102(a)
5	section from
1	retain all
1	year 2009),
1	(c) expedited
2	supplement, shall
1	section 360c(a)(3)(b)
5	proper. the
1	penalties, or
1	(19) state;
7	medical and
1	1058; 

3	pharmacy is
1	u.s.c. 136w(d)]
1	(b) regulationsnot
3	data (including
1	purposes at
1	import permit,
1	authorizes a
1	address if
1	unaffected; responsible
1	person aggrieved
10	standard recognized
6	address in
1	
 605.
1	14 individuals,
1	routine maintenance
7	type required
1	reviewable. (june
51	reasonable assurance
3	eggs by
1	may harbor
1	paragraph (6)(b),
3	(a)(1), the
15	two or
1	faxed, or
2	importer means
1	award the
1	(a) $97,722,301
57	quantity of
1	submit or
9	appropriate advisory
1	submit on
3	two of
3	estrogen or
2	subsequent offense,
5	quantity or
1	prohibition; compliance
2	persuade, induce,
1	(q) certifications
1	therapy (as
1	request. (b)
1	prevention strategies
1	(12) bongs;
1	accredit a
1	imitation or
1	personal slaughtering
1	parties, to
7	define the
2	security, in
3	1988, the
1	practice within
15	similar to
1	receive regulatory
4	imitation of
1	claimant, to
3	warrant and
2	vendor of
1	crime to
1	administration (including
3	march 1
1	manufacturers; (vi)
6	deviation from
1	compound not
1	receiving reimbursement
1	order reporting)
1	chillums; (12)
1	political purposes,
1	justified, or
1	chloride. (d)
1	withdrawn, shall,
1	ghb, including
5	food, food
20	definitionsfor purposes
1	problem; (3)
1	subsequent offensea
1	label, distribute,
2	regulation relating
1	farm; (c)
1	(a) bearing
3	average of
2	titled regulations
1	sites, as
1	coordinate educational
1	proof by
1	division director
1	(1). (d)
13	ch. 373,
9	42; and
4	establishments (a)
1	preempted if
5	acts amendatory
3	meeting is
13	(4) if
1	(including members
2	necessary. (b)
1	generalupon application
1	industry trade
1	subsection (e)(7),
2	evaluation carried
4	only. 
1	drug, that
6	respect to,
3	widely recognized
1	receives information
1	misconduct. 
2	provision shall
29	(c) for
1	otherwise disposing
1	believes similar
6	plan described
8	food, if
1	physician, on
1	1996, issue
1	enhancement grants
1	information conveyed
1	354. veterinary
3	children, and
2	shall review,
1	chapter: and
1	particular, the
1	compel their
2	action. (ii)
1	field office
1	importers, packers,
4	value to
1	materials, ingredients,
1	violation shall,
2	paragraph (n)
1	care facilities,
1	growing on,
2	delegated. 
33	found to
32	changes to
1	previously disclosed
1	(10) progress
3	promote deception
2	secretary over
1	completeness, coding,
1	title. an
2	youth, which,
1	operates, directly
1	(b) facilitating
5	eligibility determination
2	work performed
6	secretary, with
1	amount exceeding
1	
 614.
2	keep confidential
1	to, inter
1	initial importation,
1	preparedness goals;
1	2007, for
1	granted only
1	(g) 1000
1	neuroscientific advances;
1	differ based
1	website: 
2	made public,
13	entities to
4	drug. if
1	industry guidance
7	appropriate credentials
3	act and
2	brand name,
1	international organization,
1	approval), the
6	report developed
1	misleading without
2	who, to
6	age group;
3	therefor by
1	egg, fish
2	domestic facilities,
2	shall notify,
1	practitioner, the
2	created the
2	servant or
2	person, will
1	abstract of
1	information, certified
1	continued availability
1	(4) sell,
1	phenomorphan. (37)
1	2672 of
1	drugs, taking
2	heroin or
1	including gamma
2	distributed such
3	information; (ii)
1	(g) written
1	judgment governed
1	(c)(iv) not
1	appropriated as
2	made shall
1	states. (j)
1	distributed, if
4	drug (such
2	courts the
1	360bbb4a. priority
3	without reimbursement
1	(ii), paragraph
1	chemical control
1	study reports.
10	priority to
2	rendering conducted
2	thereafter, but
2	wide variety
3	immediately after
56	drug abuse
4	section 661
5	facility, or
1	826a. attorney
1	foreseeable crisis
1	chapter, cooperate
2	property seized
1	quantity dispensed
4	(excluding farms
1	55; aug.
1	initiated, if
3	homepage of
8	devices to
7	credentials and
1	strategy; 
3	(c) unless
3	human beings
5	recommendation with
3	actions, such
1	
 1040.
1	professional or
1	patients of
1	avoid unnecessary
1	10), the
4	-year exclusivity
1	membership 
1	11 of
5	advocacy groups
1	(1)(e) the
1	per year,
1	food supply,
1	(g) presidential
1	142; regulations;
1	allow such
1	cultural activities.
3	material false
1	cosmetic provisions;
1	associated registrationsif
1	675, 562,
2	provision requiring
1	innovative and
1	(b) adding
1	paragraph (2)(a)(ii)
3	(iii) records
1	exclude from
1	generalas promptly
10	circumstances described
1	data reviewed;
1	requests issued,
1	programs. (i)
1	(ii) both
4	(r) the
5	secretary, such
3	(a) one;
1	public interest;
1	unit for
1	amendatory of,
1	benefit, and,
1	appropriate relating
1	 pursuant
1	amounts allocated
2	testimony, as
1	fashion; and
1	limit, modify,
1	member, receive
2	otherwise unable
22	552 of
54	regulation under
1	required, and
1	restrictions adopted
1	(in which
1	papers or
1	processing such
1	paragraph, presubmissions
1	en-product quality
1	standard. a
13	identity, strength,
1	decision that
1	1542. duties
2	reported $100,000,000
1	health; (ii)
3	552 or
5	expenses account
1	states, be
2	individual 
5	person knowingly
2	recommendations required
1	systems, to
2	addendum to
1	prescribing or
1	number; (ii)
1	matters considered
1	subsection; (3)
1	additional options.
1	spaces during
1	limit potential
1	policies by
4	clause (1)
1	review, unless
5	proprietary name
4	resides, by
3	iv, unless
1	continued compliance
2	acid (including
1	403, as
1	(d)(2) during
1	successful law
8	sold by
7	discretion to
1	community to
23	terms and
1	action. (iv)
5	apply in
1	person. subsection
3	food; (c)
1	without permit
2	(and all
5	satisfactory to
2	amend such
1	secretary variances
1	capacity (a)
1	exporting eggs
3	certificate provided
1	completeness, and
12	accreditation of
2	1050 of
13	preceding the
2	taking such
1	(riboflavin) (g)
1	justified by
1	training, data
22	standard for
1	subchapter. (g)
13	methods to
1	harvest those
6	violates any
3	food; (ii)
1	formula required
1	(3)(c), the
1	methamphetamine, and
1	subdivision applicable
2	implemented by
1	children including,
58	manner as
1	biomarker 
1	675, 310,
1	semiannual basis,
3	consignee within
1	(c) activities
1	seq.] regarding
1	involving any
1	discovery prior
1	(2) process
1	granting a
1	retailer from
2	agency (i)
1	(e) prohibited
1	clause[2] (i),
1	representation for
1	control agencies,
2	steam or
2	counterclaim under
1	rent, lease,
2	registration requirements
20	constitute a
1	642. recordkeeping
1	annual report.
2	security shall,
2	per adult
1	labeled, distributed,
1	whenever possible,
1	report are
1	secretary, matchbooks
1	section 360hh
16	licensed under
3	center with
1	 inositol
1	1057; aug.
4	annually submit
1	health. regulations
2	joint or
1	phenylpropanolamine during
1	household, guest,
8	sponsor to
1	(f) recommendations
1	introduced for
7	manufactures, processes,
1	secretary. (g)
1	ongoing safety
2	underage tobacco
1	devices (in
2	subsection, further
1	wholesale distribution;
10	(d) shall
1	(2) operating
8	state, the
3	schedule determined
1	evidence) relevant
1	practicable degree
2	drug. nothing
7	database shall
2	prescriptions, or
1	substances nor
1	previous distribution
1	may add
1	devices; 
1	section 314.70
2	exporter that
18	grase and
2	pays a
7	inspections conducted
1	secretary amends
1	403, and
1	311, as
1	recognized worldwide
8	licensed as
1	directly purchased
3	dentistry, or
1	advertising described
1	facts developed
1	individual without
3	(3) nothing
3	entity certified
6	2012, and
1	23, formerly
1	producers capacity
2	health issues
5	safe meat
1	products wherever
1	register (61
2	impose undue
2	2012, any
3	wholly within
1	adulterationan infant
3	section, imposition
1	pediatric epidemiology;
1	(for imports)
1	petition, including
11	facility or
1	(rr) 
1	(a) corporations
2	item means
3	of, criminal
1	participating under
1	account, which
5	chemical residue.
1	standard applicable
10	applications submitted
7	manufacturing a
1	brought to
5	facility of
4	subsection. (2)
4	organization of
1	reporting information
2	facility on
3	direct or
1	findings eggs
1	(a)(1) available
3	reports or
16	(c) an
1	official) with
1	substance. as
1	reusable medical
1	date has
2	discontinuance was
2	18. (b)
1	grows tobacco
1	arguments if
35	reports of
29	needed to
1	(e)(1)(c) shall
12	price index
2	persuades, induces,
1	(a) more
9	reports on
1	physical, mental,
1	funds authorized
1	manufacturer seeks
1	knowing importation
8	scientific or
4	387h, 387i,
1	(i) importation
3	territorial, or
1	(k) written
1	(2) esea
1	imports) during
1	(ii) contractors
2	program; (5)
8	compensation at
4	(3) other
1	regulatory controls
9	petition submitted
10	coordinator shall
1	will need
2	vessels or
60	(a) or
1	subsection (q),
3	subsection (q).
2	health (referred
1	website or
2	(3) designation
1	appointment; vacancies
1	thirt-day period.
1	ingredients; and
1	operations provided
2	provides assurances
12	requirements to
1	testing the
62	(a) of
1	(popularly known
1	packets or
1	consulting center.
7	(a) on
1	action upon
5	and, to
1	relevant conditions
1	v; exceptionsit
4	suspending approval
1	subchapter. (2)
1	(4) (hereinafter
1	plans developed,
1	assessment was
1	ivit shall
1	abuse programs.
1	commercial food
2	protective of
4	appear better
1	360ll(a) of
1	administration protocols
1	duty to
2	radiation. (june
1	maintained separately
1	establishment. in
1	partnership, shall
1	etc., arriving
1	mean that
1	consulting centers
40	promulgate regulations
1	inflicts increasing
1	title 49,
1	star-up costs
54	180 days
3	improved advers-event
5	controlled substances;
1	action indicated
6	funds to
1	(2)(b)(iv), and
1	
 2013.
1	data privacy
1	products. (x)
3	attempts or
3	pay rates,
1	described in[1]
3	market, or
1	sciences to
1	(iii) shall,
1	marijuana,[1] cocaine,
1	act) on
4	pertinent to
1	studies means
1	including nicotine
1	name is
1	675, 569a,
1	framework established
1	requesting any
1	nutrient requirements
2	including children
2	promptly upon
3	action proposed
2	final, is
1	accountants, or
1	identity the
1	effect effective
1	publication, at
1	license provided
1	secretary rejects
1	final regulation.
16	secretary determines,
1	action initiated
2	affiliates. (c)
1	regulations (issued
4	chemical designation:
2	primary purpose
2	withdrawal and
1	provision as
1	(2);[2] 
1	exercises carried
49	importation of
16	definition and
38	result of
1	packaging inserts;
16	substance for
14	duties under
1	response plans
1	rulemaking, or
1	time, require
6	importation or
1	information; (c)
1	fora; and
2	6 nominees
1	(a)(3) for
1	(j). (3)
1	partnerships between
2	retail grocers
1	chapter regarding
1	freebase kits.
1	publications. (4)
1	persons at
4	persons as
1	board. (h)
2	permanently or
2	persons an
1	service; or
3	tobacco the
2	particular uses
1	schedules. (d)
2	drug. (b)
1	repackager transfers
1	like writing,
1	discretion, dispense
1	america 
2	health. (e)
4	public from
1	audit process,
1	satisfaction. (june
1	appropriate fora,
2	use without
1	conclude operations
2	informed 
1	(ii), an
1	558.3(b)(4) of
1	staff510(k) device
1	equivalent, the
1	columbia, to
2	entice, or
58	basis for
1	process a
1	includes public
1	applicant regarding
1	employee, if
1	include discussion
6	examine the
1	least ninety
1	regarding drugs
5	tobacco regulation
1	supplement). 
2	carrier that
14	involving the
1	evidence regarding
1	28. process
3	u.s.c. 951
1	estimated population
4	professional practice;
3	also include
5	lists of
1	proposal shall,
2	applicationsthe secretary
1	(5) financial
10	professional practice.
4	professional practice,
2	shall visit
1	secret. 
6	groups; and
1	law described
2	recognize the
5	42 and
1	eggs. 
1	products specified
6	individuals described
1	campaign, the
2	filled prescription
1	830(a)(3) of
1	(gm) 1.8b
1	classification, the
3	dependence or
4	forth for
1	subsection (b)(2)(a)(iii)
1	reprimand, retaliation,
2	(c), with
5	(e). 
1	dependence of
1	shortage as
1	ongoing criminal
1	heads, or
1	349. bottled
73	generic new
3	pallet, tote,
1	outreach regarding
2	marihuana, except
1	competent jurisdiction
15	adversely affected
1	(1) those
1	regulatory assessment,
1	licensed means
1	350, 1,
3	office for
3	medicine therapy
1	value, or
1	appointment by
12	title. (3)
1	extension the
2	relevant or
1	(7) betacetylmethadol.
1	reindeer the
2	application concerning
1	(2) designations
3	antimicrobial active
5	state meat
1	tracing the
1	fact with
1	1547. staff
1	interdiction strategy
2	permit for
1	
 360bbb2.
1	may restrain
2	regulate official
1	federal agenciesthe
1	sunscreen means
2	reach the
4	deemed guilty
1	(ii) further
2	evidence which
1	trends, or
2	labeling contains
1	(f) strengthen
1	(i) utilize
1	progeny of
5	federal law,
1	subsection (a)(4)(a);
3	federal law.
1	(9)(b) not
1	whenever either
1	years national
1	675, 586c,
1	sentence upon
1	industry; two
1	(13) dextrorphan.
2	subsection (a)(4)(a),
4	federal law;
4	introduced in
1	subsection (d)(1)(b)
1	risk, may
2	(1) establishmentnot
2	2017 (including
1	adjustment act
1	product; (g)
1	marijuana and
1	court, apply
1	retail pharmacy,
5	guidance, or
1	unused singl-use
2	safety reports
1	serious and
7	ingredient under
1	application seeking
1	skin irritation
1	675, 561a,
9	830 of
1	(1), or,
4	(b) otherwise
4	drug submissions
1	assign such
3	recipient to
1	use (for
1	agreed upon,
3	proximate cause
1	legitimate purposes;
1	appropriations used
1	section 262(i)
1	foods. (

4	national methamphetamine
2	reductionthe term
1	perception of
4	office and
1	(c) formatthe
1	abuse; (4)
2	times of
1	timely, and
1	discoveryif a
16	beginning with
1	360c, and
3	practice pharmacy
1	standard. (b)
1	fish is
4	clinical research
1	neighborhoods and
1	current counterdrug
1	usefulness, multiplicity,
1	drug products).
1	consignee is
1	flavorings, or
2	drug submission,
1	
 213.
1	object but
2	gathering the
1	regulate thir-party
1	drug products);
1	tobacco smoke
19	employees, and
1	five schedules
1	docketing and
1	populations under
1	drug submission;
3	practitioner means
14	fair evaluation
7	10 years,
2	requirements, applicable
1	seq.), involving
2	provide grants
1	apply and
1	study regarding
1	warrant. (2)
2	supervisor or
2	section 379dd(l)(2)
1	reports, premarket
1	private instrumentalities
1	dismissed, or
1	applications pursuant
1	supervisor of
1	2023. 
1	cure; (b)
1	inhumane slaughtering
1	interest not
1	ch. 696,
2	auditors 
1	(iii) definition
1	cleared alternatives
2	imported when
2	title 42);
4	may seem
2	may seek
3	general, a
1	information, indictment,
1	violation occurred,
1	manner). (iii)
5	(b); and
1	
 2221.
1	upon controlled
2	national oceanic
1	secs. 2420324207),
1	involvement and
1	960. prohibited
10	title 42),
1	findingfor purposes
1	title 42).
1	mea-inspection law
1	refuse by
1	cooperative programs.
1	often called
2	proposed reclassification
1	thereof conform
1	(iii)amendment of
9	received such
1	assessed. upon
5	conducted on
1	commerce. a
2	publish any
1	supervisors, receives
1	poultry, except
1	2016 exceeds
6	sufficient quantities
1	drugs contained
1	electronic searches
3	sentence for
3	within an
2	(3) notwithstanding
1	determined are
1	packs, unit
20	shall cause
1	section nothing
1	contract between
1	entered are
1	compounding before
1	summoned by
1	notice. (b)
5	subpart; and
8	material to
1	shortage, as
1	director. (b)
1	centers, and
1	interest. (ii)
1	deadline applicable
1	arrives at
6	residue levels
1	(ii) food
4	tax and
3	(h) collection
1	shall be,
6	safe under
1	355f. extension
1	193.)
 

1	(a) delineating
1	denied entry
1	hormone 
1	terrorism, into
8	360c(f)(2) of
1	potentially the
1	experts were
1	675, 569c,
1	out, to
1	883. enforcement
1	(b) based
1	(a) revise
2	methodologies; and
3	notice, the
1	campaigns. (3)
2	date, in
1	135 of
1	time used
1	885; 1940
35	administration for
2	eligible product,
1	period. for
2	identifier that
1	(3) assess
1	initiating pivotal
2	opinion and
3	harm and
2	(b) all
1	qualified countermeasures
1	health records;
7	undue economic
1	(b)(4)(b), (c)(4)(b),
1	infectious or
2	director. 
1	physician 
1	(ii) importation
4	mineral, and
1	
 802.
1	part means
1	declaration with
2	tobacco dependence
1	identifying reportable
4	brought on
1	interdict illicit
1	flow through
1	2223. enhancing
2	order temporarily
1	health organization,
1	type, and
2	veterinarian is
2	minimum sentencing
3	tolerances established
1	notify health
1	purchase by
1	sections, including
1	activities). (14)
1	brought or
1	contributions of
1	reagent kit,
1	countermeasures and
1	programs is
1	academia. such
1	among law
1	notice, after
1	identifying particular
2	needed on
1	1531(a) of
5	subchapter i,
1	(11) shifts
1	treat drug
47	(or any
11	(b) provide
1	(4) enforcement,
7	funded by
1	data fusion,
1	evaluate by
1	(2) access
2	director documents
6	(or, in
1	allegedly violated
1	commodities and
1	pharmacist; unauthorized
2	establishment, notwithstanding
2	(or, if
2	report entitled
2	slaughter, shall
2	misbranding, such
30	responsible party
2	drug, information
1	bioequivalence means
1	therapeutics, and
1	803, as
1	fraud and
3	grant, after
1	(a)(1)(a). (6)
1	agency documentation
2	(c) safety
2	food purports
1	advertising, or,
1	(a) animal
5	lon-term and
1	processing, which
1	training 
1	credit or
1	order direct
1	therein. such
3	otherwise), or
2	discontinuance, the
9	appointed for
1	costs clause
3	showing by
1	355a. pediatric
1	creative themes
1	testing, inspections
1	production quotas;
1	vary by
1	date assigned
1	section 1533(a)(2)
1	turkey, duck,
3	prescribed to
1	preclinical and
1	maintain patient
1	may utilize
2	applicability thereof
2	(d) scope
1	membership, and
1	area for
1	(1)(b). (l)
1	livestock industry
1	paragraph (a)(1)
1	(b) appropriate
1	advance; and
1	(4), select
1	exemption. (d)
1	years, including
2	centimeter exceeds
1	675, 586a,
1	hand; and
1	discovery against
1	contains ingredients
1	damaged, or
1	ophthalmic or
1	project. 
2	350l(a) of
1	subsection (b)(4),
1	government does
1	use, availability,
1	determined based
6	meet such
1	facilitate such
2	subsection (b)(3)(a).
5	filed, the
10	official duties
1	shall analyze
4	approves an
1	355, or
1	services; (ff)
1	years 2013,
2	section 849,
1	list submitted
1	intended; and
97	order to
2	poultry product.
1	$149,000,000 for
1	(l) not
1	veterinarian shall
1	ethnic minorities,
13	4 fiscal
1	currently lawful
2	(b) general
2	practitioner for
14	secretary, permit
9	title because
1	$100 for
4	normal course
1	(ii) allow
1	particular concern
1	loss means
3	measured from
4	examinations, investigations,
2	appropriate under
1	promulgate from
1	states. nothing
1	applicant. (ii)definitions.in
1	seal placed
3	panel of
1	condition. (june
1	exemption; refusal,
18	manner in
1	formerly 360,
3	ready for
1	section. with
2	including evaluating
1	assessment at
1	regulation) shall
4	tobacco. 
2	(a), in
1	706, formerly
1	(a), include
1	interest 
10	panel or
2	cooperation of
4	(a), if
1	(a) post
12	outside of
1	regulation activities),
5	special government
4	penalties) of
1	section 237a(b)(4)
1	review. (i)
1	occur, and
4	residues which
1	liners. (m)
10	facility. 
10	known or
1	publish, on
1	order, license,
1	outbreak response
1	title; (r)
17	patent infringement
1	adul-only facility,
1	known of
4	(2) effect
1	subsection (c)(1)(a)
2	adul-only facility.
14	application the
1	likely or
1	conduct reasonable
1	entire application
1	information product
2	identical to,
1	(1) $10,000,000
1	intended, whether
6	act, the
8	published pursuant
3	monograph system
2	systems of
1	review must
3	supporting methodologies.
7	microorganisms, as
2	committed by
1	academic or
1	treasury on
1	prescriptions under
11	recognized under
1	of, complaints
1	supporting methodologies;
1	trial including
1	remuneration shall
2	individual resulting
3	affirmations, examine
1	conditionall-approved new
1	(1), in
1	initial benchmark
1	complete; and
1	upon fraud
1	minimal and
1	application; substantial
5	(1), if
1	predict lon-term
5	drugs may
4	impose recordkeeping
3	(a); or
2	secretary, before
1	subsequently shipped
1	business. (iv)
6	order made
1	rebuttal and
1	scientific understanding
1	additional margin
11	preceding sentence.
1	accept an
1	(2) task
4	issues such
1	made personally
2	clean, and
3	1 gram
1	
 141.
2	american psychiatric
1	(e) prohibitionsnone
24	60 calendar
1	350c(d) of
1	sale thereof;
1	drugs without
1	12, 38
1	matter listed
1	(ix) safety
1	reviewer with
1	collaboration between
1	assessments (including
1	diethylthiambutene. (16)
4	mailing the
1	desires may,
1	active federal
7	harvesting of
1	requested; or
387	attorney general
1	qualifying pathogens,
1	continued or
1	board for
1	radiation; he
1	
 1545.
1	increased airway
1	monographs of
1	claims against,
29	biological products
1	general, at
2	term knowledge
1	government voluntarily
1	facility fees
7	recommendations not
1	control purposes
1	economic consequences
3	administer, or
1	temporary assistance
2	assistance is
1	residues receive
2	symptoms of
1	disease advocacy
2	basis as
5	employee in
3	21 days
1	section, priority
2	verification beginning
6	employee is
1	(3)(c) or
1	purchaser, when
1	site a
3	determination whether
4	assistance in
1	laws administered
1	supplement requesting
1	effects observed
1	system. (2)
1	prior service
2	shall select
1	facility fee,
1	facility fee.
1	additional meetings,
1	effectiveness submissions
43	conformity with
6	printed, or
2	drug, (ii)
17	biological product,
2	country involved
6	biological product.
2	assessing a
1	submitted. (4)
1	seal any
3	effective regulation
1	appropriate, without
3	october 30,
4	biological product;
1	permanent staff
6	integrity of
2	veterinary professionals;
2	new methods,
2	guide, as
1	applicant upon
1	(1). a
1	586f, as
1	petitions the
6	local jurisdiction
2	revised official
1	bioterrorism. 
1	rule[1] of
4	except a
1	license, instruction,
4	seal of
2	views orally
3	(3) unless
1	clearance not
3	business name
2	secretary. (ii)
1	2011; or
2	(6) may
1	fee beginning
2	recipient has
3	activities means
2	advisory committeethe
4	base in
13	steps to
2	shall occur
2	survey on
2	farms 
1	other, with
1	penalties, by
2	federal district
1	prominence on
4	electronic format.
2	cooperate under
6	unless and
3	circumstances, extent,
1	(b) sites
1	order reviewed;
1	research protocol,
1	include leaders
2	instance has
2	obtain patents
2	unless any
1	request; (2)
1	identified hazards,
2	electronic format;
1	root, cocculus
1	(2); plus
4	committing such
2	supervision a
3	(c) state
3	applicant failed
216	public health
4	subsection (a)(1)(c)
4	343(a)(2) of
2	means information
8	successor regulations)
1	675, 715,
2	distributor license,
1	statement, invoice,
1	(through notice
2	removal shall
1	(b)(2), (c)(2),
1	collaborative, cros-disciplinary
1	natural form
3	european union
3	601(m) of
1	therapeutics and
7	february 1
2	citizens living
2	kind which
1	notified firm
1	1225.)
 

1	intervene as
1	(c)(3) prohibits
2	scientifically appropriate,
1	42 at
1	
 2012.
6	conditions in
5	transaction. 
4	advertising which
3	conditions is
3	pay paid
1	387b(6), 387d,
4	(b) except
1	stockpiling, approval,
4	limited quantities
1	scientifically appropriate;
1	natural resource
1	general population;
1	various content,
2	pertains to
2	public generally.
1	actsany person
1	social council
1	findings by
5	may appoint
1	council established
1	675, 518,
29	administration to
1	proper name,
1	support measures;
3	possible to
1	may consider,
1	identification required
2	limited purpose
1	(2) defraying
2	1,000 feet
1	normethadone. (33)
1	people. (2)
1	price and
1	sativa l.,
1	(b)(3), and
34	 the
1	agents; (c)
2	extension thereto
1	presents to
1	(d)), up
1	231 of
1	afte-early child
3	regulation proposed
4	shall, prior
1	financial affiliations
3	singl-use devices
1	marked inspected
1	connection therewith,
1	be, final
1	facility warehouse
2	intended conditions
1	lot number,
1	6, 1958,
1	persons exemptedthe
6	obtain approval
1	insecticides nothing
1	hearing described
1	drugs. (x)
1	(4) beginning
1	country, in
1	holding, transportation,
1	(7) not
1	section 1333(e)
2	u.s.c. app.)
1	drug marketing
2	(ii) confirm
3	effective immediately
5	parties to
2	importer under
1	licensed individual
2	finding imminent
2	60.0 
1	pharmacists with
2	food solely
1	tracing systems,
1	social security,
3	1049; 

1	section 952(a)
1	mental state,
2	debarment to
1	diethylamide; or
1	distributor notified
1	verification request.
1	201.57 of
15	encourage the
1	singl-use device:
1	excepting solution
2	(bb) neither
6	processes to
1	liquors, and
3	pharmacies of
1	product, not
1	framework of
2	commission, office,
10	shall appoint
3	clauses (ii)
1	product, nor
2	22, 2009;
1	645. federal
2	pharmacies or
2	singl-use device.
1	retail are
1	singl-use device,
1	affairsthe deputy
33	22, 2009,
20	drug intended
2	extent possible
1	(iii) provided
1	country official,
8	decreased likelihood
1	adult indication
1	pharmaceutical, biologics,
1	documents themselves
1	(b) improves
1	(6) drugs
1	rationale why
1	material made
1	(b) award
1	workers, and
2	granted an
1	programthe secretary
1	another agency
1	(xiv) the
1	order changing
1	target state
1	u.s.c. 387];
2	proviso shall
4	year unless
1	cognizable under
4	$30,000,000 for
2	remedial purposes.
2	persons other
1	matter, so
17	render it
1	(19) piminodine.
1	360ll(f) of
1	353(b)(3) of
1	term susceptibility
1	message. such
1	2000, the
1	testify and
2	suppliers have
3	respectively; or
1	american diet
4	hermetically sealed
1	individual facility
4	applicant certifies
8	facilities 
1	thousand, in
2	destroy the
1	regarding conflicts
3	deployment of
2	(d) conditions
1	appropriate relief.
2	subparagraph. (b)
2	opportunities that
2	(including smoke
3	drug complies
1	establish at
1	manufacturing for
1	(b)(1) will
1	institutions), product
1	investigations; (v)
19	period under
1	1602. definitions
2	accepted or
14	establish an
1	586d, as
4	schedule pay
3	consumers for
2	business systems
1	abuse indicates
1	subsection, amend
1	documents are
1	drug. where
2	health to
1	residue; (b)
3	practicable, be
10	clinical investigation
1	(5) job
1	railroad car;
1	intact mucous
1	reclassification, including
2	intended only
1	(a)(i) continue
1	response required
1	(2) limit
1	upon so
1	legislation as
1	improving information
1	become effective;
1	(a)(2) have
1	quality control;
3	applicant prompt
1	(1) preservation
2	committee and,
1	commodities in
1	adequately determined
18	states government
1	receipt to
1	national narcotics
1	inclusion would
1	evaluations provided
3	inspectors from
16	funds appropriated
3	shall classify
2	microbiological hazards
2	made 
1	360fff2(b) and
4	drug, means
2	shall perform,
4	total percentage
2	reports; and
4	food system
1	ordinary and
1	ground in
1	repackager; (iii)
1	paragraph (1)(c)(i),
1	recipients use
2	endeavor to
1	
 383.
1	specifications was
1	section 830(a)
1	contracting the
3	(a) action
1	comment during
2	prescriptions of
3	within 100
8	alleged to
1	801. congressional
2	population that
1	both) 
1	applicant before
3	51 and
1	chemicals, with
2	egg handlers
2	nurse is
1	board, or
1	sept. 3,
9	secretary, shall
1	states environmental
1	material, electronic
6	convictions of
2	perform any
2	file to
1	mistakes in
29	upon such
1	contract law.
3	(1)(b). 
1	plants subject
1	1997 the
1	center that
2	risk products
2	without cause
1	quality that
1	respective functions
1	state enforcement
1	prevent retail
1	budget priorities.
3	inspection if
1	improve event
1	april 20
1	including early
7	considering the
3	manufacturer, that
3	become effective,
1	terrorism task
1	thereof have
1	(iv) designing,
6	agencies for
5	condition or
1	preparation thereof,
5	products distributed
1	(4) unique
2	pending proceedings
2	initial report,
6	inspection program
2	lon-term commitment
1	labeling identifying
1	accuracy and
1	(a) representatives
1	sharing and
2	(c)(2) and
1	applicable statutory
3	five members
8	cause serious
1	(c) individuals
4	(c)(3)(e) and
2	law applicable
1	brought, arising
2	title despite
1	introduced; and
1	1906. enforcement
1	526, as
1	representatives. (

1	consider which
69	(b) for
1	specified area
1	section, approved
1	ensure timely,
1	fish in
1	accessory, which
1	radiation; (c)
1	margarine, or
1	individual applying
1	death from
1	involving product.
1	implant after
3	adequate assurance
1	generala publication,
3	injunction proceedings
2	(c) improving
3	office under
1	labeled; (b)
1	revise, or
1	obligation contrary
1	enrolled in
1	ketamine; (iii)
1	custom operation
1	issue forms
12	represented as
1	diversion. (f)
1	required patient
1	innovative monitoring
1	keep correct
1	section 353(a)
1	(2)(a), except
29	well as
15	order that
2	payments, including
1	(f) until
1	designated. 
2	granting such
4	subsection alters
2	$15,000 for
1	(3) suspension
1	chemical name,
1	illegally manufacturing
1	distributed directly
1	deemed scientifically
1	remediate. 
1	solicitation, and
1	raised regarding
1	5, as
1	filed following
1	prominently display
1	news media
1	safe food
1	services current
4	section 360fff3
2	trials under
4	procedures under
1	(k) transitional
1	342(c), 351(a)(4),
1	contributions, during
1	respective manufacturer,
2	identification, validation,
1	provider); (b)
1	issues, consumer
1	report within
1	case as
1	internet, pursuant
1	testing programs)
1	(5) retention
1	order from
4	advisory review.
1	submissions (including
4	iv, 12,
2	manufacturing industry.
1	false, fictitious,
2	manufacturing industry,
1	suspension if,
2	papers, processes,
19	hearing, the
2	determines before
1	requirements provide
2	product. (2)
1	use unless
30	(2), the
1	title) acting
1	lawfully entitled
2	manufacturing industry;
1	prescribe different
1	miniature spoons
2	evidence shows
1	sections. (2)
1	deleting a
2	substantial deception
1	814. removal
1	temporary permits
1	2014, issue
6	regulation exempt
1	review, such
1	measurement, radiographic
1	families, or
1	places no
1	limit a
1	imposes ante
1	medical practitioner
1	quality has
1	name, complete
1	with, less
2	42 on
1	contain an
7	(a) types
9	subsection: 
1	residue among
1	former position
1	reinstating the
2	harm from
1	(c) schoo-based
2	forbidden or
1	listing, prescribe
2	certified copy
1	subsections (d)(4)
1	salts. (k)
1	(aa) a
1	expose them
2	person submits
2	order; and
6	examinations and
1	purpose; identification
10	adjusted for
1	statements and
1	export permit
1	(t) database
1	5. (m)
1	proceeding communicates
1	(which person
1	sale provisions
4	due no
1	data sources,
1	use, that
34	require a
1	advisory reviews
1	food nothing
1	initial quota
2	stating good
2	data have
3	23 of
1	component within
1	etorphine. (10)
5	provided such
1	675, 584,
1	regulations lawfully
1	(g) 1.5d
1	revisions of
1	life while
1	concluded at
1	false, except
4	legally responsible
1	animal science.
1	specified, and,
43	(a). 
3	sponsor; and
18	appropriations act
3	853 of
1	section 1703(d)
1	negative any
1	awarded in
2	items that
2	comply is
1	aside. in
1	temporarily unable
1	625. inapplicability
2	slaughtering poultry
2	comply in
1	separate certification
1	(f) initial
1	purification, or
1	awarded is
1	comply if
1	authority, to
1	regulation)). 
5	proceeding, the
1	chapter, for
3	will pose
3	governments with
1	health requirements
1	reclassified or
1	factors on
2	division to
6	deny an
16	(iii) of
1	phosphorus, paris
1	preparation contains
1	determine from
1	3 minutes.
3	desiring to
1	21, formerly
21	(3) for
1	(2)(b). (c)
1	(14) shall
1	practitioners acting
1	analyses. (5)
1	security precautions
3	(1) modified
1	provisions, where
1	electronic logbook
1	threats. (c)
1	professional societies
1	provide, pursuant
1	recipient from
6	separately from
1	including civil
1	historic purposes
1	operator may
7	show cause
1	(d) foreign
3	(as applicable)
1	terms local
1	title 20)
1	(1), such
1	stat. 649;
1	supply, and
1	instructions under
1	safeguards, and
1	section 360e(g)(2)(a)
1	describing any
14	development tool
1	strategy approved
5	available. 
1	section. under
1	repackager, a
1	hearing an
1	part 110
2	part 113
1	(n)(5)(c), any
2	foreign establishment
3	strategy programs
4	assessments described
1	fair pricing
9	products inspection
1	facilities presents
1	target species;
1	(11) chillums;
1	network, or
2	353(g)(5)(a) of
3	health risk
1	(b)(i) may
1	drugs available
9	paragraph (1)(b),
1	agencies. each
62	date that
6	secretary believes
1	patient. (b)
3	consistency of
1	contract, as
2	(f) an
3	coordinate the
4	director in
2	2017, not
1	anticipates will
4	consumer organizations,
1	storage is
2	dru-free america.
1	(g) counterterrorism
1	registrationnotwithstanding any
1	farm, as
2	initial sale
7	standards, and
4	determined necessary
1	completed, records
1	validation, packing,
1	wrapper which
1	41 to
1	(i) accepted,
1	bearing a
5	services under
2	(1) identify
1	proceedings, upon
1	consent documents
3	classification for
1	376. examination
7	thereof. 
1	protections, including
2	authorization in
1	approach and
1	conducted the
1	25,000,000 patients
1	establishment, reinstate
1	addresses best
1	(b) potency
2	food additives,
1	518a, as
4	conviction under
2	section 350l(b)
2	import milk
1	hydrate. but
2	registration the
1	(2) descriptive
1	(2) applicable
1	leasehold interest)
1	gift fund
1	(b) contentsfor
1	food additives;
1	(1) assess
2	(b) consistent
1	easily searchable
1	replacement products,
2	longer grase
1	nurse 
2	lon-term federal
1	recommended to
1	regulatory practice;
1	demonstrates substantial
2	amount, the
1	human tissue
1	lawfully maintained
6	words, statements,
7	developing the
28	(i) and
1	campaign, subject
1	supervisory concurrence.
4	size and
16	(i) any
85	construed to
2	guidelines to
4	abuse, and
1	primary architects
1	960(b) of
7	outweigh the
1	(i)in general.the
1	willingness to
1	(vi) 1
1	agriculture and,
1	relationships that
1	formula has
1	may direct.
1	applicable conditions,
1	exemption fails
1	data sets
2	denial specified
1	indicate which
1	year 1986.
2	safety. such
1	pain. (ii)
1	alphamethadol. (6)
1	cardiology, toxicology,
3	except under
1	prescribing and
1	islands, or
1	members could
2	publi-private partnerships,
5	dispensing or
2	(a) annual
2	swimming pool,
1	category are
1	(3) there
1	(e), no
4	aggregate of
1	build upon
1	determines and
2	granted on
1	considered eligible
3	scientific, and
13	shall, on
5	minerals in
5	classified into
1	(after consultation
1	authorize its
1	probability; and
1	natural shrinkage
1	(d) prohibited
1	act took
2	effect; or
1	(c) it
1	controlled directly
1	alleged misbranding
1	(i)(i), except
1	transfer program.
1	transported materials,
1	(c) circumstances
1	require notification
40	grant under
1	subparagraph (2)(a),
2	issued and
3	conclude that
2	animals, each
7	storage, and
1	deems proper.
1	saf-use conditions,
3	responds to
2	exports, or
1	determinations if
2	(1)(e) refusing
1	people in
1	360g1(a)(3) of
1	possible time
1	determinations in
3	proportion or
12	license under
3	public, upon
1	(1)(a), (b),
1	benzethidine. (7)
2	28 to
1	device. during
1	meals at
2	existence for
1	shall partner
2	limits prescribed
1	1, 2011,
1	program, would
1	reasonable search
2	percent cal
3	kills or
6	secretary, through
1	obtaining public
11	development protocol
1	 $263,180
1	already controlled
1	governments, as
1	(ii) determines
1	forth elsewhere
1	cost, of
4	duplication of
1	cause means
1	
 360j.
1	(v) not
5	facility has
2	separate and
3	cocaine or
1	customer, unless
4	grant awarded
1	accredited pursuant
1	dismiss an
1	subparagraph (a)(iii).
1	concern, (e)
1	30, 2009
1	adjustment). the
12	seized and
1	permanent. (iii)
1	transport vehicle,
1	ii, special
3	territory means
1	secretary (under
1	director (referred
4	record by
1	1962, and
5	(a) conduct
25	greater of
3	rule, or
1	dismiss as
1	grant renewal,
1	prosecution of,
2	subjects involved;
6	quality systems
1	background and
1	substance, bulk
1	persons shall,
14	unless specifically
1	abbreviated applications;
2	health. (4)
2	regulation, exempt
1	353(a) nor
1	section 601
1	pharmacy for
1	404, as
1	reflect adjustments
1	825. labeling
1	studies) in
2	section 607
3	abbreviated applications.
2	records every
17	abbreviated applications,
1	2017 within
4	will permit
1	appropriate, results
1	modifies under
1	template for
1	repleviable, but
1	secretary prescribed
2	(c), if
1	recruitment for
3	it. the
1	(c), in
1	designation granted
1	secretary prescribes
3	animal is
1	regulations apply.
1	abuse upon
33	general of
1	term group
2	regulation). 
1	others to
1	9[1] of
2	senate, the
1	(c) nonnarcotic
1	elections 
8	thereof for
1	court signs
1	substance; (6)
1	strategy developed
1	products, devices,
1	(i) two
1	(2)(b)(iv) are
1	cigar in
1	reports; (c)
1	year. (2)
3	inspections 
1	effectiveness research
26	subparagraph (c)
1	aid; limitation
2	1524(a) of
1	slaughter; treatment
2	convene all
1	dollars, for
8	improving the
1	population is
2	document in
1	protect trade
1	2007, shall,
2	serious disease
1	allowing consumers
1	classification, in
2	determinative of
2	secret is
1	(2) petition
1	2010. (

3	fee published
1	products, fees
1	may prioritize
4	human life
1	sections 191
1	part 54
2	document is
3	population in
1	(ii) report
1	groups regarding
16	title. (b)
2	person known
5	corresponds to
3	validation of
1	de novo.
1	points; and
1	common, standardized
1	may defer
16	good faith
4	manufacture, process,
4	drug (including
1	9831 et
8	facilitate an
3	office as
1	distributions to
1	agent acting
1	 bthe
1	person knows
1	affairs); (bb)
1	informationthe food
1	device received
1	label any
1	specifiedthe objectives
1	certain activities
2	data, the
1	analyze such
1	inspections, checking
1	conclusions from
1	findings requiredexcept
1	(b)(1)(a)(i), (c)(1)(a)(ii),
2	october 2011.
3	subsection, including
1	to, significant
2	diet; and
2	composed wholly
4	ante mortem
4	import, any
70	approved application
1	country apparent
2	program framework
1	section 691[1]
1	
 1038.
1	psychological effects
4	particular; or
1	appropriate country
13	iii device
3	recommends that
1	offices established;
2	animal without
1	(2) rather
1	mislead 
2	(d)(3) 
1	outlines the
1	representatives. (e)
1	6.0. 
1	(whether a
1	agriculture act
1	1.04. (d)
2	rendered, boned,
3	destined for
1	applicants, to
2	addict and
5	enforce any
1	form, shall
1	oil, such
10	title as
5	hearing, to
3	title at
1	31, 1974.
1	determines, to
3	attending meetings
2	section 1050
6	authorized person
1	respectively, to
1	675, 1003,
9	amount that
1	
 384c.
1	769
 

2	generalupon the
1	immediately furnish
1	statistical data
1	centum below
20	comptroller general
6	registration issued
18	program. 
1	patients treated
1	(b) permissive
1	essential fatty
1	physiciana drug
2	sponsor fees
1	county referred
1	675, 503,
2	term selected
2	negligently to
3	consumers at
2	(a) advisory
6	consumers as
1	approval, before
4	labels and
20	emission tomography
1	(b)(3)(a), the
2	that, prior
2	models that
1	unit responsible
1	document, published
1	narcotics trafficking.
1	health due
1	chemicals, has
1	farm (as
3	process the
2	chemicals (or
1	
 675.
1	interviews. (c)
2	resources under
2	feesof the
15	shall terminate
1	outcomes 
2	section 3502(3)
13	late payment
23	period referred
2	suggestions, estimates,
1	materially assisting
1	rejections of
12	processing, and
1	(j) expungement
1	(2) manage
1	noticea notice
6	pet food
1	thereof, for
1	individuals, by
1	2420324207), shall
1	691. omitted

4	stage of
1	relevant agencies.
1	(3) bases
1	toxicity; and
1	evidence (within
1	ris-based inspectional
1	statement, conditionally
6	slaughtered and
2	type that
1	significant center
16	system for
1	hearing, each
1	adjustmentsfor purposes
1	certification. such
3	section 360b(b)(1)
1	independent national
2	specific actions
1	retailer) for
2	defense, or
2	place subject
2	revoked pursuant
1	officials (a)
2	liniments or
1	extract, or
1	0.7 
1	
 1103.
1	recommend ways
2	355(d) of
1	convened for
1	(iii) projected
1	remedies of
31	of, or
2	360 or
8	international narcotics
1	thereafter, make
171	unless the
2	identifier, that
1	significant reduction
4	entered by
2	c fre-choice
1	(b) period
1	labeling contentsthe
1	reasonable timetable
2	involving an
1	(iii) each
1	188 to
47	failed to
1	needed, the
1	trafficker in
1	assurance, but
1	including lot
1	writing, at
1	judicial proceedings
1	disproportionately high
1	extracted, isolated,
1	be, that
1	guidelines as
5	considers appropriate.
2	failed substantially
72	application of
1	assistance, training,
1	114d6. repealed.
1	sets, as
1	orders for
2	considers appropriate;
1	(3) narcotics
2	poultry science
1	comments in
1	writing, an
60	interpretive criteria
1	331(gg) of
1	oaths; subpenas;
6	him, evaluated
10	shall, except
616	 (b)
1	(iv) shall
1	(b)(2)(c); (x)
1	market); and
1	party detected
6	relieve any
1	(b) workload
2	appropriate safeguards
1	(e) reauthorization
20	within 60
1	 (aaa)
1	bulk form,
1	washing, waxing,
1	whoever willfully
1	(v) establishing
12	(4) a
1	redactions made
1	information appear
1	application complies
1	cause shall
1	substance abuse).
2	infrequently in
1	written determinations
1	(b)(1), (b)(2)(a),
2	product identification
2	investigation with
1	application) or
1	data completeness,
1	disclosure any
1	efforts through
1	enterprise; (7)
142	application or
3	administration, shall
1	actions. 
1	lower economic
2	programs nothing
3	(b) identify
1	comments received;
1	level. (c)
15	owned or
4	bound paper
4	dispositioned; and
1	273, 2,
1	diarrhea and
1	imprisonment, such
1	received, notification
3	form to
8	date described
4	preserve such
6	inspection authority
7	reporting concerning
4	criminal proceeding,
2	fide research
5	toxins, and
1	2014, with
1	seller sells
1	poultry by
5	(b) hold
1	(1), (2)(a),
1	(4) updates
1	(2) deadline
2	attorneys and
71	year. 
1	misbranded is
2	reviews the
5	salting, packing,
4	care services
1	continuing need
1	
 1201
2	emergency shall
1	state prekindergarten
4	reasonably applicable
1	agreements prior
1	replication of
1	authority, as
2	foreign material.
1	protect all
1	misbranded in
2	annually a
1	account all
12	inspection requirements
1	new determination,
1	tissue engineering
1	useful drug
4	increase shall
2	(b) whose
3	(in a
3	addicted to
1	cocoa, chocolate,
1	public posting
1	facilities, as
1	 (5)thir-party
10	additive may
2	facility will
1	working groupthe
2	placed or
1	death had
10	paragraph as
1	strategies (a)
3	repackager, or
1	3913, 34
1	employ any
4	label and
1	dose; (d)
2	sources, and
2	recordkeeping requirements;
9	assessed an
3	(1) development
1	(1)(d) is
17	person subject
1	imposed only
1	frivolous or
1	assessed at
1	reports, necessary
1	containing three
1	tools, diagnostics,
1	vomica, physostigma,
1	recordkeeping requirements.
1	terminate, with
1	recordkeeping requirements,
11	farm to
1	users is
1	thereafter under
1	standardized information
2	restrain violations,
3	packed, on
2	term shipping
1	papers; or
1	partner, employee,
1	geneva on
1	adjudication programs
6	judicial review;
2	implant; or
14	listing of
1	certain funds
1	uses proposed
10	amounts of
1	section 897.34(a)
31	packed, or
13	judicial review.
1	amounts on
1	(2) posting
1	pathologic, or
32	states shall
27	appeals for
1	anticipated port
1	sections 101(a),
1	be) from
1	marking of
2	drug. (june
1	(b) purposethe
2	coordinators designated
1	results. (4)
1	except pursuant
1	repackager, as
1	(c) sales,
1	title 41)
1	area (whether
1	organization. the
4	(d) authorization
7	marking or
1	occurs outside
1	(8) for
2	additive, as
1	threshold effect),
4	registrant who
2	general (a)
1	experiences (as
1	(ii) illicit
1	review provided
1	exists solely
1	timely submission,
1	animal surveillance
1	whether denial,
1	ibogaine. (9)
1	states provided
2	additive, an
3	medical reasons,
1	
 112a.
1	immediately before
1	accessory under
2	patients, the
1	experts, and
1	psychological dependence.
1	applicable, any
1	claimant proves
1	criminal activity.
2	event an
1	(25) the
3	request, in
1	(ii) 500
1	color additivesa
1	prescribes but
1	quality, etc.,
1	substances. (6)
2	finds it
2	conduct that
1	disadvantage based
1	prescribing for
1	operation, activity,
1	statutory timeframes;
1	operational activities
1	100 grams,
1	(c) preservation
1	reporting requirements.
1	decedent that
2	content 
1	(n) referral
1	(7) national
4	section 284m
1	procedure except
3	revoked by
1	675, 564a,
1	stockpile; (d)
1	donated land,
2	paragraph 8
1	7 approved
3	office may
1	entity complies
1	interchangeability described
1	forfeiture is
1	7,[1] shall
1	(5) enter
1	ongoing dialogue
2	pending; or
2	need and
1	color additives;
2	shall store
1	use, consumption,
1	works in
3	among hospitals
5	general, shall
1	reconstitution; (iv)
1	closely with
2	penalties, and
2	certificationthe secretary
4	body to
2	no-delegation determinations
3	disease priority
1	color additives)
3	color additives,
1	product, drug
1	addiction; (vi)
1	modify prior
1	alphaprodine. (2)
5	paragraph (6),
1	term return
1	court pertaining
1	(ii) applicationupon
1	(c) oral
9	1927, ch.
1	rejected or
2	grounds set
1	subsection (b)(1)(b).
12	place outside
1	subsection (b)(1)(b),
1	formula, including
2	code reader
1	paragraph (6);
2	year on
1	packaging, logo,
1	in, interstate
5	executed in
1	(b) acknowledge
2	neither course
1	379dd. establishment
1	review. (8)
1	section 387f(e)(1)
3	practical method
1	jointly review
1	licensure, as
1	agency. (3)
1	fix the
1	active program
1	need therefor)
2	college, junior
1	period. no
1	without diluents,
1	scientific community.
1	submission a
9	transaction in
4	1532 of
1	675, 801,
1	violation but
1	inspecting or
1	furthers the
1	application, (5)
8	responsibilities under
1	needed among
17	(3) a
1	constituents in
1	negotiation or
1	qualifying it
1	specified or
1	statement relating
6	notification submitted
1	testingthe regulations
1	plan; (ii)
2	food only
1	administration after
1	(a) testing,
4	director regarding
1	department to
6	exempt any
2	diverted for
1	drug; (f)
1	fully remedy
1	administration (hereinafter
1	drug originally
1	anticipated and
1	another similar
4	marketing 
2	(b) application;
1	practitioners, or
1	(a) copy
1	showing blood
2	applicant demonstrates
2	average, consistently
3	(b) application.
1	etc., matter
1	final rulemaking
1	shall supersede
20	safe for
2	formulation. an
17	effect an
5	secretary notifies
1	awards to
2	delivery, in
1	establishes, that
1	2016, $12,300,000;
5	without conditions,
6	prior public
1	hereinbefore provided
1	exacerbation of
6	council shall
17	food product
7	interfere with
1	immediately, or
1	(6) and
9	motion for
53	period beginning
11	year or
2	completion has
2	food manufacturing,
1	effect at
9	effect as
1	fdabeginning with
2	stores and
1	made (in
1	agriculture) only
1	(5) $280,000,000
2	amount paid
1	avoirdupois ounce
1	(i) approving
2	withdraw, inspection
1	(e) expedited
1	11 and
2	personnel, facilities,
6	section 342(a)
1	killing or
2	(d) definition
1	(8) expert
1	consecutive sentence
1	year. (ii)
2	provided, if
2	killing of
1	adolescent admissions
2	initial receipt
3	record means
1	entitled by
1	operations or
1	list pursuant
3	(g) review
6	costs. 
1	reviewing divisions,
1	submitted, for
2	imported articles;
1	covering each
2	provider, having
5	strategy shall
1	intermediates and
2	available; and
2	days, for
2	regulatory commission
1	civil service
1	federal advertising
13	operations of
1	1974). (2)
1	time necessary,
1	punishment any
1	publish notice
1	related therapy,
2	assistance. 
1	incurred, as
2	forfeited personal
2	february 1,
1	sponsor with
1	congress detailing
52	false or
1	organizations or
1	reviewing countermeasures
1	businesses. 
1	manufacturing, importation,
1	organizations on
1	certifying entitiesfor
2	379j41 of
1	representatives, except
1	(1) lacks
1	360ddd. definitionsin
1	organizations of
1	675, 403b,
1	created acted
1	registration suspended,
1	representatives, in
1	(4) compensation
1	cause finds
2	data the
1	rape), against
1	emerging postmarket
4	states. (

1	propagating, compounding,
1	control diversion;
2	exist in
1	bribery of
3	suspected food
1	new rights,
1	supply reporting
1	importer participates
1	(ii) prescribing
2	befor- and
1	international traffic
2	secure the
1	
 379o.
1	sponsor gives
2	target animal,
1	strategy; (c)
1	833; 

1	(2) provision
1	pest eradication
2	application. (iii)
4	benefits under
2	(i) use
1	transaction if
1	turn the
1	shortages; (5)
2	named on
2	guidance is
1	physician, and
2	applications and,
1	outlets; or
1	metabolite, constituent,
1	science activities
1	therapeutic benefitfor
1	(b). (f)
2	appropriate standard
2	states. subpenas
2	patent before
1	feeds; or
1	rendered on
2	similar file
1	inspection required
2	compel compliance
1	(a) reviewing
3	section 381(e)(1)
1	penalty, the
6	homogeneous case
1	health, economic
1	material transfer
1	vote, appoint
5	including obtaining
52	notwithstanding any
1	care settings
2	administrator determines,
1	detailed lon-range
1	original priority
1	amide. (6)
1	create all
1	commodity, such
1	tolerance 
2	may exclude
1	thereof, other
1	objection filed
1	debarment immediately,
1	sections 5702
1	foundation; (8)
1	opium, commonly
1	section, relevant
1	supplied shall
3	2014 under
1	sums of
3	import the
1	(4)(b), (5),
10	deemed unsafe
2	coordinated effective
2	entered, or
1	3432. dietary
2	smoke does
64	may require
1	$124,000,000 for
5	among federal,
1	unless at
2	young people
4	paid within
1	entry made
3	acceptance for
5	entering the
1	240 days
13	information necessary
3	providing appropriations
1	(ii) extends
1	verification; and
3	revising the
6	content the
1	plan if,
1	(2) discovery
1	guidance if
2	one additional
1	surveillance network
1	repackager responds
1	homeland securitynot
2	appropriate, on
1	regularly and
1	schedule vit
1	request (with
6	thereof, shall,
2	forfeiture prescribed
1	consumer 
1	resubmissions may
1	expected demand
46	combination of
1	states resident
8	licensed pharmacist
1	methicilli-resistant staphylococcus
1	trials, or
1	methyprylon. (7)
1	proceeding, (b)
5	accord with
1	conveyances where
2	take custody
1	combination or
1	solicit, review,
1	states will
1	receive evidence
1	regulation. any
1	conviction as
6	reauthorization 
2	$652,709,000 multiplied
1	programs, or
1	expertise can
3	drug, animal
1	(j) definition
2	effective action
11	formerly act
1	scientific expertise,
5	otherwise agree.
1	215. consul
1	373, 374(a),
1	(a) practitioner
1	states sanctions
6	sustaining human
4	performance goals
4	manufacturer; and
1	(6) tolerance
1	examinations, inspections,
1	exemption, (ii)
3	(2) revision
1	subsection (d)(7)(a).
1	chamber pipes;
1	petition (inclusive
17	ester or
1	i, general
1	drugs, clearly
1	statement within
1	
 602.
5	making any
2	methamphetamine, including
1	fraud, perjury,
2	paid, if
1	slaughtered poultry
2	drugs; (b)
1	care. 
5	restaurant central
6	department designated
1	misbranded; 
1	processed food.
1	(3) would
3	processed food,
1	suspended, revoked,
1	506g, as
1	year, is
1	530, 70
2	based in
1	goals established
1	42. (2)
1	contaminant under
1	indexed; (c)
1	viruses, fungi,
1	section 4202
1	(4) where
2	year, if
1	(e.g., bass,
1	suppliers in
3	cases shall
1	year, in
2	responsible connection
1	review), shall
4	adjustments under
1	date. (ii)
1	adolescents (60
1	u.s.c. 101
4	no. iv,
1	9, 2012)
11	9, 2012.
25	9, 2012,
1	requirement may
2	estimates, and
1	prioritize which
3	incidental to
2	witness shall
3	(a) apply
1	additive; (ii)
2	9, 2012;
10	manufacturer is
1	judgments the
3	stat. 832;
1	trust for
7	health emergency
4	use specified
1	racemethorphan. (21)
1	subregulatory guidance,
1	section 379j12
1	denial. 
1	proceeding alleging
1	genus may
2	regulations, to
3	payable for
2	requirements apply
1	data at
4	section 343(a)(2)
3	requirement shall
10	general beginning
4	application (including
4	data as
1	hundred thousand;
1	tribe arising
1	otherwise justifiable
1	product except
2	issues and
2	decree, (a)
1	formerly 906,
1	withdrawal periods;
1	(h) notification
3	(i) under
2	distributors that
1	chain, take
1	no-fo-profit medical
1	(2) four
2	(l)(3), or
2	section 375(b)
1	establishment. (june
4	intentionally subjected
1	354 of
2	security, as
1	states depend
1	device establishments.
1	applicable, need
3	scientific principles,
4	economic hardship
1	scientific principles.
4	request, to
1	(2) reviewin
1	constitute proof
1	inform regulated
2	applicationthis section
1	significant foodborne
1	regulation, which
1	senior than
1	submitted, pending,
1	derived, directly
1	information concerns
1	abuse conditions;
19	inspected and
1	product detained
7	devices or
3	correspond to
1	continued, terminated,
1	(c) success
1	package contains
2	use standard
1	(mg) 7.0d
1	10a, as
2	matter published
14	initiative of
3	clause (iii),
1	uses: 
1	262(i) of
3	title before
1	diagnostics, manufacturing
1	devices of
4	discuss the
4	operation and
2	section 360eee1(a)(7)
1	objectives within
1	authored by
3	903, as
1	definition. 
1	change on
1	export permit,
1	imposed, as
5	change of
1	part, as
1	(3) report
1	prohibited: (a)
2	farias and
1	patient based
1	question has
1	condemnation, such
9	tobacco control
1	supplement. (iv)
2	part, an
1	exported, manufactured,
1	maintain teams,
3	revenues to
3	defined the
1	dru-free america,
1	formula, (b)
6	length of
1	exist; (4)
1	passed under
1	resource conservation,
2	law requiring
1	enforcement, suspension,
1	(6) under
1	expedite any
1	2, 1956,
1	(q) safrole.
3	security, foreign
1	(iii) relating
3	sponsor means
1	filtration, packaging,
1	isomers. (4)
1	(2) partnershipsthe
2	proposals for
1	(a) 20
1	risk allowed
82	requirements under
2	inspection, as
3	paragraph, an
1	activity of
1	chain sector
1	service, not
1	(b) income
1	identify methods
1	purchases meat
2	appropriate labeling
2	constituting the
1	(3) definition
1	beyond that
16	change that
1	drug free;
2	reasonable costs
2	selling drugs
1	serious unexpected
1	entity whose
1	written submissions.
1	clause (i)(i),
1	campaign in
1	outbreaks. 
1	pathogen, as
1	holds under
1	prescribing such
1	confidentiality during
3	(52 stat.
3	substance abuse,
3	books, papers,
1	period, does
2	prescribing of
1	
 346b.
1	critical issues
2	facts, such
2	accrue interest,
1	coordinating and
1	campaign is
13	tribal law
7	1523(9)(a) of
2	federally regulated
1	collectively, of
4	section 841(b)(1)(a)
2	director, make
1	incubation and
1	criminal charge
1	1053. inspection
1	relating to)
1	(9) all
1	1971, which
1	designated book,
1	funds paid
1	conventions designed
1	section 355(c)(2)
2	appropriate, refer
3	otherwise dispose
1	(f) compromise
2	gram or
1	otherwise affecting,
1	practitioners to
1	pharmacokinetic, pharmacodynamic,
1	filing decision
1	telephone, wire,
1	both) to
2	invalid, the
4	higher education
1	constituting, or
2	official establishments
1	associate returned
3	package and
1	tobacco products)
1	june 24,
23	tobacco products,
12	prescription for
1	hereunder, or
2	recipients for
1	device deaths
1	conditionally approved.
5	consider 
1	crisis means,
3	minimum united
1	regulations prescribe.
1	maintained; (iii)
16	event report
6	tobacco products;
1	hereby appropriated
1	(2) under
1	successful strategies,
1	counterterrorism activities
1	soil or
1	recommend a
5	product. (c)
5	investigations (other
3	(d) public
4	subsection by
2	administrator, including
1	publicly available;
17	submission for
8	establishment shall
1	may establish,
1	assumptions, methods,
1	investigations 
6	publicly available.
1	waiver. (3)
1	objections and,
1	desired for
17	submits to
1	tobacco productsa
1	(i). (v)
1	notice requests
1	thir-party auditors;
1	(g) guidance
1	section 214[1]
1	respondent, discovery
8	manufacturer, the
1	man means
3	affiliate shall
5	advertising. 
1	clause (iii)(ii)
1	receive, hold,
3	chemical is
1	reserve amounts
5	licensed veterinarian,
1	exempt tobacco
1	licensed veterinarian.
1	licensed veterinarian)
1	subsection each
1	surgically produced
2	whoever violates
2	transmitted under
1	begins a
1	manufacturer, may
1	(f) fund
1	protocol completed
4	states. (b)
1	treatment has
1	(2), that
1	logbook for
1	(3) rules
1	drugs. (june
3	official homoeopathic
1	analysisthe owner,
1	319 of
1	industrythe secretary
1	physicians, patient
1	food and,
3	director; and
1	considered licensed
2	retailer directs
2	whose application
1	section), such
2	receptacle, wrapper,
1	purposes prior
2	investigation. the
1	conditionally approved;
1	(e) incorporation
1	amounts received
4	(i), and
10	(a); and
4	provisions respecting
2	periodically report
1	strengthening that
8	circumstances in
1	(b)failure to
2	notice establishing
1	first of
1	section 262(a)(3)
1	requirements beginning
1	importer that
1	2014, $1,736,000
1	identify, record,
1	year 2004,
1	iii, 536,
1	(c) record
2	purity characteristics,
5	modified in
1	oil, pcp,
4	drug dispensed
1	void, prevent,
1	
 1048.
3	conviction of,
1	(1)(d) the
1	votes or
1	cases; limitations
1	year 2004;
1	protocol). the
2	practicable, a
6	performance report
1	networks are
3	congress referred
2	criminal investigation
1	(2), except
1	business recovery
1	obtain devices
1	(i) half
1	handled so
1	distribute, through
3	refer a
1	domestic use
3	(2) accompanying
1	agriculture. (mar.
3	contract carrier
1	unauthorized use
1	medicare &
1	subsection (b)(3)(d).
2	render adulterated
1	medications; and
1	precautions, side
1	assure access
8	used. 
2	pharmacopeia recognized
5	treat and
6	pendency of
1	(independent of
1	350b. new
1	value, with
1	change from
1	type than,
2	lawfully filling
1	1988, to
5	(b) shall,
1	projects, in
1	reasonably determined
1	cos-effectiveness of
2	duplicate reports
6	budget requests
1	website; and
1	register proposing
9	agency under
6	state by
3	occurs in
1	1 year;
1	distributor confirms
1	initiatives, which,
7	title; (d)
1	(established under
1	general are
2	prevent distribution
1	seq.) is
1	title xviii
1	vacate a
12	posed by
1	services regarding
2	mandatory background
5	signed by
4	thermally processed
1	manufacturer with
2	military emergency,
1	burden exists,
1	involves the
1	requiring labeling
6	revenues established
1	law enforcement.
2	academic research
1	participants representative
1	sustained, the
2	title. (6)
3	information means
1	verified under
1	accredited laboratories;
1	representing interest
3	states person,
1	cocaine, hashish,
2	release; removal
1	organizer, or
1	defendant charged
121	authorized by
2	trials in
1	designated) in
2	data) for
1	school nurse,
1	diploma. (mar.
1	gas no
1	strategyfor each
2	application, no
2	available, through
2	regulation prescribed
7	(i) except
1	violate subparagraph
1	actions. (i)
2	ingredient, and
3	center. 
2	convicted as
1	data); and
1	used. (g)
2	regarding their
2	authorized agent,
2	necessary, then
1	import; (4)
1	rest or
3	scientific purposes
12	action plan
1	finding pursuant
1	notifier and
1	review review
2	education, or
1	jurisdiction; or
1	documentation under
1	supplier. (b)
3	returns a
4	local laws
4	reserves of
1	714b or
4	(5), or
1	manner. no
2	intending, knowing,
1	used, tar
2	eggs, capable
2	person residing
4	affairs shall
2	technically qualified
1	regulation prescribe;
1	creosote, chloroform,
1	trader shall,
1	(2) scientific
1	2202 and
2	effectively identify
1	sulfate per
2	formula complies
2	including as
2	including at
4	report, supplement,
1	harmful impact
1	technologies existing
1	greater understanding
1	whether live
1	regulation prescribe)
5	regulation prescribe.
1	regulation prescribe,
1	pharmaceutical purchase
2	priority for
3	sections 46,
1	including suggestions
1	product, whether
1	nonprescription means
4	application upon
1	ground. 
1	(iv) information
2	licensed health
2	upon finding
1	administration 60
1	effectiveness. (b)
1	opportunity, prior
1	155, 4,
5	rules for
4	secretarys decision)
1	(b) coordinationwith
1	secretarys decision.
1	seq.], this
1	hazard identified,
3	shall compile
1	provider located
1	pending motion
2	substances except
12	agreements with
1	prescribed prior
2	enforcement against
1	(5) trade
1	1542(a)(1) of
1	budget, the
1	contents, the
3	serious illness
4	conduct testing
1	applicants experience
1	treatment procedures
1	1997. (june
8	coalition shall
1	351 et
1	misleading marking,
1	tracing system,
2	person engaging
10	data management
1	eliminate an
1	present less
3	animal, or
1	ordered or
2	(iii) whether
1	paragraph (3)(b)).
1	function. 
1	seller violates
2	entity who
1	intermittently. 
6	system that
1	(b)class ii,
2	prepared, sold,
3	safety, the
1	succeeding fiscal
1	certain trends
1	(c) encryption
2	conducting an
1	individual took
2	means best
1	permit, as
1	(d) withholding
1	823(h) of
5	public inputprior
1	360ccc1. index
1	will contribute
1	radiation. as
1	u.s.c. 71
5	devices which
2	agreements the
1	criminal penalties,
1	usual place
3	ambient temperature
1	physician distributes
2	clinical needs,
1	(4) comment
1	(v) transition
1	act; (c)
2	determine its
2	moneys in
2	purchasing organization
1	18, no
1	agreement referred
2	(a) whose
1	research data
1	(35) does
1	applicationsexcept in
1	inform ris-based
4	changing the
1	analyze how
1	priorities 
2	subparagraph (a)(vii)(iv)
1	
 885.
1	narcotics control.
1	include peer
1	human tissue;
1	ensuring more
2	applies; and
1	food establishment.
1	
 454.
1	degradation productsif
6	secretary) shall
1	(b) nonnarcotic
4	advanced therapies
18	shall, after
1	general public
1	brought, from
1	protection factor
1	formerly 3rd
2	342(f) of
1	deceptive act
2	(c) criteria
3	relies on
1	imprisonment or
1	litigation costs,
2	chemicals for
1	administrator considers
1	coordination, and
1	applicable, section
2	prevents the
1	proposed active
1	functions. the
37	imprisonment of
1	urban, suburban,
1	limitationssubsection (a)
8	(5) a
1	epidemiological, pathophysiological,
6	term tobacco
1	maritime claims;
1	consideration if
1	media campaignin
2	submitted within
2	domestic emergency,
1	cosmetic intended
2	section 860
1	submit directly
1	875. administrative
1	(3) procedure
2	food establishments
2	level was
4	facility (or
7	cream is
18	may make
1	cholera, each
1	cream it
1	paragraph, that
1	maritime claims,
1	4(g) of
1	estimated medical,
4	packaging label
1	organizing, training,
1	year; (d)
1	networks (a)
1	states does
1	produced the
2	379g(3) of
7	required and
1	(c) this
1	disclosed, under
21	may present
1	means cattle,
1	amounts. (7)
7	meeting to
1	nonacceptance the
1	hour during
2	operations have
1	containing individual
1	farming the
1	update and
1	subsection (c)(3)(a).
1	subsection (c)(3)(a),
1	including aircraft,
1	selection by
2	hillory j.
2	(b)(2)(b) shall
2	medicine, and
8	procedure for
1	rulemaking proceeding
1	pollutes an
1	(1) establish,
1	(a) employed
10	year may
16	persons in
3	potential immediate
2	debarment periods
1	model development
1	
 825.
1	notifications by
1	(g) limitationsnotwithstanding
1	followed. (g)
1	place; (iii)
1	living abroad,
1	(d), in
1	order, while
1	conditions shall
1	section 350(b)(2)
1	entity, for
1	party objecting
2	upon prescriptions
1	wet dressing,
2	procedures identified
5	therein in
1	employee, as
10	cause the
2	(b) manufacturer
2	acts that
1	testing, by
1	(g) enhanced
4	employee, at
1	requires by
2	freezing, dehydration,
1	prevent, curtail,
1	detailed, comprehensive,
1	sustaining; or
2	$15,000, multiplied
10	years. 
1	placed; or
1	public docket
1	histories; (5)
1	statements, throughout
60	may include
1	specified shall
9	drugs shall
1	inflation adjustments
1	(c) indication
1	success or
1	admission for
1	hearing. (3)
2	contribution. (b)
10	and/or cream
1	(13) ice
1	vegetables, or
2	success on
1	(b)(ii), undergone
3	submission requirement
1	label disclosure
5	success of
2	bias and
1	committees regarding
1	22. 
1	frequency 
10	promotion of
2	testing or
1	farm owned
5	testing required
1	influenced the
1	business subject
1	355(b)(3) of
1	675, 505d,
3	respecting any
1	time. (2)
1	resolution proceeding
1	documents, or
1	plant nutrient,
1	publications as
3	patent referred
1	experimental permit
1	educational assistance
2	issuing permits
1	products prescribed
1	amend final
1	respecting drug
4	(1)(b) or
2	services as
2	services at
1	(24) -[-(ethylthio-2,-dimethoxyphenyl]ethanamine
1	period termination180
1	1997, and
1	patients, such
1	records; and[1]
2	(iii) provide
2	summarizing such
1	contain data,
1	process; (ii)
2	established so
1	secretary, refer
2	(1)(b) of
1	period pursuant
1	675, 406,
1	resume agriculture,
14	brought into
1	freezing. (june
2	veterinarian within
1	stores with
3	transferred before
1	preserve any
7	chapter. (2)
1	including veterinary
1	thereby indicating
2	containing chloral
1	milk, egg,
1	designated); 
2	appropriate registration
6	free of
2	available, information
1	states prompt
1	intrastate cannot
2	requesting agency
2	state: provided,
4	marihuana, or
1	category means
1	supplement, when
1	availability, impact
1	total amounts
1	procedurein issuing
2	(d) recovery
2	review employees
7	term pesticide
1	age, information
6	(d) such
1	(a) pharmacies
3	flavoring, and
2	(a) state
3	meat, or
1	arguments. 
6	cost, per
1	national uniform
1	title were
1	listing) as
1	swine populations
1	agencies (as
2	regulation when
2	information; jurisdiction;
1	drugs indexed
1	u.s.c. 264].
1	(2) membershipthe
1	acid. (5)
1	disproportionately affects
1	labor organizations
2	submitted serious
1	(6) additional
2	reasonable samples,
1	(d)2 obligation
1	66 percent
2	device should
1	(b) classification
1	application, that
1	whichever best
1	(d) that[1]
1	28. for
3	shall dismiss
3	(2) notification
2	designates a
1	articles imported
3	may extend
1	379j42. authority
1	products, (d)
13	cause of
1	help coordinate
1	manufacturers are
1	undertaken, of
2	subpena. witnesses
1	1972, and
30	for, the
1	estimated demand
1	appropriate, establish
1	lawfully introduced
3	three years;
1	methods, tests,
1	physician, if
139	term of
1	claimant after
3	certain drugs
2	evaluate methods
3	reporting to
1	professional 
2	new suppliers
1	
 332.
1	single enantiomers
4	section 262(a)
1	deposited with,
1	measurement based
1	import permit
1	completed by
1	may accompany
1	laboratory seizure
1	counted toward
1	encourage uniform,
1	consumer right
1	15, on
1	(m) devices;
1	2014. the
1	7, for
2	subsection, an
1	title 5and
1	judiciary, and
10	place on
1	anileridine. (3)
1	advertisement involved
1	discretion in
1	aggregate amounts
1	research contracts
1	gain approval
3	(b) providing
1	(a) thir-party
1	national thereof;
1	program within
1	oleomargarine (a)
3	shall monitor
1	(d) applies
1	fraud, forgery,
4	notice referred
2	evidence consisting
1	379dd2. activities
1	annually develop
2	compare the
1	taken respecting
1	negotiations. 
16	action for
4	$10,000,000 for
6	obtain review
1	adjusted, as
1	appropriate. (ii)
1	administration). 
4	applications described
1	submission, that
4	label, or
1	572, as
1	milk imported
1	pesticide issued
1	commits minor
1	sold, to
1	thereafter, require
1	$9,000,000, adjusted
1	general determine
1	2242. foreign
2	different types
48	(including any
2	(c)(ii) by
2	year concerned
1	reinstatement remedy
3	drug (or
1	samples obtained.
1	two inches
1	forfeiture, restore
1	patient through
1	foundation as
1	agreements, as
1	use regular
2	distribution, manufacture,
1	contractors with
1	foundation at
1	deadlines in
2	describing 
1	area means
1	providing goods
1	significant decision.
1	drug alone:
3	unhealthful, unwholesome,
1	(3) active
1	manufacturer intends
1	675, 506g,
1	corporations engaged,
1	directive is
2	drug study
3	encapsulating machine,
1	health data,
28	country to
1	prescribing, or
1	interest between
4	beginning in
1	campaign pursuant
1	available. (iii)
1	675, 749,
1	policies respecting
1	indication, route
8	earlier of
1	annually (1)
2	subclause. such
1	prescriptions by
3	records documenting
2	persons pursuant
1	marketed, in
8	packaging, or
1	sponsor as
2	earlier or
1	387d, 387h(c),
2	order being
1	diligence; (5)
11	secretary grants
1	963. attempt
2	trade such
25	(a), (b),
3	pleasure of
1	
 387f.
2	interest means
4	increased punishment
1	360h1. program
3	exporting the
1	operations (a)
3	seeks approval,
1	decisionmaking; and
1	secretary provided
9	reports for
1	reasonably practicable
1	facilityfor purposes
1	(4) state
1	limited inspection;
1	registered. subsection
28	iv, or
14	secretary provides
9	plan submitted
1	subsection (b)(2)(c);
1	clinical isolates
1	pending issuance
2	(8), not
3	substance intended
1	fixing and
3	possession with
9	5 or
11	imprisonment under
1	(29) morpheridine.
1	patient quality
1	subsection, without
1	repository for
6	become contaminated
1	subchapter, each
1	both. (b)
18	5 of
1	reimburse each
1	imitation, process,
1	(b) life
1	$25,000 or
1	regulation, instruction,
1	trafficking in,
1	commission and
3	findings with
2	inspect not
1	123.3(k) of
2	necessary expenses
1	monograph system.
5	shall periodically
1	reviewing information
2	report such
1	concerning refused
1	seller places
2	explain the
1	novel or
1	expressly proposes
2	(g) annual
4	(c) requests
2	2005; (2)
1	(6) studies
1	discontinuance in
1	commission any
1	effective pesticide
1	another facility.
2	(ii) following
61	regard to
2	website in
2	shortfalls 
1	place related
1	section 319
1	violations related
1	
 831.
1	(2); (7)
1	321(q)(1) of
1	ingredient will
1	individual purchasers
2	raised for
1	114e to
1	products referenced
1	generalno restrictions
1	threats, including
2	reasonable probability;
3	identifier affixed
1	applicant involved.
5	expertise to
2	use thereof,
1	(iii) may
5	subsection (b)(1)(a)
1	submitted based
1	suitable controls
1	(i) how
1	360(k) report
1	formerly 15th
1	discovery in
4	additional provisions
1	enantiomer not
1	(3) contract
1	timeframes. 
6	supplement was
1	unsafe new
2	408, as
2	analogue to
1	ingredient was
1	2000. (g)
1	audit report,
7	clinical hold
1	cell therapy,
1	property by
1	u.s.c. 247d6b].
9	requirements as
8	central intelligence
1	directly relate
1	hearing, may
2	enforcement effort
2	come into
1	entire backlog
4	registrants under
1	safeguards to
1	audit report;
1	unless (i)
1	manner, the
7	(15 u.s.c.
3	attorney general)
14	(a) except
1	plant number,
20	attorney general.
64	attorney general,
1	1921 et
1	356a. manufacturing
16	active ingredients,
1	data bases
3	beyond a
2	fees applies
13	calendar year
3	reclassified as
1	(a)(vii), the
1	support data
7	committee. 
1	year upon
2	safety (a)
1	section 822(g)
1	apply, if
2	certified statement
3	attorney generals
1	seeking food
1	675, 1006,
1	sell, finance,
3	subsection. in
2	funds in
1	give rise
1	labeling (as
2	subsection. if
2	reliable information.
11	(a) within
2	prohibition the
10	executive director
1	requirement authorized
3	petition and
42	cause to
1	actsno person,
1	licenses a
191	drug control
3	audit reports
1	order reviewed,
1	health situational
5	policies established
1	otherwise. (may
2	scientific expertise
1	misleading promotional
1	said food
8	licensed to
1	usethe elements
1	professionals. the
1	separate apparatus
1	clarifying information,
1	furnished or
1	title.[2] 
1	(specifically administrative,
1	terminate designation
1	significant question
1	appropriate: 
1	animal whose
1	acids (linoeate):
1	importation exceeds
1	392. exemption
3	terms, the
1	chemistry that
1	issues regulations
1	70 percent;
1	advisory opinionsas
1	establishment, subject
28	consider the
1	bulk active
1	another substance
1	patients, which
1	includes initiatives
1	(b) contentthe
3	9 months
4	receipt and
4	imposed therein.
3	communications to
1	uncondensed gothic
4	within which
1	disintegration of
1	report, taking
2	committee, or
1	strategies under
1	one nontopical
1	performs accreditation
1	reports about
1	
 347.
2	secretary adequate
3	studies will
1	standards, (2)
1	convicted (under
3	care professionals
1	afforded opportunity
2	application, together
7	distribution until
1	injury, respectively,
4	substitution for
1	practice that
2	organized territory.
1	tested before
1	constituent) or
1	fingerprinting strategies,
1	(a)definition. 
1	respect misleading
1	agencies programs,
1	packages, holds,
2	appropriate sampling
1	drug according
2	(ii) subject
1	(b) lacks
1	risk assessment.
1	reasons any
1	coordination, as
2	(1), an
1	program areas
1	matter, or
2	strategy, including
1	risk assessment;
1	particularly those
1	agriculture, consider
1	assessing 
4	(1), as
1	website). 
1	branches), or
1	(1)requirement.subject to
4	paragraph (16)
1	science of
1	diversions, (d)
1	(b) activitiesin
32	substance containing
1	per management
1	113a. establishment
3	assessment conducted
1	stat. 885;
1	payments, shall
4	body, or
2	falsity of
1	inconclusive, the
1	regulation. a
1	recommendation; publication;
1	formed by
18	index for
1	promulgate amendments
1	provisions designed
2	standard; (e)
1	average, over
1	render full
2	states. (4)
2	role in
4	paragraph by
1	(b)(i), an
1	controls, except
1	immediate containers
2	distributors, dispensers,
1	annual revenues
1	serious drug
2	long term
1	823. registration
1	prior written
1	350f, 350e,
1	steroid, the
1	section) that
1	in[1] 381(q)(3)
2	court determines,
1	paragraph be
2	contents are
1	seq.] which
1	section 360e(f)(6)(b)
14	maintenance, and
1	domestic no-hig-risk
1	stage means
1	visits on
2	remove from
1	regarding advisory
1	360c(f)(2), 360e,
4	humane methods
3	additive) which
8	strategy is
1	pharmacies in
2	office. (6)
1	food if,
1	(including both
2	device identifier.
1	product requirements.
1	samples should
1	different investigation
1	additional opportunity
1	sale, the
1	rules, the
1	regarding womens
1	additional authoritythe
2	may establish)
1	disease, and
2	first submitted
1	day shall
1	auditor, except
2	information identified
1	misrepresentations with
1	applicant. (c)
1	regulation classifying
1	days remaining
1	act. (m)
2	court finds
1	(iii) validating
3	(a), as
1	(e); 
2	identical with
1	day and
13	 (v)
3	article into
1	professionals; and
2	assessment in
1	(d) inspections
1	(c) (except
5	following circumstances:
1	usual name.
1	usual name,
1	dietary supplement:
1	(a), an
2	equivalence of
1	pr- and
2	both. (7)
1	residue protects
1	rulemaking; (4)
2	international treaty,
1	heroin. (11)
7	organization described
3	(iii), the
5	review fees
1	specific fruits
2	foods the
1	resuscitation, when
1	diversion will
2	petition as
1	became effective
1	china for
1	enact such
1	collective weight
1	characteristic or
1	branded as
1	unlikely to
2	claim against
1	(e) $8,467,000
14	manufactured or
3	substances. (2)
1	benefit, public
1	section unless
7	clinical and
1	advertisements, the
2	pay any
1	regulations). (e)
1	(3) required
2	regimen, or
1	335b and
1	residue based
1	54.0. 
2	delivered before
1	government authorities;
1	importers percentage
1	crisis, the
5	iii under
1	electronic gateway,
3	conduct 
1	limitationapproval of
11	real world
1	2012, including
8	either 
1	manufactured, received,
1	assessments that
1	include either
1	identifies such
1	tank the
1	undertake with
1	manufacturer offering
4	certification in
1	eliminated, report
1	0.5 
1	interim guidance
2	issued (whether
1	registration recommended
1	flavor, herb,
2	360b(e)(1)(a) through
2	patient for
32	petition for
2	adjusted further
1	gas submitted
1	notices 
1	title (taking
2	establishment pursuant
17	certification is
5	application withdrawn
1	talent costs
1	review fee)
1	claims notwithstanding
1	stat. 1235;
1	7,2 by
1	committing or
2	concurrent use
8	february 15,
1	sensitivities and
5	section 501(c)(3)
4	section 335a
12	expenses with
3	manufacturers, distributors,
1	sunscreens that
1	leadership act
1	scheduling to
1	held before
3	documents regarding
1	bases used
1	(q) restitution
3	distribution security
1	distribution history
1	sponsor involved
2	identified, and
1	(f) annual
4	applicant seeks
1	clause (ii)(iv)
3	prosecution or
1	maximum civil
2	empowered to
1	branded no
1	applications were
2	sticker or
1	(3) adjustment
1	emerging threats.
2	initial report
1	sites where
1	activity, that
1	government (including
10	recommendation to
2	identity, quality,
2	logbooks under
2	chapter, but
2	be, distributed
43	may have
1	issued, bring
1	lymphatic filariasis.
2	sources the
2	enable secure
1	board vessels,
1	authority, submits
3	managerial agent
1	scientific use.
2	statistical, and
4	unless, within
1	possessed with
6	qualified employee
4	(1) within
1	dissemination shall,
2	(b)(1)(c) is
1	30, 2016.
4	(b) give
5	30, 2016,
2	expended, without
3	resulting final
1	month in
2	bar code
2	determining, for
2	smuggling, or
2	broker means
1	him, except
2	party receives
4	complained of;
3	 (18)
1	2014; and
1	675, 510,
1	regulations requiring,
2	101 of
5	term advisory
6	counterfeit, simulated,
1	advanced surveillance,
1	destination, and
10	enactment date
1	proper, except
1	considerations set
1	pipes; (3)
24	medical gas
1	formerly 746,
1	1503 to
1	appointed (by
1	actions will
1	(a)(4) (relating
1	dispense, procure,
1	survivors by
8	subparagraphs (a),
1	communication, except
2	section) to
1	(2) articles
1	previously received
1	past year.
1	superiority trials,
3	manufacture controlled
14	(h) the
1	playgroundsnotwithstanding any
1	subsection, funding
1	accountability measures;
1	public is
14	petition or
5	pending on
1	(2) submissions
1	retailer) who
8	pending or
1	1395w104(b)(3)(c)(ii) of
3	hair dye
1	prescription which
1	law. (2)
1	inflation adjustmentbeginning
2	comprehensive plan
1	data determined
1	determination 
2	prevent use
2	meets one
1	initiatives for
1	effect not
5	u.s.c. 451
1	fees equaling
2	documents to
1	made use
2	designation by
1	convention for
1	effective investigational
2	amended order
1	(1). (

1	one package
1	rules repackaging
10	states upon
1	(3) bears
1	findings congress
1	department (other
2	4 months
1	slaughtering cattle,
1	described as
1	embryo chicks
3	certificate means
3	preparation by
1	assessed, the
1	degradation. (ii)
2	(g) any
1	licenses, instructions,
62	secretary. 
4	(g) and
7	batch of
3	21 of
1	total sales
3	run into
1	two years)
4	designation: 
1	initiate discussions
1	675, 913,
2	conduct; or
1	epidemiological data;
2	prescribed with
1	(7) memorandum
3	offense have
1	donation where
1	committee. (b)
1	
 353b.
6	section 387k
1	treatment. (ii)
1	trade organization
1	complete. (e)
8	section 387j
2	person acted
1	appropriate communications
3	appeal shall
2	section 387i
3	fully and
1	it, make
1	information; abbreviated
1	ammunition, or
1	registrations the
1	adequate 
1	(a)(2), fails
23	secretary; and
1	regulating food
4	planning and
1	support (including,
1	(2) $24,000,000
2	useful and
1	desirable, the
1	scenarios that
3	person executing
2	evaluation. 
1	oxygen deficiency
2	valid prescription.
1	material, which
1	expenses the
1	misdemeanor and,
1	flavoring or
2	legal entity
1	concerning storage
1	conduct inspections,
1	case section
1	format specified
1	doctors, and
1	applicant by
1	administration. notification
1	secretary physically
1	higher priority
1	stevens olympic
1	investigation, and
1	standardized analytic
1	furnishing in
3	plants and
1	faculty. 
1	place within
1	confidentiality described
1	least 21
1	absence, substitution,
14	date for
1	(aa) purchased
2	business which
1	countermeasure approval,
1	notifications under
2	ordered, or
2	2219a of
1	properly implemented
1	commerce otherwise
3	third parties
8	may return
4	remit, with
2	(2) termination
1	every school
2	limited population.
1	limited population,
1	samples which
1	(7) distributor
1	concerned: 
2	statement, in
1	regarding biosimilar
1	feed control
2	counter without
1	conditions or,
2	feesin establishing
9	total fee
1	bringing of
3	notice by
1	presents demonstrable
3	food; (4)
1	input is
4	partners beginning
3	production costs
2	revised draft
13	interim final
1	athlete means
1	outlet then
1	law concerning
1	ability (a)
1	fraud upon
1	must not
1	association, within
4	section 387a(b)
1	continental or
1	considering in
3	practicable means
4	1412 of
1	territory, district
1	infectious disease,
1	(b) timinga
2	subsection. (d)
1	designating such
2	components intended
1	(1) qualifying
1	labeling. (d)
1	action appropriate
1	including hazards
2	disclosure could
2	agencies on
1	priority that
1	interactive and
1	regulatory, licensing,
1	drug administrationbecause
1	investigation has
2	materials, containers,
2	 (20)
1	claimed exemption
2	biologic under
70	 
2	eligible for,
1	274a.2(b)(1)(v)(b) of
1	sentence which
1	samples from
1	secretarys request
1	excluded (or
1	(3) extension
7	defined as
3	(5) when
16	secretary issues
2	collectively, a
1	identical substance
1	commissioner. if
1	biological fluids
1	stone, plastic,
1	cases, sufficient
2	secretary issued
1	statutory authority
2	$5,000, or
18	state coordinator
3	initial public
1	priorities on
1	formerly 1011,
4	62 stat.
2	executive order
4	attend a
6	priorities of
1	(1) commerce
14	case in
4	service under
4	accreditation 
1	action. until
4	manner which
1	case is
4	case it
5	tentative approval
4	criteria deemed
1	section 4(g)
1	approved professional
1	information given
1	pay tort
1	biologics 
1	issued. the
2	diverted, including
1	plants located
1	851 of
3	manufactures a
1	delivery is
1	(11) supply
1	1701(10) of
1	(only with
2	children in
2	specific duties
1	import adulterated
1	coordinate communications
10	products or
1	delivery to,
4	drug application;
6	(b) additional
2	complaint, of
1	petitioner rather
1	$1,000,000, or
1	subsection (p),
10	approved, the
1	(b) minor
1	media form,
1	meet expected
1	(or fraction)
4	drug application)
2	complaint, or
1	(e) refrigeration
1	respects except
39	products of
32	drug application,
8	drug application.
1	379h1 of
5	products on
1	denied approval,
2	use. (6)
1	
 2110.
1	exemption while
1	assay in
1	(f) post
1	343. misbranded
1	original notice
1	avoided, the
1	individual agrees
3	geographic location
14	certification of
2	drug should
1	representations or
1	elsewhere, of
2	(b)(2)(a) or
1	concerning exemptions
1	profession. (3)
1	employee having
1	isosafrole. (q)
1	
 350.
1	avoided by
64	drug applications
1	oxide when
1	(iii) requirement
1	(a)(i) shall
1	error. 
1	legal costs
1	(4) late
1	comparable approved
6	restricting the
2	public, academic,
1	foundations that
1	thereof. any
1	transitioning into
1	application imposed
1	section 841(b)(2)
1	shipments. (d)
6	path publi-private
4	(c) applicability
1	manufacturing) at
1	subsection, no
1	extension, outreach
2	means unless
1	ingredients, identified
1	index, and
1	adulterates a
3	assistance provided
11	food purposes
1	compounding; (ii)
1	sharecroppers. 
1	order allow
1	adopt technology,
6	anhydrous ammonia
4	abstracted therefrom;
1	guidance, policy
1	requirements; redesignation;
2	dose injection
6	constituents, including
1	medicine, medical
1	(b)(1) before
2	certification referred
1	states tobacco
2	2012 to
2	determination; and
1	general, subject
1	made. (mar.
1	(n) any
1	protections consistent
1	lower than
1	unsatisfactory or
1	regulators forum,
1	list, shall
2	subsection (c)(3)(e)(ii)
1	recipient. (iii)
1	countermeasure, provided
1	(22) thebacon.
1	formula are
1	corporations excepted;
1	(n) and
3	supplement not
3	filling the
1	reasonably accessible
1	subsequent drug
1	419, as
1	(b)(2)(b), subsection
1	account established
2	effect. if
1	budget 
2	(c) interagency
1	determination, and
1	5316 of
1	capacity 
2	case described
1	v compounded
1	classes that
1	warehousing, or
1	assessed, or
1	retail class
1	section 374(a)(1)
1	discrimination provided
2	health because
1	treat, mitigate,
1	title, issue
1	by, an
1	dangerous drugs
1	known hazard
1	livestock that
4	analytical testing
1	346a regulations
1	official abstract
2	reception, holding,
3	years. in
58	cosmetic act
1	shall entitle
5	1, 5,
1	manufacturers thereof
1	move to
1	(5); (b)
1	laboratory records,
3	brings a
1	register whenever
1	give each
1	retesting, or
1	(18) returns
1	title 7,2
1	(2), (5),
1	supported by,
1	2009. (f)
1	food. (c)
1	combat methamphetamine
1	defendant a
2	verified statement,
1	(a) efficiently
1	ensure against
2	condition, outweigh
1	product offered
2	better coordination
1	section 379i(8)
1	will consistently
1	title between
5	administer oaths
1	350(c)(1)(b)(ii) of
1	year multiplied
1	purchasers, and
1	necessary, testing
1	propose conditions
1	measured and
5	purchase advertising
3	termination under
1	rx only.
1	practicable opportunity
1	operators or
9	1903 of
1	years is
1	law consistent
1	expected completion
4	section 379h(a)(1)(a)(i)
1	quota increases
7	possessed by
1	agreement has
1	(9) carry
2	orders, instructions,
1	(1) state
2	operators of
2	years thereafter.
1	
 467f.
1	refusing administration
1	360l. postmarket
1	372a. transferred

2	direct through
3	authorized activities
5	shall cease
7	bioavailability studies)
8	years thereafter,
1	diameter; standard
2	general policies
2	uses under
3	greater quantity
2	387p of
2	effort already
2	tribes (as
2	health emergency,
2	processed, bought,
1	critical informationexcept
1	determination. such
1	manufactures both
1	section), transaction
1	radiation, the
1	inspection compliance
1	(a) contents
2	outstanding fee
1	threat response
2	certainty. 
1	jurisdiction involved
1	chairman, the
2	indole ring
1	rules agreed
1	(g) return
4	(i) no
1	percentages were
2	product. (june
1	delivery of,
1	drugs included
1	secretary only
1	802(54)(f) of
4	introduce into
1	468. cost
1	removed as
1	either from
8	title, section
6	drug until
1	(ii) determine
1	radiation; (b)
1	information dissemination,
1	u.s.c. 2012))
1	processing operation
1	(f) fee
1	reimbursement (user
1	entity. (d)
26	administration. 
1	sales quantity;
1	strength. 
1	(1) united
1	recalling such
1	901. severability
1	labeling; destruction
3	component for
6	term new
14	establishing, modifying,
1	information collected
1	1056. separability
2	(a) 100
1	pay under
1	interagency agreement
2	initial regulations
7	programs or
13	advertising and
1	benzaldehyde. (w)
1	methodology. if
1	facilities c-located
1	device first
1	devises, or
1	hallucinogenic substances,
3	emergency, or
1	enrollment, data
1	lead such
1	wholesome, otherwise
1	jury. when
1	facility requirement
2	site established
5	administrative costs
9	programs of
1	longer valid,
1	installation, operation,
1	$153,000,000 for
2	42, including
2	ending april
1	sections 842(c)(1)
2	general notifies
1	populated with
1	evidence; and
1	distribution (as
1	fiber produced
1	medical services,
1	necessary; in
1	identity (by
1	term special
1	chemical pursuant
3	by, the
1	occupying a
1	therapeutic value;
1	proceeds. (

55	information and
1	heroin, marijuana,
6	identification number
2	section prohibits
6	appropriations act.
1	register after
1	authorized manufacturers,
2	retail any
2	combat drug
2	director concerning
1	drugs listed
2	(b) more
1	secretary, supported
1	term therapeutic
3	submission the
3	penalty assessed
3	cooperative or
1	substances furnished
2	business; finality
1	
 98.
5	means that
1	business in;
1	format. until
1	conduct regular
20	period as
1	effect. the
1	387c. misbranded
6	notified of
1	applicant believes
3	system 
2	appropriations acts
1	term. (2)
1	includes conditions
1	plan contained
1	default, shall
1	(b) articles
1	date this
2	health as
1	(k) and
6	patients to
1	2020, $14,800,000.
1	establish, continue,
1	(e) broker
6	entity 
1	subsection. (ii)
37	supplemental animal
7	with, a
2	lists under
1	completion. (h)
1	agriculture, or
1	private institution
1	criteria determined
1	tools or
2	substances, which
2	may directly
2	measured by
4	diseased cattle,
7	whenever any
1	processing activity;
1	seq.] on
1	societies; (ii)
1	noncompliance if
1	(ii) limiting
1	(d) payment
1	board, through
5	control policy,
1	justifying emergency
1	agency meetings
1	device) 
4	control or
5	instituted under
2	of, contact
1	covered with
1	abstinence from
1	coalition the
1	inadequate requests
2	trials with
1	fixed. the
1	due to,
1	chapter who
1	boards; and
71	control of
1	court considers
1	date no
1	level. 
1	4, 1923
3	360cc(a) of
2	developing medical
12	period the
1	shall occur;
1	(1)(g)(iv) shall
1	care organizations;
1	(1)(c)(i), and
1	reinspections; and
1	661. federal
1	meeting approval
1	enable a
1	etc., meat
1	characters used
2	national laboratory
1	place undue
1	detailed justification
1	establishment fees.
1	twice annually
1	establishment fees,
3	(1) identifies
2	probation, or
1	(1)(e)(ii). fees
1	compliance on
1	practitioner shall
1	(b)(2), shall
1	identification is
1	different route
2	oleomargarine, butterine,
1	outlet, if
1	definitionswhenever used
1	act). (b)
1	otherwise) notifying
1	systems, or
1	product covered
3	section 247d
2	training provided
1	amended, under
2	safe access
17	regulations the
2	web sites,
1	17 and
1	offense. (4)
1	military forces
2	affiliates shall
1	submissions, animal
6	population as
1	entities. such
1	u.s.c. 387
2	456 of
2	secretary expedited
5	(b)(2) or
1	(2) extrapolation
1	i, 11,
1	deadlines with
1	experience of
1	name, serial
1	seafood imported
9	form, strength,
1	2009if the
1	(a) utilize
12	transportation, in
1	regularly licensed
1	distributor had;
1	filing fee
1	(3) community
1	american feed
8	section 384b
1	1971) has
1	100 if,
1	draft and
6	transferred to
1	(6) miniature
1	granted exclusivity
1	than, any
1	(iii) establishing
2	final assessment
1	(c) condemnation;
1	term production
5	360c(e) of
2	26 stat.
1	comprehensive report
1	biological product),
14	effect for
4	chemical means
3	unlawful actsit
1	mitigation or
1	identify substance
2	section within
1	stores shall
1	transportation, placement
3	testing 
2	water that
1	commission, upon
1	capsules, which
1	partial substitute
1	subparagraph (b):
1	final at
1	including qualified
3	tribal food
1	request pertains
1	importer shall,
1	dosing and
2	medical products,
2	medical products.
14	disclosed to
3	term importer
4	taking of
1	auditors in
16	submission to
2	consignee, into
1	mixing, reconstituting,
1	exception shall
1	(5) milestones
1	practices each
1	needed medication
2	medical products;
1	inspection, but
1	harvest. 
1	among public
12	(2) shall
1	387n. jurisdiction
1	challenge testing.
1	condemned they
1	added, or
1	(2) limits
2	use, any
1	iv, 404,
14	residues of
1	countr-product combination,
1	consumers. (mar.
22	title is
1	(under federal
17	(c) 
1	commissioner. (c)
51	coordination with
1	extracurricular programs
1	adolescent psychiatry,
46	subparagraph (b),
1	2004, and
3	review committee
1	notification authorized
21	title in
1	262; (d)
2	cos-effectiveness, and
1	nutritionally equivalent
19	title if
1	valid sample
5	adulterated shall
1	(1) approves
9	states; and
2	endpoint is
2	notice regarding
1	industry sectors,
1	every 30
1	nongovernment organizations.
1	waivers consultation
4	 (bb)
1	(f) applicationthis
7	committees and
2	requires approval
1	6151 of
1	(b) do
1	forfeited be
2	entirely from
1	compensation, terms,
1	surrounding the
2	832833) (commonly
1	[4] if
2	director there
9	limit on
1	laws governing
1	national survey
3	repacked in
2	stat. 1058;
1	grants, contracts,
1	definedin this
1	limit of
1	speed of
1	importers, 1
1	applicable (as
1	observations made,
1	identifying potential
2	only, and
27	title i,
1	18. (e)
1	aggregates the
3	limit or
2	section 384d
1	applicable inspection
1	22, 2016
1	mineral (or
3	using, or
1	states law,
1	distributor), request
4	commodities, including
2	1472 or
6	modifications to
1	airway obstruction
1	veterinarian issuing
4	notification has
2	thereof, will
1	compounding under
2	state agency;
1	identifying contamination
1	335. hearing
1	safe, wholesome,
1	abuse the
1	tested using
2	state agency,
4	general, after
1	distributors (a)
1	pay fixed
1	alphanumeric serial
3	another such
2	similar establishment
1	hydroxypethidine. (26)
1	(a) recognized
5	patent validity
3	exemptions are
1	relationship. this
1	stored, to
2	violate requirements
1	vulnerability assessment
1	notice being
1	regarding prior
1	optical or
1	donations and
1	tool determined
1	reached. each
3	secretarys discretion,
2	vocational, or
5	material, compound,
1	regions or
1	goals; 
3	posting such
1	areas with
1	limiting any
146	notice of
1	total prescription
1	insect and
1	device. whenever
1	effective may
2	apples contained
4	secretary. any
1	chemicals could
1	agriculture attributable
1	powers to
1	area clearly
5	safety programs
5	infringed by
1	either without
12	contain such
3	performanc-enhancing drugs
2	enter such
1	list. for
1	order form,
3	67 stat.
2	section 355(c),
1	etc. 
4	application. if,
6	clerical and
1	maintain its
2	approved, shows
2	ingredients as
1	new views
1	regulations (which
1	distribution schedules.
1	sell, at
6	imposing a
17	shall identify
1	light, mild,
2	farm sales
1	specific exemptions
4	wel-controlled clinical
1	suspended, if
1	(ii). (3)
2	fact raised
19	201 et
9	effect before
1	novo, and
1	bind the
1	foregoing substances
42	1907, ch.
10	except that,
2	agency management
1	(a) quarantine
1	policy changes
1	animal drug),
3	clauses 1,
1	implant unless
1	phenylpropanolamine that
171	title. 
1	concentration proposed;
1	(a) united
1	30, 1978,
1	
 379b.
1	deferral that
1	trial are
2	requesting the
2	reflects data
1	preempts or
1	(9) conduct
1	regulation presents
2	reasons, the
1	concentration proposed,
3	help mitigate
2	device. (v)
1	contractors the
1	675, 512,
4	defined under
1	3 distinct
1	liability set
2	state license
1	list referred
1	achieved. 
1	website, and
6	dietary supplements
1	impedes r-exportation
1	consensus regarding
4	state will
1	listing; (b)
6	verification from
1	administration, demonstrate
1	article, equipment,
1	information), such
1	certain substantially
1	387j. application
1	drug marketed
1	processors; and
2	(d) state
1	section, knowing
1	360b(b)(2), 360b(c)(1),
13	rare diseases
1	informers the
1	equines on
2	subchapter as
2	testing services
2	827 of
1	accept data
3	treatment with
2	produce is
2	average proportion
1	mission of
1	section 841(b)(1),[1]
2	sale; or
1	unobligated fee
1	term administer
1	involving moral
1	mixing, diluting,
1	recipients. (e)
1	ceased distribution
2	produce under
1	(by majority
1	-ray equipment,
1	veterans health
6	adopted by
2	assure its
5	account any
2	district courts,
2	system, the
4	seized under
3	account and
2	approvalthe secretary
1	(1) coalition
1	introduce evidence.
1	(less a
1	effective. nothing
2	medical association,
1	approval, specified
1	service shall,
1	recommendations; appointment
4	inspection conducted
2	labeling. 
1	agricultural producers,
1	biosurveillance integration
1	entry, and
1	wet wipes,
1	compounding 
1	subsection but
1	internal systems
1	regulations prohibiting
1	 nutrients
2	distributed only
5	purpose. the
1	sellers any
1	finding. 
1	properidine. (41)
1	355. new
1	controls (a)
1	individual quotas
2	(c)(3)(e)(ii) of
1	deposited with
1	review committees
1	packed. (2)
1	activities), only
2	chapter, are
1	without hearing,
3	mixes or
1	term foodborne
1	council relating
1	food other
1	(2) applies
2	drug prevention
1	(9), and
2	shall, insofar
8	part shall
8	understanding, or
1	improving regulatory
1	drug referring
1	sections 1034(e)
4	reviews and
1	(e) distributors
2	relevant pediatric
8	selected establishments
2	(3) consultation
5	relationship to
1	sections 3612
1	international labeling
1	(6) all
20	petition under
1	practical impact
3	controls prescribed
1	agriculturein implementing
1	met shall,
1	requests shall
1	4(h) of
2	symbol it
1	(8) of
1	legalization (for
1	proceeding pending,
2	provider that
1	methamphetamines. (

1	person must
6	final and
2	institute a
1	additional notice
2	illicit trade,
1	device exemptionsupon
1	radio frequency
21	denial of
1	completion date,
1	required additional
1	(vii) 100
1	jurisdiction, until
1	(b)(5), or
1	indications, and
1	detection, and
1	114d2 to
1	exporter will
1	temporary order.
1	format, limit
117	carry out
2	chairperson the
1	trend analysis
1	(3) governing
1	compendium, except
1	(v) benzaldehyde.
1	ii compounded
1	risks; and
1	demand in
1	violation rate
1	ghbin the
1	advertisement advisory
1	410
 

1	improving public
2	approve abbreviated
1	secretary file
1	(ii)(ii) publicly
2	puerto rico)
1	department wherein
2	animal food;
5	puerto rico,
4	puerto rico.
25	section 360
1	(1)(f), the
1	coordinated enforcement
5	use described
3	action, and
1	paragraph than
2	therapeutics shall
2	632.)
 

1	(9) any
1	including varied
2	committee member
3	dietary supplement,
3	found. 
3	dietary supplement.
4	secretary. (

2	claimed to
1	registration; qualifications;
1	interest standards
1	360e3 of
1	section. (6)
1	committee. the
32	test interpretive
1	conferences. 
1	december 1st
2	section that,
1	disease under
1	ergonovine and
1	review. meetings
1	official compendiums;
1	45] with
1	(b) hazard
1	antifungal drug,
1	however, such
3	 (15)
1	public, scientific,
5	thir-party accreditation
3	(2). the
1	approval of,
2	adequacy, necessity,
1	stringent controls
1	675, 571,
1	help resolve
1	nongovernmental recruitment
4	500 grams
1	section 453(a)
1	maintained, under
3	files an
1	executing this
1	agreements, with
1	appropriate, specimens
8	schedule for
1	action; but
1	filed 
2	(g) meetings
30	may prescribe
1	time purchased
3	extent or
3	1 business
1	afforded to
14	title; (b)
47	written notice
8	owner, or
1	prescription medication;
1	understanding with
30	extent of
1	aqueous format,
4	imported articles
3	violation continues,
1	petition requirementsany
3	marketed would
1	together a
1	feasible. 
1	him, and
3	populations or
5	device. (b)
2	thereof, are
31	registered under
2	5 kilograms
1	piritramide. (39)
2	commonwealths, territories,
1	(oo) the
3	accessible to
1	promulgate, and
1	physician; and
2	applicable statute
1	(i) emergency
1	concepts to
1	approval will
1	narcotics traffickersnot
2	title was
1	import. 
1	health significance
3	prevention consistent
1	offenders second
1	successor internet
1	strategy. (b)
2	private organizations
1	bonds and
10	violations adjudicated
1	drugs or,
2	first action,
1	1701 et
1	barriers at
3	product development;
5	exported under
1	
 350l.
1	importation, exportation,
1	scientists, or
1	directions consistent
1	available analytical
1	offering a
1	flavor of
1	needs the
1	product development.
6	product development,
16	notice from
1	exceed ninety
1	(h) exemption
1	chapter, have
1	amounts equivalent
1	developed, and
1	675, 404,
1	relevant period.
14	shall state
1	(iii) finds
1	poison, or
1	board considers
1	subject with
1	involved if
1	burdens of
1	new york)
1	products; venue
2	written prescription
1	(5) evaluated
1	hoarding or
1	378. advertising
3	burdens on
1	article. an
1	facts pertinent
1	poisonous substances
1	subchapter, shall
1	suspension (a)
1	institute; (2)
2	developed without
1	remedy a
1	demonstrated an
1	drug) if
2	subsection (a)(3)(b),
4	42 stat.
1	procedure provided
1	manufacturer; (ii)
1	360fff4. guidance;
1	consolidation and
1	1320a7(a) of
1	(f)(2), (n)(3),
3	sanitary, quality,
1	objectives established
4	products per
1	petitionsthe secretary
1	devices; mandatory
1	(i)effectiveness of
1	files with
1	facility loan
10	effect it
2	effect is
1	paregoric, the
1	459, 461
1	containers may
5	upon determining
1	(4) procedure
1	research, training,
1	scientific dispute
1	
 360bb.
1	offsetting receipts
1	harm. 
1	experts, established
1	safety, including
1	poultry; (3)
1	day during
10	effect in
7	extend to
3	business; and
1	cream where
1	property. (f)
2	year, not
1	 (d)2
1	true or
1	facility, nursing
1	labeling concerning
1	dairy farms
2	foreign animal
5	u.s.c. 811(j)].
1	conduct, at
1	(as authorized
2	ii in
1	head the
1	title. any
2	existing tobacco
9	continues to
8	product standards
1	(13) -ethy--piperidyl
3	poultry item
1	(ix), and
1	initial reportthe
1	level; how
1	conduct is
1	desired labeling
1	including demand
1	discloses individually
2	combination makes
1	reasonable times.
3	clinical endpoints,
3	assess potential
8	recordkeeping and
1	indirectly supplies
1	other; and
1	(vii) have
1	invalidate the
1	gao report
1	locate first
1	sources specified
1	enhance intergovernmental
1	upon nutrient
4	base, pseudoephedrine
1	naphthoyl or
1	reviews equal
1	experience datafor
2	age is
1	construction of
1	practice. (ii)
2	conducted prior
2	conducting clinical
9	decision by
1	targeted direct
1	secretary; applicability
1	chapter prior
2	1934, ch.
1	commence surveillance
1	exemption does
3	product standard.
1	background of
2	semipermanent or
1	210. pharmacist;
1	ch. 613,
11	revoke any
1	refrigeration and
1	2235 of
9	meetings of
1	18; or
1	animal: provided,
5	decision be
3	thing of
1	generalthere are
1	secretarys inspection
1	optimize national
1	[1] shall
1	regulations become
1	segregate the
2	common name,
2	redesignation of
1	(a)(3) within
1	multiple convictions
1	(1) responsibilities
2	section 360e(d)
1	authority. 
1	agriculture; (2)
175	application for
1	equipment, all
1	times be
1	extr-label use
2	identifier which
2	corrected the
1	lyophilized powders;
1	consumption of,
1	addiction; (17)
4	regulations specify,
3	criteria used
1	gives such
1	(d) internal
2	thereunder. 
1	dyes. (b)
2	replacement products
3	criminal offense
1	methods (a)
1	applicable, has
1	841(a)[1] of
1	holder notice
1	requests. (d)
1	(2) authorization
1	section 360j(g)(2)
3	certain classes
2	corrective actions
1	quality factors,
6	difference from
1	cause inspection
1	title, constitute
1	compromise of
1	give or
2	section 2656f(d)(2)
1	regarding nonliquid
1	vegetables) intended
3	common names
1	commission shall,
1	methamphetamine on
1	directors (referred
1	period that,
1	force, and
1	violation. each
1	retailers request
1	(h). (q)
1	significantly lower
1	goals. the
1	provided five
1	added mar.
1	manufacturer (as
7	fungi, or
1	$635,000,000. (j)
1	509, as
1	detect such
1	indexing new
1	processed; or
1	1 category
1	subsection (b)(1)(a)(i),
1	boobytraps on
1	fahrenheit after
1	submitted; (4)
1	assigned shall
1	transfers or
1	omitted (

2	services. in
1	data. (h)competitive
1	respecting false
3	conducting such
1	written to
2	(b) practitioners
13	performance standards
2	term outsourcing
2	certification contained
2	(by reason
1	(iii) proceedings
1	360g. judicial
3	emergency conditions
2	proceedings; notification
1	product, evaluated
1	death, that
2	identified during
1	complainant to
5	criteria are
1	drug abstinence
2	terms investigational
4	imported from
65	submitted by
1	(c). (l)
2	court deciding
3	whose possession
2	inclusion on
1	(ii) hearing
1	physicians shall
2	perjury that
1	leaker means
1	states exporters
34	chapter and
1	(2) except
1	fed to
1	detention authority
1	notation, approved
1	hearing after
1	places where
4	secretary, except
2	regulation, the
1	unlawful actsany
1	book entry
1	guns, ammunition,
1	entity specified
1	swine populations.
1	subchapter, if
1	commodities based
1	officio members;
5	one member
3	title 15),
2	counterclaim to
4	regulation provide
1	emergency condition,
2	institutions. 
1	officio members,
1	investigational tobacco
1	following exceptions:
1	(a) conditions
5	order such
1	fees; definitions
1	appropriate, expedited
1	directed by,
1	modified devices.
2	situations, seminars
1	possessed and
1	certain administrative
2	discontinued the
1	minimal, financial
1	drug dependent
1	search warrants,
1	device reclassified
2	will improve
1	representatives, as
2	therefrom into
1	section 379j(a)(2)(b)(v)
1	(a) between
1	body, solely
3	meat item
3	upon presentation
1	(1) action
1	amount 
8	federal agency
1	staff fellow
1	auditor, through
3	person named
1	
 360n1.
1	immediately; (b)
1	year, at
1	(b) timing
1	required determinations
2	expeditiously as
1	article; if
8	year, as
1	divisions for
12	year the
1	projects pending
1	manufacturer affecting
1	proclamation, suspend
3	percentage change
2	submission reviewed
3	charitable organization
1	board initially
4	commercially available
1	haccpthis section
2	seq.], including
1	(d) develop
1	use, on
2	permit granted
1	period expires
4	database a
1	diverted; and
1	summaries are
1	9, 44
2	drugs, may
1	scientific soundness
2	submission. a
1	
 371.
2	sell such
1	entering information
1	diagnostics the
1	practice includes
1	commerce, he
1	broken shell
2	anticipated present
1	ensure coverage
1	audit checks
3	manufacturer as
7	penalty for
2	dangerous, toxic,
1	(d)(iii) shall
1	ensuring safety
4	earliest possible
1	 6.0.
1	times display
1	farm if
1	(d), if
1	however, notwithstanding
8	establishment, and
2	invoke the
1	special circumstance
2	governmental unit
1	applicable. (g)
2	enjoined from
1	2013, be
1	regarding oleomargarine
2	drug shortages;
1	term modified
3	maintained for
1	tissue; 
1	i, 7,
1	objective clinical
3	section 501(a)
1	and/or of
1	agency; (d)
1	recover damages
3	enforcement 
2	(b) gao
1	voting stock,
1	emergency situationsin
1	declaration if
1	formerly 360c,
1	additional grants
1	such, after
1	transferred. (b)
10	331(j) of
1	3663a of
1	consider binding
2	steroids if
2	paragraph (1)(c),
1	commercial vessel,
1	advertise the
5	approved as
2	appropriated (1)
1	hearingthe attorney
1	held using
1	hearing provided
1	indications; and
1	(f) veterinary
1	layers. (5)
1	device without
1	drug applicationsexcept
1	druggists, hospitals,
2	paragraph (1)(c);
1	distributed domestically
6	part and
1	notification each
1	programs; (g)
16	clinical data
1	risk. before
1	on, product
2	vendor. (c)
1	abstract, book,
1	u.s.c. 181
1	sections x.c
2	corporation, shall
2	2003, the
2	applicable national
1	800, 2,
1	licensed distributor
1	least minimum
1	review employeesfor
1	physician has,
1	device, then,
1	(a). (5)
1	businessesnotwithstanding paragraph
1	sources, foundations,
11	activities necessary
1	suggestions proposed
3	payment penalties
1	(u) hydriodic
7	finds, after
1	generalthe united
1	fees assessed.
1	television advertisement)
1	statutes, regulations,
1	(a) purposesthe
1	court permits
30	qualified by
2	television advertisement.
1	chemical composition,
1	(e) staff
1	addiction certification
1	section 360e(d)(1)(b)(i)
4	shall either
1	incarceration or
3	(c) action
2	notification with
1	moves for
2	manufacturer, of
1	intentionally causing
2	inspection procedures,
1	amount representing
1	action indicated.
24	extent to
1	may a
2	information, a
3	(1) develop
2	areas program;
2	forms in
1	factors contributed
1	available prior
1	respecting changes
8	pediatric patients
2	conclusiveness of
1	released to
1	(iv) limitation
1	(5) schedule
5	attending conferences
1	time, conduct
2	human consumption.
3	(e) definition
2	order refusing,
1	360(k)(2) of
2	smoke constituents),
2	medicated feed
31	used by
1	wel-being. (3)
1	local medical
4	may relate
1	(b) seek
1	recall. (b)
3	government agencies
1	resubmission for
1	(c) venue;
1	consideration. nothing
1	facility, offer
1	paid a
2	allowed by
1	harvesting, or
2	(not more
1	public; (iv)
1	crops, including
1	obtained, directly
3	least eighteen
1	permitting inspection;
1	national thereof
1	management; and
1	country, refuses
1	agents; (b)
2	(iii) provisions
1	(b) related
1	american nurses
1	transitional provisions
4	(c) shall,
5	entered against
2	authorized representatives,
1	declined by
2	employees: provided,
2	chapter because,
1	medical schools,
1	advisory meeting,
1	(d) two
6	violates a
1	remains drug
1	manufactures drugs
1	trade. in
1	18 and
2	vit shall
1	(ii) finds
2	indication. 
2	administrators services
1	benefit on
1	following civil
2	(b) individuals
4	believes such
1	(2) he
2	exclusivity and
7	benefit of
1	paragraph; (g)
1	following. 
1	final regulatory
1	(4) schedule
1	description, the
8	need to
2	education, extension,
2	legally constituted
1	2016, which
13	devices intended
1	registrants (a)
3	reinspectio-related costs
1	earliest practicable
1	nicocodeine. (19)
4	records for
4	prevented from
2	useful in
1	department as
2	section 353b(b)
2	submitted that
1	e (iu)
1	person incorporated
1	justice any
1	requests, the
1	3rd par.,
1	delegate. (b)
1	enhanced surveillance,
1	summary. 
2	approved; (2)
2	(ii) deselect
1	360ccc] or
5	mitigation strategies
3	performance standards,
1	instrumentalities when
1	(f)(2)(c). 
2	conviction reversal
6	may appeal
1	objectives specifiedthe
1	(7) phencyclidine.
1	consignee. (3)
2	pediatric studies.
1	pediatric studies,
2	participated as
4	assuring that
1	indications; or
1	research protocol.
1	facility, (c)
8	entities. 
2	agencies (such
1	shown, keep
1	suspension actions
1	
 1603.
1	detected such
1	acid; (e)
1	schools. 
1	vital to
128	shall submit
1	future, or
8	may apply
1	tolerance. (f)
1	either affirming
6	association of
4	defense, and
1	constitute multiple
3	(1) issue
1	876 of
15	may determine
1	(1) previously
2	relevant exposure
1	internet, except
2	issued because
1	section 16.
1	136. additional
1	products; (c)
15	secretary (or
1	additives; and
8	applicant with
1	law; (d)
2	subsection (f)(6)(b)
6	process and
1	limited as
1	particular disease
1	contain advertising.
2	imitation and
1	tolerancenotwithstanding subparagraph
7	consumer or
6	elements of
1	naturally formed
1	different recordkeeping
2	bringing in
4	(h), and
1	proceeding would
1	safety law;
1	(2) expedite
1	1992. (m)
1	section 825,
16	contents of
1	termination by
1	relations with
1	products outside
2	unknown; 
1	stored under
2	consumer of
2	include adequate
1	ii, 203,
1	1996, after
1	testing services.
4	deducted from
1	intended purposes.
2	384e of
1	fee means
1	grams. 
1	order, taking
1	water, shall
1	seeking assistance
1	products directly
2	december 11,
5	entity under
4	person committing
2	direct contact
1	director any
1	toxins, or
1	met (or
1	pet foods
1	misleading name,
34	definitionsin this
1	(24) the
1	
 379r.
2	cautionary statement
1	benefits otherwise
2	$75,000,000 if
1	corporation may
1	agent first
1	pharmacist licensed
3	detention period
3	every month
1	samples, or
1	item that,
1	software, color
1	tank truck,
1	consignee for
1	requiring, or
1	disease, the
3	(7) to
2	purpose; or
1	restrictions are
1	import controlled
1	said inspectors,
1	feasible, it
2	treaties and
1	products then
1	source for
1	provide, in
1	counterfeit or
1	exclusivity provisions
1	section 10.30
1	establish offices
3	shall deny
4	may bring
2	-dimensional data
1	
 379j61.
1	742; 

2	(g) biennial
1	general summary
1	403(a)(10), 66
1	feasible, in
1	grams). any
1	(except coastal
1	packaging). the
2	shall recover
1	(12) dextromoramide.
1	hearings, sign
1	timeliness or
1	safety, dependence,
3	particular food,
1	transferee of
1	particular food.
1	dispenser requirements
2	species, the
1	(c) may,
2	operation, of
1	substances screening
1	title minor
1	(i)confidentiality and
1	arrangements; and
4	public. 
1	person employed
4	timeliness of
2	authority over
2	place and
1	drug prevalence
1	made is
1	food category
1	retail outlet,
1	secretarys proposal,
1	1999, begin
1	term local
1	person develop
1	forth those
1	shall give,
3	application failed
3	nutrition labeling
3	specifically ordered
1	mail, or
1	reevaluation has
2	preservative, unless
1	obtain signed
1	(n)(1)(g) and
83	service act
1	may justify
2	appeals decides
1	body structure;
14	consumer advocacy
4	appropriate. the
2	taken the
1	etc., where
1	subparagraph (f)(i).
18	subchapter. 
2	(c) definition
2	applications. with
1	investigators supervision
3	anticipated to
1	another schedule
1	athlete competes
1	identify whether
5	optional ingredients
2	comment upon
1	(2), this
3	(g), or
1	foundation; (vi)
1	relative marketability
2	sponsor described
1	required by,
1	(i) 7
1	28. such
1	emergency by
1	(i) 4
1	allows public
1	collected; or
1	(i) 1
1	container. labeling,
2	categories to
1	electronic product;
3	including in
1	(v). (cc)
2	index 
1	467b of
3	basis, to
1	substances on
1	including if
1	regarding carryover
2	trafficking. 
1	(b) omitted
1	relevant agency
1	control; (iii)
1	company or
1	for, devices,
1	(b) applies.
1	actions (including
2	accessed by
4	labeling, distribution,
1	(d)(1)(a) shall
1	combined. 
1	gifts, both
1	supplement. if
2	manufacture, that
1	legal means
3	topical application
4	variance is
237	25, 1938,
1	either, at
1	recordkeeping regarding
1	(b) mult-drug
55	(i) a
1	(2) continued
1	dimethylthiambutene. (19)
1	802(54)(e) of
1	variance in
15	subsection (f)
3	name for
2	(d) prior
3	compliance has
1	compound used,
4	5 governing
1	thereto; except
1	chemical 
2	effective final
1	(2) prepare
1	experts for
2	product code
1	consuming a
5	stay the
1	youth (or
2	misrepresentation of
1	(2) periodically,
1	drug shortages,
3	transactions involved
4	applicable percentage
1	trade secrets,
1	requirements were
3	(i) collecting,
1	trade secrets)
6	list 
4	services with
1	120 days,
1	circumstances. 
1	putrid, etc.,
2	ch. 839,
2	safety data
1	seeking either
2	(2) without
1	
 826a.
1	
 1117.
2	(i) changes
1	youth. (ii)
1	include monitoring
1	control number
1	drug cultivation
1	(16) psilocyn.
1	(d) augmenting
1	authorizes the
1	chocolate, cherry,
1	(e) terminating
3	applicable number
1	authority; (4)
1	post a
1	transport, labeling,
1	(3) who
1	seq.). (june
4	animals, which
5	local law;
1	1401(4) of
1	premix to
3	establishments. 
1	aside. a
1	necessary: 
2	duplicate the
2	scientific advice
3	made prior
1	initial letter
1	uses (including,
1	qualifications prescribed
1	authorized government
1	exceeds $25,000,000
1	violative of
1	seq.) as
1	special needs
2	related activities
1	substance may,
3	substances from
7	specific deficiencies
7	contract under
1	production thereof
1	feed but
1	healt-related condition
1	(2) commence
1	single box,
4	(iii) ecgonine,
28	secretary, after
2	year such
1	rapidly resume
1	forfeiture; and
1	published less
3	system; and
7	additives for
2	witnesses, and
1	packages, exports,
1	manner. (d)confidentiality.
2	reinstate or
1	either displays
1	disability, veterans
1	renumbered 4
6	condemnation or
1	distributor, violated
1	punishment; duty
3	(h) definitionsfor
6	entities that
3	study required
1	slaughterers or
1	$50, to
1	number of,
2	fee failure
1	athletes, and
1	butterine, imitation,
1	better recruit
1	to, if,
8	describe the
2	drug samples,
1	ethnic and
3	drug samples.
2	qualified individuals
1	including claims
1	corporations subject
1	safety, effectiveness,
1	act,[1] the
1	category, the
1	commission would
2	section 344,
1	food (such
3	impedes, intimidates,
1	process approved
1	powdered milk,
17	whether to
1	cream at
1	submitted, submitting
2	care system
1	control techniques.
1	(h) limited
3	genuine issue
1	ne-drug application
1	provisions except
1	
 1522.
1	exemptions; regulatory
1	is, as
4	discussion and
1	clinical holds
10	2007. 
1	professionals practicing
1	medicines, and
1	agreement made
1	(50 u.s.c.
2	commit any
1	excluded if
2	(a)(5)). 
1	certification, described
1	injunctions 
1	180 days.
1	9-day supply;
1	180 days,
2	chemical designation.
5	ant-doping agency
1	stat. 1239;
1	drug, determines
2	meet criteria
1	(c) submissions
1	necessary, and
1	provided. 
1	reinspections in
5	index) for
1	section. during
1	
 156.
1	logbook requirement;
1	section 360g1(a)(3)
1	every sector,
1	net cost
1	(b) criminal
2	secretary thereupon
1	material, and
2	manufacturers in
2	substances. the
1	containing or
1	manufacturers if
1	otherwise handling
9	general, the
1	various enforcement
1	open containers
1	convention, to
1	melons. in
1	sel-sustaining. 
1	subparagraph. (e)
3	356(c) of
2	basis, or
1	timetable or
1	 (5)[3]
1	value or
2	chemical seized
1	list, whichever
1	response. (d)
1	ii which,
3	setting; adjustments
1	imported prior
1	(k), and
4	certification from
1	(dd) an
6	(b) this
1	601.45, or
1	governing emissions
1	subsection (b)(2)(a)(i);
1	statement referenced
1	paragraph (13)
12	minutes of
2	including judicial
1	frontier area);
1	modeled after
1	(k)(3) to
5	reduce harm
4	seq.] and
6	(b)(2) for
2	information previously
1	substantially limit
1	1, 1953,
1	code, labeler
3	and, beginning
1	supplement, means
1	directly into
1	holder receives
1	searches, for
1	used against
1	food defense;
1	subpena. the
1	morphine methylbromide.
1	extension, outreach,
1	maintains, places,
1	medical needs.
1	appointing the
1	subsection. amounts
1	
 2102.
6	tracing 
8	commitment to
4	becomes available
1	emergencies, including
2	compensation the
1	added june
1	program pursuant
7	records under
2	surety bond
1	employees; (f)
4	returns processor,
2	consideration, to
1	designated at
1	chemicals, products,
3	private nonprofit
1	(g), shall
3	degradation product
1	fifty states,
4	interested parties,
2	interested parties.
8	fee has
1	date; (vii)
3	distribute, before
1	(21) suspect
1	releases information
1	(including treatment
1	designees: 
1	committee members
2	products; (ii)
1	pseudorabies is
3	part c
1	import any
2	part e
1	commissioner and
2	outweighs the
2	subsection (a)(1)(c),
6	organizations. 
1	subsection (a)(1)(c).
1	recommendations, including
2	pseudorabies in
1	upon motion
2	include sufficient
1	addresses such
16	approve the
1	violation; or
5	consultation between
19	drug means
2	cause upon
3	cooperative arrangements
1	offered through
1	(b)(2)(b). if
3	identifier (except
1	
 360kk.
1	whichever terminates
2	multiple doses
2	special rules
2	2 years;
13	studies or
2	committees consulted
1	exemptions, as
578	pursuant to
1	limit 
6	web site.
2	term nonprescription
12	studies of
1	consider an
1	unlawful; employment
1	zone. (d)
1	law 103417);
1	21 years
4	otherwise listed
1	powder, softgel,
1	2 meeting
1	675, 569,
2	cigars other
1	consumer. nothing
1	2013, except
2	specific timelines
5	order either
1	policy has
2	351(a)(2)(b) of
1	permit are
1	strategic national
11	agrees to
2	official designated
1	treatment, research,
1	decisionmaking, and
2	part 1
1	fourth and
6	predict clinical
4	finding as
4	list to
2	1935, ch.
4	species to
2	label, packaging,
1	national strategies.
8	thereof, shall
2	conditions: 
1	inadequate (whether
1	new timeline
3	web sites
1	(d) buruli
1	article, a
1	notified firm,
1	(6) develop
1	showing reasonable
2	division and
1	(b). (v)
1	nations are
1	(d)(1), the
1	619. marking,
1	 (29)
1	studies ethical
2	use data
1	consul as
2	notice setting
1	orders. 
1	violation; (2)
1	include charging
1	act, suspends
1	year without
1	(iii) within
1	policies on
1	agreement authorized
1	trustees, or
1	reclassification is
1	(g)(2)(a)(ii), such
3	paragraph (7).
1	1802(18) of
3	may appear
1	received, by
10	standards prescribed
1	(a)(2)(a)(viii), and
1	fees based
7	identity and
1	ordinary course
1	(bb) except
1	section 1333(d)
14	commission under
1	adjudication, or
1	379d1. conflicts
23	sold or
1	additional articles
1	management plan.
2	product presents
1	signature in
1	imbedded therein
1	evaluations at
1	ordinarily caused
2	information gathered
1	evaluations as
1	facilitate ris-based
19	sell, purchase,
1	day. 
4	testing device
1	b medicated
1	economy, efficiency,
1	orally and
1	thc in
1	samples. (e)
6	otherwise affect
2	obtained in
1	467 of
2	awarding initial
2	related by
1	peer norms
1	statistics directly
1	(12) $114,000,000
3	review activities
1	(3); (c)
1	values which
1	services, funds,
3	combination product;
2	enforcement authority
1	470. omitted

1	insure care
5	screening program
1	notices, bulletins,
1	suspension should
1	dispensing (including
38	program under
1	(d) testing
2	section; 
2	requested. (b)
5	requirements with
1	valid trademark.
1	cream lawfully
1	foundation shall,
1	3 shall
2	persons representative
1	(c)[1] of
7	facility, including
1	coordinating such
11	services in
1	3, 1999,
1	considers the
3	chapter. such
1	(b)(1); (vii)
2	services is
1	product resulting
1	current briefings
1	152. importation
1	licensed wholesale
1	582; aug.
2	foundation is
1	general designates,
2	treat addiction;
1	enclosure to
1	prescribing), by
1	ii, in
1	(6) manufacturerthe
1	involving drugs
2	new submission
1	
 205.
1	(b)(1) no
3	may under
2	inspection, building
1	makes distributions
1	denial, obtain
2	writing of
1	developed prior
3	foundation in
1	accelerated approval,
1	programs. (

1	supporting initiatives
2	private college,
1	deadline, or
1	
 335c.
3	denial, revocation,
4	effectiveness reasons,
22	directly to
4	effectiveness reasons.
2	time is
1	(c)(1)(a) recognition
2	535, formerly
2	drugs throughout
4	area; (b)
2	section 360eee3(a)
3	series of
1	sponsor is
4	persons for
2	prepare for
1	samoa, the
5	approved before
1	party issue
1	(e).[1] the
1	establishing 
2	(b) returns
1	problems, such
1	enforcement agency;
1	reporting period
1	(a) rulemaking
17	harm to
1	(42) trimeperidine.
1	native americans
1	(f), fees
1	(2)(a)(i) shall
1	therapy.) 
1	(2) confer
2	2013 under
2	thereof. all
1	(5) crediting
1	prohibits submissions
1	notification contain
2	part 
1	26 percent
1	decertification of
1	shortage, the
2	waived by
1	4.0d 
1	(e) transfer
9	preparation, compounding,
1	packaging, isolation,
1	clinical trial;
1	5, relating
2	absorbed from
1	343(q), or
1	personnel detailed
1	relates under
1	grams, without
1	clinical trial.
1	distribution, until
1	estrogen, or
1	monoxide, use
1	(e) collection
57	provide the
3	submission shall
1	product effective
22	salts, isomers,
3	receives, holds,
1	(2) biosimilar
1	dispensers; and
3	economy of
3	make or
1	personthe term
5	proposed regulations
1	approved drug:
1	poultry article
1	smoke, or
1	(iv) relief
1	2010, this
2	final under
5	inspection, and
1	law) of
1	jointly develop
6	interest. 
1	lung diffusion
1	contamination; and
1	(e) center
4	aside of
1	ingredient notification
1	communities. the
2	independent consulting
1	products, changes
4	years. the
2	people with
5	payment 
3	jurisdiction; disposal
1	(b) matters
15	reports by
4	products is
6	reporting and
1	deny any
15	actions taken
1	determining bioequivalency
4	food as
1	targeted by
1	dengue/dengue haemorrhagic
2	committed knowingly
3	distributor may,
1	exceed $50,000,000
16	proposed regulation;
1	history. for
1	funds may
1	collect, by
3	simultaneously with
1	discloses that
1	revoke it.
1	specific order.
1	individual cans
7	2 or
9	first sentence
3	proposed regulation.
1	complainant brings
5	proposed regulation,
1	scientific advances
1	conference, that
2	healthy poultry
1	body if
2	explanation for
3	stakeholders and
1	benefitfor the
1	(cc) other
3	radiological health
1	patients insurance
2	person believes
1	section 401(b)
1	products if
1	exposure than
1	information requests
1	aggregation, as
1	development. (in
1	$672,000,000. (k)
1	form on
1	1702. office
2	without warrant
2	generation of
1	condemned; reinspection
1	on-page summary
4	data derived
1	policy alternatives
1	organization.[1] 
1	title[1] unless
1	classifications stated
1	section. (g)
1	usual, except
4	recognized and
3	administration, a
4	information, history,
1	particularly identifiable
1	approval; criteria;
1	(d) protection
1	respond promptly
3	limitation 
1	account within
1	important to
13	establishing the
1	consulting laboratory,
1	drug control,
3	standard which
1	describes, for
48	use and
1	disclosed information.
1	transmission, storage,
2	(1) require
4	period 
1	term farm
2	25 employees.
1	administration during
4	substantial quantities
2	action. (2)
4	knowledge and
12	poultry and
2	suspect or
1	establish fees
1	record. the
1	1502a. transferred

1	including complete
2	attack with
8	use any
1	agriculture accounts
2	25 employees;
2	background checks
1	 (cc)
1	consultative affiliation)
1	
 864.
2	preventive control
1	business. (2)
1	has, by
1	person duly
1	constituent), or
9	month of
1	ethnic health
34	notification under
20	receiving the
1	harm; and
1	submitting any
1	(i); 
1	partially or
1	(a) summary
1	shipment offered
2	document available
1	require, when
2	section 1034(d)
2	(d) exceptions
3	unless (a)
1	use. (4)
2	need the
1	board, but
1	powers, duties,
1	subpoena to
3	rarity, or
1	clinical investigator,
23	state agencies
1	(7) meprobamate.
3	designation for
1	plant classified
1	fumigating, and
1	waived under
5	investigations, studies,
2	sales restrictions;
1	oxygen 
1	appropriate decisions
1	(1) contentsan
1	modification authorizing
2	states while
1	practices; (g)
2	displayed or
48	local, and
1	(f) dru-free
3	expired. 
5	taken as
43	paragraph (2).
1	feed mill
1	product among
2	title 42)
1	strategy. (3)
1	full data
33	title 42,
1	service time
2	2016, $2,976,000
1	testing obtaining
1	implement coordinated
1	animals. (mar.
1	(b) reportthe
1	identified, as
1	360ccc1(i), 360e(f),
1	initiate guidance
24	title 42;
2	system described
1	individual criminally.
5	document the
1	laboratories of
3	(b) identification
1	methamphetamine, shall
1	standard. any
3	chapter which
5	bona fide
19	applicability of
2	part 208
16	distribution or
2	(a)(ii) for
130	biosimilar biological
1	practitioner requesting
1	part 201
8	owner thereof
1	enforcement agency,
1	owing permanent
1	inventory, including
131	distribution of
2	columbia, except
1	drug. (4)
1	determination. (iii)
2	57 of
1	stat-operated program),
1	review, provide
1	secretary approve
2	(1) authoritythe
4	met, the
2	title respecting
1	chemical preservative
1	shall enhance
2	(2), including
3	exercised. the
2	party without
1	nanomaterials; and
1	accredited. (3)
1	necessary data
1	drug applications)
2	title) initiate
10	drug applications.
24	drug applications,
2	act giving
1	prominent notice
1	right. 
1	shall choose
1	prevent entry
2	drug applications;
1	proceeds under
2	dispensing, for
1	centers, the
1	recalls the
1	1973; $100,000,000
16	voucher under
1	enforcement initiatives
1	(3) renewal
1	requirementsupon application
2	1011, as
1	report all
2	appeal has
2	conviction or
1	compounding defined
2	(a) developing
1	transmission to
1	cases, arising
4	developed or
2	address unmet
1	(iii) published
1	eligibility in
2	current level
1	scientific ideas;
1	u.s.c. 101);
30	appropriation account
1	514, as
1	term community
1	8 individual
4	device included
13	state the
1	industry, which
1	year. when
1	trac-an-trace or
2	days spent
1	section 360h
4	section 360i
1	device includes
2	rape drugs
3	section 360m
1	title), recommendations,
1	(c)(1)(a)(i), issue
22	section 360b
19	section 360c
19	section 360d
37	section 360e
7	section 360f
1	created or
1	container thereof
1	(15) the
1	food) to
4	inspect any
6	list in
1	days. regulations
1	drugs who
2	species in
1	actions following
1	(a)(2). 
1	species is
1	product listevery
2	circumstances exist:
2	inspect and
1	early pursuant
1	star-up amounts
10	list is
10	valid prescription
3	(ix) the
5	request, unless
2	(f)(7) revoking
5	role of
3	reported in
1	(a) authorizationthe
1	individualized treatment
1	repackager 
37	section to
1	district whereof
1	products; (5)
1	research for
1	patient safety,
1	section 3607
4	standards development
3	brought against
32	susceptibility test
3	(a) results
4	section 360,
1	(8) provide
12	proceedings in
1	section 830(b)(3)(b)
1	temporary reassignment
2	met for
3	least as
1	import food,
1	forfeited upon
1	services, with
1	part under
1	abuse including
1	filed to
1	coloring matter,
1	including experience
1	permanent. (ii)
1	identification technology;
1	grower of
1	agree upon),
2	whether proceedings
1	person either
2	device is,
3	subsection (a)(1);
1	system design
1	quality, grades,
1	information properly
1	duties, without
1	
 471.
1	sections[2] 823(f)
1	211. preservation
3	decision; or
1	reason; (d)
7	particular use
1	filled or
1	
 969.
1	samoa, wake
1	butter, and
2	show an
1	
 356.
4	section 552a
36	relates to
2	1968. 
1	regulation; (5)
1	reprocessed device.
3	fine otherwise
1	of, two
9	certification as
1	(b) meeting
1	act. (5)
1	methodologies determined
1	necessarily result
1	may know
1	channels; and
3	date. the
1	law, may
2	base; (d)
2	known theft
1	labeling; (vii)
23	general a
2	develop the
1	353(e)(2)(a) of
1	(e) repealed.
1	property pursuant
10	withdrawn before
5	persons accredited
1	state regulation
1	standards, including
3	styles and
2	service act,
1	communit-release provisions
1	efficient response
1	practice is
2	communication (a)
1	principles set
1	occur, or
1	term extension
2	states) in
2	located upon
1	governments; (ii)
1	general. if
16	term official
1	contractual relationship
1	term significant
16	fee amounts
1	section 552.
1	computed in
2	subsection (a)(1))
1	resin. such
10	distribute or
1	professionals with
4	(i) approval
1	(12) peyote.
1	meeting, make
1	risks described
2	practice in
1	402, 52
1	owned property,
1	written materials
1	special registration.
1	control, from
1	(1)(a)(ii), (2)(a)(iii),
4	100 grams.
1	proceeding. for
1	registrations of
30	clause (i),
1	facility certified
17	clause (i).
1	actual distribution
1	updated quarterly.
2	clause (i))
2	gas (as
3	borders of
1	elected to
1	duties arise
1	(3) are
3	substance unless
1	material, use
1	importer would
1	selection. clauses
1	(e) protective
5	clause (i);
1	statement limited
1	providers who
1	(8), the
1	(27) levomoramide.
1	(b)(2)(b), debar
6	positions for
1	clabels and
1	proposes a
1	thereon, orally
1	operates, including
1	(vi) rol-you-own
1	transaction, be
1	issued, unless
2	(d), as
18	clause (iii)
1	humans; (ii)
1	concerning imported
4	formed, or
1	change such
1	enhanced interagency
1	cooperation in
1	xviii of
1	permanent or
1	hardship to
1	environment; and
1	analogous products;
1	infected plants
4	prevalence of
6	anticipation of
1	
 387s.
2	care facility
5	shall extend
1	usethe secretary,
3	analogous products,
2	place stated
1	analogous products.
1	components 
1	percent to
1	387b(5), 387b(6),
44	good manufacturing
1	analysis similar
1	petition in
1	laws (as
1	paragraph. (iii)
1	various sun
4	may collect
1	certain programs
2	pay in
3	disapprove a
1	occurs only
15	petition is
3	term territory
5	columbia circuit.
1	situations. 
3	columbia circuit,
4	receptacle or
1	(e) declaration
2	exempted. 
1	2012, $477,000,000.
2	poultry ingredients
1	parole until
5	section will
1	coordination through
1	interim or
1	appropriated. (

1	holding for
1	educate health
4	act which
1	possess in
1	on-fourth of
1	615. inspection
1	coloring only,
1	(3)(b)). 
1	article. (g)
2	jurisdiction, any
22	duly authorized
1	broader than
1	committees described
1	technology transferred.
1	exception 
2	served the
1	deputy attorney
3	jurisdiction for
3	(c) invite
1	direct access.
1	article held
1	articles; validity
5	device pursuant
770	described in
1	1997 unless
3	42. such
1	submitted via
125	whether the
2	difference, as
1	preventing enforcement
1	formerly 1012,
1	(c) petitions
3	thereby appeals
1	activity; and
1	code, trade
1	iv; controlled
18	shall register
2	preventive controlsthe
1	samples requested,
1	
 1181.
1	accepting or
1	permanently debarred
1	constant evolution
1	federal governments;
1	heath[1] professionals.
4	tobacco warehouse
1	2021], and
1	administration do
1	(e) within
1	health alert
1	device, dietary
1	methodology be
2	treatment technique
1	timely interchange
1	give any
1	1531. establishment
6	medical devices;
1	675, 920,
1	another for
3	postmarket drug
1	stakeholder comment
2	notice, or
1	constitutionally required.
1	order compounding
2	part (or
2	chemicals. (

2	permit individuals
7	medical devices,
2	medical devices.
2	certain of
1	disseminate a
1	dispensing; 
2	finds (and
2	year before
3	states food
5	product involved
1	collecting and
13	may direct
1	
 467e.
1	information. within
1	harmful, any
1	butter shall
1	cigarette in
2	harmful, and
1	documents pertaining
1	675, 306,
2	substance satisfies
8	prescribed or
1	2008, 120
3	domestically and
1	$50,000 in
2	(c) classification
1	october 2002.
1	sixth sentence
3	unfavorable to
1	(f) permit
1	pending the
1	subsection (f)(1)(c)
1	prescribe, to
1	cheese transported
1	(a) sending
1	october 2002;
4	health (if
1	funds required
1	(iv) individuals
1	675 of
1	level is
2	title), associated
3	(3) develop
9	food 
1	(a) did
1	timely dispute
1	possess scientific
6	applicable date
1	production after
4	387f(d) of
1	accords to
1	authority whenever
4	october of
1	productivity. (5)
1	chain. such
1	(a) maintain
1	preparation upon
2	(b) penalty
1	consensus definition
1	335b. civil
1	introduction, or
1	recall. (3)
1	term addict
1	existing data
1	paragraph (2),[2]
2	records, files,
2	clandestine laboratory
1	reviewable in
1	mixing, blending,
1	administer devices
1	general, which
1	directed. 
1	containing limited
2	transfusion, does
4	infringed (including
1	including postapproval,
3	clause (i)(ii)
1	barrels or
3	incorporates or
1	that, not
1	syringes) shall
2	applications approval,
10	tomography drug
1	illness associated
1	diversion a
1	via either,
2	general ruleexcept
1	therapeutics (a)
1	secretary[1] acting
1	application subsection
1	order have
1	(b) consumer
1	qualified manufacturers
1	coordinating council
2	testing, including
4	date fixed
1	represents that
1	paid. (f)
1	acres, income,
1	possible time.
1	record; (2)
154	defined in
8	list shall
2	product commercially
1	claiming its
2	possible time;
1	drugs near
2	lawful if
4	352(o) of
2	paragraph (11),
1	exposure levels
2	section 351(a)(6)
1	indicating an
3	animal drug)
10	animal drug.
28	animal drug,
2	safety means
1	criminal sexual
1	(i) failure
1	violated the
5	clause (iv),
3	clause (iv).
6	animal drug;
5	42 shall
2	committed or
2	obligation, for
1	youth the
1	clause (iii)(i)
1	election campaign
2	consult the
4	labeling thereof,
2	achievability of
5	labeling thereof.
1	measures and
1	seq.) with
4	treasury pursuant
1	registrant. any
7	shall certify
8	person so
12	labeling thereof;
1	providers, or
1	supply, cost
4	waivers 
3	patient without
2	prescription pursuant
2	circuit or
4	reasonable certainty
5	reporting the
1	unit is
1	recognized the
10	care providers
2	conditioned on
1	estimate. (2)
3	deter its
1	359. nonapplicability
3	approval supplements
1	original rare
1	practitioner, except
1	expand an
3	regulation. (c)
1	save the
3	amending or
1	
 617.
61	animal drugs
1	concerning ethical
1	16) shall
1	direct responsibility
1	2010, for
1	action specified
2	no-federal sources
2	term youth
2	president; or
1	imminent hazards
1	with, controlled
1	filed. (b)
1	establish one
2	regulatory action
2	physiologic effects
3	strengthen the
1	employee not
1	imposes mandatory
1	drug upon
1	otherwise places
1	expertise, for
1	enactment) and
5	(d) coordination
9	hearing before
1	disbursement of
1	use, distribution,
1	make annual
1	name, including
1	ch. 268,
1	transactions are
1	real and
1	no-opiate drug
4	updated susceptibility
4	financial conflicts
2	purchaser, and
1	affect national
2	periodic inspections
1	assay as
4	deception of
1	determinations; data
1	making requirement[1]
1	(b) process
1	information concerning,
1	targeted, including
1	repackager, including
1	appropriate, may
4	suspension if
5	unavailability of
8	timely and
2	(viii) such
1	acquired the
2	(d) may
1	(1) registrationthe
1	continue carrying
1	time. (iii)
2	distribution means
3	domestic place
1	thereof, from
15	general except
1	(iii) cleared
1	material. in
1	lawful business
1	coordinates warehousing,
1	radioactive biological
2	7 percent
6	track product
1	stage). (6)
1	subsections (i)
3	purposes, or
2	drug include
1	29, 1970,
2	chapter, whether
1	2, 1944,
2	government employee
2	complete operating
1	recipient in
5	budget submission
1	outbreaks necessitating
2	(including, but
1	collected until
1	funds requested
2	payments), provided
1	given training
1	disasters affecting
2	purchased from
1	grant amountthe
1	
 350h.
8	estimate of
2	transmit notice
1	605, 610(b),
4	stat. 1264;
1	vehicle (other
1	training food
3	original request
3	finds that,
2	report available
1	(1) intending
1	assign, transfer,
1	moved 
4	geographical areas
2	award an
1	limitations specified
1	resided, at
7	designated to
1	(1) executive
1	(30) noracymethadol.
1	order, grant
2	dates during
1	material from
1	settled such
1	preventable behavior
3	article from
1	scientifically driven
1	854. investment
2	vessel, vehicle,
2	voucher for
4	(ii) who,
4	distributor to
1	ask that
3	represent that
2	(a)(vii)(iv) shall
2	value therefor
10	reactivation fee
1	underweight, overweight,
1	
 133.
1	inspectors, after
2	contrary is
1	subsection there
1	agriculture government
1	chapter 9[1]
1	(2) transportation
1	process drugs,
2	items under
1	(20) -(2,-dimethox--ethylphenyl)ethanamine
1	meeting, if
1	conform 
1	curtail, or
1	milk from
1	notice, which
1	examination, or
1	(1)(a) may
12	packaging and
1	menthol or
2	607(e) of
1	flow, such
1	739, 49
1	(e) specific
2	firm distributes
5	business address
3	advertisement submitted
1	1605. procedures
1	shifts in
2	tobacco users
2	address, telephone
8	destroy any
1	order siluriformes;
4	may cause
4	document titled
6	issued within
5	data collection
1	continue funding
1	data about
1	(d) filingany
1	tobacco as
1	2, 44
1	(xiv) a
1	ii after
1	title, applies,
2	clause (ii)(i)
4	program that
2	otherwise by
1	promulgated, in
16	conduct an
2	prescribe through
1	section 1334(c)
1	significance than,
3	registrations for
1	(ii) beginning
19	type ii
1	nucleic acid
1	postapproval production
1	u.s.c. 136a1(g)]
1	(h) importation
2	fac-t-face transactions
2	commission. the
2	30, 2020,
10	violates this
32	regulated person
1	drug trade
3	restoration act
1	-cyan--dimethylamin-4,-diphenyl butane.
1	stage, each
8	products, including
4	inspection authorized
2	907, as
1	documents generated
1	remains a
1	prevention; (d)
1	675, 522,
1	experimentation data,
1	years strategy.
2	experimentation data.
1	iii, 541,
1	protocol which
2	procedures of,
1	relationship requirement
1	potential electronic
1	regarding cigarettes
1	notification, reporting,
4	generalif the
2	last 4
1	union, are
1	device against
1	experimentation data;
1	(9) electric
1	selling or
1	dispensing without
1	unobligated advisory
2	direct, after
6	secretary reasonably
1	capacity, function,
1	-month period.
1	health administration
3	(y) the
1	thereunder, or
16	data are
5	decides the
14	(ii), the
1	(6) model
1	animal studies
3	contract, fellowship,
2	program which
2	advertisements specifically
1	studies, services,
1	-month period;
1	effect beginning
1	pay established
5	year 2017
1	prepare summaries
1	360c(i)(1)(d) of
3	1996, the
1	(b) judicial
4	package of
1	353c2 of
2	(5 u.s.c.
2	columbia with
19	proposed regulation
1	146. authorization
145	purpose of
1	overcollections if
1	(80 stat.
1	period expires,
1	(2) importer
5	factor described
1	1930[3] (19
1	tomographic diagnostic
6	package or
1	section 518d
2	condemned it
3	director concludes
6	issue to
17	drug may
1	(3) regarding
1	(2); 
1	recommended classification.
6	section pursuant
2	duration the
2	30 preceding
1	threats, harassment,
1	regarding proposed
1	(ii) explain
42	believe that
1	justification and
1	administration) levels
1	including inspections
24	prior conviction
1	preclinical investigations
1	him. (2)
1	report number
1	(vi) specify
3	individual basis)
1	fungus; (ii)
1	persons debarred
1	special expertise,
1	timing for
1	senior executive
1	drugs. (i)
2	fre-choice medicated
1	chapter, may,
4	procedures or
1	section, determine
1	(h) upon
1	date after
1	advertisement shall
1	environmental agencies;
4	illness and
1	misleading statement
1	service be
1	
 24.
6	procedures of
2	section 335a(b)(3)
1	service by
1	file for
1	administrator appointed
1	shall any
6	direct and
1	purchasing a
3	(5) no
1	make inspection
9	significant change
1	authorized holder
1	appropriate disposition
1	including independent
1	violation did
1	practices 
3	capacities of
2	payments or
3	thereafter until
2	cas-b-case basis
1	facilitys hazard
1	953, 954,
5	without further
1	ii, there
2	(j)(2)(a)(vii)(ii) of
3	period if
1	pharmacodynamic, and
2	title 15on
2	gross sales
12	period in
1	existing requirements,
1	health is
1	children, including
1	section 379h(a)(2)
1	projects, demonstration
1	2011 and
1	(d) trading
9	person engaged
1	law (or
1	address tort
1	findings or
3	properties of
1	shipment data,
1	term harm
1	clinical investigator
1	advertising sufficient
1	distant from
1	therapy, on
1	(l) option
1	investigation, evaluation,
12	supplement that
1	residue be
8	state from
16	findings of
1	section need
3	lawful course
1	require, through
10	transportation in
17	order, the
1	particular electronic
1	variety, the
1	387l of
1	provides athletic,
4	decision) a
1	 (ix)
2	important public
1	advances (a)
1	retail packaging
1	675, 708,
2	352(x) of
1	arrangement or
1	courts shall
1	material produced
1	treatments to
1	dispenser, on
1	drugs withdrawn
1	exists; and
7	file in
3	inspector, or
2	matters 
1	coordination to
2	products may
3	exemptions, reductions,
2	random sampling
1	otherwise apply;
1	director, partner,
1	moved or
1	
 212.
2	file is
1	disagree with
1	arising therein,
1	1151 to
1	notificationin conducting
2	reduction regarding
4	$250,000 for
1	unique alphanumeric
2	located; and
4	proposing the
2	collaboration among
1	relied upon.
9	submits the
1	treasury. if
3	involved submits
12	states under
2	countermeasure development
2	neonates, as
1	permit have
1	1706 of
1	upon them
10	adjusted under
2	consent to
1	 chloride
1	nonliquid formswith
8	provides for
1	active participation
1	section, publish
3	subsection (b)(2)(b),
5	appropriate, and
2	delivers a
1	will ensure
1	justice authority
1	aforesaid of
1	substance, (c)
1	expertise on,
1	(d) forfeiture
1	administration office
2	appropriate, any
2	state, unless
1	$155,000,000 for
3	experiences as
2	established name,
38	(iv) of
11	801 et
1	contracts or
4	(2) recommendations
1	section 355c(b)
2	(a) whether
2	furnishing to
1	uncommon method
1	(iii) testing
1	budget) in
1	occurs for
3	chemically or
1	symbol for
1	810, 52
1	period, initiate
5	including guidance
1	date thereof
5	drug use;
1	requestor initiates
1	u.s.c. 247d6b]).
1	multiplying such
1	inspections; (e)
1	chairman the
1	951. definitions
1	injection; (q)
1	harvesting, preparation
5	holder to
1	general. a
1	privileged be
11	may designate
1	attorney generalnot
1	(b) ensuring
1	(o) repealed.
1	thereon: cautionthis
3	format that
1	net weight
1	invalidating the
6	section 360(i)
1	drug paraphernaliain
2	section, receives
1	mails or
3	825 of
1	study including
12	safety risks
2	effectiveness that
98	approved under
1	(2) processing
1	586g, as
1	country requesting
1	
 399e.
1	procedures), and
1	implant, in
1	regular importer
1	clearly indicate
3	provide, where
1	costs, consistent
20	penalty of
1	oil, the
1	proposed design
2	statement informing
1	equine meat
1	paragraph (6)(a),
1	section 314.161
5	penalty or
1	ordered and
1	auditors as
4	death, the
1	recreation of
2	secretary, may
2	$2,786,000 for
2	shipment was
1	subsection (a)(3)(c),
1	417, as
1	1994. 
2	additional measures
1	description made
1	include government
1	inspection obtains
1	(or specified
1	(1) made
1	optical isomers;
2	clear manner
1	patent. any
2	thereof; (2)
1	safety risk;
6	360j of
1	secretary take
12	authorizing the
59	representatives of
1	section 518d(c)
1	device. any
1	(f) renewal
54	sentenced to
1	date) an
3	representatives on
1	choose the
1	consumers); (v)
2	notification described
1	condition the
1	eliminated after
2	representatives or
1	summary may
2	test, and
1	disciplinary action
2	law. (e)
1	compendium. (d)
3	technical, and
1	(ii) assessing
1	u.s.c. 387a1(a)].
1	animals.; and
3	1.8 grams
1	appeal a
1	potentially intentionally
1	notice, except
1	filed has
1	individuals. in
2	preceding sentence)
1	prescribed, and
6	$5,000,000 if
8	program 
1	potential drug
1	cosmetic unless
1	head, or
1	transmission. (iii)private
4	to, the
4	immediately register
2	(1). (e)
1	quota applicable
1	originates; the
1	(i) -(1,-dimethylheptyl--[(1r,3s--hydroxycyclohexyl-phenol
5	criteria of
1	full pedigree,
1	years. (d)
1	interest to
2	1997; and
1	stakeholders, prioritize
3	restrict the
2	eggs than
1	economical food
4	institute on
1	assisting in,
1	eggs that
1	(a) improve
1	plaintiff any
5	person authorized
7	institute of
2	inspector, and
1	(a)(2)(a)(viii) may
4	device within
2	approval after
1	assess signals
1	listed. the
1	summary review
2	petition, may,
2	smoke may
4	regulation which
4	transactions and
5	safe or
5	effect upon
2	chapter when
1	new slaughtering
4	(including lot
1	representative, during
2	written advertisement
1	court would
1	substances notwithstanding
1	information sufficient
9	rule controlling
1	practitioners, effective
1	stat. 512;
1	section 202).2
1	hotline for
1	i, 9,
30	distributor of
2	even if
1	adequate; (3)
2	will activate
1	detailed summaries
4	agents, or
8	(in this
1	import no
1	675, 705,
9	distributor or
1	(1) after
13	act providing
1	results of,
1	agent appropriate
1	giving away,
2	(b) will
2	commissioner an
1	method (including
1	establishment (1)
1	limit any
2	aug. 1,
1	foreign facilities.
2	foreign facilities,
1	exchanged in
6	requirements. 
1	area during
1	leaders 
5	5, eff.
1	42), unless
7	march 4,
1	presenting drug
1	providing dual
5	found not
1	preparation thereof
1	(i) working
1	physicians office.
1	corrections 
1	third year
2	readily available
1	successor regulation))
2	product produced,
1	31 days
2	inspected device
1	(c)(2) only
1	1047 of
1	approval received
2	already given
1	classification panels.
1	formerly 18th
2	year 2007;
1	successor regulation);
1	controversial issues,
1	recommendation. where
1	provisions, applicable
5	verification of,
1	assist federal,
1	expungement has
1	unavailable on
1	benefits or
1	database; (f)
1	regulation)); 
3	permitted pursuant
1	antimicrobial drugs,
1	walnuts), wheat,
1	application, reinstate
1	effective, but
1	2009, if,
1	(b)(iii)(ii) if
1	purchasing the
1	producer thereof,
1	individual except
1	commitments, to
1	reinstatementa transaction
1	identify, through
3	available registry
1	750.0 (225
1	functions); (b)
1	official) in
1	stay all
2	animals shall
1	(iii) d-stems,
1	person present
1	accurate inventory
1	installments as
2	facility unless
2	recommendations or
1	state with
1	indicated. scientific,
3	marketed (other
3	corporation or
1	claims for
1	commerce; (15)
1	opening for
7	listing under
18	recommendations of
1	approved usesa
1	360fff. definitionsin
17	substance from
1	authorized; (b)
2	petitioners determination
5	states; (2)
1	uses notwithstanding
1	alternative treatments
2	corporation of
1	necessary process:
1	(4) coca[3]
23	10 years
1	(c) does
1	drugs; conditions
1	representatives 
5	general as
6	credible evidence
1	(1)(b) within
1	subparagraph, publish
20	required in
1	$1,000, to
2	owned and
2	states which
1	adulterated need
1	published notice
3	county, or
9	information upon
1	diseases if
5	will cause
3	safety activities).
2	exchange between
4	foreign or
1	worldwide as
1	safety the
1	administrative powersin
1	chapter. no
1	proper administration
1	drug control;
2	cosmetics, if
8	section referred
3	comments, the
1	issuance, for
1	approved uses.
1	authorized such
1	360a, as
4	morphine, or
1	office, including
1	gymnasium (including
1	describing improvements
2	use fees
1	period; (c)
1	reasons therefor
1	sets in
1	necessary assistance.
1	360b(e), 360b(h),
1	describing whether
3	nitrogen atom
2	subclause (iv)
1	whose representative,
1	human subjects,
1	(5) generic
2	use shall,
3	agricultural commodity,
1	(2) states
2	installation of,
1	treaty, convention,
1	complete, was
1	determination. for
3	production facility
1	initial importation
1	received any
2	received and
4	agricultural commodity;
1	consumption. no
1	331(i)(3) of
1	263a], to
3	secretary assesses
2	administration responsible
12	container or
1	(7) product
2	bottle or
1	partnerships, consortia,
1	quantity prescribed.
5	use a
2	inspection, or
3	standards described
1	460. miscellaneous
1	pose no
1	 (iv)contents
3	shall agree
4	published for
5	adequately served
1	controls should
1	3324(a) and
1	court (i)
1	repackaged and
1	section 5315
2	submit supporting
1	periodic reanalysis
1	recall means
3	cosmetics are
2	condemned may
1	(ii) extrapolation
2	(a) coordinating
1	time appoint
5	restraining order
6	shipment in
1	retail such
3	provide training
2	investigations, conducted
1	subitem (aa),
1	inspections, commission
31	october 1,
1	persons (excluding
1	includes mail,
1	allocations under
2	forwarded by
1	writing a
1	produce any
1	title); or
1	736, as
1	(ff) staffing
1	physical health
2	specifically applicable
1	general (which
1	agent referred
1	gas for
1	1971; and
1	generic drugsbeginning
1	foundation may
1	iv unless
1	produce and
3	remaining portions
1	force resources
7	amounts made
1	involves ephedrine,
1	agencies; (4)
1	fees. (b)
14	activities to
1	preceding such
1	files to
1	(with 15
4	sold, less
1	deviating from
1	acceptance, solicitation,
1	strategy goal
1	building; (2)
24	center for
1	certificate; (5)
15	fine of
5	premises and
2	solution intended
1	warrants (a)
1	applicants conviction
1	(e) reporting
1	(ii) appoint
3	(c) during
1	secretary d-identified
1	controls; (c)
1	support for,
1	letter; or
1	sentence. (d)
3	august 23,
1	 (6)[2]
2	cosmetic in
1	675. assaulting,
3	360c(f)(1) of
2	evaluations performance
1	situations involving
1	agencies submit
1	section new
1	details on
1	practitioner practices
1	355(k)(4) of
10	standards set
7	federal agencies,
1	(iu) 0.7
3	federal agencies.
4	distributes, receives,
3	notice identifying
1	auditors, including
1	sector of
1	governments on
1	
 333.
3	case, pallet,
1	(g) determinations
2	another active
5	governments of
5	harmful virus,
1	articles, which
1	(c) duties
1	(e)(1)(a), (e)(1)(b),
3	met and
6	(b) other
1	illness due
2	section 342(a)(1)
1	cause, or
1	athlete who
1	withhold information
1	unless immediate
1	(8) definition
2	(ii) address
3	variances the
1	646, 32,
1	(j) judicial
1	proceedings applicable
1	fourth fiscal
1	advertising directly
1	 phosphorus
1	chewing tobacco.
1	efficacy. the
2	articles so
5	outside thereof;
1	(a)(6) regularly,
2	equitable basis.
9	shall enter
1	enforced with
5	reauthorization and
1	determine, and
1	pharmacy with
2	specifications or
1	received, shall,
4	outside thereof,
15	(3), the
3	funding levels
1	155. permits
2	device. (j)
2	actions, or
1	solely engaged
3	year 2013.
17	year 2013,
2	requirements than
2	party submitting
9	product subject
1	tribal agencies.
1	360b(c)(3), 360b(d)(1),
1	activities without
2	(b) consultation
1	(c) law
1	include soap.
1	matter de
2	assistance; (2)
1	public. it
3	(f) and
4	drug having
1	hearing; basis
5	title (or
1	fine, but
13	requirements that
1	data, such
1	establish compliance
1	orders which
2	designated for
2	diligence; (b)
3	managerial or
1	distributed further
1	knowingly participates
2	disparate dosing
2	claimant did
1	batch form,
30	criteria for
3	facility, and
1	title; except
1	oaths or
1	1271 of
1	308, as
1	products packaged
1	minerals: calcium
1	u.s.c. 355a],
2	(2) whoever
1	test, in
1	350d(a)(3)[1] of
1	use. (d)
1	675, 907,
1	party; and
1	establish exemptions
1	authorize holders
1	-acetylanthranilic acid,
1	funding level;
1	obscure the
4	(d) reauthorization
1	aggregated clinical
1	(c) but
16	except to
1	submission if
2	voucherthe secretary
9	article and
1	child education
1	drug appears
1	justify administrative
1	section 501
2	participate because
2	submission in
1	however, must,
5	section 505
6	necessary or
4	submission is
1	terminated, or
1	order. (2)
1	language designated
1	subparagraph (h)
2	order if,
1	346a(i)(2) of
1	eggs after
2	(2)(b)(i), as
1	360eee1(e) of
1	forfeiture if
1	marginalized populations,
1	building, construction
1	agreements from
1	$70,000,000 for
1	(b) informal
1	product included
2	placing the
1	year according
1	orders no
3	enters into
1	may ask
1	products transferred
4	regularly scheduled
1	shortage may
1	changes the
1	(e) federal
6	ultimate user
2	product includes
1	(c) securing
2	veterinarians professional
1	acquisition and
6	animals, the
1	applicable; (ii)
1	2291j1 of
1	(i) assure
2	framework shall
3	communities. 
1	customers in
1	means manufacturing
5	ingestion in
1	(ii) internal
1	written confirmation
1	reviewed after
2	provision within
1	information; (5)
1	means operations
2	business, as
1	claiming an
1	
 1401.
2	documents, and
1	greater severity,
1	meeting conducted
1	regulations applicable
1	(a)(3)(b)(i) and
2	scientific training;
1	testing carried
1	amusement containing
3	reactions to
2	agricultural commodities.
6	agricultural commodities,
2	teams of
1	initiated shall
1	taxes paid
10	act (42
2	agricultural commodities;
1	measurements of
1	importer subject
1	name (regardless
1	person obtained,
1	decision immediately
2	activities, except
5	501(c)(3) of
1	30, 1890
3	detained by
3	territories of
1	may challenge
1	(1)(a). (b)
1	least 85
1	administrative expenses.
1	distribution notify
1	capabilities, that
7	concurrence of
1	(i) funding
1	made. (2)
2	entityin this
1	drug, include
1	
 360b.
1	including demonstrating
1	exported 
1	practicable; (iii)
1	(2) update
1	379r. national
1	smuggling methamphetamine
1	article ordered
3	vii. 
9	(5) to
1	regulated solely
1	drug purporting
5	standard, or
1	processes may
29	route of
2	secretary each
8	379e of
1	(guine-worm disease).
2	powers as
1	agreement act
1	(c) domestic
7	approval may
4	water and
3	give high
1	eligibility 
1	two separate
17	horses, mules,
4	manufacturer. 
2	$250,000 in
5	conventions, or
1	(1) drugs
1	water navigable
2	provide persons
1	subchapter; except
3	goals. 
11	agency or
5	deems necessary,
2	deems necessary.
1	imported, or
3	believes to
1	systems; (6)
1	conducted, in
2	1, 1992.
7	1, 1992,
1	secretary designate
1	(d)(2) of
1	information about,
1	title; second
5	criteria 
2	paragraph (1)(b)(i),
6	deems necessary;
20	combination product
1	medical therapies,
1	tobacco. if
1	injurious or
1	design, logo,
1	records. (2)
4	aiding or
1	income, or
3	country, the
7	(a) which
1	food shipment.
1	section 360c(g)
1	independently determines
6	meaningful therapeutic
2	marketing, outside
1	africa-americans, hispanics,
1	enforce safety
1	requires additional
1	managing pr-submission
3	account both
1	recreational facility
1	statements, or
1	be. (7)
1	section controlled
1	use amounts
1	trial data
2	response network
1	section 460(b)
1	testing site;
4	term product
1	purposes, approved
1	resolving the
1	penalties; boobytrap
1	granting or
1	appeal. (b)
1	offense, one
10	health, and
1	assisted or
1	policies may
1	facilitation, direct
7	owned by
1	entry; (h)
1	2, 42
1	criminal enforcement
1	backlogs in
4	examinations, testing,
2	trade commission,
1	contain all
2	compendium or
1	general cautionary
2	applicable, may
2	corporation, the
1	income accruing
1	sample, in
1	formats) and
1	contents; and
9	matter under
1	export transactions,
1	discovery with
1	(e) each
1	shipment shall
1	9, 2012),
1	representative described
9	exempting from
1	benzyl cyanide.
2	fact to
11	enforcement administration,
1	identification requirement
1	violations. (

5	radiation and
3	$1,000, or
1	opioi-dependent patients
1	(c). (d)
1	u.s.c. 220501(b)(2)).
1	article, then
1	(3) documentation
1	threat assessment
1	contractual agreement
1	levels detected,
1	findings from
1	(ii) notify
1	subchapter, as
1	case only,
1	dates, the
2	recommendation, make
1	agencythe term
1	legitimate needs
1	(a)(6). (4)
1	benefits identified
1	food testing,
1	following limited
11	use from
2	team and
1	facilities inspected
1	
 346.
1	proceeds the
1	(d)confidentiality. 
1	paragraph (12)
1	costs, hiv
1	(a)(iii); and
12	take any
1	mitigated and
1	so, and
1	marking food
1	studying continuous
2	territorial business
1	filing application;
1	(b) strategic
1	industry, shall
2	secretary awards
16	marketed in
22	person other
2	federal standard.
1	community the
1	treatment, environmental,
1	committees may
1	parts, except
3	food; (3)
1	take and
2	title xiii,
1	sealed it
1	reasonably substitute
5	assessed to
1	ictaluridae; and
1	substance having
3	research under
5	subsection (c)(4)
1	established, the
13	transportation, or
2	(c) under
1	6 months.
1	(a)(1), and
5	foreign establishments
1	
 379.
6	property which
1	car; (b)
2	scientifically valid
1	education, training,
1	affected the
3	listed on
1	director, acting
1	product developers,
1	unknown, or
1	shall schedule
1	worldwide basis
3	smokeless tobacco;
1	(d) imposition
8	(1) has
5	958 of
4	flexibility to
6	regulatory and
1	night, whether
7	shall the
2	imprisonment if
3	(2) effective
1	trade association)
2	(e) state
1	declaration as
1	comments and,
1	orders. (2)
1	7 if
1	slaughter) of
4	355d of
2	(ii) exception
3	cost to
2	2008, not
1	(2), (4),
1	entity, fined
1	746, formerly
1	need, by
1	section 374(a)(2)(a)
2	junior college,
2	consideration under
1	(3) posting
1	training fellowships,
1	(3)(a), and
1	gs10 of
4	database. 
1	contents such
2	verify under
1	
 1710a.
4	consulting firm
6	accepted medical
1	involved before
13	manufacturer has
1	(i) merely
1	copies thereof;
4	total cost
1	operations as
3	joint military
4	unless appropriations
1	dispense any
1	resources, authorities,
1	insert may
1	following whether
1	filing, the
5	specific purposes
1	verification that
1	jurisdiction there
1	otherwise); (4)
2	presiding officers
2	350d(a) of
1	addressing national
1	enhance medical
1	specialties or
3	commensurate with
1	registration statement
1	means providing
1	conspire, or
23	information, and
1	355(j)(7)(a) of
1	(bb) such
1	420.)
 

6	data for
2	oct. 26,
1	acts. there
39	engage in
1	register or
7	official device
1	june 6,
2	scienc-based mitigation
2	small businesses.
2	imprisonment is
4	small businesses,
1	343(w), or
2	present evidence
6	applicant made
1	devices, requirements
3	receives such
1	identification system
1	import, submit
6	governments to
1	agreements on
1	committed, or
1	(1) describes
1	expended and
2	(including travel
1	shell eggs,
1	subpenas, administer
2	equally to
1	(15) rol-you-own
4	review thereof
1	(including scientific
3	strategy under
1	matched by
2	electrolytes (such
1	4 subsequent
1	
 862b.
1	credible. (2)
1	emergency, an
3	another applicant
2	term commingled
1	substantial conformity
2	1, 1971,
3	recommendations made
4	reported under
1	(b)(2)(a)(i); and
1	extended date
1	pose significant
2	payable to
2	requested, in
1	seeks only
5	seq.). 
1	1333(d) of
1	(a)(1); or
1	section 1046
1	letters; 
3	section 1040
1	testing requirement
1	year 1998;
1	package. (d)review.
1	exported. 
2	development, manufacturing,
1	hypoxic challenge
1	hazard analysis,
1	domestic methamphetamine
1	collected shall
2	members (other
6	(3) use
1	art as
1	(i)definition of
26	(6) the
1	countermeasure reviewers
1	product, taking
2	inspector and
1	program conducted
1	rates exceeding
1	institutes (a)
1	such[1] subsection
2	review process
1	is[1] based;
1	secretary specifies
1	(ii) discontinued
1	benefit means
1	substances other
1	(iv) nothing
1	requirement subject
2	revocation order,
2	bonus payments
4	records (including
1	specify any
1	may represent
1	amount so
1	appropriate acute
1	649; 

3	track and
1	state registration
1	regulation. (2)
17	presence of
1	assist such
5	secretarys estimate
3	[50 u.s.c.
1	(b) acted
1	it, certify
1	identity unless
1	(a)(1)(c) for
1	keeping every
1	department if
1	almonds, pecans,
1	notice, requests
1	18. (mar.
1	services, except
3	(b) may,
2	court from
1	problems, emergencies
1	obtain prescriptions
4	misleading labeling
1	safeguards. to
1	(2) assessments
1	manufacturing (a)
2	exemption withdrawn
1	1, 2009.
1	supplant those
1	1, 2009,
1	implementation failure;
1	forfeiture. such
2	substandard, adulterated,
1	drug experiences
1	971. notification,
1	conditions; (c)
1	importations of
1	2002 after
1	essential oils
1	identified until
1	persons, whether
1	phenylpropanolamine, its
1	allergy, and
2	fund the
4	(c) publish
7	licensed physician
1	longer effective
1	detailed rationale
1	care or
1	
 884.
2	reduction shall
5	initiate a
50	fee shall
2	manner or
1	phenylpropanolamine may
1	initial identificationthe
1	
 693.
1	formula 
1	device. (p)
3	care of
1	61, 3(c),
3	effectiveness. if
4	spread of
4	policy (a)
1	statement, racketeering,
3	will stop
1	originally issued
1	outside stakeholders,
1	articles; except
1	study based
1	packaging, labeling
1	section, 80
1	facsimile labeling;
1	illegal manufacture
3	distribute, dispense,
1	certification provided
1	stat. 1486.)

1	attorneys fee,
1	conduct private
2	licensed pharmacy
3	secretary, fail
1	whose identity
1	subclause (i);
1	techniques. 
3	management, or
1	congress this
1	administer and
1	(2) time
1	379k. information
1	authorize that
3	user who
3	petition which
1	distributes (or
1	379j. authority
1	provided; or
1	(4) one
1	
 21.
2	fully meets
1	(iv) complete
1	statutory compliance
1	sellersthe attorney
1	comment rulemaking
1	limited in
2	inspections the
2	signed certification,
1	affidavits, that
2	section 393a
5	panels of
1	force or
1	including age
4	(a) suspect
1	ending after
1	section 355(j)(7)(a)
3	witnesses, receive
1	defendant, and
6	morbidity or
1	section 2680(k)
20	enforcement administration
1	present national
1	noun without
2	2009 (excluding
2	chapter concerning
1	force of
1	(6) advice
1	time equal
1	recordkeeping pursuant
6	revised recommendations
1	format understandable
1	impaired by
1	property, real
5	iii, or
1	testing industries,
1	emissions, may
3	drug sample,
1	362(c) of
3	drug sample.
1	steroid that
1	reconstitution; (dd)
1	provide evidence
1	product; (2)
1	title, consider
1	(11) package
1	shall automate
1	file numbers
1	change, made
9	15, 1927,
1	isomers, esters
2	(ii) ensure
2	qualified entities
1	predominant business
1	proper to
1	secretary. (v)
29	containing such
1	(g) expedited
2	644 of
2	may operate
1	(that, at
1	permitting pharmacists
1	dispenser; (ii)
1	factor levels,
1	assignment, and
1	upton, new
1	panels covering
1	immediately suspend
1	(16) repackagerthe
2	tobacco for
5	conditions are
1	(b)(2) was
1	fees) reasonably
1	(g) supporting
1	penalties or
1	committed under
4	scientific merit
5	fees due
1	place from
1	public information,
1	detect accurately
1	public information.
1	(b) makes
1	(2) state,
2	(5) whether
17	drug samples
1	standards with
4	organizations; and
1	(e) contemporary
5	title. (ii)
1	website established
4	penalties of
1	worthless or
4	secretary, be
1	2009 multiplied
1	(h) with
4	annually to
2	facts, if
1	assessment imposed
44	drug enforcement
1	u.s.c. 136a(c)(5)]
1	orders; examination
1	file number;
1	statement (as
1	deposited amounts
1	agency actions
2	remove such
1	708, as
2	fulfillment of
1	list required
17	(i) not
1	contamination; (ii)
1	exporter mean
1	review submission
1	early interactions
1	removed. (d)
6	injury or
2	subclause (i)(cc),
1	(b) policy
4	application referred
1	programs may
1	2011 
2	nominate individuals
1	disclosed all
4	executive officer
1	360bbb(b) of
1	includes section
2	strength differs
7	approval 
2	centers within
1	intervention 
4	section 353(c)(1)
8	compounded basis
1	entry the
1	fact in
1	sections 314.70
6	(b) use
2	regulation waive
3	(i) certify
1	(ii) cover
1	penalties, to
1	rehabilitation services
1	raising poultry
1	351(f)(1) of
7	containers or
1	(26) ketobemidone.
4	seeking a
1	names; false
102	issuance of
1	(2) benefi-risk
1	term suspect
56	general may
2	period. (d)
6	containers of
1	issuance on
1	
 1044.
1	453 of
1	dependence on
1	identifier on
7	users of
1	general through
1	punches, dies,
1	disregard of
4	identifier of
1	which, after
1	(e) limitation
5	(i) there
4	products comply
1	actual consumer
1	describe in
2	statements any
2	device, except
1	(c) fees
1	approach to
3	device does
3	publication or
1	criteria such
2	permitting the
3	applications subject
1	medicine whose
2	level higher
1	assisted state,
1	360cc. protection
1	(c) contentsa
1	positions. (b)
1	include comments
1	judgment. if
6	criteria described
2	medications for
8	(d) other
1	1967, and
1	stakeholders with
6	360ccc1 of
1	ionizing radiation;
1	notifying as
1	promote a
5	generate a
1	copies the
1	18 for
1	propagated and
1	reinspections of
5	fee collected
2	evaluation that
1	(e) dismissal
45	application that
1	incident of
4	agreement of
3	section not
2	purchaser for
4	intelligence program,
2	applicable final
1	(2) reportable
1	food; regulations
1	treatment are
2	requirements, such
1	(2)(a)(vii)(iv), the
1	member, organ,
4	section 355f(d)
1	information accompanying
5	united states)
4	year, to
1	(ii) alone,
1	shall bring
1	medical expertise,
1	notice sets
1	worldwide. (4)
1	product disposition.
1	10, 1962,
1	iii because
1	charges concerning
1	sustainabilitythe coalition
1	307, 63
6	fiscal report
1	strike paragraphs
1	later determines
1	transaction referred
1	(f) notification
1	1998; (2)
1	imported, moved
1	rebuttal or
1	scienc-based offices
327	provisions of
9	major disease
1	application unless
1	ethchlorvynol. (5)
1	esters and
2	existence at
11	contracts under
1	prohibits a
1	rate specified
1	(e) immediate
1	control policythe
1	addiction rate,
1	chorhexadol. (3)
2	property pending
1	(c) meetingthe
3	generalwith respect
1	(c) weighing
4	small food
2	335b of
1	(g) publicly
1	resources, (c)
2	paragraph respecting
1	resources. (5)
1	services. (9)
1	shall impose
3	severity, rarity,
1	necessary improvements
2	burdensome appropriate
20	pseudoephedrine, or
1	grant received
1	concludes 
1	commercial channels
9	property is
1	title (not
1	(a) collect,
4	diversion; and
1	major species.
1	trials which,
1	including 31
1	shall receive,
24	section 351(a)
1	address (street
1	forces, under
1	indication in
1	media), of
1	disappearance of
3	(c) authorization
1	store for
1	sanctions (a)
1	persons a
2	subsection (f)(1),
6	proceeded against
1	subsection (f)(1).
1	total annual
1	1031. congressional
2	program fee
1	section 319e
1	220501 et
1	916, as
1	international trade;
3	approved to
7	laws or
1	treaty, entitled
8	ending september
1	proof on
1	devices by
2	household consumer
1	specific resources
1	(c) (other
4	communication to
1	(b)(2) after
4	order required
1	represents, or
41	laws of
2	u.s.c. 8301
2	is, if
2	identifier 
1	agencies, in
1	updated good
7	is, in
14	change to
1	344, 348,
1	designation contained
1	pilots or
11	intended solely
1	integrated response
2	register designating
1	relevant information;
1	(e) extensions
1	reviewed, the
1	claims shall
2	(a)(ii); and
148	set forth
1	date labeling,
1	device, (v)
1	submitted master
1	reinspections an
1	substance (or
1	(h) special
4	relevant information,
3	processes for
3	proceeding. (

1	packed with
1	350a. infant
2	improperly labeled
1	$50 and
3	date, the
7	minimum standards
1	including complaint
5	establishment registration
2	retailer a
3	(f) additional
3	exported; and
101	human drug
3	(iii) identify
1	provides evidence
2	listing shall
1	
 1904.
1	290aa(d)(16) of
1	establishments inspected
2	dispensed, acquired,
1	undertake examinations,
1	(which list
2	tested under
2	petitions referral.
1	norpseudoephedrine, its
1	needed prior
1	first demonstrates
1	valuethis clause
38	shall contain
1	cure; and
1	(bb) does
16	(b) that
1	requesta single
1	foundation duplication
2	would, but
1	protocol upon
1	state governments;
1	appropriate location
1	paragraphs (h),
3	recommendations from
4	contact surface
2	investigators, information
2	biosimilar initial
1	clinical, or
1	(f)(2), as
2	prescriptions for
1	individually accredited,
1	18, relating
1	conduct[3] under
2	indirectly be
1	expert panels
1	bylaws of
4	indirectly by
2	receiving funding
3	(3) persons
1	submission notification
2	paragraph (2)(a)(iv)
1	maintenance agreement
32	color additive
8	propagate, compound,
2	schedule ii.
12	work with
2	employees may
1	673 of
2	promulgated; (ii)
3	foods, drugs,
1	position may
1	promote comprehensive
1	drug means,
1	section 1532(b)
6	antibacterial and
1	(b) operates
2	(1) purpose
1	(4) procedurenotwithstanding
1	matter. (d)
1	1952, ch.
2	practitioners of
1	cod), crustacean
1	appropriate, revising
2	advertising 
15	storage and
1	evaluation purposes
1	rehabilitated; or
1	u.s.c. 136p)
1	or, upon
1	including monetary
1	period after
19	assure the
1	(3) acting
2	change, the
7	chapter. (mar.
2	642 of
6	section 802
1	nations that
1	characteristic the
3	provide authority
1	expert panel,
1	(iv) whether
1	authorization system
7	class iii,
1	section 343(e)(1)
1	estimate by
1	expert panel;
1	to) this
1	disease outbreaks;
1	accountabilitythe director
1	countermeasures by
1	debarment. (b)
2	witnesses of
1	entry inspection
28	(4) 
1	stamped, tagged,
1	denial based
5	affiliates. 
1	may deliver
2	accrediting a
1	ii that
1	extend for
2	surveillance data
1	professionals. 
26	shall specify
1	criteria website.
3	section 201
2	section 202
3	section 203
1	18. suspension
1	violations and,
5	section 208
15	(7 u.s.c.
2	dosing regimen,
1	approval; minus
1	witness protection
9	amendment of
1	agency discretion.
2	articles that
5	drug distribution
1	practices, or
1	independently reported;
1	develop plans
1	denies any
1	77 percent
1	food, dietary
1	common carrier,
2	death. 
1	5, 38
1	fait-based organizations
8	use conform
1	5, 37
1	brand the
1	submits or
1	
 360bbb8b.
2	materials related
1	(q) schedule
1	(iii) safety
2	(j)(2)(a)(vii)(iv) of
2	trials conducted
1	1101; 1940
1	(d) false
2	allowing for
1	term loss
1	customers upon
1	premix supplier.
1	administration of,
1	bring them
1	(i) contains
1	single point
4	members with
2	direct possession
1	reporting (in
1	(iii) plans
2	current or
2	8, 2008,
2	bodies 
1	675, 561,
3	finding in
1	2017, after
1	regions who
1	communicates to
1	registration containing
2	(i) records
1	regulatory system
3	added substance
3	secretary describing
2	suspension upon
2	tobacco manufacturing
1	auditorsan accredited
2	foods advertising
1	several states;
2	title. no
2	forms the
1	agency no
1	drugs unless
1	impact in
2	manufacturing. such
2	(1) effect
3	conduct not
1	formerly 902(b),
1	violation involved
2	type for
1	participant in
6	kilograms or
1	surcharge that
1	consular district,
1	subsections (d),
2	form, which
1	
 1047.
1	(ii) state
2	requirements otherwise
1	cause that
8	adjustment shall
2	assign staff
3	section, but
1	(b) restrictionsan
1	iu/gm linoleic
1	public institutions.
1	assist them
13	secretary, acting
3	applications the
1	entity funds
1	title fails
1	elsewhere the
2	(f) research
1	347b. contravention
2	(a), afford
6	reduction, and
6	employs more
3	slaughter, unless
1	abstinence (whether
32	evidence that
2	fact shall
1	physicians prescriptions
4	(i) upon
1	record, and
1	separate occasions.
10	earlier than
1	added apr.
7	compared with
2	remitted or
1	residue. (ii)
11	implant that
2	policy the
1	products bearing
1	actual changes
2	treasury, the
2	obligation or
2	prejudice) for
14	educational agency
2	section 1705(c)
1	disclosed, except
2	renewed, the
2	shall suspend
1	title, adulterated
2	advisory assistance
2	(a) notification
1	1179. national
3	obtained an
1	secretary prescribing
1	includes generic
3	sales transaction
2	conduct examinations,
2	best knowledge
1	logo, trade
1	increased scientific
1	new owners
1	identifying an
3	section 356(c)
1	affairs and
1	office unless
2	efficacy supplement
1	practicable shall
1	stage status;
1	prioritization of
1	farm. 
1	considered final
2	nongovernmental entities
1	dairy industry
3	additives are
2	naming each:
3	(c) adjustments
1	applicant did
7	meeting for
1	(as appropriate)
1	statements do
1	significant, provides
1	consumers the
4	years, after
1	received. 
1	condition, prohibition,
1	administrator based
1	(3) pos-hearing
1	(d) notice
6	(1)(a) and
1	containers to
2	preliminary clinical
2	commerce until
1	(10) metazocine.
5	regulated industry
1	prepares meat
1	strategies, for
1	inspections, taking
1	secretary. members
10	measurement of
1	papaver somniferum
45	development and
1	subsequently referenced
1	representative anyone
1	following terms
2	preclude a
2	products who
1	registered narcotic
2	protocol, shall
1	55 of
1	distributors, for
1	food, drugs
1	358. authority
1	tribal demand
1	evading or
9	(a) means
1	387k(g)(2)(c)(ii) or
1	health interest
3	paragraph (b)
1	perform food
1	lettering on
15	person acting
1	board; (vii)
2	enactment date.
1	packages, labels,
12	filthy, putrid,
1	28, unless
18	year, and
1	1997 multiplied
1	name, contact
5	charged, as
7	imported by
1	wrapper thereof
1	rulemaking) or
2	following standards
3	discontinuance, and
4	provisions shall
8	medical device
90	food, drug,
1	another person.
1	institutions and
2	administration, with
2	evidence defined
5	title except
3	petition requesting
1	listed shall
3	executive branch
1	possesses or
2	preproduction design
1	
 398.
1	substance which,
1	designation. (2)
2	commerce, whenever
2	person upon
1	naming each.
6	training, and
2	(within such
1	154. regulations
1	(h) based
1	condition without
1	hereafter be
1	(a) exemptions;
1	measurements. when
11	prescribe to
10	(c) no
1	(1) alphaprodine.
1	ml; (ii)
2	president, by
2	treating, or
1	seq.] do
1	raw state,
1	(5) regulations
1	(a)(ii), fees
5	congress finds
2	(2)(a) shall
3	time fixed
4	immediately preceding
2	(f)(6)(b) declaring
1	withdrawn for
1	safety, that
1	disapproves a
1	2003 as
44	upon which
1	grade; and
3	plan may
9	repeal of
2	accepts direct
1	completely eradicated
2	substance law
1	feasible regarding
1	secure means
1	adverse[3] event
1	sale of,
2	patients who
1	pinball and/or
1	provisions; conduct
1	presumption at
1	26, 41
1	iv, 410,
1	certain health
8	(a) request
2	place a
1	public welfare
1	supply reduction;
1	survive notwithstanding
1	persons. (h)
14	register under
1	telemedicine, within
1	describedthe activities
9	18 years
1	final publication
3	whenever processing
1	(a)(ii)(iv) is
1	(b) penaltiesexcept
1	drugs presenting
1	gathered through
3	including access
1	nominee provided
2	200,000 persons
1	675, 770,
2	list has
1	direct reports
1	certification under[1]
1	needs; (b)
1	reasons includes
2	(i) other
1	826. production
7	specify a
1	program authorization
1	use hard
13	rodenticide act
1	salts. (f)
1	audit reports,
1	states when,
2	health hazards
3	dangerous weapon,
1	additional 18-day
1	(2) suspect
1	adult tobacco
2	(f) identification
1	issue temporary
1	manganese (g)
1	man, including
2	approval, approve
1	seizure has
2	appropriate committees
1	response shall
1	designated); or
1	(m) and
2	labeling requirements;
3	minor or
1	
 853.
8	transaction involving
1	inspectional priorities,
2	(including travel,
1	(f) nonprofit
1	electronic communication
1	extent not
30	substantial evidence
1	(d) has
1	413, as
2	utility of
2	funded drug
2	serve after
2	violations have
1	direct. the
4	qualified data
2	dispute regarding
1	marketing such
1	countermeasures, security
2	upon, and
1	repackagerthe term
7	data collected
1	subsection (b)(1)(d),
1	federal natural
15	describes the
1	certification with
2	grants, in
1	responsible parties
1	74, 8,
1	(b) wholesale
7	material and
2	misbranding of
1	adverse impact
1	$1,000,000 that
18	applicant and
8	scientific issue
1	longer benefitting
1	otherwise, acquired
1	(a) unless,
2	subchapter if
1	completed, under
1	significant presence
1	youth could
11	days from
2	territory within
1	misbranding or
1	cosmetic act).
1	subpopulations affected
1	learned, by
1	purchased, to
1	support; faca
5	application be
17	effectuate the
1	(6) specific
1	except matters
1	germination. (17)
1	conclusions concerning
1	1704. coordination
1	experts who
1	(a) compliance
1	expedited hearing.
1	387f1. enforcement
1	technology. (v)
1	storing a
1	meetings related
1	disclosures relating
1	360e(d)(1)(b)(i) of
1	(b) topics
1	written reports,
1	facility by
1	organizations referred
1	matchbooks for
1	tort system;
1	sentencing except
1	previous renewal
1	device requirements
1	
 464.
1	
 361.
1	(e) 10
2	2013), prior
1	extent. (v)
1	exported food,
2	(xii) a
1	thereof. whenever
1	task that
1	will promote
1	manufacturing dosage
1	(c) identifies
1	production, and
3	contained therein
10	selected by
2	unsafe, and
1	373. records
18	transferred
 

2	multiple reinspections
1	general note
15	food allergy
1	carrier, public
1	poison the
1	faith, and
1	3, 44
1	manufacturer, seller,
1	3, 42
1	publication that
1	assessment. (4)
2	purchased directly
1	 (4)2
1	updated standards
1	cafeterias. (e)
1	misstatements of
2	suspension occurred
1	official federal
3	general otherwise
1	user receives
1	(i) reporting
1	availability, as
1	(a))[1] and
2	article contrary
1	360bbb1. dispute
1	(a) he
1	process), only
2	appropriate regarding
1	claims data);
6	satisfy the
1	clinician or
1	standard new
1	subsection (m)(4)
1	drugs, investigational
1	finds there
2	modifying, repealing,
1	(e) index
1	employee. 
1	physostigma, phytolacca,
1	adopt an
1	(1) add
2	items specified
1	board. (e)
1	variance are
2	schedule to
1	share access
1	355f(a) of
1	(b) quorum
4	(c) application
1	commerce at
2	experts when
1	responsibilities described
1	commerce an
1	current illicit
2	(4) past
1	cultivate, produce,
1	states, even
2	veterinaria-clien-patient relationship,
1	(15) morphine
1	identified. 
2	cigarette tobacco,
2	obtaining from
1	necessary, coordinate
1	carriers are
3	tribal agencies
1	title) any
2	failed. 
1	found, the
7	reportnot later
1	accurate; (ii)
1	353(b)(1) or
1	term nicotine
1	secretary agree
3	extraordinary circumstances,
1	standard means
2	-year periods.
2	begun, the
1	package reviewed
1	time inspectors
6	significant controversies
10	title) and
14	353(b)(1) of
1	(3), with
1	346a(g)(2)(b) of
58	internet web
1	immediate family
3	single human
1	patient be
1	complexity and
2	support center
2	(2) supervision
10	equipment, and
2	water, whether
3	(b), of
1	(ii)disposition of
2	guidance, the
1	advice the
1	overall reductions
1	(f) critical
1	electronically downloadable
6	circuit wherein
1	smuggling. 
14	substance, or
1	collaborative relationships
1	basis thereof
1	support policy
2	regulations governing
19	(b), or
2	benefit and
1	ris-based approach
1	title, manufactures,
1	stat. 420.)

1	patient risk
7	apply. 
1	respects with
1	secretary recommends
1	disclosure the
1	(f) internal
1	pasteurization or
2	libel proceedings
1	approval. any
1	405, 52
1	seeds of
4	waiver, as
1	lands, or
1	(iii) conditions
7	disclose the
1	(2)(a)(vii)(iv) for
1	approval period
2	sales were
9	health professionals
5	equivalence under
1	order. such
1	commerce; (3)
1	local officials;
2	back to
2	level due
1	taken if
2	include material
1	(2) compromise
1	(2) individualsif
1	only; or
1	local officials,
2	therein and
1	proceeds thereof,
1	segregate, and
2	inpatient hospitalization;
1	ethics in
1	(i). (viii)
1	industrial researchers
1	marijuana. (g)
1	$10 million
6	(as compared
2	practitioner authorized
1	action required
1	tool if
1	declared not
1	
 360bbb1.
1	include conclusions
1	(c) mult-drug
2	activities undertaken
2	notwithstanding subparagraphs
1	selling tobacco
1	
 360ddd.
1	properly trained
1	(b)(i), the
1	hold, manufacture,
1	references the
1	protocol that
1	produced was
1	listed, are
2	practicable, with
1	requirement inapplicable.
1	lon-term drug
2	statistically sampled
2	senate. 
3	stat. 862;
10	ii, or
1	account when
1	entity subject
1	program a
2	research agenda
1	active, no-narcotic
1	411, formerly
2	register his
1	additional basis
1	law, states
1	populations, designated
1	panel failed
1	small amounts
1	information); (3)
1	exemption. the
1	properly and
1	cigarette papers;
1	2014; 
1	(c). (7)
3	labor charges
1	loan made
1	consideration, consistent
4	implement subsection
15	statement for
1	distinct enclosed
1	procure needed
1	practice, so
1	subdivision thereof.
118	section. 
2	provider shall
1	alcohol abuse
1	(1) persons
1	recommending methods
1	(c) $125,767,107
1	enhance federal
11	declaratory judgment
1	exclusivity 
2	acts a
1	(a) appropriate
1	acts c
1	holding food;
1	including purchases,
3	generated by
1	commence an
1	directly with
2	adequate summary
1	classify all
1	administrator, may
1	unaffected; authority
2	organize the
3	total user
15	submitted the
2	proceedings, including
1	practices document,
1	definitions for
1	licensing process
1	labels, or
4	352(e) of
1	designations authorized
1	views thereon,
3	(5) nothing
1	term sterile
2	prescription shall
5	patent will
3	terminate any
1	material document
4	contain or
1	reported are
1	routinely and
4	affected under
2	otherwise formally
1	lif-threatening or
1	communication planthe
2	(2) require
1	paragraph require
1	regarding sales).
1	product through
3	data, or
3	dates of
1	 $252,960
1	(b) contentfor
4	otherwise distributed
1	practitioners wishing
25	year; and
1	highly, statistically
1	practitioners referred
3	detention of
1	network, group,
1	use. in
1	obtains the
1	chapter unrelated
16	ingredient drug
1	subparagraph (a)(vii),
1	prohibition, and
1	secretary exercise
2	(iii) resulting
2	imprisonment, which
1	(1). (mar.
3	likeness thereof,
1	
 41
2	waiver before
1	gelcap, or
1	detention or
1	order containing
1	time donated
1	title,,1 the
1	prescribing that
2	(e) maintenance
1	compendium (and
1	employees initiative
1	(iii) annual
1	term applicable
1	certificationsthe secretary
44	abbreviated application
14	pay an
1	sample packages
1	found; preliminary
1	dissemination. (2)
1	audit interviews
1	commerce. however,
1	tolerance has
16	permit such
1	determine by
1	foreign agency
3	(or intends
10	suspended under
1	body and
1	different small
1	advisories, health
1	354, 355(i)
1	cake, or
1	parts and
2	conducting lon-term
1	1543(a)(2) of
1	(1) petition
1	fraudulent statement
1	fine, twice
1	permit each
1	(b)(1)(a) and
1	1034. inspection
1	(b) on-time
1	explaining the
9	maintenance or
2	methods reasonably
1	advocacy in
1	(b)(1) with
1	$693,099,000; (b)
3	(i) set
1	receiving, holding,
1	354(a)(3)(b) of
1	(1) applies;
4	submitted but
1	clause (iii)(i);
1	finally, unused
1	program, prior
1	location, which
1	
 356c.
2	used only
1	manufactures active
3	regulation, to
1	priorities developed
1	882. injunctions
1	new owner
1	natural vitamin
1	needed. 
1	(bb) for
1	
 387k.
3	senate, a
3	personal consumption.
2	personal consumption,
1	sitesthe court,
1	including health
1	paragraph publicly
1	original foreign
2	inspect establishments
1	uses covered
1	served (or
1	tobacco grower
3	additional penalties
1	basic pay,
1	subsection (e)(3),
4	residue for
9	need not
2	may reveal
1	budget year
1	may apportion
1	section 1(a)
1	(g)(1), a
1	(2) timely
1	problems emerging
2	received, records,
2	section 360fff3(b)
2	information supporting
1	(b) full
1	micr-organisms by
6	authorized the
2	adjustment of
4	information acquired
3	sold contrary
3	risk from
2	35 employees
1	to, advertising
1	target drugs
1	of, type
1	(2) affidavits
2	thereof, fail
1	603, 52
1	recipients who
10	annual percent
1	drug industry
1	reviewed as
1	identify other
23	maintenance of
1	fully establish
1	term bulk
1	promptly available
1	review division.
1	judgment issued
12	available solely
1	(a) suspension
2	manufacturer are
3	state, designates
1	(e) notification
2	organization; or
1	services, who
1	efficient review.
1	seizure the
7	review division;
4	(c) such
4	section 360j(e)
4	inspected in
1	amended [21
1	arsenical classes
3	submissions and,
1	requirement was
1	tol-free number;
1	nonprofit organizations,
2	either by
1	campaign (a)
2	irrigation, or
1	utilize good
1	proposal. the
4	use has
7	(1) such
1	statute made
3	number so
1	unlawful acts
1	chain, including
1	subsection (e)(3);
2	reduction activities
1	testing. (viii)
1	percentage that
1	projections of
1	other, at
5	circumstances and
1	(b)(2); or
3	large and
1	suture materials
1	milling, grinding,
1	(a)(iii)(x), if
2	(3). (3)
1	via mail)
1	hold additional
1	people to,
8	commerce in
13	authority conferred
6	signed and
1	sunscreen. (june
1	334. seizure
3	difficulties for
2	subsection. such
1	agent at
1	subsequent application
21	program to
30	states or
2	fact specifically
1	(d) procedures
7	said sections
1	states) from
1	exceed 30,000
4	53 of
36	product 
2	allocated among
1	requesting designation
2	sanitary standards,
1	minimizing burdensuch
20	states of
1	(aa), a
1	(b) aid
1	checks of
1	states on
2	petitioner. 
15	factory, warehouse,
2	entire record
1	congress. (3)
2	information, to
2	offenses or
1	352. misbranded
5	country. 
2	document issued
15	period described
1	74, 12,
1	official names;
1	anything done
2	issues, including
1	(b) records
2	including processing
4	states has
1	conforms, to
1	keep exposed
4	asserted if
2	order providing
1	stat. 2298).
1	379o. environmental
3	(2) are
1	monitoringto ensure
103	disease or
1	extension, and
3	official functions
1	(6) limitations
1	licensinga drug
1	(4) direct
1	names have
2	campaign operates
1	unit as
9	application. the
3	treatment program
2	fee each
2	affiliate, the
1	manufacture, many
1	parts used
2	considered misbranded
2	reputable practitioners
1	domestic establishments
3	period and
30	grounds for
9	constituent part
1	reduction agencies;
10	life imprisonment,
1	decision. if,
1	research). (b)
1	refusal 
2	(after giving
1	packaging the
1	section 600.3(ee)
4	containing information
1	subsections (b)(1)(a)(i),
1	381(e)(2) of
1	(3), (k),
1	commission 
1	(a)(2)(d)(ii)(i)) shall
1	including biological
1	benefitsnotwithstanding any
1	labeling resulting
1	less in
1	children); and
4	existing users
2	application contained
4	evidence strongly
3	region of
4	cases of
1	161 to
1	(7) report
1	report summarizing
6	meets all
1	service herein
6	nationally or
2	evidence with
1	nonnutritive substances.
1	(5) procedurein
1	supplements, that
1	vessel does
1	preliminary testing.
1	(3) nonapplication
1	221 to
1	organizations, industry,
1	trafficking problem
1	functional in
1	persons bound;
1	investigations. any
6	strategy to
6	comments received
2	(9) is
1	appointment; duties;
1	(2) name
1	forth on
1	petition. (b)
9	section 355(j)(5)(a)
1	times from
1	makes revisions
6	articles and
4	shall (i)
1	various processes
1	
 1542.
6	agency and
1	discussions and
1	section 1542(a)(1)
1	matter, the
1	produce, so
1	order, shall
1	national borders.
2	intelligence activities
1	including sales,
9	paid the
1	
 878.
2	panel in
3	rapidly and
2	crime and
1	secretary) alleging
3	meaningful disruption
2	election provided
1	section 352,
1	(f) disposition
1	$114,000,000 for
1	costs, of
1	section 841(b)(1)(d)
3	means those
1	integrating foodborne
1	employment, (ii)
1	biomarker; (b)
3	fixed therefor
1	(d)(2)(a). 
1	acetone. (c)
1	
 144.
1	assigning a
1	experts from
1	section 851
6	paragraph; (b)
1	(viii) for
2	(a)(1)(b) together
1	1204. repealed.
4	(9) if
3	assessment by
1	section 354(a)(3)(a)
1	scientific justification
1	foo-related hazards
1	denied any
2	part in
1	known by
1	minimum amount
1	(d) articles
1	indications in
2	emergencies; and
3	territories, or
1	(b) compensation
1	subsection (a)(3)(b)(i).
1	bezitramide. (4)
2	identifying characteristics
4	promptly review
1	historically been
2	amounts deposited
1	section 61
1	$25,000,000 for
1	provided through
1	drug, not
2	paragraph (c).
1	promoting the
1	studies by
1	award is
4	risk posed
1	section 343(c)
51	title 42
1	provided; (ii)
2	deferral extensions
6	ingredients, and
1	title 47
3	title 44
1	new sources
1	studies demonstrates
1	i, 13,
5	filed as
1	dependent persons,
1	(b) either
1	eligible partnerships
2	data other
1	parties in
1	electronic system
20	notwithstanding the
1	applicant plans
1	activity solely
1	means such
9	applicable, of
1	must act
1	composition, heating
1	corporationsupon an
8	within ninety
1	42 by
1	care costs,
1	2014, $534,000,000.
1	year. (14)
1	accountability office
2	anticipated annual
1	monthly basis,
1	amounts owed
7	considered adulterated
2	pricing data,
2	foods in
1	attorney may,
2	applicable, or
1	year. unless
4	report (a)
1	margarine having
2	chemicals or
1	environmental and
1	temporary and
2	omitted in
2	subsection (n)(2)(b)
1	dextromethorphan; exemption
3	health within
1	first. this
2	avoid false
1	sec. 1,
1	sentence, and
1	compounds; (iii)
2	applications are
2	1980, and
1	1985, any
5	control policy.
1	deferral extension,
2	transportation, offer
2	itemthe term
1	false. (i)
1	product could
1	elimination to
1	(if applicable)
1	contains clinical
1	(3) requirements
1	(3) strengthen
1	years, review
1	proportion to
1	request, whether
8	manufacturer means
1	adjudication of
1	shipment, at
1	request forms
6	custody thereof,
2	certified to
1	additional statutory
81	shall apply
1	matter shall
1	take administrative
1	18, which
1	payment pursuant
1	evidence required
1	acknowledge a
1	appropriate postapproval
1	contributions that
2	individual. 
1	licenseexcept as
1	(c) market
1	distance of
1	activities, public
4	personal use
2	advertising material
1	sufficient basis
2	published after
3	recommendation for
1	(a) notwithstanding
1	identifier (which,
1	issuer, in
1	(c)(1) and
1	effectively disseminated
2	331(p) of
1	2012)), or
2	(a)(2)(a) for
1	$14,100,000; and
1	practice pharmacy,
1	emphasize prevention
1	commissioner, may,
1	oxygen provided
1	(f) current
1	360h of
1	foundation, may
1	determination; judicial
1	designee to
1	cigarettes. 
2	geometric isomer.
2	unused advisory
1	prescribes) of
2	animal, except
1	drug within
3	381(e)(1) of
4	samoa, and
1	drug treatment;
7	documentation of
1	355a(f) and
2	motion or
4	carcass of
1	granted; and
1	reasonable terms
1	level equal
2	level information,
1	reference tobacco
2	(5), and
1	level information)
1	motion of
1	lead, mercury,
1	contributions) from
1	facilities, one
1	withdrawing such
2	ii. within
1	(am694); (xiii)
1	hopper truck,
21	information under
6	provide any
1	infringed, whichever
1	stop means
2	1 percent
1	established five
1	providing educational
1	board determines
3	including genetic
8	person have
1	1, 1958,
1	advances; (b)
1	topical application;
1	priority areas,
43	small business
1	practices if
1	predominantly by
1	covering under
1	products brokers,
1	made on,
1	individual allegedly
1	1985 and
2	section 954
3	18 of
29	(2) for
1	interagency coordination;
1	serious riskthe
1	supplies regarding
1	including labeled
1	(1) information,
5	title relating
31	18 or
1	objection to
1	(b)(3)(b), and
1	contributions the
6	treatment programs
19	systems and
1	every person,
8	collecting fees
2	require as
1	pending review
1	strategy. (xii)
1	(d) funds
1	reopened for
1	current quarter
14	(ii) any
101	 (5)
5	permit a
1	(c) assaulting,
1	serious hazard
2	formal enforcement
1	packers, or
1	prescription. this
1	(e) reference
2	place where
1	emissions of,
1	menu in
1	trained personnel.
4	immediate previous
1	defraud and
2	shall prioritize
2	application. (c)
2	permanent scheduling
1	rulemaking may
4	classified or
2	lawfully imported
1	credentialing center,
1	section 331(gg)
1	u.s.c. 360ccc1],
1	education; (b)
12	schedule iii
1	animals; he
1	securities; and
1	section 360a2
2	section 379i
1	deadline provided
1	1996) an
1	appointed jointly
2	1703 of
1	labeled indications;
4	feed are
1	program. (d)
1	sources to
1	available, except
2	generalin this
1	director rejects
5	hold such
1	shall advise,
17	request. 
8	buying or
1	products solely
1	
 215.
7	(ii) and
2	infant formula)
1	substances, listed
2	(d) judicial
3	particularity the
4	drug store,
1	360e(f), 360j(g),
1	useful information
4	infant formula.
3	senate. (b)
5	require an
1	mental faculty.
1	(2)(a)(i)(i). 
1	prevention; (c)
1	pesticide tolerance
4	upon filing
1	eligibility issued
2	government accountability
1	reasonably have
1	(b) exemptionupon
1	rendered other
1	bag containing
1	tested and
5	active, nonnarcotic
1	statistically significant
1	subsequent shipment,
1	invention, development,
1	(cp47,497); (ii)
1	issued, or
1	longer is
1	food; inspection;
6	january 15,
3	longer in
3	regulations not
1	similar food
1	award amountsaward
1	853]. (4)
2	upon certain
4	different use
1	proposing that
17	expenses of
2	transport or
1	(b)(2) set
1	(i) reinstatement
1	paper format
2	drug other
1	(iii) i-process
1	packaging, in
1	communication described
3	paragraph. (b)
2	section 352(x)
1	(5) timelinesthe
1	research requirements
1	(b) evaluation
1	2, 32
7	infant formulas
1	analysis, carrying
2	liners) of
1	criteria standardsin
1	(iii) scientific
2	registration simultaneously
5	practices for
3	mean an
1	act chapter
1	(a) known
1	affidavits of
1	enforcement resources
8	provision for
1	sold during
3	condition; (2)
1	transport stolen
13	makes the
8	interdiction command
1	661(b) of
2	eggs for
1	data carrier
1	within 150
1	cause bodily
1	formulation, may
1	premises in
1	consider where
20	manufacturing practice
1	i, 4,
1	various ports
26	annual fee
4	section. (c)
1	prosecutions for
1	ensuring such
1	(f) transition
19	using such
1	(11) may
1	sponsor, or
1	less, (3)
1	(d) opportunity
7	records, or
3	specific drugs
5	affects the
3	1036 of
1	origin: provided,
1	year next
2	implement systems
1	records showing,
1	obtaining payments
1	contractor who
1	acids and
8	directive drug
2	claims such
1	upon review
1	probation prohibited
1	states) with
1	different characteristics
1	chapter, then
1	exportation insulin
2	objections are
1	prescriptions, except
1	of, pediatric
3	trafficking threat
3	subsection (f)(1)
1	gain admission
2	enhance secure
10	limitation. the
1	article, to
1	year less
9	period, or
1	dosage forms,
1	quarterly. (2)
2	food without
1	organizational component
1	teachers, administrators,
3	attempted distribution
1	device. (5)
2	subsequent reports
3	(b) data
9	make recommendations
3	appropriate with
1	hydrates of
1	requirement would
1	surveillance activities
2	repealed. may
1	administrator that
3	(2) date
1	shall administer
1	specific drug,
1	(2) data
3	sole item
1	established; (b)
5	licensure under
1	(c)(1)(b)(i), (d)(1)(c)(i),
1	1332(7) of
1	desirability; use
28	rare disease
1	site; or
1	section. as
1	publication should
1	marine fisheries
3	20 to
1	whose bacterial
1	equitable relief
6	(b) include
2	section. an
1	206. revocation
2	(c)(2), a
2	state cooperation
2	product being
1	membranes to
1	chemicals usable
3	care delivery
12	section 353(b)
1	17th par.,
1	manufactured controlled
1	testing, or
1	sales excepted
1	distribution, currently
9	food industry,
1	(6) annual
1	(iii) correct
5	substance; and
1	sel-certification submitted
4	separate standards
1	individual exportations
3	order declaring
10	lead to
1	(f) did
2	citrus fruits,
1	drugfor purposes
1	countries. (

7	both. 
2	service corps
1	served at
3	title subsequent
1	notification prior
3	conveyance, or
1	raised and
1	(a) rules
1	passenger, commercial
1	parenteral drug,
1	communication should
1	evaluate domestic
7	area. 
1	consumers, restaurants,
19	local educational
6	drug substance
1	42 may
2	appropriate. (d)
2	(ii) subsequent
6	goals, for
2	mortality in
1	coalition means
1	859. distribution
2	recklessly sell
1	
 384b.
1	sanitary inspection
3	complete such
1	staff, parents,
5	jury of
1	approve biosimilar
2	processors, or
1	community initiatives
2	promotion and
1	(iv) 18-day
21	clauses (i)
2	records access
1	(h) fascioliasis.
1	navigable for
2	(2) inclusion
1	agenciesthe secretary
2	control activity
1	(b) adequate
1	removing, and
1	consumption, including
2	commands, induces,
37	determining the
2	targeted technology
1	section 360ccc1(e)(2)
1	current food
1	requirements needed
1	713 or
1	(a) take
1	provides accessible,
2	ii. (2)
2	resubmitted or
2	restricted in
1	(c)class iii,
1	unprotected; (2)
4	upon issuance
2	(c) content
1	departments; (5)
1	system as
2	ii for
1	1946, and
1	chapter, when,
1	designation. if
1	(20) the
2	postal service.
1	provided shall
1	criteria; proposed
1	hardship or
1	prepared, packaged,
1	controls but
1	receiving food,
10	shall request
1	enable seamless,
1	designation with
4	conviction, be
1	warehouseman. 
1	agreements, and
1	(2) reasonably
2	tobacco, and
1	risk. an
1	5. (h)
1	purchases. (b)
1	formula powder,
1	(2ce). (21)
8	address, and
1	interim review
1	vehicle. (d)
4	holder involved
10	analysis and
1	beneficial in
4	submit assessments
1	resistance. (vi)
1	governmental entities
1	grant; (c)
1	jurisdictions, such
1	certain egg
19	regulation issued
1	421, as
1	protect against,
1	paraphernalia definedthe
1	foreign state.
1	1914, ch.
1	subparagraphs[5] (1)(b)(i)
3	commerce within
1	species indication.
1	precursor in
2	elimination of
1	427i(a) of
1	auditor under
1	 (nn)
44	derived from
1	job training,
27	new information
1	license every
1	12 inches
1	standard. (2)
1	exposure from,
1	allocation results
1	species indication;
1	accept saleable
3	collectionsfees collected
2	population likely
3	comparative bioavailability
1	certificationsnotwithstanding section
2	following information,
3	applicant submitting
1	case when
1	wanton, or
7	country which
1	821. rules
1	kits. 
1	domestic, military,
1	consumption then
1	comment pursuant
2	(e) for
1	sanctions provided
6	following information:
1	inspect notwithstanding
1	sales direct
23	products to
1	hearing distant
4	became known
2	pizzas have
1	provides detailed
10	create a
1	priorities published
1	reporting shall
1	671. inspection
1	inspectors) designated
20	grant or
2	direction issued
1	implementing any
27	or, if
3	suspends or
3	implementing and
1	identifying inspection
3	indicate that
4	required as
16	or, in
5	grant of
1	subchapter. except
3	of, inspection
1	specific dietary
1	magazine, handbill,
1	provided herein,
2	outsourcing facilities,
1	standard efficacy
1	accurate assessment
1	including modified
1	limitations no
1	illness outbreak.
2	illness outbreak,
3	proposed performance
1	108; july
2	order) to
13	grants a
2	operations; and
1	device provide
46	schedule i
1	inactive ingredients,
1	submissions. (c)
1	illness outbreak;
1	(mg) 55.0
1	administrative expenses,
1	seizures. 
1	needs (including
1	isolated, or
2	public process,
22	(2). 
4	abuse treatment
1	productssubparagraph (a)
1	(c) thir-party
3	charter act
1	accompany food
1	medicine of
1	132. transferred

4	unless that
2	intravenous use
1	
 350c.
1	fell during
2	proceeding against
1	alternative methodsthe
1	terms lif-supporting,
4	hearing with
1	phenobarbital. schedule
1	provider sufficient
2	petition., with
1	enterally under
3	record, or
7	authorities under
4	order act
1	u.s.c. 247d],
2	states: provided,
3	seq.]. (b)
1	pacific islanders),
1	
 161
2	1046 of
1	flavor (other
5	illness outbreaks
1	record, of
1	indian shall
1	sites for
1	regarding priority
1	418, as
1	take affirmative
1	order relating
1	(i) evaluate
1	china to
4	recall. 
1	chemical. the
1	covered entities
1	operating expenses
2	(a) regulations
1	general food
2	information), transaction
4	inflation in
1	investigative efforts
1	cut, ground,
1	disparities issued
1	whether revision
1	transaction constituting
1	repair the
1	section 379j(a)
1	declares to
1	working toward
6	agreement shall
1	potential toxicity
12	abuse and
1	imprisonment. (3)
1	2, 69
1	(b), remaining
1	security acceptable
3	device have
1	antibiotic resistance,
4	whether any
4	chemical residue;
1	exemptions granted
2	commercial loss
1	tests associated
1	understanding and
1	ease and
1	either electronic
2	process, to
5	shipment as
1	nutrition and
3	344 or
1	appropriate, teams
1	whether and
4	agencies concerned
1	recognition agreements
1	involvement as
2	certain functions
5	order refusing
1	safe production,
2	applicable); or
1	element under
4	subchapter i.
2	imported. (2)
1	timingnot later
1	2015, and
1	draft guidance.
1	48 months
2	of, illegal
2	director, may
4	secretary before
2	application. there
1	complete or
1	(40) properidine.
1	mutual agreement
2	manufacturing change,
3	products other
1	section 5,
23	processes and
3	made from
1	application other
3	supplement which
1	(f) -acetylanthranilic
11	chemical residues
1	first. (iii)
8	contractors of
1	information also
1	operator intends
4	commence a
1	warrant), shall
1	904, as
4	validating any
3	body (or,
1	(1) partial
1	manufacture move
1	regulations affecting
1	requires otherwise
1	(v) available
1	(c) conflicts
5	additive, and
1	marihuana for
1	initiating proceedings
1	professionals. (xi)
3	property, including
4	instituted and
1	indica, digitalis,
3	ii substances
1	facilitate safe
1	partnership programs
3	positive for
1	conclusions. (v)
1	necessitating such
1	area involving
1	programs) required
2	colorings may,
1	(i). (c)
1	acting director
1	360dd. open
1	suspension, threats,
2	concealment of
10	substance described
1	subsequent repackager,
1	physically inspecting
2	represents the
65	federal food,
49	substance abuse
1	generalthe ex
1	360i(e) of
1	board composed
1	material. (4)
1	renewala conditional
96	authority of
1	flunitrazepam shall
1	category (as
1	materials, constitutes
1	charge. 
1	(including delivery
2	regulation remove
1	measurements that
33	preceding sentence
16	government of
1	development; (3)
1	device only
8	requirements shall
1	biennial basis
1	cros-disciplinary review;
1	15, 1967.
1	detailed written
19	government or
3	(a)(2) (relating
1	resulting accreditation
1	person inspects
1	thereof) shall
2	said secretary
2	facility with
2	processing procedures
2	appropriate offices
2	to, knowingly
17	extent practicable
1	360, 360b,
1	designation has
1	u.s.c. 355f(g)],
1	sampled, including
2	letter, or
1	name included
7	relationship with
2	carcass, of
1	proposal designed
6	application) submitted
1	section 6103(a)
2	accept any
2	prepared during
1	substantive dispute.
1	aircraft owned
5	carcass, or
4	accept and
2	(b) new
1	353(c)(2) of
11	criteria website
1	
 360e1.
203	(ii) the
1	conditions with
1	hold 
1	defense; and
2	sodium, chloride,
1	court review
2	summary data
3	dependence. 
1	premises; (2)
3	animal quarantine
1	thing was
2	filter, or
1	officials engaged
1	animals, intended
2	administrator a
2	15, 1967,
1	judge and
3	applicant 
1	(b) voluntary
2	product (except
1	baseline determined
1	section 387a1
1	pharmaceutical dosage
2	committee a
1	(3) new
1	(i) holding
1	emerging pathogens
1	report submission
1	performance audits
1	poultry itemthe
1	coalition information
1	animal before
1	crises (a)
4	first became
1	(ii) by
2	direc-t-consumer advertisement
4	(b) duties
1	revocation any
1	year 2020,
1	disclosure informationeach
1	revocation and
2	section 355(d)
5	(ii) be
2	1961, and
3	decision is
2	adoption in
1	threats 
1	employees, except
2	mature stalks
1	manufacturing facilities,
1	aggregate allowable
1	distributing free
1	planning, overdose
5	action package
1	abuse). (xii)
1	(ii) transfer
3	reducing illicit
1	production threats;
1	uses susceptibility
2	335a(b)(3) of
1	jury. the
2	scheduled as
2	dispensing narcotic
1	solid dosage
1	transaction and
2	otherwise handled
1	label identifying
2	submission as
14	salts, optical
1	so, shall
2	specific tasks
2	changes if,
2	purchaser, the
1	committees shall
1	believe is
1	appropriate; (b)
1	(d) cause
3	device prescribed
1	firearm (as
1	(e) separate
1	mediu-, and
3	board may
1	871a. semiannual
1	1.35 percent
1	exceed 0.53
2	fish classified
1	valid applications
1	18; (v)
2	360e(d) of
1	restitution to
4	including clinical
1	design life
1	meet, match,
31	products are
1	teeterboards. (2)
1	committees for
2	trials to
1	export data
20	progress of
70	(b) of
1	receipts into
1	require special
1	patient. such
1	supporting coordinated
9	(b) on
2	things which
1	age. 
2	compliance division
1	recovery and
16	agency that
1	significant apparent
2	contract to
2	policies governing
1	rendering carcasses,
1	emissions. 
2	recognized shall
6	loss of
2	disseminate to
1	representing certain
1	counterdrug activities
1	need refers
1	(3) communication
2	affiliate thereof
1	order prohibiting
5	loss or
1	2206. alcoho-related
1	may coordinate
1	standard; (ii)
1	certain safety
1	
 850.
1	study the
1	may accept,
2	(5) selected
1	directive applicable
2	panel respecting
2	periodic reevaluation
1	effect, develop,
1	ingredients only
1	service, assessment
1	biennial plan
1	commissioner for
1	assure purity,
1	including actual
1	people. (3)
1	similar, serious
20	interest in
1	means children
1	(e). (e)
1	program; (ii)
1	886a. diversion
1	agriculture may,
1	party determines
2	supplements: 
2	raise different
2	treatment programs,
1	398 of
1	iv, which
1	pediatric use;
1	therefor. the
1	609. examination
1	(c) advance
1	264 of
1	247d6b(c) of
1	procurement contract
4	made, formed,
2	extension that
1	chemical the
10	periodic reports
3	tobacco tax
1	ulcer. (e)
1	capture transaction
1	
 1035.
1	court rules
1	assessment means
1	bodily fluids
2	consumer research
14	section. the
2	secretary determining
1	advisable to
1	act (and
1	combat international
1	made, be
1	human activities
1	(3), nothing
1	religious belief
4	(h). 
1	response; hearing
1	said federal
1	committee determines
1	measurement tools
14	determined appropriate
1	practitioner submitted
4	made, by
1	96. repealed.
4	additional time
23	360 of
1	(i) inapplicability
8	prevent such
1	petition contents
1	bioequivalence study;
1	developing drugs
2	campaign, except
1	section 2012(b)(1)
4	(2) required
1	year 2016;
1	
 1532.
1	religious dietary
1	pharmacy. 
1	will refer
1	manner, such
1	379aa1, 387i,
1	portion and
1	(v) carry
1	transaction informationthe
1	compounds drugs,
1	section 453(g)(8)
1	address every
1	patients. any
2	(1) include
1	foreig-chain distributor
1	new means
3	slaughtered or
7	treasury shall
7	action pursuant
1	single mode
1	term prior
1	use pending
1	product capable
1	commonly abused
1	communication about
12	title by
2	causing to
1	devices found
2	971 of
1	(2) consumer
16	includes 
1	effective october
3	providers about
1	file. 
1	among governmental
3	probable risk
11	departments and
2	limit work
5	(i) appropriate
1	applicable executive
2	control over
8	establish such
7	services (referred
1	identify. the
1	dates. (ii)
7	federal rules
2	longer make
1	savings nothing
1	consequences which
1	841(b)(2) of
1	substantial damage
1	owner; copy
1	involves buying
3	giving rise
3	slaughtering of
1	guidance in
1	specifications were
1	channel for
1	public report
1	seve-year period.
1	either declare
1	(c) color
1	suspend immediately
261	drug administration
1	periodic basis,
1	provide effective
9	(b) content
1	communicating safety
2	commenced (or
4	facility manufactures
1	shall call
1	provide fuel
1	engage. 
1	included under
1	2011, enter
1	343(f), 343(g),
1	election, give
1	biologics approved
2	infringed; 
3	act that
1	duplicative requirements
1	hyperlink to
2	practicable, shall
1	upon implementation.
1	hundred thousand:
1	h of
1	emergency uses
1	ineligibility referred
7	 (o)
1	person violating
1	risk was
12	milliliters or
1	(b)(1). for
13	minor use
1	notice system
1	(6) training
1	(f) minimize
3	marketed as
1	hundred thousand,
4	ris-based preventive
3	360bbb of
1	secretary add
1	and/or gymnasium
1	(iii) rule
1	379h. authority
1	o-call basis
2	profile of
1	impose temperature
1	actionthe action
2	registrant that
1	nondiscretionary duty
1	(b) exceptionsif
1	(2)(a) or
1	registries, or
1	application, within
1	storage, retrieval,
6	free samples
1	must conduct
1	back pay,
3	coordinated and
3	(2)(a) of
1	back pay)
3	1 year.
5	1 year,
1	disseminated. 
2	submit recommendations
2	appropriate consideration
3	are, in
1	application, abbreviated
1	egg of
3	recommendation from
1	necessary as
6	2013, a
1	receiving information
1	(a), paragraphs
5	specific suggestions
3	petition, notification,
3	exclusion from
3	packaged on
4	shall post
1	(i) finds
1	guidelines available
1	(f)(i) shall
2	periodically, or
1	year refers
1	names in
4	container does
1	names is
3	societies of
3	persons specified
1	(e) powers
1	grounds, or
9	pay fees
1	laboratory run
1	specify (1)
1	amountssubject to
1	(3) dru-related
1	coconut, licorice,
12	determination. 
1	mandatory ante
70	(4) the
1	obtain tobacco
2	assistance, including
2	health reasons
4	demonstrable difficulties
2	exemptions provided
1	additive likely
1	make to
1	2007, a
4	racemic drug
1	upon december
1	processed as
1	manufacturer) specified
1	new productsif,
2	section 346
3	(b) activities
3	(2) final
1	quarterly, not
2	packing, processing,
1	methyldesorphine. (13)
2	patent involved
2	 schedule
1	record, recording,
2	secretary using
1	tried all
1	leaders, received
5	application; or
2	traditionally and
1	industry, agricultural,
2	regulation the
1	comment rulemaking.
19	2014 through
2	process, notice,
1	competitive conditions
1	comment rulemaking)
1	(37) phenoperidine.
1	issue recommendations
4	conditions associated
1	canada as
2	safety issue,
1	substantial income
1	violation, except
1	substancesnotwithstanding sections
1	publish it
1	1013, formerly
1	completion. (2)
1	marijuana, heroin,
1	auditthe government
1	territory; (iv)
1	undertake enhanced
1	(l) assessment
45	enforcement of
1	(2) facility
1	package sizes
1	product expertise
1	suspension, and
3	fruit or
1	enacts a
1	offenses which
1	gang crime,
2	additive, including
1	whose activities
26	labeling and
1	evaluate new
1	body in
1	animal. (4)
1	lawsfor purposes
1	drugin this
1	(2) technical
3	request issued
1	operations 
1	nonradioactive reagent,
3	submitting an
45	drugs and
1	(2) filing
3	862; 7
1	setting in
1	supplies a
1	subsection (b)(2);
5	preceding calendar
3	owner, by
4	may 13,
1	75 calendar
1	effect 
1	term incubator
1	country the
1	extensions were
1	customer, such
1	stat. 822.)
1	treatments that
1	regulation impose
8	subsection (b)(2).
1	congress. (b)
6	subsection (b)(2),
1	mercury, silver,
4	biosimilar development
3	adverse eventthe
1	bringing any
6	reasonable variations
31	subparagraph shall
1	transaction provides
1	(a)(iii) to
1	senate; (b)
2	represents an
1	practices. 
1	(c) notwithstanding
1	structure is
1	bylaws under
1	structure in
2	professional organizations,
2	filing with
5	financial and
1	control a
15	centers for
1	section 355(b)(3)
1	manufacture, evaluation,
3	reports (a)
1	sunscreens marketed
21	drugs 
1	(i) comprehensive,
1	updated interpretive
1	(e) costs
1	credit corporation.
3	vitamin or
3	industry, academia,
1	(1)(a), a
2	(1)(a) of
2	chemical (other
2	substance pursuant
2	misleading; (5)
1	channels, including
1	import, the
2	mandatory system
1	manage or
2	controls). 
3	devices reclassified
1	studies. minutes
2	veterinarian, the
5	(1)(a) or
2	constituents (including
1	enact, adopt,
1	relief. (3)
1	terminated pursuant
1	fraudulently obtained,
1	issue warrants
2	facility meets
2	enterprise in
1	appointments are
361	 (c)
5	publicly identified
1	(i)(ii) 
1	u.s.c. 45,
1	professional organizations.
1	participating state,
19	director may
5	aggrieved by
8	establishment has
1	serious diseases
1	instruments, promote,
1	individuals designated
7	country; and
1	restriction on
4	essentially a
1	alphameprodine. (5)
2	produces for
1	
 903.
1	updated guidance
2	oral hearing;
1	
 360ccc1.
4	information demonstrating
1	concerning first
2	program year
1	may, through
1	ceramic pipes
1	1967. 
1	deemed, alone
1	oral hearing,
3	dispersed); (ii)
2	training, education,
2	federal control
5	central kitchen
1	shall send
1	u.s.c. 45]
9	guests and
1	(b)(2)(a). the
1	foods, that
6	(2) public
1	(i) temporary
1	device, from
5	protocol, or
1	exceeds such
2	respecting control
1	thereof; (d)
1	machine, and
1	subchapter) shall
1	studies. (ii)
1	262(a)(3) of
1	pharmacist. the
6	(d) to
1	harmful components
26	exemption for
1	(ii) clauses
1	(f) awareness
6	(ii) information
1	possible, be
4	(1) unless
3	supplement containing
1	annual meetings
2	revisions made
2	section 360ccc(a)
1	account (among
1	adequate by
2	forfeiture to
1	(c)) and
1	675, 506b,
1	application, (6)
9	threat of
1	request containing
4	assessments, deferrals,
1	quantity sufficient
1	countermeasures, populations
1	appropriated $20,000,000
1	quantity, chemical,
8	otherwise unfit
1	ii by
1	18[2] until
1	charged and
1	analysis, documenting
1	generalupon determining
3	(ii) make
5	drug. (c)
1	(26) -(2,-dimethoxyphenyl)ethanamine
3	tobacco additive,
1	members whose
1	878. powers
10	official plants
1	897.30(b), if
1	summarizing the
1	(ii)(i), in
1	purchase do
2	otherwise bearing
3	will give
1	specified country
1	affects security
1	violation; (ii)
2	businesses (including
1	unsafe devices;
1	campaign are
1	meet regularly
1	refunds 
2	animals found
1	form; contents
1	(f), no
1	ch. 192,
1	dying, disabled
1	papers filed
1	30.0 
1	thereof; except
2	(e) information
1	child nutrition
2	instruction, or
1	may recover
1	hearing. (f)
2	quarter. (3)
1	charged. 
1	includes information
1	chapter, where,
1	architects and
1	fees) to
1	policy, law,
1	release whenever
1	(f) office
1	provide and,
1	blood ring
2	life threatening,
1	purity differing
1	
 2205.
2	made public
1	burdens, and
7	prompt notice
2	(b) would
1	advertisement after
1	1161 to
1	updated as
1	safety criteria
1	first month
1	determinations not
1	section. except
1	establishing automatic
1	anaphylaxis; (v)
1	equine is
2	commits any
2	reduce duplicative
1	safe); and
1	assistants, or
1	22). 
1	(f) monitoringto
4	antifungal drugs
4	subparagraphs (c)
1	$10,000,000, or
1	compel, nullify,
1	(iii) businesses.
2	affected persons
1	periodic patient
1	imports; denial
1	(4) liability
4	approved application;
1	(1) specify
2	action requested
2	believes, on
2	entity engaged
1	517.)
 

5	451 et
2	deemed unsafe,
36	(1) 
2	tin, canvas,
3	believes, or
2	approved application.
1	chlortetracycline, chloramphenicol,
8	showing that
1	foods identified
3	(1) advisory
3	on-half of
7	countries to
1	undertake such
9	reorg. plan
2	consent from
9	committee with
1	supplements, premarket
8	made pursuant
1	-(-naphthoyl)pyrrole by
1	recovery goalsecure
1	calculating the
1	courts, corrections,
1	98 of
1	species. such
1	drug addiction
1	summoned under
2	respond and
2	906, as
1	(or, where
1	law; or
1	auditors, and
1	margarine clearly
1	920, as
1	upon him
6	paragraph that
1	(4) repealed.
1	section 379g(8)
1	(2) financial
2	standards means
1	necessary updates
1	accessory. 
1	damages to
6	hospitals or
1	judge who
6	following factors:
1	(3) articles
1	substance, possession
5	audits conducted
2	subsection (a)(3)(b);
1	criminal laws
1	programin conducting
1	fee account,
1	specifying, as
1	restriction; project
7	reasonable times,
1	(3) solely
1	authorizationthe secretary
2	report made
1	practice veterinary
231	(june 25,
2	amount available
48	list i
1	cellophane), in
1	employee therewith.
2	that, without
1	subbrand. (2)
1	regulation, require
1	materials, or
1	whether product
1	(i) improve
4	ephedrine base,
1	may 2007,
1	fact at
4	stat. 631;
1	quantity which
1	compounded drug;
1	(i)), over
1	customer, on
1	clinic operated
1	successor regulation)).
2	subchapter, to
5	information not
1	program, similar
1	initial inventory
1	drug substance;
2	including sanitary
21	prior approval
3	disclosure statement
32	use, or
1	(d) notwithstanding
3	ii to
1	1001 to
6	conducted pursuant
1	(13) package
1	section 355(k)
1	28, when
7	entity. 
1	(6) grant
3	regular customer,
1	regular customer.
2	composition has
1	order. (e)
26	advisory commission
4	diversity of
1	(4) describes
4	device, food,
1	26, the
1	prohibit such
2	risk factorsin
4	experimental conditions
1	avoid, reduce,
1	action, to
4	revision described
1	services concurs
1	consult with,
1	integrated with,
1	ingredients described
1	seq.); (e)
5	action letters
1	coordinated research
1	subchapter, nothing
1	(ii) preventing
2	regular customers
1	fined any
1	467e. no-federal
1	eligible lon-term
9	article to
1	employment. (b)
1	2018. (h)
1	container ordered
1	identified potential
1	penalties anyone
2	smaller than
1	risks), particular
1	safety surveillance,
1	(v) publication
1	similar activity
2	photograph and
2	trials (if
1	
 1051.
1	sponsor proposes
1	rigorous than
1	(4) process
3	orders and
3	federal assistance
6	effective control
2	commissioners request
2	port in
1	remedies available
1	commissioner, and
1	secretarythe sponsor
1	suspended. (2)
1	regulationsbased on
1	food, has
1	serve colored
1	identit-preserved labels
1	consumers. (b)
1	(s) -methylephedrine.
1	fees has
1	675, 744i,
3	360ll of
1	security threats
2	existence in
3	year regarding
2	term package
1	year increased
1	electronic formats)
4	invoking subsection
1	determinations, and
1	(a) prohibited
1	hearing whether
2	drug products)
2	mitigate, prevent,
1	abuse, may
1	drug products,
1	fraudulent, or
3	drug products.
2	previously paid
1	sale including
2	representative selected
1	alleged violations
1	 (ii)request
1	exemption was
1	sold within
1	
 844.
1	355(p)(1)(a) of
5	stakeholders, including
2	(c) employing
2	secretary identifies
1	parts also
1	feet above
1	include, notwithstanding
1	interventionexcept as
3	title, no
11	investigate the
1	(mg) 4.0d
1	situations except
1	documents describing
8	that, with
2	coordinating the
1	submitted, (ii)
1	procedure; conditions;
10	education program
1	age verification;
1	pending, or
1	require; (e)
1	pesticidal use
1	accessing health
2	packaging for
1	periods shall
1	hydroponically grown
3	cause any
1	vitamins. (b)
3	supplier shall
1	nonprescription drugthe
9	chapter. the
390	paragraph (1)
1	food designation
1	897.16(d) of
1	(a) available
3	excepting products
1	minor nature,
3	u.s.c. 151
1	section 1701(11)
1	reached through
2	device; 
1	situations 
1	360f. banned
1	youth; (4)
2	term indian
2	decision regarding
1	(a) finds
1	childrenin establishing,
1	(9) issue
1	section 356c(g)(2)
2	unique identification
3	(d) request
5	administration through
2	intelligence sources
2	waiver and
5	form or
1	discovered through
1	request referrals
1	year, but
1	(iv) invite
1	(k)(4) of
1	use up
1	of, as
2	1928, ch.
4	representative shall
2	(7)(c) of
1	(2) commerce
1	second country)
2	among national
1	shall survive,
3	second country,
34	form of
1	fees fixed
1	appropriate. (k)
1	prescribing practitioners
1	impact that
3	final product
1	injury, harm,
1	formerly 909,
17	term drug
1	committee deems
1	chapter (or
1	school programs
1	labeling, under
1	2007 for
1	application. an
1	sanctions or
1	1; (ii)
1	avoid conflict
1	2003 multiplied
2	inspectors of
1	including determining
1	third person,
3	packaging, transporting,
6	requirements would
1	policy gift
1	expressing concerns
1	contenteach of
1	humans within
1	cell and
1	licensure; and
1	distributor anticipates
1	compelling testimony
4	prescribing practitioner,
2	appropriate relief
1	different type
1	options. 
1	fact. at
1	partial fillings
1	order of,
10	amend the
5	conduct which
1	treat; (e)
2	potential need
1	specifies 
3	(c) authority
1	case was
1	supplier; (ii)
2	retail dealers
3	corporation charter
10	drug substances
1	unavailable to
13	2016, the
1	device required
1	outpatient diagnostic
1	change, summarizes
1	inspect nonconforming
1	buyers during
1	support implementation
1	treatment research
2	section 355(o)(3)
1	may share
1	offenders, which
1	necessary. (e)
1	investigator proposed
7	imprisonment, a
56	21, code
1	without modification,
1	144. unlawful
1	chain for
1	year quarters,
3	two years,
1	impractical, an
1	immediate proximity
2	refuse or
1	(b)(1)(b). (f)
1	liquid form
2	designates the
2	privileges of
1	using biomarkers,
1	fusion, advanced
1	675, 529a,
1	term rea-time
1	priority drugs.
6	antibiotic drugs
1	elements 
3	requests received
2	(ii) every
1	paper, electronic
1	systems; (3)
1	order disapproves
1	(v) detailing
1	federal cigarette
1	initiate any
1	point based
1	(7) penalties
1	344, or
1	establishments operated
1	parolees. 
1	entitle him
1	certified, in
1	revenue from
4	judiciary, international
1	and, notwithstanding
3	evidence (and
1	fruits, or
1	provider licensing
2	businesses; fee
1	i) for
1	jury trial
7	no-racemic drug
2	serve the
3	auditor and
18	identification and
2	valid or
2	(e) supplement
1	(including neonates
2	perception, behavior,
1	used and
1	meeting their
1	destruction, obliteration,
2	standards respecting
1	day it
3	addresses the
2	chapter (other
1	appropriate subject
9	sums transferred
1	refilling any
1	(f)(1)(c) or
7	event occurring
3	one general
1	(f), in
1	application. as
1	(d) did
1	oral hearing);
1	property where
1	health with
2	omitted 
4	signals and
2	372 of
3	submissions and
1	retained on
9	threat to
2	submission (within
2	judgment be
1	including packaged
4	tests and
1	taken office.
7	states interdiction
3	section 360cc(a)
6	general schedule
1	articles pending
1	
 346a.
1	communication; and
14	approve a
1	45, 53,
1	(e) inapplicability
5	requirement relating
1	financial information)
1	tolerated in
2	parties, including
1	with, more
3	plan as
1	device, they
1	(3) rescission
8	records 
1	(e) ergotamine
2	article refused
1	(known as
2	debarred persons
1	data requirements
2	informed persons
3	debar such
1	claimant in
1	diagnostic biological
1	petition) the
1	effectnotwithstanding any
5	research, testing,
2	unwholesome, or
1	(j) representation
1	sanctioning of
1	partnership definedin
1	sunscreen order.
4	adverse safety
1	initial panel
1	methods, consensus
1	punishments any
25	article shall
1	expert testimony
1	repackage, process,
1	amateur sports
1	coffee, that
2	section 282
1	within specific
1	be, unless
7	drug. (2)
2	uses, persuades,
1	warehouse 
1	smokefree, smok-free,
1	states; annual
3	thereto, unless
1	(b) identit-preserved
2	control performance
1	detail to
1	neither false
2	r-exportation from
1	similar authorities
1	controlsthe owner,
1	reporting (a)
5	interest will
1	support clearance
1	1996). 
1	data requirement,
1	42, to
2	additive under
1	command the
1	workload adjustmentsubject
1	(2) govern
1	made, but
1	application, protocol,
1	agencies pursuant
1	(d)(4) and
1	employees no
2	action; or
1	agent whom
1	practicable, license,
2	cumulative effect
9	shall hold
1	nanotechnology (a)
1	(7) an
1	343(e), 343(f),
1	error of
1	exceptions from,
8	authorized representatives
1	(2) bulk
1	convention, for
1	(3) refusal
1	hospital pharmacy,
10	section 331(j)
2	entity, to
1	containing these
2	year 2007.
1	drops or
1	
 872a.
1	(7) at
1	acts bany
2	section 1606
1	needs as
1	section 1604
5	section 1605
1	sums owed
1	respecting tobacco
1	needs at
2	inconsistent with,
1	document, record,
1	distributor intends
1	section 353(b)(2)
2	filed. 
1	thereto. (r)
1	applicant (i)
3	may lawfully
3	u.s.c. 300g1),
1	caused death
4	(i) necessary
1	establish device
1	subjects when
6	extent feasible,
2	biological and
1	persons name
1	ecgonine (and
1	(a)(iii) of
2	use, for
1	proprietary food
1	(4) periodic
1	associations, hospitals,
2	tolerance) or
3	state into
2	violation exists
1	agreement, that
2	acts or
2	seller may
2	abuse. (

2	april 25,
1	affiliates. in
1	sufficiently complete
2	marihuana; or
1	meetings; submission
2	carries on
8	acts of
1	functions. (2)
1	(ii) establishing
1	(f) use
1	retail during
1	(b)(2)(a)(i). 
1	education, entities
1	authorization and
1	may, notwithstanding
2	restaurants, when
1	substantiated by
1	radiation; (4)
4	age established
1	control over,
2	prior owner
1	safety. (k)
1	fee. (e)
5	priority in
1	either promulgate
1	(b), 953,
4	products described
1	(e)(1)(c), or
1	exhibit the
1	16th par.,
17	list under
1	(h), or
2	(2) dissemination
2	terrorism (as
1	incidental powers
1	effective correction
1	u.s.c. 262(a))
2	regulations pertaining
1	u.s.c. 262(a),
1	harmful effect
1	involving, in
2	350e, 354,
2	requests described
2	chapter; (3)
1	health exception
1	narcotics crops
4	referral under
1	earlier. such
1	reasons therefor.
1	whether resources
1	dried vegetables,
1	675, 412,
1	slaughter and
1	drugs makes
2	noncompliance or
10	manufacture, use,
1	assistance, the
1	331(q)(1)(c) of
1	spoons with
1	agents deemed
1	transportation the
1	longer period.
1	explicitly, a
1	582, as
1	necessarily caused
1	consultation to
2	handling, and
1	lon-term plans
3	generalthe administrator
5	specifically the
1	anabolic steroid.
2	procedures that
3	anabolic steroid,
2	reported information
1	
 1037.
1	case for
3	case, verify
2	(i) notice
1	protect negligent
31	isomers, and
6	purposes. 
2	30 days,
2	regarding reimbursement.
1	2010, $235,000,000.
1	504, as
20	treated as
1	(a) include,
1	entity, subject
2	manufacturing partner
5	established, by
2	subsection (m)
1	remote location
1	applied by
1	sold. such
2	cattle and
2	30 days;
1	inspected as
9	applicable state
2	subclause (i).
1	
 379e.
5	subclause (i),
1	letter was
2	subclause (i))
1	ensure access
1	service campaigns.
1	applicant subject
1	829. prescriptions
1	(e) helium
1	chemical knowing,
1	successor databases.
1	director; 
1	year from
6	fined under
2	(i) requests
18	34 stat.
5	standards. 
2	worker relations
12	u.s.c. 262(a)]
3	applied pursuant
1	governmental affairs
1	charitable or
5	describes 
1	agency. (b)
1	acid) (mg)
1	remaining submitted
2	(i) requires
1	transactions after
1	fund), consisting
14	ninety days
1	(b) 5
2	supplement proposing
1	14a. transferred

1	policy under
1	(j). (4)
1	criminal charges
1	providing product
1	additional deficiency
2	conclusions, made
1	(i) approaches
1	constitute not
4	publication unless
1	later determined
2	dietary need
4	requested under
7	every manufacturer
1	safety protocols
2	laboratories; (b)
1	contract, memoranda
5	(6) minutes
1	activities), except
1	in, state
1	classified form
2	reasonably available
4	similar manner,
1	warning. (june
1	raising, or
1	(9) indian
1	purchase a
2	lawful veterinary
1	laboratory nor
2	achievement of
1	per biosimilar
2	regulations restricting
1	package accepted
1	dried, frozen,
2	(4) limit
1	will prevail
1	member. (3)
1	drugs, intended
4	agency action.
3	thereof (but
1	beginning 270
2	response detailing
1	resident who
1	(a) sanitation;
79	(b) a
1	155, 3,
1	requirements developed
1	otherwise stop
1	(1) regarded
1	telemedicine by
1	section 360ss
3	shall so
1	states originates.
1	3(d), 64
2	gas as
10	transmitted by
2	offering for
2	1702(d) of
1	(i). for
1	entity; 
1	reserves, and
1	obtain damages,
1	original submission
1	
 823.
1	(j) abbreviated
1	acceptance factors;
1	(1)(c). (3)
1	conformity that
3	confidential. 
11	director determines
31	whether or
1	package liners.
1	distributing drugs
1	repealed, and
1	restrictions upon,
1	observational studies
2	informal petitions
1	budget any
1	preparations sold
1	drug violations
1	meet diagnostic
5	ensure timely
1	formulation, from
1	paid during
17	designated medical
1	393a. office
1	(c) receipt
2	(12) if
42	capable of
1	
 608.
1	implead the
3	proposed uses
3	(d) provide
1	defect relating
15	inspection service
1	(i) date
1	longer authorized
1	general dutiesin
2	needs. 
1	19, 1948;
1	confer a
1	health protection.
1	generala fund
1	health protection,
2	selection or
2	surrogate endpoints
2	forge any
1	symbol rx
1	revision 
1	issued, determine
4	supplier of
2	applicant obtained
1	(2) substitute
1	section, this
13	selection of
1	financial sanctions
1	
 845
1	(4) if,
1	information except
1	(p) safety
1	(20) standardized
1	absorption or
1	timelines the
1	operate outside
1	detained. any
1	will foster
1	generally disposed
2	revoke or
1	action. (d)
4	(but not
1	redirected to
1	13, as
1	warning surveillance
7	claims a
1	1040; july
10	absorption of
1	logically relevant
7	within its
15	reasonable grounds
1	streamlined hiring
1	(mg) 6.0
1	holds, packages,
1	dietary risk.
1	vital for
1	dietary risk,
2	1365 of
1	feeding infants
3	circumstances as
1	value that
1	(e) activities
1	food previously
2	promptly publish
2	(ii) 30
1	559, 4,
4	value than
1	meeting. (b)
1	repeated violations
1	objects used
2	adult consumer
1	requiring each
6	360e, 360f,
1	(iv) contained
1	1505. repealed.
1	animals. (b)
1	categorization would
1	(1) convene
70	labeling of
2	sanctions as
2	providing additional
1	counterfeiting, simulating,
1	comment. after
2	processing animal
1	labeling on
2	seafood hazard
37	labeling or
2	comprising a
21	subsection (a)(2)
1	documentation: 
1	-phenylacetylindole or
1	use consistent
1	identification methods
2	30 month
6	provided, however,
2	transferring a
7	(a) are
2	despite the
1	type, provided
7	fee and
4	commerce if
2	dedicated to
1	-year periodthe
4	inspection. 
2	shall affix
7	reason or
1	certain organizations
1	health. (j)
4	360b(j) of
1	renumbered 1001,
1	commerce is
1	
 857.
1	provider, in
1	products including
1	considered on
1	schedule, the
1	paragraph requires
1	prescribing requirements
2	dietary risks
2	entity compliance
2	records, make
44	reason of
1	qualified health
1	possessions. (c)
1	(b) standards
1	part is
5	names under
1	6, 1996)
3	person alleged
1	integrating data
1	justifying such
1	cream or
1	6, 1996,
7	concerning any
1	additional controls
1	looks at
3	drug shortages.
2	drug paraphernalia;
1	scientist. the
7	resources available
3	proposed risk
1	(10) carry
4	administration shall
1	device marketed
4	twice any
1	altered. (2)
1	integrated into
2	documentation from
1	office) shall
1	delivery and
1	signals. 
1	620. imports
7	submissions. 
8	practicable after
2	nonpractitioners to
2	care practitioners
1	1712. termination
1	year. (h)
2	organizations as
16	(g) the
15	procedures and
1	675, 531,
1	awarding rare
1	final guidance.
2	years 2007
1	sourcing of
1	persons holding
1	number, notwithstanding
1	reproduction of
1	affect (1)
1	separated therefrom
1	removal such
21	within thirty
2	reasons, or
2	application); and
1	authorized repackager,
1	2014, make
2	per violation.
1	conduct demonstration
1	manufacturer relating
4	360fff3 of
1	manufactures animal
3	per violation,
1	section 360c(a)(1)(a)
1	organizations. (ix)
1	classifying or
4	(a) drug
1	supplements under
20	food shall
1	authorization a
2	temperature controls,
1	liquid eggs,
1	title. (8)
1	member, would
1	occupational prevention
2	procedures a
1	hospital shall
10	prevent or
1	faith. (i)
20	drug will
1	purposesthe purposes
1	entity independently
3	dealers or
2	charges by
1	actual written
1	quantity requested,
3	supplier and
5	stimulant, depressant,
2	withholding use
3	contains or
1	website. such
11	enforcement intelligence
2	measurable objectives
6	(k) of
1	section drugs
2	term law
1	1043; oct.
1	mislead consumers
1	
 603.
1	briefings and
1	underlying such
1	separate itemization
2	seller maintains
1	claiming that
1	year, means
1	specific facility
2	proceedings 
1	locations, then
4	unwholesome, adulterated,
23	component of
1	tool at
1	247d6b(c)(2)(a)(ii)]; or
1	website is
1	services. (

1	adequately safeguard
4	entity, or
2	near schools
2	subsection information
2	reaga-udall foundation
2	evidence concerning
1	675, 576,
1	life supporting;
1	(a), without
1	and, except
1	marijuana, inhalants,
1	higher numerical
5	patent does
1	discovers that
4	(iii) responding
4	personnel action
5	scheduling decision
2	framework under
3	comparable to
1	life supporting,
2	250.0 
5	review that
8	term animal
1	(4) definitionsin
3	departing from
1	cease the
1	give official
1	contracts, management
1	additive, whether
1	related laws.
1	drug, referred
1	susceptibility, including
1	verification, investigation,
1	505e of
1	51 of
1	include criteria
4	plate, stone,
3	if, prior
1	aggregate, in
6	altered official
1	399. grants
1	proposed set
1	(a) national
9	manufacturer, importer,
1	section 360(o)(1)(a)
1	(b) sunset
1	forth existing
3	required, unless
1	fined, or
1	874. advisory
1	humans. (2)
1	trip wires
1	paragraph supplants
1	full hearing,
1	second portion
1	production with
1	chemicals (a)
2	consents to
1	specific type
1	technologies; and
1	medical personnel
1	food import
1	drug induces
3	material or
3	nonprofit organizations
1	term sold
6	device; or
2	commercial and
1	deficiencies. (iii)
5	section, any
1	study. 
1	title, licensure,
18	section, and
1	affect individuals
1	keeping, transporting,
8	appropriate; and
1	(i) active
5	additional requirements
4	otherwise required
1	within 45
1	387g, 387k,
2	(b) request
1	drug sponsors).
4	committee prior
1	providing recommendations
3	$125,000 for
1	risk foods
2	systemic antibacterial
1	treated and
10	immediately notify
1	review statistically
1	practitioner, as
1	designate that
21	unless it
1	rising violent
1	first offensea
1	laboratory preparedness;
4	adjustment result
1	1001, formerly
25	product by
3	(d) exception
1	nonprofit organization;
1	order reporting.
1	(3) animal
1	1048. administrative
1	regulation apply
1	i, title
1	vests in
2	351(a)(6) of
2	waived or
1	qualified employee,
4	previous year.
6	importation by
1	policyit is
1	benefits; and
1	subsection fails
1	writing their
1	reclassification, and
2	(b) agreements
2	salts or
1	(5) unless
1	circumstances surrounding
1	book chapter,
3	youth in
2	previous year;
8	applicant may
1	(6) qualified
2	exchange rate
1	(vii) storage
3	(a) because
2	$15,000 and
1	kingman reef,
1	379j(h) of
2	application, but
1	pesticides, drug
4	studies) essential
1	weight unless
1	nalorphine. (d)
1	requirementa class
2	identity for
3	clarify the
1	(c)(3) 
2	seq.) 
11	right, title,
1	379d3a. hiring
3	351(f)(1)(b) of
2	percentage determined
3	distribution, holding,
1	first offense,
1	transit of
1	processes 
6	provider from
2	commission act
1	confined to
2	drug substance,
1	4 and
2	kept for
1	(c) explanations
1	test of
1	(c) standardization
1	concerning new
1	emergency resulting
9	information relevant
4	risk listed
1	675, 742,
1	codein--oxide. (6)
1	pay, effect
1	transfers, and
1	article presents
1	identifiers under
2	notices published
1	chapter[3] 21,
4	capability and
1	courts are
1	may think
1	listing; or
2	substantial likelihood
1	(g) reference
1	circumstances causing
10	ii device
1	predictive data
5	practicable for
1	whether sampling
1	fiv-day period
1	(18) smokeless
1	disposition under
5	food offered
1	(pp) the
1	(b)(2)(c), the
1	containing filthy,
2	experience associated
9	fee revenue
2	agency from
1	days; (ii)
5	articles not
1	1997. (e)
2	retail establishment
2	consistency between
1	conducting investigations
6	v of
1	permitted, the
1	(c); 
2	31 and
1	indicates, means
3	generic drugs
1	tubes and
1	evaluate its
4	develop or
1	temporary exemption
5	area; and
1	term submission
2	data, pricing
1	determine otherwise;
4	(c) scope
1	materials, yield
2	data summaries
1	attack the
1	inappropriate for
142	based on
1	(a) who
1	conduct pediatric
2	minimize, consistent
1	testimony on
16	imprisoned not
1	
 356b.
1	relationships, but
1	fraction) of
8	testimony of
1	(3) certification
1	use. each
1	(or that
4	means each
1	(e) emergency
2	activities otherwise
2	natural disasters
3	nurse tank
3	historically have
1	u.s.c. 355]
1	it, supplement
3	subpenas for
2	(c) civil
6	testimony or
1	question is
3	requirements the
4	inspected at
1	issued either
4	devices that
1	apprehension, prosecution
1	(e) may
24	order is
1	income derived,
1	energy commission,
1	eggs received
2	paragraph (4)(b)
1	intervention. (b)
1	subsection (b)(1)(b)
1	device, such
1	process. (b)
18	order in
2	application meeting
4	close of
1	phenylpropanolamine, except
1	office, independent
6	order if
1	chapter (1)
1	198a to
1	(6) consult
1	producers slaughter
10	individuals for
2	agent is
1	party other
4	supplier to
4	said inspectors
2	force and
1	since 1997.
1	made, kept,
1	agent if
1	european free
3	research programs
1	documents from
4	(c) reimbursement
1	knowledge, there
28	agent in
1	679a. safe
1	will expire
1	organization, network,
1	message is
1	treatment, when
1	4461544618). such
1	476; 

1	circumstances, as
1	sensitive informationin
1	dataif the
2	trade representative
1	annual egg
2	identifying characteristic
1	actions after
1	either scientific
1	dependence liability.
3	subsection (f)(2)
1	compounding necessary
2	judgment, skill,
4	purchasers of
1	thereby. (june
4	least annually,
1	(a) -year
2	section 360j(m)
2	coalitions in
1	g/gm of
1	fees, a
1	factors listed
1	research companies,
2	receiving evidence
1	sit and
28	sheep, swine,
2	animal drugsthe
1	$1,736,000 for
1	licensed pharmacist.
1	began. (c)
1	u.s.c. 136a1(k)].
1	labels animal
1	675, 586d,
1	substance, either
4	warehous-based third
1	trade obligations;
1	designating products
1	substances contribute
4	title; (4)
1	animals); 
1	term gross
6	extracts of
1	assurance. (c)class
1	title, describing
1	standardized analysis
1	expert stakeholders,
1	(iv) availability
1	networks for
1	investigator to
1	availability, and
3	security countermeasures
1	open participation
1	process as
1	process at
1	350k. laboratory
2	temporarily suspend
2	regulations be
1	modified, revised,
1	personnel performing
1	process an
1	intake; or
1	risk; (c)
1	675, 1005,
1	conference. no
1	areasnot later
2	petitioner, extend
1	requestor means
1	tests (including
2	national organic
2	requirements until
1	require data
9	mark, stamp,
37	reason to
1	produce. the
1	compliant with,
4	program are
1	pending; and
1	(b) responsible
2	communications, or
2	chemicals (as
1	registrant conducts
1	imported milk
3	product distributed
1	requirements no
1	133 and
2	government authorized
1	programs directly
2	clause does
1	same, and
2	possesses with
1	countries is
2	stat. 1103;
1	federal resources
1	compliance in
1	usually supplemented
1	cigars, the
1	(6), (7),
1	terms serious
1	priorities; and
1	processing sector
1	authorize lon-term
1	corporation, who
1	residue. for
1	period extending
1	standard, and,
1	use sanitary
1	make periodic
1	including complementary
1	hidta and
1	grades the
2	(b) who
5	set by
1	teleconference review.
3	corporation, partnership,
1	(b) packaging,
9	november 16,
1	cooperative investigative
2	name (pursuant
1	(1) $250,000,
1	distant more
1	methods repository
3	special attention
5	financial conflict
2	request; (ii)
1	permit, and
7	exclusivity period.
1	results to
1	853. criminal
1	equipping animal,
2	primary container
1	otherwise ordered
1	(j) traceability
1	section assess
1	exclusivity period;
4	granted and
16	revenue amount
2	balance in
5	process under
1	performed, or
1	additional controls;
1	administrations procedures
1	forfeitureany person
1	violation with
1	assumes an
1	1996. (2)
12	regulation establish
1	(a), be
1	title involving
1	construction subsection
2	undertaking signed
1	dependence; (i)
2	measures that
1	excluding descriptions
1	(a), by
1	may supervise
3	supported, or
9	human body
1	add species
1	provided strong
4	(1)(b) shall
2	(i) provisions
1	evidencenot later
1	rendered only
11	product would
1	modification under
4	waiver shall
1	(a) methods
1	finalize regulations
1	shall interpret
1	commenteach notice
1	section 353(g)(5)(c)
1	teleconference review,
1	animal after
4	paragraph if
1	average review
2	sentence with
6	coca leaves,
1	secretary about,
2	use measurement
1	inventories maintained
1	importer pursuant
1	accurately the
1	screenings of
5	designs, or
1	administering or
1	administration unless
2	regulations made
20	rationale for
1	has, under
60	notice and
4	points program
1	notice any
2	withhold the
1	store product
1	policies; (3)
236	1938, ch.
1	animal, mineral,
1	avoid an
1	fees submission
1	fill voting
39	production of
1	modifying the
1	morphin--oxide. (17)
1	annual estimates
2	show to
3	provisions applicable
1	certifies, accredits,
1	proposal regarding,
1	promote support
8	requirements relating
6	legitimate medical,
2	paragraphs (a),
1	use pursuant
4	secret information
4	production or
1	foods at
1	secretary), taking
1	credentialing bodies.
1	receipts from
1	legislation that
2	private, independent
1	priorities the
85	wholesale distributor
14	pilot projects
1	tobacco, substances,
2	using dispute
9	both. (2)
2	quality falls
2	(2), issue
1	employees thereof,
1	discussion regarding
3	devices, including
1	holder thereof
6	2112 of
1	represents law
2	considerations the
2	marketed. (c)
25	expertise in
1	shipment, if
1	program where
8	elects to
4	deemed available
7	supplied by
19	standardized numerical
5	continue discussions
1	receipts, either
2	section 360e(f)
1	term claimant
2	lawful order
1	criteriaa drug
1	relevant devices
1	exclusivity period,
1	harms of
1	services unaffected
1	with, development
7	program, including
1	sample subject
1	him, a
1	proof specified
1	decision described
1	criterion in
1	ingredients, a
1	(4) stay
1	(including poultry
4	(f) specimens
1	regulations). (f)
9	parts thereof
3	formulary monograph,
1	protective measures;
2	conduct food
1	obtaining controlled
2	(2) content
1	387t of
9	state shall
1	recertification by
2	seller does
21	products which
1	patients, sponsors,
5	meeting request
1	515, as
6	deadline for
1	otherwise has
1	(b)(ii)(ii), the
1	(including bacteria,
1	exemptions pursuant
1	productsa tobacco
2	correcting the
1	manufacturing laboratories
1	applies only
1	resources. the
13	(1) no
1	alteration, mutilation,
1	liabilities (a)
1	recommendation the
4	use disorder
2	dye and
1	outbreak, or
1	established regular
3	approved, licensed,
7	approval and
1	uniformity for
1	meat broker,
1	drugs) under
1	preventing abuse
1	(2) authorize
1	controls the
1	selling, furnishing,
1	fiber, oil,
1	plants 
1	1101.)
 

1	assurances beginning
1	production from
1	prescription article
1	value to,
1	(c) organization
1	harms the
1	holder. the
17	particular drug
1	subclause (iii),
1	whether tobacco
3	judgment with
1	upon reviewing
1	misconductno person,
2	study planning
12	resources of
1	planning the
1	area, within
1	requests; (5)
2	(viii) a
1	cause substantial
1	double the
77	percent of
1	holder during
24	information from
1	export an
1	proposed; (viii)
1	title authorizing
1	export at
1	level tracing
1	utero exposure
1	(g) notification
5	registration granted
1	518d(c) of
1	it, together
1	petition by
2	drug involved.
2	states, excluding
1	submission from
1	individual requests.
1	(3) return
5	filed in
1	(ii) reviews
1	labels a
1	quality systems,
1	exercises in
1	drug produced
2	suitable antidote,
1	violate paragraph
4	persons the
3	75 days
1	controls means
2	(b) coordination
2	issue public
1	675, 738a,
1	providing reasonable
2	application (excluding
1	allowable safe
1	(whether on
1	fee amountssubject
1	preventing drug
1	assets the
2	additional establishment
6	dietary exposure
2	territory the
1	1904. blocking
1	service. receipts
1	retail, predominantly
10	accepted by
1	809, as
2	facilities (as
1	fact has
1	causing by
3	small proportion
1	effective communications
1	360j(l)(3)(d)(ii) of
25	shall file
1	chemical product.
1	change. (3)
2	chemical product,
2	nonprescription sunscreen,
1	tar and
5	(b) petition
14	regulated by
8	understanding of
1	witnesses. the
2	establishment, in
1	equines, that
10	drug user
1	drug uses
1	stones, labeling,
9	conditions that
1	development, accelerate
1	allowing timely
1	exemptions that
3	projects designed
1	state, local
1	(4) letter
5	disposition the
4	standard 
1	witnesses; evidence;
2	person involved
1	therapeutic, pharmacologic,
2	necessary shall
4	promulgating a
1	360e(d)(5)[1] of
2	chemical products
11	u.s.c. 801
1	paraphernalia means
1	widest and
3	marketing) in
1	records; (b)
8	national institute
1	correctness of
1	(1)). the
1	corporation. (d)
4	process, pack,
4	facilities (a)
2	registrant last
1	invited participants
1	reasonable surcharge
1	2005; (9)
1	1996) is
2	(d) approving
1	section (where
1	defects if
1	practitioner, including
10	guidance for
1	pharmacists of
2	plant means
5	changes and
2	technologies, and
1	(3) commitmentthe
1	offer technical
1	testimony concerning
4	section 1412
1	research contracts;
1	maintain information
3	drug use,
1	practitioner at
1	regulation accordingly.
6	activities, and
18	business in
1	product fully
1	indicates otherwise,
1	without amendment
1	complete; (ii)
2	protocols prescribed
1	consumer per
1	(b) claimantin
1	714, as
1	person are
2	cause therefor.
7	drug would
3	chapter through
1	type, require
1	675, 910,
1	recipient agency
1	another approved
1	operation emits
1	year 2000
1	proceedings. (b)
1	occurred or
1	1331 or
1	treatment programs.
2	magnitude of
3	bond in
1	causing it
1	subchapter) with
2	shipment, documentation
3	service and
1	1986), and
1	bond if
1	disseminated information
1	office, and
1	articles; and
1	products, requirements
2	905, as
1	dispenses or
1	license until
2	withdrawal period,
1	year 2005
4	commodity credit
1	title. while
1	administrative provisions
2	subpopulations; and
1	fee, in
1	(a) groundsa
1	required, manufacturing
1	business information,
4	business information.
1	(ii) agreements
1	specify principles
1	centimeter in
1	submissions is
10	submissions in
3	supervisory review
3	information, published
1	necessary, shall
1	submissions if
8	lien against
2	files, papers,
1	convictions could
1	without upgrading
1	351, 360,
1	time before,
1	(11) phenobarbital.
3	identifying symbol
3	compliance and
1	things specified
1	biennial inspections
1	particle of
1	animal. (v)
1	rulemaking finding
3	standard has
1	to, injunctive
2	(f) with
2	arising from
2	(a)(1). 
1	risks, which
1	(b) programin
2	population; or
1	completeness assessment,
1	pesticide registrations
1	policythe deputy
1	locked cabinet.
1	camera. this
1	(c) i
1	practices prescribed
4	commerce of,
1	ground, powdered,
1	use existing
1	states should
1	treasury, determines
1	medical foods
6	administration; and
1	information, at
11	composition of
1	establishment, if
2	training programs,
1	training programs.
1	pathway for
1	regulation removing
1	national preparedness
3	purchasers as
1	business organization.
1	columbia, guam,
1	packaging); or
1	sel-service displays
1	dismiss a
1	must state
6	assess fees
1	ion shall
1	further, this
1	fact sold
8	copy all
2	licensure (as
1	(a) contrary,
1	submit, the
41	ingredient or
6	precursor substance
3	supervision or
1	licensed pharmacists,
1	number the
1	463. rules
2	offering illegally
1	(b) manner
1	(k) prevention
1	office directors
1	proffer was
4	section. if
2	section 361
5	violation, be
1	$3,000,000 for
1	promoting attractiveness,
4	appropriate, that
1	impose conditions
2	chemistry, manufacturing,
6	assess a
6	amending, or
2	section 343(i)(2)
1	(f) failure
1	
 1032.
2	narcotic, or
1	adults 
2	secretary state
1	food does
8	misbranded if
1	1046; mar.
1	concerning whether
1	alleged is
3	hearing held
1	healthy at
4	subcommittee of
3	extraction from
1	97d. omitted

2	(a) requirement
1	terminate, and
7	commission or
2	will interfere
2	services; and
1	(a) penalties;
3	signed by,
116	prescribed by
2	74, 1,
1	title inapplicable
1	ignorance or
6	manufacturer shall,
6	alleged in
1	tobacco shall
15	commission of
1	witnesses for
1	paragraph (8));
1	(f) define,
7	basis and
1	research, education,
1	regulations). if
28	subsection and
4	shall (a)
1	medical product,
3	containing (1)
15	342 of
4	fields of
1	necessary packing
1	measures reasonable
13	seq.]. 
1	promote private
1	product testing
1	standards consistent
3	generalupon determining,
1	substance classified
1	conspicuously thereon,
1	contains 50
1	court under
7	goals referred
1	value from
1	professionals under
1	evidence, including
3	ecstasy, and
3	serial number
3	title who
1	675, 201,
2	products imported
1	(xii) -(-fluoropentyl--(-iodobenzoyl)indole
1	related statistical
2	conditions respecting
6	reasonable and
4	responses to
1	(aa) may
1	title) less
1	making application
1	verification which
3	881 of
1	(2) contentsuch
1	fine; but
1	expires on
9	medical products
46	applications for
2	controls in
3	sell any
6	inedible by
1	program, in
1	(1) regulations
1	plan within
1	implement any
1	limits user
1	(k) research
1	(1) (referred
2	court order
3	experts and
1	delivery, the
1	year by,
1	features any
3	system is
2	8) or
2	liquid form,
1	6, 1996.
1	
 827.
1	effectiveness issues
1	authentication technologies.
1	appropriate national
1	effective. if
1	(2) notificationif,
5	section 342(a)(2)(b)
1	(1) affiliatethe
1	minimum the
1	states, if
1	board membership
3	rail vehicle,
10	drug experience
14	products, or
1	requiring direct
1	design, construction,
1	enforcement strategies;
1	identify hig-risk
1	menthol. (f)
1	doubt. 
1	(gg) the
1	graduate, and
1	linear or
1	(3) chloral
14	includes any
6	number described
1	requirements, that
1	countermeasures (a)
1	implant. (5)
1	(2)(b) shall
1	(m) methylamine.
3	title, amendments
1	fact; (c)
1	money, or
1	regulations, when
7	(2) each
3	particular; (2)
1	discretion, has
1	387e(j)(3) of
1	(bb)first applicant.
2	additive shall
2	transgenic animal
1	summarily discharged
6	support to
2	research in
1	(i) maintaining
1	abuse education;
2	fees, generic
1	revisions to
1	2015. (c)
1	committee[1] on
3	language and
1	(c) secondary
1	512, or
3	requirements related
2	infringed; or
1	classification information
4	strength, and
1	 (5)3
1	committees, at
1	johnston atoll,
1	characteristic is
1	resolution, unless
1	postfebruary 15,
2	containers under
15	least burdensome
3	state authority
1	resolve whether
1	(g) public
1	brain development
1	(2) beginning
1	(ii) describing
3	following substances
1	mitigating vulnerabilities
2	countermeasures (as
19	total number
3	(36 u.s.c.
1	pediatric access
1	paralympic sports
2	data upon
12	reasonable cause
1	additional actionsin
1	shall announce
1	(g), as
2	(ii) shall,
1	plant species
1	already operational
1	multiple pesticide
2	given and
2	mixing in
1	drug above
1	379j21. authority
3	8 years
3	(a)(ii). 
1	repackages a
1	(g), an
1	government has
1	designation; review
1	secretary then
2	group have
1	vha during
25	issued pursuant
2	way other
57	use or
2	(1) assistance
1	significant risks
1	facility inspection,
9	person convicted
1	laboratory. (n)
1	506a, as
4	indian country
368	use of
1	request, at
1	application or,
5	restricted under
2	(iii) establish
1	manufacturer notified
8	use on
1	valid measurements
1	condemned by
1	506d, as
3	finally determined,
1	dispensed other
5	chapter; (b)
2	active pursuit
1	pathogen 
2	full demonstration
9	state which
1	office, to
13	substance. 
1	(c) facilityfor
34	controls used
28	federal government
1	rate, and
1	treated food
1	lon-term manner,
1	device identified
2	proportion, or
2	drug establishments);
1	control drugs
2	occurring during
1	restitution, or
2	additional drugs
1	accepting the
1	cooperation between
1	used. (3)
1	treatments among
1	level; and
1	675, 1011,
12	assistance and
1	articles have
1	bridging linguistic
1	panels. 
1	(ii) issuance
1	363. regulations
1	evaporated, condensed,
1	requestor unless
1	documents with
8	characteristics of
2	review guidance
1	policies the
1	(h) public
1	803 in
1	(2) contrary
1	website shall
1	(b) very
1	business practices
2	(f) labeling
1	chemical without
2	ship such
1	conversion product
1	(1)(a), including
10	time the
1	programs. in
6	person does
1	 (xi)
4	adverse decision
1	address all
1	10782 (21
1	entities. (f)
2	rulemaking not
1	protects consumers
2	service in
2	official plant.
2	guarantees of
5	dispensing the
2	(d) rulemaking
1	387d, 387g,
1	faith, etc.
1	sanitation under
3	remove drugs
1	section 2291j
1	service is
2	longer exist;
2	360fff2(b) of
8	upon receiving
1	sanitary operating
1	seminars and
1	effort with
2	establishment with
38	whether such
2	health by
2	expire on
3	experts established
1	states attorneys;
1	paper format,
1	care goods
1	360e(c)(2) of
1	(x) -penty--(-chlor--naphthoyl)indole
7	names and
2	351(i) of
1	(8) matching
1	constructed of,
1	(3) establish
2	authoritythe secretary
1	(a) radio
1	drugs once
1	acid, the
1	sharing with
2	paragraph (2)(a)(vii),
1	$20,000,000; and
1	notice, unless
1	fusion center
2	shall (unless
2	recommendations respecting
2	approved only
1	methodologies are
5	member may
1	revoked, if
1	paragraph (2)(a)(vii).
1	period at
1	years multiplied
3	timeframe, and
1	wholesaler 
1	regulatory hazard
1	(2) hire,
1	syrup, (3)
1	(9) levorphanol.
1	establishment, a
1	existing practices
1	regulations proposed
2	diseases relevant
1	iii, 533,
1	(h) release
1	impose restrictions
1	preventive strategies.
1	marks. (mar.
1	feeds manufactured
1	(ii) direct
1	request adequate
1	(a) oxygen
1	chemical. (e)
2	exemptions of
6	security, shall
1	or, as
8	postapproval study
1	2007. (g)
1	orders dispensed
1	(iv) plans
3	party and
1	establishments failing
1	step, or
3	379g(11) of
2	subchapter punishable
50	conducted under
1	promoted in
1	topics addressed
1	feasibility, as
1	343(r)(5)(d) of
2	avoiding detection
1	derogating the
1	verification submitted
1	tobacco leaf,
8	shall revise
2	shall forward
1	title 22).
1	party any
1	associations, animal
2	purposes; and
1	file by
2	hearing, when
1	(f) dissolvable
1	payor, committee,
1	commodity between
1	chapter. each
3	chapter, under
18	year that
1	management entity,
1	filein establishing
1	formerly 702a,
1	specific business
1	(2) plan,
1	16. (6)
2	thereafter imported
4	allocating inspection
1	(b) characteristics
1	within 210
1	services. (c)
1	zinc (mg)
2	regular importer,
1	poultry inspected
2	can, pot,
1	62. manufacture,
1	shall mark,
1	wholesaler means
1	authorized immediate
2	practitioner, without
1	dangerous drugswhenever
6	new findings,
1	lawful partial
3	u.s. customs
3	market the
2	(b) filing
1	secret, confidential
1	otherwise. 
9	patent has
2	bureau, board,
1	306, as
1	designee, at
5	(a) this
1	contracts, leases,
1	therewith, the
2	use funds
1	elements, at
7	ensure that,
2	programs by
1	entity. such
1	recordkeeping requirement
1	wholesale prescription
1	time, shall
1	date) notify
1	(addled eggs),
2	recall. the
1	exacerbate a
4	package level
1	identification of,
1	misbranded drugs
1	cure, treat,
2	intentional, is
1	hearingwithin 180
1	justification for
1	testing methods
1	conditional upon
1	provide direct
1	records, documents,
2	(j). 
2	agencies; (ii)
1	102, 206,
2	829 of
2	container unless
1	1036. pasteurization
1	ingredients required
1	section 675
2	(2) director
2	bears any
1	commencement by
1	regulatory policy.
2	drug, provided
1	provides anything
1	court unless
2	applications. (b)
1	specific roles
2	residue are
8	matter to
1	feed differs
1	campaign includes
1	
 610.
1	testing procedures
1	manufactureit shall
3	extraction and
1	expertise is
1	felony, based
1	2017. (c)
1	person, under
1	violations the
4	353(c)(1) of
1	service agreements
1	appropriate, enter
1	ii; (6)
1	medical countermeasures.
2	(e) audits
5	subparagraph (a)(i),
18	products (a)
1	(d) key
1	enter upon
1	approved with
1	countermeasure and
1	additional extension
1	1 in
2	secretary; (ii)
1	form, a
1	forfeiture, if
5	annual index)
1	event determined
1	title), but
2	contains (by
2	term safe,
1	revision thereof,
1	listing published
1	8 hours
1	collaborative groups
1	360k. state
3	(iii) take
1	unwarranted suits
1	distributes no-alcohol
1	(g) contains
4	obtained as
1	 first.
1	director from
7	establishment listed
1	products analyzed
2	base amount,
1	plan was
1	said secretaries,
6	products (as
1	certificate granted
1	(d) ethyl
1	been, in
1	ingredient defined
7	media campaign,
1	packer or
13	media campaign.
1	(g) eligibility
1	identity[1] opportunities
4	statement, which
13	first applicant
1	sampling a
1	subsection (b)..[1]
3	listing a
1	346b. authorization
5	media campaign;
1	pending with
1	develop additional
1	paragraph but
1	abroad. 
1	records; scope
1	misleading there
1	666, 5(2),
1	authorize persons
11	labeled and
1	strong and
1	(f) duration
1	funding was
7	administer such
3	among infants
1	states (or,
1	1040.)
 

1	filled cheese
3	379h of
1	packaging (without
1	section 343(g)
3	title. (g)
1	person owning
1	u.s.c. 263a]
1	dispenser makes
1	following, as
1	disclosures required
1	bearing labels
2	actively pursuing
2	targeting of
1	disapproved by
2	support such
3	period covered
6	342(a) of
5	designation 
1	pipe, paper,
1	25) through
2	final, all
1	paragraph (5)),
4	interest at
1	data summary.
3	partnership, or
1	risk/benefit balancing
14	authority under
1	(b) address
1	vessels the
3	(f) 
1	corporation, in
4	claimant caused
1	stakeholders, such
3	provision which
11	information with
2	funds, including
1	360fff3(c) of
1	extramural research
1	$50,000 per
1	technology, and
2	shall regularly
1	approval with
11	office. 
217	(i) the
46	administrator may
2	fact manufactured,
1	letter. if
2	0.15 
1	guide not
1	section 1531(a)
1	additionally, such
1	(1) highes-risk
1	minimum scienc-based
1	error under
1	(3) powers
1	facilities shall
3	dissolvable tobacco
1	patterns among
1	commingled ingredients
1	proclamation of
2	within each
1	
 360fff1.
2	improvements to
1	household. (28)
1	gas; (b)
1	interactive outreach,
2	products derived
1	buildings, and
5	notification that
3	manage opiat-dependent
6	reduction under
2	whole taking
1	strength; and
1	ordered detained,
2	compounds the
1	submissions. (g)
2	comprehensive review
2	protocol 
1	made, shall
1	necessary, together
1	taxation. 
1	irreversibly debilitating
3	competition and
1	(except paragraphs
1	years on
1	clearance are
1	color includes
1	certification: i
1	stat. 1055;
3	aid in
3	written plan
8	knowledge of
2	exposure and
1	met. (j)coordination.
2	(b) program
5	files a
1	methamphetamine, or
2	(a) if,
1	barter, or
2	include furnishing
2	article; the
1	lot. 
1	knowledge or
1	sufficient description
2	393(g) of
3	antimicrobial new
1	(h) protection
1	generate revenue
1	notifying persons
1	forward it
2	years are
1	drug expected
6	sizes and
1	advertising; (ii)
1	knew that
2	risks are
1	granted unless,
1	applications do
1	following: repackaging,
17	(5) 
1	community. (

2	harm, or
1	(i) specific
1	night if
1	marks or
2	(e) implementation
1	degrees fahrenheit
2	means, and
4	final year
1	(i) $50,000,000
1	vesting of
1	900, as
1	high psychological
1	regulate, direct
1	respectively, of
1	final finished
1	excipient manufacturer.
1	ongoing review
1	565, as
1	section authorizes
1	(n) substantially
2	essential chemicals
5	portion thereof
1	prohibited actsthe
13	products thereof,
1	capacity; (vi)
1	part thereof.
1	phenylpropanolamine (including
1	substance an
1	(b)(1)(a)(i)(iii) for
1	probable risks
1	term current
1	duplicates information
65	act [21
1	initiated a
1	(d) restrictions
1	including interagency
1	laboratory has
1	investigators responsible
1	professional acting
5	pharmacy to
4	medical gases
1	findings prescribed
1	conducted 
2	formulation was
5	shall describe
1	change (whether
2	chemical, product,
1	investigation. a
1	individuals, of
1	national exercise
1	manner; and
1	-(-fluoropentyl--(-iodobenzoyl)indole (am694);
5	manufacturer from
3	application no
2	(2) coordination
1	office (a)
1	paragraph, in
3	fees charged
1	(4) develop
1	year 1994
1	fraudulent identification
4	paragraph (1)(e)
1	species before
2	data show
1	 fee
1	constructed, designated,
1	 sodium
1	(4) notwithstanding
1	registrants reasonably
2	separate serving
3	$250,000 if
1	diseases. (may
3	2, and
2	2012, establish,
1	mean expanding
1	authorization outweigh
1	year 1993
2	registered as
3	shorter or
1	(ii)timeliness of
2	entered in
1	grower cooperatives,
1	water. (3)
1	order. (8)
6	existing therapies
1	programs include
3	operation thereof,
1	skill and
1	(p) yaws.
16	disposed of
1	changes) that
3	commission of,
2	operate using
1	marker, such
1	(viii). (b)
1	persons upon
1	(a) prevent
1	vaccine shortage
1	(d) penalty
1	successor regulations)[1]
1	(3) certain
1	(i) verification
1	cigarettes, smokeless
5	subjects of
3	paragraph (2)(c)
1	(2), for
1	educational programs,
2	obtaining, where
2	30 years,
2	inspect poultry
2	knowingly made
2	modified findings
2	cooked form
2	affected thereby.
1	investigational device,
3	review times
1	(a) establishmentthe
3	abuse is
16	include any
1	unless, when
2	response provided
1	furnishes assurances
1	baseball, soccer,
1	packaging been
7	chapter by
1	law the
2	intended uses
1	(jwh200); (vii)
1	organizations, consumer
2	mechanical and
1	solicit contract
1	export. (4)
1	(h) temporary
2	disclose to
3	-year periods
1	measure relating
1	refunded in
1	contentsuch regulations
3	(2) workload
1	person filing
2	rule promulgated
1	otherwise determined
2	antibiotic drugs,
8	activities. 
1	identity prescribed
1	distributes, leases,
1	may transport
4	paragraph (1)(d),
25	secretary does
1	permanent advisory
20	scheduled listed
1	(h) effective
1	postmarket data
1	released from
1	first approval
3	damages for
1	modified finding,
18	device, the
2	841(b)(1)(b) of
1	requests not
1	18. (l)
1	family ictaluridae;
1	384 of
1	262(a)] may
1	health problems
1	activities verification
1	forfeited. any
2	qualitative and
1	substances dispensed
1	period until
4	-year period.
1	675, 505e,
5	-year period,
1	sell from
1	gas. (b)
1	establish licensing,
4	species for
26	recommendations to
4	(2) consultation
1	prior approved
2	(lsd); (vi)
1	of, whether
1	(1) forging,
1	audited eligible
1	criminal, libel
2	demonstrates a
1	include graduate
2	permit requirements,
1	2009. until
1	certifications. 
1	documentary proof
2	petition be
3	fabricated from
1	regarding theft
1	instituted promptly
1	paragraph (24)(b),
4	ch. 559,
1	section 1331
1	modified within
2	distributors. 
3	sentence 
10	plan and
2	(1) they
1	csa in
1	act[1] [25
1	act[1] [21
1	degradation of
2	semblance of
12	made each
1	24 hours,
14	regarding whether
1	(e) measures
2	safety grounds
1	sales. (3)
1	(b) comply
2	1996 through
2	title revoking
3	physician holds
1	used exposes
1	resolve issues
1	given when
5	clause for
1	qualified en-userthe
1	(d) nothing
2	exceptionthe secretary
1	enjoin the
3	title after
2	prior investigations
2	identify, implement,
5	appropriate scientific
3	bring such
2	aid of
1	blending, pasteurizing,
1	manufacturer reports
1	regulations described
1	agent identified
1	preserving the
1	postpone the
7	section 331
4	section 332
1	section 333
2	section 334
1	practice shall
7	fair packaging
1	hiring and
2	provide oversight
1	importer if
1	findings under
1	train to
1	executed a
1	etiology of,
2	trafficking of
4	on-year period
3	branch of
1	additive, constituent
3	holds, or
4	importer is
2	360e(f) of
1	territory providing
1	substances, compounds,
2	may safely
1	elderly, women,
5	drug does
1	terminated, report
1	dispenser, including
1	accurately describes
7	pose a
1	(a) conductthe
1	industry. (b)
1	inspectors, such
1	diminish the
1	comment prior
1	safety. each
1	
 863.
1	675, 572,
1	(5) wholesaler
4	sufficient for
15	 (10)
1	facts supporting
6	matter of
1	carrier for
1	identify demand
1	675, 919,
1	women, in
1	1,4butanediol in
24	resulting from
1	findings: 
20	effective for
1	1232g of
1	natural food
1	(i) prescribe
1	(2),[2] as
3	assistance from
1	suspended pesticide
1	serving bears
2	title; (e)
1	satisfied 
2	product manufacturer,
48	secretary may,
1	written plan,
1	yellow over
2	(g) violations
5	licensing of
1	(ii) medical
3	demonstrated by
1	furnish a
1	amounts. fees
1	alert by
1	detriment. (m)
1	marijuana, particularly
1	notification thereof
26	entered into
1	questions relating
1	violator for
1	30, 1961.
1	except on
3	keep a
2	executive office
1	approved, since
1	know of,
2	parties described
1	address, town,
1	
 467c.
1	receipt, delivery,
2	appropriate. (2)
2	obtain judicial
1	panel member
1	delivery thereof
1	(i) local
4	consumers in
1	completion which
1	section loses
2	(1) and,
1	discriminated against
2	locations of
2	statements conveying
3	seq.] means
5	refund under
2	event later
1	petitions that
1	reduce, or
1	demonstrates, by
8	fees. 
3	going forward
2	activities on
3	affiliate, as
2	representatives who
1	purpose a
9	statement, or
1	drug conducts
1	deleting it
5	representatives; (b)
1	u.s.c. 254l
10	initial owner
1	full payment
3	distribute drug
4	therapy under
1	42 because
1	term active
1	national treatment
2	security activities
1	arrangement, as
1	data environments,
1	stat. 486.)

1	abusing drugs;
1	856[3] of
1	countries. 
2	sentence may
1	(c) prospectively
33	affect the
1	space or
2	reports, required
1	obliteration, or
1	normal life
2	356(c)(2)(a) of
1	indictment, or
9	applicant will
1	space of
1	require name,
1	betacetylmethadol. (8)
28	scientific and
1	(ii)request for
6	director 
2	basis the
1	poppy, both
1	innovation, enabling
1	dissenting views
8	justify the
2	activity (as
1	title informing
1	secretary, identify
4	manual of
3	judgment the
10	ch. 145,
2	(1) administrator
1	agencies federal
2	(aug. 30,
2	table in
2	website 
1	both. (c)
1	business they
1	(2) while
1	meet an
19	states attorney
4	least 30
2	title: provided
1	section 282(j)
3	warrant is
3	remove inspectors
2	(b)(3) to
1	drug production,
1	minimum, an
2	ingredient, combination
2	(1)(c) shall
1	modernize medical,
1	issued to,
1	funds that
3	(g), (h),
1	meet at
2	one priority
1	gas has
2	conduct required
3	require for
1	paragraph from
1	activities no
1	rare condition,
2	convention in
1	ingredients, except
2	interest, as
1	379dd(d)(2)(a)(ix) of
2	also shall
1	determine other
2	term consumer
1	analytical procedures),
21	views and
1	taxation under
2	individuals subject
1	pending. for
1	less. the
1	convention is
2	section 342(f)
1	repealed. (feb.
2	therefor, within
2	correction of
1	commerce, (b)
3	governments; and
1	nuclide generator,
1	(ii) before
1	treat as
2	period from
1	provision, but
1	379j62. authority
3	correction or
2	emissions of
5	review team
2	organizations who
5	order described
1	evaluationthe secretary,
8	holder shall
1	2013. nmic
2	section 454
2	whether portions
1	(b) offer
1	certification every
1	chapter, exercise
1	receive submissions
1	384e. recognition
1	device (each
1	process, or
1	(a) success
5	(ii) take
1	capabilities; (iv)
1	director awards
5	protein targeted
2	necessitating an
7	countermeasures for
1	required. such
4	deliver the
1	possess, manufacture,
1	practitioner which
39	logistics provider
2	dispenser, having
1	section 2291j1
1	19th par.,
1	groups. (june
1	2007, an
2	criteria which
1	declarations no
1	affected agency;
1	title, even
1	193[1] of
1	forward to
1	strategy, the
7	section 360e(c)
3	manufacturing establishments,
1	responsibility. (b)
1	considered at
6	condition, including
1	(h) information
1	262(a)], allow
1	spent by
2	title, (c)
1	instruction of
1	therefor, the
14	safe use
1	recall 
3	vested with
1	136w(d)] or
1	vacancyany vacancy
1	establishments which
2	views, that
1	state; and
1	orders as
1	facility retain
1	basisthe determinations
1	preparations put
1	transshipped (i)
5	application, and
1	requirementsto reduce
2	department, or
1	future tobacco
1	usable to
1	(3) where
1	
 379j.
1	states military
1	consumers; (viii)
4	among experts
1	assurances as
26	soon as
1	fees from,
1	interruptions of
1	smallest individual
1	be. subsection
1	case corresponds
2	stocks thereof
1	-year performance
1	 (xiii)
1	protocol. the
1	purposesthe national
1	share the
7	(b) has
1	impractical for
2	appropriate response
1	penalty provisions;
1	local efforts
2	structure, or
1	consultations with
1	symptoms, overall
1	record makes
1	intrastate. (6)
3	petition that
1	341 and
1	drug during
1	electronic, the
2	following findings:
1	campaign may
1	drug distributed
1	918, as
4	2421,54 stat.
1	attorney offices);
1	transfers any
1	both: provided,
1	maintains records
1	shows, by
2	holder agrees
1	request justifying
1	making requirement
1	enter amenable
2	3-month period
2	section 321(h)
2	(3) serious
1	national consensus
2	summary and
10	extend the
1	equipment as
1	warehouseman, when
1	surface. with
1	federal health
1	understanding, including,
2	opium per
1	necessary, of
2	tribal organizations
1	(a); (6)
1	necessary land,
1	witnesses, the
3	acknowledge differences
1	contain poultry
1	periodic review;
1	higher levels
1	outreach on
1	event more
2	agreement and
1	exigent circumstances
1	limitations any
1	tetrahydrocannabinols. (18)
1	modifications determined
1	potassium, solution
1	64. regulations
1	require bioequivalency
23	received under
1	harmonized tariff
3	kept or
2	veterinary diagnostics
12	produced by
2	incorporated into
1	importer related
1	(7); and
1	helmithiasis. (p)
1	team, and
1	paragraph (4)[1]
1	among children.
1	advertisement reviewed
3	federal inspection
1	possessions, and
1	prior referral
2	21, 1997).
1	collectively to
1	transfusion; (vii)
1	official classification
1	
 379g.
1	report, advice
1	petition before
1	traffickers 
1	dispenser obtained
1	neonatal population
3	reliable analytical
3	staff and
2	drug used
1	administer contributions
1	imprisonment. (e)
8	secretary specifying
3	appropriate qualifications
1	sponsor agrees,
4	partner to
1	approval, manufacturing,
1	certified organic
2	persons; murder;
1	dismissa defendant
1	sections 355,
2	establishments, the
2	drugs, chemicals,
4	processing poultry
1	coalition, at
1	establishment receives
1	675, 744a,
7	expended for
1	member participates
1	use containing
30	pediatric disease
11	toxin, or
1	intervening, to
2	maintains the
2	expertise regarding
1	resources among
2	(h), including
1	action; judicial
1	registered, except
1	966. authority
4	half of
1	standard. (june
4	origin and
1	available resources
1	sold. (mar.
1	competitive procedures
10	evidence and
1	unduly restricted;
1	data, sales
1	auditor. such
1	implications of
1	formulas (a)
1	destruction and
3	enforcement agency
8	(3) annual
4	ring, whether
1	sponsor unless
22	information or
2	designated unless
1	user fees.
1	(a). thereafter
4	product review
1	conducting program
1	assessments submitted
1	plan, he
2	multiple recalls
3	fees otherwise
1	audits an
2	grade and
10	information of
1	relevant entities
6	may, upon
3	admission pursuant
1	advance. 
1	
 376.
55	information on
3	subsection (b)(4)
2	agency shall,
3	device submitted
1	maintained to
1	determining which
1	dispenses only
1	activities subject
1	investigational uses
1	qualified on
1	conveyance identified
3	information. a
1	21 and
2	provide opportunity
3	tw-year period
2	section 379j62
2	(b) controlled
1	chairman, vice
2	reid dat-rape
1	purchase at
1	warrants shall
2	qualifying laboratory
1	(2) chewing
1	upon shall
2	administration (or
1	term rol-you-own
1	maintain, in
1	unavailable 
2	trials (a)
3	chairman thereof.
1	obtain federal
1	incorporators and
1	consecutively in
1	$100,000 if
3	thereof moves
1	subsection. (j)
1	caused significant
1	(3)(a)); and
3	preventing and
1	1054. annual
1	labeling. (b)
1	returns, and
1	received, within
2	grant application;
1	(7) required
1	without smoke,
2	justice. 
1	appoint outstanding
1	(iv) conditions
1	extensions other
1	states, enter
1	grantsthe administrator
1	term bioequivalence
1	initial panel,
1	product radiation.
8	findings required
2	thir-party auditor.
5	(c) annual
1	identified, if
1	clinical benefit;
1	(a) manufacture
2	healt-related event
2	notice, with
5	product radiation,
1	advertisements (a)
3	identified, in
1	chemicall-related or
1	formerly 901,
1	activities (as
1	amend, or
1	formula, or
1	eligible entityin
2	consignee 
1	statutes at
1	839, 9,
4	advisory panels
1	establishing dates
3	effective only
1	(2) whether
1	underlying or
1	studying drugs
5	specified under
1	correcting misstatements
1	section 355(i)(3)
1	application. (5)
1	28, any
1	675, 527,
3	selected from
1	law; (g)
1	(1) taking
1	(b)(1)(b), (c)(1)(c),
2	1001(a) of
1	benefits. 
1	term shall
1	(i) submissions
1	(am2201); (xii)
1	quantity delivered,
1	section 843(f)
1	(vii) for
1	ice pipes
1	fees. such
1	models for
1	fda staff510(k)
1	applications. (iii)
5	proposing to
1	refused entry;
2	(1), may
3	24 months
2	adjustments pursuant
1	firm, has
2	determines, upon
1	affected industries
16	unfit for
6	listed chemicals,
1	statement office
1	nondrug control
5	transporting, in
1	(g) investigational
1	(a) mandatory
4	one generic
3	notification submissions.
1	notification submissions,
1	waiver. the
1	actions committed
2	serving the
2	(c) systems
1	enable agents
1	establish specific
3	shall, before
1	investigate offenses
1	implementing voluntary
1	notification submissions:
1	supplements thereto)
6	investigation and
2	require that,
2	forms are
1	supplements thereto,
3	twenty days,
1	(xvii) the
1	goods prior
11	exportation of
4	different manufacturers;
2	prepared or
1	2007, publish
5	secretary; (b)
1	two solid
2	administrator issues
2	effect may
1	imports) that
3	prepared on
2	subparagraph (2)
1	commitments as
1	larg-scale foo-related
31	abbreviated drug
1	subsection (a)(3)(a)(i)(viii)
41	respecting the
3	improvement in
1	distribution may
1	disposal 
1	comment not
1	less risk
5	necessary, a
1	sponsors to
1	secretary, determines
1	
 1606.
2	vehicle. 
1	diseases, the
1	applicant enters
2	quantity, method,
1	chapter[1] as
1	concerning initiatives,
1	(a) voluntary
1	possession, exposure
3	commenced during
2	cigars, all
1	committees from
1	safely used
1	(20) racemethorphan.
2	exceed $500,000
2	tribal governments,
1	administered an
1	general procedures
1	article 16
3	limited by
3	tribal governments;
4	notice announcing
5	subsection (d)(3)
1	paid. (4)
9	reasonable period
1	genetic targeting
7	study and
1	inhalation, ingestion,
21	register with
1	pathological, or
2	(b) definitionsfor
6	including all
1	title 7,[1]
1	graduated from
1	retain, segregate,
1	21, 1997;
3	return, the
2	strategy (a)
1	cream: provided,
2	publication, the
1	incorporation the
1	boards, swingsets,
1	legislation. it
1	modified. (e)
3	understand the
2	illness, and
1	(b) laboratory
2	drug use.
2	evaluating device
1	(13) law
2	manufacture, promotion,
7	that, if
1	chemical when
1	persons, as
1	(4) revisions
1	355c. research
2	level information),
1	health system,
6	that, in
2	health system.
1	committee (hereafter
1	developing innovative,
1	packing establishments;
1	notification termination.
3	immediately, and
1	(a)(1); (c)
1	structure. 
1	establish regulations
1	methods as
1	chemical, which
1	distribute, receive,
1	involved) be
1	concerning indian
2	methods at
1	to, controlled
3	secretary. (c)
1	accelerated inspection
1	and/or cutting
1	decision and
1	authorization pursuant
1	decision any
2	facts, the
1	(2) notice
1	chemicals are
1	substance more
1	illness originating
1	may withhold
4	time they
1	persons (where
1	account that
1	will implement
4	appropriate, in
1	guilty or
1	endangered children.
2	section 350d(a)
1	serving minority
2	appropriate, if
15	secretary, or
1	secretary institutes
3	appear and
5	secretary, on
3	business if
3	(ii) disposition
5	funds are
3	antibacterial ingredient
1	history supplied
2	applicant who
6	secretary, of
23	appropriated to
2	subclause (i)(cc)
1	employees area
1	360c(f)(2)(a), 360e(c),
1	various forms.
11	may withdraw
9	records, reports,
1	247d7e, and
1	oxygenation therapy
1	pathologic processes,
1	supplement; (3)
1	variety, which
1	listed, or
1	outside expertise
1	(b) regulatory
1	priority as
2	 (viii)
3	products required
2	regulationsnot later
24	identify the
1	review and,
1	2603]; (iii)
1	devices every
1	use) of
1	section, $195,000,000
1	suspension proposed
1	standards than
1	pharmacy license
1	subsection, good
1	stalks, oil
1	18 years,
1	129. omitted

1	thereto. (j)
3	prohibited performanc-enhancing
2	conditions imposed
1	distribution; (b)
4	$10,000 or
1	packages, if
4	individuals, and
1	medicare program
3	growth of
1	storage in
9	standards that
2	panel substantially
1	furnished (before
1	food imitated.
1	request on
1	(18) phenazocine.
2	coordinate, and
84	request of
1	additional risk
4	1002(a), formerly
1	delineating the
8	substances by
1	promulgate nor
1	facility identifier;
2	forestry and
1	contains their
1	subchapter (1)
1	hearing the
1	clear, concise
9	secretary upon
1	identifier (which
1	(2) nurse
2	disapproves the
2	(b) definitionsin
1	notice means
1	variance to
1	thereof, duly
6	product a
1	pharmacologicall-related drugs.
2	convicted in
19	account of
2	transfers under
1	(4) meat
1	including efforts
1	designated as,
1	examining addiction
2	science, or
1	commercial container
1	standard, may
1	standards relevant
1	inspection means
2	need; and
1	product tracing;
1	changes qualifying
1	(h) changes
2	maintain current
1	compounding unless
1	manufacturers, academic
2	organic program
74	statement of
2	centers of
1	unless, upon
1	
 852.
1	vote. 
1	registrations. in
1	statement on
2	requested such
1	means not
3	feasible, the
1	thereunder). 
3	conducted for
5	discussions with
1	election, such
1	serious risk;
1	construction with
1	842(a) of
7	statement or
1	period prescribed
2	website. 
2	included therein
1	commissioner) who
1	standards. the
1	$258,019 
1	
 619.
1	use marijuana
1	illness resulting
2	30, 1981.
1	substances, 1971.
1	existed at
1	1181. contract
8	(7) if
1	mixed after
2	secretary) that
2	subdivision may
48	article is
1	
 1178.
6	subparagraph as
6	inspectors shall
7	article in
1	(7) is
1	(d) summarize
1	30, 1981;
2	hidt-funded initiatives
1	determining compliance
1	article if
1	involving methamphetamine
1	barrel fails
1	intentional, wanton,
1	review. such
3	convey the
1	additive, under
1	monitoring); (dd)
1	receives actual
1	wherever he
1	debarment involved
11	supporting the
10	court to
1	containers; legible
6	purchase and
1	man and
2	parole in
1	exportation under
1	omits any
1	alcoholic liquors
1	dissemination. (g)
1	2 shall
1	360c, 360e,
38	consequences or
1	educational achievement
1	within canada
1	transfer under
1	health 
1	
 470.
1	paragraph (1)(a)(i))
1	paragraph (1)(a)(i),
1	providers (a)
2	paragraph (1)(a)(i).
31	subsection (e)
2	definitions as
1	driven clinical
7	consequences of
1	operation under
1	devices attached
1	imported product.
1	implemented on
2	health programs
2	262]; or
1	seeks conditional
2	section 374(g)
3	products manufactured,
1	conducted as
1	gas if
1	involves 
1	uses in
17	conducted at
2	(in addition
1	appropriate, fulfill
5	auditor may
5	movement in
1	although the
1	bond is
1	(d) exercises
1	(iv) no
1	imported products
1	matters subsections
1	creates the
1	request. paragraphs
3	contrary, in
1	title. (bb)limitation.
1	360e(a) of
1	medications; (3)
3	usefulness and
3	term substantially
1	hazards under
2	hearing, that
1	canceled or
1	instructions, or
1	filled, the
3	implement strategies
2	product, assembled
1	notified. (2)
1	administered with
1	drinking water.
1	registrations at
1	article received
1	marketed products
1	1961. (32)
1	manufacturer could
1	privilege with
1	importer 
1	longer met.
1	provision, of
1	timely information
1	secretary except
1	secure manner.
1	paragraph, since
1	establishes by
1	academic organizations;
2	(a) describes
1	longer met;
4	period within
2	who, if
1	provider, and
1	(3) bezitramide.
1	quotas. however,
1	information. (2)
1	states international
6	(e) representatives
4	confidential business
2	(b) partial
1	costs expended
4	(c) priority
1	review division
1	identifying publicly
5	chapter. (

6	schedules of
4	authorized wholesale
1	709, as
2	received through
1	decision support;
1	international control
1	appropriate number
8	exempt under
1	targeted recall
1	operated as
2	intelligence shall
11	territories and
1	applicant manufactures,
1	federal food
1	recorded and
1	denaturing or
1	means interstate,
2	waiver authority
1	swiftly and
1	registration. (2)
2	killing results,
1	amount which
2	cash or
1	nations pursuant
1	(l)(1) apply
1	patient preferences
9	device described
1	add indications
1	total funds
1	minimizing exposure
1	admission 
1	section 341,
1	seafood names,
1	foundation any
6	foundation and
9	offense under
1	cited as
8	ordered by
1	review studies
1	circumstantial evidence
1	start or
1	meetings) and
1	record maintenance
1	may, before
2	food a
2	supply reductionthe
3	among individual
1	relevant private
2	(a) prior
1	quarter following
1	26, 1934,
13	extension of
1	subsection susceptibility
1	strikes and
1	average american
1	house and
1	hearing, with
4	filed over
1	(c) duration
2	investigational use,
1	transaction which
1	property within
1	notice, rule,
3	indefinitely, as
1	
 882.
1	
 453.
1	inspection warrants
11	reauthorization of
3	canal zone.
1	342(a)(2)(c)(ii) of
1	packs is
1	advertising, sale,
1	statements specified
1	removal. (2)
2	interaction of
1	proceedings nothing
1	(b)(1); and
1	percentages of
1	palatability of
1	equines are
1	testing. (iii)
1	size 
1	microorganisms (a)
4	387a(b) of
1	salts. (e)
2	licensure reporting
1	proposal until
1	(5) training
3	enforce this
2	part an
1	(9) as
1	i, 22,
2	transcript made
1	shipper of
1	ch. 3915,
1	subsection (a)(1)(d).
2	treasury. (iii)
1	(2) establishes,
2	processes necessary
7	sufficient bond
7	title within
1	consumer, the
2	will assist
1	response goalensure
1	cigarette labeling
1	vehicle, vessel,
2	part as
3	currently prevailing
1	section 360b(a)(5)
1	360eee2, and
1	product. (i)
1	discovery limited
1	modeling tools
1	(f) crediting
4	edible portion
4	person will
90	priority review
1	trainingthe secretary
1	nonsterile drugs.
1	services after
1	context other
1	(ii) file
1	handler means
1	directors assessment
1	supervision and
1	programs are
8	16, 1988,
1	16, 1988.
8	section 812
1	commerce, of
1	act) be
1	insurance plans,
1	animals; (3)
1	exceeding twenty
1	(1)(b) 
1	specifying 
1	chemicals. (2)
1	act, 1921
1	term petition
12	inadequate to
1	inference, processes
1	recipient the
3	authorize an
2	investigation; and
1	alternatives, including
1	fee amountthe
1	area will
1	(4) use
1	drug conventions
1	defense, 50;
3	years 2011
1	adverse, including
12	years 2013
1	following rules
1	years 2015
18	years 2014
2	assigned and
2	years 2016
2	findings, by
2	demonstrated clear
4	fact; or
1	intended, alone
1	(e)confidential information.
1	subject only
8	(a) during
1	truck, hopper
1	require revision
3	clear and
1	article seized
1	unappealable order,
3	execution and
2	term substantial
1	epinephrine by
2	designation upon
1	(k) date
8	suspension under
3	group; (iii)
2	identify appropriate
2	federal provisions
1	(13) effective
1	u.s.c. 355].
2	shall assure
1	subsection (b)(3).
1	practicable. 
2	subsection (b)(3),
2	take final
8	examination or
1	allocating funds
1	territory for
1	quality consistent
1	foods. (2)
2	information, report
1	joint laboratory
2	act while
17	inflation adjustment
1	agency actionthe
1	(i) actions
2	circumstances is
1	device, if
1	promptness. in
14	adequate to
1	(6) false
1	nanotechnology; (c)
1	provide, sections
10	secretary if
1	exemption; or
4	depletion studies
1	welfare, requiring
1	renewed conditional
2	governing body
1	675, 539,
1	including planning
7	recipient of,
2	unwholesome, otherwise
1	unapproved. (2)
5	income and
3	15(except paragraphs
5	conditioned that
4	condition; and
3	(i) have
1	360i(e) or
1	(d) serving
1	356b. reports
1	2007, products
1	determination. (2)
1	import under
1	60 milligrams
1	nonprescription status
2	science, medicine,
2	(1) knowingly
2	content is
1	license contains
1	advertisement means
1	dispensing) a
4	contact substance,
1	threat that
1	veterinary hospitals;
1	evasion of
103	receipt of
3	forces in
1	possessed in
1	memorandum; and
1	investigations on
1	must also
1	under[1] 381(q)[2]
3	may vary
1	apply so
7	established to
1	360d, or
9	investigations of
2	salary and
1	facie showing
9	initial or
1	terrorism, the
1	u.s.c. 714
1	remedial action
6	shall update
1	subsection (b)(3)(b)
2	paragraph (2))
1	debarment, and
1	covering the
12	risk tobacco
73	paragraph (2),
4	interested person,
19	information provided
1	applicable authority
1	may identify.
1	
 337.
5	beginning january
1	consider international
1	(5) drug
1	consisted only
11	chapter with
2	(2) changes
1	named substances
1	outside a
3	on-time backlog
11	requirement that
1	undergone the
1	corporation with
4	general with
1	arguments respecting
1	(h) reporting
1	neighborhood safety
1	injunction in
19	goats, horses,
1	greater danger
1	countermeasures. 
1	procured, and
55	electronic product
12	chemical residue,
1	iv shall
1	pharmacist, licensed
3	(c) registration
1	complainant demonstrates
6	demonstrate the
1	seize all
1	colors not
1	agricultural adjustment
1	ethy--phenylpiperidin--carboxylate. (17)
1	owning, partly
1	exemption. if
1	chemicals on
1	published writing.
24	2009, the
1	882(c)(6)(b) of
2	agreements nothing
1	following qualifications:
2	1989, the
1	denial information
1	partnership; (2)
1	device (i)
2	(ii) identifying
3	(1) shall,
2	contentseach application
1	achieved; and
1	100 ml;
1	tremendous pressures
1	property expenses
1	(1) compounded
1	marking on
1	2008; (3)
1	will secure,
1	resources devoted
2	address local
1	(b) covered
1	base fees
2	conduct 1
1	are, as
1	sentence, if
1	term carry
1	possess, or
1	360pp. enforcement
21	imported or
1	data, gathered
2	commerce, except
1	offense while
2	thereafter, on
1	reference. (b)
1	materials do
1	739, as
1	establishment, shall
1	with, (1)
1	liquid) which
3	amended, and
29	manufacture, processing,
7	act upon
5	ground for
3	payable 20
1	timing, contents,
5	resolution. 
1	tribal leadership
1	act (ieepa)
1	public notices,
1	materials with
1	specificationsa biomaterials
6	shall implement
1	1984. (6)
1	
 395.
1	inspected during
1	(8) requestor
1	furnished raw
3	regulation prescribing
1	affairs; (11)
1	requests (a)
1	tools; and
2	related series
1	destruction. (2)
9	received from
1	feasible, use
1	administration intercenter
2	(a)(i), a
1	pending and
1	year), multiplied
1	preservation and
1	disposition, with
1	designation prior
1	met through
3	establish requirements
2	significant disability
1	protein shall
8	inspection to
1	
 202.
1	proceeding whether
26	conduct a
1	treatment availability,
2	sections 343(r)(1)(b)
1	type b
2	type c
1	section 360eee3(b)
3	criteria included
1	(29) wholesale
1	procedures any
1	secrets 
6	compensation of
1	unless modified
3	disposing of
1	(a) risks
3	4 years.
36	supervision of
5	4 years,
1	require and
9	chapter 37
1	(c) fift-six
2	$2,976,000 for
1	uses that
1	product; (4)
1	personally or
1	significant public
8	illness surveillance
2	(3), or
1	inventory date
1	informationin promulgating
1	(p) electronic
6	review any
1	danger 
3	(2) types
1	675, 713,
9	paragraph, and
1	(3), of
1	share confidential
1	(31) the
2	(h) guidance
2	consumers from
1	secretary adds
1	custom basis:
3	(3), and
1	representatives, clinical
1	tests. (2)
1	emergency useit
2	pasteurized milk
1	(4) new
3	article be
1	sections 802(52)
1	transaction conducted
1	section, until
1	imitation cheese,
1	(b)(1) in
2	commerce, under
1	various timelines,
4	furnish on
1	distributed through
1	august 28,
1	consumer, at
1	furnish or
14	application approved
2	(10) of
1	certify the
1	water; (c)
1	vehicle, a
1	ris-based schedule,
1	general during
2	section. each
1	possession (a)
1	verification requirements
7	notification program
1	c-licensed partner,
1	25); or
1	potency which
1	determines applicable)
1	adequately and
2	(j) which
1	section 387e(h)
6	international agreements
1	(c)) the
1	consent will
1	marketed for
1	sections 348,
1	application, to
1	common salt,
1	package where
1	establishes standards
1	formerly june
1	earlier. 
7	applicable. 
1	applicable shall
1	paragraph (2)(a);
1	2008, through
1	representative. as
1	(c)(3)(d) of
1	revised agreement,
2	specifically, in
1	bear or
2	order an
5	decree of
1	vice chairman
3	order as
1	person, during
2	(cc) in
42	national media
2	bear on
1	may deal
2	donations from
5	commence not
1	(f) program
7	states agent
1	countermeasure may
3	including progress
1	sections 355(i)
1	abuse policy.
1	changes ownership
1	be. (ii)
1	workers fluent
3	licensed or
1	effectiveness, including
1	(1) qualified
1	organization respecting
6	2018, the
4	ordinarily render
1	illness data
1	services, seek
2	prosecute organizations
1	days, to
2	data; or
1	383. office
1	interstate incidents
1	report issued
1	subsection (k)(2);
1	list listed
2	apr. 15,
1	leader of
4	may satisfy
2	product, except
23	device shall
1	new final
2	adequate pediatric
1	regular importer.
1	labeling: type
11	section with
1	storage, cartage
1	309, formerly
2	advised by
1	527, as
3	brought by
1	event surveillance
1	applicable domestic
4	section 355d
1	native american
1	evaluation. a
1	retailer has
1	952(a) and
1	civil fine
1	filed. (2)
1	purposes 
1	modifications: deciding
2	animals from
1	(k) or
2	sector entities
6	general any
1	name, identifiable
1	submissions). 
1	(2) determinationnot
1	practitioner submit
1	reports an
1	(11) any
6	(1) upon
3	needed by
4	domestic or
2	section 355e
1	services. (feb.
1	diminished in
1	855. alternative
6	labeling) and
1	questions for
1	(e) compliance
2	(b) validation
3	(ii), and
4	approved premarket
1	2015; (c)
3	submission, shall
2	(e) guidance
1	arrangements (a)
7	process in
1	secretary, consistent
1	following documents
2	perform this
2	evaluated on
1	process is
1	(f) traceback
10	(a) provide
1	representative in
2	health status
4	committee shall,
3	830(e)(1)(b)(v) of
1	adequate, wholesome,
13	ensure compliance
3	farm directly
1	section, not
1	margarine containing
33	person under
1	section, nor
2	inspection procedures
1	strategies that
1	drug: 
2	disagrees with
2	registrant is
3	products have
1	(i) register
1	paragraphs (5)
1	registrant in
3	agriculture in
1	containment. (b)
2	months, including
1	registrant if
3	meats and
1	system; (3)
4	made part
1	(2) bribed
1	jurisdiction; (ii)
22	number and
1	2-month period,
5	match advertising
2	exceeded the
3	commerce to
1	effective 120
1	drug paraphernalia.
1	study objectives
5	expended. 
1	310.305 of
1	(f) biosimilar
2	corps loan
1	courts that
1	prescribing regulations
1	drug paraphernalia,
1	exemption has
1	less harmful;
1	services. (d)
1	facts found,
2	agency 
1	special verdict
1	amendment shall
1	salts derived
1	monitoring in
2	year immediately
1	caps) at
1	mission and
3	professionals and
1	substantial source
1	stabilizing, cooling,
1	section 454(a)(1)
2	conspicuously displayed
1	product. such
2	section must
1	establishments described
2	(m) for
1	paragraph (6)(b).
2	(c) dutiesthe
1	resolution, with
1	contract authority
2	partner from
1	terms supplemental
2	definitionsfor the
6	extent authorized
2	staff, including
1	stat. 1054.)

2	(b), be
3	medical judgment,
1	chemical, an
2	evidence presented
1	(n) funding
1	containers; nonconsumer
2	risk related
1	congress 
1	said establishment;
2	convictions occurring
1	pesticide. notwithstanding
7	seizures of
1	necessary. data
1	631.)
 

1	302, 52
1	99. repealed.
1	672. administrative
1	864a. grants
1	listeach person
22	records, and
8	may waive
3	investigators) obtained
1	(3) compliance
2	time limits
1	owner that
1	status pending
1	20 days,
1	aircraft within
1	threatens the
2	dependence relative
1	reissuance of
1	subpart iii
1	occurred. (b)
9	provided the
1	government agencies;
3	shall confirm
1	demonstrate and
7	traffic in
1	(c) harmonizing
3	unless extraordinary
2	periodic audits
4	issued. 
1	qualified researcher;
1	official certificates
5	paragraph (2)(a).
1	supplement ingredients
1	commission without
1	ounce does
1	respectively) shall
1	chapter. and
1	product conforms
1	developing promising
1	reportthe secretary
1	prescriptions dispensed.
1	committee, be
1	1055; june
1	manufacturing practice;
2	transacts business,
1	section 353(d)(3)(e)
2	transacts business.
1	certification when
1	9 and
2	requires to
1	count; (c)
1	organizations commit
3	(b) method
2	inspectionthe secretary
1	prescribed from
6	antimicrobial drug
2	shown, specify
1	equines which
1	risk; (iii)
1	section 1333
1	prohibitions contained
1	381(q)(3) of
1	360c(a) of
1	elementary school,
4	informal conference
1	presubmissions and
1	stability testing
17	patent which
1	colleges, other
1	antitrust laws
1	budget submissionsas
1	found. if
1	priority efficacy
6	panel to
1	ensure effective
1	coalition and
2	prescribe. no
10	shall coordinate
1	full extent
1	chemical identity
2	proceeding on
1	limit areas
1	743, as
1	price including
1	provisionsthis subsection
1	including biomarkers,
2	proceeding of
1	time not
1	1333 of
3	reasons. 
1	supplies such
1	ask for
1	ready, and
1	procedures. (b)
1	apply; 
1	medical product;
4	section 262(a)(2)(e)
1	regarding use
1	term prepared
33	(a) that
1	article affirmatively
1	addition there
7	composed, in
13	acting on
1	involved) requiring
1	devices, marks,
1	made demonstrable
1	food: 
1	201, 52
2	upon thirty
1	(2) studies
1	214. previous
1	voting members.
1	(g) change
1	voting members,
3	person, that
1	after, the
1	add such
1	5) on
1	section 379j43(a)
1	organizations included
1	purposes, as
1	(iso) and
1	response. any
1	voluntary provision
1	2, 62
1	therapy or
1	health; (3)
1	know with
1	batch, (ii)
2	2 nominees
1	local authorities
1	staff director
38	classification of
1	111, 112.
2	tribal affairs,
1	regulation, determines
1	submitted. (iii)
1	applications; or
1	safe diluents
1	secretary describes
7	bacteria, fungi,
1	assets committed
1	processed means
1	reports, to
3	classification or
1	centers involved
1	departure from
1	adequate staff,
1	-(-hydroxycyclohexyl)phenol with
1	representative after
5	ful-time employ
1	(h) vesting
3	written and
1	destroyed, altered,
3	section any
1	program, he
1	valid basis
1	(b)(2) upon
1	additional time,
3	merely advocates
13	draft guidance
1	timeframe 
2	infringed. (c)
1	siluriformes; and
1	importationa person
1	worldwide gross
53	section and
1	receipt. after
2	plans, agreed
1	explanations for
1	
 957.
2	statement submitted
1	possession, nonetheless
4	16 of
1	substantial increases
2	permits for
2	supply. 
1	traveltime) during
3	(b) grant
5	suitable and
1	appropriate activities
1	hearing (acting
5	shall revoke
1	ed., title
1	official business
2	government concerned,
1	technologies are
1	pharmacyan action
1	360c(f)(2), and
1	839, 4,
1	(4) annual
1	2015, $566,000,000.
44	written request
1	purpose into
1	herein, means
1	subsequently recovered
1	order prescribe,
1	 (aa)in
1	building construction
2	register that
1	members, not
1	deadline; (b)
12	parts for
1	term standards
1	proximity are
1	act, for
1	earlier, petition
5	certification by
1	iv, the
1	(m) fees
1	assign an
2	generally accepted
20	action brought
1	involves prolonged
2	unfitness based
1	reasonably achievable,
2	establish advisory
1	136a1(k)]. such
3	(c) which
1	devices (other
1	section 331(ll),
2	adverse device
1	official sample
1	paragraph which
2	including interim
1	1979, there
10	15 days
1	determine, on
1	stream of
9	subparagraph (a)(i)
3	content, complexity,
1	establishment. (8)
2	one shall
1	(ii) timing
4	monitoring the
2	truck stop
5	term prescription
1	(ii) startup
1	recommendation as
4	shall reimburse
2	fact. 
3	regulation, as
7	administrator 
3	facility from
1	mail, telephone,
1	contracts are
6	adjustments made
2	30, 2013,
2	persons referred
5	determine, or
1	packaging a
1	require completion
2	samples, where
1	devices; (4)
1	20 per
1	comments the
35	subsequent fiscal
2	administration an
1	sponsor, not
1	188n. repealed.
3	prosecute any
1	promptly transmit
1	product code,
1	rate during
1	essential that
1	(e) exercises
1	3551. risk
1	
 61.
1	component. (e)
1	section 321(s)(4)
1	notification (referred
1	1995, ordered
9	administration as
2	registration described
1	products industry.
1	coca, cannabis,
55	federal or
1	13, 38
1	otherwise discriminate
1	severable shall
2	previous 10
1	designate drugs
1	elected in
3	facility c-located
1	entities engage.
1	personal assistance),
1	timeframe, within
1	definitionas used
1	conducting, and
1	exposure. (3)
3	previous 12
1	additive. 
1	pharmacopeia or
1	payments notwithstanding
2	28, bring
1	secretary; procedures
1	exchange programs,
2	approving such
2	misleading. 
2	drug (regardless
1	disease not
4	required because
1	concealed or
1	contaminant is
1	(3)(a); or
3	contaminant in
1	condition. (f)
1	views, and
2	method. 
1	warrant, suspension
1	animals, articles,
7	advertisements for
1	country where
3	commercially feasible
1	committees each
2	(d) inspection
65	regulations promulgated
2	provide appropriate
3	business at
3	business as
1	formula) for
1	assessment center.
2	application therefor,
1	42, been
1	breakthrough devices
1	 may
1	hazards; (e)
9	prohibition of
8	one active
1	maintain their
1	assessment center;
1	obtain by
1	agencies; patients
5	cause for
4	chemicals. 
1	contentthe program
1	inspections (including
1	adequate reports
1	thereof, given
2	advers-event reports
1	development organization,
1	practice standards
1	distributors under
1	offense and
1	civil proceedings
1	reverse such
1	ex parte
1	requiring substantial
6	operated in
2	timelines set
1	sustained the
1	report received,
1	large retail
1	fee, as
6	leave the
1	obtains substantial
1	violation. (b)
1	evaluating countermeasures
1	disposition thereof.
1	offense any
1	process issued
1	technically infeasible,
2	effective is
12	device may
1	endpoints, consumer
1	quarantine suspect
2	hig-risk foods.
1	360fff3. grase
1	hig-risk foods,
1	regarding imported
2	private right
1	675, 305,
3	premises, building,
8	entity means
6	(b) are
2	event received
1	(vi) information
1	device, (vii)
2	device, (ii)
1	filariasis. (m)
4	evaluation under
1	therapy that
6	effect prior
1	given disease
1	ergot, hyoscyamus,
8	(ii) was
1	total time
1	(18) shall
1	imprints with
1	675, 918,
1	country maintains
1	articles published
4	identify all
1	sales subparagraph
1	considers advisable
1	different operating
1	(b) assistancethe
2	resisting, or
1	22), shall
1	documents in
1	physicians office
1	pay. 
2	consignee from
4	food containing
2	register stating
1	databases within
3	workload of
1	vacate an
1	yet approvedthe
1	apply. (c)
3	trends in
1	9, formerly
14	prescribed in
1	owning, or
2	two grains
1	(d) waivers
1	(e) assessment
1	314.70(d) of
1	obtainable under
1	entities within
16	agency shall
2	faith the
3	accepted in
1	pharmacopeia, the
3	eligible partnership
1	delivered. 
3	person, which
1	standardization (iso)
1	health data
4	voting members
1	fee amounts.
3	partnerships with
1	unapproved products
3	sales for
1	determination (a)
1	(xviii) the
3	(d) rule
2	pharmacies and
108	carrying out
12	preventing the
1	countries selected
4	certifications and
7	379aa or
1	states, so
1	1- and
2	relied on
2	(b) ris-based
2	domiciled in
1	inability of
1	required conditionswith
1	dehydration, milling,
1	(b) refuse
1	master filean
6	objectives and
1	need therefore)
1	(b) reduction
1	geographic sense,
1	repackager pursuant
2	indictment which
1	update on
1	alleged an
2	distribute the
11	exclusively for
1	biological for
1	weekends. (j)
1	inability or
1	office setting.
5	government shall
1	authorities; (15)
1	preference of
1	health impact
1	section 1802(18)
3	obtaining a
2	grant activities
1	means. such
3	either paragraph
1	regarding annual
1	thir-party auditors,
2	thir-party auditors.
1	thereof. (7)
12	inspection act
4	export controlled
1	(1) order
14	feeds bearing
1	intelligence information);
2	387f(e) of
1	declaration, notification,
1	arguments and
1	corporations whose
1	thereafter 
1	containers as
1	created and
1	file referenced
3	open to
2	methods not
2	appeal inspection,
3	chapter. (c)
1	to, specifications,
2	hold is
1	publics health
1	monoxide that
1	(2) purposethe
4	practice requirements
3	products, of
1	additives) shall
1	tenure on
43	unless such
1	(h) assign
2	surveillance using
1	registrant submitted
214	person who
1	committed within
6	(b) reports
1	foundation) shall
1	intent; 
1	(a) (including
1	ensure enforcement
4	held legally
2	review. (g)
2	(2) inapplicability
3	produce the
1	pricing data.
1	2003, an
1	compelling the
1	activities, unless
1	bulk vehicle,
3	criteria: 
2	(a)(5)), a
1	(f) establish
6	protect public
2	agent means
6	federal drug
3	considered appropriate
1	gave rise
2	division, or
2	minority communities.
1	deficiency in
2	mules or
1	be, under
2	system in
1	technologies (a)
2	use, to
3	acting under
9	homes or
1	allowable under
5	coalition awarded
2	failure; (2)
1	first biosimilar
2	information, in
1	program. (3)
48	2 years
1	manufacturer. any
1	school year,
1	research activities
1	examine whether
2	information, if
2	time, manner,
2	limitation such
2	tobacco under
1	power, or
1	efficient inspection
1	inform him
3	another federal
1	(a) posting
1	decisions under
1	commercially distributed
2	outbreak and
1	media, and
1	licenses thir-party
1	regulations a
2	college of
1	rulemaking. (f)
1	(f) warrant
1	399c. improving
3	processor, without
1	level, not
6	247d6b of
1	restaurants; other
2	breakthrough therapy
1	documentation described
1	advice to,
1	section 572
1	appropriate criminal
1	representative) of
1	interoperable standards
1	protections do
1	controls, as
1	(a) contains
2	regulations providing
4	chemical shall
8	appropriate panel
2	amended or
7	following conditions
1	505f, as
4	otherwise becomes
1	inspection services.
1	research as
1	groups recommendations,
1	substances, the
1	order (or
1	time thereafter
1	provisions any
1	(ii)(iv) (through
1	nullify, void,
1	inadequate, in
4	consistent and
1	(1) will
1	representations made
2	definition if
1	(1)(a)(i) for
1	alcoholic beverages
1	priority. 
1	
 1907.
1	identification where
1	violation regarding
1	paragraph (2)(b)(iv)
1	v; (e)
1	research proposals
1	compounds from
1	directors under
1	(vii) requests
1	permit on
2	manufacture, provided
2	387b, 387c,
2	countries involved;
1	permit of
10	applicable, the
1	authorized activity
1	repackaging, transport,
1	paramount criterion
2	29, 1928,
3	(2) against
5	permit or
1	benefit 
4	chapter 
1	continued marketing
7	purpose in
1	rules at
1	sale; labels
1	plant is
1	education has
1	(ii) mechanisms
1	rules as
1	persons handling
1	wherever feasible
3	applying any
1	manufacturers 
1	invalid, all
1	6-calenda-day period
1	grocers from
1	device regulators
2	forth by
2	exemption which
1	act subject
1	promptly facilitate
14	tropical disease
1	cited by
1	schedules if
1	mechanisms under
1	send observers
1	advertisement of
2	provided, the
1	inspections are
2	research plan
2	upon said
1	residue studies
1	fresh vegetables
1	(1)(b) that
1	title 36;
3	(f) whether
1	sterilization of
1	(1)(b) than
1	principal within
7	advertisement or
2	section 360fff5
1	675, 521,
4	may rely
16	section 360fff1
1	youth; (7)
1	handling, keeping,
1	section 360fff2
3	plaintiff in
1	(ii) published
1	vacancy for
1	travel, subsistence,
1	testing described
1	substances; (b)
21	notice under
1	person whom
1	party. (c)
1	(6) final
2	significant loss
1	(1), nothing
1	operator; and
2	dihydrocodeine per
1	pharmacoeconomics, biological
4	real or
1	569c, as
1	child and
1	auditors; and
1	activities among
6	sets forth
1	829(e), or
2	appropriate, revise
4	secretary providing
3	(6) knowingly
1	7.0d 
1	amendment) greater
16	shall grant
1	(4); by
1	misbranded barrels
1	persons arising
1	government. (f)
2	hig-priority or
2	minority health
1	dyes or
1	education programs,
1	drug advisory
1	review during
16	whereby it
1	protocol under
1	office. (i)
1	filed. service
3	shall accrue
2	(a)(1), based
1	education programs;
1	products, poultry
1	fluids or
2	device, evaluated
1	sources other
1	(iv) 10
2	finished and
9	accreditation under
1	identifier, shall
6	person who,
1	subsection prohibits
1	egg packer
1	concurs that
1	(a)(1)(c) by
1	letter, a
1	property. the
12	medical or
1	drugs concerned
1	conforming to
1	(b)development of
1	link and
1	(a) offset
28	without regard
21	state that
4	service as
4	shall refuse
1	42 apply,
1	(a) petitionany
1	regulation be
1	least four
2	give testimony
1	application, supplemental
3	products, the
1	established specifications
1	333 of
1	sentence, such
2	sale other
1	mechanisms similar
2	policy regarding
1	(b), amend
1	scientifically relevant
1	477, title
2	pharmacys internet
1	ecstasy; (ii)
1	rulemaking procedures.
3	stat. 511;
1	chapter;[1] 
1	feed shall
1	384d. accreditation
2	packaging act
2	outreach, education,
1	concerning matters
4	facilities, inventory,
6	setting aside,
1	upon examination
8	year following
1	deposit. 
32	request to
1	concerning that
11	subjected to
1	periodically request
1	general. (

1	average value
1	(20) shall,
1	residue. subsection
11	device, mark,
2	compliance status
1	clinic with
1	analyze, or
1	basketball, baseball,
4	order a
1	states, a
4	indian health
3	final determination,
41	paragraph, the
1	(a) anthranilic
3	demand for,
2	administration related
2	plans available
1	veterinarian.. a
1	committees, as
3	section 321(p)
1	entities, the
1	withhold a
3	medicine therapies
1	practitioner regularly
1	initiatives this
2	deadline the
1	62 fed.
82	meet the
1	include employees
1	(d), each
3	establishments other
5	remove any
1	additional mechanisms
4	diseased poultry
4	fee from
1	prior conviction.
1	good handling
1	violating of
1	343(b), 343(d),
1	regulations, unless
1	(or pharmacologically
21	covered by
1	order involved,
1	illicit activity
4	controlled under
1	preceding 1996,
1	counternarcotics enforcement
3	210 calendar
1	investigation, disposition,
27	 (iv)
1	production pursuant
1	certification requested
1	physical hazards,
1	2011. (4)
7	order withdrawing
4	qualify as
1	(i) documents
4	drug whose
2	sunset the
1	553(c) of
1	subpopulation) if
3	columbia from
1	controls comparable
1	pot, canvas,
2	controls referred
18	offer for
1	office within
1	similar agencies
1	safe use,
1	president timely
1	practices used
1	successful or
1	shall exclude
1	(j) report
2	registrant filing
4	matters as
1	(a) substance
1	persons. any
25	pediatric studies
19	product, a
1	export list
1	(4) evaluate
1	transacts business
1	new analysis
3	(b)(1) because
24	accreditation body
1	located not
1	filed not
1	reduced shall
1	(1) enhance
1	state, may
1	issuing, on
1	recall involves
1	outlets the
1	2103. ensuring
1	dye (as
1	(3) applies,
1	(a)(3)(d) and
1	sufficient audits,
1	charge against
1	advertisement knowing
3	may specify
1	(i) screening
1	promptness furnish
1	period. (31)
1	candidates, which
1	finds, based
1	(ii)[1] recoupment
5	official names
1	(7) -methy-2,-dimethoxyamphetamine.
11	eighty days
1	aggressively to
2	machine, encapsulating
1	metabolite or
1	attorney a
1	marketed unless
2	petitioner is
3	users and
1	outcome means
1	governments shall,
3	deposited and
1	additional nominees
1	injecting, ingesting,
2	center involved
2	dispenser that
1	recommendation, together
1	advised and
3	elderly populations,
1	
 862a.
4	ensure food
1	privileges granted
7	furniture, scientific
1	
 1034.
3	cigarettes or
1	dates, and
1	achieve advanced
28	operation of
2	inherent risk
1	premises means
1	trial, hearing,
1	(july 24,
3	article, as
1	notification states
1	amending any
3	1902, ch.
1	secretary declare
2	operation or
1	interested parties
1	farm under
1	clarify procedures
1	(c) stakeholder
1	committeesit is
4	disapprove an
1	inhabitant, carries
1	section 242a(a)[1]
1	manner provided
3	device; (c)
3	consolidation of
4	shall conform
4	submission submitted
2	box, can,
1	(a) inflation
1	appropriate. (e)
1	processed: provided
2	application mean
4	ii, and
1	packaging outside
2	ii, any
4	(2) use
1	arrangements for
1	maintained; and
1	act, if
6	derogate from
1	(b)(4)(e), (c)(1)(b)(i),
3	both. whoever,
1	advanced approval
1	unpublished data
1	regarding compliance
1	may begin
1	appropriate content
1	attorney general);
1	42), security
1	(v) developing
1	designate hig-risk
1	information prepared
1	4, 68
1	databasenot later
1	disinfection, and
2	physician, or
1	controlled substancesnotwithstanding
3	labeled with
1	aggregate to
1	final revised
1	together. (

1	findings; and
1	
 661.
1	sterile tissue
1	additional physical
2	workshops, or
1	action carried
1	geographical area
1	antiquated -ray
1	met; (4)
1	cease use
6	patients. 
51	intensity drug
87	effective date
3	make required
1	techniques that
1	person confirmation
103	addition to
1	
 399b.
7	definitions 
1	revocation appropriate
1	commonly accepted
2	section 1532(a)
1	repackaged in
1	contains information
2	participate as
1	(ii) inclusion
1	patient made
1	contexts; (2)
1	hand; (6)
14	aware of
1	(r) facilitating
1	agreement executed
1	needed; (vii)
1	fees) shall
1	enforcement officers,
1	person obtained
2	otherwise) any
1	appropriated $24,000,000
1	(b)(1)(b), as
2	(except when
1	economic consequences,
1	individual was
1	greater, or
1	clause as
6	violation shall
1	
 813.
2	355(c)(3)(e) of
1	section) any
1	separation of
1	ongoing clinical
1	malt beverages,
1	powers, but
1	safe by
1	(b) develop
1	material respect.
1	
 399h.
1	thereafter issue
1	issued thereunder),
1	issued thereunder).
1	dispense, any
4	$6,000,000 for
1	delay authorization
3	2013, for
6	drug monograph
1	warrants a
3	distributors, or
3	age groups
1	expertise related
1	7 for
2	0.53 ounces
11	organization that
9	available information
1	amounts obligated
1	(2) clarify
2	shall cooperate
1	(c) 100
2	label on
5	labeling approved
1	1999, whichever
1	experienced personnel
1	regulations comply
4	large volume
1	existing medical
1	subject. (11)
1	requirements; misbranded
1	regulations allowing
1	pigment, or
3	seq.]; or
1	equivalence for
1	fifteen members
2	nonapplicability of
1	
 1901.
1	on-half ounces
4	(1). (b)
1	annual distribution;
1	creative services,
9	withdraw the
1	required timeframe,
1	continue any
1	resources from
4	applies, or
10	revoke the
1	care facility;
1	commodity; or
1	arrest warrants,
2	(i) crediting
2	review. the
1	operations, including
1	hearing, withdraw
2	delivering such
2	establishments by
1	dye, pigment,
1	barns, and
4	experts or
1	352(f)(1), and
1	1996)). 
1	equines. (f)
2	sunscreen that
1	age, which
1	appeals as
4	imported contrary
6	average cost
1	priorities which,
1	(n). (3)
1	theft, destruction,
3	drug (except
4	(b) submit
1	reasonable comparable
1	early agreement
1	conduct with
14	patients in
1	(k) records
1	2016, exceeds
1	patients is
1	law governing
1	(iii) were
1	so, general
2	offense, including
1	(j) training
3	drugs other
1	360aaa6. omitted

1	total appropriations
1	study. the
1	equity against
1	any, risk
19	action taken
1	committed repeated
4	conditionally approve
2	estimates of
1	plan, the
1	355c(f) of
4	kilogram or
1	secretary disagrees
1	publi-private education
1	quarters, or
2	acquire such
1	violation were
1	shown, that
2	effectiveness before
1	existing authorities
1	registry available
1	previous convictions
1	(3) n-cost
1	software functions
1	(7) a
1	subchapter, all
1	international organizations
11	identified as
1	per petitionsthe
6	penalty imposed
1	cause order;
1	report, record,
2	chapter) refuse
1	requestor the
2	reproduce the
2	last made
1	(4) regarding
1	2105. enhanced
1	uniform process
1	product used
1	facilitate and
1	nominees. 
1	permanent order
2	regulations on
4	consumers to
1	introduce significant
1	safely employed
1	stipulation or
1	register before
2	5. (c)
1	(i) provides
51	result in
1	issue, or
1	standards applied
1	claimant would
2	plan; (b)
1	subsection no
4	chapter. in
2	care professionals,
1	utilizing real
16	chapter; and
3	making available
2	acts, uses
1	supplement, including
1	fires, and
1	(i) provided
1	
 387r.
2	tactical and
1	president a
1	children. (f)
1	furtherance of,
37	nonprescription sunscreen
1	fishing vessel
1	orders that,
2	involved, the
1	parasites, allergens,
1	effectiveness. regulations
1	principles. if
1	section 208.
1	research consortia,
3	found (by
18	proposed for
1	694. authorization
1	title concerning
4	adulterated food
3	criteria otherwise
1	inform those
1	distribute, human
1	support program
4	(without a
3	amateur athletes
1	center; and
1	warning statement
1	exempt test
3	commissioner by
1	activitiesthe recruitment
1	otherwise combined
1	including supervisors,
1	employment; and
2	impose sanctions
2	reimburse a
1	access under
1	chairman. the
2	delay, or
2	comprehensive, lon-term
1	federal election
2	assaulting, resisting,
1	separately and
1	import drugs
1	units in
11	factors as
1	2006 through
1	(3) tobacco
1	(7) isomethadone.
1	performance targetsthe
1	adequate review
1	order directing
1	300 calendar
1	aforesaid, shall
1	obstacles to
1	physician. 
4	not, unless
1	groups, professional
2	species that
1	stat. 344;
2	affairs, including
1	(6) benzethidine.
2	establishmentnot later
3	impact statement
66	notice to
3	first offense
2	interpretations of
1	exclusively with
1	single drug
13	amendments made
1	term warning
11	package level,
2	package level.
1	suitable book
2	notice, and
1	request). (2)
3	state food
1	misbranded drugs;
2	overdose reversal,
1	discharged or
1	commerce. (c)
2	shipment, and
1	(c) benzyl
1	year. (

1	(13) courts
1	1005, formerly
1	relationship in
3	factual and
1	application who
1	(1) following
1	treating, detecting,
1	vessel (as
1	available. (b)
1	exempt formula,
2	professional society
1	hospital emergency
3	premises the
8	(or a
1	establishments where
1	normorphine. (21)
2	hold be
1	prompt hearing
1	criminally. however,
1	eradicate pseudorabies
1	securities used
1	require by
1	(7) postapproval
1	purchaser. (iii)
2	administrators, organizers,
1	proposed revision
2	contract, or
1	fee associated
1	magazines or
4	means as
1	(d) assurances
1	stolen anhydrous
1	means at
2	models to
1	progress implementing
2	security acting
6	approved pursuant
1	(f)(1) of
1	have, in
1	(3) terms
1	states, managing
1	inspections. for
2	medicinal dose
3	bases for
1	lawfully hold,
2	revenue needed
10	means all
1	term defined
8	compound, or
63	means an
1	invest, directly
4	performed under
1	persons engaged,
1	person. (aa)
8	(2), (3),
1	behalf a
1	federal commitment
199	required to
1	interpretive standard
3	patient subgroups,
1	scientific research;
3	validity, amount,
1	(2) chloral
17	paragraph (4)
1	nature and,
1	(2ct4). (26)
7	apply for
1	seeking elected
1	determination shall
2	(h) for
1	675, 506,
11	chapter for
1	expended, such
1	postmarket study
1	exceptions in
1	health, in
1	adequacy to
1	manufacturer, subject
1	federal healt-related
1	activities relate
1	corrected such
2	reduction missions
3	hold the
2	262], including
1	interpret, and
2	(a)(1)) after
5	protocol and
2	threat posed
2	synthetic vitamin
1	(f) carbon
1	fact concerning
1	1261; renumbered
1	(vii) available
1	method by
1	among sectors
1	times, by
7	(2) collections
1	intake. (c)
1	prepared, is
1	assembling, or
1	protein and
1	offsetting fee
1	body solely
2	action necessary
1	exception, or
1	facilities, to
2	association within
2	term foreign
1	development. (7)
1	out; and
1	unavoidably persist
1	(18) -methylmethcathinone
1	branch to
83	fees under
1	so. 
1	elected official
1	subsection (a):
18	subsection (a);
1	prohibit administration
1	granted, to
1	petitioned for
1	regulation complained
1	access protocols
1	system; (b)
5	meetings conducted
2	subsection (a))
1	meet new
79	subsection (a),
4	partners. 
35	subsection (a).
2	responsible person.
56	repealed. 

2	responsible person,
1	state initiatives
1	data gathering
1	international conventions
2	responsible person)
1	years 1999
1	substantially complete,
2	discretionary and
1	(b) beyond
1	smoking and
3	provide technical
1	years 1991
1	age group.
3	one use
1	years 1994
2	years 1996
1	scientific, educational,
2	secretary believes,
1	quotas applicable
1	hereinbefore mentioned,
1	recent change
2	discontinue active
1	funds. 
1	complex of
1	concerned on
1	possesses on
1	approval; and
7	regulation for
2	diagnose, monitor,
1	transaction covered
3	priority review;
1	active risk
1	finding and
1	30, 2007,
1	assessment. in
7	priority review,
1	population; (iii)
3	priority review.
1	individual projects,
1	(f)(i) the
3	significantly higher
2	approval status
1	
 877.
1	chickens, turkeys,
1	private parties
1	elected office,
1	1997); or
1	derivatives, and
1	debar 
1	subsection together
5	standards to
1	(h) violations
1	13 of
1	scheduled to
1	powder of
2	individual indian
11	necessary by
1	(iii), a
1	concerning traffic
1	traceback. 
2	slaughters or
1	regulation granting
1	years. penalties
6	due datethe
1	1713. authorization
5	safety signals
1	drug. (e)
1	taking appropriate
1	5). 
2	18; (c)
6	i-person medical
2	proceed expeditiously
1	diseased animal
1	title, antimicrobial
2	(ii) awards
10	person. 
1	exceeds three
2	summary or
1	(1) findingsthe
8	contaminated, dangerous,
1	summary on
7	may exempt
2	shall delete
8	reimburse the
2	381(q) or
2	year 2010,
2	fresh, salted,
37	summary of
1	fee amounts).
1	
 1054.
1	thereby. (

1	(m) depositions
1	entitled deciding
3	inform purchasers
1	dispenses, or
1	cyclohexyl ring
1	(g)(4)(a); and
1	period notifies
2	factors for
21	register a
1	(k) should
66	60 days
1	$299,000,000. of
1	provides original
1	steroid; and
8	study under
1	order prohibit
1	
 350i.
1	pineapple, vanilla,
6	presiding officer
1	$1,000,000 or
5	predicate device
1	ii, include
9	year if
1	property appropriate
2	treasury and
40	year in
1	675, 401,
1	shall record
7	year is
1	improper use
1	675, 902,
1	federal rule[1]
3	twenty years
1	en-o-phase 2
4	person designated
1	569a, as
1	lawful export
2	filled by
2	(a)(1) and
1	disorder research
5	health system
1	stored. drug
2	hydrate or
2	area and
2	regulatory policy
3	penalties as
329	approval of
1	correspondence or
2	pending, measured
1	vessel, commercial
1	registered pesticide
1	improvements or
1	complete testing
1	administrator within
26	approval or
1	certifying its
1	salts. (g)
3	actually used
1	
 1535.
1	records showing
1	entitled for
1	meetings, conferences,
2	considerations listed
1	effortsthe attorney
1	registrants initial
1	authority related
1	proceeding. (6)
1	purposes only.
1	 b12
2	plan, scheme,
2	(3) ris-based
1	sworn to
1	certain goods
20	proceedings under
3	subchapter; or
1	extracted; (6)
18	program established
1	national security.
1	(c) patient
7	national security,
1	consistent food
1	public notificationin
2	claim that
4	(i) develop
1	
 1503
1	injury and
1	betaprodine. (11)
6	tests or
3	years before
1	public notificationif
1	knowingly violates
1	every license
1	positrons and
1	one copy
1	proper under
1	falsification. 
3	tests on
1	harm associated
19	point of
1	(iii) orders
1	following individuals
11	perform the
5	issuance, amendment,
2	held on
26	designated under
1	improving food
2	determines, on
1	packaging. 
1	self determination
2	includes those
1	use; (viii)
1	need associated
1	(a) enables
1	section 57a
2	shall institute
2	agriculture coordinating
1	beginning the
1	determined, may
1	interruption in
1	pharmacy; (6)
5	name, and
1	(x) of
1	subsection agrees
2	goal described
1	using reliable
1	safety. to
6	and, when
1	devices utilizing
1	(8) apply
1	
 360a.
11	authorized trading
1	safrole. (r)
1	statement, unless
1	exists, in
1	years, whichever
1	threat international
1	following interoperable,
2	upon obtaining,
1	(b)definition. 
1	i, and
2	becomes final,
10	deliver for
1	becomes final.
1	states law.
1	item, is
1	integrity issues.
1	given away
2	24, 1948,
1	sought. (4)
1	numbers, with
5	identify such
2	drug, to
1	device; (b)
1	capabilities, and
2	orders in
82	year after
1	clarification for
1	(1) acetorphine.
3	postmarketing study
3	pharmacy, the
1	strength and
15	least equal
2	conditionswith respect
1	2007, if
1	determine not
1	administration. (d)
3	(3) with
3	withheld pending
1	among physicians
1	section 343(j),
6	drugs, as
1	extensions granted
1	harvesting, holding,
1	areas including
6	cigarettes and
11	notification shall
1	(b). (3)
3	2008 through
1	costs; 
3	commission does
1	submitted, exempted
2	capsule, or
1	least 100,000,000
1	waiver requests
1	conditions; or
2	timely development
2	announcing that
1	designated 
1	understood to
1	981(g) of
1	(t) -methylpseudoephedrine.
1	tobacco, as
1	adequate evidence
1	collected according
1	term plant
26	person for
1	including limited
1	5. (i)
1	designated foods
1	description that
1	intended 
1	receipts of
1	fishing vessel.
1	receptor) agonist
1	residue only
8	trafficking areas
2	disseminated in
2	carry firearms;
1	stay such
2	local officials
1	section 2219a
1	funds transferred
1	(xi) any
3	released under
1	247d7e(e)(1) of
4	recall authority
2	secret information,
1	fund amounts
27	6 years
1	packer holds
1	partnerships are
1	permanently prohibiting
1	with, as
1	service it
1	(4) advisory
15	reasonable probability
1	process, for
2	categorization of
1	wrapper. (l)
1	longer. 
1	licenses, memoranda
2	48 stat.
1	presidential report
4	promptly as
2	dextrose and
1	fee) for
11	trafficking area,
1	(j) leishmaniasis.
1	various fields
1	reef, johnston
1	substantially equivalent.
2	fishing vessels
1	act; jurisdictional
1	(2) contains
1	pound or
7	punishment authorized
2	confidential access,
1	manufacturer responds
1	(3) reasonably
6	timelines for
1	additional single
6	consumers (all
1	review unless
1	graduate training
1	(2)(a) be
1	1531(d) of
2	208(a) of
1	services; continuation
6	party controls,
1	
 679.
1	title) being
4	die, plate,
1	drugs, medicines,
1	renewal grantees
13	decides that
4	held with
1	determination submitted
1	reasonably cause
4	water act
1	(a) pilot
2	administrative detention
4	tribe or
1	effectiveness. a
1	
 345.
1	govern any
1	negligible and
1	threshold level
1	without inspectors
2	payment, shall
1	solutions related
2	includes (until
1	management activities)
1	federal intramural
2	piece of
1	relief. (5)
3	$10,000, or
1	seq.]. this
3	framework for
3	isomer means
1	compensate, and
2	guidance entitled
1	terms, through
4	diagnose, or
3	containing as
2	registrant for
1	agriculture for
16	section of
1	regarding exposure
1	known, incidence
1	voluntary service;
1	sections shall
5	risk that
5	section on
1	(b)(2) is
1	federal effectiveness
1	applications an
2	v unless
1	recipients, other
1	exceeds fifty
1	2009, shall
1	business, taking
1	needed scientific
6	(a) there
42	section or
1	nonconformity; (e)
1	effect: 
1	subsections (b)(4)(e),
2	v, or
2	varying sizes
1	farms, except
1	exception subsection
1	reviewin developing
1	individual, limiting
1	commitment of
1	recall information
1	nutrients 
1	violation. (3)
1	budget determined
3	(e) use
1	
 2001.
1	(i)) that
4	government entity,
1	criminal, initiated
1	government entity.
1	dispenser additional
7	prevent, or
1	clause (i)),
1	distribute, at
1	reach acts
1	entered domestic
1	groundsa registration
1	property at
1	depressurization or
1	file supplemental
1	organization; (ii)
2	states. any
1	clips: meaning
1	new productsan
3	plant shall
2	slaughtering by
2	(2) involving
1	property, buildings,
5	share of
1	containerif it
1	state, pursuant
1	552(a)(3) of
1	(g) 0.15
1	(c) before
1	oversee, coordinate,
1	compensatory damages.
1	nicotine through
1	residue data
4	audited by
1	humanitarian device
1	briefs. 
8	(1) does
2	subsection. (b)
1	timeframe; and
1	u.s.c. 552]
1	committee within
1	required bond
1	section, issue
7	voucher is
1	387t. labeling,
7	filing the
1	delegation of
2	employed intermittently
1	otherwise, to
1	intended; (b)
2	court with
7	considers appropriate
1	960(b)(1)[1] of
19	approval for
7	fined in
2	otherwise developing
1	(a) (referred
1	nonconflicting laws
1	increases at
10	manufacturers or
2	behavioral, or
1	673, and
1	increases an
4	misbranded. 
33	disposition of
1	agency, 10.
3	(61 fed.
1	pathogen controls
12	prior convictions
1	accordingly. the
20	evaluated together
1	procedure. (2)
7	level, including
22	information about
1	360fff5. sunscreen
2	specific prescription
1	constituent, extract,
1	determines otherwise.
1	report, make
1	provide food
1	defense in
3	promptly respond
3	832; 

2	processing any
1	processors transitioning
1	order, at
1	reasons not
8	order, as
1	drug) by
1	drink that
1	(f) public
1	program amounts
1	objectives related
1	7 business
2	suppliers do
5	united nations
1	involved provides
2	executive branch;
3	section 360c(f)(1)
1	strategies. (b)
1	pesticide is
1	threatening, (ii)
2	june 30
2	using performanc-enhancing
1	drug which,
1	unless exigent
3	28. the
1	thereafter, if
1	(4) size
1	(c). (e)
1	order specifies
2	standard, including
1	3.5 percent
1	(5) roach
1	membersupon the
1	economy; (2)
14	increase in
1	requirements; applicability;
2	significant contribution.
116	person shall
1	agency, use
1	authorize them
6	relative to
1	practitioner means,
1	exporter to
3	private agencies,
2	entry is
1	sold, delivered,
1	adulteration (a)
1	committee nominations;
18	commerce for
1	gas, alone
2	who, as
1	raw cream
1	device unless
1	(5) paragraphs
153	submit to
1	7. (e)
1	fluent both
1	iii, 535,
1	pharmacopeia, pharmacists
1	occur within
3	entry in
1	country programs,
1	packaging eggs,
2	381(e) of
1	deliver (other
2	increased federal
2	applicant may,
2	approved and
1	(3) cooperation
1	comes in
2	authorized as
1	poultry. (4)
2	similar or
2	(a) include
1	reject means
11	report not
48	provided under
2	complete application.
1	iv to
1	panel). 
33	person from
1	authorized purposes
1	repackaging and
5	will provide
1	review. (6)
1	without opening
1	10, 38
4	vacancy in
1	improving treatment
2	(11) of
1	residues, decomposition,
3	administrator, the
14	registered with
1	activities, be
1	upon proper
1	executive department,
1	panel recommends
2	4.0 
1	(c), submit
2	contaminants and
1	(c) on-third
7	depressant or
1	subpopulation. (c)
1	states other
1	community; 
4	area, the
2	(august 28,
4	shall adjust
1	public informationany
1	general administration
20	paragraph. 
3	incorporate the
1	banned substances.
1	(e) personnel
1	seized would,
1	sharing law
1	effectively carry
1	(3) $260,000,000
1	women; (5)
1	lessee, agent,
1	holding), except
1	(ii) labelingthe
2	projects, including
3	retailers of
1	title 47);
1	1033. definitionsfor
1	patient regarding
1	balancing in
5	past experience
1	title, (referred
1	countries, 1
2	(h) appeal
2	term sunscreen
1	origin; authority
2	confidential treatment
1	isolation, and
3	2000, and
4	considerations in
13	least once
1	plan contains
1	maintained and
2	subsection (h);
2	person permanently
2	user of
1	susceptibility to
1	companies to
2	projects 
1	changes or
1	product sponsors
2	360d(c) of
1	patient, which
1	title 18[2]
1	term veterans
4	date shall
1	supplements). the
3	user or
2	person (a)
1	required with
1	(vi)expiration of
1	might contribute
1	trials intended
2	5 miles
1	products enable
26	authorization under
3	360e(c)(4) of
1	
 881.
2	packed into
1	(a)(5)), upon
1	(j) status
1	safety provisions
1	that, at
1	(b) construction
8	supplement means
11	licensure, or
1	or, at
5	ten years,
5	that, as
1	2011, for
3	(1)(a) to
25	collected and
2	informationthe term
8	prepared, propagated,
1	stat. 832.)

2	preparing, treating,
9	disease area
1	(b). (6)
1	services; pharmacists;
1	direct farm
1	supplements, prescription
2	prepared, compounded,
3	information derived
2	(cc) the
2	claimants principal
1	including things
6	exceptions 
1	(2) evaluation
1	plansthe strategy
2	use; (4)
1	section 132
2	grant amount
3	new proposed
1	inspector appointed
2	among domestic
2	documentation detailing
1	emergency exemption
2	determines bears
1	(17) dimepheptanol.
1	secretary initiates
1	upon resubmission
1	tree nuts
1	 nutrient
2	consumer grades
4	part from
4	intelligence, the
1	fourteen years
1	serious diseasesany
1	appropriate, at
1	warnings against
1	drug exemption
76	(a), the
1	(j) temporary
4	supplement, the
2	repayment program
1	(c) privacy
1	suburban, and
3	court enters
1	countermeasure, and
5	special projects
1	general); or
1	determinations. such
1	obligate funds
1	(3) purchase
1	(1) real
2	administrator under
14	among the
5	damages in
1	repackager. if
4	order making
7	agriculture, and
12	expenses appropriation
1	
 301.
2	separate from
1	(a) under
1	hazard is
2	gratuity, or
1	501 of
1	section (specifically
2	(2) compensation
2	drugs used
1	white rots,
1	firm means
3	otherwise relating
1	recovering from
5	adul-only facility
2	improve pediatric
1	processed, on
1	subsection. a
2	substance based
2	certain petitions
2	exemption following
5	laws. 
1	effect, procedures
1	retailer who
1	(c) controlled
2	supplant, any
1	(mephedrone). (19)
3	processed, or
2	pesticide within
1	board whose
1	parents, and
1	renumbered 17
2	either such
1	section 356(g)
1	class other
2	plant of
3	entity has
1	helium, the
1	(c) small
3	453(g) of
3	60 percent
1	354(a)(3)(a) of
1	initial notification
2	decision times
1	containers; determination
2	including to
1	task of
3	services who
32	information before
1	u.s.c. 61
1	prominent and
2	on, the
1	factors with
2	term list
1	bioequivalency under
1	whole of
2	basis, in
3	person (as
1	submitted does
2	prescribe) for
2	and, with
4	decreased by
1	including fines,
1	order, including
1	meat, poultry,
1	(a)(1), if
2	action, as
14	developed and
3	(1) twice
1	removals and
1	$12,300,000; (4)
1	ethylmethylthiambutene. (22)
1	humans for
2	(g) 
1	certain unapproved
1	certain usesnotwithstanding
1	exercise supervision
1	cream brought
1	date when
1	credentials, certification
1	(1) waiver
1	scientific investigators
5	subparagraph if
3	3-day notice,
1	page 13
1	379i. definitionsfor
1	available fee
1	article an
2	provider for
1	2018. (c)
1	(4) oversee
1	resolutions; (ii)
1	submit evidence
1	dioxide, use
2	qualifying pathogen
1	article at
1	article as
8	subparagraph is
2	387f, 387g,
1	matters such
1	renumbered 18
1	(j) piperidine
1	(xiii); 
1	unusable medications;
1	commission notifies
1	section 353(c)(2)
1	350c(b), 350f,
1	marketed sunscreens
1	airway resistance.
1	notice relating
7	introduce or
1	food packaging)
6	(iii) 
1	anhydride. (p)
1	pharmacys drug
1	methods in
2	expected pharmacological
1	unless controlled
1	conveyances, where
1	clauses (i)(i)
5	352(f) of
5	security, the
1	applicant promptly
1	civil penalties.
1	definitions in
1	stat. 1045;
3	law, a
1	allocations of
1	thereof, is
1	stat. 882;
1	c-chairpersons from
1	practice set
2	nervous system,
1	civil penalties:
1	civil penalties;
4	devices. 
1	accredited. (5)
1	places an
7	congress to
2	following december
3	facility described
1	distributing new
1	caused, directly
1	quota under
1	admitting to
1	conviction, an
1	conducted if
1	councilsthe secretary
2	listed, upon
1	authority referred
1	active, with
1	shipped. (e)
20	conducted in
2	copies; samplesthe
1	(a) extend
1	conducted is
3	removed shall
1	section 843(d)
3	201 of
2	with, 1
2	days announcing
6	writing the
1	(as a
1	good laboratory
2	requiring disclosure
3	purpose, an
123	applicable to
1	states, between
6	applicant; or
1	(1) employs,
1	effect. (ii)
1	capacity prevents
1	products, derived
1	involving, any
1	having, a
3	order deemed
1	462. reporting
1	outcomes research
2	issues in
1	unless, after
1	petition seeking
3	dispensers with
1	small entities,
5	factors shall
1	communit-based coalition
1	instructions to
1	seafood. 
1	delete it
13	regulated industry,
3	chinese subjects
9	regulated industry.
25	annual report
1	contentsfor each
5	committee, the
1	collection 
1	surveys in
1	health, provided
1	grains. the
1	engineering, biological
1	directly support
1	lives; and
1	1 establishment
1	(iii) concurs
2	authorities, if
1	defined or
1	(c) required
1	(i) adverse
2	(4) procure
1	1044(a)(1) of
3	medical services
7	increased by
1	create an
1	secretarys findings
1	patients, family
1	maximum limits
1	regional or
1	(b) determine
17	collected for
1	audit conducted,
1	program, based
1	petitioner or
1	608. sanitary
1	section 353(e)(4)
1	affixed a
11	effective as
1	transactions as
4	petitioner of
4	manufacturers, importers,
1	subsection (f)(4),
1	360, as
1	information stating
1	subsection (f)(4))
27	manner that
14	risk identification
1	defense. (h)
1	since fiscal
2	employed more
1	data. (4)
2	patent had
1	disseminate model
1	(a)(1) shall,
2	used such
2	requires that
1	directive requirement
1	principal, ultimate
4	invite interested
1	foreign cooperatives
1	felony, and
3	vegetables, including
1	oversee and
1	2007 and
1	submissions, 3-day
1	term agent
1	services unaffected;
1	with. such
14	bureau of
1	production, harvesting,
1	provisions through
1	countries and
1	year millions
1	wrote the
1	intelligence, shall
1	poultry from
3	primary message
1	industry related
1	(d) reimportation
1	direct interactions
12	may also
1	books or
1	(b) although
1	previous tax
1	managers of
7	general fees
1	seller delivers
8	drug activities
1	violent crime
1	including managing
1	accreditation or
1	828 of
1	2006); and
1	expedited consideration
1	including package
1	provide mentorship
1	advertisement 
2	manufacture, preproduction
1	(2) less
1	thousand: provided,
1	consistently applied.
6	seq.], and
2	inspected, in
1	
 153.
1	manufacturers products.
2	deemed amended
1	territorial jurisdiction,
1	suspensions the
1	(a) facilitating
2	dates shall
5	appeal of
29	testing and
1	private entity,
1	importation; (2)
2	claimant; and
1	community; (c)
7	processes, and
2	(e) other
3	stat. 832833)
1	agency guidance
2	practicable, when
5	pharmacy, drug
1	margin will
1	avoirdupois ounce,
1	from, a
1	illnesses by
1	contracts that
1	barrels which
3	transaction. (2)
1	registration $2,575
1	formerly 360b,
2	45 stat.
1	v, who
4	ordered detained
1	right 
1	eligibility under
1	basis is
1	thereof, obligations
2	60 days.
1	establishing whether
6	reauthorization; reporting
1	(e) color
2	paragraph (1)(e),
2	standards, practices,
12	person with
1	medication that
1	(ii) allocations
1	manufacturing supplements
5	surgical intervention
1	researchs office
1	began. 
1	defendant 
1	title, clause
1	formerly 14th
1	value. 
1	plants referred
1	subsidiary the
1	mental and
14	regulation prescribe
17	year limitation.
1	356f. hospital
1	year limitation,
1	model accreditation
2	agent thereof.
1	avoid a
1	subpenas; witnesses;
3	271(e)(4)(a) of
1	communication is
1	(3). (f)
1	products whose
10	away from
2	(j) other
4	any, that
2	devices at
6	site or
6	following activities
1	purposes regarding
1	section 360ddd(1)(h)
1	excluded by
1	proceeding, any
1	(d) accounting
55	site of
1	stakeholders during
1	pholcodine. (22)
4	application fees,
1	formerly 910,
1	final crystallization,
1	substances mentioned
1	section 384b(c)
1	projected for
2	(which measures
1	components or
2	use proposed
2	render inspection
1	however, the
1	project designthe
1	manufacturers; (h)
1	alcohol or
1	recommending improvements
1	title. (m)
15	components of
1	requirement pursuant
16	product tracing
4	821.)
 

2	transportation or
1	surfaces and
1	administration, could
1	understanding that
1	license, order,
2	business that
1	otherwise recognizes
1	menu items
1	paragraph (3)(c),
1	physician, as
1	schedules, he
1	(c)(2). (2)
1	designations 
1	medical, veterinary,
3	program fees
1	appropriate. (b)failure
1	first report,
1	term sanitary
6	omission, or
1	inadequacies and
3	species are
1	importer produces
1	(3) label
2	therefrom by
3	military intelligence
1	studies described
1	$10,000,000 or
1	provider is
1	(3) discovery
1	(3) implement
1	comply, and
1	detail of
1	repacks it
1	1403. pesticide
1	(c), to
1	section since
1	portfolios for
1	provider if
1	requests; (3)
1	section 274
2	longer requires
1	(f) farms
1	ch. 530,
2	early warning
21	unless 
53	standards for
1	clearance includes
2	(b) contentseach
1	section 360e(g)(1)
2	(2) issues
1	otherwise prepared
1	made, issue
1	local health
2	(a) providing
1	reg. 8961,
4	meat products
7	1 and
1	written regulatory
2	administration employees
1	persons request
322	new animal
1	statementsany statement
1	properties. (vii)
1	advertisements shall
1	diagnosis, or
83	calendar days
1	money or
1	directive drug.
5	facts, is
1	directive drug,
2	consumers. the
2	product refused
2	 (22)
2	succeeding crop
1	years preceding
1	imprisonment without
1	section 673
3	regulations) concerning
1	(6) facilitation
1	initiates a
11	public interest.
4	proper expenses,
2	(1)(b)(i) or
1	consider for
1	evidence at
3	conducted, supported,
21	pharmaceutical distribution
1	following, and,
2	facilities, including
1	357. qualification
1	participation the
9	processed by
1	624. storage
2	upon failure
1	homogenization. (e)
1	including, to
1	r-exportation described
1	collectively, but
1	subchapter. (e)
1	(1) exist.
1	ability, and
2	-position of
1	(b)(1)(a). when
2	facility, is
2	organization is
5	material which
1	
 171
1	field. (ii)
1	(b) alternative
1	care insurers;
1	(b) requirementsthe
1	15 years,
1	comment period.
1	populated and
1	food presents
1	fact although
1	shows that,
1	holder for
3	shall, unless
1	raw, is
1	generalnotwithstanding subparagraph
1	development (referred
2	public identification
1	constructive, or
1	womens participation
1	purchasers during
1	imports that
1	products when
1	describes in
1	substantial equivalence,
1	interest. the
1	generalthe national
1	meet, with
1	concerning infant
1	permissibility of
1	adverse experience
1	conveyed via
1	persons providing
1	deciding whether
3	80 per
1	prepared, under
1	675, 419,
1	request; (b)
9	private entities
2	similar advertisement
1	(iv) assigning
1	complaint requesting
1	diseases under
1	bears (1)
1	director a
1	evading the
1	specific interpretation
1	
 2106.
2	year based
1	dracunculiasis (guine-worm
1	subparagraph (1),
51	date the
1	section 360ll(a)
1	ch. 1263,
1	goods to
1	may convene
1	employing individuals
1	case study,
1	june 27,
3	licenses, or
1	establishment be
3	requirement imposed
1	1991, and
1	(2) label
3	effective chemical
1	title. this
1	(e) proceedings
1	immediate chemical
6	processes, packs,
2	including electronic
1	facilitate communication
6	using appropriate
9	ch. 155,
1	general control
1	economic devastation
1	ii, 202,
1	675, 422,
1	(b) manufactureit
1	food; (e)
3	distributed any
1	refusal, withdrawal,
1	262]; (b)
1	division; (iii)
1	ingredient information.
1	regulation reinstating
7	internationally recognized
1	response, and
5	prohibit a
58	safety or
3	timeframe for
22	unsafe within
3	common law
1	citizenship of
1	circuit. judicial
2	material the
12	hearing under
1	including criminal
1	system, it
6	verify such
7	following shall
1	count per
5	(1) was
1	biologic/device, or
2	nicotine delivery
1	price paid
1	system, if
1	offense that
1	
 620.
1	fraternal organizations.
3	(iii) other
3	nicotine replacement
8	manner of
1	agency (if
1	paragraph (g)
1	relationship that
1	communication plan.
2	manner on
1	form, at
1	obtain access
1	harassment, reprimand,
1	distributed and
3	entities which
1	identifiable pattern
1	issues, or
3	dairy or
1	registrations, verification
1	pos-february 15,
4	device recall
2	(1) carry
1	bacterial sinusitis,
1	states; (d)
9	country in
1	economic hardship,
1	(2) foreign
1	repay, for
1	placed a
1	judgment; supreme
1	country if
1	distributed commercially
8	internal revenue
1	(a) postmarket
1	title (referred
2	response that
1	purchaser enters
1	subsection (c)(1)(a)(ii).
1	advertisement. the
3	economic hardship;
2	cause, a
1	expertise which
1	manufacturer, for
5	support for
1	physician, dentist,
3	food meets
1	import, export,
3	site that
4	document that
2	thereof. (4)
1	regulatory audits.
1	(2) acetyldihydrocodeine.
1	translate to
1	35, or
1	immediate recipients,
1	(f) distribution
1	convention signed
4	senate, and
1	nonnutritive object
3	without authorization
9	term state
1	distributor if
4	misbranded poultry
1	(7) (hereinafter
2	maintain establishments
1	appropriate procedures,
1	constituents 
1	bears adequate
1	 unless
4	technical, or
1	among state
1	247d6b, 247d6d,
1	(7) nonprofit
4	sale, for
5	hig-risk foods
1	assessed, any
2	law. in
2	strategies). (v)
1	peer reviewed
1	three hundred
11	design and
2	law. if
1	types, especially
1	annual assessments
3	sale, transportation,
1	recommendations. in
15	application 
16	mitigation strategy
2	distribution without
2	efficient execution
1	serving thereof
1	employ technical
1	index of
2	1890, ch.
1	360a2 of
9	official plant
1	may (by
1	states. (27)
1	availability not
20	making such
3	5 by
1	involved. (b)
1	586a, as
3	conclusive unless,
3	353(e)(1) of
1	actions regarding
2	requests made
1	sellers with
1	definition 
1	conducted effective
1	employee uses
1	preservation except
1	approved use
2	aggregated data
1	applicable, for
2	establish) of
4	centum by
6	substances, or
7	uses for
1	service means
1	will address
1	officer. 
1	protocol, a
1	reports if
9	(11) the
3	(b) assessment
2	filled milk
4	reports in
2	order assessing
1	arguments so
1	document conclusions
1	data every
1	occurring after
1	1535. supplemental
1	name), and
1	use conditions
2	following goals:
1	health advocacy
2	coordinate regulatory
1	data requirements,
1	intent on
2	outside container
2	physical presence
1	inputs, and
1	warrant it,
2	poisonous alkaloids
12	intent of
1	postmarketing data
1	revised, or
1	specificity, or
1	(a) imported,
2	conducting periodic
10	food; or
1	training on,
2	statement not
1	
 22.
1	without being
1	program prior
1	superseding or
1	212. offenses;
1	establish, with
1	timing, or
5	award grants
1	(6) pursuant
1	360c(g) of
2	assurances satisfactory
2	legitimate need
1	following penalties:
1	agriculture at
1	additives listed
4	14 of
2	prepared, inspected,
1	(b) dismissal
1	agriculture as
1	section 360d(c)(1)
3	meat, and
1	8 feet
1	portable tank,
3	subsequent owner
1	fascioliasis. (i)
1	(a)(ii) or
7	committee provided
1	(aa) completed
1	costs referred
1	authorities. 
1	(d) limitationsthis
1	devices, under
1	immediate exportation,
1	subchapter. (3)
64	code of
2	constituents, ingredients,
2	(b) quarterly
1	(d) registration
1	prominent manner
3	year nor
1	l., except
1	seizures (as
7	presented to
1	(a)(ii) on
32	risk to
1	assess practices
1	communication between
3	defraud, or
1	reasonably included
2	residue, means
2	legal right
1	year; (e)
1	food, reports
7	procedures established
2	(4), to
1	practices; (b)
1	(2), notify
8	subsection. the
1	plant whose
1	(5)3 restrictions
2	reasons to
1	days. in
1	experience or
3	appropriately diversified
1	(3) beginning
1	glass, roughened
2	necessary prior
1	monitoring as
1	additives suitable
2	term patent
3	(a)(3) (relating
1	application $248,000
2	title 47,
1	invalidate any
1	i. for
2	referendum enacted
1	subsequent submission
1	
 364.
2	four members
8	applicant submits
2	population served
1	
 97
1	title 47;
3	effect, except
4	eggs in
1	title. without
1	(e) definitionsfor
2	plant disease
1	person responsible
5	de novo
1	party; (c)
1	committee exists,
1	reduction, state,
1	$200,000 if
1	best interest
2	person distributing
2	common control;
2	subparagraph (5),
1	practicable, infer
1	dispensed during
2	state officials
5	controlled premises
1	(19) 3,-methylenedioxypyrovalerone
1	offense. and
1	concentrations on
2	recommendations about
1	confirming the
2	1996, shall
1	verdict of
1	eighty days,
18	take action
1	applicable, along
1	proprietary or
11	food imported
4	formulary, or
1	(1) provided,
117	drug for
24	plan for
1	(a)(1)(b) of
2	radiation; (3)
1	food importer
1	fellow and
1	suppression of
2	fund of
1	fraud, or
1	2007; (2)
1	needs or
2	offense will
4	requesting a
2	labeling changesthe
2	paid to
1	declining the
1	360(a)(1) of
1	1706. high
1	implementing inspection
1	following federal
2	provider to
1	division; (v)
1	vendors about
1	nurse tanks
4	classification information,
1	classification information.
1	appropriated $30,000,000
1	time specified.
1	advertisements are
1	property used,
1	becomes necessary.
25	substance has
1	illegal transaction
1	changes requested
1	sunscreen under
1	development, activity
1	gather, analyze,
1	brings or
1	(b) renewal
1	(ii) -(-naphthoyl)indole
1	foods. 
1	qualified laboratory;
1	model laboratory
2	fixing such
1	promote food
1	email address;
1	physically incompatible
2	section 321(ff)
2	pollution fund
1	year. (g)
1	email address.
27	need for
1	term returns
1	product obtained
1	thir-party auditorsan
2	consumer interests
1	including, when
3	any, under
2	disruption or
10	transferred shall
1	said budget
21	removed from
1	dismissed, if
3	secretarys procedures
1	(3) disciplinary
1	elect one
1	employment involving
1	harmful; or
1	costs. (

1	shall submit,
1	known food
2	disruption of
1	countries through
4	produced from
1	remove, alter,
1	regulations containing
1	binding upon
1	314.70 of
1	quantities before
1	supporting a
1	costs. the
1	term food,
1	safety; or
41	court shall
2	properly designed
5	holder that
1	authority uses
3	goals for
3	order. a
1	children, that
3	paragraph, may
1	context most
1	
 360bbb4.
2	kitchen prepares
7	interdiction committee
2	eligible entitythe
2	commence) a
3	intentionally to
1	blood rings,
2	indication, new
1	entry program
11	product was
3	methods adopted
1	duty imposed
2	substances; (5)
1	importers; hearing
3	authorities having
30	death to
40	thirty days
1	ascertain that
1	proper. following
2	authorization described
14	abuse prevention
1	treatments (a)
6	357 of
2	identifying any
4	submitting tax
14	withdrawal period
1	identifying and
27	procedures for
1	transaction does
1	death, including
4	applicationthe term
1	360e, 360(k),
1	handling. (b)
3	general nothing
1	growth or
8	investigation that
3	operate to
1	results do
13	product if
3	modified, or
1	act; consistency
1	employee with
1	(h) disposition
36	product in
1	efficiencies; or
2	effective beginning
2	adults and
3	service, that
1	hiring bonuses,
1	product it
6	determination as
92	product is
1	pay by
3	1970, and
1	ratio of
2	importation, entry,
2	shall issue,
2	diseased animals
1	preemption for
3	actions the
2	previous order
1	deferred adjudication,
14	conflicts of
2	conduct activities
3	(d). (b)
1	commission, shall
1	nonclinical data
4	public information
1	devices periodic
2	may invoke
3	subsection prior
1	851. proceedings
1	criminal organizations
2	addiction psychiatry,
2	members, as
10	manufactured by
1	term efficacy
1	either transfers
3	retail sale
2	avoid inconsistency
1	involving controlled
1	community, make
1	determination definedfor
2	41; and
1	theretofore issued
1	techniques as
5	secure facility
1	include participants
1	health condition
2	clause (1),
3	since july
2	pot, tin,
1	supervise the
1	order outweighs
1	successful case
1	(b) restrictions
1	(1) fees
14	notifies the
1	easily accessed
1	agency authorities
2	poultry in
1	decisions or
1	july 12,
3	penalties the
1	substances. (june
3	additional -year
1	stores, if
2	proceeding, or
2	foreign establishments;
1	completed, except
2	materials, design,
17	negotiations with
3	decisions of
1	chemical, shall
1	844. penalties
1	undertaking activities
1	undermines our
1	expeditiously. if
2	made later
1	(5) collection
2	employees, committees,
16	administration in
1	(e) corrective
1	indexed use
8	administration is
1	section 1622(h)
1	measurement) that
1	leaf, including
1	(c) at
2	(2) benefits
1	every 180
2	file, the
2	instances of
1	(e) biosimilar
1	
 207.
1	$175 for
1	manufacture, sale,
1	(1) possesses
3	regulations that
4	collaboration with
1	field in
7	agencies, and
1	title describing
1	national networks
1	written agreements
1	arguments in
1	fund substance
1	penalties: 
1	response issued
1	section 16(b)
4	farm that
1	wel-grown specimens,
3	reinspection fees
1	scientist, shall
2	grant recipients
1	systematic manner,
1	(1) periodically,
2	(2). (4)
3	contains one
1	potential health
1	conferences; (b)
3	notwithstanding subchapter
1	(2), amend
1	patented inventions
1	practices. (b)
1	opioi-related deaths,
3	credible threats
1	influence of
4	amount collected
1	introduce testimony
19	greater than
5	initiatives that
1	vary from
1	wholesomeness of
1	coloring or
1	federa-state standards
1	divisions on
2	(b)(1); (h)
1	hydrate, except
1	beginning 48
4	transaction is
1	shrimp), tree
1	title, or,
18	contain the
3	protocols for
1	aiding, retarding,
2	file has
1	unclassified report
1	food listed
1	(b)(i). 
2	$2,748,000 for
5	commercial manufacture
1	fourth sentence
1	written agreement,
1	director. (h)
1	track research
6	355 or
1	$50,000,000 for
1	355(b)(1), 355(b)(2),
1	exportation, if
2	initiates or
2	provisions in
2	waived unless
3	opiat-dependent patients.
3	section 355(p)
1	areas; and
1	facility. (iii)
2	establish scienc-based
1	amended aug.
1	accused, by
1	amended pursuant
1	person ceased
48	title; and
10	agencies in
1	tobacc-related disease.
1	903. application
1	health, (b)
1	inconsistency, sections
5	dispensing a
1	manufacture, the
1	additive, constituent,
1	clear description
1	(e) applies,
29	providing for
1	limitation. (b)state
1	(a). (i)
1	location. (b)
1	duplication and
1	vehicle, for
2	rates not
1	regularly updated
1	enabling and
1	components that
1	acted as
1	proceedings, any
1	section 360fff3(a)
1	(c) 1
2	every successive
4	exception the
1	interstate, foreign,
3	stringent than,
1	drug store
1	evaluate known
8	regarding a
2	training under
2	canned, salted,
1	department duly
1	larger confirmatory
36	program agency
1	section 1605(c)(3)(b)(i)
2	years prior
1	number belonging
1	application process
1	amounts designated
3	policy to
2	than, those
4	procedure. 
3	355(j)(5)(b) of
1	records pursuant
2	documents as
1	dose to
2	protocol differ
1	21-, or
6	section 360j(f)
1	iii, why
1	accompanying directions
1	action (except
14	school or
1	survey of
2	(1)(b). (b)
1	permission for
2	recommended is
1	(2) food
126	opportunity for
2	equivalent products
2	contingent on
1	paraphernalia (a)
152	established under
1	store, apothecary
1	regulation, in
3	necessary means
1	scientific research
3	secretary conducts
1	october 2007.
6	informing the
1	concentration. 
1	device after
1	intelligence relating
1	applicable commercial
2	regulations, except
1	additional human
1	increased citizen
1	quarter by
2	affiliates gross
1	paragraph, multiple
1	$50,000, or
22	(c) a
1	fact, information,
2	travel, education,
2	identified, the
4	carryover user
2	persons any
1	preparation the
1	management or
1	title. only
29	investigational new
1	dyes (as
3	substances into
2	require, he
2	illicit dru-related
15	management of
3	subchapter, it
1	though such
1	aircraft or
2	responses by
1	receive, for
1	surveillance 
1	employed or
9	persons and
1	u.s.c. 136a(c)(2)(b)];
1	compatible or
1	device users)
1	master filein
1	without intermediate
1	stat. 1261;
10	audit of
1	related article,
1	section; (9)
2	state, any
1	substances moneys
1	personnel; (2)
1	(a) congressional
3	law that
2	term manufacture,
2	tried by
47	judicial review
1	directly responsible
1	advice, information,
1	available, or
1	audit or
1	product. (dd)
1	subsection (c)(2)(c)
2	comments, and
3	addiction medicine
2	per customer
6	committees so
9	ordered forfeited
1	means testing
1	uses; (b)
1	individual unless
2	countermeasure with
1	pathophysiologically related
1	thing (other
1	2018. such
1	food packaging);
1	full study
1	users, manufacturers,
1	number. except
1	applicant on
1	administrative remedies
2	objections. the
1	target audience
6	applicant of
11	consist of
3	13, 2013,
4	director, the
1	jurisdiction authorized
2	year, where
4	section 351(a)(3)
4	term manufacturer
1	prescriptions may
6	cooperation and
1	abuse. (c)
1	federal regulations).
1	(d) immunity
1	substances means
1	trial have
3	term egg
1	columbia; or
1	individuals aged
1	admission, and
1	controlled, or
1	felony by
1	evidence demonstrates
2	term manufactured
1	360aa. recommendations
1	departments discharge
3	pursuit of
5	administrations internet
5	substances to
3	matter within
5	obtaining any
1	traceability in
1	foreign governments,
2	entrees only
1	poisonous character
1	mineral acids,
1	clarification this
2	federally funded
1	communities seeking
1	licenses 
1	goat or
2	foreign governments;
8	sufficient information
1	risks cannot
1	first country,
1	following certification:
2	substantiated scientific
1	identify smuggled
1	505(c), 512,
1	proceedingson receipt
1	packer, distributor,
1	indication; or
23	whether a
1	stat. 1045.)

1	hypersensitivity to
1	use; (v)
5	residue is
25	known as
2	fertilizer nurse
2	applicant makes
2	labeler code
1	enables consideration
1	exceptions; presumption
1	year, abbreviated
1	(ii), then
1	permitting a
1	activities may
8	additional or
2	addressing the
1	micr-organisms during
1	food importationa
12	imminent hazard
1	(3) limitationan
1	characteristic (such
1	usually have
1	103226; 5
1	353(g)(5)(c) of
1	states persons
1	parking facilities
1	unexpected adverse
1	chapter a
1	membranes intact
22	represented to
1	603. examination
2	reasonable for
2	stat. 1040),
2	bodies that
1	requires more
4	expended without
1	subchapter, is
8	officer, employee,
1	man, the
1	subsection (m).
4	standard referred
3	section 351,
1	controls, to
2	instruments and
1	related substances,
2	section 334(a)(2)
1	documentation the
1	841(b)(1),[1] and
10	deemed appropriate
1	collected 
2	electronic health
1	implemented, and
2	374(g) of
22	(1) with
3	commerce by
2	court orders
17	report submitted
1	official, department,
4	subsection; and
1	manufacturers estimated
1	payable at
2	importer on
32	applicable requirements
1	(f) regulatory
104	conditions of
1	government. (v)
2	seafood, juice,
1	(2), how
1	ensure safety
1	(b)(1)(c), or
8	conditions on
1	appointment the
1	paragraph (2)(a)(vii)(iv),
1	
 854.
2	drugs filed
2	wholesale distributors.
2	internet sales,
1	
 360eee2.
2	offense except
1	block during
1	ingredients classified
1	issue his
1	betaine. (3)
5	substance by
1	
 147.
1	prescription by
2	alcohol administration
1	trade representative.
1	drug policies
2	trade representative,
1	(for example
1	condemnation; appeal;
7	site. 
1	unduly burdensome,
1	violated. the
1	writing, no
1	particular pesticidal
3	(j)(5)(f), subject
2	clinical evidence
3	process 
2	(3) plans
1	person considers
1	redesignation; designation
1	regulations). (k)
15	responding to
6	international standards
1	volunteer leaders
4	notice, such
5	(5) transmittal
4	title 15
1	675, 505,
1	market approval
6	export from
1	initial reportnot
1	thirty days.
1	require codes
1	drug excludes
1	initiatives, in
1	inadequate, (b)
1	bureau authority.
1	chapter), and
3	alignment of
6	attempt to
1	reducing drug
3	located, or
1	cause. (

1	agency submits
1	butter defined
3	plant processing
1	case less
2	(i). (2)
1	made, insured
6	beyond the
3	burdening of
1	pending requests.
3	necessary; and
1	possession, the
2	(b) reasonable
1	additional restrictions
2	judicial processes,
1	establishments. (3)
1	data sufficient
3	foundation under
3	(3) abbreviated
1	member appointed
2	section without
1	issue subpenas,
10	iv or
1	initiative, establish
1	represented and
1	348(g) of
1	heads with
4	attempting to
32	united states;
3	united states:
1	methamphetamines at
1	(3) detection
2	form (which
2	(e) publication
1	statistical information,
2	adequate notification
4	percent by
5	code number
2	duties prescribed
1	product, each
3	(2) subject
123	united states,
99	united states.
1	section) an
1	cohort. 
2	import, or
5	obligation for
2	transportation, which
1	circuit. (b)
2	law, following
2	substantiate such
2	available, for
1	year concerned,
1	standards, requirements,
1	orphan drug
2	library of
1	government to,
1	practice until
1	601, 52
3	secretary fails
5	infringement and
1	providers through
1	(iv) provide
1	existing cavity
14	filed by
2	destroy markets
2	advisory committees.
1	signs a
1	(excluding expenses)
1	commodity (including
1	per submission
1	feed, information
3	segregation, and
5	offense punishable
1	provisions, by
1	order require;
1	rule any
3	events or
2	committed, such
1	rule and
1	reviewing notifications
17	investigational animal
1	technologies; (b)
1	alkenyl, whether
1	production by
2	examine such
1	classes. 
36	paragraph (3),
10	paragraph (3).
2	coordinates the
1	however, in
1	bad faith,
1	administration involved
2	food, when
1	ris-based activities
1	however, if
1	done while
9	hospital or
1	(iii); (ii)
1	revert to
505	 (2)
1	submit copies
1	activity recognized
6	paragraph (3);
1	extent feasible
8	sell, transport,
1	 $268,443
2	decision, in
1	(1) reviewthe
1	(k) relation
1	administration inspections
2	extent appropriate
1	promotes the
1	publish for
1	sector. (d)
6	(a); (c)
1	person, provided
2	medications. 
3	supplements with
1	effectively disseminated.
1	successful programs
4	expenses, shall
1	title prior
1	withdrawn under
1	(l) salable
2	subsequent offense
7	remainder of
1	one variety,
1	buyer and
2	territory, shall
7	(2) that
1	(ii) required
6	recognized therapeutic
1	360j(g)(4) of
1	reserves within
1	348, 360b,
1	officials; or
2	exercise concurrent
1	rule the
1	attitude tracking
3	homogeneous case,
1	previous month
1	misleading marking
1	received; (d)
2	reports; required
1	standardsthe secretary
1	expenses and
2	premises (a)
1	necessary each
1	changes except
1	states. oaths
1	indexing based
1	patients; and
1	number, (b)
1	records where
80	262 of
1	ii is
3	application licensed
2	wholesale distributors;
1	offender, deferred
1	data tabulations
1	demographic composition
1	not, except
2	data obtained
1	budget recommendations,
2	preserved by
1	appropriate enforcement
7	applicable law
1	frame from
1	societies, voluntary
4	reflected in
1	511, as
1	grants such
2	unknown; and
1	(e) recall
1	triggers described
2	sunscreen monograph
1	compounded; (vi)
1	medically underserved
2	31. (e)
2	fahrenheit, as
1	situational awareness;
1	directorin carrying
2	matters in
2	parts have
2	affording an
1	1938, (ch.
1	formerly 357,
1	(f) rules
1	136a(c)(5)] on
2	construction, components,
1	resolution the
4	geographic areas
1	360b(a)(4), 360b(b)(2),
2	purchased under
1	territory and
1	section 352(j),
8	person (other
1	foods imported
1	batch, or
1	timetable required
1	versus superiority
1	seq.]), and
1	submitted applications
1	(4) document
1	hydriodic acid.
3	listed drug;
1	smoke, smokefree,
4	country that
4	different withdrawal
2	contain detailed
1	consistently grant
1	seller who
1	part owner
1	pharmacists, but
1	dependence, including
1	administration electronic
1	listed drug)
1	sold a
2	submits evidence
3	term major
8	listed drug,
2	warning notice
1	homogeneous case;
1	proceeding with
3	food product.
3	profession and
1	1932 (d.c.
19	administrator determines
1	(a) assistance
1	parte and
2	(iii) by
2	debilitating disease
1	(a) certification
9	anabolic steroid
1	detection goalimprove
1	report confirmed
5	(iii) be
2	libel cases
1	grants to,
1	inspections has
1	(b) production
1	determine, after
2	traceable to
1	including persons
2	approvable and
1	10101 of
1	subparagraph (b)(i);
2	(5) past
1	request following
1	designation; exempted
6	presenting the
1	subparagraph (b)(i).
1	reimbursed through
1	missions or
3	(2) inflation
1	states dealing
13	2012. 
19	act [7
1	applications involving
1	act [5
5	4, 1923,
1	property; (b)
6	requiring inspection
1	including dispensing
2	2013 toward
9	less often
4	mitigation of
53	person is
1	barrier that
1	summary to
2	authority, a
2	tag, label,
1	1114. repealed.
2	places and
21	person in
1	requiring training
1	(ii)definitions.in this
1	entities such
8	person if
1	domestic manufacturers
1	section 387e(e)
1	corporation adversely
1	approval. authority
1	353(e)(3) of
1	subsection (d)(2)(b).
2	(b)(2)(a) (in
2	disclose information
1	ingredients if
22	good cause
1	duty 
1	675, 707,
1	outbreak means
14	ingredients in
2	product, irrespective
12	ingredients is
1	question. in
1	(b) chief
1	order applies.
1	became final)
1	practices designed
1	2004; (8)
1	inclusive, of
1	section 10101
3	business, the
1	contract, loan,
1	files, abbreviated
1	commission by
1	(ii) 5
1	demonstration projects,
1	exporting, may
1	mechanism by
1	compounding, packaging,
1	end, he
6	manufacturers that
5	adoption of
1	year. notwithstanding
4	acid diethylamide
2	action involving
3	secretary inspected
3	label required
12	term eligible
1	provisions becoming
4	trade in
5	made applicable
1	programin carrying
1	may, not
2	unincorporated association
1	handlers and
1	contact information,
1	enforcement entities
1	fat: gm
1	dru-related crime
1	trials a
4	paragraph (5)
7	provided further,
1	675, 738,
8	ground that
1	3433. disclosure
2	detection methods
2	utilize existing
2	hold) if
1	(1)(b)(i), a
1	(including rapid
2	foreign purchaser,
3	contracts the
1	necessary, guidance
4	human consumption
1	(a)(4)(a) or
1	entity does
1	trafficker and
1	subsectors, including
2	fee collection
1	thereof contained
1	scientific, public
9	clause is
1	devices into
1	(b)(2)(b)(iii), (b)(3)(a),
3	technical achievability
1	sales package
2	1994 (public
1	mist; or
5	development organization
1	(c) emergency
1	individuals involved
1	section) if,
1	seal, which
1	appendix to
5	renewal of
10	online pharmacy
1	establishments conducted
2	supplements and
2	practicable through
1	(a) completes
1	section amending
4	(q) the
7	claims the
1	262]. (b)
1	(34) or
7	meetings 
1	damage suffered
1	assistance on
2	basis a
1	(i) integrating
1	local authorities.
1	alternatives, to
1	assurance, including
1	territory, political
3	serve on
2	thereof by
2	(b) terms
1	renewal process
1	establish multiple
2	clauses (ii),
9	section 343(w)
3	recordkeeping or
2	products, to
1	represented on
1	1702(a) of
1	considered adul-written
1	(1). (j)
1	possible but
3	(b) whether
2	facilities, which
1	revise, as
20	drug use
1	products otherwise
1	central or
1	administration means
1	(who is
1	agrees that
2	expired; (bb)
1	c[10]h[14]n[2], including
5	offices of
1	wholesale drug
2	355(a) of
1	director takes
1	5, on
1	project, may
1	343(j) of
1	reduced fee
4	shall contract
1	completion dates
1	feedback letter
2	ch. 1357,
1	procedures elected
1	documents, the
1	teaching or
1	upon exporters
6	provide notice
3	section 353(g)
1	relinquishing of
3	shall allow
1	peritoneal dialysis
5	sections 360d
3	if, at
5	research to
1	fruit juice,
1	november 3,
1	preparation; and
1	(b)), exceeds
1	cargo entered
1	standing; or
1	
 871.
1	$263,180 
1	6103(a) of
3	expire, or
1	clear a
1	anatomic characteristic
1	also require
1	imprisonment. (feb.
1	comparative national
2	representative being
1	facilitate reviews
1	nonliquefied, or
1	endpoint to
1	use; (f)
1	secretarythe secretary
1	compendium. (c)
1	statementsthe interpretive
1	ginseng dietary
1	(d)(3). written
1	maintains status
1	(e) remedies
1	logbook), except
4	partial waiver,
2	(2)(b) relates
1	make onsite
1	shall survive
1	laboratory analyses;
1	(1) metal,
1	(b)(3)(d). (f)
2	audits. 
1	(3), for
2	populations such
1	(f) false
1	schools served
3	hours, after
1	profits on
1	academic experts,
4	profits or
1	title) can
3	documents 
1	store a
2	identical with,
1	enantiomers 
6	academic experts;
2	pharmacies which
1	information disclosure
1	act with
1	commodity, or
3	if, before
1	illicit drugs;
3	added substance,
1	detriment identified
2	registrant an
1	paper, document,
2	paragraph, including
1	about, a
1	particular communication
1	(a) relate
2	years, nor
1	electronic logbook,
1	label as
3	dispositioned; (ii)
1	emerging medical
1	plans that
1	title proposing
1	new staff,
30	due to
2	functions as
1	announcements. before
1	paragraph against
1	simulates, or
1	one dtc
2	held as
1	steroid. (d)
2	(1) when
1	which, it
1	thereto) intended
3	evaluation 
1	(sr18 and
1	(c) inclusion
1	administration approval
1	researc-based, lon-range,
4	rate, for
31	effect under
5	treasury. 
5	payment shall
1	said purpose;
1	1992, does
1	them; and
6	safety; and
1	advertisement disseminated
1	efficient flow
2	limitations in
1	i-person or
1	injunction authorities
1	substantiation of
22	order and
1	quarter in
1	comparative claims
1	dirty egg
8	transported in
3	rulemaking procedures
12	held at
3	current status
2	appropriated, out
3	(4) exemption
1	penalty between
1	u.s.c. 19011906);
5	practice, and
2	meeting, the
1	meets appropriate
1	wherein the
3	promotion of,
18	duly designated
3	safety surveillance
1	order any
1	centers. after
1	common indicators
5	state 
3	additional compensation
1	section 802(39)(a)
1	(3) assisted
30	(b), the
1	conviction, or
3	impracticable or
1	distributor by
1	(d) discussions
3	proposed labeling;
1	may possess)
1	encourage, to
1	entitled, an
1	
 360ff1.
1	furnished owner
1	means sweet
1	soundness of
1	processthe consultation
111	engaged in
1	chemical applied
1	recordkeeping, records
1	practice upon
1	commercial carrier;
1	factors in
1	timely postmarket
1	marketed devices
1	mortality associated
1	component thereof.
1	(c) incorporates
7	children and
1	2011, complete
1	(f) qualified
2	housing authority,
1	preclude requests
8	prior to,
3	1705 of
1	foodborne contaminants.
1	classrooms and
4	added thereto
1	otherwise effect
2	liability similar
1	means, subject
1	private agencies
1	children any
1	review, adulteration,
1	(vi) does
1	timely basis,
1	served is
1	finalize guidance
1	section 5703(b)[2]
1	agency will
10	355a of
4	action and
1	breakthrough designations
1	appropriate, age,
3	possession, distribution,
1	basis regarding
1	1953, shall
1	proposed labeling.
1	section preempts
1	border, and
3	covered under
1	industries, consumer
1	information becomes
4	(d); or
9	served in
1	accounting to
9	federal register;
1	(a)[1] not
5	impracticable to
1	section 848
1	two sentences
5	suggesting that
1	website with
2	areas affected
1	year 1991,
1	30, 1975.
6	section 382
2	due not
1	track and,
1	(2) dextromethorphan
7	notice as
1	child care
2	(4), and
7	federal register.
1	granted or
17	federal register,
2	sanctions pursuant
1	amendment; revocation
1	(1) actionsfor
1	commander in
4	applicable circumstances
1	exist. the
1	available, publish
5	accept a
3	person lawfully
4	agents to
2	toward expediting
1	imports food
2	tests for
1	misbranding prohibition;
1	31 percent
1	states regarding
1	situations as
1	measured earlier
3	market because
1	(n) review
10	waive the
1	recipients; and
2	affecting, modifying,
1	groups often
1	radiopharmaceuticals. 
1	may immediately
1	evaluated as
1	prescription the
1	plan, would
1	manufacture, planting,
1	rule, by
2	establishing conditions
1	(a) creative
1	regulation requires;
1	dietary problem,
1	produce, one
2	writing, which
8	forfeited to
1	regarding methamphetamine
1	suspending such
1	otherwise) that
3	term director
1	regulation grant
1	shall order,
5	shall amend
1	exportation, manufacturing,
2	(2) limitationthe
1	voluntary recall,
7	procedure in
7	one such
1	sufficient space
1	(and exempt
1	item (aa),
1	possession a
2	payable. (3)
1	generalthe director
1	pos-hearing recall
3	health officials
1	tracking to
4	record or
1	amended july
2	determination may
1	additional standards
18	supplemental application
1	medically appropriate,
3	business the
1	medically appropriate)
2	(1), to
1	phenylpropanolamine purchased;
1	point methodology,
3	20. 
1	relief standard
1	household survey
2	affected agency
3	official standards
1	shortages of
1	negative impact
1	expert, as
2	whether produced
1	state laws;
1	(g)(4). 
1	361(a) or
2	control. if
1	use associated
1	actions that
1	assess bioavailability
1	submitting separate
2	(c) final
2	duration; pending
1	healt-related purposes,
2	necessary, including
3	maintain for
2	(1) work
1	panels opinion
8	(a) issue
2	certificate; (2)
3	361(a) of
1	addiction. 
1	package insert,
1	item (aa);
1	products consumed
1	tobacco; (e)
8	552(b)(4) of
1	cosmetic condemned
2	fish described
2	engages the
5	health services
74	 (g)
1	relevant science,
1	(3) fees
1	42), the
3	age who
1	(ii) standard
1	secretary established
5	information, the
1	human environment;
1	processes, pathologic
1	fora. (4)
15	must be
1	evaluations which
2	quarantine laws
1	matter expertise
1	(d) ensure
1	increased fee
1	110 of
2	entitythe term
1	secretary establishes
1	islands. 
3	materially related
1	team throughout
1	water provided
1	shor-term and
8	control budget
1	889. production
1	duplication in
1	known; and
1	revoked 
1	activities exclusively
2	section 360i(a)
2	360b(j), or
1	(f) drop
2	subparagraph (11)
1	(ii) complies
1	penalties provided
1	awareness of
1	(5) and
3	proceeding against,
1	strategies, training
6	may receive
1	(4) reprogramming
2	subchapter; (ii)
1	expedited and
1	additional actions
1	agriculture, at
1	agriculture, as
3	shall solicit
2	one applicant,
1	research; (e)
2	period applicable
4	2011. 
4	determine 
2	commingling of
1	(ii) encourage
2	microorganisms to
1	package configuration)
1	expedited under
1	order together
8	audit agent
2	information resulting
1	rejection not
1	
 350a.
1	(2) increased
2	establishmentsin carrying
1	letter, unless
1	machines, the
1	holding, distribution,
1	strength; (iv)
2	eggs under
1	(b) prehearing
2	major species
1	(5) allocation
1	protocol not
3	isomers whenever
1	1521. findingscongress
2	committee may
1	reanalyze the
3	pharmacological action
1	known. (3)
5	360d and
1	another drug
2	use whether
1	(2) activitiesafter
3	years, to
23	general in
1	discouraging the
1	employment because
12	general if
1	products; (6)
2	quotas the
1	legal authorities,
2	pathogens described
1	contains (i)
1	sel-generated paper,
1	feed) is
1	expertise the
14	general is
1	959 of
1	value furnished
1	
 860a.
1	inadmissible under
1	section 552(a)
3	prescribing, amending,
2	year. (4)
1	distributor transfers
4	tobacco; and
1	addressing chemical,
2	(b) requirements
1	recognized susceptibility
2	year at
2	decision or
1	level greater
1	services. amounts
2	obtained for
12	decision on
1	imported as
3	prevent adulteration
15	permitted by
1	drugs, listed
1	violated a
18	decision of
1	(e) licensing
1	federal sponsorship
3	substances import
2	synthetic or
1	department and
5	section 554
1	drug establishment;
1	1996)). (4)
1	recordkeeping relating
2	person referred
24	section 552
6	section 553
3	contain information
1	299b1 of
7	circumstances shall
10	year 2018.
1	federal officials,
7	year 2018,
1	also result
1	cure a
1	conduct additional
1	1204; amended
1	establishment preparing
2	belief that
1	(viii) -penty--[-(-methoxynaphthoyl)]indole
1	year 2018;
4	64 stat.
1	proposed advertising
2	frozen, or
1	substantial amount
2	(unless such
7	limits and
8	45 calendar
2	establish, for
2	supplied at
2	foreign factory,
1	intact and
2	antimicrobial resistance).
1	data submission
1	(a) techniques,
2	which, or
21	activities described
1	enforcement authorities;
1	various communities.
1	which, on
1	1 [part],
1	opening or
1	nighttime as
1	evidence, such
2	subclause may,
1	subsequent export
1	involving conduct
1	service, and
1	significant harmful
1	eradicated in
5	practices that
1	improving foodborne
1	15. repealed.
3	held and
1	section, other
1	produced shall
1	(21) the
3	draft or
1	675, 409,
4	drug establishments
2	sheep carcasses,
2	schedule v,
1	product, then
1	flounder, or
1	receipts, and
1	received clearance
1	form prescribed
1	60.0. 
1	(4) advanced
1	obtained, expedited,
1	regulatory efforts
1	compliance budget),
1	importer taking
1	preempt any
2	(bb) an
2	international relations
1	member before
2	food recalls,
1	thereunder. (4)
14	applies to
2	(within the
2	safely used;
1	conferences to
1	transactions both
2	amateur athlete
1	(f) fees
1	(4) allocation
1	(1) 3
1	(19 u.s.c.
1	secretary revises
1	safely used.
3	safely used,
1	(iii) labeling
5	act (15
1	(iii) issue
1	(c) detect
1	cream, for
1	provided), transaction
1	item, as
1	participants the
1	maximum term
2	person, $250,000
10	program shall
1	year, increased
2	consisted in
2	subsection, expire
1	reclassifying a
13	poultry product
1	(3) will
1	food harvested.
1	campaign has
1	methodology based
2	falsely purports
1	device, treatment
1	(a)(1)(c), excluding
1	activities) with
5	abuse in
1	ensuring enforceable
33	(1) a
2	had, or
4	moved by
5	plan shall
3	(iv) implementing
1	residue. in
1	saccharin. (z)
1	(g) at
1	petition, if
1	interoperability with
1	application resulted
1	application are
1	guidance, and
1	experience, including
3	2011 through
1	threats; (19)
1	method described
1	(2) national
1	written response;
4	federal laws
1	(c) custody
2	(ii) within
2	altering of
1	thereafter register
1	made if
1	approval should
1	amountsthe applicable
1	certain medical
1	reported; notice
37	made in
1	product listeach
1	clove, cinnamon,
2	gamma butyrolactone
2	psychiatric association,
1	perception; (e)
1	whose physical,
1	voluntary. nothing
1	requirements requirements
1	programs; prioritythe
3	organizations to
3	itemization of
1	satisfied; (d)
2	partnerships for
4	regulation prescribing,
27	information regarding
1	3 requests
20	device, and
1	pesticidal purpose
2	conditions, as
1	early head
2	custom basis,
1	stimulate the
18	drug sponsor
1	including working
1	twent-one (a)
1	be. (2)
1	agreement. 
1	documents referred
1	number which
1	pay biosimilar
1	delegation authority
1	subsequent animal
1	subsection. all
2	sentence) shall
1	(h) teens
1	methylphenidate. 
2	1, 1997.
1	dispositions or
1	acts. however,
1	
 962.
1	wel-equipped and
3	on-third shall
1	manufacturer unless
1	remedies in
3	affiliate submits
2	use (a)
3	section 360c(b)
1	costs. (d)
1	small enterprises;
5	studies. 
1	
 387g.
1	practicable procedures
2	prospective surveillance
1	oversight in
5	affiliate is
1	imparting color
2	seizure by
64	1 year
3	processing, preparing,
2	incapacity; or
1	license 
1	seller meeting
1	prevent united
1	teleconference, 30
2	identifier, for
2	production, if
29	determine the
1	(i) 1;
1	notice ends,
1	uncertainties, risks,
1	subject all
1	year, except
1	practitioner are
1	injury. (2)
1	making widely
7	sponsor and
1	canada engaged
1	term check
1	v that
1	(f) definitionsin
1	comments of
2	ii. (

1	and/or cream:
1	academic institutions,
37	comments on
2	youth center,
1	(c) prominence
1	board aircraftit
1	acquisition. 
1	practitioners, the
1	confectionery, and
1	(i); (7)
2	report, including
2	academic institutions;
1	strengthening rehabilitation
1	informationthe data
1	of-labeled indications,
1	agriculture designated
1	1012, as
1	(e) accessibility
1	packers and
1	(f) application
4	accounting of
1	prescribed are,
1	ingredient submitted
1	written; and
1	applications if
4	minimizing the
1	chemistry (iupac).
3	65 stat.
2	protection, shall
1	8th par.,
1	monograph (a)
1	proposed tolerance;
1	4402] 
1	area after
1	definitions of
1	organ, or
4	letter shall
3	effective enforcement
2	inspections closing
1	format 
1	(4) through
1	31, 2013,
3	human growth
1	505b, as
22	later of
19	 (l)
2	article described
1	things, the
8	volume of
42	food that
1	shall rule
1	request upon
1	indian programs
1	causes food
1	similarly filed.
2	360eee1(a)(7) of
2	auditor. 
1	authorized changes
5	subparagraph and
1	agencies participating
1	(b) exploring
1	www.fda.gov/medwatch and
1	supports his
1	therapy includes
1	advertising industry
1	467d. administration
1	collect data
16	patient and
13	property described
2	aid to
16	packer, or
2	whether existing
2	securely sealed
1	financial responsibility
1	without additional
1	employee, including
3	$250,000, or
10	notwithstanding paragraph
2	campaign were
1	fellowships, whether
1	law so
1	enantiomer that
1	orders have
2	seeking an
1	applicable industry
1	1998 federal
10	requirements: 
2	designation, the
1	(3) basis
1	radiation, which
1	entity conducting
3	voucher may
6	misbranded or
20	operating reserve
2	investigating potential
2	dispensed, or
1	year 2011,
1	level 
7	barter, exchange,
5	entities under
8	license issued
1	team that
1	manufacturer, be
6	extent as
1	general so
11	increases in
6	naturally inedible
3	prescribes as,
1	(c)(2) before
1	whole, include
1	intrastate activities;
1	assurances to
1	export without
1	mainland by
5	(3) public
1	(4) award
1	fined as
1	ascertain any
3	intentionally tortious
2	report has
3	regulations effective
2	reflect developments
4	paragraph of
2	$8,000,000 if
1	respectively. (b)
2	includes each
1	specifications of
1	misdemeanor and
6	hearing by
1	past, rising
2	appropriate, not
12	paragraph or
1	trial, an
1	(b) outlines
4	devices filed
1	(d) contemporary
1	report had
1	
 1151
2	1947 [50
1	compounding from
5	isomers, or
1	soil. 
1	(2)) with
1	duty provided
1	(1) good
2	829(e) of
7	minimum, includes
1	authorization (including
1	health consequences;
2	information referenced
1	consumer information
1	consent required
4	safe, the
1	director, including
1	observed a
1	implemented. 
1	withdrawn; and
1	requirement essential
1	(a) lif-supporting;
1	cancer causing
1	(6)affiliate.for purposes
11	product directly
4	detailed statement
1	(3) recommendations
3	optical isomers
1	identifying bulk
4	devices classified
3	listed by
2	execute and
7	enforcement activities
1	biomarkerthe term
1	approved a
1	time deems
1	(8) an
1	country (referred
1	5. proceedings
1	administration, except
1	information. paragraph
1	diluents, of
1	requirement facilities
1	writes upon
1	materials, conditions
9	ingredient is
1	allowing safe
1	order determines
3	provide assistance
1	affairsthe term
1	(d) facsimile
1	market names
13	information shall
1	schedule, dosage
1	opinions under
1	imprisoned as
1	control officials
1	propose one
4	shall proceed
2	individual schools
5	suspended, or
2	ingredient in
1	sales means
2	18-day supplement,
6	involving 
1	operating reserves.
1	forfeiture event,
6	operating reserves,
1	issued, accepted,
1	issued, allegedly
2	opium convention
1	(ii) indicating
1	logo, registered
1	(m) authority
5	plan. 
1	except by
1	ergotamine and
4	thereof and
1	reinstated. the
3	government that
3	agencies have
1	675, 746,
1	exporter involved,
1	of, devices
1	illness. (e)
6	 (vi)
1	hold foods
1	(ii) data
1	termination shall
1	decedents property
1	poses an
1	files no
1	threat notwithstanding
1	families the
1	(6) limitation
3	drug labeling
4	radiation, unless
5	activities by
3	laws, regulations,
3	substances listed
1	development agendas;
4	apply the
1	accepts such
5	amenable species,
2	intent, a
4	shall possess
3	animal health,
2	lower fee
1	marketed devices.
2	100 feet
2	studies requirement
6	document shall
3	control point
2	regulation activities.
1	31, 1997)
1	rehabilitate victims
1	considered labeling
1	denied or
1	local planning
1	facility conducts
2	surveillance, outbreak
4	(1) subject
1	findings is
1	investigation required
1	(bb) has
1	coast of
1	(jwh019); (vi)
2	experts acceptable
1	associated type
3	technology systems
1	(2) timingnot
1	regulations finalized
1	(2) timing;
1	accurate; (b)
1	retail pharmacy;
2	reclassification from
1	reached, or
1	independent appeal
22	termination of
3	determined using
1	(iii) procedures
1	scientific evidencenot
1	population, the
2	on-half years,
1	pseudoephedrine, its
1	termination or
2	sponsor regarding
2	therapies, and
2	delivering the
1	(c) failure
1	provide consultation
2	331(jj) of
1	rehabilitation programs;
1	disputes concerning
1	chooses not
1	(4) limited
1	advanced drug
1	single brand;
2	(b) set
1	(i) purchased
1	fully implemented,
3	drug, (b)
1	standards, premarket
1	selling an
1	procedures developed
2	pediatric indication
1	rehabilitation programs.
1	food purchased
3	different sectors
1	chapter; the
1	schedules: 
4	consultative audit
1	agency prior
1	cocaine and
1	restriction under
1	200b. repealed.
1	136p) for
1	protest, not
5	projects to
1	corporation; or
1	(ii) requests
1	operating characteristics
1	-year period;
1	new producersevery
1	storing food
2	december 23,
1	bears 
1	omitted (b)
1	residue, such
1	interpret such
1	prescribe this
1	staggered terms
1	report disclaimers
1	(iv) reallocations
1	indicated. (ii)
1	protocol opportunity
1	1996; (ii)
1	(a)authorized fees
1	675, 901,
1	information location
1	make operating
1	reasonable allowance
1	purposes without
6	permitted, and
2	who, in
2	regarding successful
2	drugs may,
1	provision an
3	expectation of
1	recordkeeping, testing,
1	pharmacies, and
1	(2)(a); or
1	certification method
3	(1); (3)
1	business may
1	lacking abuse
1	meeting means
1	established legal
2	becoming aware
1	otherwise responsible
1	biological responses
1	imported whose
1	(h) authorization
1	$1000 per
1	developing data
1	(i) generic
1	valid permit
1	nervous system;
6	specified period
5	qualifying pathogens
1	$2,500 or
1	purposes directly
2	secretary refusing
1	(a) distributes
1	proper. (mar.
1	entry order
1	(vii) maintain
1	present views,
3	inspection, if
1	years. (3)
1	(d)(3), (g),
4	may hold
1	orders the
2	committee process
2	207.3(a)(4) of
3	enforcement strategies
1	
 2206.
2	provided, or
1	initially introduce
1	produced, is
1	qualifying pathogen,
1	condemnation in
2	require, with
1	fresh and
1	exemption no
1	379k1. electronic
1	(a)(5)); and
1	reliance upon
2	drug, an
1	receives, packages,
1	paid and
12	drug, as
1	indirectly, from
2	methamphetamine in
1	wooden, acrylic,
1	establishment conducting
1	streamlining, where
1	destroy, repel,
6	change. 
4	toward the
2	recommendations shall
1	environmental oxygen
4	technology and
4	signal of
1	claimant means
1	(2) contenteach
1	(b) reimbursement
1	(b)(8). 
1	42). 
1	333, or
1	agreement as
1	contractors performing
4	permits or
1	methadon-intermediate, -cyan--dimethylamin-4,-diphenyl
1	(h) dissemination
1	practitioners a
1	defense, including
1	effectiveness based
1	(5) perform
1	(c) nitrous
1	manner; (3)
1	fairly evaluated,
1	condition who
2	random inspections
1	partially filled.
1	partially filled,
1	manufacturer. (3)
1	capabilities with
1	387a1(a) of
2	prescription in
1	entered: 
1	dru-related goals
1	recommendations relating
1	data, research
3	(iv) 
1	pesticide at
1	request. not
4	subsections (c)(3)(e)(ii)
11	panel shall
2	rulemaking and
1	use; contents;
7	liability of
1	chemicals producing
7	promptly to
3	substituted, wholly
2	guarantee of
2	liability on
2	effectiveness to
1	state intends
1	(a) catfish
3	modified to
1	
 379j31.
1	drugs. (2)
1	logbook his
1	created has
7	procedures set
1	alleged, sworn
2	synthesis: 
1	country have
1	(d), via
1	order, promptly
1	prescription if
1	combined. (e)
1	nutrient in
2	imported, transferred,
2	margarine at
12	later date
1	zika virus
1	handled do
2	period. (c)
2	claim, and
1	364. repealed.
1	forging, counterfeiting,
6	mental health
1	pharmacy site
1	2014 
2	multiple sources,
1	precedent: 
1	2009; (13)
2	379g(6) of
1	intended; the
3	regard for
1	preparing to
2	canned, corned,
3	sources and
1	adopt, alter,
1	foundation, any
2	health, acting
1	
 2108.
1	contract the
1	usesthe funds
3	expire upon
3	first day
1	identify public
1	(ff) the
1	available only
1	device. (xii)
1	data constitute
1	establish, or
3	occurred more
1	term first
1	(c) denial
2	years unless
2	regulatory rationale
6	secure facility,
1	project will
1	book by
1	patients only
3	plan on
1	generalupon initially
1	steroid has
1	consumers. unwholesome,
1	accreditation, as
6	may request,
2	govern the
1	may request.
8	1604(d) of
1	22.)
 

1	offenses. (b)
1	imported, and
1	purchase, sale,
1	weight classes
1	communities and
3	321(p) of
1	months from
1	copying. (mar.
1	receipts and
3	outsourcing facility;
1	yaws. (q)
3	otherwise provided,
1	prosecution; (c)
5	issues an
2	omission of
1	distributor, including
1	501, as
4	outsourcing facility.
1	assessment methodologies
6	outsourcing facility,
1	use. (iii)
1	stimulation. (v)
7	using any
1	otherwise qualify
1	seq.) shall
1	excluded pursuant
2	diverted, or
1	section 321(g)(1)
1	agencies. (xiii)
1	authorities, as
1	section. after
1	clause (vi)
20	(i) such
1	owner. 
1	(c) limits
1	tuberculin test
1	(e), respectively,
1	quality. 
1	1998, and
1	(c) preventive
1	university consortia,
1	term council
1	prevention, education,
2	staff to
2	approval was
3	event shall
2	identify new
6	penalties 
1	presentation, the
6	term process
1	fact by
1	
 674.
2	whole. 
3	cosmetic, and
1	suspension, revocation,
2	basis, as
1	discussion (a)
1	premix certifications
2	prescribe: (1)
1	scattering ultraviolet
6	use, by
1	relates solely
3	applicant, concerning
1	adequacy and
1	may consolidate
1	(8) encourage
9	sanitary conditions
1	kit, ingredient,
1	(5) has
1	136a. collection
1	cigarettethe term
1	guide setting
1	official use
1	pharmacies under
1	official government
12	change is
102	comply with
10	applicant from
1	depth of
1	paragraph; (6)
1	(9) surrogate
1	microfilm, tapes,
52	change in
2	drug into
1	shor-term goals.
1	communicate unwillingness
5	unduly burdensome
1	amenable species;
5	application, a
1	cream. the
2	exemption provided
1	419(5) of
3	based his
1	transportation safety
1	title). (11)
1	fee, not
1	formula, make
1	section 355f(a)
3	violation. 
1	year, so
1	information, can
1	packaged meat
1	farmers and
1	importers participating
1	between, by,
2	bioequivalence studies)
1	(c) proposed
3	product of,
1	(ii), such
1	useful data
2	operator thereof
1	whites, eggs
1	certain pos-february
1	begun; the
2	ch. 901,
1	concerning preventive
8	(a)(1) shall
1	(4) contrary
1	(ix) such
1	applications a
1	paraphernalia involved
1	effective response
8	90 calendar
1	section 360c(a)(3)(d)
2	including costs
1	foster greater
1	poisons, or
1	costs when
1	(g) 250.0
2	truthful and
1	imposed after
6	removed to
1	withdrawn prior
4	submissions from
2	(e) upon
2	parties, may
1	upon him.
1	(c), 52
1	methamphetamine laboratory
2	title, which
3	deferrals and
1	(2)(b)(i) or
3	distributes drugs
1	state petition
1	inspections otherwise
1	399b. office
1	(which area
2	regulation a
3	requests such
1	provided, or,
1	licensed professional
1	information. any
1	word consul
1	debar an
1	rico and
1	process agricultural
13	shown to
3	slaughter any
1	safety questions
1	27, 1970
1	residue if
1	systems standards.
1	(g) 40.0
4	conformity with,
643	fiscal year
1	convention. (c)
1	person obtaining
1	government sponsors
1	 (e)use
6	recommendations; (d)
17	submit an
2	i-kind contributions
4	relevant factors
1	stocks. production
1	(4) bufotenine.
1	may emphasize
2	prescribe conditions
1	section 355(i)[1]
1	applicationthe secretary
1	subparagraph (b)(iv)
2	syringe exchange
1	trial standards
2	countermeasure as
2	1974, and
2	class is
1	componentssuch term
1	appropriate actions
1	(1) determine
4	administration not
1	certain tobacco
1	submission based
10	proposes to
1	(3) generic
2	(d) small
1	herbal ingredient
1	devices if
1	881. forfeitures
2	full information
1	producersevery person
1	(3) remedy
1	adjustments for
1	species, inspection
4	devices in
1	importer found
3	establishments 
4	devices is
8	decision under
1	fines, to
1	21 -
1	(iii) congressional
1	(ii) annually
1	may terminate
1	security seizing
1	meet obligations
1	bass, flounder,
1	importation otherwise
1	article included
1	v by
1	regulatory issues,
1	compounds, and
4	meeting or
1	caution against
1	distribution system.
3	meeting on
1	nonconformance material
1	impleader under
3	congressional findings
41	used for
1	contamination; (b)
12	meeting of
1	generala manufacturer
1	appropriate action;
1	providing inspection
1	certain food.
3	353(g) of
3	submits such
1	transition ruleeach
1	b6 (pyridoxine)
1	695. payment
4	methodology or
1	certification process
1	physician, is
1	involved upon
2	wants to
1	hydroponic marijuana
1	reallocated to
6	substituted on
4	matters within
1	(2) evidence
3	species of
1	response, inspection,
2	person engages
5	optical isomers.
1	plan, together
17	drug with
2	(g) 60.0
1	distributors; (x)
2	director with
1	(2) chairman
1	(b) adjustment
3	american medical
1	appropriate quality
1	nonprofit, community
1	veterans benefit
1	shall docket
1	chemical: 
1	local situation,
3	upon removal
1	public nature
1	uninterrupted supply
3	extend such
2	isoquinoline alkaloids
1	surgery; and
2	employees in
2	business a
1	state, country,
2	often as
2	includes performance
1	states, allowing
1	columbia in
1	secretarial authority
1	person holding
1	subparagraphs (m)
3	supplemental nutrition
37	report on
4	costs other
1	investigational submissions:
2	actual or
2	standard costs
1	covered into
2	abetted, such
1	section. (june
2	(h) limitations
3	(4) limitation
2	application previously
1	negotiations relating
5	investigational submissions.
1	investigational submissions,
7	freedom of
2	concerning an
1	(b)(1)(a) in
1	qualified and
5	granted to
1	courts having
1	food shipments
4	issued thereunder
1	terrorist organizations.
1	purposes not
11	compensation for
3	combination thereof)
1	7, formerly
1	iii, 538,
13	times and
2	appear in
1	limitation subsection
4	applicant otherwise
1	section 841(b)(1)(b)
1	amount estimated
1	kilocalories. 
2	requirement specifically
1	571 of
2	fift-four months,
1	norms against
3	council. 
2	1040), and
2	security, a
1	respective staffs,
1	strategy, a
3	sponsor intends
1	appropriated or
1	regulations relating
1	records containing
9	television advertisement
1	(e) repackager
1	outstanding deficiencies
3	results and
6	chemical, food
1	generalsections 351(a)(2)(b),
1	product, deviations
1	test markets)
1	establishment identified
1	support surveillance,
1	premarket applications
1	(4) proceedings
2	(b). (e)
1	generated during
1	affiliate. 
1	health published
2	(ii) identifies
4	severity of
2	for, obtaining
1	(v)agreement with
3	number assigned
7	facility, as
1	doses of
2	excess amount
11	found by
2	destroyed if
17	provide that
1	otherwise identifying
17	reporting requirements
4	device so
1	inaction of
1	(b) proposed
1	pasteurized, condensed,
1	(f) specific
2	including racial
1	colors ground
1	reagent, or
25	(21 u.s.c.
1	education, shall
1	year 2002;
1	describes an
1	rule (a)
9	premarket application,
1	101, 67
2	premarket application.
1	regarding investigations
1	(e) hearing
11	times the
2	different than,
1	(c) media
1	images; and
1	secretary; exception
2	year 2002,
2	year 2002.
5	states after
1	industries. 
1	equivalence determinations.
2	facts material
5	differs from
1	legitimate purposes,
1	any, each
1	675, 564,
6	year involved.
1	secretary reports
1	(2) record
1	waivers for
1	returned thereto;
1	secretary. (h)
1	consistently stand
1	year involved:
1	critical to
1	training law
1	appropriate. such
2	secretary must
1	fairly be
2	title, with
1	shall sell
1	take place.
1	drug profits
1	(ii) furnishes
1	supplant funds
1	years, (b)
3	inclosed in
1	including investigation,
2	networks, as
1	(ii) high
3	completed not
1	only. (b)
1	administration relating
1	eradication aimed
1	exceed 80
1	monograph 
1	verification activities,
1	include complete
1	agenda of
1	(e) obligation
1	regulations). (5)
1	infrastructure protection
1	(v) shall
1	section 903
1	clandestine importation,
1	675, 411,
1	laboratories for
1	includes at
1	article condemned
1	support communities
2	matter or
2	operation, and
1	applicable; 
1	acceptance and
4	whether intended
1	(5) increases
1	key personnel.
1	individual being
7	(e) shall
2	reporting is
2	otherwise become
1	service activities
1	stated, the
1	detained (in
11	pesticide residues
3	transaction or
2	used a
6	knowledge that
2	receive information
2	required testing
2	effective shielding
11	efficacy of
1	565a, as
2	access. further,
2	vary based
1	data and,
9	(i). 
1	inventory or
1	body charged
1	individuals ability
3	change has
2	hardware is
1	general public,
1	
 1177.
4	inventory of
5	negotiations as
1	section 360e(d)(1)
9	identifier system
5	public a
1	participating federal
1	methamphetamine manufacturing
2	dispensed directly
1	health maintenance
1	copy to
5	therapeutic ingredient
1	dispensed. (b)
2	2011, that
1	
 360fff.
1	regarding assessments
3	fees notwithstanding
26	reduce the
1	products (such
1	dispensed, a
3	processing facility
1	improvements and
1	achievement resulting
1	centers, professional
3	secretary showing
2	partnership, association,
3	mortem inspection,
1	healthif, at
1	360e(f), 360i,
1	laboratories, laboratory
1	services; (2)
1	appropriations which
2	filed; or
1	product, from
1	current and
4	name so
4	foundation to
2	particulars of
4	class i,
1	-year and
13	term person
1	states who
1	(1) first
2	use personnel,
1	503c, formerly
1	similar to,
1	agencies detail
2	compound, manufacture,
3	held, and
1	262(k)(4) of
1	television advertising
2	country as
1	order whenever
1	term informal
1	adequate resources
1	exemptions; criteriain
1	state employees.
2	food allergens
1	(g). such
2	conspiracy any
1	seq.). (n)
1	federal level;
3	exhausted, (c)
1	narcotic drug;
1	results, nor
5	conducted to
1	hazard reasonably
1	preapproval inspection,
2	vasopressor; or
1	order applies
2	submitted 
1	requirement, relating
1	petition has
1	sale, movement,
7	met: 
2	increased from
3	statements as
3	submission required
1	(b) schedule
3	animal use
1	places it
1	reference a
1	claimant, was
2	prescription orders
1	describe each
1	business confidentiality
1	clause may
1	section 310.305
464	food and
1	(d) domestic
10	shall meet
1	potential need.
1	agriculture; and
1	lieu thereof;
1	prescription order.
1	fifty points
3	trade, to
4	homogenous case
1	forfeiture, and
1	found therein,
5	requirement not
24	request by
1	exhibits spontaneous
1	(which notice
1	intermediary used
1	indicated in
1	(i). (vi)
1	trials; (iv)
1	42); and
2	product sold,
2	paragraph the
1	patients symptoms,
1	(h) report
1	(5) evaluation
11	(aa) the
14	identified under
1	legal entity;
1	
 387n.
1	rule is
1	registry and
1	justice provision
1	renewal during
1	(d) one
3	viru-serum toxin
1	similar types
1	making amendments
1	(p), if
1	neonates, such
1	legal entity,
2	554 and
1	only, shall
1	effectiveness. (d)
1	marketed prior
1	(including native
1	partner, in
1	reconsider the
1	1993 and
2	suited under
2	1313, 58
1	communication relating
1	requirements by
7	interest, the
1	reported, the
1	annual hidta
8	federal employees
2	articles at
1	composition; standards
1	date, and
1	background, character,
1	convention, transferring
1	208. 
6	controlled by
1	(2) $20,000,000
2	351 or
8	determines necessary
1	stat. 271.)

15	certification under
1	publications which
1	involve pediatric
5	years for
16	court decides
1	paragraph. the
1	grounds specified
1	proposed and
2	flow of
3	execution by
25	351 of
1	court, or,
3	prescribe so
1	(c) waiver
1	countermeasure involved;
3	321 of
1	(i) authorized
1	panel chairperson,
9	thereof or
4	1059; renumbered
1	pharmaceuticals for
2	shall vest
1	petition means
5	seven and
2	exceeds one
1	(w) nitroethane.
5	(d) whether
2	document 
3	permits the
2	section during
4	finding with
2	analyses are
1	(3) denials
1	(11) appoint
1	refund all
2	article was,
1	business. (mar.
1	issuance 
1	point the
1	exchange 
4	may, on
1	(b)(2)(b) may
1	(1)(a)(i)) with
1	was, with
1	necessary with
1	without clear
1	conditions that,
1	recommend strategies
1	675, 532,
2	commission as
1	 100.0.
1	approved, it
1	liable; scope
1	shel-life or
1	cases; (d)
4	350j of
10	adjudicated in
1	immunity of
1	designations concerning
4	regulation, standard,
4	(including underlying
1	inventory to
8	criteria set
245	health and
1	
 856.
1	use aggressively
5	wherein such
1	promptly undertake
1	consider scientific
2	postapproval safety
2	modification would
2	(iv) statutory
1	dimepheptanol. (18)
1	distributors; fees;
2	standards committee
1	product, for
6	committee 
1	records. such
2	tribal organization
1	$477,000,000. (e)
1	(iii) product
4	resources for
19	human food,
2	abetting, such
9	application a
1	
 461.
1	health laboratory
1	register, any
14	infants and
2	secretary, who
1	recognized, but
3	(3) make
1	353(b)]. such
1	(d) applicationthis
1	international trafficking
1	agencies, develop
1	person, government,
1	
 2011.
1	3, 37
1	labeling exemptions
6	general has
1	inspected meets
1	559, 3,
1	medicine, which
1	intent regarding
1	minimal strategyfor
1	met. (2)
1	evidence, the
2	(1) prepare
1	reported disclosed
8	imported under
1	petition. the
1	(13); and
3	exporter may
1	355(n) of
2	congress has
1	(p) report
1	675, 506e,
1	soil and
37	subsection (a)(1)
1	(5) studies
1	doses; or
6	detach, deface,
2	undertaking supplied
1	including product
1	programs; 
1	conducts one
1	supporting information;
1	rapid detection,
7	5 and
1	dissenter. 
9	association, or
1	best protects
1	initiative. (3)
1	amount required
1	misdemeanors; felonies:
1	data list
1	(with each
1	contained ma-made
69	activities of
1	transaction; (iii)
7	proceedings to
2	segregated pending
1	2007, submits
1	agreement; (b)
6	persons or
1	section 356c(c)
1	fundseach local
3	(vi) a
1	partnerthe term
1	committee. (e)
1	custody, advertising,
1	(k) bar
1	appropriate (including
1	undertaken 
3	distributor has
12	taken to
4	persons of
3	reports described
3	shall, during
1	affiliate, an
1	reporting, or
1	unique pathology
1	reinspection the
2	(1) would
1	intentionally uses
1	2009 and
2	retailer may
4	control points
1	one clinical
2	animals, taking
1	education progra-sponsored
1	gross deception
1	fostering medical
2	commission who
2	completing such
1	issue only
4	term facility
22	extent practicable,
52	title 21,
2	property comprising
2	used therein
1	applicant proposes
2	(e) drug
1	address that
1	patches, nicotine
1	state laboratories,
1	sanctions shall
1	labeling must
1	said product
3	substantial work
1	policies; transfer
2	offers to
1	(5). in
1	768) butter
1	(including rape),
3	authorized prior
5	use among
1	publication, and
1	milk except
1	assessments; (iii)
1	bodily harm,
1	title (1)
3	public, may
1	nontobacco users,
2	fact and
3	diagnosis of
4	committee regarding
4	criteria, the
2	subsection affects
1	prescribes, recommends,
3	times upon
1	 manganese
1	reinspect said
2	(1)(b) if
2	product injurious
1	investigations by
1	description and
1	discontinued). (ii)
1	
 1714.
8	foreign countries
1	sliding boards,
1	(1)(b) is
3	including their
1	wholesale, shall
10	drug when
1	recognized interpretive
1	(3) updated
1	sign. such
1	youths smoking
33	applicant shall
2	outreach, and
1	(d) modifications
2	veterinarian in
1	institution, or
1	(b) coalition
2	subsection (n)(1)(g),
1	approaches that
1	government during
3	allowing the
1	reason such
1	lawfully sold
4	title. (5)
1	party on
1	procured the
1	fahrenheit. (feb.
1	graphic that
1	voucher, if
1	october 1996.
1	conducted, or
1	deemed acts
1	silicone) may
1	regulation establish.
1	(a) office;
1	regulation establish,
1	pos-hearing corrective
1	fentanyl. (7)
2	(b) licensure
1	than, directly
1	coupon, in
1	serious risksthe
2	meat for
1	(a) on-third
1	audits assessing
1	(1) contact
1	exported. (mar.
1	(d) development
1	modification; hearing;
1	oaths, examine
1	space on
1	subsection (c)(4).
1	leaf through
1	linguistic and
9	reported to
1	formerly 19th
1	regulation consistent
1	e. coli
1	services (in
1	votes to
4	ingredients, or
1	331(b), (c)
3	fined a
1	withdraw inspection
21	drug which
2	convention, the
1	exist concerning
1	codex maximum
2	residue standards
1	reach agreement,
1	active commercial
2	measures deemed
1	emergency, that
4	675, 1002(a),
1	purchases in
1	risk productsexcept
1	defense capacity
1	pay costs
1	false labeling
3	attained the
1	chemical activities.
2	natural person
1	health consequence
3	requesting such
2	(a) product
1	central counte-drug
1	timeline to
1	commitment that
1	basis, the
2	fee limit
1	(j) 
1	revoked or
5	nervous system
1	(i) -(-hydroxycyclohexyl)phenol
1	device if,
6	processing egg
1	request) 
1	country. abuse
3	handled by
7	substances which
3	subsections (b),
23	discretion of
3	inspection as
5	inspection at
2	jurisdiction, for
5	statistical information
1	prescription requirements;
1	production. 
1	locally collected
9	received within
1	proposal for
1	imported and
1	risk based
1	company which
1	resistance task
1	establishment (including
6	limits of
20	penalty under
11	within any
3	noncontiguous areas
1	damages should
111	related to
2	council determines
16	established for
1	$65,000,000 for
6	year during
1	definitions, licenses,
3	responsibly be
1	threats in
2	shortages that
2	establish criteria
9	(a) unless
2	reimbursable basis
1	data element
1	1 type
2	salt, compound,
2	research involving
2	recommending classification
3	either (i)
1	20), patient
14	revoking a
1	title not
2	territorial jurisdiction
1	county with
1	dissemination. (9)
13	regenerative advanced
1	(g) 35.0
1	pending shall,
1	511; amended
1	interagency transfer,
1	knowingly distributing
2	allocate resources
1	individual purchaserseach
32	investigational use
2	updated information)
1	extent. (iv)
2	report no
1	estrogen. 
1	handlers; inspection
5	will enable
1	fees actually
1	regularly, but
1	public, of
2	food. (3)
4	imposed in
1	standards recognized,
1	synthesized or
1	sentence prohibits
1	41) to
2	correct the
1	imposed if
1	seal under
1	technology; (2)
1	form describing
1	term laboratory
1	haccp 
1	directive or
1	investigation activities;
1	grants by
2	together are
1	
 387l.
1	defect. in
1	printing, and
1	deficiencies and
1	title. (3)mail
1	675, 741,
2	directly by
2	(d) coordinate
1	pharmacopoeia, the
1	(user fee)
1	animal observations
1	chain with
2	ascertaining whether
1	revenue amountsthe
1	product an
4	expert review
1	term request
1	include validated
1	identifies major
1	cancer that
1	(b) componentsthe
1	
 2223.
5	title applicable
1	examined as
4	applications pending
1	legitimate business,
1	section 202(a)
1	(b)(2) 
9	made. 
1	abetting, a
4	completed, or
18	product at
1	(3) glutethimide.
26	product as
1	subsection (k)(4)
1	(aa), shall
3	term compounded
1	adulteration prior
1	3501 et
1	particular ingredient.
1	abuse, or
1	extent available
1	public health),
3	acted in
2	articles inspection
1	illicit growth
5	accessible manner,
1	premarket submissions,
2	iv, and
1	(i), except
1	identifying drug
1	harmful. (mar.
1	unconstitutional, or
1	demonstrate good
2	requirement, related
1	disposal plans;
1	country. (4)
2	establishment, after
1	processed, packaged,
18	general subject
118	will be
1	revise and
1	consignee as
1	carry into
1	upon stating
6	clearly identified
1	exercises of
1	3551(g)(2)(d) of
1	defendant, nor
1	preparing, freezing,
1	persons participation
1	qualifications; waiver
1	(3) procedures
1	(c) proceeding
76	shall make
4	three years,
1	(q) filovirus
2	prescribe specific
1	(c) internet
1	revise any
5	$10,000,000 if
1	_____________. i
1	summaries to
1	notice) that
2	hazardous electronic
1	informing them
1	food certified
9	insanitary conditions
1	indexed product.
1	furethidine. (25)
28	reports to
1	production quota
1	become too
4	discontinuance or
1	written receipt
1	
 360ddd1.
1	proposed; and
10	chemical product
15	grants and
1	involve one
12	national security
2	vitiate the
1	sunscreens nothing
1	weight, quantity,
3	25 or
2	training that
5	section 331(t)
113	30 days
1	ongoing training,
7	(d) information
1	pests. 
2	certain facilities
1	review every
1	(1) programs
1	gases has
14	website of
1	grants any
1	(authorizing and
1	(b) malaria.
8	otherwise subject
3	enhance tracing
1	appropriate delta
2	1906, ch.
1	indictment for
3	colorings without
12	requirements in
1	360rr. federa-state
4	case later
4	of, this
2	said cattle,
4	sealed containers
1	welfare and
1	establishment have
1	condition defined
1	1531(c) of
1	person given
1	(c)(2) 
1	toxins, pesticides,
1	authorize delivery
2	tribal officials
1	certain sites
1	desire of
1	paraphernalia, in
1	deems adequate;
1	changes needed
1	(i) conform
3	321(ii) of
1	 cretinol
1	cigarthe term
2	overdose of
1	diagnostics (a)
2	subsequent periods
1	(b), for
1	addiction medicine.
1	persons organization
2	672 of
18	grant a
1	original prescription
5	requirement prescribed
1	states receives
1	center operated
1	act). (2)
1	30, 2016;
3	genetic injury,
1	emit) such
2	208(b)(1) of
1	publications that
1	675, 586g,
1	appropriately assessed
1	recreational or
1	applicable, identified
3	associations and
1	findingseach notice
1	valid surrogate
2	standard; (9)
1	825, 952,
1	including studies
1	upon, nor
1	feed; or
1	wholesaling the
1	paragraph (2)(c)(i)
1	share no
1	term amenable
3	chapter; (c)
1	term maintenance
16	condition for
1	pulsenet of
1	section 360e(f)(6)(a)
1	food; except
1	evidence, based
8	(a) one
1	burdensuch elements
1	684; 

1	relieve the
2	developmental milestones
1	shall undertake
1	committees that
1	884. immunity
1	proportions as
3	product contained
1	offering such
1	agencies at
3	agencies as
20	applications, and
1	including 1
1	survive, notwithstanding
1	requiring postmarket
1	faith claim
2	priority shall
2	working on
2	intended target
2	induces, procures,
4	631; 

7	(a), or
1	subsection (f)(5);
1	time; or
1	priority pursuant
44	assessment of
1	(g) not
2	states standards
1	(2), if,
8	dangerous, or
1	proceeds. 
1	(3)(a), the
1	drugthe terms
1	(i) terminating
1	request does
2	admiralty and
1	services administration.
4	services administration,
1	facilities performed
4	necessary; (ii)
11	died otherwise
1	solicit 6
1	(ii) nonreceival
4	patent expires
10	exceeds the
2	another food;
3	retail of
15	device intended
1	community that
1	(j)(5)(b)(iv); or
16	offer of
1	basis: provided
1	outcome monitoring
1	response during
1	genome has
1	additives that
1	information sharing
15	accepted for
2	monograph system;
1	regulation. (oo)
2	supplement an
1	administrative records
1	required statementsthe
1	lactose, milk
1	nicotine, or
1	grantee shall
5	best of
1	including categorization
1	consignee shall
3	consortium of
9	issuing a
11	order approving
1	competitive awards
5	section, such
1	importer, if
14	(iii) and
1	(b)(2) are
5	effect any
2	law, by
2	international union
1	(1), of
1	360qq. repealed.
4	law, be
4	section 384a
1	research, development,
3	effect and
2	section 384e
1	shall a
7	(1), or
10	(iii) any
2	review commission
1	ammonia fertilizer
1	(a) coverageno
19	milk or
1	substanceswith respect
1	allows additional
1	alcoholic beverages.
1	administrator, shall
1	entity pursuant
1	(h) whether
1	9-, 21-,
2	certain controlled
1	submitting reports
1	sponsor elects
6	inspection the
1	independent agency,
1	certification no
2	381(h)(1) of
1	generalin the
1	(p) forfeiture
1	seller 
1	distributions are
3	year, every
1	threat, and
1	clause, notwithstanding
1	
 1547.
3	drugs marketed
1	necessary so
1	radius of
2	pathogens under
1	additives, that
3	information among
1	(a)(1), a
2	months ending
1	military preparedness
1	tactical intelligence
7	initial classification
18	develop a
1	manufacturing certain
1	314.70 and
1	(b). testing
2	determined with
9	fees (a)
1	acting capacity
1	biological products.
7	post mortem
1	prescription use,
1	place unless
1	strategy or
1	occurring estrogen.
1	occurring estrogen,
1	treatment expansion
1	515c, as
1	457(d) or
1	subchapter applicable
2	obtain tentative
13	dead, dying,
3	caused the
1	administration, other
5	paragraph, a
4	implanted in
1	invoice, or
2	facility each
1	reasonableness and
1	ii, 201,
1	security notification
4	packaging requirements
1	reasonable jury
1	seeking any
1	tolerances having
1	4321 et
1	regularly provides
1	for. (mar.
5	territory not
1	authorized amount
1	phone number);
8	business days
7	accrued interest
1	marketing violations
2	controlled by,
1	mineral, other
1	issue contaminan-specific
1	identifier associated
1	space that
1	testing protocols
1	licensure requirements
1	testing, inspection,
1	approval supplements,
3	submit, for
1	undermine the
7	animal drugs.
1	administrator makes
10	animal drugs,
1	civil enforcement,
1	allow united
1	establishing fees
8	(1) each
1	labeler, relabeler,
10	amendment, or
10	secretary based
1	anaphylaxis and
1	(a) assure
1	intense magnetic
8	nonsaleable product
2	receipts that
5	28, 1976,
1	(2cp). 
1	28, 1976.
1	broader population.
2	drugs permitted
1	provides advice
1	regulations). (c)
1	facilitated consistent
1	package across
2	government entity),
1	administration, including,
3	thereof, any
1	28, 1976;
3	notification publicly
1	export regulations;
1	unlawful 
1	387c, 387d,
1	complete new
17	upon receipt
1	content; meeting
1	person has,
1	actions against
2	manufacturers, shall
1	license; requirements;
2	combination, respectively,
5	applies. 
4	certain small
2	may stay
2	recipients that
3	techniques to
1	(7) $70,000,000
1	supply of,
8	information technology
2	congressional notice
5	foods that
1	title) is
3	whoever knowingly
1	159. enforcement;
7	action that
2	hires, uses,
1	failure, upon
4	removed; (ii)
1	indicated should
1	rapidly removing,
1	determined according
3	(b) recommendations
1	(ii) document
1	license, an
1	(d) does
2	(a)(6), the
1	animals whenever,
2	pay of
1	article, court
1	(9) paraldehyde.
1	2008 the
1	(1) reports
1	accessory is
40	drug master
1	initiated or
3	communication from
1	substances provided
35	-year period
1	insurance claims
2	identified after
1	centralized database;
1	simulation of
2	submitted certifications
1	drug supply,
1	deferral; and
2	product, that
4	requirement established
1	(ii) takes
3	medical profession
1	secrets, for
1	experience, can
5	notice, as
1	goats delivered
5	clinical protocol
1	nicotine lozenges)
1	(4) apply
3	center charged
5	authorization to
1	procedures imposed
6	public review
1	address. (3)
6	extent such
1	(a)(1). (c)
1	846. attempt
8	alleged violation
2	initially approved;
1	upon condition
1	establishment, including
1	efficacious treatment.
1	permit 
1	requeststhe director
3	(1)(d), the
1	patent information;
1	purported deficiencies
1	(a) three
6	secretary so
1	act, (b)
1	frequency, method,
1	unapproved uses
1	regulatory, ethical,
4	period specified
1	350j. targeting
1	(1)(c) is
1	effected by
5	commissioner. 
1	effectiveness information,
1	
 379aa.
3	undermines the
1	gateway, on
1	decontaminating and
1	commercially and
2	slaughterer and
1	(f) exemptionsthis
1	applicant. (june
1	australia, canada,
2	exposure shall
2	exhausted, (d)
1	commerciall-available techniques
1	(1)(c) if
4	(ii) providing
1	dressing, ointment,
13	provides the
1	administration; 
1	publicly distributed
4	classification and
2	alcohol, tobacco,
2	1994 and
2	ingredient, or
1	sales (which
1	physical inventory
1	commerce, (a)
1	cargo tank
20	services and
1	shall assist
1	2110. rule
1	findings contained
1	own, intended
3	certification qualifying
1	manufacturer required
15	applicable under
2	sel-administration of
1	suffered harm
54	adulterated or
1	(2)(b), (ii)
1	armed forces,
2	summary developed
1	administrators initiative
1	quotas, the
1	school, elementary
1	changes which
1	imported article
50	responsible person
1	rule prior
7	formula shall
1	governments towards
1	neither a
1	ten pinball
3	third party,
1	who, for
1	(b) effective
1	review regulatory
2	use, with
1	(2) shall,
1	third party.
3	pending in
1	(a). (iii)
1	data, request
7	(f). 
1	(iv) governmental
5	period to
2	will comply
1	29, 1884,
3	policy it
1	prescribe medications
1	year, each
1	title. (25)
1	503, 52
3	section 360nn
1	credentialing bodies
1	generalthere is
1	bears, to
2	receive payments,
1	product manufacturerthe
1	methamphetamine, violates
1	regarding other
1	every sale,
60	whole or
18	one hundred
4	ban under
1	(3) approval
1	goods the
1	regulation, authorize
1	problems and
7	committee and
1	(g) financial
5	committee any
2	poppy straw
2	classified by
2	individual that
1	(sr19 and
1	intelligence determines
2	methamphetamine; and
3	significant adverse
1	states duly
2	divided equally
1	receipt, security,
3	section. (f)
2	previously manufactured
1	effectiveness, unless
1	contemplated is
2	6. 
1	manufacturer recalls;
1	(b)(1)(a). 
1	larges-selling tobacco
1	pork industry
1	recordnot later
1	day for
1	solicit public
1	(a), during
2	program strategy
1	(7) review
6	therapeutic class
2	suspending under
1	peyote. (13)
7	(a) publish
2	cooking, freezing,
1	penalty. in
1	employed. 
1	mandatory debarment
1	committeesthe congressional
4	within 120
2	part that
1	travel, including
4	exports a
1	notification; and
1	site other
5	issue the
1	trade as
1	(a)(1) with
1	behavioral and
1	medical specialties.
1	testing fees.
1	pethidin-intermediat-c, -methy--phenylpiperidin--carboxylic
1	membrane oxygenation
1	product. (11)
1	pharmacies 
1	675, 308,
1	panel on
1	samples in
1	shall estimate
1	registrants registered
1	(a)(2); or
1	2nd par.,
1	framework, which
4	schedule[1] i
1	full assistance
1	(l)(5). 
1	thefts or
2	advocacy organizations,
1	participate; (ii)
1	regulated and
2	barrel bears
2	hearing. the
1	substances. (3)
1	(i) denies
1	whose affidavit
1	item which
1	outcome assessment;
1	secretary evidence
7	regulations. 
1	publicly by
6	complete application
1	food be
2	subsequent annual
1	-ethy--piperidyl benzilate.
1	population groups,
1	
 951.
51	provide a
1	moving in
2	food by
1	thereof. (

3	diverted to
26	extent and
2	psychiatry, the
8	valid scientific
2	(b) liability
1	continued, modified,
1	pathogen identified
5	(c) each
1	immediate steps
1	professional scientific
1	states, either
2	reflect new
1	benefits do
4	device. (2)
1	leprosy. (l)
2	submitted during
1	substance already
1	jury to
2	pharmacist within
1	notification. within
1	natural causes
1	commence prescribing
2	users under
1	675, 505c,
1	use, under
1	affairs who
1	patients lives;
1	dtc advertisements,
3	products, for
1	accreditation, were
1	74, 4,
1	community antidrug
1	orders an
1	-[-(ethylthio-2,-dimethoxyphenyl]ethanamine (2ct2).
1	immediately submit
2	foo-producing animal
1	file must
1	(2cc). (23)
1	
 2243.
2	(c) requirements
2	datethe annual
1	advice, to
1	misbranding has
1	(ii) makes
1	followed; or
1	industries and
1	(2) intending,
1	document to
2	(c)(2), or
1	asking applicants
1	request) submitted
1	morals, health,
1	maintain compliance
1	(6) internal
7	responsibility for
2	believe, by
3	bases. (iv)
1	actions brought
1	additional capacity,
11	subparagraph (a)(ii)
1	savin; croton
1	
 824.
1	review operating
1	sites, in
1	compounding physicians
1	section 31301
1	reportingthe secretary
1	needs exist.
1	tar content,
1	council 
2	effectiveness; and
2	includes appropriate
3	performing official
2	penalty prescribed
1	ch. 712,
2	section 360(b)(2)
1	subsection require
1	computer systems,
2	controls, is
1	$25,000,000 combined.
1	(d) no-prescription
2	person an
1	shall, through
1	person as
1	exemption authority
1	2013 inflation
1	recruitment activities;
1	penalty by
4	ingredient, the
1	imposed unless
2	signs and
1	approval until
2	dispensing prescription
1	nations demographic
1	controls, if
1	regulation reinstate
1	routinely contract
1	disapproval by
1	tolerance fees
2	(g) effective
1	design characteristics,
7	update the
1	pharmacy, including
1	(h) exception
1	whether inadequate
1	paragraph (2)(b)(i)
2	development meeting.
2	(b) contain
12	require. 
5	conclusion that
5	states ant-doping
1	emergent and
1	(1)(b). if
1	inhalation drug
12	president shall
6	clearance to
1	upon interstate
1	(aa)in general.
12	amounts established
1	drug, facilitate
1	approved product).
1	program, that
1	(4) deferral
1	subsection, assess
1	(aa) considers
1	center shall,
1	(m)(1) to
1	accept, catalog,
1	symbol required
1	including major
1	hearing, if
4	regulated seller,
1	(a) labelingto
1	sections, be
1	provider as
2	marketed under
2	fair dealing
1	individual article
1	shall decide
2	patterns of
1	conference, such
1	proposed intended
2	(f) limits
2	transaction described
1	patterns or
2	(a) designation
5	shall debar
1	(i). (iii)
1	becomes lawful
1	tariff act
1	discuss with
1	(a) impleading
3	meat of
5	caused to
1	support, through
6	satisfied that
3	regulated sellers
1	2015. (d)
10	ending june
2	honesty and
1	preserve each
3	fellowships and
1	regulatory teams
1	convention different
1	egg ingredients
2	agencies, institutions,
3	(a) review
1	functions in
1	item should
1	(9) sulfonethylmethane.
2	matching requirement
21	qualified infectious
1	fines imposed
1	developing, manufacturing,
2	requests issued
1	go into
1	(e) (except
4	drugs from
1	379j12 of
8	single convention
6	reporting requirement
1	territorial limits;
2	foods likely
1	application. (10)
9	343(w) of
7	cause such
3	device not
3	quarterly basis,
2	shall, from
2	drug traffic
1	whose chemical
1	(with 0.7
3	(i) standard
1	(3) withdrawalthe
1	contains and
6	adulterated and
1	licensing such
1	minimum (1)
3	hazard or
1	commission. (4)
1	case involving
1	term retailer
1	device, indicated
44	contains any
4	person (or
1	activity after
1	first. if
1	comparison with
2	timeframe specified
1	supplier that
1	(ii) $249,000,000
4	verificationbeginning not
1	procedural matters
1	public both
2	technologies, including
1	valid prescription;
2	effective means
1	designation, and
1	subsection, there
5	inspection panel
3	terms pesticide
1	liabilitynotwithstanding any
1	frequently if
1	(d)(2)(b). 
1	health reasons.
1	consignee upon
2	applicable; (2)
1	residues that
2	animals after
3	grade minimum
1	additional determinations
2	title 31
1	determines in
9	if, in
1	prepare, and,
12	register and
2	otherwise introducing
1	exception set
1	services. (25)
1	personally upon
5	food; (2)
1	(1) detention
9	title; 
1	(1) evaluation
5	(in the
1	area, provided
2	register any
16	refused for
1	appropriately qualified
1	significant difference,
5	shipping containers
2	818.)
 

1	issue emergency
1	nearly identical
2	regarding its
2	year 1999,
1	675, 1012,
2	pediatric population;
2	may examine
1	mil-based. 
1	property being
1	destroyed. (iv)
1	(c) serving
1	(c)(2)(b), that
1	batches of
1	consideration standards
1	interest a
1	meeting, provide
4	pediatric population.
1	period, no
18	accredited under
1	principals any
2	investigated, and
3	controls required
4	retail pharmacy
1	(b) include,
1	notified in
1	(a)reporting.beginning january
1	specific countermeasures,
1	5332 of
4	841(b)(6) of
1	participation is
1	contract awarded
2	personnel demonstrate
1	(iii) distributions
1	2014 falls
1	achievable, but
1	american consumer;
1	(i), as
2	fine, imprisonment,
1	2007, inspection
1	updating the
1	manufacturers, packagers,
2	medical reasons
1	regulated sellersthe
1	egg producer
12	participation in
1	additive). (4)
21	ability of
1	license immediately,
1	(1).[2] (h)
1	importer the
1	(c) 28
1	seq.], shall
4	(b) includes
3	cancer when
1	619(5)], when
1	resources needed
2	(d) publicly
2	national uniformity
1	exercises shall
1	(c) 26
1	(a) significantly
3	states patent
2	cheese, or
1	made) contained
1	18, formerly
1	transportation any
1	protections set
1	act) before
5	amount assessed
2	drug imported
1	ingredient requirements,
1	product listed
3	paso intelligence
1	(b)(6), the
3	(4) all
1	delta values
3	paper book
6	otherwise would
26	emergency use
1	appropriated, the
1	require recordkeeping,
1	upgrading such
1	plan process
2	produced, assembled,
5	periodically review
2	persons responsible
1	period applies);
3	chapter. a
2	no-clinical and
1	clearance; (c)
2	medical reason;
1	(mg) 20.0
1	held. 
2	maintain liaison
1	injury under
1	protected and
1	3431. national
2	package 
3	employee detailed
3	11, 1955,
4	national agriculture
1	affecting agriculture
1	education, prevention,
1	(c) appointed
1	designating a
5	organization for
1	282(j)(2)(a)(ii)(ii)(gg) of
1	tobacco. (vi)
1	(b) supporting
16	compensation and
1	prohibit, or
1	advisory committeesit
1	planthe content
1	results; (e)
1	(b) seizure
1	coordinator and
1	reporting outsourcing
1	
 848.
4	request 
1	failure, of
1	proceeds remaining
1	foreign countries,
1	recipient meets
2	foreign countries.
1	observation identified
1	assignment. the
1	(2) employs,
2	(3) status
1	plants; 
2	interest collected
1	as, an
2	(4) that
1	(viii) 50
13	local government
2	standard on
2	unique number
1	(b)(iv) shall
2	occurs after
3	report a
1	medicated feeds;
2	appropriate united
1	amounts remaining
1	advertisement with
1	drugs (referred
1	applicant agrees
1	addressed through
1	sku, or
1	thereby affecting
1	4, as
7	retail food
1	training addressing
2	containers which
2	conditions if
1	assurance, or
1	(4) there
2	supplement within
1	distributing the
1	protect 
1	inquiry, that
1	evaluate all
1	(a) violations
1	veterinary practice
1	today will
1	scale or
1	2016). 
1	nonspecified use.
1	points according
1	classifying cases;
1	public docket,
1	products around
2	opium poppy,
1	agency; (4)
1	reason bearing
1	bylaws for
1	(h) any
3	agents that
8	concludes that
1	initiatives among
2	imprisonment authorized
1	qualified indication.
1	register by
5	agriculture, in
1	
 1050.
5	depressant, or
1	animals prior
1	committee (other
4	commodity bears
1	game, meet,
2	(1) other
3	committed the
1	vehicle, render
1	product. (iv)
1	(2), whether
4	(d) refund
10	device has
1	(vii) specify
2	establishing timelines
2	manufacture, exportation,
1	states during
1	(ii) certificationthe
2	general provides
1	360ddd2. inapplicability
1	deemed a
1	2013, $505,000,000.
1	methadone. (12)
1	emergency departments
1	butane. (13)
1	harvesting or
1	secretary followed
1	sections 353(e),
2	(including small
1	food certification,
1	policies would
7	income tax
2	elementary, vocational,
1	$60, as
3	nontopical antibacterial
1	assessed. in
1	methodology 
3	body, such
1	policies; and
1	section 624
1	distributor will
1	health. (6)
2	disposal, inventory,
1	pronounced and
1	question the
1	5304 of
1	community, such
1	(n) packaging
1	subcommittees and
1	publication with
1	unlawful in
2	private research
3	general at
1	plans 
2	statements the
2	exercising any
1	564, as
1	348 regulations
1	small fruit
1	testing records),
1	context otherwise
2	telephone number,
2	records except
1	replacement of
10	general an
2	matters; prohibition
1	carrier, distribute
1	necessity for
1	divisions, including
1	device (including
2	residues and
2	statement sale
1	reducing dietary
1	(including cellophane),
4	slaughter, and
2	702 of
1	previous 5
1	concepts or
1	physician will
1	previous 6
1	among european
1	misbranding do,
1	applicant, (b)
1	concentration, or
2	force shall
1	(b) presents
1	zinc, the
1	422, as
1	(5) shall
2	subparagraph (e)
1	people; and
1	batch certified,
1	term clean
3	counterfeit drug.
2	available, including
4	counterfeit drug,
4	subsection which
2	document on
1	penalty (plus
1	general powersthe
1	price index.
1	disapproving an
1	responsible parties,
1	changes (a)
1	(a) penalty
4	review within
2	document or
1	firs-applicant status
1	exercising other
1	general documentation
1	343(h)(1) of
1	food, financial
1	amounts specifiedfor
1	particular person
1	distribution; (2)
9	excepted or
1	
 154a.
1	functions; (b)
1	facilitate or
1	cleaning, disinfection,
1	another device.
1	whether incentives
1	section 387e(i)
1	1,000 or
1	disclosure. responsibility
1	cause harm.
5	title. (d)
2	another device;
27	shall report
5	inspected or
1	bacteria, viruses,
1	applicable prescribed
1	nominees. (f)
14	(a) has
1	cause harm;
3	area, or
2	clause with
9	states pharmacopoeia
1	unincorporated business
2	drug that,
1	
 1194.
1	contract may
1	agricultural chemical
1	device into
2	 (iii)no
1	1 to
2	animals slaughtered
4	evidence standard
1	bidder on
1	
 3433.
1	whose genome
1	term fair
1	(d)(4), (e)(1)(a),
10	(ii). 
1	counterfeit drugs
5	list the
1	isomers. (l)
1	following inspections,
1	regulate activities
1	reporting be
1	contact surface.
1	responsibilities 
1	declarationscongress declares
1	review prior
1	dealing and
1	conducting activities
2	regulated matters;
1	surveillance program,
1	staffing roles
1	
 384a.
1	national stockpile;
1	manage the
1	(a) creates
1	informationin selecting
1	revoked under
2	approval described
1	(i) fully
1	contact surface;
3	iii devices
1	approved; (b)
4	seizures and
5	facility; and
7	device classified
1	practicable, assuring
1	establishment feeeach
2	cosmetic act.
1	detected, (e)
2	cosmetic act,
3	enforcement activities;
1	include documentation
4	administrative inspection
5	coalition, including
1	secretary declaring
2	applicable penalty,
1	appropriate, questions
1	detail from
1	(b)(i); or
2	information first
1	prohibiting an
1	2109. publication
5	substance means
2	cosmetic act;
1	2007 
1	warrants, arrest
2	appropriate, require
2	sought would,
23	secretary pursuant
1	manner practicable,
1	petition, as
1	progress by
1	(k) pseudoephedrine,
2	substance appears
1	will submit
2	iii device.
4	iii device,
1	(a) failure
1	repackaging as
1	limitations described
4	submissions. (b)
1	retail; (2)
2	person exporting
2	commerce; or
1	42; (iii)
13	publicly available,
5	ingredients which
12	contact with
1	(l) lymphatic
5	transaction statement,
1	specific standards
1	debarmentthe secretary
2	annual compilation
2	metabolism or
1	conditions, review
1	others 
3	issue involved.
1	administration (1)
2	agency (1)
1	nonprescription sunscreen;
11	made at
1	substance named
1	limit is
7	(i) may
9	made as
5	(p) the
1	apples the
1	made an
1	dietary intake;
1	pharmacys telephone
1	30, 2017,
1	require. a
1	(xi) information
3	nonprescription sunscreen.
1	(iii)private sector
3	ingredient means
1	productan authorization
2	year, upon
1	dated july
3	review not
1	existing online
1	nonapplicabilitythe foregoing
1	checks, and
2	committee (a)
1	possession having
1	(13) moramid-intermediate,
1	authorized consular
1	861. employment
1	ginseng labeling
3	action pertaining
1	way of
1	genome contains
1	dramatic increases
1	assess trends
1	fees associated
2	increasing or
1	persons expenses
2	stat. 1487.)

1	promulgate the
1	ii. the
1	provided him
1	section 897.34(c).
4	inferiority has
1	360e(g)(2)(a) of
1	studies fairly
1	term trading
1	commissioner on
1	produce one
1	available, 6
1	competition). (vi)expiration
1	214), from
33	commissioner of
1	interagency agreement,
1	men and
1	needed, on
1	director not
1	(a) cooperation
1	proposed amendment.
2	convenience of
13	act [15
1	alimenterius[2] commission
10	judicial district
1	authorized repackager
1	(1) 15
1	399d. employee
1	355c(b) of
1	675, 511,
1	otherwise introduce
1	international relations.
1	product experiences
1	using procedures
3	regulations prescribe
1	inclusion with
1	labelingthe requirements
1	predictability, the
1	(j) exemptions
1	manner, will
7	prescription of
1	made, in
1	commerce, science,
1	device assure
3	interagency agreements
57	containing a
1	administrators, and
12	total costs
1	care intervention,
1	admission if
1	standards provided
1	making determinations
3	team of
1	community regarding
1	(b) substantial
1	quarantine the
1	team or
1	persons believed
1	word poison
1	product measured
1	smoke. 
2	(b)(1). 
3	secrets or
40	possession or
1	individuals; and
2	person, with
1	training described
1	verified the
1	1121 to
1	updated on
1	schedule c
9	enforcement and
1	2016; or
1	commission, when
17	basis to
15	appointed by
1	contents, and
240	 (d)
11	beginning not
1	prohibited.; (2)
4	appropriate means
1	periods 
1	director. (3)
2	(d) data
4	u.s.c. 262(a)(3)].
1	requestor involved
36	operator, or
1	prescription from
1	(10) seller
1	375. publicity
1	set an
1	inspectors employed
1	address. 
1	barrels misbranded
1	removed because
4	advertising for
1	upon qualified
1	property declared
2	(a)(2); and
3	individual; or
1	(b). this
1	procedures notwithstanding
5	origin of
1	clause (ii)(iii).
1	(14) -methy--piperidyl
1	regulatory predictability,
1	food, not
1	process prior
2	potential use
5	carcasses, portions
1	origin or
115	finds that
4	finds to
1	recor-keeping and
2	section 387f(e)
1	response. (june
3	abuse; and
3	pay 
1	commission the
2	include with
1	standards minimize
1	precautions respecting
1	2, 1951,
1	ii, that
1	specified substances
1	2011, involving
1	manufacturer: 
4	902(a), 52
1	days, request
2	subparagraph within
3	direction and
1	purchaser; 3-day
1	partner agreements
1	elected state
1	activities; (ii)
1	carbon dioxide,
1	prevents any
1	(e) devices
1	procedure shall
1	marketing approval;
1	1103; 1940
1	prevents persons
6	modifying, leaving
1	certificates; simulations
1	viscera have
3	13, 2016.
1	type. the
13	24, 1984,
2	24, 1984.
1	distribution, sale,
1	vessels, which
2	total fees
2	auditor the
1	state subject
1	(c) violation
1	entry where
1	(4) treatment
2	funds under
1	said secretary;
1	electric pipes;
1	24, 1984;
1	place an
1	chemically, or
4	(4) verificationbeginning
17	federal trade
1	species, such
1	subsection (referred
1	affiliations between
1	(1) recognized
6	chapter; or
3	retailer and
1	(g) based
1	published as
1	drug; (j)
2	transactions were
1	acceptable by
1	products, under
5	postal service
1	applicant gives
1	25 calendar
1	entity. (7)
4	payments payment
44	programs and
1	(a), there
1	standards; applicability,
1	distributed all
4	may engage
5	territory in
3	quarter of
1	citizen participation
1	(b) deputy
6	(8) if
1	dimenoxadol. (17)
1	consortia means
2	longer appropriate
7	orally or
1	targeted technology;
2	title, all
11	premarket report,
1	representative employed
2	section 1365
2	application; (ii)
1	(8) it
1	documents. 
1	section 1361
1	unauthorized release
1	subsection (b)(1)),
34	used for,
4	quarterly fee
2	(1)(e), the
1	(a) premises,
6	professional supervision
1	(including amendments
39	class of
1	guard licensed
1	(2), after
2	brought. the
1	parents. (iii)
3	monograph does
1	(iii) applies
1	federal international
1	concluded, except
1	requires each
1	significant incapacity
1	expected adverse
2	(b) prohibition
2	medicine, the
1	injury, the
1	agency. (c)
1	different tobacco
1	fees obligated
2	testify in
1	chapter respecting
10	inspections under
1	local target
2	alert or
2	appropriation for
1	data suggests
5	applicable, shall
2	repackager has
2	subchapter manufacturing,
1	almonds, pennyroyal,
1	neonates, infants,
1	uniform nutrition
1	affecting its
1	chapter, he
1	patients, patient
3	provided that,
1	importations by
1	withdraw, or
1	(9) unless
1	bodies described
1	ginseng. 
2	printer, or
1	provide, directly
2	vehicle, or
1	(i). the
1	fluent in
1	(14) wired
1	forged prescriptions,
7	residue depletion
2	derived wholly
2	butter and
6	recommendationsafter negotiations
1	countermeasure for
1	objected to,
1	questions in
10	untrue statement
1	2015, any
1	remote; (11)
1	chain, or
1	period will
2	liens all
1	response which
1	resistance). (2)
1	section 343(q)(5)(h)(ix)
1	will address.
2	seq.] to
2	owner and
1	possession, use,
2	advertising contains
1	appropriate) under
1	distributor licenses
1	(or drugs).
1	alleging a
2	devices. (b)
3	property in
1	section 748(b)(1)
1	mg 300.0
1	policies. 
2	intended or
1	collaborates with
3	procedures used
2	provide 
1	responsibility vested
2	(d) repealed.
1	facility within
1	registered, or
1	requesting assistance
6	awarded to
1	with, scientists
1	use it
2	sale, delivery,
1	matters under
3	falsely labeled
1	registrant whose
1	denial; (2)
3	products before
1	thereof, offered
7	 (13)
3	individual saleable
2	et seq.]),
1	life sustaining
1	
 953.
1	pending its
1	collaborationin carrying
1	supplemented to
1	(8) savings
1	methamphetamine treatment
1	trial enrollment,
20	30 calendar
1	abuse means
1	thing as
1	scientific gaps
1	product promotion
7	(2) has
1	decision establishing
1	security, under
1	federal funds;
3	requirements respecting
1	programs carried
4	filing final
1	1920 of
1	rotating, sequential
13	file such
1	judgment if,
1	(a) removal
1	-methy--piperidyl benzilate.
1	category described
1	applying because
2	providing information
1	handling or
1	federal funds,
1	subsequent impleader
1	establishments designated
6	setting aside
1	strategy; (18)
1	2002 (6
1	detailee shall
1	1701 of
1	labeling pertaining
1	using targeted
1	drugs, any
1	(1) rare
3	administer the
1	biennial registration
2	device. (d)
2	free from
1	lobster, or
10	drugs, and
1	officers official
1	altered by
1	(a)(6), (b)(5),
1	services coordinating
1	grape, orange,
1	(e) pediatric
2	prominence of
1	675, 807,
7	standard in
1	conduct litigation
1	20.0 
1	$64,000,000,000; and
2	officials in
9	information related
2	202 of
1	application, (3)
1	constitution. the
2	section 360eee(26)
2	(1) periodic
1	department listed
4	30 months
1	intended, if
4	unit of
1	facility because
1	retailer shall
13	standard is
2	information relates
2	reject such
2	may delegate
1	subparagraph (b)(iii)(i)
2	(ii) technical
1	28, 1996,
4	thereof shall
1	ingredient as
2	national food
1	ingredient at
1	investigations as
2	chapter, include
36	persons who
1	normally used
1	activity, as
1	shipper thereof
1	animal under
2	manufacturers. 
1	treatment; (d)
3	food allergen
2	repackager from
1	(g) may
1	thereafter, there
2	subsection after
2	objectives, and
1	(2) working
8	812 of
1	general, institute
2	records necessary
1	systems compliance,
1	i, 16,
4	award under
1	docket for
3	1951, ch.
1	providing financial
1	commerce consistent
1	578, 1,
1	hospital, ambulatory
1	import a
1	child with
8	subject matter
1	added amount
5	(1) during
1	1701(11) of
2	drug, in
26	agricultural commodity
8	filing in
3	activities (a)
2	misleading, or
1	accord a
1	153. inspection
3	drug, if
1	access records
2	subchapter; (2)
1	verify, the
2	pediatric drug
4	borne by
1	program after
2	components thereof,
1	(ii) available
2	drug, is
1	management, either
1	drug, it
1	initial training
2	(i) requirement
1	portions shall
2	deciding when
1	(a) amendments
1	vulnerable points,
1	state, for
1	proper use
1	vegetables and
1	court. the
1	nanomaterials; (5)
1	vulnerable points;
1	misbranded device,
1	trafficking, that
4	except 
2	genetically targeted,
1	requests an
2	comes into
4	article being
2	without attempting
2	commerce; inedible
1	application made
1	(b) performance
6	shall inspect
11	thir-party auditors
6	implant. 
1	web sitethe
1	direction) a
5	suggesting changes
1	available information.
1	physician writes
1	signatures in
1	therapies, accelerated
1	available new
1	rights or
1	accompanying any
1	organizations in
1	resource and
5	basic pay
1	food, temperature
5	part, the
1	research training
1	nanomaterials on
2	standard recognized,
1	appraisers, accountants,
1	qualification submission.
1	also apply:
1	measures regarding
1	natural 
1	possession offenses
1	detail each
2	secretary lacks
1	samples made
3	indian sel-determination
1	pending generic
1	official has
3	individual may
1	rate, use
1	propose to
2	discontinued participation
1	replace the
1	making contact
1	produced on
1	standard, an
2	order deny
1	691[1] of
1	limit). 
1	877. judicial
1	information presented
1	ketobemidone. (27)
1	objective established
1	person. notwithstanding
1	(except at
3	4, 2011.
17	(except as
1	
 360mm.
8	produced or
1	(a) (subject
3	registration renewal
1	fees; penalties
1	following means:
1	(n)(1)(g) or
1	person listing
1	system; 
10	repackager shall
1	including objectives
1	effect limiting
1	experience, tests,
4	designed for
2	distributed; and
1	forfeiture, taking
1	2 dosage
2	order proposed
1	(c) pharmacy
1	affix and
1	18 unless
1	(2) $250,000,000
2	meets such
5	manufactures or
1	trust, association,
1	acts. (june
1	council. (

1	diminishing the
1	pediatric dosing,
1	(vi) 400
1	(under such
9	paragraph (2)(b)
1	election not
1	pipes; (10)
1	away, or
2	sale with
1	claim. (3)
1	(c) wholesale
1	262(a)], the
1	implementation 
1	retail sale.
1	enforced without
1	restrictive use
1	proceedings, except
1	permit analysis
1	complete until
1	stockyards act,
1	person was
1	investigation conducted
1	ant-drug coalition,
2	term container
3	eligible coalitions
1	 (y)
2	technical, regulatory,
1	abuse research;
1	inspection for
2	establishment. (d)
1	problem; and
28	multiplied by
2	took place.
1	defense shall,
1	notwithstanding title
10	assurance that
8	paragraphs (3)
2	equipment, chemical,
1	instituted separately
1	classified, and
1	accreditation, poses
1	regulating devices
2	compounded therefrom
5	similar experimental
4	performance evaluations
4	(e) that
3	advertising, or
1	(2) unauthorized
1	unresolved safety
2	smoke contains
8	general that
9	modification or
1	strategy the
1	addiction by
1	farmthe requirements
1	section 384(e)
1	
 382.
1	bond. if
1	him, such
12	modification of
1	(b) transfers
1	coordinationwith respect
1	(1) study
1	similar uses.
1	foodborne diseases
1	levophenacylmorphan. (29)
1	standards act
1	sealed or
1	case giving
1	379j11(5)(b) of
2	subchapter shall,
4	identifier for
4	fullest extent
1	qualitative or
3	sector and
1	compliance[1] with
1	seq.). (s)
4	additive; or
1	ingredient: safety
1	therapies (a)
1	discrimination, demotion,
29	developed under
4	mislabeled, or
3	section. for
1	categories as
1	petition, waive
1	term finished
1	device constituent
1	misleading, the
1	section 1498(a)(1)
1	publicly if
1	assessments referred
2	refunded. 
1	federally owned
2	complied fully
1	$100 or
1	animal use,
4	data concerning
1	capabilities, including
1	termination 
1	application, notification,
1	limitationsparagraph (1)
2	species, and
6	concerned with
1	permit states
1	veterinarian, shall
14	cease distribution
1	authority (which
1	practices under
1	five days.
2	batch certified
21	given such
10	allergy and
1	congress, or
1	lovibond tintometer
1	2012, references
4	patent term
1	states representative
12	review user
2	periodically thereafter,
4	title. (mar.
1	regulations fixing
1	allowing or
3	(3)(a). 
1	process, before
3	food. the
1	build state
2	paragraph (b),
1	interest renders
1	information. (june
1	(a)(ii)(ii) to
5	suppliers of
2	chain that
7	facility for
1	priority vouchers
2	regulated person,
2	314.510 or
1	pursues coordinated
2	subsequent calendar
1	feasible, cost
2	steroids 
68	manufacturer of
1	planning since
1	(2) nonprescription
1	generally applicable
1	including countermeasure
1	testing results,
3	section 247d6d
134	manufacturer or
1	entrythe secretary,
1	section 354,
1	changes shall
4	section 247d6a
6	section 247d6b
1	agreements or
1	1532. program
1	863 of
1	seq.] referred
2	delete the
3	protect information
1	manufacturer directions
2	regulated persons
1	present identification
2	holder provides
1	metrics for
1	(1)(a)(ii) for
1	section. but
1	administrative action,
1	thereunder with
1	show 
7	executive board
2	provided; nor
1	appropriate internal
1	chemical, whether
1	medications, specifically
1	concurrence. the
2	appropriation equal
4	purposes described
1	(d) agree
2	narcotic and
1	authorities equal
1	subparagraph. (3)
77	necessary for
1	register shall
1	title. a
1	exercise other
1	(6) signal
1	strategy in
49	appropriated for
2	normal retail
2	university, or
1	product entering
1	b1 (thiamine)
1	misleading labeling.
60	require that
1	supporting, or
1	(2)(a)(vii): 
1	drug, submits
2	audits performed
3	(i) death;
1	patients exposed
1	highest percentages
9	forfeited under
4	(n) the
2	adequate warnings
1	questions to
1	paragraph. (6)
1	death; (b)
1	size to
1	receipt describing
2	bribery, extortion,
1	(a) final
3	confirm or
1	marijuana, poppy,
1	include benefits
1	xix of
2	termination. if
1	court. (mar.
1	clause, which
1	event.in this
1	outbreak interviews.
1	manufacturer), unless
2	multiple doses;
1	manufacturing heroin
2	(a)(1) exceeds
1	low birth
1	management grants
1	therein, but
6	safety for
2	generalthis section
1	substance. (4)
1	made. (ii)
15	published under
2	for, with
2	(a) or,
3	atomic energy
1	pathogens, including
1	529, as
3	book shall
1	showing probable
19	alter the
6	customary conditions
1	(a) farm
1	detaileesthe maximum
2	holiday pay
2	specific disclosure
3	change as
1	consultation under
1	container; consistency
1	affairs shall,
1	suffers from
5	shall inform
1	chapter. (t)
8	(ii), (iii),
1	(c) nalorphine.
1	packed beef,
1	(15) in
1	thereof does
1	satisfies each
2	685.)
 

1	sources, with
1	following: (1)
1	over, the
3	clearance, and
1	convention, or
1	(3) period
1	appropriate law
1	u.s.c. 392(a)),
1	subsection (a)(4)(a)
2	tribal drug
1	(d) issuance
2	outbreaks during
1	usage of
1	twelve years.
1	and, although
1	requirements colored
5	379v of
2	enforce restrictions
1	provide surge
9	connected with
1	(8)); (b)
1	contains, for
2	combinations for
12	353(b) of
2	(b) make
2	(c) treatment
1	health: provided,
12	disabled, or
1	returned. the
1	subsequent human
5	contents in
1	describing that
1	(2) testified
11	title, in
4	business (as
8	congress that
1	cosmetic act[1]
4	taken from
1	247d6, 247d6a,
1	abuse. (9)
1	guidance describing
1	enacted in
1	secretary, regarding
4	distributes, or
2	obstruction of
2	cured or
2	(i) reflect
14	(2) no
1	(a). (2)
1	cosmetics, devices,
3	including, where
1	sunscreen; and
2	sanctions imposed
2	information system
3	introduced, or
18	generalnot later
1	requirements, based
15	combinations of
1	institute for
1	despite good
1	(b)immediate publication
1	years experience
2	-fisca-year period,
1	economy and
1	office). the
1	state upon
1	rehabilitation of
3	proposed findings
1	pouches. 
1	authority. (2)
2	suspend inspection
1	naturally, or
1	(4). (iii)amendment
1	shall coincide
1	2016), including
1	chain, which
4	1, 2007,
1	warrantsa warrant
1	trends. nothing
51	high intensity
7	term secretary
3	birth defect;
1	product ceases
4	contemplated proceeding.
1	classification changes
1	relabeling of
1	repackager, the
1	date. (d)
1	rate as
20	amount equal
1	precluding action
1	poison, such
15	effectiveness data
1	members described
1	appropriate cases)
1	program. (e)
2	aug. 27,
1	general controlling
1	written inspection
1	available subject
2	facility the
7	days unless
1	investigating animal
3	food derived
1	toward developing
2	notice, order,
6	event associated
2	pharmacy compounding;
1	includes circumstances
25	making the
2	(2) protection
1	locality that
5	additive or
1	501 to
4	fees fees
1	received during
2	eat when
1	year, subject
1	americathe director
2	prescribing any
1	performance appraisal
1	secretarys judgment
1	resulted from
1	acquired, held,
1	survey with
6	adopted under
1	health waiver
1	judgment or
2	bulk chemicals
1	as, habit
2	appropriate, which
2	(f) recordkeeping
1	two dosage
2	judgment on
1	reviews previous
3	fee, and
17	proceeding under
1	receiving it
1	343(d), 343(e),
1	term implant
28	judgment of
1	as, but
3	247d of
2	enter a
1	subsection (f)(6)(h)
3	by, such
1	act at
1	(which other
1	section 103(q)[3]
2	pediatric adverse
1	corporation shall,
1	consultative auditthe
1	importer. (6)
2	determine. 
1	granted. based
5	government. 
4	secretary whenever
1	rehabilitation program,
1	leases, packages,
4	title, to
20	classes of
3	(c) fee
1	similar arrangement
6	(2). such
4	mandatory term
1	determined necessary)
10	drug was
5	compounding of
1	land, and,
1	formulating recommendations
7	authorized and
1	findings: (1)
1	ombudsman for
1	organization.if a
1	previously was
2	species verification
1	including expenses
1	plans under
1	future needs
1	destroyed, or
1	masks; (5)
1	independent establishment,
3	section 457
1	companion animals
6	beginning 6
2	beginning 7
3	beginning 4
3	beginning 5
1	beginning 2
9	period ending
4	program (as
1	made unlawful
3	statement by
1	machine. each
1	analogous product,
6	device; and
1	indian self
6	practices, and
3	denied under
1	expand activities
2	changes. 
4	verifying the
1	(a) accords
1	(3) administration
1	poultry producer,
3	program. (

1	quantifiable and
1	validity a
1	use, transfer,
3	schedule of
2	slaughter in
1	notice; deadline
3	methods by
1	(b) sunscreen
1	govern proceedings
2	(i) effect
1	administered for
1	review, was
1	enterprise; (ii)
1	individual) under
1	restrain dealers
1	section 387j(c)
1	data were
1	subsection, plus
1	(i) indicating
1	rule 15
1	14. any
2	(7) no
1	drugs distributed
1	(a) devices
3	applicable united
6	register requesting
1	proportionate basis,
1	applicable annual
1	traceability system
1	379j43(a) of
5	foreign commerce.
1	surveillance, observational
1	247d6d, 247d7e,
1	security affairs;
5	analogous products
7	members appointed
3	differences among
4	quotas for
3	board certification
1	otherwise, notify
1	872a. publi-private
1	decline participation
6	program (a)
1	countries with
2	professional background,
3	finalize the
5	ingredient and
5	seq.) or
1	corporation; (2)
1	1, 2021,
1	cases that
1	202, as
1	one million
1	article entered
3	has, with
1	(aaa) a
1	administered, as
7	writing to
1	officio members.
7	subsection (h)
1	regularly come
1	nasal cavity.
1	material submitted
2	inspected 
2	subparagraph. a
3	previous source
1	populations, in
1	paragraph (9)(b)
1	equipment); and
1	legalize the
2	engaged therein
2	patients; or
1	transmitted the
1	populations, if
1	history required
1	pharmaceutical security
1	states standard
1	aggregate information
1	intermediate endpoints
3	person submitted
2	accredit persons
1	provides, for
1	(6) response
2	section 387q(c)(4)
1	(iu) 40.0
1	roadside facility
1	articles. such
1	transfer 
1	(1) protects
4	crediting of
1	notice specifies,
5	immediate precursor
15	350d of
2	time order
1	noticeany notice
1	(f)(1) require
1	general.not later
1	animals annually.
1	protocol will
6	business means
1	responsibility in
1	formula) 
1	harm as
1	products) are
1	performance demonstrating
2	investigations performed
1	board; and
9	increased or
1	next supervisory
1	(b) is,
1	substances as
5	food sold
1	shortage upon
1	substances at
1	determine, the
2	unless naturally
1	conviction but
2	dependence; and
1	registration applications
1	trafficking the
1	average total
1	products (before
2	drug no
1	designating this
1	(ii) patients
1	becomes effective,
1	10 days,
4	conditions applicable
1	general, before
1	directions, as
1	supplier, then
2	shall authorize
2	expenses actually
1	(ii). (c)
1	eggs), sour
2	(ii) procedures
2	weight; or
1	remedy such
1	part, otherwise
2	establishment; (2)
1	adjusted to
1	penalties: (1)
1	alter, impede,
25	commercial distribution
6	recommendation respecting
1	ingredient, if
3	costs the
1	(2) health
1	area, conditional
1	section refusing
1	1974; $160,000,000
4	bioavailability or
2	including diagnostics,
2	artificial or
2	direct final
1	(c)) or
2	participation, through
1	chapter) may
1	42), including
1	packed. (v)
3	may refuse
3	clauses (i),
6	reasonable notice
1	2009, $85,000,000
1	otherwise open
1	term supplemental
1	evidence, clinical
9	accredited persons
2	applications, including
1	counte-drug programs;
2	necessary inspection
1	management participation
1	termthe term
2	monitoring program
3	legal basis
2	imitated; (4)
1	containing only
5	(1), including
3	american society
1	developed; (g)
1	application. (

3	imprint a
1	section 387t(a)
1	veterinary medical
1	section 314.550,
3	(public law
1	fee (if
1	writing setting
1	campaign) in
1	agricultural, or
1	purpose may,
2	label with
1	practitioner that
1	services have
1	31, the
68	title shall
2	taken final
1	food packed
3	importing of
2	poster, sign,
1	accredited person.
1	155, 6,
9	accredited person,
2	security that
2	regulation except
8	agreement to
1	exportation, in
2	different processes
2	importing or
1	export; petition
1	360h. notification
5	facilities undertaken
2	investigation, has
1	successor entity
1	thereafter: 
2	(1)(a); and
1	writing specifying
2	360, or
1	(13) of
2	secretary demonstrating
3	official united
5	inputprior to
1	march 9,
1	priorities, the
1	license referred
1	organization such
2	engineered seafood
1	102 to
1	make competitive
3	acts as
1	include licenses,
1	bulk, with
2	patients, payors,
1	deems adequate.
2	immediate notification
5	(b)(2). 
3	identifiable subgroups
1	accompanying the
3	secretary, among
1	title). whenever
1	physically incompatible,
1	(b), that
1	(b) effects
1	community; and
1	criminal, administrative,
6	administration personnel
3	supplier 
1	(d)) in
1	longer engages
2	section 842
1	section 843
28	committee shall
3	2012, a
2	headquartered. the
2	section 844
1	site by
1	federal agencies;
1	required, any
15	given the
6	laboratory supply
1	strategic planthe
1	-(2,-dimethox--nitr-phenyl)ethanamine (2cn).
1	section (or
1	plain, uncondensed
1	condition targeted
1	sums then
2	mitigation strategies).
1	shipped; any
1	denied approval
1	(mar. 2,
1	pounds. 
1	identifies, measures,
1	provided prior
2	articles, are
1	products sold
1	campaigning any
1	
 158.
2	inspection reports
34	(iv) the
1	applicable exclusivity
1	
 456.
52	years of
1	crustacean shellfish
2	207 or
1	relief necessary
2	(5), reasonable
1	(iii) knew
2	shall define
1	forfeitures 
1	on-year waiting
1	
 457.
1	laws, to
2	drug could
1	accredited. 
1	extent found
1	antiseptic for
1	making, selling,
1	practically free
1	money from
1	support dosing
11	monetary value
2	practice, such
1	effective after
1	(iii). (c)
1	chief of
1	term additive
1	exempt said
1	expected need;
2	foreig-grown tobacco
1	(533 u.s.
1	him, pursuant
1	date had
1	proposing a
1	applicable, is
1	stat. 208

1	sell, serve,
4	year; (b)
1	leveraging of
1	constitutes gross
1	relevant specialty;
3	secretary proposes
1	poultry; or
1	compensation (excluding
42	july 9,
1	
 469.
2	approved. (4)
1	oral suspensions
1	(2) acceptance
1	conducted. 
1	chairperson or
3	(3) except
1	womens issues,
1	1395nn(h)(4) of
2	become so
1	met, including,
1	rail vehicle.
2	manufacturers, and
1	manner, with
61	exceed the
2	initial completeness
3	(iii) there
1	(b)(iii) unless
1	officers of
1	regulatory efforts.
1	framework 
1	regulatory efforts,
1	following data
2	(a) reports
2	determinations upon
1	cigarettes, cigarette
1	slaughter; use
1	agencies referred
3	otherwise specified,
1	(5) explanation
1	secretarys notice,
1	knew of,
1	protect confidential
1	rings, and
3	of; or
1	therefore) orally
1	administration conducted
1	commodities (as
1	shall they
3	similar information
1	745a, as
1	review, clearance,
1	whether, after
1	knowledge. if
3	shall improve
1	diluting, pooling,
4	successor regulations);
2	personfor purposes
12	100 milliliters
5	shell egg
1	otherwise facilitating
2	compliance guide
1	apples were
1	community boards;
1	supervisory position,
2	dietary uses,
3	processed or
1	quality controls,
1	reasonable doubt.
1	activities pertaining
1	constitute such
11	supreme court
1	order, issued
1	imports the
2	also cause
1	1958(b)(1) of
1	even though
1	581, as
1	cannabimimetic agents
1	coordinated with
4	states not
1	formulation described
1	history provided
1	expertise, and
2	filled; and
1	distribution; (ii)
2	may develop
1	nutrients contained
1	schools; and
5	chapter. (4)
2	approval, or
3	representative, any
1	eggs containing
2	in, any
1	secretarys referral
1	reported $30,000,000
1	pharmacy, pharmacology,
1	uses, 
3	dismiss filed
1	days set
1	subparagraph (1)(b)(i)
3	device do
2	establish special
5	organization to
13	preceding sentence,
4	(3) review
21	repair of
1	possible links
1	marihuana means
1	1123. repealed.
7	differences of
3	meat articles.
1	quality controls
1	manufacturer requirements
1	306 of
1	referral) to
1	
 1713.
1	scientific issues,
1	letters in
1	senate, or
2	eggs, egg
2	management advisory
4	submitted such
1	(4) studies
1	relevant health
6	psychotropic substances,
1	recommends, or
2	term record
1	1165. repealed.
1	(g) qualified
1	$50,000,000 by
1	orders must
1	subsequent purchaser.
1	review; application
2	territory. 
1	address emerging
3	manufacturer under
2	hazards from
6	motor vehicle
1	operators of,
2	first premarket
1	requirement; and
1	pipes; (8)
1	consumer audience.
1	may determine.
4	technologies for
1	charged upon
6	corporation engaged
1	stat. 54;
1	formerly 6th
4	omitted or
1	1040 or
1	judicial forfeiture,
10	mail or
1	
 334.
2	technology; (b)
2	panels 
3	1040 of
1	term brand
1	instance of
1	consequence assessment
1	another account
1	continuing education
1	steps, if
1	reviewin conducting
1	approvals under
4	cooperation by
1	inches above
1	significant economic
4	purity, and
2	period, not
1	(ii) timetable;
1	ingredient. the
3	151 et
1	inserts; (ii)
1	(a) above.
1	combination, and
7	reclassification of
6	inspection in
1	section 282(j)(1)
1	toward reducing
6	inspection is
1	industry standards
1	device (less
1	achieve destruction
4	section 360ll
1	analytical, or
2	provide due
1	(j)(5)(d)(i)(iv) and
1	particular farm
2	implementation the
3	nmic and
1	regarding defects
1	order, obtain
1	u.s.c. 141
3	address an
1	instrumentality shall
3	dispenser of
2	lif-threatening; (b)
1	food; (ix)
2	section takes
1	insular, subject
1	sections are
1	(e). regulations
2	substances sold
2	dispenser or
4	article does
2	services (a)
7	substances referred
1	civil liability
2	effectiveness, except
1	outlines and
1	(c) plans
1	cancer, including
2	including technologies
1	prior comments
1	requester to
17	secretary regarding
1	corporation engages
3	petition within
1	including coordination
2	dismissed without
1	disagreeing with
1	(a). except
1	significant negative
7	section 1523(9)(a)
1	$1,000,000 may
1	
 961.
2	cause under
28	convicted of
1	periodic substance
4	fluids and
1	(b) 2
1	licensure each
1	be, the
1	immediately. (b)
1	(including seizures
1	mandatory conditions
15	refuse to
1	imposed as
1	
 396.
1	federal benefits:
1	either (a)
1	chemical intending,
1	area (the
1	previous determination
12	facility fee
1	subbrand. the
1	dates by
1	potential threat.
1	shipmen-specific certificates,
1	apply except
1	written determination,
2	entity, including
1	inaccessibility or
10	(42 u.s.c.
1	contents; description
9	denying approval
5	least twice
1	terms abbreviated
1	payor, formulary
21	may enter
1	following and
1	timely renewal
14	eligible entities
3	receipt, possession,
14	case where
5	resources are
1	387q. tobacco
1	(15), if
1	severity, specificity,
8	debarment under
5	settlement order
1	rural areas,
1	restrictions and,
1	830(e)(1) of
1	premarket submissions
1	submitted. notwithstanding
2	subsection (including
1	foods, provided
7	proceeding before
1	
 387d.
1	335b(a) of
5	available pursuant
2	parts, and
1	available (directly
5	regulations regarding
1	addition of
1	product stage,
1	antiseptic shall
1	mea-canning, rendering,
1	among children,
1	federal benefits.
16	amount specified
1	(f) percent
1	quitting behavior
2	additives, or
1	additional conditions
1	elements set
3	abuse potential
1	(b) secretary
1	350d. registration
1	him, if
2	section 321(v)
1	requestors under
1	information. (3)
1	information specified
1	22, 1996
1	coverage; rules
2	also the
2	mar. 16,
1	particular nonnutritive
1	countermeasures, through
1	1201 to
2	reconstituting, or
1	(b) 5,000
1	phenylpropanolamine as
1	(3) destroyed,
1	treat or
3	aside in
10	centum of
3	test marketing)
2	directed by
2	take place
1	official) from
2	device indicating
2	immediate container.
3	centum or
1	(h) reoffer
9	medical countermeasure
1	make up
4	(2) if,
1	whether approved
2	average, employs
1	described) during
110	general the
2	courts, the
2	goals, the
1	compelled under
1	priorities. (iv)
2	services, may
1	powder, when
1	face raise
1	equivalence, established
3	title iii
7	country, and
2	division may
1	infectious agents,
6	year; or
1	(3) whether
8	years; and
1	(a) federal,
2	paragraph. such
1	relevant federal
1	secretary allows,
3	following categories:
14	confidential access
5	humans. 
1	additives. (2)
1	suffer from
1	
 379j21.
1	respective states
1	(iii) 50
1	special studies
1	type introduced
4	360ccc1(e) of
1	surveillance systems,
2	evidentiary hearing
1	safety information;
12	keep records
1	labeling; (2)
1	improvements, which
4	classify the
1	(2); (5)
1	previously established
4	months, and
2	safety information.
2	derives profits
5	safety information,
1	equipment each
1	feedback letters
1	investigations has
2	ethylene oxide
1	particular need
9	amounts 
2	institute is
1	interstate. thus,
7	title ii,
1	thereof, but
2	animal which
1	(i) human
2	merits of
1	research laboratories,
6	section (including
2	request. the
2	interstate, is
1	evaporated milk
4	conducting inspections
1	specific appropriation
1	subject by,
1	subsection (b)(1)(a)(ii)
1	prevent illicit
1	2009 that
1	assistance, as
2	preempt state
1	new hazards
9	exclusivity under
3	identified individual
1	current pattern
1	summonses issued
1	nonmedical electronic
2	upon oral
1	applicable; enforcement
2	subsection (f)(7)
4	individual as
4	reasons or
1	360ddd1. regulation
2	infections due
2	legitimate purposes
2	2012, or
2	listed chemicals;
2	necessary expertise
3	consumed throughout
1	appropriate circumstances
19	technical assistance
1	residence with
3	judiciary of
1	approves or
1	(d) rebuttable
2	inspector: provided,
5	(4), or
1	balanced consideration
1	current trends
6	reasons of
1	355(j)(5)(b)(iv)(ii)(cc) of
1	technology. (iii)
2	hours of
3	number, and
2	(4) or
1	develop metrics
5	states authorized
1	exceeding such
1	conditionally approved,
3	qualified scientific,
2	supplier was
1	name, common
1	
 889.
2	premarket approval.
2	employ, hire,
2	premarket approval,
1	675, 1008,
1	notice, shall
1	documentary or
3	processors of
1	subsequently transferred
3	enforce a
3	accept ownership
1	tribal participant
1	(ii) actions
1	application within
2	general upon
5	government entity
2	presubmissions or
1	devices, for
79	owner or
2	order following
1	 while
1	notify practitioners
2	transaction statements,
4	extensions); or
4	part therefor;
3	ensuring the
26	owner of
1	swingsets, and
5	listed chemicals.
1	business. (4)
1	carrier does
1	additional resources,
1	submission following
1	government over
1	enforcement relates
1	(b) referral
4	seq.] for
1	inspection programs;
9	programs. 
1	warnings, health
1	subchapter. it
1	authorized, upon
1	separate registrations
2	another health
1	(xv) -penty--(-chlorophenylacetyl)indole
1	products broker,
1	i, 21,
1	increased efficiency
3	local law.
3	notice, request
3	investigations must
1	360(h)(3) of
1	informationif the
1	within close
2	type included
35	regulations prescribed
1	sel-certified in
1	stat. 500;
1	(7) elements
1	items; u.s.
13	commerce, and
1	warnings section
3	proceedings with
3	entity organized
1	sprayed on,
1	(2) streamlining,
1	developing improved
1	886. payments
1	collectively; and
2	ingredients included
20	imprisonment and
15	(mar. 3,
1	(2), fees
1	imply to
3	regulations prescribes
3	commerce, any
1	hazards, implementing
1	sanction such
1	(b) bond
1	(iii) facilities
2	inspection training
1	exemptiona drug
1	devices; (10)
1	systems using
2	withdraws the
1	mucous membranes
1	otherwise achieve
1	facility a
1	initial reports
1	reporting) applies
1	defect, the
1	response from
1	system; (iv)
42	2907, title
1	
 967.
1	make him
1	sources including
1	anticoagulant; (ff)
2	studies. (b)
11	report the
2	treatment; and
3	parties shall
5	parole during
1	council, including
5	regulations prescribe,
2	providing 
1	(d) mixture
3	time. the
1	county. 
3	27, 2013.
8	device, a
1	consistent manner;
1	1,000 poultry
1	1996. (9)
1	interference with,
1	check, dirty
1	1603. general
1	prescribe procedures
1	jurisdiction. (6)
1	(2), further
1	conducted may
1	total worldwide
1	
 679a.
1	(4) lysergic
1	allow a
1	343(i)(2), 343(w),
3	provisions apply
1	practice. (b)
1	(bb) a
1	assessments, and
2	secretary seeking
1	identify, clarify,
1	iron (mg)
35	september 30,
1	(d) strategies
1	section 331(b),
26	schedule iii,
1	agency act
7	judge or
1	following requirements,
1	pictures, or
3	human efficacy
1	necessitates the
5	appeal from
1	
 472.
1	15 to
2	provisions only
1	judge of
3	fraud or
2	360c(a)(1)(b) of
1	clinical endpoint
1	inert ingredients
1	proposed federal
1	accrue from
5	developed in
4	strategies and
1	applications thereof.
1	621. inspectors
1	inspection; certified
1	significant prevalence
1	publication entitled
1	organizations, of
1	(c), make
2	committed outside
2	policy related
1	grams. (4)
1	4439644615 (august
1	science research
1	clauses (1)
2	track the
8	with, and
4	costs fell
3	nevertheless be
1	litigation costs;
1	with, any
3	(b), as
1	organizations, or
1	eggs may
3	exemption that
1	act) such
21	results in
1	tobacco health
1	qualified en-userin
2	heroin; (b)
1	whose label,
1	varieties of
1	entry programs
1	products; violation
1	order granting
1	preceding -month
2	decertification issued
1	331(i), 343(f),
1	day deemed
1	shortages (a)
2	federal grant,
1	medical professional
3	level that
3	corporation who
3	states dollars,
8	enforce the
1	analogue shall,
1	rarely been
2	chapter except
2	biosimilar user
1	entities; and
2	thereof from
2	award to
1	gratuities, fraud,
3	drug users
7	bond while
2	commodity which
1	promulgate proposed
1	352, 355,
12	manufactured in
1	food coming
1	2012. the
1	manufactured is
1	enabling patients,
1	1523. definitionsin
1	criminal violation
4	artificial coloring,
7	petition of
1	suspended, expired,
5	establishments registered
1	section over
11	designated as
3	seriousness of
1	(d) take
1	monitoring; or
1	panels recommendation
1	section 844(a)
1	risk above
10	145, 1
1	206, 207,
1	level requirements
38	request under
1	$252,960 
2	manufacturer must
1	regulations (through
1	marketing. (s)
1	others. (july
1	debarment; judicial
1	inspection, investigation,
1	shall stay
4	committee appointed
1	several principal
1	register following
8	systems, and
1	(a) design
2	poultry products;
6	devices are
1	designation developed
5	5304(e) of
1	second offenders
1	effectiveness the
7	recommendations under
1	safeguard public
3	1996, and
1	marketing the
12	31 of
3	receiving any
1	endangered children,
2	fine, or
1	written feedback,
13	certification or
1	death penalty
1	opium. (3)
1	384a. foreign
2	(d) collection
1	device. (iv)
13	1-month period
1	
 954.
3	trial design,
2	administration. (2)
1	meetings and
1	prescribing recordkeeping,
3	general, or
12	information, transaction
1	basis testing
1	(4) benefit
2	including trial
1	(i) publication
1	360c(a)(3)(b) of
1	device imported
1	current experience
1	271(e)(2)(a) of
2	poison prevention
1	$652,709,000 plus
1	beneficiary health
36	shall consider
1	good standing;
1	ounce, or,
4	updates to
2	(g) judicial
1	alter, or
1	concurrence. (4)
1	applicable legal
2	notification, and
5	july 22,
1	18, except
2	intravenous solution
2	537, formerly
1	possessions and
8	guilty of
1	material (except
1	dutiesthe tobacco
3	2013. 
1	if, however,
24	collection of
1	held (1)
1	cut, harvest,
2	owed under
2	used, in
1	 (i)confidentiality
2	section applicable
1	subsection (c)(1)),
3	retail store
1	deadline a
2	27 percent
4	body function
40	together with
1	subsection (a)(2)(d),
8	person shall,
1	independent research
1	provide advance
2	electronic products;
2	information when
3	subgroups, including
1	proposed index
1	programs, seminars,
1	avoiding or
1	transactions described
1	considerations involved
1	violation occurs,
3	electronic products,
4	tracing requirements
1	(1) so
1	final regulations.
1	base establishment
1	physician, manufacturer,
1	person located
1	purchaser shall
1	adequate inclusion
2	contingent at
1	(3) board
1	safer pesticide
3	imported for
5	revocation under
1	actually treatedin
2	(d)(3) is
1	different symbol
1	index contents;
1	packaging that
1	filed whether
1	production control
1	time, make
3	coloring) present
1	(2) between
1	applicant had
1	manufacturing industry
1	(a). (iv)
1	requirementsbeginning on
5	section, except
1	video production
1	evaluation as
2	1949, ch.
1	exported and
3	persistent or
1	use drug
34	applicant has
5	thereafter be
2	licensing program
1	(4), each
1	secretary), acting
2	inhaling, or
2	nonsupervisory employees),
2	no-compliance with
2	becoming final,
2	panel with
2	automated risk
2	relationship, as
2	proposed strategy
1	thereafter by
1	handbill, or
1	general.the secretary
5	marking and
1	areas relevant
1	data between
1	ch. 804,
1	account. for
1	transactions quarterly,
1	(b)(1); (e)
1	product corresponds
1	permanent but
1	transaction that
1	topics for
1	defect is
2	transitioned to
1	specifications that
1	originates. the
8	strength of
1	15, except
1	timely submitted
1	justice a
2	part (1)
1	(i) amount
1	meeting; (ii)
3	forces of
2	period on
14	credited to
4	standards (a)
6	last day
1	defect in
1	675, 915,
1	(2). an
3	1604(c) of
4	strength or
1	month succeeding
3	drug designated
1	licensing under
1	360ccc, or
3	commodity; (ii)
1	(b) on-third
3	treated in
1	drug crisis,
6	entities described
4	registration shall
1	(10) participate
1	studies, registries,
1	individuals, equipment,
1	1102; 1940
1	term hair
1	uses for,
1	drug derived
2	administration by
7	trials and
1	five and
1	improve coordination
1	data relevant
2	activate such
1	(r) temporary
1	concept and
1	device, (2)
1	(v) taking
1	assistance that
1	include performance
1	applied after
1	include standards
8	chapter that
1	act referred
1	commissioner. the
1	pediatric applications
1	42) to
1	concerning, research
11	notice required
1	352(r) of
1	entity. (ii)disposition
1	otherwise assure
1	862a. denial
1	proceedings below.
1	board, as
1	claimant thereof.
1	1541. establishment
2	(e) evaluation
1	conduct, coordinate,
2	protocol submissions
1	investigate, regulate,
2	people, people
2	states, to
1	title, has
1	ris-based foreign
1	meetingfollowing any
2	trier of
2	agencies over
1	(a) emergency
11	patent that
7	milligrams per
1	inspectors certificate
4	reduce substance
1	continue, or
2	approving all
2	food ingredient
1	abuse. (h)
23	products scientific
1	affirmations or
1	transport by
1	limit, or
1	review. (r)
1	(a)(1) under
1	quota, has
2	coordination the
1	number at
1	number as
1	commission upon
23	finding that
1	law; (c)
1	sponsor disseminates
1	come from
1	(b) processthe
1	establishes in
1	additional investigations
1	substance. (c)
9	facility means
2	testing plan
1	varied means
1	formerly 16th
1	american consumer.
1	testimony. if
1	generalthe term
1	suspension before
2	pharmacists, and
1	timely patient
2	3(a)(1)(b) of
2	detailed summary
1	subsection. (c)
1	approve had
1	decreased to
5	period or
2	food imitated;
1	identification technologies
2	required from
1	commission). 
6	requirements regarding
1	practice. nothing
1	evaluated, including
1	subsection (b)(1)(a)(i)(iii)
1	whether accredited
2	entity described
1	expects to
1	established. 
1	provides reasonable
2	drug among
2	information requirements
4	database developed
1	resources necessary
1	conducts food
5	real property
2	drug differ
14	public health;
1	public health:
1	alleged misbranding,
1	dairy product
1	distribution practices
11	retention of
1	interested stakeholders.
7	combination products
1	surface; or
3	new indication,
2	(g) 5.0
5	agency with
1	(5)(a) shall
1	permits, credentials,
2	credible scientific
50	public health.
44	public health,
1	impleaded into
1	farms if
4	subpena issued
4	sound and
1	interest. (8)
2	satisfactory alternative
2	priorities in
1	demonstrating equivalence
2	assessment becomes
1	compounding pharmacies,
2	accreditation from
1	sufficient authority,
1	1967, that
1	program), the
1	bring together
1	387f of
1	(k), upon
5	2 years,
2	declaring a
2	2 years.
1	integrated. (f)
1	labelingnotwithstanding clauses
1	constitutionality of
1	2010 through
1	appropriate organizations,
1	ordered forfeited.
4	(2) requirements
1	standard would
1	family educational
1	product made
2	substance abuse.
1	
 372a.
6	manufacturer may
1	appropriate of
1	concerns that
1	register modify
1	(4) tolerances
1	including fingerprinting
1	veterinary drugs
1	seller complies
1	chemically synthesized
1	(e) feedback
3	level information
1	party, a
8	time in
1	criminal forfeitures,
1	different articles
2	(1) performance
15	circuit in
7	establish within
2	74, 6,
1	data; (ii)
1	custom prepared
1	concerning prescription
2	submitted. the
1	executive of
1	regulations. (5)
1	products). 
4	food, unless
19	subchapter shall
1	still relevant
12	fast track
1	admission unless
1	official having
1	behavior of
1	biotechnology companies,
12	certified by
1	reasons; (x)
1	smoke constituent),
1	(a) compounds
1	1402. foreign
1	453, 455
15	products in
1	(i) pose
7	committee act
1	coalition shall,
1	customers, if
3	parameters of
1	comes within
23	subparagraph (c),
1	1961; 
10	subparagraph (c).
1	request were
9	shall not,
3	encourage treatments
2	(i) on
1	held thereafter
2	workforce planning
1	foundation a
24	term does
2	annually, review
2	subparagraph (c);
1	relates only
1	mobility of
1	parties prior
1	research, including
1	permit him
1	upon patients
1	secretary function
1	effectuated through
1	ensure continued
1	subsection (1),
1	(2) labelingnotwithstanding
4	entry and
6	jurisdiction may
5	persons with
2	data bank
4	deceptively packaged
1	columbia. (june
1	pharmacy recognized
1	mitigating drug
1	unit dose
1	sentence, requesting
2	regulations required
5	activities are
3	assistant is
1	hearing; except
1	exceeds $20,000,000;
3	trial; united
1	fish (e.g.,
1	gift, money,
1	coordination on
1	24, as
3	full or
1	labor, the
6	(b) fee
1	applicable. (10)
18	coordination of
1	tank, pond,
1	review; report
14	within one
20	title, a
1	x.c and
1	obtain informed
1	carcass, and
4	secretary has,
1	secretary has.
1	directions contained
14	device will
1	(i) estimates
1	them, the
1	subcommittee[2] regarding
1	subsections (a)(3)(d)
3	package is
1	(1) licensed
1	correcting any
12	use 
1	applies: 
1	emergency prescription,
1	of[2] chain
1	emergency prescription.
1	(3) fee
2	evidence presented,
2	one thousand
1	whoever, while
4	agency, and
1	labor. 
2	implicit representation
13	group of
7	(a) officers
6	(iii), and
1	effective sharing
1	substantial improvement
1	714c) for
1	amount agreed
2	distributes the
1	(l) harmonization
1	substances, identifying
6	program or
1	may choose.
1	meet urgent
1	unnecessary duplication
1	(2) availability
1	2018, $13,500,000;
2	informal or
1	election referred
12	360j(f) of
1	entry; (d)
1	manufacture only
3	record, report,
16	program of
1	applicable, an
3	2013 and
9	procedures prescribed
1	renumbered 5
1	profile in
1	facility compounds
5	year are
1	(3) panel
3	actual and
1	period contained
1	(o) reprocessed
2	operating such
14	title 31.
1	facilities including
1	submitted, updated,
1	insert, if
1	675, 524,
1	paragraphs (g),
1	pack, box,
1	(i) postmarket
2	space, respectively.
1	carburetor pipes;
2	government entities
1	second review
1	animal; provided
1	(j). any
1	duties, for
1	136a(c)(2)(b)]; (b)
4	additional grant
1	 (b)immediate
1	corporation dispensing
1	foreseeable biological,
1	vehicles; (d)
1	infant formulas,
1	denied; (d)
1	animals, unless
6	possessing with
1	felony means
1	shall document
1	oxygen can
2	employee, upon
1	379d5. guidance
1	subsection (e).[1]
1	(5) leins[1]
2	(e) withdrawing
2	certification may
1	secretary do
1	conservation, and
1	foreign intelligence
1	technology should
1	(iii) criteria
1	(a) proposed
1	strategies. 
2	public swimming
1	following chemicals:
2	entity the
3	attributes necessary
5	continue the
1	biological, and
1	participation an
3	use be
1	discussions under
1	amphetamine. (4)
1	convictions; other
1	facilitate, the
1	uniform assessment
2	additive, intended
1	reinstate recognition
1	in[3] voluntary
2	(iii)offer of
4	permanent impairment
1	state enacts
1	report also
6	title 7
4	term transaction
1	numerical designation.
2	product using
1	(ii) nothing
1	participation at
43	use by
1	exceeding identified
2	action, consistent
11	withdrawal or
1	passed or
1	licensing, and
1	account his
1	groups; (b)
1	similar device
1	evaluation data
1	(b)(iii)(i) and
1	607. labeling,
1	(1) only
18	withdrawal of
3	evidence, that
1	(2) -methox-3,-methylenedioxy
2	yet submitted
1	obtain samples
1	(b) fined
2	ingesting, inhaling,
2	residue will
1	so, the
1	stage and
1	(c) based
1	(including substance
1	immediate risk
1	paragraph (34)
1	plant, except
3	purity, safety,
6	developing recommendations
1	category identified
3	identifiers to
8	punished by
1	(8) $80,000,000
2	account or
2	committee (or
1	section 1707
1	section 1706
3	section 1705
2	fait-based organizations,
2	section 1703
1	increased punishment.
1	section 1701
1	formulation under
1	(c) lysergic
2	consuming public
2	direction to
11	name, address,
1	
 1
4	247d6a of
1	response laboratory
2	subchapter, including
1	(or within
1	food sold;
1	nature, complex
1	entities. (b)
1	dissemination, to
1	crisisthe term
1	disclosures that
1	additional labeling
1	reaccredited. 
2	information supplied
1	states grain
21	prescribe the
9	(iii) or
1	subsection (c)(1)(a)(i),
4	determination or
2	patient. 
1	hydrocyanic acids
5	section 360ccc1
3	(f) any
1	system collectively
2	(i) conviction
341	
 

6	determination on
4	conform, as
2	3502(3) of
3	nations total
2	use; (7)
2	approaches such
1	corporate seal,
54	determination of
1	exportation constituting
2	relief and
1	impact; and
5	due under
6	subsections (c),
4	360j(f)(2) of
1	knowing at
2	regulation on
2	(b) consult
1	experience, for
1	device through
1	hearing when
1	involved intends
44	regulation of
1	uniform proportionate
4	2012; and
1	section 1401(4)
1	(3) defraying
1	undertaking to
3	taken that
1	term vessel
19	condition that
71	regulation or
1	321(s)(4) of
3	30, 1980,
22	upon by
1	year, for
3	term administrator
14	respecting such
1	defective. (2)
1	heroin consumption
1	limitationthe director
1	confirmatory evidence
1	law (if
1	use; 
5	manufacturing, and
2	enforcement administration.
5	substantive proposal
3	parties. 
1	short to
2	date, a
2	like products
1	sulphide of
2	proceeding other
1	materially falsified
1	type styles
1	out, and
1	o-site inspections,
2	incentive program,
1	141. prohibition
1	transshipped from
1	(a)(1), as
21	product intended
2	advisory review,
1	commodities (other
2	diagnosis, prevention,
1	species may
4	device because
1	patent owner.
4	members the
7	civil or
1	product). (2)
1	transshipment to
2	states. this
1	significant advantages
1	additional sites,
1	impediments identified
1	thereof. (mar.
1	respond aggressively
1	effectively protect
1	eligibility review
1	warranted and
1	(ii) waiver
1	drugs. nothing
1	thir-party organizations
1	whole, or
1	(7) residues
1	per product
1	include procedures
2	evidence (other
1	survey as
1	criminal or
1	467d of
7	section; (c)
1	misbranding; notification
1	researchers to
1	
 613.
1	secretary requested
4	(1) establish
1	(3) considerations
1	resistance) and
2	accreditation body,
1	authority by
1	methamphetamines. 
1	except where,
1	distributors, except
1	supervise clinical
1	profits (a)
1	vulnerability assessments
1	(a) exemptions
1	(iv) establish
2	clinical significance
2	recordkeeping, and
10	less frequently
1	675, 735,
1	affecting national
1	(2)(a). (c)
2	device until
3	proposed tobacco
1	(a) basis
1	procedures each
8	sponsor has
1	frontier area
1	appoint 11
3	subparagraph shall,
2	1938, it
1	environment. (d)
1	regarding providing
1	collection, to
1	supplying to
2	societies, and
2	2017. (h)
1	
 1908.
1	administered are
34	identification of
1	premises definedas
1	conclusions thereof.
1	emergency economic
1	subsection (b)(4)(a).
1	regulated product
1	inspection; suspension
35	accredited thir-party
2	synthesis, or
4	human resources
1	producers do
2	(2) postapproval
1	exempt class
1	(6) shall
2	product introduced
6	esters, ethers,
1	health, except
1	4, 38
21	costs for
1	generallyfor the
1	control can
3	(7) in
3	known address
2	working days
2	2016; and
3	obligated or
1	providing to
1	development organization.
3	frequency and
1	evidence developed
1	384b. voluntary
1	states. (f)
1	country. (g)
1	seizure authorities
1	otherwise supplied
2	require 
2	fee applies.
1	415.)
 

1	locations) and
2	penalty any
1	development organization;
2	practices to
1	chemicals; behin-th-counter
1	nux vomica,
21	premarket notification
1	(5) codein--oxide.
2	subpopulation that
1	physicians. any
1	benefit relied
1	transfer title
1	person presiding
9	european economic
1	exclusivity any
15	ch. 74,
1	period. (11)
1	intended use.
1	temporary period
1	condemned and,
1	practice regulations,
1	acts until
2	applicant named
2	exercise the
1	entity (or
4	reliance on
1	advertising; and
1	section 1395nn(h)(4)
1	secretary estimates
3	distribute controlled
1	threat. (d)
1	262, for
1	(d) aggregated
1	tests conducted
2	effect; (d)
1	4332(2)(c) of
1	disclosure for
2	prioritize and
1	to, electronic
4	section 352(e)
1	international, state,
3	generala person
1	phytolacca, strophanthus,
1	unsafe food
2	agreement, the
1	
 321b.
1	356, as
3	reviewed within
1	conditions; (3)
1	alternatives available
2	sponsor who
2	register, that
1	rapidly track
8	refund the
1	981(b) of
1	teams established
1	law. (c)
1	conducts an
198	title or
2	reasons that
1	(i) define
1	upon certification
6	title on
3	word imitation
1	person, firm
2	maintaining an
2	467a of
10	title of
15	drug sample
1	shorter than
1	(c)(4) during
1	assay have
11	determines appropriate.
1	behalf) a
10	determines appropriate,
1	facility making
1	section 343(j)
1	wel-being; or
7	(b) by
1	certificates, permits,
1	(including financial
1	(b) ensure
1	offenses; and
2	general, except
1	trade dress,
2	(c) immediate
2	material required
6	(b) be
3	determines appropriate;
2	drug or,
2	handler shall
1	
 360fff4.
1	clause (a):
1	exclusions from
1	warrant identifying
1	medical practice
1	carrier has
2	prescribe, the
1	model number,
1	882; 

1	packaging. (6)
2	lawfully obtained
1	therein any
7	care entity
1	(iv) issuance
1	(7) revoking
1	(4) animal
2	quantitative listing
1	distribution located
1	animal; or
1	documentation regarding
1	312 of
1	333(c)(3) of
1	section 1531(d)
1	health. (ii)
17	regulation promulgated
1	
 360ddd2.
1	section 524(c)
2	way affecting,
2	derivative, mixture,
3	governmental agencies,
1	(4)(a), as
2	subparagraph (a)(vii).
1	present statements
1	manufacture, propagation,
1	trials; and
1	departments, school
1	governmental agencies;
3	any. 
2	successive -year
2	(ii) conducting
1	(iii)(ii). the
1	intangible personal
1	city average;
1	treat within
1	ingredient, route
1	contamination is
3	secretary his
1	v, 501,
1	469. authorization
2	curricular and
1	970. criminal
2	field investigation
5	city average)
1	identified shall
1	contamination in
1	setting ris-based
1	drug trafficking.
19	application, the
1	foods, including
1	states determines
27	notice in
1	consumers, if,
2	margarine or
1	termination serves
2	summary description
1	required record;
1	notice if
1	meet appropriate
1	(1) verification
1	
 379h2.
1	tools under
11	acts. such
1	labeling, including
1	notify congress,
1	opaque material
7	gross receipts
1	appoint federal
2	packaged, are
1	conducted; (ii)
1	malfunctioned and
1	reviewers have
13	notice is
1	debarment; food
3	default as
1	judicial affirmance
1	transferee involved
1	implemented or
1	writing, similarly
3	i, or
4	may, without
1	unfinished materials,
1	saccharin includes
1	facility, legally
1	way involve
1	(4) procedurein
1	1(100), 45
1	subsection (d)(1)(b).
287	tobacco product
1	encouraged to
2	officer and
1	data, in
2	(before or
2	views, either
3	applicable fee
7	record the
3	term counterfeit
1	scienc-based standards
1	reimbursed amounts
21	paragraph (1)(b)
1	subsections (b)(1),
1	detailing emergency
1	reimbursement and
1	including changes
1	harmful viable
1	quota shall
1	constituents, to
1	therapy. 
1	safety collaborations.
1	registered trademark,
1	subject under
1	title, 
3	eggs fit
1	exceptions under
1	meat science,
1	(b)(2)..[1] (d)
3	means by
1	micrograms of
1	later withdrawn
1	secretary, are
6	552a of
1	law with
1	fictitious, or
1	jurisdiction, from
2	unique device
1	understanding to
1	(e) reliance
1	hardship, which
1	meetings held
1	directors the
1	surfaces of
9	(c); or
2	field personnel
1	(6) methohexital.
1	defined pursuant
4	5 grams
3	distributor for
1	coordinator to
1	
 616.
1	agents in
2	recommendations if
1	exclusionsthe term
2	type to
1	move toward
1	assessing conformance
2	employees; and
1	(b) random
13	recommendations in
1	substance; (2)
2	official capacity,
1	18th par.,
1	issued. (b)
1	360m. accredited
1	hyperlink is
1	pivotal animal
5	incidence of
1	contracts. for
2	republished on
1	repackager for
1	hardware and
1	new findings
1	next quarter.
1	sued in
1	cosmetic bearing
2	convention will
2	(b); (2)
1	services throughout
1	importing a
1	descriptions: black
2	bribery, payment
1	provisions would
1	reasonable standard
1	development, improvement,
1	states was
1	assuring access
1	extension, identify
1	notice, 30
1	quotas shall
2	emits (or
4	360eee2 of
1	person, after
1	demonstrate how
2	adequate expertise
1	meetings; and
1	360d. performance
1	packaged, or
2	analytical method
1	(a). for
1	within ten
1	notice given
6	regulations implementing
1	methodsthe secretary,
1	(a) sanitary
1	resident alien,
1	pose questions
1	name, its
1	contain not
1	1005 of
3	term advertisement
2	review time
1	publish, and
3	confidential under
1	drug; (b)
2	tracking of
5	activities 
1	section 342(c),
1	refuse access,
1	last quarter;
1	annually, publishing
1	poultry producers),
1	testified or
2	prohibition act
1	linoleic acid)
3	investigate a
4	title 15,
1	relates, except
1	extent considered
3	information exists
1	har-drug users,
2	applies, subject
1	tracking or
4	pseudoephedrine base,
1	pipe tobacco.
2	members who
1	suitable size
1	consignee submits
9	case the
3	specific serious
1	(2) grounds
1	dealers is
1	(a), whichever
1	exercise enforcement
1	postpone sentence
4	attributable to
1	disqualify a
1	debarment, temporary
1	importer be
7	approved labeling
1	agencys budget;
4	effective administration
1	subsection (a)(4)(c).
1	(except matters
1	subsection (a)(4)(c),
5	districts of
19	right to
1	judicial, regulatory,
1	sanctioning for
1	accept voluntary
2	said can,
1	promptly disclosed
4	monitoring, or
1	(c) specific
9	shipment of
2	testify at
1	close proximity
1	(1) describing
1	provider 
1	423, 62
1	(iv) 100
1	(2) definition
2	private citizens
2	collected. the
1	verification. 
9	including requirements
2	senior managers
1	innocent persons
1	cautionary statements
1	milliliters of
1	government agreeing
2	section 880
1	scienc-based guidance
2	paragraph (3)(b).
1	abuse or
1	appeal no
3	specifications, as
6	issuing such
10	training to
1	(iv) provides
2	incorporated in
1	nongovernmental organizations
2	another entity
1	
 358.
1	domestic production
1	condition, such
1	persons about
2	required surveillance.
1	trace food
3	will use
1	accreditation, within
1	identity if
13	section 348
5	administrative and
2	include prominently
3	term financial
1	marijuana are
5	section 341
4	(e) no
3	section 343
15	section 342
1	order suspending
3	section 344
1	states pharmacopoeia;
1	675, 508,
1	identity it
1	microorganisms of
4	states pharmacopoeia,
1	states pharmacopoeia.
1	have, under
1	identify adulteration
2	local partnerships
4	factor. 
1	registry under
1	done in
1	less food
1	association, (b)
1	new time
8	42, the
7	administration that
4	protocol described
2	equivalent means
1	references scientific
1	laboratory measurement,
1	deem appropriate,
1	(9) office
1	(xiv) -cyclohexylethy--(-methoxyphenylacetyl)indole
1	order permanently
2	puerto rico
5	section. (4)
3	act (including
1	operations with
1	drugs act
1	periodic consumer
1	members willing
1	considerations; (gg)
1	2018, $672,000,000.
1	reason, (2)
1	formula to
1	cosmetics this
1	informationnotwithstanding subsection
2	controls authorized
2	misbranded article
1	
 214.
1	(1) oversee,
1	vulnerabilities (including
2	agents thereof,
11	availability the
3	951 et
2	fine in
2	group purchasing
1	written permission
1	participants and
1	applicabilityregulations promulgated
8	20 calendar
1	chapter; term
1	compliance datethe
1	post such
1	exported; but
31	promulgated by
1	supplying of
1	(a) focus
1	somniferum l.,
25	applicant, the
1	noncash, i-kind
3	respecting approval
2	general does
1	definition given
1	manufacturer expects
2	(b)(2)(a), the
1	liquors or
1	methylamine. (n)
11	effective under
1	reclassified into
9	secretary, which
1	(ii) none
1	individuals understand
3	intelligence information
1	registering as
3	laws regulating
1	information filed
1	2234 and
2	security. 
1	updated to
1	novo. (k)
1	values for
1	otherwise misbranded,
2	disseminating information
1	section (1)
1	portion, during
2	cros-examine witnesses
1	significant unmet
2	writ of
1	separate information
1	(c) limitationssubsection
8	filth, or
1	
 350j.
2	private entities.
1	emergency treatment
1	drug order
1	states according
5	practices in
1	approved product:
1	animal trials
1	convention to
1	portions and
2	shortage not
3	term restoration
1	exceed 100
1	drop shipments
5	firms, or
4	2016, and
2	issues relevant
1	officials as
1	month for
3	(1) limitation
1	exists when
4	present their
1	private entities)
1	evidence sufficient
1	department) is
1	675, 402,
1	(e) duration
2	will exceed
1	animal owned
1	otherwise complying
1	regional capacities
1	secretary, carry
1	food maintains
1	applied. 
1	requirements.each contract
1	(m) requests
4	file objections
4	pharmacy that
2	section 360bbb1
1	employee has
5	section 360bbb3
1	(5) too
1	section 360bbb5
1	permanently ineligible
1	section 360bbb6
2	chief financial
1	center (referred
1	conditions, including,
1	followed under
1	etc., or
2	(a) processing
1	advisory opinions
1	(ii) that,
1	maintain in
5	2014 and
1	institute; (4)
4	protected by
1	animal industry
2	given with
2	term positron
1	office with
1	procedurethe secretary
1	segregated from
1	expertise, to
3	conduct postmarket
1	(3) discontinuance
2	otherwise used
1	publication, but
1	
 360rr.
1	processing, transporting,
11	secure electronic
3	title. all
1	certificate that
3	implemented to
6	probability of
4	effective use
6	applicable provisions
1	reviewing reports
1	labeling; (ii)
1	consumers, he
1	physicians, dentists,
1	chemicals than
2	identification prior
2	may subject
1	product, food,
1	respectively; 
1	section 2012(a)
7	shall withdraw
1	(2) determination
1	modify such
1	98. transferred

1	medical centers,
1	jurisdiction other
1	research; (4)
2	completed with
3	granted prior
1	control receipts
27	ii of
1	codes the
1	given not
1	(a) determining
4	data supporting
1	ch. 810,
1	drugs, an
18	ii or
1	broken so
1	(ii) changes
1	844(a) of
1	(e) preventing
2	approval issued
1	morpheridine. (30)
1	institute appropriate
18	drugs that
1	reporting on
1	demonstration purposes
1	notice does
1	filled on
2	respondent at
1	paragraph (2)(a)(i)(i).
2	specific pediatric
2	travel time)
36	made to
1	depressant effect
1	parole, or
1	(2) exemptiona
1	public website
1	1333] and
1	title 39,
9	regular places
1	promptness; exclusions
2	coordinated lon-term
3	every case
1	document regarding
1	(5) there
3	seizure conferred
1	comparison of
3	thereafter provide
4	food imports
1	(2) exemptions
1	36-day period
1	issuance, and
1	detailed examination
1	tribes; and
1	379h2. reauthorization;
1	available of
2	u-t-date list
6	public in
1	
 360d.
1	caring for
3	nanomaterials with
57	enter into
1	1044 of
2	made not
1	(iv) because
1	material. (8)
1	huma-readable form
3	application therefor
7	carries out
1	experts, qualified
2	complainant and
1	(v) establish
1	background in
13	term qualified
2	accreditation. (d)
1	submissionin developing
1	(6) coordinates
1	increases are
1	treasury. the
6	renewal grants
3	(b) if,
2	exclusion the
3	federal departments
1	(f) travel
3	video arcade
1	subdivision as
1	misbranding, or
2	him, that
1	675, 1,
3	disputed issues
2	technology to
1	life threatening
1	expertise when
5	transporting in
1	products through
1	state medical
1	comprehensive, researc-based,
6	powers of
1	proceeding 
2	issued when
1	administer refers
2	sponsor within
1	4, 26
4	countries in
1	investigations, such
2	results therefrom,
1	inspection, and,
6	determination has
1	showing, for
1	accuracy, timing,
1	explaining in
1	to, to
4	additive and
1	applicable, was
1	shall accord
10	appropriate conditions
8	proposed clinical
2	standard, in
12	submitting the
1	organizations coordinating
6	general rule
1	2014, where
4	experience that
1	inspection act,
1	(2) veterinary
3	fund advertising
1	need by
1	refunded from
1	articles 19
2	agricultural act
2	ounces (15
5	phone number
1	design, epidemiology,
1	expectation based
1	meetingsto facilitate
8	term serious
4	biologics license
1	information would
1	deems most
1	yields do
3	leave in
1	clauses for
1	establishment; appointment
1	logbooks for
3	sample or
1	losses of
78	effect on
1	(g). (3)
43	effect of
2	device exemption,
5	commercial information
4	(ii) developing
1	issues that
2	recall shall
1	analysis, (iv)
2	(1) coordination
13	sample of
1	losses or
2	congressthe secretary
1	section 1320a7(a)
1	regards a
2	storage, handling,
1	sale; licenses
8	effect or
1	(j) has
1	2007), the
1	treatment requires
2	uses, such
2	combinations, quantity,
11	title iii,
1	thereof, meat,
1	actions for
29	exemption from
1	revised policy
16	clinical testing
1	area which
1	inventory required
1	(2) sell,
11	year 2008
5	year 2009
1	referrals from
1	powers act
3	 (q)
1	
 680.
2	year 2002
4	year 2003
1	general advice
1	amend paragraph
3	year 2007
1	year 2004
11	owed by
1	agencies, (b)
1	(3)(e) unless
4	count: provided,
1	licorice, cocoa,
1	formerly 1st
1	drug. any
6	(c). (b)
1	dietary management
1	considered, as
1	transport said
1	legislation will
3	products not
1	commitment shall
1	referral and
1	applicability nothing
1	sanitation; (b)
1	(i) or,
2	eligible under
3	medical need
1	states demonstrates
3	register findings
1	inspectors certificates,
2	secondary school
1	surrogate endpointthe
1	strict confidence
1	question; (d)
2	purity shall
2	effect from
1	financial certification
1	official responsible
1	unaware that
1	fine, and
2	lake success
1	immoral character;
1	merchant wholesalers.
1	particularly antiquated
1	facilities associated
5	post the
2	28, 1996)).
1	requirementsto the
1	require premarket
1	classes established
1	(iii) data
5	requesting public
1	acid amide.
4	products were
1	559, 1,
2	purposes specified
2	formula from
1	3109 of
1	commercial truck,
1	360b(c)(2), 360b(c)(3),
1	
 348.
3	particular, he
1	overlap, if
2	facilitate judicial
2	official plant,
1	secretary (1)
1	wel-controlled investigations
1	researchers for
8	use that
1	deal directly
1	
 373.
2	obtain patent
1	make modifications
1	mentors for
1	(b). a
1	subparagraph referred
1	tobacco contains
1	issue another
1	practice; (x)
2	disease. 
12	control strategy;
1	secretary increased
1	noncompliance and
4	subsection (c)(2)
6	article for
1	antimony, or
1	formula) is
1	children who
1	chemicals, all
1	(ix) establish
2	absent infringement
2	(f) dispute
3	study 
1	title requiring
1	analysis system.
1	greatest contribution
1	warrant control
1	9, 26
2	individual plan
2	distributed free
1	steroid, unless
1	379. confidential
1	another provision
3	isomers is
12	(d), or
19	7 of
1	element set
3	notice terminating
5	201(j) of
5	provisions to
1	distribution. such
1	section 360c(i)(1)(d)
1	official establishments;
2	stat. 1260;
1	1543. membership
1	factors, such
1	country unless
1	143, 1,
2	coerce, a
1	procurement. (b)
1	subsector to
1	removed, or
1	device, including
1	companies, relevant
2	ingredient derived
3	defense strategy
3	salaries of
1	360(o)(1)(a) of
1	warehouse excludes
3	section be
3	(2)(c). 
2	similar course
4	7 u.s.c.
1	issue shall
1	addressing issues
5	(in such
2	transactions, transportation,
1	(3) restrictions
14	section by
3	five years,
12	trafficking area
1	(i) protection
1	release describing
6	applicable regulations
1	(4) interagency
1	(8) any
1	collections notwithstanding
2	manner designated
1	(including manufacturing
1	councils on
1	importers. (b)
1	(1) total
1	(b)) that
1	occurrences since
1	accreditation shall
1	impacts, of
1	periodic training
1	near the
1	(g) supplier
3	applicants to
2	ii; or
1	substance among
5	activities, as
1	(d) bad
1	importation milk
1	substanceif it
1	justice solely
2	capture through
7	section 360c(f)(2)
1	(1) but
4	tax returns
1	ii, with
1	newl-approved drugs,[2]
3	 as
1	702a, formerly
2	contempt thereof.
1	analyses described
1	product, consult
1	datethe fee
3	medicine, dentistry,
44	subsection (b)(1)
1	arcade facility
1	(15 grams).
2	restrictions and
1	sponsors, when
1	cosmetics, and
1	claimant against
1	(3) costs
1	employees (a)
1	determination from
1	applied consistent
11	complied with
2	statements required
1	maintained in
1	lsd, and
1	distributor includes
2	bidding procedures
7	paragraph (1)(b).
1	documents. (3)
1	recalling a
2	extrapolation between
1	reprogramming and
1	trafficker means
1	dru-free state
1	packaged eggs
3	disposition by
1	copies to
1	mainland of
1	extension if,
1	343(k), 343(q),
1	person establishes
1	conditions necessary
2	system (including
1	paragraph (1),[2]
2	tax return,
1	committee includes
2	section 343(r)
1	360bbb0. expanded
1	adequate scientific
1	islands, american
1	
 644.
1	(ii) suspension
1	alternative or
11	environmental protection
1	made, other
1	entertainment group;
1	electromagnetic or
2	subsection (a)(6)
1	entities), and
1	exports (a)
1	availability, if
1	(ii) specify
1	(1) have
5	cooperative agreement
1	investigator who
1	704, 52
1	5, this
4	national health
1	system who
2	left the
3	employees, including
1	(iv) developing
2	year. such
1	paragraph (1)(b);
1	combination interferes
1	packaging design,
4	reduction is
1	recovery support
1	changed, except
1	documentary standards
26	excess of
1	executed and
1	
 393a.
5	issued an
1	amendment establishing
2	unless, before
1	racial subgroups.
1	material presented
1	(b) 500
1	(2) submission
1	(a)(ii). (3)
1	modify agency
1	relevant declaration
1	(4) prioritization
1	medication guide;
1	consult before
2	(d) summary
1	regulations, guidances,
2	reversed, the
1	repackager of
1	(b) modification
2	medication guide,
1	fda reportnot
1	phosphorus ratio
1	search of
1	chemical compound
2	law, regulation,
1	framework; (c)
3	recommendation shall
1	subsection (e)(1)(b)
4	authorization is
2	tol-free number
1	closing meeting;
1	subsection (d)(4)
1	countries consistent
2	protected from
6	360fff(7) of
2	modified, the
1	hydrate. (4)
1	intended; or
1	half the
1	egg food
1	initial schedules
1	closing meeting.
34	form and
1	sale deposited
1	ingredient to
9	section; (b)
1	(11) $109,000,000
1	chapter, officers
1	transportation under
1	receiving funds
4	device classification
1	protections 
2	basic principles
1	for, illegal
2	(vi) of
5	court that
1	903 of
1	causes, and
1	inspected, the
3	legislation to
1	prevalence in
1	state substance
1	chemical which,
1	application may,
1	operational standards
1	consideration; (b)
1	initiative, may
1	increase; and
2	involved; (d)
1	print or
3	(c) pediatric
1	it, the
2	reimbursement. such
2	order suspend
1	
 1601.
3	$15,000,000 for
5	condition under
1	available services,
1	inconclusive, in
1	actionsfor purposes
1	property transferred
1	device determines
1	subsection[1] (a)
2	(b) take
1	744h, as
1	alcohol not
2	d-identified surveillance
4	recommendations the
1	filing to
1	title, subject
4	title during
6	part, a
8	prepare, propagate,
1	cas-b-case waivers
2	262] (as
1	guidelines will
4	originated with
2	effective drug.
1	designation not
1	(h) relation
1	testing positive
2	attorney or
2	 (ii)filing
10	direct the
2	matters that
1	determine appropriate,
2	sample, the
1	section 102
2	section 101
1	butter, except
1	
 2252.
1	675, 1014,
2	including ongoing
1	major sources
1	attorney on
2	organizations prior
2	reserves, then
1	term analogue
1	networks as
6	shall provide,
1	(6) review
2	substance; 
5	patient experience
2	chapter shall,
1	consumer is
1	treasury designated
5	consumer in
1	assigned under
1	given it
1	prohibit particular
1	drugs
 

1	355[1] 360b,
1	issued through
2	senate of
2	device. upon
1	(7) subsequent
1	fee schedule
1	(a) control
2	submission; (ii)
5	staff of
3	administrative procedures
1	2002, to
7	except where
1	establishment manufactures
1	states owning,
3	electronic database.
1	program (in
1	electronic database,
1	mineral within
1	oversight authority
3	product upon
1	appropriately trained
1	faith efforts
1	license, the
2	next year
1	1308. omitted

1	interest charges
1	copper, there
1	use disorder;
5	interest that
5	body for
15	6 months
1	device package
1	formulation or
1	related inspections
1	quarter involved.
1	regular screenings
1	nuclei by
1	unsatisfactory to
1	new hazard
2	en-user, with
1	derived, with
1	minorities in
4	formulation of
1	(2) investigate,
1	services projects
1	$1,250,000, to
1	(b) encouraging
1	whether alone
2	clear ant-drug
1	agency agrees
1	sponsor who,
1	(f) evaluation
1	continued presence
3	transaction with
1	slaughter at
1	finds (i)
8	bulk or
1	revised quota,
2	cost between
1	single return
2	secretary, he
3	determined each
1	
 175.
1	bulk of
1	talent costs,
1	(c) contentthe
3	section regarding
5	shall, subject
8	(b) authority
1	sponsor; (ii)
2	setting and
1	combining, admixing,
1	interior and
1	syrup, (4)
3	order classifying
4	systems placed
1	 potassium
2	(b) waiver
1	shall this
1	director estimates
1	(within 30
3	matter (1)
1	party involved
3	nation and
1	article. (iii)
8	schedule ii,
1	original order.
7	regulating the
1	title made
1	money as
1	plants packing
1	system means
1	timing not
1	means programs,
1	day period.
2	states through
1	false information
1	reduced under
2	endpoint that
1	obligations to
1	(k) dissemination
1	section 321(r)
1	(f), including
1	another state
1	overwhelming increase
1	similar benefit,
2	shall increase
5	performance measures
1	(ii) clinical
1	provide compensatory
2	(ii) counterclaim
1	clause. 
1	problem. 
1	intelligence systems
2	meet all
1	(5)), that
3	populations, as
1	approval. (b)
1	communication includes
1	subsection (m)(1)
12	materials or
1	flood; (vi)
4	(d) monitoring
1	license. (mar.
9	secretary; or
1	
 1045.
1	manufactured specifically
1	(2) referral
8	accurate statement
1	387e, 387f,
1	coalition awards
1	deferral would
1	practicable, not
1	pricing of,
12	administration, of
1	facilities such
1	balanced view
1	675, 515,
4	possess with
1	grants, devises,
2	stat. 1040)
130	ensure that
1	gas into
2	existing approved
3	contemplated shall
1	livestock, the
1	methamphetamine; (e)
44	substances in
1	additional public
31	make available
1	(iii)(i) or
4	import such
1	seek any
1	5 public
3	duties and
1	businessesnotwithstanding any
2	subtitle e
1	required. (3)
1	(iii) program
2	precludes a
1	emergency use,
1	director. (

7	notice 
1	appropriate disclaimer
2	obtain this
2	identifier is
1	number, of
3	identifier in
1	motorists.truck stop
1	promoting individual
4	distributing such
1	least 300
6	monetary penalty
4	regulations). 
44	product under
11	recommendations developed
1	federal determination.
1	(4) definitionsfor
1	1531 of
2	initial filing
1	exercised and
1	statement: this
1	
 1115.
1	safe use;
2	facility owned
1	found, without
1	(a) timing,
1	sells, distributes,
1	temporary reductions
2	safe use.
1	boardthe board
1	hockey event
33	authorize the
1	request. (d)
1	paragraph (h)
7	(not including
1	area countries,
4	personal property
1	necessary, such
1	agency prescribes
1	sponsor) for
1	entity transferring
2	(e) to
3	law nothing
1	user; and
1	animal, as
1	awards, bonuses,
2	communit-wide strategies
2	development, stockpiling,
4	interests and
1	adult population
4	communication and
2	ground specified
1	control act.
1	police, probation,
2	size, but
1	office, establishment,
2	development. 
3	commissioner may
2	strength differ
1	subject propertythe
2	(4) prior
1	manufacture, importation,
1	efficiency, predictability,
5	imprisonment, or
1	slaughtering, processing,
5	preserve the
1	irrevocably barred
1	(a) term
4	person serving
3	general. the
2	representations concerning
2	receive, buy,
1	target animals,
3	section 353(e)(1)
1	giving such
1	enforcement on
1	knowingly providing
2	supplement of
3	august 27,
1	material. (h)
1	hours undertaken
5	concerning 
1	limitation not
1	approval. (ii)
5	allowed under
5	sale under
1	(2)[1] 
17	substance and
6	supplement or
1	include whole
1	broadcasting networks
4	purposes by
1	supplied raw
1	describes circumstances
1	hyperoxia. (vii)
3	biologics, and
1	1357, 1,
1	placement). for
1	importation, showing
5	seized or
1	(xiv), (xv),
1	emergency circumstance
1	(1) ingredient
2	retail level
3	headed by
1	conviction. 
4	standards shall
1	potential sources
1	thereunder, the
5	section 207
1	(hh) other
1	committee), for
1	(2)(c) of
4	(2) describes
1	(b), this
1	importer for
72	exempt from
1	schedulesin making
1	nicotine patches,
2	suffering from
1	(d) grants
1	admissibility of
1	ensure consultation
4	except such
2	order been
1	foods described
7	distributed or
2	(2) rules
1	regarding recordkeeping
1	subsection refers
1	(m), are
1	evaluated. (june
1	society for
1	preparation pursuant
1	design, device,
1	(e) revised
1	behin-th-counter access;
1	exception established
1	guidance (or
1	including rights,
2	clause (a),
1	clause (a).
1	commonly flow
2	imports tobacco
1	communities timely
3	officer acting
1	(b) setting
2	taken. the
4	substance the
3	unmet needs
1	355(b), (j)];
1	device, its
1	
 1506
1	commodities. the
3	device being
1	summarizes test
6	fed. reg.
1	believed by
5	paying the
2	implant and
1	reviewing disciplines
1	classify a
1	march 1.
1	concerns any
1	authenticated by
1	change. if
3	tolerance, the
1	evaluations; 
1	efficacy supplements,
5	except when
2	repackager and
1	paris green,
1	chapter); and
1	manufacturers on
1	unless conditions
2	(4) policies
1	investigation data
10	manufacturers of
2	(b)(2), to
1	fill orders
1	rejection may
1	animal generic
5	request may
1	general nanomaterials
2	finding required
1	compensatory damages,
6	containing an
1	treat rare
9	laws relating
1	(4) $270,000,000
4	outbreaks of
2	endocrine effect
1	period approved
1	children, africa-americans,
1	compound physicians
3	security to
1	communities that
3	repacking establishment.
5	changes required
2	occurred before
1	of; (iii)
3	355(p) of
1	studies pursuant
1	composition; (b)
3	potentially harmful
13	diversion control
23	july 1,
1	article originates;
6	shall obtain
11	(as in
3	times a
1	adjustmentsubject to
1	disposal program.
1	including notification
1	plasma protein
1	identification practices,
1	-diphenylpropan-carboxylic acid.
3	determines will
1	classify under
1	indexed for
2	section 811
1	(c) animal
1	plus amounts
3	reviewed, that
6	report. 
1	nonnutritive substance,
1	conviction; and
2	meaning and
1	360a1. clinical
2	finds such
15	1915, ch.
2	5. such
4	engaged; and
1	prohibit, limit,
1	inspection; 
2	propanamide; (vii)
2	(a) contain
1	approvable. the
1	illnesses or
3	least 6
2	retail outlet
1	upc, sku,
1	facts regarding
2	harmonizing regulatory
1	manufactures, possesses
1	lif-threatening; and
1	(a) qualified
1	title 16)
1	added july
2	quarterly reports
1	(2) period
1	prescription, if
2	electronic product,
3	found or
1	generala dietary
2	2007, during
1	alcohol; (iii)
10	reference in
1	prescription, in
1	least 7
1	mentioned shall
1	(d) conducting
1	drug. in
4	defect which
1	tracing drugs
1	721, formerly
1	518, as
2	actually incurred
1	prevention function
2	exists valid
1	possession and
3	found on
1	prevention. (3)
1	studies relating
1	petitioners acquisition
1	(ii) submit
1	science pertaining
2	(xiii) such
1	retailers the
1	355) for
1	restricted; (b)
1	505e, as
1	strength; or
1	expire during
1	forfeited, the
1	burden, facilitate
1	letters as
3	witnesses in
2	ingredients determined
2	person files
1	regulations). (2)
2	(c) one
5	finding of
1	pr-production design
1	findings, on
1	person represents
8	paragraph with
1	sponsors no
1	desiccated, to
1	2006; (10)
1	85 percent
2	findings, or
1	seq.) manufacturers
2	chapter). 
9	services or
1	electronic portal,
1	42 was
1	device the
3	1111 and
1	two such
3	license a
1	previous sentence
21	impact of
1	proactively identify
1	achieve total
1	stat. 1087,
1	number); and
2	patient need
1	paragraph limits
1	523, as
11	impact on
1	1361 of
1	subparagraphs (d)
2	title compliance
2	rem; libel
1	ingredient contained
1	reported; (3)
1	 (27)
1	(iv) focus
1	difficulties completing
1	(8) modify
1	created, caused,
1	prescribe for
1	(b) federal
1	require, a
1	lifetime risks
2	(including specific
4	reporting by
1	(f) good
1	committee upon
4	product, including
1	provide treatment
3	standard; or
12	period following
3	every establishment
1	ensure coordination
2	therapy 
2	(b) affects
1	organizations which
1	substance whose
20	bulk drug
1	term until
1	activity, except
1	subpopulations, the
1	promotional labeling
1	notification, but
3	compounding that
1	assist importers
1	property constituting,
1	reduction by
1	syrup that
2	independent organization
2	led to
1	expressly authorized
12	treatment or
1	moving defendant
1	thousand or
12	services. 
1	list). such
1	days. if
1	will obtain
1	new regulatory
1	disapproved, the
1	term market
1	labeling branch,
1	assistance to,
1	proxy votes
1	(b) nonapplicability
2	health regarding
2	limited englis-speaking
1	ounce, nor
3	fees. the
1	(ii), unless
1	higher education;
2	(iii). (iii)
2	findings (including
2	1970 (15
1	regulatory or
2	certain establishments
2	of, domestic
1	controversy, including
1	unauthorized access
2	used when
1	clear any
2	records described
1	combination contains
1	745, formerly
15	needs of
1	controls may
13	subchapter and
1	deviate from
2	corporations engaged
1	section 360ll(f)
1	trademark. 
13	(h) of
11	official name
2	review; record
1	stock in
2	chemicals, to
1	136h]. 
3	medical needs
2	committee; or
54	established in
6	387e(j) of
1	avoid the
4	amount authorized
1	incomplete applications
1	science, meat
2	action (the
4	section 3
1	formatted in
4	licensee, assignee,
1	applicant after
1	manner required
1	voucher, as
4	notice issued
1	specific local
1	(b)(1)(d), if
1	telemedicine (a)
1	5382 of
1	update susceptibility
2	index established
1	previously identified
7	both. notwithstanding
1	(c) revise
1	manufacture affecting
2	infringed only
1	writing an
1	occur; (iv)
2	4 shall
1	term subsidiary
1	general, determines
1	combination that
1	them. (k)
3	internal review
1	individuals knowledge
1	city average),
1	property; and
120	sponsor of
1	(iv) to
4	(iii) information
7	food facilities
1	term original
1	events submitted
1	required submission
1	compilation, publication,
1	physiologic, pathologic,
2	revised by
1	
 335a.
41	sponsor or
10	product (including
1	employee) 
4	general regulation
1	common carriers
2	specify. 
1	material determined
1	section 360e(d)(2)
1	title, misbranded
1	meat canning,
442	purposes of
1	positions shall
1	otherwise have
2	(e) registration
3	(ii) issue
1	access; logbook
1	federal agricultural
1	maintained a
1	states; (g)
3	harmonize regulatory
1	resubmit a
1	term illicit
2	storing, or
2	criminal forfeitures
2	make reports,
2	federal cooperation
6	purposes or
1	correction reports)
3	credit corporation
1	ethinamate. (6)
1	(j) international
2	penalty is
1	samoa. (june
1	remain unanswered
1	definition. (b)
1	rapid shipment
1	narcotics control
1	(2)(c) or
1	(c) endanger
1	study requirements.
1	(2) covered
3	shall within
1	addict means
1	regarding hospital
1	recall; (ii)
1	dropouts, and
1	675, 714,
1	new qualified
16	examination of
3	processor, or
1	panel meeting
1	reasons underlying
2	state then
1	manufacturers seeking
1	1395 of
1	section 1044(a)(1)
1	licensed veterinarian..
1	states constitution.
4	sell or
2	oceanic and
1	(b) placement
1	application requirements;
1	effectiveness beyond
1	order (including
1	relative percentages
3	may refund
2	reduction activities;
1	organizations. of
1	gram negative
2	controlled or
1	factor means
1	request; (3)
1	conclusive. (4)
1	assistance division;
3	healthcare research
4	product does
4	master files
2	develop, as
1	accommodate the
1	consider hazards
1	fees. (5)
2	notice thereof
1	section $15,000,000
1	molecular entity.
3	released unless
1	intent described
2	ethical and
1	programs; (3)
1	adulterated, it
1	enforcement, nonprofit,
2	thereof be
3	applicable in
2	15, 1954,
2	form, by
1	limitation under
1	notice will
1	section 331(d)
6	u.s.c. 262]
7	substances are
5	corporation, association,
2	development, evaluation,
2	master file,
1	initiate an
1	master file.
1	foundation on
1	samples taken
1	specific registered
1	following uses:
3	monograph exists,
1	epidemiology; and
1	time whenever
1	prescribed, by
1	master file;
1	use outsourcing
1	reduction. 
2	 $3,872
1	guidance. (4)
1	slaughtering, meat
3	foundation or
1	possessed, distributed,
2	(a) cooperative
2	calories (such
1	-cyan--methy--phenylpiperidine. (16)
1	article were
1	registration, a
1	(7) such
1	individual is
2	safety with
1	alternative treatments.
2	conduct training
42	(1) any
1	cigarettes by
4	set of
1	despite diligent
1	part; (b)
1	subsequent proceeding
10	negotiation meetings
1	regulations. (2)
56	(1) and
1	therapeutic intervention;
1	(2) testing
1	(1) audits
1	1996 subsection
5	individual in
1	prevent, destroy,
11	reprocessed singl-use
1	applies, its
7	recall order
2	monitoring by
7	(which may
1	1988, no
1	section 841(a)[1]
1	
 621.
6	facilitate a
1	modification, amendment,
1	rare, serious
1	sunset of
1	bloody white,
1	incompetent with
5	initiate proceedings
1	beginning compounding
3	given appropriate
1	33 of
1	(a) adjustment
1	901, 1(92),
1	certain programsthe
3	invite the
1	1976; or
1	(including manufacturers,
1	referral necessary,
1	appropriate investigation
1	mandatory debarment;
3	owner designated
1	machines, or
1	estrogenic substances
1	notice, hold
1	inspection, reinspection,
2	drug proposed
1	collaborative agreements,
10	previously approved
1	pipes; (9)
1	planning under
1	address funding
2	supplier as
1	supplier at
1	represented health
2	public will
3	(but within
1	violated any
1	policy; (2)
1	age, or
14	day before
4	exceed twenty
1	3,-methylenedioxy amphetamine.
1	including contact
1	controlsthe term
1	methods, cannot
11	states obligations
1	firm with
1	substance (a)
1	investigations where
1	practices; (e)
1	productivity lost
1	education, unless
1	applied research
1	americans a
6	establishments that
1	enforcement. (viii)
1	deferrals granted.
1	studies, are
1	(k) food
8	control the
1	general effective
1	agency meet
1	shall exist
1	(iii) 280
1	time periods
6	evidence so
5	adulterated, or
1	shortage (a)
1	of, that
17	application may
7	congress the
1	reduce premarket
1	conduct exercises
1	intent whatsoever,
1	reciprocal arrangements;
1	(ii) federal
1	paragraph (c))
1	(iii) requirements
1	$450,000,000. (d)
8	distributions of
2	approval, except
1	(b) actionsthe
2	states owner
2	time period,
3	timely manner.
2	practical functional
1	tolerance in
1	immediately across
1	paragraph (1)(e)(ii).
1	(including patients,
1	retail level,
5	drugs the
1	1984; (ii)
1	compile a
1	establishmentthe secretary
1	maintain, on
1	attaining the
2	committeenot later
2	secretarys evaluation
6	process to
1	regulations) for
1	affects poor
1	surveillance, tracking,
1	notwithstanding this
3	preventive controls,
1	suspensions or
1	(2) agreements
1	federal laboratories
2	technological data.
1	(ii) from
2	covering in
1	106, 107.
1	withholding, use,
72	development of
2	executive director,
1	(5) retrospective
3	foregoing subsections
1	reimbursable basis.
2	379dd(l)(2) of
2	warn consumers
2	supplementing the
16	development or
2	executive director;
7	administrator, in
2	appeal (other
1	terminated at
1	november 19,
1	allegiance to
1	release is
1	injunction, or
3	title, prior
34	allocated for
1	(c) reviewing
3	(3) drug
1	drugs, (d)
2	petition procedure
2	shall preserve
3	(c) confidentiality
1	including reasonably
1	generalthe total
2	eligibility of
2	1997). 
2	relisted. after
1	samples where
1	center, shall
11	person, the
1	information clearinghouse.
2	articles: provided
1	veteran in
1	packaged liners)
1	requested. (june
1	inspect all
1	financial assistance;
1	pharmacological activity
3	inspections as
1	country any
1	possesses any
1	deferral approved
6	(a) definition
1	meals that
1	diligently prosecuting
2	efficient completion
10	country and
1	drugs, medical
1	(e) establishing
1	species. the
1	standardsif through
1	generalfor the
1	k (g)
1	defendant owns,
2	permanent food
3	may prescribe.
5	stat. 1059;
1	title (submitted
4	agencies, the
5	(b), is
1	prescription. such
1	appropriations; fiscal
2	(b), in
2	purpose. (2)
1	(1) import
2	original application.
2	species or
8	(b), if
1	district wherein
1	enterprise. the
5	practitioner is
1	declare that
1	manage quantities
1	(iii) importation
1	following such
1	potential benefit
1	disclose, to
4	order thereon
1	reregistration eligibility
1	residents of
1	complainant, and
1	establishment. this
1	import notification
1	specific technologies
1	(c) received
1	title 31,
1	positions on
1	(2) animal
1	inform veterinarians
3	data access
3	(b) exclusion
2	entity within
1	(m) onchocerciasis.
1	advertisement) to
1	355e. pharmaceutical
1	undertake a
7	secretary. (2)
3	food, except
1	effectiveness. no
1	paragraph, then
20	(a) through
2	read-t-eat in
7	second or
1	covering, or
1	employees supported
2	term compounding
1	2004 or
1	assessment 
2	(c) exceptions
2	concerning state
5	341 of
1	manufacturer. notwithstanding
1	establish clarity
1	enforcementnotwithstanding any
2	importation, manufacture,
2	device safety
1	(b)(3)(b) of
1	base the
2	fraud, and
2	subchapter, such
1	sufficient operating
15	continue in
1	encompasses both
1	member with
1	periodically assess
1	designee shall
1	meet his
5	therapeutic benefit
1	requiring such
1	commenced an
1	(7) repealed.
3	(a) unsafe
4	entity. the
3	list, the
1	(2) surveillance
1	title, whether
2	rapid pesticide
1	stat. 279

1	samples under
5	persons required
1	
 206.
1	legally accessible
1	(7), and
2	conference. the
15	agency center
4	certain drug
1	strategy. in
1	343(q)(5)(h)(ix) of
2	uniformity among
1	algae, and
1	fees only
1	electronic synthesizer,
2	animals, human
1	provisions with
2	conspired to
2	country, territory,
1	transcribed at
1	general, to
1	inspect, within
1	2251. jurisdiction;
6	unsafe in
1	(b) facility
1	insulin which
1	(c)(4). such
2	subparagraph (f)(i)
1	years beginning
1	(a) amending
1	steroids) and
1	section 387k(g)(2)(c)(ii)
3	placement on
1	(under conditions
1	section 971
1	healthy diet,
7	domestic facility
1	adjustment since
2	quarantine, segregation,
5	(1) general
3	sanitation requirements
1	requirements; (b)
2	facts of
1	proportion as
2	standard will
7	paragraph (2);
1	persons distributing
2	reviewing official
1	effectiveness nothing
5	regarding 
1	department. 
3	funds were
1	findings regarding
1	protect animal
1	adults of
1	identify strategies
14	exclusivity period
8	adjustment is
2	service pursuant
8	state boards
1	adjustment in
7	grant, contract,
1	variability of
1	(a) power
5	date or
1	encouraging formal
2	prescription required
1	formerly 360e,
1	surgery; or
1	expungement under
1	lif-sustaining; or
1	exits); (ii)
1	affidavit has
1	(ii) states
2	(j) to
12	device, tobacco
2	conducting exercises
1	
 463.
1	software, sterilization,
1	manufacture through
1	article regulated
1	methamphetamine production
3	knowing, intending,
1	device, (iv)
1	$45,600,000,000 to
31	directly or
2	appropriate; 
1	decreased from
1	applicable) under
3	matter that
1	42. (k)
1	be) and
1	listing any
1	1102. congressional
1	any) responsible
7	administration 
1	aircraft used
1	(2) priorities
1	detention an
1	research centers,
1	stamped or
5	violates the
1	622. bribery
1	articles (other
2	business unfitness
1	relevant date,
2	rule issued
3	investigations or
5	listing and
132	request for
1	
 356e.
3	arising out
1	duties. 
1	secretary independently
1	risk identified
1	(c) identification
1	event less
1	897.3 and
1	section 467b
1	manufactured an
1	encourage states
1	design protocols
1	test shows
1	prominently printed
2	pay or
1	tariff laws
1	enforcement purposes;
1	african trypanosomiasis.
1	humidifies tobacco
2	(ii) state,
3	reaching agreement
1	pharmaceutical master
4	documenting the
1	particular 
5	manufactured at
1	clinical development.
9	critical path
1	meat; and
1	potential 
2	youth. 
1	documented, using
1	sponsorship of
2	third party;
1	matters arising
1	reaction; (vi)
1	(4) action
1	legend and,
11	date specified
1	year; (iii)
1	correct these
1	360bbb3. authorization
1	applying sections
1	services, provide
1	resolution if,
4	amount and
1	specific requirement
1	practice 
1	professionals administering
4	targets and
1	found. (aug.
1	treatment; 
1	auditors, the
1	
 387q.
3	whoever, in
1	final change
1	thousand and
1	subsection (b)(1)a),[1]
1	physically compatible
1	system during
4	june of
2	cream are
2	lifesaving medical
1	relationships of
1	especially with
1	inspectors post
1	health, disability,
1	complainant the
1	(1) undertake
2	information after
2	purpose of,
1	adverse tobacco
3	eliminate or
1	investigationan investigation
1	contributes to
2	committee described
1	including individuals
3	identify each
1	thereof shall,
1	2017. (12)
1	limited and
1	section 342(a)(1),
1	illegal use
1	swearing, or
2	counseling and
1	components, source
1	commerce has
1	interruption; or
1	confidence intervals
1	(2) is,
2	payment under
2	requests submitted
1	no-occupational sources;
1	misbranded. if
1	official supplies
1	commitments require
2	community involved
1	administrator; (2)
1	judicial branch
2	classification panel,
1	bringing under
2	including technical
1	misbranded. it
1	issues, pediatric
1	may send
2	prevention packaging
1	hopper car,
1	(b) vacancyany
2	deposit in
21	(b), and
1	term audit
1	incorporate any
2	calculation determined
2	enters a
2	confirm that
1	arguments submitted
1	animal. (c)
1	audit agentsan
1	compile the
2	device establishment,
18	drug, device,
3	representatives; and
1	affiliate the
1	(ii)(i) an
4	(b), any
1	section 387j(c)(1)(a)
1	food product,
1	secretarys absence
1	expire at
1	rooms, or
3	periodic evaluation
1	inspection any
1	providers under
1	risks which
1	pricing of
1	endpoint. 
17	administration, the
1	rule, the
1	registrations were
3	may prohibit
1	willfully neglects
1	allow device
24	advance in
21	inspection and
2	committees to
1	63. penalties;
4	supplement contains
2	secretary; (6)
4	number is
2	section 360fff2(b)
1	amountthe administrator
1	specified changes
1	1543(a)(1) of
1	responsible parties.
8	device establishments
5	drugs. such
1	revenue for
2	samples and
2	perjury, false
1	law, move
1	(5) develop,
1	protective material.
8	determination made
1	section; the
1	require dealers
1	number in
1	(m). (2)
1	1973) he
1	25 milligrams
2	product prepared
1	laboratory facility
3	15), and
4	center shall
1	world trade
1	(1). prior
2	individuals at
1	determination before
1	dismissthe following
1	oxygen, the
1	laboratory facilities
1	event patterns,
2	(a) presents
1	excluded) from
1	humans and
2	264(c) of
2	one animal
1	(3) does
1	lysergic acid.
1	importer. (mar.
1	ant-drug message.
1	differences; and
1	paragraph (2)(c)(iii),
2	objections shall
1	submission, review,
1	relabeler, or
1	compound, combination,
2	results not
1	petitionany person
3	shall maintain,
1	commercially. such
1	times. 
1	commerce, during
1	cooperatives, nor
2	protocol was
1	person whenever
2	states consumer
16	13, 2016,
1	increasing rate
2	costs, and
1	888. repealed.
2	general) or
1	sample. (f)
1	strategies between
1	legal issues,
11	suggestions for
1	(1) may,
1	standard; (2)
1	appropriate; (e)
2	states. (ii)
2	juice, and
1	formulations; (c)
1	amendments. (b)
1	commodity, including
3	labeling could
2	use referred
1	powdered, or
1	summary judgment,
1	colored glass,
1	early, no-food
1	affiliation) with
1	transaction. (c)
2	shall remove
4	section 802(6)
5	frequency of
2	milk by
1	practicable study
1	item(s) to
1	resulting pesticide
1	(3) work
1	smoke. (3)
1	hazards, and
1	internationall-recognized standards
1	
 904.
1	protocol if
1	chemical contamination
1	event reports;
1	(23) -(-iod-2,-dimethoxyphenyl)ethanamine
1	360ccc1(e)(2) of
28	time as
1	counterdrug research
2	time at
1	intent at
1	indexed products.
1	animals; (b)
1	free trade
2	event reports.
2	556 of
1	
 615.
1	time an
1	(c) extension
2	without conducting
1	intermediate or
1	enforcement officer,
2	times more
4	serious illness.
2	administration; (2)
1	use in,
2	intentionally kills
1	permitted, at
13	considered incomplete
1	release to
1	colombia. (3)
1	furnish pharmacological
2	heroin, methamphetamine,
1	green, carbolic
2	competent jurisdiction.
1	poultry for
2	(i) state
3	predicate tobacco
2	division, that
1	amphetamine; or
1	350c(a) of
1	(5) make,
1	employees, the
2	kit does
1	chain prior
1	narcotic drug,
37	suspension of
4	timeliness and
1	man); the
1	355(c) and
1	remote sales
2	record, history,
1	products broker
1	1901. findings
1	convention. a
12	suspension or
1	both. section
2	writing, with
1	medical associations,
1	combined into
7	general, in
104	forth in
1	government, states
35	drug referred
1	where, despite
1	made. requesting
3	(4) has
1	reverse distributor
5	liability law
4	affirm or
2	shall preclude,
1	2000 and
1	articles within
1	review product
1	emergency, authorize
1	form, including,
3	assaults, resists,
10	device with
1	(6) no
2	patents for
1	hold hearings,
2	paid witnesses
4	may lead
1	683. interstate
1	approval. (june
1	enforcement officers
1	another commodity,
1	assesses fees
1	device, issue
8	system to
1	(1) place
8	accredited by
1	decision pursuant
1	disclose, in
3	35 of
1	assistance (a)
1	section 354(a)(3)(b)
3	fully to
2	contaminated food
1	413 of
1	(3) revocation
1	743, 49
2	december 3,
1	development activities;
2	exception subparagraph
1	raw materialthe
1	(2) certain
1	without selection
1	571, as
1	support services;
1	columbia. (z)
1	violator shall
1	(e) service
1	i, 19,
1	1972, shall
1	belonging to
1	employ chinese
1	estimated duration
4	party logistics
1	children. (b)
1	procedures fiscal
7	title 28
1	(3) applicability
6	act, omission,
2	donated or
2	title 20
5	title 21
1	title 22
1	control; procedures
2	board. 
4	title 26
2	food. in
1	presentation by
2	require in
7	shall consist
1	programs between
1	cracked or
2	foods on
1	awards for
1	standard relief
1	executed licenses,
1	activity, or
1	egg packers,
1	2007, is
1	procedure; presentation
1	chapter. all
1	cost, the
3	(3) rule
1	director, or
2	another designated
1	greater significance
7	commencement of
2	section 503(b)
1	limitations that
1	584, as
2	(f) inspection
1	trust responsibility
1	356(g) of
1	(g) limitation
2	(a), any
1	applicable, if
8	(a), and
2	protocol in
1	fas-track product
1	accomplished within
1	ingredients comply
3	published. 
1	person. (k)
1	crisis that
2	administrator unless
5	drug facility
1	mortality for
2	section 360e(g)(2)(b)
1	organizations: _____.
1	chairperson. (c)
2	psychotropic substances.
1	(2)) not
14	products at
1	allylprodine. (3)
1	sufficient 
1	frequency with
6	products as
3	exist. 
2	legible form,
1	uniform product
2	ch. 578,
3	species verification,
1	955a to
2	(g), to
1	(i) label
2	waiver), the
3	dollar amount
1	major national
1	manufacturing transactions
4	represented as,
1	federal benefits;
1	title continues
2	208(b)(3) of
2	subsection (a)(3),
1	agreements, grants,
1	fund shall
1	30, 2022,
3	experience, or
2	foregoing upon
3	eating place
1	salts, derivatives,
1	public. (3)
1	failure so
1	type 1
2	shall transfer
1	label clearly
2	allow shipments
1	(1)(c) by
1	consumers; manufacturers
1	implement food
1	(i) do
2	wholesaler. 
10	recommendations on
1	five members,
1	environmental assessment
1	special effective
1	hazards. such
1	(21) -(2,-dimethox--methylphenyl)ethanamine
1	(2) approval
2	1996. 
1	requirements contained
2	exceed 50
1	registration. it
3	shall follow
1	animal be
1	additional pay
1	clause (ii)(iv),
2	format of
1	investigators; and
2	drugsthe term
4	effective period
8	regulations, the
1	national advisory
1	27, 2013:
1	27, 2013;
1	379j61. definitionsin
1	hig-risk facility
2	reporting required
1	675, 506c1,
3	demonstrated to
2	causing the
2	meanings for
26	27, 2013,
1	court involved
1	children, or
1	remedies as
1	devices; or
1	provide (1)
1	jurisdiction except
1	(a) ensuring
1	706, 52
2	per year
1	2003, means
6	control activities
1	met if
1	levomoramide. (28)
1	seq.] shall
1	restaurant which
1	notification on
2	met in
1	(9) nothing
1	(4)[1] a
1	longer consistent
2	fraud, bribery,
28	notification of
1	international passenger,
2	final is
3	secretary but
1	international harmonization
3	overseeing the
1	inspections related
1	goals set
6	notification or
2	territory, in
2	may propose
1	growers, regarding
1	cleared conditions
1	causing or
2	may as
1	nonfinancial assistance
1	campaign under
28	requirement under
2	effectiveness. 
1	reports annual
1	100 days
2	schedule notice.
1	authorizationan authorization
2	basis, such
2	significant barrier
2	purposes; (2)
1	substance, increase
4	trading partners,
1	settled the
13	trafficking area;
1	bacteria or
29	case may
3	payments in
3	proceeding arising
3	refrigeration at
1	confidentially maintains
5	certificate of
2	28 by
2	seeking permission
148	period of
2	committeethe secretary
1	activities nothing
1	therein the
3	voucher the
1	center in
9	certificate or
1	
 355c.
33	sufficient to
1	far addicted
1	plant, as
1	terms state
15	substances and
1	salts, isomers
1	consecutive tests.
1	355(i)[5] of
3	shall limit
1	manner described
12	classified in
1	impactin allocating
1	(b) experts
21	health of
1	(including intelligence
1	devise, bequest,
1	entered, unless
1	decree and
2	datethe initial
3	(b)(i) shall
2	identification under
1	(28) levophenacylmorphan.
3	states; or
1	car, hopper
3	adulterated (except
2	(b) publication
1	administrators functions
1	assessment; (iii)
1	section 427i(a)
1	substance activities
13	health or
1	bear, directly
1	major category
2	request. any
1	whose assistance
2	mitigate or
1	following structural
1	since december
2	determined not
1	final, substantive
1	wherein that
1	determining when
2	defendant files
1	(i) establishes
9	legitimate medical
1	1(92), 45
1	properly necessary
2	require manufacturers
1	(g) partnerships
4	petition referred
1	chewing gum,
1	increases the
2	commerce the
1	raise valid
1	supplements. such
19	requirements 
1	senate. (d)
2	assessments for
1	means generally
1	assessment granted
1	provided therein.
1	(c) fishing
12	transportation of
1	biannual report
2	proceeds traceable
5	labeled in
1	4721, 6001,
2	basis, a
1	colombia and
1	dye shall
6	powers conferred
5	summaries of
13	prohibit the
15	paid under
1	section 381(b)
1	withdrawal, or
1	subsection (j)(5)(b)(iv);
3	criminal penalty
1	selling carcasses,
6	facility which
1	pharmacology, addiction,
1	(g) exemption
1	file on
1	(2) allocations
1	available through
1	(h) an
1	using facilitated
47	make such
1	(4) recommending
15	packing of
1	qualification reviewthe
4	food on
1	services. (june
1	applicable. (4)
56	protect the
6	food of
1	documentation submitted
4	ceased to
1	technical effect;
1	2016 for
4	preclude any
1	sale thereof
1	health organizations,
5	(3) authorized
3	commerce as
1	(f) objections
26	food or
1	379j41. definitionsfor
1	(a) data
1	otherwise; 
2	applicable for
9	paragraphs (1),
1	general requirements
3	(aug. 11,
4	overtime and
1	country listed
2	violation as
1	(e) testingthe
1	services receives
3	authority with
1	improve foodborne
2	effectiveness claim;
1	general requirementa
1	(c) prioritization
2	355(j), or
8	requirements established
4	1, 1971.
2	reports a
1	evidence, as
1	(ii). (ii)
3	payment penalties,
1	360bbb8a. optimizing
1	paying duties
1	format, or
5	application. (ii)
1	following notice
1	refilled. 
1	years thereafter,,[1]
2	examination, inspection,
1	persons registration
1	involving private
1	staffing needs.
1	(july 22,
1	will potentially
1	(1) solely
1	(f) in
1	(4) risk
2	experts employed
1	homoeopathic drug,
1	(2) service;
1	another capacity,
2	establishments (as
1	deem appropriate:
2	objective. in
2	delays in
2	persons contacted
1	affect and
2	require, the
2	year 2010;
1	mixture with
1	conduct education
1	food. this
9	affect any
1	(2) trade
7	awarded a
22	section 360(k)
1	expired drugs.
1	forms submitted
2	taking an
2	illness. 
2	(b) partnerships
1	
 399g.
10	renewal grant
1	otherwise processes
1	product any
1	cases, the
1	food, such
27	product and
1	586c, as
1	linked thereto
1	contest, such
7	may, under
4	supervision by
1	carburetion tubes
2	evaluate, for
2	subsidiaries or
1	appoint committees
1	in; and
1	penalties; acts
1	likely for
1	(c)(2), (d),
21	receives a
1	disregard for
2	test positive
1	product, it
2	(b), (b)
1	law enforcementnotwithstanding
1	determines helpful
1	event, with
1	(a) regulation
1	risk, consider
3	product, in
3	remove the
7	qualifying practitioner
1	similar contained
1	11, 1946,
1	basis only.
3	sanitary transportation
2	clearance in
2	sell directly
1	industries; (ii)
2	type, amount,
1	system, that
2	individuals, particularly
1	holds the
1	demonstrate methods
1	hearing) if
6	quality control
1	(iv) chewing
1	committees concerning
2	use; (c)
1	advertising containing
1	103417); or
1	equipment. (b)
2	apply equally
2	state costs.
4	believe the
1	triggered by
1	converting, concealing,
1	restitution as
14	caused or
1	allergens that
1	disease information
1	(e) prohibit
1	plants if
1	completion should
1	(a) reasonable
8	employee duly
5	secretary, a
1	harmonization continues
1	protozoa, algae,
1	(7) staff
1	acts regardless
1	contract as
3	section 371(e)
2	equines, capable
1	whose position
1	(i)), be
10	combination product,
4	specific information
3	postmarket regulation
1	reusable device
1	(f) food
2	appropriate identification
6	government as
2	blank space,
12	remedies provided
1	characteristics, that
1	executed under
1	services, publish
1	vehicle. (b)
1	court (and
1	considered acceptable
1	repackager or
2	institute an
1	oleomargarine for
2	(4) additional
1	vitro, and
4	prevention, treatment,
1	lon-term quantifiable
1	(v) schools.
1	also revoke
1	contributions notwithstanding
6	control plan
1	compendium. (f)
1	social media),
2	patent (or
1	collecting, reporting,
1	claimant submits
1	times. (3)
1	fees were
1	subjects will
2	jury in
1	violations, the
1	(f) exemptions
1	animal means
1	patients. (c)
1	determined 
1	(a) contractors
1	orphan disease
2	development not
1	(vi) sole
1	$6,250,000 in
2	321(s) of
1	payments; or
1	1978, to
1	2222. integrated
2	product safety.
1	efforts; (b)
1	panel shall,
1	(b) biosimilar
2	litigation resulting
1	(b) hereof
1	processing the
10	including whether
1	operations under
3	use prescribed
1	address potential
2	control act,
1	sales). 
1	countries from
3	chapter 35
1	program using
1	353b of
4	program carried
1	published articles,
1	section, subject
1	structure to
9	3 of
1	chapter 33
1	(d) affect
1	collaborative efforts
1	subsection (e)(2)(b)(ii),
2	(b)(5) of
2	listing 
1	reported; and
1	eligibility determination.
1	term reinspectio-related
2	approved on
2	seal until
1	degrees of
4	april 1
1	appropriate directions
1	administrator after
3	pesticide analytical
1	part after
1	(2) conduct
3	approval has
3	article may
1	2615] in
1	form, is
2	deny clearance
1	give such
1	product. extr-label
1	pharmacist the
5	refunds to
1	(9) betamethadol.
1	located, whether
1	conditions required
1	affix to
1	(5) it
1	scientifically insignificant
1	reaccreditation to
1	taken against
2	2007, in
1	dining rooms,
1	distinguished from
3	secretary approving
1	turkeys, dogs,
1	eligibility determinations
1	controlling such
1	(thiamine) (g)
1	full waiverat
1	assessments shall
1	entities. (iv)complementary
5	(2), or
1	(b) enter
1	(xi) the
1	searchable drug
2	delegate the
2	states pursuant
1	identify system
1	campaign, or
1	forfeiture, the
1	
 102
1	commercial information)
1	(b) during
4	funds made
11	recommendations as
6	olympic committee
1	canning, salting,
1	retail outlets;
1	order. (5)
1	techniques, equipment,
2	panel determines
1	648; 

1	subsection (b)[1])
1	achieved through
2	100 miles
1	(b) medical
1	temperature requirements
6	substance (as
1	rational or
2	protect children
1	1710. drug
2	licensing authority
4	calculated under
1	841(b)(3) of
5	e of
3	required or
2	contracts, memoranda
1	(2) general
1	history the
39	(2) a
1	winning bidder
2	portability and
1	published from
3	required of
3	shall engage
1	concealing any
1	otherwise directed
3	recall and
1	safety questions.
1	slaughtering for
1	committed any
2	purchased such
66	review and
1	device; (iii)
9	household and
4	record and
1	(1), section
3	(ii) determination
1	existing networks
1	outlet. a
1	one field
5	ways and
1	explanatory or
4	by, and
1	methodologies have
1	(b) real
4	official, in
3	inspection rendered
1	terminates on
3	one geographic
3	section 823(g)(1)
5	cleared or
1	technology available
1	include software
1	740a, as
1	contamination at
1	including heroin.
1	reveal that
1	(ii) response
2	(a) inspection
1	section 6333(c)
1	valid provisions
12	person means
1	lay persons.
1	official, is
1	enforcement agent,
2	30, 1976;
18	shall keep
1	(b), (d),
1	considered registered
1	chemical store,
1	physically inspect
1	sole discretion,
1	met because
1	applicable timelines
1	expended. (d)
2	induces cancer
1	pending decision
5	subsection (c)(3)(e)
2	institute. 
1	violation. with
2	taken on
1	illness, disease,
1	investigation 
1	reasonable promptness
1	(iii) financial
1	estimated size
1	827(e) and
1	noticeseach year,
1	prescriptions shall
2	facilities at
3	purpose other
1	another organization
2	request, meet
1	1701. definitionsin
1	regulations), or
1	section, by
3	subclause shall
1	websites; (d)
20	smokeless tobacco
1	expenses provided
1	including published
21	(i) for
1	refund 
1	significantly reduce
1	warehouseman has
1	458. prohibited
1	primary point
2	warning letter
1	default to
1	5703(b)[2] of
1	relationship by
1	finding a
1	section 5332
1	correct errors
1	vaccinesif the
1	dress, trademark,
2	(c) product
16	receiving a
1	appropriate body
3	title this
4	poultry is
1	transfusion; (ii)
1	biennial date
10	submitted with
5	law regarding
1	identifier related
1	editing, printing,
2	overestimated the
1	records. (

2	(including neonates,
2	item shipped
1	indexing contains
1	resided on
1	eggs only
1	guidance and,
1	consideration variances
1	agreement acceptable
1	retail consignees
1	disorder treatment
1	chapter based
1	issued declaring
1	fact; (3)
1	recommendation which
1	athlete the
1	identity, and
1	enter onto
1	(especially in
4	testing under
1	identifying or
5	granted by
1	companies and
1	(b)(1) is
1	403b, as
2	drug rehabilitation
3	secretary cannot
1	agencies; (6)
9	providing an
3	traveltime) they
1	remedied, (2)
1	appropriate elected
1	confidential information,
1	confidential information.
1	1997, to
2	714
 

9	used, or
1	protection achieved
31	secretary the
102	(3) the
1	drug crisisthe
1	yellow phosphorus,
6	violated section
1	paragraph. (5)
1	mutated gene
2	confidential information;
2	year; and,
1	submissions during
4	distributed commercially.
4	matter referred
1	records shall,
1	distribution is
1	(acting upon
1	deficiency which
1	coa-tar hair
1	equivalent device
1	2002 for
1	(b) jury
1	investigate, block
1	sentence. (f)
1	(6)(b), 1
1	387g. tobacco
1	violations, including
3	campaign needs
36	year under
1	management guidelines,
1	346 regulations
6	safety, and
1	exclusive approval,
1	causeissuance and
1	section 3324(a)
1	qualification an
1	order disapproving,
1	diet. (june
4	tribal affairs
9	destruction or
1	small enough
4	different and
1	30, 2002,
1	certifies the
1	(3), which
2	governments in
14	destruction of
1	may facilitate
10	adequacy of
1	rights for
1	customs officer.
1	disseminates false
1	(n)(3), or
1	audits, conducted
2	restaurants owned
5	requirement or
1	difficulties described
1	(a) sponsor
1	available; (f)
69	requirement of
7	periodic reporting
2	death; and
1	manner set
2	requirement on
8	unapproved use
29	cattle, sheep,
1	corporate name,
31	intends to
2	trafficking in
60	holder of
1	seized for
1	joined with
2	occurred after
1	daily amount
1	individually scanning
3	awarding of
1	
 350b.
1	year 2015;
1	carcasses examined
1	provision the
2	provides notification
1	submission (after
1	subdivision after
3	coverage of
6	year 2015,
1	activities (other
1	year 2015.
1	claims in
3	practices as
1	cultivating or
1	section 1541
2	on-quarter grain
1	preparation valuable
1	related manufacturer
1	testing expenses
1	complaint 
1	new conditions
1	august 31,
2	1421 et
5	date 
1	201 and
1	 ecalcium
1	pharmacy undertaken
1	similar packaging
4	person intending
1	affirmance of
1	chemically altered.
19	august 3,
2	address for
1	vehicle a
1	evaluating and
2	conduct sufficient
1	dissemination with
4	section 355(c)
1	opium. (4)
1	1707. counte-drug
1	provide at
1	deception, or
1	agreementswith respect
1	handling confidential
1	2223 of
14	inspected under
1	unreasonable, direct,
1	states exceeds
4	states. (c)
1	persons, company
1	products out
3	use. (b)
1	manner permitted
2	subsection (b)(2)(a)(ii)
2	(3) or
1	adopt appropriate
2	standards should
1	pending animal
1	proceeding described
1	(g) amend
1	diseases; research
1	1401. pesticide
1	without identifying
1	pharmacy; or
1	element involved.
1	transfer each
1	(a) examination
1	risk; (iv)
10	(3) of
18	necessary in
2	(b) investigate
1	purpose, sells,
1	restricts visibility
1	recruit meeting
3	(b) drug
1	improperly imported
6	(3) on
1	particular person,
2	shall determine,
1	section 314.70(d)
1	1946), signed
1	implant value
10	provide an
7	regulations are
1	permanently affixed
9	national primary
3	transferee or
2	drug, narcotic,
6	specifically to
2	private youth
2	ingredient information
1	demonstrates by
3	prior notice
1	not. (i)
1	(b)(ii) by
1	risk over
1	electronically and
1	favorable and
2	registration should
3	ingestion of
1	tolerance. the
2	request, such
1	subparagraph (a)(iii),
3	powers, and
2	harm allegedly
1	conclusive decisions
1	attractiveness, or
1	3, corresponds
2	classify such
1	
 1403.
3	progress in
2	expert or
2	(i) relating
1	suspended at
2	determination. if
4	twent-one years
1	controlled premises;
4	admission into
1	notwithstanding sections
1	declared forfeited
2	interest on
1	sellers that
1	report; time
1	issuance or
17	appropriate congressional
21	distribution supply
2	food would
17	interest of
1	include biological
1	section 842(b)
24	december 13,
1	(b) written
1	(9). (5)
1	357,[3] 360e,
3	may find
1	product. (g)
1	interest or
1	force development;
8	refer the
1	sample requested
1	assessing pediatric
2	warrant authorizing
3	analysis for
2	fact, the
3	finds has
2	inclusion the
12	considered as
1	slaughter), may
1	valid microbiological
1	refilling a
1	
 360l.
4	(6), or
2	examines the
1	treat substance
1	(8) sulfondiethylmethane.
2	meet to
1	seq.); or
3	(a)(1) to
1	(2). (c)
7	effective. 
1	rural or
1	refuse admission
1	200.0. 
5	used, and
1	appropriate schedule,
2	average ful-time
1	veterans, their
1	criminal enterprise.
1	limits specified
1	standard than
1	information consistent
16	whichever is
1	areas. with
1	(4) increased
1	conversion to
1	1044. exemption
7	inspection or
6	period preceding
1	twent-four percent
7	request, and
1	party. (2)
1	
 1534.
1	names (a)
2	ensure public
42	title; or
3	thereof) to
1	consultation prior
1	398. notices
5	merit of
1	contentsthe labeling
1	holdnotwithstanding section
3	granted the
2	one in
2	fully disclose
1	(b) amount
1	operate not
1	tribe to
1	commission from
129	years after
2	rule a
2	one schedule
1	6(b) of
1	utensils and
3	gas deemed
2	(b)(2)(a)(ii) or
4	infringement could
3	initiative, or
1	injury results,
1	approved rare
2	otherwise rendered
1	(c) debarment
2	positions that
1	one violation
1	interstate source
1	appropriate health
1	establishes the
2	effectiveness can
5	element of
1	incorporate local
3	urgent needs
3	strategy report,
5	section 360c(e)
2	committee. each
6	may impose
1	hear and
1	manufacturer a
1	1976, is
1	convictions, unless
1	861, 1,
1	675, 751,
3	following criteria:
2	surveillance data;
1	occur not
26	illicit drug
1	drink for
1	panel (except
1	telemedicine for
3	scientific, research,
2	subsection (j)(5)(f)(ii)
1	decrees, and
1	submit with
1	term narcotics
1	containing poultry
1	establish 
3	public dissemination
6	generalthe fees
1	likely source
2	reviewing applications
2	foreign facility,
2	degradation. 
1	(i)review of
1	institute, applying
10	another schedule,
3	legend means
1	(i) 25
1	5, while
1	arrest, prosecution,
30	illegitimate product
1	applicant, refer
1	officers, agencies,
1	probable causeissuance
1	possible illicit
1	applicant could
1	establishments conducting
1	including modifications
1	clearance shall
1	830. regulation
1	party (as
1	truck, rail
1	u.s.c. 300g1],
1	10.85(d)(1) of
1	docket, notwithstanding
2	pay payable
1	equipment, personnel,
1	rebuttable presumptionthere
10	assess the
1	appropriate authority
9	differ from
1	surgery in
1	numerator class
2	petition; and
6	immediate container
1	(i) effective
1	establish rules
2	(including information
1	corrections, parole,
1	law, enter
1	(b), effective
1	timely, informed
1	antibiotic drug,
4	creation of
1	(j) venue
1	service. any
1	characteristics regarding
1	disqualify any
1	tissue the
1	information other
2	amend section
1	minor species.
1	studies (including
3	considers appropriate,
1	pursuant to,
3	granted for
1	pending proceedings;
1	sizes; definitions
1	matter issued
2	additional country
1	subparagraph (c)(iv)
2	ch. 350,
1	2012(a) of
1	homogenous and
1	shall reevaluate
3	technology. 
2	also submit
1	
 360ss.
1	whom, or
2	committed such
6	agent for
1004	 (i)
1	business exception
1	binding precedent:
1	period involved.
1	program nothing
1	indirectly, anything
1	any, as
1	hidta, with
3	activities, the
3	exercised for
1	use during
1	butyrate. (20)
1	5) as
1	353(b)(4) and
3	laboratories accredited
1	extent raised
4	substantially similar
1	sampling is
4	dispenser is
1	name, other
2	initial grant.
1	declaration may
1	acid to
2	product, but
1	standards; (iii)
1	storage, packaging
1	
 129.
1	administrative proceedings
1	chemical, respectively.
1	(d) neonatology
1	use, including,
2	present on
1	921 of
1	ends, the
2	present or
1	slaughter for
1	petrichloral. (11)
1	phosphorus (mg)
1	coordinating councilsthe
3	regulatory responsibilities
2	investigation. any
1	pending petition
1	(g) definition
2	sponsor, the
1	pediatric product
2	chemicals into
3	object that
3	may refer
1	providers as
7	substances (a)
1	achieve, in
1	action, with
1	paper in
1	paragraph may,
1	(c) subparagraph
1	limitationno civil
1	formed or
1	(e) evaluated
1	comply. 
3	cream shall
5	believes is
1	outbreaks; (b)
1	appropriate procedures
3	order becoming
1	medical applications
1	makes it
2	assess 
5	require to
1	
 129a
1	(i) eligible
1	pooling, reconstituting,
1	675, 905,
1	expenses associated
1	dru-related activities.
1	4-day period,
1	
 1121
1	institutional controls
1	commerce wholly
1	(o) patent
5	action authorized
7	shall accept
1	term data
2	felony for
4	term date
1	coalition enhancement
1	that, due
1	ingredient standards
3	formulation cannot
1	performs no
6	prepared by
1	(3) national
1	interpreted such
2	application contain
2	(4) report
1	international product
1	metazocine. (11)
1	114h. repealed.
1	corporations shall
1	additives (a)
1	675, 802,
1	performance bond,
2	packaged. unwholesome,
1	3, formerly
7	administration, contractors
4	studies to
1	assessments on
2	alternative therapy
10	court costs
13	consumer price
1	uses, and
1	adults, usually
1	meeting (as
1	cooperated with
8	assessments of
1	seq.] an
18	business entity
2	25, as
1	maintenance, for
1	207. restrictions
1	seamless, rea-time
1	seq.] as
6	explanation of
1	(4) unless
1	(d) commissioner
1	prescribe good
1	3 different
1	forth, as
1	flexibility and
6	predicate device,
37	27, 2007,
6	predicate device.
6	27, 2007.
1	forfeited. (q)
2	human health;
8	formula is
1	assurances in
1	expedited withdrawal
1	recite or
1	formula in
1	(5)thir-party logistics
1	predicate device;
2	(iii) not
4	manufacturer, as
1	license of
1	memorandum described
1	section 352(aa)
5	human health,
1	467b. seizure
15	federal funds
1	conveyed by
1	cigarette, that
1	course or
1	principal or
3	information developed
3	preclude the
8	(b)(1) for
1	services related
3	structure of
2	parts in
1	evaluation via
1	product prepared,
1	alcoho-related facilities
1	tolerance limitation,
21	hearing on
3	date determined
1	year 2009if
1	parts is
2	reports as
1	thereafter, upon
1	meaning, such
2	chain stakeholders,
1	(e) matters
1	toward automatic
3	device. (iii)
3	structure or
1	upon august
1	grant 
2	authorities in
2	practicable 
3	projects in
1	section 102(33)
2	parenteral drug
1	understanding the
18	issued in
1	claims to
2	emergencies. 
3	section 360ddd
1	workload adjustments
2	enforceable contract.
1	information proposing
3	manufacturing, packing,
1	renewal grants.
2	2016. 
10	general and
1	filled milk,
2	years, by
3	standard to
5	(2) product
1	nature or
1	basis, review
1	otherwise harmful
1	benefit as
6	letter under
1	(which final
3	destruction the
2	determining substantial
1	life); and
2	regarding direc-t-consumer
19	(a) establishment
1	reform, the
1	identify susceptibility
12	nature of
2	variations in
4	records thereof,
1	(together with
1	building construction,
2	2021 of
1	dietary laws,
1	clause, antibacterial
1	information applies.
125	department of
1	handling, sale,
1	thereby be
3	substance will
1	
 360a1.
1	opinion. 
2	meeting not
1	(e) procedure
1	member at
1	(b) vacancies
1	dispense by
237	necessary to
1	protocol, in
1	subsection (k),
1	placing into
1	experienced review
1	act (60
5	(d) no
4	controls and
1	exploitation of
2	authority that
1	paraphernalia; (2)
1	importations in
6	tolerances for
1	fund to
2	subsection (k):
1	whether commenced
1	569b, as
1	electrolytes; (bb)
1	(27) transaction
1	basic research
1	programs held
1	persons slaughtering,
9	allocation of
1	data, that
4	 (14)
2	poultry shall
1	made, produced,
4	differences approved
1	shown for
1	will mitigate
2	periods: 
1	manifestations primarily
1	transfusion, radioactive
1	incremental change
1	commerce except
1	reporting deadline
1	biologics under
2	642, 643,
2	approval fees
1	355(c), 360b,
1	revisions not
3	(2) designated
1	engineering products,
1	satisfaction; and
1	features; and
1	product reduces
28	products. 
2	foreign supplier,
1	343a. repealed.
1	opioid maintenance
1	means department
1	list on
1	(i)(ii) or
1	surplus revenue
1	adulterated cosmeticsa
1	labeling can
4	adequate grounds
1	(4) exception
2	(a) use
2	inventories, and
2	may produce
4	conviction, include
1	administration; (c)
1	fee. (ii)
1	appropriate internet
4	(a) jurisdiction
2	disclosed an
1	consumer interests,
1	revoke licenses
1	(12) appropriate
1	capacities for
1	extends from
1	patent extensions
1	food, offered
5	individual shall
1	examinations provided
1	proprietary business
1	certain individuals
1	therapy prior
1	proceeding. (3)
1	achieving legislated
1	enforces a
1	schools, early
1	(ii) results
5	payment the
1	subsection (a))[1]
1	food regulated
3	prepared at
2	medical, or
3	plainly labeled
1	import alert
2	ensures that
1	exist. (june
1	
 2203.
1	qualifies as
2	section 101(4)
2	currency of
1	data showing
2	(3) effective
1	reimbursement or
1	constructionno determination,
2	tissue or
1	term domestic
4	42, as
1	
 360bbb.
9	public to
1	wholesale to
1	committee officers
1	(6) may,
1	foreign suppliers
1	interoperable product
3	court jurisdiction
4	reimbursement of
1	(ff) a
6	imports or
4	drug bears
1	smok-free, without
1	advocates a
2	rulemaking published
1	application; (d)
14	controlling the
1	call upon
1	eggs, with
1	fresh produce
1	governmental agencies
2	200,000 in
4	(including increases
1	limitation each
1	section 352(b)(1)
1	pathogens 
1	articles, to
1	dru-free communities.
1	(v) whether
1	handled as
1	(a) six
1	913, as
12	administered by
1	food intended
1	specialty; and
2	designed or
1	nanomaterials; (8)
1	property, the
1	enforcement a
1	defects, except
3	purity, or
3	activities authorized
1	withheld. 
1	
 14a.
1	obligation. 
1	(b) revocation
1	cases covered
3	assessment shall
2	initial transaction
1	greater) period,
1	manner, controlled
8	title 
1	affidavit that
1	nondesignated states;
1	(a). determinations
2	foregoing is
2	practice and
1	test food
1	institutions, or
1	care program
2	dollars, and
4	notice was
2	plants (a)
1	car, cargo
1	substancesthe drug
1	reliefthe court
1	afforded prosecution
2	funds allocated
1	(b) promotional
1	require. (ix)
1	term singl-use
2	aside his
1	cabinet level
1	schedule not
1	u.s.c. 262(i)).
1	ma-made structure
7	secretary prior
1	awards of
1	(2) investigation
3	safeguards against
3	listed, by
1	92. transferred

2	exclusivities or
1	periodically testing
3	difference in
2	equivalent review
1	section 1039,
1	packed under
1	injury may
1	pharmacies repackaging
12	grants under
1	deaths of
1	lon-term strategies
1	suspect and
1	preinspection at
1	-penty--(-naphthoyl)indole (jwh018
1	safety, only
1	cream into,
1	administrations performance
1	device notifies
3	consider such
1	allergy management,
1	allergy management.
2	2013 
6	seek to
1	judicial proceedings,
1	administrative hearings
2	retrospective review
1	identifying it
1	preemption of
2	authorized manufacturer,
1	locked cabinet
1	government employee,
4	prohibited drug
6	agriculture is
2	secretary refuses
3	american societies
1	employment. (d)
1	evidence apply
9	system. 
1	fact on
3	order. (c)
2	prepare, sell,
1	employees means
1	
 2107.
2	facilities, suppliers,
1	executing an
1	(vii) other
1	process improvements
3	concurrently with,
1	(iv) proposed
1	reprocessed. 
1	shall gather
1	identifier and
2	fact or
1	452. congressional
1	primarily as
2	system pursuant
1	seized, if
3	account be
3	individuals 
3	commerce shall
3	government employees
1	360jj. studies
1	dispensers, including
27	clause (ii)
1	profession, appointed
1	disregard at
1	identifier at
2	article, the
1	consumer, (ii)
1	trafficking threats
1	regarding recalled
1	considered confidential.
1	account by
5	advisory council
1	high concentrations
1	675, 736a,
1	clause (ii):
2	clause (ii);
1	states attorney.
1	defining the
1	675, 515a,
1	science for
2	registrant reported
1	except further,
4	registered mail
1	subclause (iii)[3]
1	violations regarding
12	clause (ii).
26	clause (ii),
7	issued, the
4	contributions, for
1	that, before
1	designations in
1	practitioner engaged
5	model standards
3	subparagraph (c)(ii)
1	presenting imminent
1	registries, claims,
1	(or greater)
1	procedurenotwithstanding section
1	relabeling, or
1	(i). (ix)
2	otherwise that
3	opiates, including
1	accelerate innovation,
1	twent-one days,
2	pediatric assessments
1	practices, between
1	anesthetic; (v)
3	species) required
1	506b, as
1	biomarkers, intermediate
1	chemical can
2	managers and
1	list compiled
3	report from
4	tolerance under
7	health; and
1	submissions that
1	percentage for
1	patients experiences
1	food allergensthe
1	communication, without
2	adequate service
1	prevailing employer
1	person processing
1	(1) on-time
4	device. (c)
1	public inquiries
3	supplement effective
3	justice may
1	officials promptly
1	consignee thereof;
3	violations of,
2	relief as
1	section terminates
1	purchasers name,
4	followed by
1	panel not
1	include studying
1	initiating scientific
1	necessitating the
14	virus, serum,
1	device recall.
1	provisions if
1	1891, as
2	2018, and
4	committees the
1	states, then
5	four years
2	plan has
1	$5,000 for
1	113. repealed.
8	libel for
1	antibiotic banned
1	seized goods
1	bulletins, and
2	system and
1	searchable database,
44	3 years
2	subclause (ii),
1	thereof (including
5	drugs which
1	identity has
2	relevant international
1	repackager intends
24	labeling for
2	facilities, inventories,
6	cocaine, ecgonine,
1	injury if
1	7 members,
1	shall initially
1	
 1546.
4	information identifying
1	justice supervision;
1	exchange, currency,
1	licensing boards
1	certify, compliance[1]
1	authorities is
1	post in
1	subparagraph; (v)
1	substance, pursuant
1	fees due,
1	(e) limit
2	application (as
1	administration. (july
1	nurses, teachers,
4	respects in
4	chapter (a)
1	standards. (d)
1	production process,
1	certified medical
1	it, and
1	objections may
1	goals that
1	performance reports
1	section 897.16(d)
1	areas, the
1	meets a
1	fulfilled and
2	living in
1	scientific society
1	products; treatment
1	unlikely that
18	order with
2	placed on
10	found that
1	progress measured
1	union, if
1	term security
1	information found
1	decision. findings
1	
 1708.
3	ruleexcept as
2	products into
1	verification: i
1	appropriations, no
1	occurs, the
1	outcomes, of
1	confer, either
1	second violation;
4	shall begin
2	adequate training
1	secretary. to
33	product manufacturer
1	assurance is
1	reserve fee)
1	individual health
3	application (a)
1	anticipates the
1	means factors
1	conditions may
1	assurance if
1	portions submitted.
4	product manufactured
1	modified accordingly.
1	securities. 
1	(7) shall
1	employees; (h)
1	returned at
1	biologic substance
1	mission the
1	exuding or
11	action may
1	may retract
1	dollars in
4	islands, the
1	(3) duration
1	substances each
1	proposalfor each
2	introduction, into
1	election (together
1	enhanced aquaculture
1	agency relationship.
1	preceding years
1	certain componentssuch
1	vegetable juice
1	detection capabilities
1	(b) strength,
2	review; other
3	owners and
1	(b) imported,
1	ingredients subject
1	prohibited act
1	343(i)(1), or
1	achieved during
1	utilization of,
1	loan applications
1	compendiums within
2	party for
1	seized pursuant
5	returns of
2	update as
1	disseminates or
1	persons, of
1	(8) not
1	requirementexcept as
1	(g) amendment
1	300g1], the
1	strategy (including
12	urban consumers
3	transfer (including
1	section 355(j)(5)(b)(ii)
2	egg or
1	(vi) regardless
3	appear to
1	funds; adequacy
1	developing pediatric
1	304, 402,
1	measure progress
3	articles into
1	grant application);
1	subsection; (b)
2	term thir-party
1	review premarket
1	requesting registration,
4	different requirements
1	renumbered 309,
2	outbreak that
2	30th day
1	(b) outreach
1	elect, within
5	(a) performance
1	(2) contentseach
2	consumer protection
1	following descriptions:
1	disorder, including
1	reevaluating the
1	(a)(1) (other
1	18 (relating
3	annual sales
3	shall reasonably
1	(c) unclassified
3	section 2
1	threat when
2	cost; or
6	drug product;
5	witnesses who
1	follo-up effectiveness
3	2009, and
1	(3) 3,4,-trimethoxy
8	name, or
9	day of
1	prohibits the
1	meeting regulatory
1	manufacturer conduct
6	training programs
1	playground means
1	(7) medical
9	day on
1	inspection extended
2	thereto. 
2	injury which
2	background, except
1	necessary staff
1	modification, a
2	day or
2	recommended by
4	part to
1	respective internet
6	manufacturer that
1	961. prohibited
1	salted, rendered,
1	(f) disclose
1	together with,
13	collect fees
1	23. penalties
2	listed, for
1	applicants opinion
1	consumers might
6	occurring from
2	maximum established
2	obtain from
7	determination described
2	veterinary medicine,
1	section 823(h)
3	notification submission,
1	security system
1	notification submission.
1	26 that
1	competition, the
1	preparation, storage,
1	provides or
3	risk than
1	paragraph will
1	feedback regarding
1	prohibiting transactions
1	387a1 of
1	societal, health
1	regulatory status
1	party refuses
3	subsection (c)(3).
1	dismissed defendanta
5	15 months
24	previous fiscal
12	bears the
2	(or, with
4	provide sufficient
1	hired, or
1	sound shell
1	abuse issuethe
5	processing for
1	imprisonment. 
1	(vii) assessing
1	cause may
1	chemical, the
1	numbers sufficient
1	adult data
1	expertise concerning
1	duties (or
1	developed after
1	shortage; and
1	facility involved
3	notification submissions
2	representatives, the
1	constituent means
1	authorized pursuant
18	individuals who
1	scientific requirement
1	pediatric research
4	governing the
1	unless during
3	financial resources
1	351(a)(5) or
2	based only
1	waiting period
1	federal authorities;
1	labeling; personal
2	(1)(a)(i). 
1	nonrenewal.if a
2	inspection, including
2	combination provides
1	diversified expertise
1	drug issues;
3	recognition or
1	conventions in
6	inspection resources.
1	safety commitments
3	employees to
1	chemical specified
1	order withdraw
2	shipment date
2	experience 
1	(b) exempt
1	treatment, rehabilitation,
3	convictions under
1	public notifications
1	reliable law
16	recognition of
1	first inspection,
2	faith for
1	inspection; quarantine,
1	
 1041.
11	foreign person
1	advisory assistance;
1	(b) false
3	paragraph, unless
1	elected official)
1	convention or
1	apply by
2	surrogate endpoint
1	device designed
1	tank a
1	surveys (or
1	engagement of
1	of, products
1	claim. a
1	promoting honesty
1	next following.
6	notification the
1	locality; (iii)
2	actual performance
1	listing or
1	ice cream.
1	together to
1	dextromoramide. (13)
1	secretary. (m)
3	state engaged
1	members on
1	project lead
1	preapproval review
2	activities not
1	health, agriculture,
2	federal property
1	1046; apr.
87	members of
2	information without
3	refused admission,
2	classified such
1	prescription for,
1	national average
1	carcasses all
2	control such
4	compilation of
1	short title
19	costs and
1	proposal, the
2	approved, cleared,
2	safety requirement
1	(2) twice
1	identity established
2	report, recommendations,
4	select the
1	acquiesces to
2	established an
4	reasonable person
1	(1) serious
1	encryption technologies;
1	though suppliers
1	appropriated by
1	$125,000. (6)
1	health (for
2	final list
1	apply; (2)
1	also are
1	physical, physiological,
1	sitethe secretary
1	program, using
1	156. licenses
1	container too
1	subsection (a)(1)(c)(i);
1	funds needed
33	device to
1	certification issued
18	submits a
4	third and
1	government agencies.
2	submissions submitted
2	proposals and
1	youth. (vii)
1	states. (mar.
2	probable benefit
3	government agencies,
3	appoint an
1	fund. 
1	trips, befor-
2	application, at
1	$3,000,000 from
6	application, as
2	360b(i) of
5	anabolic steroids
38	product. 
1	(4) alphameprodine.
2	transactions 
1	(iii) except
1	(e) recordkeeping;
20	trade secret
2	dismissed supplier
1	regulatory review.
3	judicial review,
1	application, an
1	aircraftit shall
1	preservatives if
1	best strategy
1	(2) specific
1	(3) protection
1	379h1. fees
1	(7) may
8	representatives a
12	fees, and
1	dispense, administer,
7	360bbb3 of
18	section 841(b)
1	conditional approval.
1	health, he
4	conditional approval,
22	regulations as
1	(d)(2). 
1	person. if
1	$75,000. 
1	section 360eee3(a)(1)
1	inspectors ante
1	managed as
2	treatment facility
2	applicable, under
5	section 381(d)(1)
1	conditional approval;
1	fees, any
2	report annually
1	da-t-day operations
32	(a) 
2	administration, fees
1	(4) on
3	minor change
1	listevery person
1	761, as
4	declaration pursuant
2	contaminated by
16	(4) of
1	(a)(i)) adversely
1	scientists; and
1	validity, completeness,
7	industry on
2	certain raw
1	legal reviewers
4	misleading form
1	application substantially
1	submissionfor purposes
1	prohibited the
3	industry of
1	(5) guidance
2	1, 1902,
1	practitioner, upon
1	sponsor considers
1	processing method(s)
1	products sold,
6	selling, or
1	acquire or
3	market for
1	furnish, pursuant
21	history, and
1	vaccines pursuant
1	(e) statute
15	360bb of
1	number, (iii)
1	appropriate reciprocal
1	manufacturer does
1	finds upon
3	regulation designated
1	found, is
8	thereof to
3	temporary suspension
1	defined; combination
1	specific citations
1	subpopulation group;
1	cause continuous
1	nonconforming plants
3	procedures applicable
1	timely, accurate,
3	c of
1	conclusion under
1	(b): 
1	claimants; jury
2	list, it
1	permanently implantable,
2	1907, as
6	products thereof
14	achieving the
1	administrator resulting
1	2017for each
1	i-kind contributions)
2	local requirements
1	(iii) fiscal
1	(5) exception
1	list, if
1	350f(a)(1) of
1	withdrawn. 
1	administration draft
1	facility remits
1	agents, and
1	practices required
1	(a), includes
1	(e)(1)(b) and
1	(at or
2	employees employed
1	67 percent
22	prepare and
1	exist; or
1	information until
1	prepare any
1	field identification
8	agriculture, the
1	(c)(1) or
1	straw. (4)
1	1500.)
 

2	testifying at
1	project from
1	tolerance, exemption,
1	person arranging
2	means, making
4	(i) documentation
1	reasonable standards
1	rule data
1	documents and,
20	application described
3	may exercise
1	waivers or
1	better therapies
1	subparagraph (b)(iv),
2	package shall
1	conduct; and
1	illness of,
6	time when
2	clauses 2
5	supplies; and
3	container have
2	waivers of
1	accreditation, but
10	manufacture, distribute,
1	675, 772,
1	objectively measured
1	application describes
3	violation; and
1	unlawful by
2	biologic product
1	summoned for
1	(with respect
1	risks involving
3	secure, interoperable
1	prejudice, except
2	subsection. (3)
1	june 29,
2	identified with
1	2017, as
1	blocking assets
4	producer of
1	chapter[2] 21,
1	voluntary action
1	existing standards
7	information indicating
2	affixed to
1	paragraph applies
1	thereof thus
1	paragraph a
1	chapter whose
40	person has
2	show either
1	general makes
1	products manufacturer
9	known and
1	eligible productthe
1	387u. studies
1	submission, implementation,
29	experience to
2	submitted; and
2	food, drug
9	ingredients are
8	18, any
1	includes persons
1	131, 133
2	address, the
1	include for
1	(d) allows
4	products manufactured
1	(i) gao
1	sulfondiethylmethane. (9)
1	drug wholesale
1	expired, damaged,
1	communicate risks
1	purchasers that
8	safety report
4	declares that
1	interactions regarding
7	may deny
1	restrictions under
1	379dd1. location
1	monitoring pesticide
2	dispenses controlled
1	(1) methods,
1	1143. repealed.
5	taken before
1	involved are
2	evaluating state
2	efficient enforcement
3	subsection (k);
1	applicant. (iii)subsequent
2	requirement because
1	(c)) at
9	1 (part),
5	reauthorization, including
1	health, a
6	subsection (a)(4)
27	licensed by
1	supplier if
1	misbranding in
1	provide widespread
2	schedule. except
1	deferred. further,
3	misbranding if
1	subsection concerning
1	license, marketed
2	package in
5	supplier is
1	tools. (2)
1	competes (36
1	administrative entities
3	studies (which
5	also a
1	chapter designating
2	subsections (g)
1	left an
1	nonclinical, clinical,
1	drug, taking
2	initiatives described
4	endanger the
1	5 years;
1	inactive ingredient
3	proposed tolerance
4	criteria the
1	
 855.
1	upon implementation
2	affiliates, or
1	petitioner may
3	5 years.
1	registered are
1	history means
1	disclosures not
1	manufacturing other
1	regulation requiring
19	supply of
1	health departments,
1	research (or
1	witness relating
6	engaged. 
4	(a) requirements
6	feedback from
29	120 days
1	purity therefor
1	meeting. (d)
2	biomaterials suppliers
6	paid in
1	conservators, appraisers,
1	3, 67
1	summary via
2	(a) improving
1	(1). subsection
2	states are
1	planning, developing,
1	3, 68
1	3, 69
1	upon efforts,
2	attainment of
1	360bbb3, 379aa,
7	registrant has
5	carcass or
1	(a); multiplied
1	agency toward
1	reevaluated not
1	analysis (including
1	violations were
1	recognized scientific
3	member to
1	substanceit shall
3	subsections (e)
1	seven hundred
1	security at
1	seek the
3	president for
2	application from
1	percentage 
1	(1)(d) of
7	shall become
1	otherwise) electronic
1	period no
1	$1,857,000 for
1	circumstances involving
1	paragraph (1)).
1	effectiveness. upon
3	special clinical
1	discharge 1
2	(2) responsibilitiesthe
1	application, unless
1	certain monitoring;
1	2008, to
1	labelthe label
1	2009, promulgate
1	another drug,
30	may, by
6	(a) no
2	entices, or
1	forms. they
129	part of
1	security under
1	(e) restricted
4	advance the
1	reports beginning
1	endpoints reasonably
1	sustained only
1	part on
1	1177. special
38	eligible entity
15	 (mar.
1	(b) commerce
1	acid. (18)
2	pharmacy, or
13	part or
2	activity taken
1	considerationsin determining
2	little cigars,
1	meeting. (ii)
1	codes, us-by
1	stat. 1048.)

4	health. (d)
4	responsibilities for
1	oversight), as
1	whether corporate
3	misbranded shall
1	sponsors, contract
1	360e(b)(1) of
1	312.21(b) and
1	prosecuting illegal
2	statute described
1	discovered by
1	representatives as
3	budget proposal
8	shall prevent
97	secretary for
2	majority of
2	appears otherwise
1	staffed laboratory
1	retention, segregation,
1	-mail address.
1	2012, at
1	-mail address,
1	may secure
1	director if
1	material, chemical
2	copy shall
1	food used
1	data, standardized
1	gifts or
1	reasons, if
1	indemnification, and
1	otherwise cooperate
1	consistency and
11	funding for
1	both, or
23	authority for
3	proceeding. (b)
1	listed, prescribe
2	subparagraph, operations
1	shall return
38	health consequences
1	unlawful receiving
1	thereof) of
2	reasons, it
2	salt, derivative,
3	48 hours,
1	least on
2	expand the
1	importation no
1	transferring ownership
1	379j53. reauthorization;
1	standardized on-page
1	positioning and
1	subpopulation if
1	device, include
3	except upon
1	require, and
1	(a) appointment
1	daytime when
1	(5) list
2	animal inspection
1	(4) build
3	administering and
3	furnish such
2	assert a
2	public; (c)
4	(u) the
1	statement caution:
2	notifications in
5	risk associated
2	submissions a
1	drug submissions:
2	open for
2	(1) notwithstanding
1	framework in
2	food sector
1	(6) assist
14	section 353(b)(1)
1	manufactured. (d)
7	organizations and
1	official compendiums
6	drug submissions.
5	subdivision requirement
3	drug submissions,
1	standard, shall
12	title. (2)
10	made the
1	communications by
3	adverse determination
1	arts, or
3	leaving the
7	secretarys authority
4	human life,
3	(c) suspension
1	greatest practicable
1	personal costs,
1	
 963.
2	filed before
80	meets the
1	456. operation
1	delay notwithstanding
2	produce health
1	submission applicant.
1	period. (ii)
1	services; 
4	component, part,
2	u.s.c. 262(a)],
1	designate inspectors
2	not, otherwise
2	communities throughout
2	evaluated for
3	products, which
2	(a)(4) of
1	personnel data
2	inspected pursuant
7	inspection by
2	poppy straw.
1	regulations referred
1	(a) foundation
3	homeland security.
1	debarment beyond
28	homeland security,
1	3664 of
1	(1) intends
1	(12) attempts
1	representatives. (5)
1	costs, expert
4	part 803
2	license applications
3	expired, (iii)
2	threats to
1	temporary period,
3	subsection (b))
1	(o)(3) more
1	services provided;
1	no-food life
1	(s) of
1	history which
1	rule beginning
2	1114 of
1	agenciesthe attorney
5	42 that
1	(5) definitions
1	found the
1	(including dosage
2	effects; and
2	grown tobacco.
1	(1) generic
1	act (or
2	current calendar
1	enhanced requirements
4	poses a
2	police powers
5	repeatedly or
1	2012. (g)
2	(4) training
1	management. (c)
1	(g) seizure
1	abuse constitutes
1	529a, as
2	schedule i)
1	emerging from
3	materials for
3	(a) definitions
1	substantial, such
4	284m of
1	nonreimbursable basis,
1	classify any
1	overall morbidity
2	(1)(c), the
1	abuse; (5)
2	diagnosis by
1	ending eighteen
1	particular; (b)
1	(jwh073); (v)
1	recommended amount,
1	logbook and
2	component parts;
1	
 360e.
2	violation for
1	processed to
1	occupant, or
1	devicesthe conditions
4	incur the
5	programs, and
8	paragraph 7
1	(i), (j),
1	software can
10	inapplicability of
1	condition, and
1	unnecessary imposition
1	generalan accredited
2	may exceed
2	patent certainty.
29	(1) may
7	health benefits
3	online pharmacies
3	levels, including
6	qualifications of
6	exclusion of
1	limitation, for
1	health. for
1	participants as
1	murder; punishments
1	section 331(i)(3)
1	guide; patient
1	(h) role
9	356e of
1	submitted comments,
1	achieve product
1	5, and
2	(lsd); (f)
1	353a or
1	authorities; release
3	illicit drugs
1	describing criteria,
1	detention is
1	reporting requirements:
1	another vessel,
1	type so
1	offices and
6	state establishment
1	(a), other
3	investigation under
1	reliable, officers
1	(d), during
1	are, or
1	children); 
1	notice, including
1	duplicative guidance
1	2012); or
10	disclosure under
9	history, transaction
1	additives, be
1	is, therefore,
1	community under
1	countermeasure applicationthe
1	$300,000. (2)
3	buy or
1	coca cultivated
1	(3) exception
5	554 of
1	reliable data,
1	device. (june
1	reasonably believed
1	existing performance
1	food. (4)
2	issue and
1	(ii) distributions
1	knowingly sell
1	brands of
2	article 7
3	comprehensive communit-wide
1	per unit,
2	identifier means
9	reasonably believes
1	statement means
1	plan; vacating
2	statement, a
1	(14) pethidine.
1	collection not
2	no-federal law
1	tank. 
14	360d of
1	additive either
1	nations, in
1	cholera. (f)
1	drug may,
1	applied worldwide.
1	traceability. such
1	aggregate 
1	evaluate whether
1	therefor (which
4	phencyclidine (pcp);
1	device granted
2	period notwithstanding
6	early payments
1	deceptive acts
1	application approval;
1	required informationthe
1	accorded all
1	substances; investigations;
2	sold over
1	may restrict
1	
 387i.
1	360eee(22) of
3	time (not
1	facts. clerical
1	venue if
7	medical use
5	informs the
1	annex. (4)
1	vessels (except
1	secretary reclassified
1	sentence, a
2	leave such
1	379g. definitionsfor
1	protocol have
2	investigations, been
22	360ccc of
1	agreement resulting
1	handler with
1	150 by
9	37 of
1	standards). 
2	premises or
8	make grants
1	(ii)timing of
1	(a) storage
1	
 379j53.
2	standards, for
1	provide modifications
1	otherwise utilize
1	coalition or
1	codeine methylbromide.
1	827, and
5	act relating
1	detail shall
3	committees information
28	report and
1	mescaline. (12)
2	treat information
29	supervised release
3	(a)(i), the
1	processing, such
5	provide assurances
1	regulations; issuance,
1	removing the
1	1884, ch.
1	devices within
2	report any
1	partner program
1	annual needs
1	approval; bioequivalence;
1	final form
1	 c
3	 a
2	(ii) limit
2	entity for
1	 e
2	subject and
1	 k
1	school and
1	distinctive proprietary
1	exacerbate an
1	agriculture, not
6	(ii) under
1	exceed 24
1	regulation. after
1	amounts. (6)
1	directly relevant
1	commerce exclusively
1	prescribe, by
1	notification identifies
32	state, or
2	shall process
1	equine, that
2	drug, a
6	computerized data
1	order so
1	(c) enterprise
1	meat products,
1	corporation, owner,
2	december 1,
1	subchapter is,
2	attention to
1	2012), revising
1	955d. transferred

1	contaminated; or
1	dru-involved premises
235	ch. 675,
1	outcome assessmentthe
1	imposed with
1	refund to
1	2008 multiplied
2	paragraph (6).
2	meetings described
1	complaints that
1	satisfied by
1	paragraph (6))
1	prohibiting a
1	prohibited: 
2	indication that
3	300g1), the
4	concurrent jurisdiction
3	submissions to
1	governmental agency,
1	certifications relating
20	significant foreign
26	law. 
1	another organization.if
1	food manufacturers,
1	collecting reinspection
1	section, evaluate
1	lozenges) for
2	chain against
1	subdivision under
3	continuous inspection
1	formerly 5th
5	guidelines described
9	6-day period
1	toxicology of
2	effectiveness, and,
7	subsection (g).
2	tribal affairs.
2	5 to
1	class includes
2	owns the
1	member is
1	current judicial,
1	coalitions or
7	shall buy,
1	360bbb6. risk
1	350e. sanitary
1	primary system.
5	shall deliver
1	file means
1	exposure under
3	made upon
1	sellera biomaterials
1	changes not
1	section colored
1	74, 10,
3	statement under
1	life functions;
11	committee established
1	cos-effective meat
1	partner with
1	(x) such
1	360b(b)(1)(a) of
2	ingredient therein
2	conditions, or
1	adequate measures
1	intentionally rent,
3	(z) the
1	products) or
1	defeat the
1	(6) if,
2	making requests
7	68 stat.
1	secretary later
1	alleviate or
2	require compliance
1	human illnesses;
3	shall operate
1	(12) shall
1	market.the first
1	drugs: 
1	bargaining agreement.
5	show a
1	transfers it
3	purpose or
1	additive satisfies
1	information) and
1	section 170.3
1	research efforts
1	manufactured without
1	handling regulations;
1	(35) phenampromide.
1	(c)(1), as
7	market exclusivity
1	consumer may
2	shall sell,
1	consul shall
2	focused on
1	position, the
1	rico. (c)
3	made adequate
1	(c) denying
1	(b) approval
1	subject (or
1	upon under
6	less of
1	(b) early
2	program, and
10	notice published
4	applicant, issue
4	(1) review
1	properties and
1	making contributions
1	disclaimers with
1	gel or
2	tailored to
1	plants; authority
1	adulterants or
2	needs and
7	applications, premarket
1	specific intended
1	section 706(2)(a)
3	hereby found
1	(8) whether
1	
 1049.
6	secretary through
1	exceptiona prescription
1	submitted; (9)
1	(b) 180
1	346 of
1	external biomedical
5	containing not
1	(a) narcotic
1	containerthe container
1	preliminary test
2	may specify.
2	authority regarding
1	fora, and
4	prohibited from
3	information (a)
1	whole, provides
1	reports, by
1	facility used
2	(2) advisory
2	oxide or
1	claimant, whether
1	states establishes
1	grade which
3	350a of
1	shall impose,
1	adulterated. (4)
1	certificate stating
2	attempt or
2	extract product,
1	rail tank
1	distribution history,
33	shall, upon
1	coming into
1	seafood 
1	exemption without
1	law, asking
1	otherwise treated
2	chapter. (n)
1	minimum punishment
1	
 387o.
1	appropriate studies
1	wrapper, if
1	(1) proposed
1	hearings shall
2	disease, in
1	circumstance involved.
4	subdivision thereof
2	resolution 
1	part which
1	relabel a
1	prior findings
2	paragraph (1)(a).
1	misbranded fooda
1	
 142.
1	387e(d), or
1	duplicative clinical
6	travel expenses
1	specific requirements
2	hidta funds
2	paragraph (1)(a);
2	chemicals the
2	review, except
2	chemical (including
1	recent 1-month
3	permit from
31	pharmaceutical ingredient
1	guidance implementing
3	supplements. (d)
12	written comments
1	regular review
1	(d) factorsin
3	(c)(1). 
4	plan, and
2	(b) improving
16	necessary, the
1	
 1544.
3	pharmacist in
2	(f) provide
1	section, during
5	injunction prohibiting
4	ch. 262,
4	brought before
18	outside the
2	commence distribution
2	tobacco growers,
3	pay such
2	levels are
5	approved; or
1	property a
1	substances, including
1	substantially reduce
1	(2) acts
4	detect the
1	(a)(1)(c) of
1	direct hiring
1	property, and
3	part thereof
2	persons debarment
1	discretion, to
1	columbia. (b)
4	time, in
1	aggregation, and
1	limitations established
1	place them
1	projects shall
1	modificationa regulation
1	52 through
1	(i)agreement to
1	serious, expected
1	planted or
1	directors or
1	crude opium,
2	section, whether
1	committee) or
1	district court.
31	continue to
1	346a. tolerances
1	individual previously
1	statement and
10	deemed adulterated
3	residue. 
1	assessmentthe term
1	intermittently. (4)
4	october 31,
1	both, to
3	rule under
5	records relating
3	representation as
1	present state
1	regulation, establish
1	increase pediatric
12	equivalent of
1	(e) oleomargarine
1	term has
1	applicable) if
1	physician means
4	diversified professional
1	187. transferred

3	equivalent or
1	racial minorities.
1	(h) additional
5	(s) the
1	proposed advertisements
1	two hundred
1	protocol had
1	limiting 
1	award compensation
1	expanding capacity
1	reporting: www.fda.gov/medwatch
2	recalls linked
1	subsection (g)(2)(a)(ii),
1	shipment, or
1	defendant lacks
3	1997. 
1	nonprofit corporation
1	strategy established
1	delivery, not
1	(c)recipients of
1	prekindergarten program
11	district courts
1	poor and
1	(e) exception
1	(iii) state,
1	tangible and
7	requests funding
1	prohibited in
2	years ending
1	secrets) shall
1	misbranded. and[2]
1	similar small
1	related public
1	officer, a
2	propose or
1	recordkeeping for
44	user fee
1	parenteral administration,
5	aggregation and
1	section 125,
1	condition if
1	actual compliance
4	protocol has
2	48, 49
7	section 1254
1	grant authority
1	(a) collect
2	requirements which
1	take respecting
2	register and,
1	(d) penalties
2	dispensing is
2	term licensed
2	traveltime; and
1	secretary, respectively;
2	title, includes
1	exports the
1	(iii) compensation
1	applicable chapter
1	shall collaborate
1	(mg) 80.0
2	abuse, especially
2	bringing the
1	specifying whether
13	(3) shall
3	act [25
1	materials, products,
1	(c) objectives
7	state official,
1	advantage or
10	information may
1	physician of
8	propagated, compounded,
1	notifications shall
1	defendant, or
1	directly affected
2	types traditionally
1	division; (vii)
6	state official)
1	authorities; cooperation
2	circumstance described
1	 folic
1	on-page summary;
1	formulas during
4	registration pursuant
1	2014. authorization
1	additional si-month
1	opiate or
15	articles which
5	shortage list
1	subparagraph (b)(iii)(ii)
1	disqualifying interest
2	waiveron the
2	355, 360,
1	practice, testing
7	generalsubject to
1	solicit the
1	repackager affixes
1	type, nature,
3	voting member
2	award of
2	actual knowledge,
3	organizations with
42	301 et
2	initiative under
1	50; and
1	authorized, requested,
1	states). (2)
1	order may,
1	export requirements,
1	(a) jurisdiction;
2	19 and
1	provide all
1	small group
1	seq.), reenacted
3	state official
1	order, stating
2	(b) membership
2	first amendment
1	area may
3	electronic copy
1	use container
4	section 360cc
1	repackaging (in
1	(d) establish
1	terminated under
1	remits the
1	modernization act,[1]
3	proposed protocol
1	seq.); (2)
1	(a) individual
1	controls by
2	section 355(c)(3)(e)
1	clinical setting;
2	sponsors and
1	(1) evaluating
1	use contained
35	 (7)
1	action no
1	regarding paragraph
1	imprisonment twice
1	hold and
1	furnish (or,
3	subchapter: (1)
1	10, formerly
2	deemed approved
3	sections 1111
1	(c) establish
3	subsection (n)(3),
1	(i) prior
2	personnel the
2	2012. nothing
2	alter, detach,
3	credited as
1	terminated, review
1	refrigeration is
1	 (75
1	forfeitures of
2	employer would
17	proposed use
1	committee. (k)
4	section 360c,
6	classified as
1	grown, or
1	national situational
1	5311 of
2	application. (e)
4	intention of
3	revenues from
1	submission may
1	found. (mar.
1	outcomes and
1	regulations shall,
1	effect such
1	entry; (3)
1	sources. (3)
1	grown, on
1	(f) collection
6	(a) full
1	express advocacy
10	may reasonably
15	pay for
1	month beginning
22	351(a) of
7	management guidelines
19	federal agencies
4	persons entitled
1	(a) class
2	concerning appropriate
1	no-narcotic substances
1	agency involving
7	letter of
1	nitrous oxide,
195	secretary to
1	professionals on
1	drug, controlled
1	letter on
1	requested order
2	title) for
1	(2) coordinates
3	 (p)
1	code), and
1	contractor the
1	device (except
6	secretary. such
1	expedited procedure;
1	terms deliver
2	(c)(2)(g) or
1	914, as
1	u.s.c. 220501
6	full and
5	secretary accepts
1	commerce required
1	-benzoylindole by
4	information (as
1	sections 372
3	nonvoting members
2	petitions and
1	programs primarily
1	therein. the
2	status as
1	promotion using
1	countervailing effects
3	(b) issue
1	law, (2)
1	(i) arrests
1	exemption already
32	business or
2	products. (g)
1	occurrence as
2	estimated disposal,
1	distributor purchased
1	alcohol beverage
3	fiscal years;
1	(3) casual
1	(b) foreign
1	issued, an
1	include mixing,
45	business of
1	phrase factors
1	submissions on
1	eyebrow dyes.
3	(a)(2)(a), a
1	data infrastructure
3	submissions of
8	promulgate a
3	801 of
1	signals of
1	(a) cigarettes
1	(11) supplemental
3	investigation, including
4	section 352(f)
1	committee) and
4	rights of
1	harm the
1	lif-supporting; (b)
1	guidance becomes
3	practitioner pursuant
1	centimeter or
3	substantial potential
1	review; (d)
1	960a. foreign
1	agency, secondary
1	actually use
1	red collectively,
2	significant use
6	date fees
1	exporter transfers
1	675, 702,
1	chemicals a
1	organizations; (iii)
1	product recalls,
1	title, (ii)
1	convention, pursuant
1	quantities exclusively
2	(c); (b)
5	pediatric populations,
3	include 1
1	periodic assessments
1	rules governing
1	technology with
1	safety performance
1	products; (10)
1	secretary; (5)
1	(26) transaction
7	collections and
1	detained, and
1	back expansion
2	jurisdiction (except
1	distributed, made
1	section because
1	section 333(b)
1	(whether domestic
1	products, if
8	drug involved
1	1509. repealed.
2	dialysis solutions;
1	inadequate funding
1	performance bonds
8	approved, that
1	submitted contains
1	(c) improvement
2	intergovernmental cooperation
1	(a) authorities
1	50. repealed.
1	5, by
1	context clearly
3	major food
1	(iv)contents of
1	(m) feed
5	persons designated
4	punished as
4	likelihood of
1	reportthe sponsor
1	persons, provided
2	purchased by,
1	(19) specific
3	statutory law.
1	evaluate on
1	reached, after
5	proposed conditions
3	food additive;
1	basis 
1	documents developed
1	vehicles, food,
3	833.)
 

7	contains the
1	law are
1	youth; and
1	device. (7)
9	article which
18	states from
1	previous laws
92	include a
3	ch. 800,
7	product, as
2	sentencing provisions
1	trials, trial
4	including data
1	(a) delegation
1	assessed both
1	57 stat.
1	administration administrative
33	appropriate by
4	information clearinghouse
2	things therein
1	acknowledgment to
1	that, except
1	entity, the
2	officials relating
2	take to
1	partners shall
1	pediatric populations;
1	74, 7,
1	132 of
8	proposed order
4	foreign country,
2	highly refined
1	(1) many
1	(iv) classifying
11	establish that
1	certain manufacturers
1	reduced price
2	property right
1	organizations), shall
1	books, records,
3	insure that
1	dietary uses
1	food, injurious
2	secretarys approval
1	opium, poppy
1	distribution that
2	populations, from
4	expedited review
2	overdue fees
1	area 
38	fees for
1	details of
1	inspection, examination,
1	forms issued
1	heard in
2	(2) qualifying
3	inspection programs
14	may render
1	storage, handling
1	take action,
2	tobacco product).
1	board), which
1	tobacco product),
2	direct effect
1	recordkeeping, periodic
3	reduction and
5	requesting that
5	contract is
1	book, book
1	interest. (5)
1	chapter. (u)
1	address other
1	subsection); (b)
1	mandatory state
1	secretarys satisfaction.
1	drugs among
1	section 333(c)(3)
1	(iii)termination or
1	holding thereof
1	outlined in
1	prescription transfers
4	document providing
2	contract in
2	secretarys satisfaction;
1	suppliers would
6	life of
2	appropriate. (b)
2	meets applicable
1	found, as
1	processors, as
11	accreditation bodies
1	development resulting
3	457 of
1	suitable) in
1	commence proceeding
1	distribute does
1	(e) expedite
3	cause shown,
1	consumption since
1	authorities; release;
2	supply are
1	(2) maximize
1	(3), applicable
4	product. (3)
1	seed thereof.
1	situationsin emergency
1	natural origin,
1	may publish
2	provide advice
2	intentional killing
1	section. (mar.
1	section 350f(n)
2	afford opportunity
2	appropriations through
2	general within
5	1 individual
1	curtail diversion
1	investigators to
1	imported drug,
1	japan, new
1	food found
4	paid from
2	provided written
1	free and
1	food service
1	contamination and
4	subsection (a)(2)(a)
1	human beings.
1	human beings,
2	contract. any
1	lif-supporting device
1	vitamin e
1	(2) knowledge
2	tobacco that
1	regular reports
1	pharmacopeia pursuant
1	schedule notice)
1	reduce any
2	hearing or
2	submitted, nothing
1	reference and
1	fifth fiscal
2	following any
1	(a) real
4	animal experimentation
1	inventories. (2)
4	processed, labeled,
1	assistancethe secretary
4	enters the
5	intervention to
1	tools in
12	wholesome and
1	grounds and
1	675, 585,
1	class for
1	weighted votes
1	infrastructure and
1	616. inspectors
1	(l), and
1	602, 52
2	imported articles:
47	product application
1	preparation, formulation
1	(c) secretary
1	toolthe term
1	which, when
2	foregoing, such
2	qualified testing
3	pseudoephedrine, and
7	penalty shall
1	2009), and
1	establishments of
11	customs territory
1	admissions for
2	(b) results
1	nominations 
1	deliver such
1	opiate abuse,
26	2011, the
1	prior, similar
1	section 1703(c)
1	279
 

4	research or
2	treatment, the
3	material time
2	(viii) if
1	distributed outside
1	introduced onto
1	science advisory
1	drug), and
4	research on
1	waived, exporters
1	subsection (c)(2)(a),
1	labeling, notice
1	512, as
3	(a) prohibition
1	store. (7)
1	title refusing,
2	cosmetic or
1	that, applying
2	responded to
1	ready or
2	subchapter v.
3	year 2013for
1	improves communication
2	commerce (1)
1	congress (a)
1	notification at
25	(such as
1	3663a(c)(1)(a)(ii) of
1	law, will
1	subchapter v;
5	reporting, and
1	documents conclusions
9	use if
6	exemptions as
1	requirements outweigh
1	(ii) certifies
1	acceptable and
158	use in
3	section 360bbb
1	food purposes,
13	illness outbreak
1	shellfish; and
17	(a) with
1	site, in
6	use is
1	enforcement decisions
1	article because
5	person identified
1	substance (in
2	practicable, and
1	perform its
2	sel-incrimination. 
1	stat. 648;
1	section before
1	furnished information
1	property, subject
1	(2) medical
1	problems of
1	(d) effectiveness
1	(2) base
1	interfering with
1	claim, subject
1	data elementsthe
1	importer. (j)
1	capacity that
2	hiring authority
1	personsthe standards
2	eggs are
1	first engages
3	order require
1	difficile. 
2	seven years;
1	(3) promising
11	reduced to
1	secretary, promptly
1	no-hig-risk facilitiesthe
3	applied exclusively
1	repatriate property
1	dentists, scientists,
1	including review
3	meet a
2	may agree
1	assay which,
1	208. certain
1	budget an
17	designate the
2	policy who
2	successor standards).
1	jurisdictional determination
1	consul if
4	(g) crediting
1	findings, conclusions,
5	unless a
2	purpose specified
3	mortality or
1	observed safety
1	
 18.
1	time equivalents
1	for; appointment;
1	food, submitting
1	shall reinstate
1	engage external
3	panel members
2	scientific purpose
1	solely administrative
4	timelines shall
1	verification the
1	literature; (e)
1	supplant an
5	substance analogue
1	clean or
1	timely action
1	ensure, to
1	inspection. each
38	determination by
3	practitioners who
1	dose recommended
1	sought accreditation,
1	purchase data
1	term anything
1	term reprocessed,
1	15 years.
1	humans; (iii)
1	lif-saving drugs
2	exceed $75,000.
3	executive order,
1	poultry under
1	interchangeability with
1	time had
3	chemical synthesis,
1	establishments shall
2	(ii) after
4	projects and
1	worldwide to
1	$50 nor
1	destroyed under
7	(iii) to
3	involvement of
1	functions excluded
1	(1) appointment
2	marketing approval
13	application which
1	assistant who
6	regulation to
3	vested in
17	september 1,
1	term homogeneous
1	markers. 
2	forwarded to
1	exemptions; variances
1	president under
1	transport and
1	funding training
1	operational and
1	(9) may
30	title that
1	vacancies of
1	animals, plants,
1	(3) reports
1	vacancies on
1	exclusiona civil
18	use. 
2	sentence. upon
5	establishment within
1	particular contaminants
1	habitual users
1	strength was
2	affects more
3	package that
1	indication approved
1	intervals or
1	reasons were
1	(including compliance
7	presents an
1	relevant agencies
1	(a)(1)(d). (3)
1	intramural and
1	low physical
1	licensure, approval,
1	orders issuing,
2	inflation and
1	amountsaward amounts
3	letter to
2	biological systems;
1	approved use.
1	body, the
1	(i), be
2	addictio-sustaining liability.
1	distribution system
2	(ii) intended
1	prescribed limit).
1	file; and
1	biological systems,
3	preliminary order
4	examine witnesses,
2	determines may
2	otherwise notifies
13	shall immediately
1	stamp, mark,
1	specific high
1	subparagraph (4),
14	claimed by
1	person affirmatively
1	prescription drug;
1	countermeasure, the
2	protest, unless
1	providers that
1	repayment program.
2	indian affairs,
2	fort-eight months
1	208
 

1	section; (h)
7	prescription drug.
3	components thereof
1	trial shall,
1	350h. standards
2	identify or
3	methamphetamine and
1	preparing and
1	(e) marketing
2	introduced by
1	distribution, of
1	(c), he
1	vaccine safety
3	kind of
1	propose pediatric
1	1, 2010;
18	distribution, or
1	360m(b) or
1	compliance. services
4	secretary respecting
2	previous to
7	general no
1	(a)(1) within
1	fat, all
2	(a) have
5	identifies a
1	360fff7. report
1	preparing any
1	prevention. (iv)
2	states person
1	congresson or
2	(c) judicial
1	ingredients, design,
13	prescription drugs
1	submit validation
2	government is
3	labeling which
1	things, if
1	personnel reviewing
4	entitled, approved
3	functions and
1	mitigated by
2	form, new
2	1705(c) of
3	government in
1	sectionthe foregoing
112	provide for
1	government if
1	reportable food;
1	advertisements as
1	level lower
1	inventory increases,
1	1115. notice
33	shall, not
1	(1)(a) if
1	(j) prevention
1	generalthe advisory
9	direction of
1	include interruptions
1	42, which
2	enforcement proceedings;
1	require redaction
3	acquired by
3	reportable food,
1	laboratory tests
4	data deemed
1	mutation is
1	acetylmethadol. (2)
1	(a)(3)(b), including
1	
 360e3.
2	behavior and
6	held by
1	deemed qualified
6	tests by
1	chemical, soil
1	assess compliance
1	patien-centered outcomes
1	(b)(3), as
1	
 611.
2	cosmetic means
2	situations, as
1	directly thereon,
1	section 387g,
1	section 615
13	acceptance of
1	experimental conditions.
3	(b) compliancethe
1	failure and
1	355f]. 
2	limited use
1	reagent, reagent
1	veratrum viride,
1	recommendations. a
13	evidence before
1	different drug
1	individual patient;
1	barbituric acid,
1	update annually
118	section, the
3	individual whom
2	tropical diseases
12	presented by
1	research populations;
1	information maintenance
3	unreasonable and
55	promulgated under
2	both. any
1	advances and
2	(a) identification
2	2015, $2,786,000
2	(b) accreditation
1	communit-based organizations;
2	reasonable proximity
1	(3) process
1	prescribing physician,
3	abuse programs
1	(g) regenerative
1	year; (4)
1	herein for
2	year. (3)
1	section 360bbb3a
1	legally treated
1	courts, and
1	thereafter imported,
1	appropriate; (d)
1	enhancing scientific
1	communications during
2	meetings, electronic
3	months prior
2	(a) patient
3	360ddd of
1	known. (6)
1	existing authority
67	subparagraph (b)
21	inspections of
35	information for
2	prosecuted by
1	different ingredient
1	returned product,
5	implemented under
1	food, for
1	surveillance, rapid
1	therefor, unless
1	research that
2	views before
2	tropical disease;
1	extensive training
1	inspections or
2	(4) generic
1	describing genotypic
14	(a) such
6	animal, and
3	consumers be
3	trade secrets.
1	term illegitimate
10	prescribe such
1	limitation except
4	identified or
31	department or
2	identified on
1	furnish samples
1	designates, pursuant
5	paragraphs (2),
1	contract, the
2	initiated the
1	undertaken solely
1	character; or
6	section 379aa
18	filed with
1	(2) executive
2	affiliates, which
3	prohibition on
1	investigation relate
1	revealing, other
2	subclause (but
2	data, personnel
1	strategies) insofar
1	declined under
1	suspended if
1	213. fraudulent
3	high managerial
1	has. 
1	obligate such
2	(v) full
2	composition or
1	savings to
1	includes black,
1	sour eggs,
1	country determines
1	persons ineligible
1	(iv) requiring
1	food using
1	maintain sanitary
1	health professionals;
1	studies, evidence
1	officials, and
1	(b) first
2	health assistance
4	evaluation, and
11	available under
1	recipients under
1	either fail
1	
 197,
1	substance contains,
2	health professionals.
1	quantity sold.
1	transferable the
1	impact statementthe
1	substantially identical
1	related, including
1	poultry are
1	federal crop
1	appointment there
1	presidents obligations
1	product, promptly
1	242a(a)[1] of
1	disease 
1	appraisal system
1	items on
1	
 384d.
1	disciplines about
1	product involved,
1	articles, prior
2	study shall
1	drugs imported
3	shall require,
1	poultry be
2	official, as
1	special control
1	part 1271
5	(o) the
1	clarification of
1	transfer. such
1	places, of
1	(17) tetrahydrocannabinols.
1	pdufa reauthorization
3	subsection (i);
1	matchbooks is
3	administering of
1	state providing
1	places, or
1	465. limitations
3	provider licensure
1	establishments used
1	clarification or
1	387j, 387k,
2	subsection (i))
4	economic area
7	subsection (i),
2	agreement, authorize
3	subsection (i).
1	determination publicly
1	section. while
2	suspension, restriction,
15	(b) application
4	unique identifier
1	sale; (4)
1	proposal, not
1	(s) referral
2	sample. for
1	use or,
2	compound, derivative,
2	thereof. the
2	descriptive printed
3	355(k)(5) of
1	(4) time
2	foundation, including
1	court challenges
1	territories. (3)
4	36 months
1	(c) work
1	progress that
2	oversight 
1	(a)(i) may
1	electronic databasenot
7	world evidence
1	(2) phenmetrazine
1	ultrasonic wave,
1	(2) denial
1	order. no
1	multiple management,
3	possess, without
7	strategic plan
1	subsections and
1	202. certain
1	(1) compensation
1	(7) all
10	persons, firms,
3	regarding an
1	august 30,
1	2007; (11)
2	withdrawn without
1	petition. not
2	cigarette or
1	guidance pursuant
2	accreditation, the
1	(h) 50
1	sale. (2)
1	promulgation 
1	statutes. 
1	moved in
1	product, pursuant
5	consignee. 
1	states inspectors
2	alters the
1	referenced on
1	statistics, chemistry,
7	(4). 
1	identified, excluding
1	(e) disposition
1	introduce food
1	months; and
1	brand company
1	significant resources
1	law, (ii)
1	provider licenses
1	certain dru-related
7	guidance or
1	prosecution, courts,
1	740, as
1	(d) crediting
8	guidance on
1	regulations including
5	manner, including
10	schedule, any
8	(b) review
4	probable consumption
1	recalled. 
1	guidance of
3	within five
1	standards, postmarket
83	act [42
1	operations. 
1	gives notice
1	will write
1	inspection; (ii)
1	testing be
4	chronic har-drug
4	protection agency,
3	384b(a) of
1	protection agency.
1	proposed order.
1	that, during
2	reduced in
1	adjustmentthe fee
1	citizens of
2	exception under
1	inspection activities.
5	human subject
20	results from
2	personnel and
2	testing by
1	final report
1	chain, shall
1	loses a
2	board. the
1	delivery thereof,
1	similar forms
1	suggesting to
3	1037 of
2	permanently implantable
1272	 (a)
2	foods; and
5	(3) when
2	threat in
3	praying that
1	schedule are
8	effect with
1	drug, be
1	demonstrate consistent
1	food received
1	prescribes interim
1	structure constructed,
2	(a) require
1	dairy farm
9	tobacco leaf
21	informal hearing
1	products; designation
1	receiving from
1	(c) revocation
1	implant 
1	sciences and
1	facilities prescribed
1	intelligence notwithstanding
1	pretrial restraining
12	agencies of
30	(relating to
1	services does
5	list such
1	effect that,
1	section 458,
1	(a)(1)(b), that
2	maintaining a
1	term holiday
1	applicants therefor
4	practicable given
1	affidavits 
1	facility. (3)
1	achieve completion
2	interstate shipment
1	manner designed
1	manufacturing egg
1	secretary), to
4	50 grams
1	duties; regulations
1	hatching operations
3	order public.
1	917, as
3	drug only
1	best to
1	gathered using
1	secretarys sole
1	alerts and
2	prescription issued
23	food contact
1	provide expeditious
1	notice explaining
2	file fee,
1	(2) adopt
1	least $11,250,000
11	packaged in
2	temporary regulatory
1	settings. the
1	counterfeited; and
1	making sufficient
1	crack in
1	export, (c)
2	section the
35	general 
1	filing (a)
27	abuse of
2	withdrawal; rule
1	incidentally produced
1	packaged it
2	establishment unless
5	order, rule,
1	1533. information
1	test systems
1	bioavailabilty[1] studies)
1	state elections
1	personnelthe technical
1	(c)(3), (d),
10	request submitted
1	(e) require
1	379aa1. serious
1	remedy, described
3	adulterated, mislabeled,
19	oleomargarine or
2	(d) contents
1	48 hours
1	pasteurized unless
1	675, 808,
1	tool, based
2	accreditation system
2	trial if
1	provisions determined
2	protocols that
1	(c)(2)(a)(i)) or
1	thereof, excepting
76	active ingredient
20	premarket review
1	examined for
1	separate area
1	entry within
1	(c)(i) of
1	person requests
1	violations involving
1	paragraph using
32	recommended, or
1	 $3,200
1	so, creates
1	practitioners; pharmacies;
2	involving federal
1	simplicity. any
3	means commerce
1	acetorphine. (2)
1	verification identifies
1	person, although
1	pediatric subpopulations;
1	improve and
1	pediatric patient
1	community supervision
2	concerning modified
1	directly administered
2	(b) eligibility
1	no. 12978
1	found, after
2	(2) remove
2	organization required
1	section 1332(2)
2	another person;
1	functional purpose
5	intended by
1	(1) biosimilar
1	secretary waives
1	outreach workers
1	occur; (c)
1	cros-disciplinary project
1	will lead
2	section 1355
2	tracing at
1	tracing as
2	publicly the
1	dies while
1	importation (1)
2	using bulk
121	shall provide
1	annual gross
2	possible infringement
1	wild fish
2	activity related
1	monthly) shall
2	establishments required
1	2014, except
1	7. (june
1	contract results
7	government to
4	international relations,
4	part, including
3	included by
1	recall, including
1	(a) state,
1	otherwise approved
2	(1) registration
2	testing devices
3	food was
1	receipt was
2	smoking cessation,
11	contain a
2	recruitment or
18	size of
3	imports and
18	business day
1	written analysis
1	shortage has
1	adverse physiological
1	ingredients (a)
1	section 343(b),
3	(1) there
1	unused fees
1	(3) denial
12	fee due
2	(c) establishing
20	(c) and
1	$599,000,000. (i)
1	agency plan
1	affidavits, in
19	(c) any
2	purchase or
1	estate with
1	grants subject
1	constituent the
1	businesses, to
2	repackager shall,
2	disclose (other
3	use would
2	reason, including
1	term communication
2	(c) recognition
7	(i) information
1	center has
3	secretary becomes
1	entitled guide
1	wave, which
1	675, 564b,
18	substance which
3	filed. the
2	(f)(6)(a) revoking
1	sufficient fee
1	subsection (a)(2)(e),
1	quality may
1	both, up
1	canceled; or
1	 vitamins:
1	waive this
2	involved, to
1	sections[1] 355
1	prescribe medication
1	employment whether
5	permit entry
1	danger involved
18	request shall
3	will aid
1	2014, under
1	historical use,
1	labeling; misleading
1	prior such
1	agency efforts
1	736b, as
1	pharmacokinetic studies.
1	abuse problem,
1	directive shall
3	(g). 
18	development fee
1	paragraph (9),
4	contains cocaine
1	by, poultry
2	safely from
1	(ii) maintain
2	collected after
3	convictions for
2	defense research
1	precursors. 
2	constituent (including
1	academic medical
1	form, the
1	condemned because
2	classified information.
1	refunded out
1	committing, such
2	law, and
1	decreasing morbidity
2	practitioner, between
2	law, any
178	means a
5	inspect such
9	(2) limitation
14	prohibiting the
2	reduction means
2	sufficient time
3	anything of
1	prescribe 
1	subparagraph in
2	legend and
2	undertake specific
1	providing advisory
1	deemed renewed
41	active pharmaceutical
1	dependent upon
1	unless (in
1	monitor clinical
3	membership of
1	chemical, additive,
1	relevant civil
2	ingredient requirements
1	seq.]. the
2	territory, under
2	prima facie
2	sold, transported,
126	subsection shall
1	publishes notice
1	machin-readable data
2	burden (as
1	(k) leprosy.
2	behavior. 
1	make known
1	trafficking areasnot
1	(g). in
1	of-site and
1	physician, health
5	constitutes an
1	barred from
1	section 379h(a)
1	persons actions
1	355d. internal
1	health outcomes,
1	hens. 
3	debarment shall
1	application, (4)
1	prepare documentation
1	laboratories accreditation
1	action means
1	goalensure an
1	measures; (iv)
1	pathogen, including
1	treatment utilization;
65	serious adverse
2	second prior
3	rules relating
1	drug abusers.
1	information programs
1	revocation 
1	antifungal resistance.
1	media or
2	detention; duration;
1	organizations serving
3	extent otherwise
9	special controls
1	nitroethane. (x)
3	written form
2	be, for
1	(g) certain
1	poppy, after
1	mixed rots
1	term base
5	section 350c
16	permitted to
1	purchase statement
5	packing, rendering,
5	negotiations and
1	budget authority
1	container from
5	receipt for
1	technical feasibility
1	applicable cases,
1	affect, expand,
1	adults. (4)
1	young children
8	means to
1	distributed, transported,
1	force as
2	2013 not
2	blister packs,
1	drug, prior
4	facility registered
1	health associations,
1	ant-drug message
2	milk, whether
1	item concerning
7	(i) subject
1	congress approved
1	anticipated requirements
1	must verify
3	comments and
1	intentional; (c)
1	include that
5	that, to
1	sulphate of
1	(a)(1), (b),
1	(c) discovery
1	section, exempt
1	(c) preliminary
1	access or,
1	waivers requested
1	processing; (ii)
1	determination applies
1	dietary supplements;
1	prosecuting a
1	nicotine. 
1	criteria nothing
1	food who,
1	(d) determination
1	obtain, install,
1	fund demonstration
1	specific scientific,
2	programs having
3	kept in
2	dietary supplements,
5	handled in
1	dietary supplements.
2	identifier beginning
1	(10) negligently
4	section 350l
1	387a1(a)]. 
1	statement identifies
1	(l) rule
4	label statements
5	adjustmentfor fiscal
1	affected pediatric
11	law for
15	effect until
2	term processed
1	arranging, conducting,
1	(3) contents
10	chapter, except
151	 (june
1	compliance compliance
1	overlaps with
2	addiction and
1	343(h), 343(i),
1	sinusitis, acute
6	leave to
1	(ii) part
1	675, 403c,
1	party or
1	safety protocol
1	1104. repealed.
1	place for
1	held, may
1	animal will
1	periods as
1	evaluation means
1	70 per
15	directly from
2	combination on
109	intended to
6	protect against
1	inspected; (c)
2	subpotent, substandard,
1	late notice
1	requirements referred
1	discontinued products
1	efforts the
2	licensed retail
3	strategy; (b)
21	establish and
3	withdraw an
1	enantiomer has
1	360e(g)(2)(c) of
1	federal benefit
1	awareness capabilities
1	component, and
1	information; serious
1	deferral under
1	individual patients.
3	basis pursuant
1	establish any
1	budget), and
1	shipped stating
1	violation which
2	conviction thereof
1	454. federal
1	regularly about
1	consumer. in
1	observers to
1	individual; (ii)
1	listthe interpretive
1	youth shall
1	(ii) enhanced
1	share as
1	administrative processes
1	automation of
1	domestic traffic
2	substantial compliance
1	additives in
1	businesses, updated
1	depresses the
1	device involving
11	reports and
1	emergencies (a)
1	effectively implementing
1	(b) docketing
1	commission, in
5	shall respond
2	criteria, if
1	federal holiday,
3	orders issued
1	species from
1	14th par.,
1	determines would
2	(b) relation
8	(2), any
1	revocation was
1	information included
1	functions, so
3	including those
2	identificationthe secretary
4	pediatric formulation,
4	paragraph (2)(a)
10	(2), and
1	(23) etoxeridine.
1	(75 g)c
1	factorthe small
3	federal programs
1	phenolic ring
2	title 6.
2	(n)(1)(g), the
1	(4) compliance
1	determine shall
13	received or
1	
 846.
1	(f) indian
4	2014. 
1	branch, food
1	therapeutic effects
1	packaging including
1	challenges associated
1	(a) encouraging
1	paragraphs (6)
1	responsibilitiesthe united
2	received of
2	seq.); (b)
2	which, under
1	youth 12
1	chemicals may
1	warrant, to
1	sufficient qualifications
1	(g)(1) shall
1	379j12(a) of
1	(g) regulations
14	located in
1	technology as
1	files. (f)
2	states; (b)
1	including intentional
1	unregistered foreign
2	measures as
1	(b), (i),
3	rape drug
2	guidelines for
8	new or
1	604, 605,
1	promptly of
1	exported of
1	congress in
1	(july 12,
1	(g) inspections
2	special consideration
8	certified under
1	designing, developing,
33	general not
3	matter which
2	(k) until
1	require persons
6	based. the
1	party confidentially
2	submit adverse
1	devices granted
2	court stating
1	licensure, and
2	single document
1	beverages, with
1	1045. limitation
53	described under
3	demonstrate to
1	subparagraph[1] (b)
1	(4), (5),
1	seq.); (c)
1	associated clinical
1	coalitions. (7)
1	condemnation, exclusion
863	respect to
1	identifies drugs
1	675, 744g,
4	chooses to
1	thereon, shall
1	liable 
4	lon-term care
1	hispanics, and
1	request, which
1	include verification
1	existing hospitalization;
1	8.0 
1	development, public
1	partial fillsa
3	conduct any
1	preclinical studies.
23	final rule
1	commerce; (ii)
10	cause or
1	foreign countriesin
5	performance measurement
1	title, violates
1	medical evaluation,
1	science, that
1	medical evaluation.
1	271.)
 

1	medical evaluation)
1	assessed product
3	(c) coordination
34	review by
1	corporation preparing
1	signals, pictures,
23	recommendations for
1	reports through
1	(i) surrogate
24	file with
18	exemption of
2	submit affidavits
1	experts 
1	suspect drugs,
1	(ii) consents
1	500; 1953
1	modification; or
1	committees, including
1	patient packaging
9	exemption or
1	reliable scientific
1	include fac-t-face
1	coalition was
1	institutions. (mar.
2	serves the
2	advertising fails
1	temporary restraining
1	acceptance, within
4	regulatory agencies
1	alternative treatment
1	district, compound
79	control program
1	(j) withdrawal
1	states descriptive
1	954 or
4	mail addressed
1	(l) records
1	(b)(2)(a). 
1	removed entirely
1	holder a
2	(i) publish
2	products, except
1	(f) other
4	intermittently. the
12	operations and
1	business; (f)
1	expenses while
2	requestor submits
1	practice) to
1	food, under
1	collect any
1	(15) to
1	agreement, guidance
2	section 351(a)(2)(b)
2	impose liability
40	90 days
1	judgment for
1	substance, a
1	condensing: provided,
1	allow patients
1	2102. ensuring
1	claimant where
1	1032. congressional
1	(1) nothing
1	agreed, may
1	satisfy postapproval
4	kit that
1	use biosimilar
2	certified (the
3	collect and
1	standard made
1	contain nutrients
20	per 100
1	manufacturer, to
1	seq.]), unless
1	applicable limits
1	formerly 907,
10	copies of
1	notification. after
1	(f) verificationthe
1	proprietary information;
3	agencies having
1	aggregate pesticide
1	criteria, processes,
1	laws means
1	vehicle and
1	single national
4	(f) a
1	fora on
8	properly labeled
2	granted. an
1	section would
16	regulatory management
2	paragraph. (3)
1	pseudorabies the
1	part described
3	vouchers under
1	functions subject
2	(d) unless
1	states substantial
1	165. omitted

1	practice, the
3	subsection (g)(1),
1	situation described
1	(a) coordinate
1	480 days
5	foreign offices
1	consignee (i)
2	case such
1	determines aids
1	public warehouseman,
1	acetyldihydrocodeine. (3)
1	term annual
1	year, no
1	parents. (k)
1	(a) bear
1	time between
1	assessment identified
1	workshops and
6	activities carried
1	assess user
2	 this
1	harbor pests,
1	renewal; refusal
1	necessary scientific
9	requests under
1	secretarys activities
1	slaughtered the
3	benefits posed
1	subparagraph (d)),
1	actionthe secretary
1	appropriations annual
1	distributed devices.
1	approval process.
4	remedy provided
2	bribe or
2	dispenser accepts
1	drug, investigational
1	(e) order
1	intentionally purchase
1	interviews of
1	revising any
3	procure the
3	authenticity and
1	germicide, except
1	deal effectively
7	persons. 
13	fees owed
1	involving dispensing
1	who, acting
58	made available
1	condition. (2)
1	means, the
2	limit, to
2	approved, conditionally
4	establishment are
3	determinations for
1	rea-time supplement
4	benefit to
1	subsequent remedial
1	treat, or
3	commitment by
1	records following
1	domesticated chicken,
1	unit and
2	analysis methods
1	animals prohibited;
7	procedure set
1	342(a)(2)(d)[1] of
1	better achieve,
1	formula, be
3	chief scientist,
1	criteriathe secretary
1	percent (or
2	(g) provide
3	transporting, or
1	corrective actionsthe
1	shall conduct,
1	shown on
1	initiative, propose
4	records are
1	field trips,
1	nongovernmental sources
1	administered, or
2	recipient, has
1	following transactions
4	certainty that
2	protocol signed
1	faith releases
5	regular ful-time
2	compounding the
1	date: __________.
1	requirements for,
9	criteria standards
1	data, rates
1	pr-trial, probation,
6	purpose for
1	used, including
1	encouraging all
2	cosmeticsa cosmetic
1	nature, and
1	raw materials.
1	container, when
4	raw materials,
1	including sourcing
3	use only;
1	586b, as
1	 mg
3	determination with
1	(d); 
18	tobacco products.
1	implicitly that
1	administration fees
1	another type
1	(n)(2)(b) is
1	designated, and
14	feed bearing
1	(a) move
1	petition were
1	duplicative testing
1	use only.
3	nonconsumer packaged
3	use only,
1	appropriately should
14	except for
1	plan. (3)
2	primarily dedicated
1	diverse expertise
2	health such
1	national organization
6	protection agency
1	556, or
1	test decontamination
1	response may
2	filled not
1	pesticidenotwithstanding any
1	improving an
7	quality, or
1	ordinarily contained
4	device are
2	appoint advisory
1	obtained. the
5	evidence, shall
2	control that
3	authority or
2	processed food;
1	(b) alternatively,
1	fulfilled during
2	formula does
1	sections 360i(h)
5	$500,000 if
1	not, at
1	cal 2.7
2	establishment. marking,
1	acts; penalties
1	final guidanceirrespective
1	shall (1)
1	v medications
1	formula. such
1	served under
1	telemedicine treatment,
4	facilities. 
2	industry regarding
1	procedures within
1	receives appropriate
1	items primarily
1	u.s.c. 2012),
1	box, carton,
3	one; (b)
1	biosimilar to
1	(a) supplying
1	response times
11	controls to
21	otherwise provided
1	(1)(c)(ii) may
1	providing reliable
3	360bbb3(a)(2)(a) of
1	countriesin carrying
6	use tobacco
3	occurs first.
1	priority application
1	forums strategies,
2	lane, system,
1	ch. 60,
1	(or directed
1	will review
1	involving inspection
1	defense capabilities,
1	emergency permit
60	approved new
1	acid, or
1	term biomedical
1	documented, periodic
1	of, postmarketing
1	destroyed and
1	(5) responds
4	bear such
2	facts, or
1	interdiction activities
1	notice filed
2	pertinent equipment,
1	destroy, without
13	unapproved product
1	termination. (c)
14	acquisition, maintenance,
6	may prescribe,
1	section, direct
15	substances act
1	manufacturer regarding
1	1039, 1040
1	submission of,
1	if, with
2	(d) electronic
3	paperwork reduction
1	way in
41	fees are
4	relabeling or
1	360e, as
2	area shall
3	government and
1	countermeasure, a
1	providing overall
5	hallucinogenic effect
1	terminate on
2	failing to
10	(a) subject
1	reduction agencies,
3	follow the
2	industry and
4	costs, excluding
1	sufficiently remote
1	within six
4	hazards and
2	responsibility to
1	entertainment industry
1	manufacturer if
1	prompt advice
1	statement confirming
4	label is
1	decide any
2	drug, any
1	section 404
3	247d6d of
1	obtained directly,
1	pharmacopoeia unless
1	standardized and
2	different name
1	year 2005;
1	declared that
1	transfer, distribute,
4	label if
82	drug, and
23	ephedrine, pseudoephedrine,
6	due and
7	storage, cartage,
1	accreditation. any
1	(xi) products
4	hospital, or
2	regulations if
1	(5) includes
1	2241. inspection
38	take into
1	anhydride. (b)
8	regulations in
1	outstanding and
1	prescribed time
1	period. (f)
1	(iv) de
1	organization, management,
1	security applications
2	consignee and
1	pharmacist shall,
1	property shall
1	
 1172.
1	supplant any
1	(g) 300.0
1	recognizing the
1	675, 414,
1	(7) thir-party
1	certain customers
1	pursuing marketing
5	term commerce
3	suspend any
1	penalty assessed,
1	primarily to
4	provisions the
4	suit of
8	1001 of
1	710, as
3	term isomer
1	accreditation through
1	countries (for
6	generalthe secretary,
1	sources for
1	(d) $7,936,000
1	1981. of
1	(2) regarded
1	respect of
2	schedules established
14	public meeting
1	844a. civil
1	100,000,000 patients
1	shortages regarding
3	responsible party.
1	secretary withdraws
2	responsible party,
2	surveillance has
1	certain preparations
1	sale substantially
6	amends section
5	benefit over
1	section 7801
1	substance abusers
1	regarding changes
1	training, or
2	means either
1	animals, delivered
1	responsible party;
1	nicotine gum,
1	complementary with
1	imposed may
1	(2) manufacture
1	products label,
1	gases 
1	facts involved
5	pending request
1	(c) neither
99	article of
15	title unless
2	secretary such
1	-methy-2,-dimethoxyamphetamine. (8)
1	states at
1	transport vehicle)
1	traditionally intended
1	novo judicial
1	seizure procedures
2	will document
44	article or
1	ieepa was
3	owner with
1	microorganisms that
1	body. 
1	citizen on
1	delay and
18	preceding 4
2	equines shall
1	(b) warnings
1	(a)(1)(f)(i). 
8	denatured or
2	registered manufacturer,
1	adverse product
1	name) of
5	conferences or
1	(2) conditionsnotwithstanding
1	(f) upon
1	(b) opportunities
1	protection program.
4	establish policies
1	ii involving
1	facilities, the
1	5 designate
1	to, creameries
1	require changes
2	device for,
1	standard set
1	include uses
1	42 
1	implemented in
15	construction nothing
1	group, or
1	excess together
2	drug sponsor.
1	item is
2	title, two
1	time, whether
49	infant formula
1	internet eligible
3	agreement is
1	workshops with
13	18, or
1	prospectively planned
1	initial notification,
1	(14) notwithstanding
1	dispensing and
1	auditor unless
2	records (a)
1	title) shall,
8	signed at
1	payment when
1	applies. (ii)
1	movement of
1	emergency (referred
2	place. 
6	report describing
1	evaluating tools,
2	least annually
1	(b), unless
1	155, 5,
1	1984. (4)
2	movement or
17	device establishment
1	review consistent
2	sold under
2	section such
1	complaint with
1	information, periodic
2	27, 1935,
1	concerning observed
4	gas or
1	u.s.c. 2615]
1	two inches,
3	3 years.
4	excluding costs
5	adjustment made
7	person fails
2	level during
2	safeguard the
6	adverse effect
1	262], for
1	determinationthe secretary
2	procedure upon
1	(a) corrective
12	new safety
1	item in
2	program; (2)
1	systems standards
3	registry established
3	sections or
1	transportation under,
1	action; (b)
2	secretary can
1	expended; (iv)
5	respects to
2	canned food
1	using databases
1	directed, or
4	device during
1	olympic and
1	360fff6 of
1	package, and
11	both. if
2	reasonable, taking
1	subsection, assign
1	individual at
1	331(d) of
2	service, the
1	secret. (

1	submission fee,
5	5 days
2	guilty, the
2	u.s.c. 41
3	animal safety,
1	species subject
4	rule published
4	left in
5	procedures. 
1	health implications
1	secretary, (iii)
4	(b), was
1	importer during
2	(b)(3) or
2	ethnic, or
3	section 360b(d)(4)
2	device. in
1	(k) exception
1	resale, and,
5	administrative record
1	(c)(3)(e) of
2	acting contrary
1	therein, directly
12	(a) does
1	requirements. (h)
1	deposited into
1	purposes; 
1	treatments (including
1	(b) subject
1	article. (t)
3	returned to
1	four fiscal
1	entity governmen-issued
1	(d) emergency
1	 (b)class
1	seasonably made
1	occupy the
2	formulation not
1	grams with
2	holding food
2	$500,000 for
1	transaction. it
1	recertification of
11	milk and/or
1	(g) dietary
2	detection technologies
1	without compensation,
1	small units
1	regulation before
1	clearinghouse and
1	shall occur.
2	investigation for
27	device and
1	replace such
3	outside thereof
1	personnel appointed
1	immediately effective
2	distribution such
1	2002. 
1	verification, residue,
6	(a) public
2	group; or
1	(ii) provides
26	shall maintain
1	en-userin this
1	separately approved
1	sections 52
2	either directly
1	counterfeit product
1	(24) furethidine.
1	offenses; punishment
1	writing, waive
1	(d) construction
11	standard established
14	dietary ingredient
2	served and
2	section precludes
1	section 1543(a)(3)
2	serving of
1	mixture described
1	experts who,
1	defect and
1	communities, including
1	postal code),
1	security for
9	label bears,
2	payments from
6	agricultural marketing
2	constitute the
1	relevant considerations,
1	community while
6	particular controlled
4	pharmacologically related
1	inform a
1	presented in
13	application contains
1	identify existing
1	sodium and
3	(1) priority
1	tank, portable
7	agriculture to
4	property subject
10	registrant to
3	multiplying 
1	particular actions
2	representatives, shall
1	826(h) of
1	present such
13	appropriation acts
3	advertisement under
1	ch. 495,
1	crime. (2)
1	distributor could
1	performed with
1	principal investigator
12	drug offense
1	substance, (2)
2	2009. 
1	labeling; (f)
2	retail quantities
1	greater health
1	proven successful
1	waived, importers
2	353(b)(4) of
1	policy, shall
2	regulated person;
1	
 2014.
1	consider criteria
1	periodic review
1	2007 such
1	387o. regulation
6	internal committee
1	(b) supplying
1	measurement system,
1	(1). this
5	finds the
3	defraud or
4	information prescribed
1	paragraphs of
1	awarded and
1	panel can
1	country which,
1	compiled data
53	issued by
1	within 7
1	
 1001
3	(9) of
1	issue under
1	reduce risk
1	playing a
1	(j) federal
2	matter for
1	longer surveillance
2	and/or information
1	letters to
1	supporting narrative
5	establishments with
1	returned. (3)
1	2, 2004,
1	majority vote.
1	majority vote,
1	otherwise may
1	majority vote)
2	42 or
1	675, 537,
1	operate in
1	material with
15	adequate and
1	cannabimimetic agents,
1	distributed intrastate.
8	appeals have
1	(c) qualified
1	devices must
2	sponsor does
4	field or
1	term school
2	holiday work
2	title. (i)
1	manufacturers before
1	 [4]
2	therein to
1	support effective
2	violation, the
1	(ghb) or
1	actually been
1	manners, from
2	tank vehicle
2	qualified en-users
8	field of
1	ch. 131,
1	marihuana. (11)
1	compounding for
1	subsection (a)(6).
9	5703 of
2	subsection (a)(6),
3	forestry of
1	apply, may
1	activity (including
2	assessment the
2	360(h) of
1	180th day
23	approved in
2	thousand feet
1	removed; cocaine,
1	project grants
1	secretary. for
1	general assessment
1	802(49) of
1	forfeiture event.in
1	device. within
2	qualified en-user,
5	paid at
5	chapter. (3)
3	title 26.
1	eliminate, (iii)
3	title 26,
1	g)c 750.0
3	contains such
2	linkages with
1	similar innovative
2	medicine from
1	title 26;
1	tolerance. in
1	 biotin
1	campaign based
1	paid an
5	permitted under
1	send a
1	
 355.
1	arrest and
1	(9) $90,000,000
1	plaintiff; subpenas
1	agent, of
1	decisions by
1	waived pursuant
3	similar retai-type
1	delivered, or
2	(c) coca
1	estimates meet
1	administer product
20	information respecting
1	component is
5	may at
1	authorized official
1	act means
1	resolving uncertainty
1	producing, harvesting,
2	partnerships, and
5	year, prior
1	1705(b) of
1	environmental, prevention,
2	application; (iii)
1	(4) study
1	upon heroin
3	creates a
1	1 month
1	clause (iii);
1	representatives annual
1	(c) accelerated
1	1334(c) of
1	interest, for
5	effectiveness in
1	letter; (3)
1	testing purposes,
2	financial affiliation
9	singl-use device
2	(in accordance
2	including from
1	(2) enhance
1	(june 5,
1	designate 1
1	one fiscal
2	secretary). 
1	goats and
4	(c)(3)(e)(ii) and
5	appoint to
8	drug abuse.
1	18. (5)
4	drug abuse,
1	research findings
2	articles, whenever
1	including fresh
2	law based
1	(a) pending
1	assistance otherwise
1	schedule. there
1	models 
1	drug abuse;
1	toward such
1	section,[1] if
1	opportunity as
1	enabling such
1	statutory, regulatory,
7	exposure to,
1	implant was
5	interested persons.
1	authorized. (mar.
1	marketed, the
1	subsection (j))
4	360b or
5	subsection (j).
2	seller enters
1	(3) engage
10	designate a
3	clause (iii).
81	device is
1	traffickers. (3)
3	chain security
24	device in
1	
 331.
1	efforts are
1	provided without
1	section 971(c)(2)
23	360b of
2	three members
1	counterfeits, simulates,
1	individuals. 
3	shown 
1	congressthe director
1	order informing
7	(e) after
5	implement a
1	influence said
1	stand together.
5	(ii) january
1	certify their
1	applications not
3	enforce, and
1	act. (june
1	1047. refusal
1	guidancenot less
1	ownership, name,
2	(g) service
1	patterns and
1	preparation is
2	form. 
4	appointment and
1	levels may
1	stat. 410

1	good title
2	consignee, or
4	available or
2	fee rate.
2	(2), no
1	internal controls,
1	refused entry.
1	type of,
18	deems necessary
4	resolution procedures
2	procedures, practices,
1	feeeach generic
1	antidrug coalition
1	prevalence. (c)
17	available on
3	defined 
4	law enforcement,
1	therefrom, (iv)
4	regular customer
2	food, solely
4	provided an
1	protein in
1	termination. such
1	discussions, including
2	food actually
1	(4) rare
1	readily mistaken
21	section 355(b)(1)
2	term essentially
1	analysis enhances
1	changes provided
1	12 of
1	safety), (a)
2	interdiction activities,
1	harmonized with
1	2, as
4	(5) all
1	discipline, including,
4	state poultry
1	(3) chairperson
1	cosmetic the
1	recall plan.
1	amount, determined
1	
 901.
2	official and
2	terminate at
1	(2) waivers
2	determinations required
1	residues other
1	substance; nor
9	definition in
2	protocol subject
1	drugs, holders
2	entered on
1	effect, no
1	describing, if
2	one premarket
1	enterprise includes
5	submission that
5	assess such
2	health priorities
2	party the
1	(a) tol-free
1	appropriate; (iii)
1	sign and
1	identifying a
2	independent cause
1	devices contained
2	drug) the
1	identify means
1	produced, or
1	switzerland, or
1	requests. 
1	(d)(1)(b). 
2	(2) accreditation
2	arcade facility,
1	(i) sufficient
2	(c) period
1	
 387a.
1	in, a
1	operations, if,
1	technological needs
1	customarily given
2	comply with,
2	violations by
1	thereof the
1	ensured that
52	title, the
1	sponsor a
1	limitationsubject to
1	allocation, until
1	identification. 
2	appropriate security
1	performs staff
1	pays an
1	representatives employment
2	541, formerly
2	customer during
1	(iv) under
1	pediatric safety
1	sponsor; preconditions;
2	hig-risk food
1	test according
2	facilities according
1	prior history
3	(10) if
1	flunitrazepam; or
1	360j(g)(8)(a) of
5	license or
29	may provide
1	(3), at
1	require approval
1	income; and
4	determined for
1	diagnostic facility
1	section, (1)
1	possess. 
1	effectively on
2	written application
28	assessed under
1	methodology to
1	targets to
1	prescriptions, and
5	materials into
4	(regardless of
1	mark. (w)
2	behavior described
1	sentence. notwithstanding
3	retained in
1	payments for
1	radiological threat
2	proceedings the
1	360i(h) and
6	developing, and
40	training and
11	requirement 
19	(v) the
3	events associated
17	commits such
1	expired. (

1	submitter, unless
1	$5,000,000, or
1	postmarket controls.
1	quarterly, of
7	reporting for
1	media projects
1	authorizes any
3	food will
1	colchicum, cotton
1	dependence (a)
1	use should
1	(2); (6)
1	enforcement efforts
1	composition, energy
1	certain applications
1	evaluation projects,
1	musty eggs,
1	2002. (11)
14	monitoring of
1	application. (8)
4	investigations, and
1	2011, $450,000,000.
3	authorization from
11	amendments of
1	appropriate, inform
1	committee an
1	testing; (b)
1	measurement system;
1	time with
27	agent of
1	petition. except
2	drugs submitted
21	fee required
1	permanent screens,
1	importers required
1	practice. the
2	poppy straw,
1	networks administered
3	title. (iii)
26	(i) that
1	age in
3	contain no
1	channels, and
17	agent or
1	statutory authority,
1	support; and
8	small or
1	period so
10	offense has
1	premises, the
6	350c of
1	section 802(33)
64	place of
1	shortage notification
1	identifying new
9	approve an
4	authorized, whenever
2	order confirm
1	identify individuals.
2	place or
1	scientist to
1	claimant and
1	pending, except
1	acted to
1	jurisdiction, without
2	rehabilitated pursuant
3	manufactured from
1	will or
2	(1) before
1	coordination in
20	agency action
4	factors which
3	inspector or
3	commerce; and
2	control with
3	national formulary
1	officer, to
1	assist, abet,
1	643. registration
1	(b)(1), shall,
2	formulation necessary
2	audit; and
1	contracts and
1	intentional adulteration,
1	675, 1007,
2	transverse diameter;
5	amounts collected
1	met, if
1	appears that
1	regulation been
1	recuse himself
3	time, on
1	section 355(i),
1	including rent
1	(a) schedule
1	doses to
2	(3) includes
4	law, or
2	date from
1	inventory shall
1	whether growing
2	techniques, and
11	title; (2)
1	hospitalization or
11	process or
1	subsection notwithstanding
2	(b) notwithstanding
1	(c) late
2	patent nor
4	receive any
2	misbranded, the
6	agriculture of
1	secretarys efforts
4	registrant of
1	5, formerly
1	(2) maintenance
1	(d) office
1	warehouses or
1	petition (but
12	process of
1	proclamation suspending
1	governors of
2	processes as
4	receive and
11	agriculture or
2	registrant or
1	sum equal
3	premises, facilities
4	thereof of
1	stat. 1101;
1	1151 of
1	(5) conflicts
1	person. (13)
39	drug shall
1	section, assess
1	slaughter not
1	term program
2	trust territory
6	attendance and
1	leaking. (2)
2	(1). (june
1	endpoint means
2	particular class
1	treatment, a
3	reports, or
1	diagnostics 
7	355a and
1	first review
6	experts; (d)
2	audit by
1	74, 2,
2	(a) inspectionthe
1	officio membersupon
1	805, as
1	methodology; and
10	revenues for
1	evaluation the
10	amounts specified
12	obtain a
1	applicable. such
6	reasonably cooperate
1	(i) authenticate
1	general, on
1	officethere is
1	state governmentsparticularly
1	u.s.c. 247d6b]
1	importing, or
1	otherwise preparing
1	becoming effective
1	(8) illicit
1	bany person
1	facilitate access
2	pertinent information
1	additive not
1	food items.
1	federal courts
6	country for
1	958. registration
1	internet by
1	food items;
1	specific training
1	(i)(2) and
1	(ii) -(1,-dimethyloctyl--[(1r,3s--hydroxycyclohexyl-phenol
2	subclause (ii).
4	submitted before
4	decontamination and
1	1058; oct.
1	(iv) seeking
1	1177 of
6	agreement entered
1	average), for
1	injected drug;
1	relative significance
1	forces, subcommittees,
5	pediatric labeling
1	treat tobacco
3	persons 
1	days after,
4	cleared under
1	special populations,
7	human health
3	establishment owned
1	lon-range plan
1	medical purposes
5	notification, the
1	devices; (13)
1	approval remains
1	specific countries
2	four and
1	information maintained
1	schedules are
2	ingredients; recordkeeping
23	may establish
23	et seq.].
30	et seq.],
1	sponsor in
8	infringement of
4	animal health
1	et seq.]:
8	et seq.];
3	standard the
1	exemption). (3)
22	known to
1	america) wherever
1	title, does
2	devices described
1	(g) conflicts
2	four succeeding
1	storing, distributing,
7	(e) whether
1	professional positions,
1	substantial treatment
1	cured, or
1	illness. (june
1	risk identification.
1	program requirements
1	(g) executive
1	training entity
1	approve, license,
2	november 10,
3	flexibility for
12	internet website
1	month and
1	technologies assigned
1	instrument providing
1	condemnations, and
1	(i) disposition
1	(3)(d)(ii), within
3	referrals made
1	assessment within
1	china any
3	ant-drug media
2	will consider
2	(b) record
1	provide each
1	devices included
1	defense plans;
1	federal land,
23	plans for
5	designation may
1	address complaints
4	commerce between
1	forum as
15	whether there
1	demonstrate an
1	practitioner possesses
1	conference. a
1	congress which
1	promote, to
26	revocation of
1	section 360fff6
1	time applicable
2	devices manufactured,
2	required unless
2	development program;
1	(e) anabolic
1	adequate time
1	writing. as
1	exported, transported,
1	2202. national
2	47, are
3	803 of
1	amount calculation
7	revocation or
2	identified patient,
1	advertising relates
1	(vi) ensure
1	organizations, pharmaceutical
1	projection for
14	issued for
1	development program,
1	condemned shall
3	food involved
4	policy and
2	acting at
1	exemption notwithstanding
1	several varieties
3	acting as
1	210 of
2	accordance with,
1	regarding nanomaterials
12	for, or
1	mislead, such
1	manufacturer; (iii)
1	prohibited an
1	(d) preparing
1	1988, whichever
1	makes more
1	related guidance
1	disposal rate
1	(a) enhanced
1	definitions (a)
1	injunctions (a)
2	908, as
1	supplemental applications,
1	(i); (ii)
2	development programs
1	379j22 of
2	marijuana use
1	(b) reliefthe
1	(5) date
1	(c) tobacco
1	activity regarding
1	medically useful
1	(c) crediting
1	cleared alternatives,
1	license rule,
2	complete an
1	guidelines may
1	slaughtering and/or
1	5, 1948,
1	comments does
1	registrant first
1	trachoma. (d)
3	classification in
2	federal alcohol
64	include the
5	sold, or
3	published and
1	voluntary steps
1	prescription drugthe
1	qualified entity,
1	
 826.
1	qualified entity.
1	fide pending
1	demonstrated ability
1	activities, to
2	deny accreditation
1	foreign entity,
21	(i) to
1	supervision. 
3	assistance division
1	product tracking
67	food products
1	excess fees
8	subsection (c)(2),
1	subsection (c)(2).
2	(c)(2), may
1	executive agency
3	formulations for
1	enterococcus; (b)
9	(c), and
5	section 355(c)(3)
1	statute; and
6	title (including
3	drug contained
1	 zinc
7	(b) fiscal
1	packages may
2	requested pursuant
2	dangerous to
2	juice hazard
2	commenced and
1	section 552(a)(3)
1	(t) 
2	swine, and
4	disease associated
1	occur prior
1	issued. (7)
1	july 27,
1	section 343(c),
1	care professional
19	commercially marketed
1	interpretationnothing in
1	antibiotics; terms
1	fee claimed
2	discovers a
3	issue raised
1	iodine (g)
2	subchapter; all
1	(m)(4) of
4	secretary (in
1	(3) amounts
5	filed on
1	postapproval requirementsthe
1	acceptable for
1	stamped, or
1	-[-(isopropylthio-2,-dimethoxyphenyl]ethanamine (2ct4).
72	designated by
1	preempts the
21	total amount
8	standard shall
3	time, as
2	cosmetic provisions
6	guidance. 
1	sponsor referencing
1	person doing
2	activity which
1	president considers
1	last time
1	reindeer. (june
2	product, beginning
4	filed or
22	patent is
4	least three
1	device upon
10	corporation, or
3	effective drug
1	nonnutritive object,
1	department shall
5	years to
1	reimbursement, shall
1	consent, establish
1	fish of
1	importer practices,
2	meeting shall
2	practitioner involved
1	facilitates trade
1	expended from
2	tribal organization,
10	section 360kk
1	(b) purposes
1	(q), in
1	proper, if
1	675, 517,
1	require establishment
2	commodities are
1	effective while
1	(3) temporary
1	officer engaged
1	prompt distribution
1	owed an
1	defense capacities
1	tobacco use,
1	contentthe regulations
1	tobacco use.
2	determine, in
1	program administered
1	precursor, to
1	(4) except
6	second business
6	graphic matter
1	demand reduction.
1	issued following
8	demand reduction,
1	device, of
1	
 387h.
4	compliance 
3	persons that
1	reasons including
23	content of
2	purchase, trade,
3	relevant factors,
1	evidence, for
8	products regulated
1	gas shall
1	education programs.
1	prevent, control,
2	384d of
1	manufacturer specifying
1	committees, a
1	content, flavoring
1	construction, sanitary,
1	(c) adopt
1	registered principal
1	grams. (3)
1	crops the
1	retail prices
1	practitioner, of
1	28, 1976
1	national system
1	purchaser providing
3	regulation applicable
1	first providing
1	consignee and,
31	methods used
2	hospitals, and
1	section 355(c)(3)(e)(ii)
1	copper, gold,
1	supporting; or
15	importation into
1	(i) that,
1	preliminary order.
3	relevant, packing
1	preliminary order,
1	
 1402.
1	board positions
1	antifungal resistant
148	 (ii)
1	campaign; (6)
1	requirements if
4	(i) application
2	concentration as
5	drug manufacturing
1	sampling shipments.
1	qualified candidates
2	1471 et
1	advance by
2	alphabetical order
1	(8) compensation
1	675, 912,
1	1396 et
1	food transportation
1	conducting examinations,
1	status in
1	subsection (c)(1)(a)(i)(ii)
1	draft guidancenot
1	inspect appropriate
1	bond or
1	importing and
1	(c) authorizationthe
5	ingredients that
1	paragraph (7)(c)
1	diffusion testing.
2	agency described
1	differentiate between
10	prior fiscal
1	collected with
1	data development
1	42 (which
1	bond of
2	adulterated by
3	products so
6	relevant committees
1	referral; and
1	effective tracking
2	product). 
2	coordination among
1	date thereafter,
1	regular employment
4	treatment, and
1	outdoor facility
2	nonfat dry
1	legal disadvantage
1	(ii)(i) are
1	356e. drug
1	gives written
2	state may,
7	including smoke
1	requirements; qualifications
1	motion, (2)
1	technique is
1	sold; (ii)
1	(3) contact
2	evaluation by
1	otherwise prepared,
22	determined under
1	will spread
1	(i) postapproval
1	precursor is
1	(3) residues
1	prescribed herein
1	(as poultry
2	authorized, by
8	modernization act
1	considerations immediately
1	safety. (4)
1	substantial experience
1	establish 1
257	(
 

1	urging physicians
2	searchable database
2	publish it.
1	(k); (ii)
1	(a) withdrawal,
5	finance of
3	forcibly assaults,
1	otherwise. (6)
5	(2) fee
1	$25,000. the
1	abuse less
2	collection shortfalls
1	developers, patient
1	give manufacturers
4	program personnel
1	case he
1	oral order,
1	months with
4	(b)(1) application
2	schedule specified
1	labeling exemption
1	(1) develops
4	premarket review,
1	otherwise eligible
8	warrant shall
1	patients; 
1	form all
2	education, labor
2	asset control
1	term nurse
1	farm. (b)
2	human drug,
2	audit the
10	fee equal
2	methamphetamine advisory
1	established offices,
1	379j1(a)(1) of
2	therapeutics from
1	counsel of
1	legal protections,
2	section 352(n)
2	531, formerly
5	regulations concerning
13	adulterated within
5	(2) report
2	firms submitting
1	unapproved product);
1	methylbromide. (5)
1	(6) direct
1	subparagraphs. 
2	required; and
1	usesa designated
1	packing such
1	animals) of
1	measures intended
2	manner determined
1	tetrahydrocannabinol level
2	substances under
1	defense the
3	information pursuant
1	(8) advisory
2	(a) recognition
1	protracted loss
1	deems appropriate.
1	371. regulations
1	representative; and
1	78.6 percent
2	compensation 
6	360i, or
1	tobacco, in
3	purity and
3	agency a
3	(b) compounded
2	filing, or
1	imposing penalties
2	receiver, or
2	advisory commission,
1	authorization marketed
1	reportthe secretary,
2	diagnosing, treating,
12	dying, disabled,
6	promulgating regulations
1	-cyclohexylethy--(-methoxyphenylacetyl)indole (sr18
1	otherwise, other
1	development. (iii)
4	governments and
2	mortem examination
1	(a) share
1	generalafter the
2	chain to
1	rights, status,
1	attorney, postpone
2	it. service
1	exchange, and
3	foundation the
1	described are
3	development authority
2	(a) definitionsas
1	kept, or
1	medical use,
1	803. repealed.
1	issue within
4	tests which
1	deposition and
1	infringed. (4)
1	subsection, on
1	use human
9	individuals and
2	patents and
1	certain civil
2	processes, or
1	identity, from
1	subsection, of
1	
 360i.
7	adversely affect
1	(b), which
1	subsection, order
1	356d. coordination;
4	subparagraph (f),
1	subparagraph (f).
10	setting forth
1	egg products;
2	active medicinal
1	factor that
1	except section
4	activity for
8	subsection, or
1	regulation upon
1	832833) [21
4	establishments are
9	mode of
1	includes tobacco,
1	regular or
8	system of
1	(vii) such
1	i, 6,
1	list that
1	plainly and
1	(1) adulterated
1	trace the
1	fact supported
1	eliminate a
1	secretary (written
1	retailers, and
18	standards established
1	property taken.
1	substances, as
2	substances, at
1	letters; and
1	coincide with
1	town, state,
1	maintain optimum
1	(i) were
1	section 342(a)(2)(c)
1	completed registration
1	(g) did
1	labeling, as
15	claim of
1	additional facts
1	thereunder, shall
4	products, as
2	(2)(a). 
1	research, statistical,
2	adequate protection
1	import supply
1	coalitions, community
14	defined by
1	2[1] are
5	backlog fee
1	global response
3	take ownership
1	reports, including
1	
 353.
7	states unless
1	(a)) 
1	(2)(a), and
2	consult an
6	degree of
1	subsection (a)(9),
1	infants, children,
1	347. intrastate
1	withdrawing recognition
4	deferrals, deferral
1	fruits, juices,
1	information. (4)
1	radiation control
1	applications where
1	section 841(b)(3)
3	regulation by
1	comment. the
2	treat the
1	(1) report
1	annually post
1	seek judicial
1	finance, or
1	expected technologies,
1	caused, or
1	paragraph (5)(a),
2	invite appropriate
5	reductions in
1	 (i)ensuring
2	athletic competition
1	26, 2014)
2	stat. 993

1	appurtenances or
1	(c) inspections
1	industrial channels,
3	(3) additional
1	traced. the
1	(6) prioritization
6	fee to
1	stat. 476;
1	surveillance list
1	registrant during
1	request studies
1	auditor have
2	corporation, and
2	provides transaction
1	authority contained
1	(2) personnelthe
2	underlying data,
1	(b) custom
6	precursor chemicals
2	860, or
5	distributed for
1	(5), which
7	sampling and
3	27, 1970,
1	(iii) applies,
7	product identifier,
1	rechannel resources
4	based, and
1	communications, food
3	reputable practitioner
23	guidance documents
1	species were
2	feed of
9	regarding such
1	if, during
1	formula a
1	360d(b)(5)(b) or
1	law; (ix)
3	auditors. 
1	permit is
66	(a) for
2	determine and
1	reasonable public
3	receive evidence,
1	determine any
1	stopper, covering,
1	1931, as
4	feed or
1	comptroller general,
6	food packaging
1	partyin any
1	annual sponsor
5	legally binding
1	permit if
3	subsection; but
75	(i) in
1	(6) patien-reported
1	limitations to
1	outreach and
1	transferred, sold,
1	compilation under
32	(i) if
5	public access
1	1543(a)(3) of
1	shell and
79	use as
1	council means
2	use an
1	1, 67
1	product identifier.
1	sale. the
3	(a) refusal
1	particular color
1	body; or
2	(i) it
3	food. (b)
1	patient; and
2	1, 68
2	352(n) of
1	communications; (d)
1	analyses; research
1	commingling, processing,
1	orderan order
1	endpoints and
2	abbreviated application;
1	(n) is
1	residue. such
1	device type,
5	hearing, but
1	(11) clonitazene.
1	schedule with
1	accurate, and
1	agriculture, shall,
1	(n) in
1	exported; (8)
1	(g) administration
1	appropriate timeframes.
4	abbreviated application,
6	may distribute
1	food ingredient,
1	exemptionsthe secretary
4	stat. 1262;
1	suggests use
3	clause nothing
1	paraphernalia (as
1	section) or
1	general, under
1	used. (5)
14	trade commission
1	appoint subcommittees
6	prior year
1	destroyed, the
1	personnel regarding
2	be) in
1	(d) limit
2	person. (ii)
1	refusal after
1	(e) modification
1	disasters or
1	(1),[2] shall
1	applicable authorities
7	met by
21	abbreviated applications
1	374a. inspections
3	pack, or
3	46, 48,
1	person, shall
1	(iii) how
2	products means
1	list representing
5	351, 352,
6	eliminate such
2	society meetings,
1	presidential decision
2	flexible approaches
1	device types
2	food production
1	in, revocation
1	353b(d)(4) of
3	request; or
1	sulfonethylmethane. (10)
3	considers not
2	business but
1	(b)(2), the
1	meaning objects
1	labeling appropriate
2	recommendation not
4	purposes other
1	19011906); 
1	consumer notification.
1	28 or
2	administrator the
1	fund (hereinafter
1	promulgates the
1	feed within
1	hearing. (6)
1	1041. enforcement
1	(i) considerationsin
2	written acknowledgment
6	requirements described
3	health shall
7	data required
1	(d) revise
60	include 
2	thereafter, as
1	appropriate, solicit,
3	(i) immediately
2	plants under
4	services administration
1	body shall
1	withheld from
1	identifier assigned
1	tunnel) unless
1	section 713
1	recognize all
1	candidate, clearly
1	(c) pizzas
1	(i) $15,000,
1	apportion the
1	classes for
1	business conducted
1	360ccc(c), (d),
1	pack or
1	occurs later.
1	2014 to
1	physician licensed
1	scored; (4)
1	risk, not
17	address the
2	states, accompanied
1	nomenclature for
3	revoked, or
3	disclosure to
2	director has
1	withdrawn, or
1	blood, or
3	specific lon-term
1	states owing
1	taken, the
1	notice for
1	blac-box warnings,
1	scientific experts
1	program; (c)
1	searches of
2	supporting information
2	(3) small
1	production, manufacturing,
2	shell membranes
1	guidance, to
1	common to
2	reviewed in
1	alleged defect
2	less stringent
1	(a) foods
1	quality for
1	prohibited actsno
2	3 and
2	proceedings; detainer
1	council for
1	persons use
3	authorization by
1	permanent resident
1	illicit marketing,
2	(e) false
1	i, 20,
3	submissions under
1	established prior
2	firearms; (2)
1	studies publicly
1	patient, the
1	section 381(m)
1	thereafter, all
3	(i); or
1	bulk manufacturer
6	exporting country
1	educational rights
1	center, the
1	both, except
1	data. (c)
4	independent study
2	maintain, for
1	period. a
2	regulations, orders,
1	1961, signed
2	cosmetic shall
2	issued only
1	stock, or
1	achieve such
1	imposes a
13	et seq.)
1	processed, sold,
1	distributors. such
1	information on,
1	bearing such
1	(a) parental
1	point from
1	1(a) of
1	568, as
2	31. (k)
1	breach of
1	 minerals:
1	law by
1	drug operations
1	treatment program;
3	ethers, and
4	repealed. july
1	general after
1	
 1707.
5	term by
2	ingredients, components,
1	(e), any
2	offers for
1	term opiate
1	involves bribery,
1	portal, from
1	methodology. no
1	container standards
2	drug solely
1	
 355d.
1	2203 of
1	drugs made
2	nonfood products
1	relevant regulations,
2	26, 2014;
1	circumstances require
1	factual evidence
1	paragraph. (q)
2	charge a
3	articles shall,
1	2011; 
1	medical questionnaire;
1	appropriations the
1	(1) without
1	refilled only
3	drug shall,
47	et seq.]
1	offense; and
1	inpatient hospitalization
1	animal feeds,
6	(a) each
2	animal feeds.
3	advertising, the
2	drug, based
1	particularly individuals
1	facilitate adverse
1	clause (iii)(ii).
1	milling. (hh)
1	clauses (a),
5	effective, the
1	(jwh081); (ix)
1	890. review
1	final, or
1	extended use
1	nervous system.
1	article maintained
1	(2) processed
1	amendment, are
1	issuing any
1	manufacturer operating
1	346a(a) of
1	charge, through
1	appropriate. (f)
1	parts (including
1	(2) train
1	fails within
6	decomposed substance,
1	effect 12
3	represent the
1	funds toward
1	impossible to
1	section 360bbb(b)
1	downloadable format.
1	securities, or
2	systems that
2	introduces into
1	labels with
2	statements for
1	catalog of
2	directly relates
2	seller understands
1	nomination of
1	active ingredients;
1	development act
1	claimed indications;
6	standards as
6	directly related
1	1037; term
2	animal species,
1	used instead
1	1001, 

2	intentional contamination
2	diversion and
1	114 to
1	(c)contents.an action
2	cigarettes for
1	center). the
1	health information;
2	research organization;
1	drug, noting
6	providing services
1	recently emerged
16	information which
1	(10) any
1	inadequate institutional
2	grant, where
7	developing a
3	representation that
26	proposed to
1	301. short
1	awarded was
1	powder and
2	property made
1	granting exemption
1	witness. on
3	scientific information)
1	licensed consistent
1	10. (f)
1	eve-numbered year,
1	one variety
1	book. such
1	avoid such
240	determines that
1	residue; (xii)
1	specifies, as
2	(b)(2)(a)(iv) or
1	made, into
2	(a); (ii)
2	food laboratory
1	pharmacist and
2	petitions or
1	(c) updates
1	350l1. annual
1	general) respecting
5	products intended
6	data with
11	assurances that
1	purchase laboratory
1	official name,
7	agreed to
1	title 20),
1	subsection (b)(3)(b),
4	drug, such
1	repacks and
1	designated: 
1	appear that
1	competent jurisdiction;
1	labeling bears
3	150 percent
2	reasonable medical
2	saleable returns
11	imported food
10	term united
1	person may,
1	data then
1	exercised its
12	section, shall
1	designations for
2	by, any
1	policy documents,
2	(c), including
5	liability for
1	patient, a
1	abuse inflicts
1	descriptions and
3	aggregate amount
1	exceed 5
4	qualified expert
1	333a. repealed.
2	exceed 2
2	exceed 3
1	delegated. (b)
1	startup costs
1	verification requirementexcept
1	investigations (a)
2	administration act
1	severability if
1	(d) verification
26	serve as
3	serve at
1	evaluated; (5)
1	help conduct
1	expertise through
1	(a) preparedness
1	(g) regulation
1	different listed
2	serve an
1	repeated dissemination
1	voluntary participation
1	title) means
1	showing patterns
1	title. (in
1	toward meeting
2	nonprescription drugs,
1	actions related
1	assessing, decontaminating,
1	(d) subsidiary
1	brief description
3	treasury a
1	amino acid;
3	anomaly or
3	exceed a
1	facilitate enforcement
2	understanding under
1	
 360fff3.
1	focused national
1	drug; controlled
5	program budget
2	currently informed
1	partyafter consultation
1	(2)(a), the
1	cream five
1	u.s.c. 619(5)],
1	submissions. (i)
1	renewal, and
3	stat. 1057;
1	exportation not
1	used otherwise.
2	determination required
47	intended use
2	constituent, or
1	practitioner, on
1	(m) patent
1	review for,
1	immediate family,
1	section pending
1	(b) requesting
2	entity (including
1	secretary stating
3	2013, verifying
23	patent information
1	regulations, may
2	scope, duration,
8	brought for
1	initiative 
1	local regulation
1	prepares poultry
1	obtains a
1	(2) contributions
2	(b) hearing
1	knowledge in
1	regulations; suspension
1	forth changes
1	knowledge is
1	although guidance
1	legislated intent,
6	federal benefits
1	implement ant-doping
1	19. repealed.
1	order, prohibit
1	aid or
2	altering the
1	31. all
5	1953, 18
4	previous year
1	expertise within
1	(2), by
1	formerly 355,
1	reconstitutes tobacco
2	drug and,
1	expert consulted
3	methodologies. (b)
1	practitioners and
6	present his
1	(f) training
4	when, in
1	500 miles
16	engaging in
2	part, from
1	commingled with
1	expired drugs
1	replication otherwise
2	paid. the
1	determines 
1	
 379h1.
1	any, would
1	dioxaphetyl butyrate.
2	be, of
2	printed matter
1	states mails
1	(b) until
1	hearing means
1	on, part
1	genotypic and
1	(b) ex
1	(b) initial
3	be, or
1	first appropriated
1	testing welfare
4	seizure of
1	nanomaterials that
1	failure shall
1	intermediate endpoint
1	manufacturing procedure
2	states, any
1	document. (ii)
1	section 387j(a)
2	iithe attorney
1	available: 
1	violator, ability
4	admission under
1	42; 
5	certifies that
1	therapies if
44	4, 1907,
2	felony or
1	planthe strategic
1	351(a)(4), or
1	360bbb5. critical
2	customs laws
1	policy issued
1	warning. (

1	device requiring
1	consumers through
1	proposes, in
1	identification by
1	paragraph1 (1)
1	section $100,000,000
1	clinicians, regenerative
3	paragraph, or
4	progress toward
1	app.) shall
6	offenses involving
1	2011, including
2	(including books,
2	laws under
1	feedback, decisions
1	successor regulation)
1	360e(d)(2) of
1	managing ports
96	secretary and
1	similar forum
1	accessed and
16	contract with
21	355(b)(1) of
1	kept so
2	transaction going
1	formula and
1	device. (viii)
2	3717 of
1	office use
1	residue than
7	labeled or
1	entry; annual
2	labeled on
1	exceptionif, during
1	quarter) to
1	(4) $40,000,000
1	federa-aid primary
3	water in
1	instances when
1	every thirty
3	appeal. 
1	execution; probable
1	comprehensive list
2	imports were
4	regulation, a
1	principles, are
1	facility inspected
10	request described
4	violation or
1	404, 52
1	protocol bringing
1	term single
1	published material
7	funds raised
1	(2)(b)(ii) and
1	2009, shall,
20	affected by
4	first engaging
1	concerning listed
1	making payments
1	disease issues,
1	performed an
24	fine not
3	inhabitant or
1	assembled article
1	regulation: this
1	accredited third
1	core of
26	complies with
2	start program
1	issue, specific
1	petition. any
2	prevent, diagnose,
1	(5) adverse
1	public, any
2	country without
5	include all
1	certain class
1	generalan individual
2	cutting up
1	675, 417,
1	 $3,750
1	processor, and
1	implemented, paragraphs
3	saleable unit
1	(k) are
1	term high
1	relevant offices
4	drug, its
2	subclause (ii)
2	further, the
1	condensed milk
2	error. the
2	1970, the
1	director. (4)
5	smuggled food
1	repackager makes
1	disorder within
2	program; or
1	exemption filed
1	forgery, deception,
1	color content
18	determine that
1	therefor is
1	assertion, either
1	meeting participants
1	serve for
1	recipient into
1	statements, and
1	paragraph because
1	agency. (june
27	device which
1	apparatus, implement,
1	device involved.
1	prevail on
2	thereof. if
2	(b) post
1	10 months
4	appropriate measures
2	tools, standards,
1	use), if
2	article thereafter
1	dispensation of
1	interpretation and
2	electronic means,
8	jurisdiction over
3	electronic means.
2	admission. if
3	(2) identify
2	use; (2)
1	experts within
1	individual, violates
1	clarify, and
1	electronic means;
1	(c), concerning
1	aim to
1	$2,500,000 if
2	presumption of
4	fee was
1	parent have
1	auditor agrees
2	discontinued section
3	methodologies for
4	drug; (e)
2	local governmental
2	registry. 
1	accounted for.
1	international medical
1	requirement each
1	body spaces
2	existing high
1	week, and
2	c, the
1	demonstrable support
1	representative copy
3	satisfy any
1	term pane-track
1	concerns a
3	jointly by
2	applicant, not
1	make relevant
1	terms new
8	setting the
1	designation a
2	will inform
1	(ii)component of
1	unless alternate
1	(c) advertisement
1	notifications, for
1	requestor. such
1	and, immediately
1	stat-issued pharmacy
1	contaminants covered
3	rest area
2	local activities
1	minorities, native
1	order until
1	including documentation
1	devices; initial
2	supplement) receives
1	reduction organizations.
1	generalthe commissioner
1	18. (b)definition.
1	(i) facilitate
3	secretary, make
1	term inedible
1	official veterinarian
3	appropriate agency
1	360j(h)(4) of
1	sidestream tobacco
3	thereof, that
7	commit, or
1	refunds except
1	hyperlink or
1	entity, and
2	enforcement personnel
1	(a)(1)(b). in
1	executive, legislative,
2	year, excluding
7	officer designated
4	system attributes
1	minimum requirements;
1	substance referred
3	summarily forfeited
1	directors decision
31	importer of
6	information are
1	additional pediatric
1	administration associated
2	matter arising
1	considered drug
1	dispenser received
6	laboratory analysis
1	drug availability
1	partnerships in
1	section. (7)
1	population antibacterial
1	9,000,000 americans
1	regulation. (

15	importer or
1	individuals qualified
1	fund are
1	transmitted or
2	dru-related law
4	(2) includes
1	possession. 
1	(i)failure to
1	introduce, or
1	1534 of
2	august 1
1	(r) piperonal.
1	384(b) of
1	birth weight,
1	recall orders
2	subsequent country
1	(f) eliminating
3	 (16)
2	women, or
1	officials by
1	(i) determines
1	variance process
4	impossible or
1	section 360ddd1
4	information pertaining
1	sector resources.
1	(2) publish
1	design validation,
3	provided, that,
4	unless (1)
7	purpose. 
1	notify a
3	person a
1	agency delegated
1	comparable commercially
2	name, place
2	pregnant individual
2	fees a
2	inspect facilities
2	drug experiencethe
8	title; (c)
3	direct supervision
1	[5 u.s.c.
28	chapter, or
6	subsection (n)
1	22, 2016,
1	compendium shall
1	senate, may
3	available from
1	3-day restriction
1	controlled, the
1	officials a
1	safe if
5	information, as
1	following may
1	months. any
1	
 1052.
1	1999; (3)
1	alert that
2	injury that
2	meeting such
1	(d) petition
1	(1) additive
1	inadequate information
2	permit issued
1	practical methods
2	identifying information
1	recall order.
1	gold, lead,
2	supplement; and
1	long recognized
1	(iv) each
1	responsible personthe
3	continues, not
1	(e) annual
2	1532(a) of
1	2021. 
1	(16) morphin--oxide.
3	section 1604(c)
2	(d) except
1	activity has
1	495, 70
1	technical experts
1	core or
1	said subchapter
5	state official),
242	(b) the
1	maintain property
3	security 
16	conduct such
2	represent breakthrough
8	additional period
2	(h) review
1	675, 407,
10	receive compensation
2	recalled human
1	term transportation
2	patients, providers,
1	accelerate foodborne
3	42, a
5	(c) that
1	silicone gel,
1	(b) protracted
1	conducting those
1	method(s) used
1	include programs
3	trials is
2	issued regulations
1	675, 563,
7	(b)(1) and
1	imported, slaughtered
1	available market
1	4 succeeding
1	(m) assessment
1	dismissed from
1	section, terminate
1	578, 2,
1	relationship the
1	public notifications,
13	submitted and
1	403c, as
1	shall attach
2	generate only
1	(3) feedback
1	adulterated products;
4	make new
2	undertaking referred
1	send the
1	paragraph, relevant
12	approval is
1	881a. transferred

1	cherry, or
8	secretary, based
1	reliable and
1	give written
3	include requirements
1	solicit input
1	additional criteria
7	approval in
1	filed, stating
1	(2) make
1	360b(a)(4)(c), 360b(j),
2	drugs compounded
3	approval if
1	operation is
16	title, except
1	dried fruits,
1	(c) recall
2	another hospital
1	(d) commingled
1	indirectly in
1	appropriate, update
2	issues for
1	(j) effective
1	262(a)] or
1	advances; reimbursement;
1	applicable subsection.
2	practitioner, or
1	(in whole
1	regulation include
1	early life
2	states, shall
1	services; or
1	certification applies;
1	made unavailable
1	42; (b)
2	analysis. 
1	term antibiotic
2	care practitioner
1	support research,
1	compendium. (b)
2	expedition of
1	0.40. 
5	estimated to
1	(b) degrades
1	limitation shall
1	therapy shall
1	sections 343(q)
2	binding upon,
1	documentation, as
4	advisory comments
2	public. (f)
2	pharmacology reviews
1	(c) necessitates
3	violate any
1	1999. 
1	rol-you-own paper
1	uniform nomenclature
1	(d) offering
1	act under
1	process, as
1	u.s.c. 355(c),
2	(c) developing
1	endangered children
2	establishments, requirements
1	onto the
2	owning partly
1	president; and
1	licensed, including
3	investigation may
1	262 not
25	shall give
1	violating the
1	general members
1	restrictions established
2	columbia. 
1	commerce. any
1	election; (bb)
1	consequences; (ii)
1	(b) appeal
1	(i). (vii)
2	certify that,
1	approaches.to the
1	devices, sales
1	455 of
1	rigorous as
1	objections, hearings,
1	exporters if
2	person licensed
1	affiliatethe term
1	chillers; (14)
6	2007, or
1	(d) identify
2	resin extracted
1	debarment and
1	(5) authority
1	decrees of
1	subsections (b)(2)
1	section 387q(a)
1	paper, or
4	cosmetics in
1	days 
1	financing for
1	drug, unless
1	(2) development
1	environmental risks
1	(b) work
1	1992, a
1	present intention
5	date rape
1	(e) request
2	facilitated entry
2	declarations: (1)
1	demonstrates in
1	living animal;
1	application, (b)
2	fine up
3	entitle a
1	users, such
2	audits 
1	
 379h.
1	agency during
4	issuance and
2	testimony touching
6	viruses, serums,
2	reasonable cost
11	enforcement action
1	living animal.
1	1908, ch.
1	story board,
1	access, at
1	required reports,
3	determines there
1	seniority status
2	title. (vi)
1	828. order
1	fees sufficient
1	powder, or
1	harm reduction,
16	labeling change
1	foundation, academic
2	life stage
13	secretary receives
1	(a) trainingthe
24	(ii) shall
1	finding before
1	time, with
2	title but
1	utilize all
1	general subparagraphs
1	(4). the
1	contentthe proposed
13	official certificate
1	safe levels
1	producers raising
2	(c), does
1	(xi) -(-fluoropentyl--(-naphthoyl)indole
4	foreign relations,
1	u.s.c. 247d5].
1	barbituric acid;
1	applicable; congressional
1	343(r)(6) of
1	appropriate declaratory
1	section 107(a)(2)
1	administrative, recordkeeping,
1	1039. eggs
1	barbituric acid.
1	assistance, technical
1	1, 1999.
1	lon-term scientific
2	1, 1999,
4	(i) coca
1	concerned, as
1	electrolytes; (ii)
1	rejoined to
7	year (excluding
1	(1)(a). a
3	(as determined
1	training (a)
1	(a)(1)(a) or
1	term pasteurize
1	prehearing order
1	blister containing
2	$2,604,000 for
3	mortality among
1	primary focus
1	container, name
1	technology in
2	effect, but
1	176 to
1	section..[2] this
1	(a)(1)(a) of
1	requested, not
1	twenty grains.
3	hardship for
1	substances. to
11	reviewing division
2	subsection (k)(3)
1	(10) sue
1	promulgation, if
1	name designated:
2	(2) after
1	destroyed, removed
2	priority and
1	receives shall
4	competition, exemptions
1	consequences, which
1	nonprofit statusin
1	section under
1	(g) dracunculiasis
2	facility. (iv)
1	establish (including
3	 nothing
1	individual small
3	section 360e(c)(4)
1	package under
4	introduced, including
1	drugs). (2)
1	(a)(1)(b) whenever
1	sympathomimetic; (xiv)
1	congress as
1	notice. (4)
1	agricultural product
1	(ii) transaction
1	scientific, regulatory,
1	manufacturer by
1	incidence, as
3	commercial manufacture,
6	100 percent
1	evidence, acceptable
1	council (a)
8	including an
2	professional degree,
1	congress an
6	procedures, processes,
1	use published
1	(e) payments;
1	contentthe communication
3	upon demand
2	(g) or
4	official) upon
1	if, notwithstanding
1	manager. (mar.
4	communities act
1	-methy--morpholin-1, -diphenylpropan-carboxylic
1	donations the
1	forms subject
11	(g) of
1	unwillingness to
1	(a)(3)(b), through,
1	research, rehabilitation
18	written agreement
1	(c) descriptive
1	(g) on
1	least restrictive
1	(i). while
1	(d) action
1	(a) timely
4	section at
5	appointed to
1	efficacy standard
43	section as
1	received valid
3	efficient manner
1	available, prior
1	chapter; unless,
1	burdensome effect
1	(e) enabling
1	(h) farm
1	387e(i)(1) of
1	laboratories run
1	using judicial
1	research, division
1	(2) inspections
7	shall recommend
24	in, or
5	approved. 
2	summary review;
3	investigations under
1	transfer requests
1	emerging threats
22	regulated under
7	property of
37	application to
1	claims; jury
1	section 350a(f)
1	proprietary name),
10	numerical identifier,
5	vitamin, mineral,
1	developing processes
1	trade commission.
2	finalized under
1	surveys to
1	plans developed
83	shall issue
1	regarding submission
4	property or
1	website, or
1	estimated resources
1	describing transactions
1	allergies to
4	pending application
1	18) any
1	provisions hereof;
1	section 387e(b),
4	1982, and
2	accurately identify
1	cost matches
2	rapidly detect
1	care cost
1	issues, and
3	produce such
1	(i) worked
5	supports the
1	subchapter; (4)
1	therein. (3)
1	(b) blocking
1	strategies. (d)
1	extensions paragraphs
1	sympathomimetic; (n)
1	disapproval. (b)
1	143, 2,
1	follows the
5	variety of
4	geographically dispersed);
6	additional number
1	regulation, changes
1	125, or
1	(5) $50,600,000
1	subparagraph. (4)
1	funding proposals
4	disposition an
2	drugs, marihuana,
7	fee account
1	egg contents
1	u.s.c. 241
1	interests 
1	silicone envelope
2	rate for
1	shall run
1	arrests for
3	(37 stat.
1	petition not
1	factors; substantial
1	applicationupon application
1	master files).
1	containing meat
1	(v) 4
1	1958, pursuant
13	nature and
1	(n)); and
1	months thereafter,
1	matter before
2	american people.
1	patterns in
1	22, 1934,
1	practitioner while
2	testing means
1	vessel for
1	obligation concerning
6	panel and
1	certification. fees
1	act unless
2	begins the
2	consolidated into
1	(vi) identification
2	irrigation or
1	360c1. reportingthe
2	applying to
3	application shall,
4	commerce, in
1	streptomycin, chlortetracycline,
1	2008 under
1	owner whenever
1	evidence; production
2	basis) of
1	qualification submissions.
4	(including by
1	(b) size
1	surveillance. 
1	commence review
2	(a). (4)
1	is, for
1	officer (whether
2	(2) it
1	(b), (c)(1),
1	whose registrations
1	3. 
7	(2) is
1	postapproval requirements,
1	frequently the
1	beverages, as
1	registrationthe secretary
33	(2) if
2	monitoring requirements
1	(o) soil
1	imposing restrictions
28	(2) in
5	recall under
1	section 106.30(c)(2)
1	allocated to
4	priority drug
2	another country,
1	adults before
3	population may
1	elimination in
1	(a) access
8	drug evaluation
4	procedures 
1	defect remedied,
1	basis, not
1	plan prior
2	section 208(b)(3)
1	seminars, educational
14	welfare of
21	transaction information,
3	reporting under
1	first approved
2	minority, ethnic,
1	device) outweighs
2	approval; grounds;
1	vendor: 
2	inadequate grounds
1	met. such
1	custom slaughterer
1	register practitioners
2	immediate threat
2	cocaine, salts
1	product submit
1	established at
2	exception no
1	delayed, denied,
2	general if,
1	established as
1	21, 1971,
2	both. when
1	practices with
2	abuse. (6)
1	administration including
1	electronic list
2	(a) findingscongress
1	contents thereof
1	information only
1	audits be
1	360e(f)(6)(a) of
8	counterdrug technology
1	date otherwise
2	priority voucher
13	352 of
1	phenotypic variability
2	respecting devices
5	packaging of
1	consolidated national
5	thereof, the
1	conduct periodic
1	dispensing; or
1	exportation is
1	(i)), a
1	(a)(4)(a), and
1	field a
4	exempted by
1	including residue
2	products approved
1	withdrawn; (b)
1	exportation in
2	message intended
1	subdivisions who
1	pediatric conditions
1	industry have
1	acts committed
1	treatment of,
20	ending on
7	classification under
1	volunteer to
6	improperly altered
2	indictment has
1	school nurses,
2	products; 
1	343(g), 343(h),
2	approve it.
1	enforcement participating
1	(d) confectionery
1	(g). clause
1	(ii) relevant
1	restore forfeited
1	360e(i) of
1	(ii) title
2	section 20
1	 (c)recipients
6	year appropriations
1	effect; and
1	section 1705(a)
1	litigation; (9)
1	not, because
2	(5). (4)
5	petitions for
1	(3) staff
1	single year
1	organization 
6	federal establishment
1	1051; oct.
10	conduct inspections
4	355f(d) of
3	(b) because
1	products provisions,
1	available detailed
7	authorized generic
2	statement describing
1	ethylamine. (o)
1	1976, through
1	actions most
1	term commissioner
2	list which
3	dispensed to
5	needed for
1	(22) thir-party
1	budget under
1	animals, indications,
1	2012) but
1	amount notwithstanding
1	schools, academic
1	residue; and
44	including any
3	appoint as
1	(ii) special
3	item of
2	acid (g)
1	growers or
1	(a)(4)(a)(ii) (relating
1	employees do
2	item on
1	952. importation
1	keep these
10	person, or
1	butter, or
1	plant and
1	describing in
2	promote, and
1	
 1604.
1	domiciled or
3	revocation order
1	evaluation, or
3	product. (d)
9	threat medical
1	laboratory tests);
8	treat a
1	incident management
6	article, and
10	sale, or
1	refrain from
1	state cause
2	practitioner, to
1	203, as
1	authorized deviations
2	proposed, the
2	testing shall
1	387f. general
3	programs relating
1	(6) serve
8	business, and
7	requests a
1	disseminate the
1	participate an
1	publications, any
4	criminal penalties
2	business, any
1	section 156
1	causative agents
1	(e) validity
1	
 2251.
2	(a) establishing,
2	attempt and
2	single agency
1	valuable medicinal
1	provide medical
1	company records
2	services, under
1	sold to,
1	(2) sold
1	569, as
6	determination in
1	353(g)(5)(b) of
1	(vi) requests
1	law, (iii)
1	(l)(2). 
5	pending drug
3	revenues shall
1	abide by
1	comment that
1	already in
1	communication (referred
1	reasons certified
2	convicted, in
1	(15) cocaine
1	term accredited
2	purported to
1	logistics services
7	acts, or
11	order may
1	safe nonnutritive
24	chapter, the
357	days after
1	medical, and
2	population drug
2	public web
7	ordinary individual
1	procure (by
1	process, any
3	(7) notwithstanding
11	diem in
3	affiliate thereof.
4	unfair competition,
2	requests; and
1	21. branding
2	registrations and
16	conferred by
2	adequate clerical
1	
 379s.
1	intentional violation
3	(c) upon
1	demonstrated expertise
1	(ii) improve
2	70 percent
1	significant disciplinary
3	initial grants
3	information will
1	cattle, horses,
14	benefits and
1	rapid detection
2	services, determines
12	falls below
2	title pursuant
2	evidence indicates
1	(7) training
3	accreditation program
3	inspection system
1	amended and
1	claims data,
2	receive additional
1	change determined
4	(2) provide
2	(b) testing
1	list; direct
1	program revenu-neutral
1	providing clarifying
5	(1)(b) and
2	abuse training
4	schedule v
1	(f)(1) in
2	hazardous raw
1	lorillard tobacco
1	subchapter, other
1	
 379j62.
2	distribute any
1	right at
1	(2) exemptions;
1	diseases; (3)
1	effective, for
3	significant decisions
1	(d) $1,000,000
2	slaughter. 
2	manufactured by,
1	(ii) coordination
1	injured as
2	groups, and
4	representation made
1	potential, he
1	section) and
1	violent teenage
3	least 8
1	applicable; (f)
7	(2) may
2	civil action.
1	petition such
2	civil action,
2	renderer means
1	5 per
7	order pursuant
2	sixt-day period
3	(including necessary
1	withdrawn unless,
1	bowls; (2)
1	renumbered 23
3	hearing may
14	levels of
3	(within 60
2	governmental entity
1	(xv) the
1	smoke constituents.
1	(5) provide
1	renumbered 21
2	formulas which
3	effectiveness by
2	programs related
1	infringed. (cc)
1	products because
2	sterile water,
2	subsection (a)(4).
1	determining or
1	generala tobacco
1	issue 
1	facility, site,
2	along with
1	humans, the
1	certain measures
1	(l) applicability
1	nearest to
5	detained under
1	(5) documentation
3	liability at
1	safety from
1	commonwealth, territory,
1	reportsthe secretary
2	liability as
1	(c) continuing
1	156 of
1	effect computerized
1	preceding provisions
1	consistent parallel
12	drug shortage
1	consider providing
1	required while
1	practices encouraged
4	upon completion
1	convalescence, pregnancy,
3	civil actions
1	illegitimacy a
1	maintains procedures
1	cheese act
1	labor (referred
1	retail vendor:
1	clearly for
11	dtc advertisement
5	smoke constituents,
2	said establishment
1	reasonably represents
1	powders; or
1	(iv) distributions
1	956(a) of
1	prohibited; preparation
3	processes the
1	103(q)[3] and
1	literature; data
1	section 823(a)
2	protocol is
1	term department
1	(e) eligibility
1	pursuing approval
2	stat. 1043;
1	states reasonable
15	authority the
1	development, issuance,
2	bases of
1	development, the
1	672, 673,
1	171 to
9	administrator shall,
1	import prescription
4	restricted but
2	general only
2	theft of
1	transport narcotic
1	designate categories
1	color thereto;
21	subsection (g)
1	list, a
1	(l) exemption
2	occupying the
2	partner of
1	i, 8,
1	822. persons
1	national ant-doping
5	report described
3	initial date
1	history, or
1	appropriate authorities
1	drug free.
2	grant if
1	authorities provided
43	reasons for
1	substance exempt
1	court alone,
3	local authority
1	(5). (3)
1	bequests, gifts,
1	7 individuals
1	necessary because
1	whenever tests
1	
 671.
1	need that
1	reinstatement with
15	year beginning
1	types for
6	legal appeals
1	risks that
1	increasing pain
1	dialogue and
1	articles capable
1	interest, that
1	387j(c)(1)(a)(i) of
3	(iii) ensure
1	(11) it
4	subsection (h).
1	enhances lon-term
1	initiatives relating
1	meeting within
1	awards 
8	grant funds
1	practitioner as
2	network of
1	14th day
1	source drug
2	(11) if
1	links that
1	transfer not
1	representatives for
1	general marketing
13	requirements (a)
1	samples 
1	biological, radiological
1	section 321(q)(1)
1	inspection fees
1	(3) formal
2	total of
1	agencies that
1	ruleeach person
1	burdensome, the
2	period was
2	seller at
1	youth such
1	determinations, findings,
1	investigations have
4	form unless
1	(jj) the
1	purchased a
1	bioavailability by
1	(1) adopt,
3	financial interests
2	hearings (a)
2	secretarys determination.
4	subsection has
1	establishments; examination
2	water or
1	development, training,
1	consumer good
1	statement provides
1	kind shall
1	(a) slaughters
1	network that
3	directs, be
1	additive deemed
2	water of
2	immediately available.
1	training directly
1	from, federal
3	epidemic product
1	ethyl ether.
1	force takes
1	compile and
1	(34) the
2	pensions and
1	include pharmacokinetic
1	reg. 4461544618).
1	subpopulation can
1	(c) determine
1	comprehensive federal,
1	riskmaps and
1	including litigation
1	881(d) of
1	activities; designation
1	safety; (3)
2	nonsaleable returns
41	scope of
1	marking containers
1	supply can
1	term recycled
1	vivo bioequivalence
1	age; or
1	analytic files
1	compile any
1	committee; (2)
1	monitors consistency
16	time for
2	reevaluation of
1	private programs
1	severity, including
1	(c) consistent
2	personally identifiable
1	(c) availability
3	section 351(h)
1	secretary uses
22	execution of
1	contractors, (b)
1	localities, among
4	contractors; (b)
1	penalty pursuant
1	360b(d)(1) of
2	thereafter shall
1	secretarys determinations
2	senior to
1	ix and
1	species. (3)
1	program demonstrates
1	importation from
1	advocacy organizations.
1	new product,
1	partners may
1	conduct occurring
1	appropriate, provide
3	supply to
1	certifications. (iii)
2	advocacy organizations;
1	675, 511a,
2	chemicals to
1	(3) data
1	existing drug
1	loans relative
3	adulterated (a)
1	(c) take
1	withdrawn modular
2	officials and
2	presented at
6	taxing authority
1	board by
1	disease for
3	outside any
1	-(-chlor-2,-dimethoxyphenyl)ethanamine (2cc).
6	enhancement of
2	partly or
1	(n)(3), the
2	successful and
1	title (only
1	personal or
1	contribution of
1	advertisements not
2	partly of
1	355(k) of
2	tests show
13	study plan
1	10 of
3	diseases (a)
5	aquaculture and
5	serious injury
1	associations if
1	laws. (june
1	new methodology
2	(ii) firms
1	potential effectiveness
1	report. (xi)
1	surveillance information
1	multiple or
2	conditions, has
5	illegal drugs
1	whose purpose
1	research needs
27	review. 
1	situation involving
1	(e) prepare
2	investigational purposes
1	slaughtering; custom
1	title, final
1	chemical, except
3	purposes the
1	site in
1	exportation to
1	strategiesthe coalition
1	(1)(c)(ii), shall
1	chapter; location
1	(b) creative
1	(vii), (ix),
1	animal feed;
2	following opiates,
1	document required
4	advantage, or
8	(c) limitation
1	guidanceirrespective of
1	(hh) the
1	term article
6	conviction record
1	drug so
2	safety, cos-effectiveness,
1	agreeing to
1	site it
1	site is
3	index shall
1	regulating virus,
2	nmic shall
1	supply; (b)
1	360hh. definitionsas
1	complaint an
1	information designated
1	radiographic image,
2	restaurant if
1	attached. 
2	one misdemeanor
2	342(a)(1) of
1	export drug
1	constitute authority
9	business and
1	(f)(1), the
2	term name
5	believe, that
1	interdiction; (ii)
3	given a
2	(b) refusal
1	(1) petitions
2	customers at
1	(3), not
2	prosecutions of
1	obligation 
4	denies the
1	title 15;
1	enforcement organization
1	free. a
1	(i) nonsaleable
1	product identifierswith
5	finding by
1	cente-specific objectives
1	supplement labeling
1	food categories
6	experts on
7	title 15.
1	shall apply.
3	prosecutions or
2	reporting deadline,
1	(21) pholcodine.
2	title, may
1	states, irrespective
3	agency (including
15	budget request
1	supervisory function,
2	requirement. such
2	provider of
1	criminal, or
1	(4) substance
1	parole condition
1	available, it
2	resolution of
1	membershipthe council
1	omission the
1	noracymethadol. (31)
1	containing no
3	available, in
1	reimbursed to
1	chapter including
1	sanctions a
1	(2) medication
1	elsewhere in
1	program benefitsnotwithstanding
2	extent necessary
2	designate. 
1	articles exempted
8	paragraph for
1	secretary declares
1	security requirements
2	circumstances or
4	person intends
1	(ii), no
1	282(j)(5)(c)(ii)[2] of
1	methamphetamine. (

1	leaf or
1	supplements where
1	sports organization
4	year until
1	b (a)
1	(2) exhaustion
1	criminal authorities
3	(a) submit
1	technologies by
1	partnership, joint
3	section 319f2
1	comment the
2	regulations. such
1	1972, $3,000,000
1	application, whenever
1	dispenser by
1	drug/device/biologic) that
1	8, 2003,
3	funding under
1	relabels a
7	transferred by
2	(1) publication
1	safety. (

7	terms are
2	stringent than
9	may in
1	institute, the
26	prevention and
2	stat. 20.)

2	states; (4)
1	regulation. such
1	(29) the
2	violate the
1	fee type
1	behalf be
1	day the
2	constitutes drug
5	prescribe a
2	section 351(a)(5)
2	counterclaim seeking
1	users unless
1	efficient operation
2	certification 
1	species designated
1	uniformity with
1	3, 2003.
1	regulations publication)
3	1970 [21
2	product which,
1	change business
1	country, at
1	(ii) matching
1	 (28)
2	factor under
1	states subject
1	consignees receiving
2	tribal affairsthe
5	(j) shall
1	domesticated bird,
1	clinical needs
2	may amend
4	seven years
2	obey a
1	device at
1	concerning drug
1	generator, accelerator,
1	387e(i) of
1	farm and
1	enter controlled
1	roles played,
1	will maintain
1	writing not
4	record upon
2	suit under
2	enters judgment
1	infusion. (4)
1	19011906). all
1	clearinghouse to
1	(8) prohibition
1	government whose
1	butter is
57	(mar. 4,
4	operate as
1	quality as
2	involved to
1	owning such
9	supplements, and
1	knowledge means
1	residues 
1	gene product;
1	renewed for
1	term propertyproperty
1	physical media
2	meetings the
1	association who
1	marked agreed
1	(b) nitrogen
32	product to
1	internet information
2	make summaries
1	standard regarding
1	unusual medical
23	regulations to
5	withdrawn after
1	container; except
1	support carrying
1	considered distributors
2	pool, or
1	conditions; exemptions;
1	specific vulnerable
1	print, or
1	(1) assessing
1	supervision shall
3	nonusers of
7	(i) quarantine
1	imported in
1	justice system.
1	reformulation of
2	clauses (b)
1	investigation, requiring
1	genuine issues
2	hearing 
3	plans and
1	warning notice,
1	ether. (e)
1	imported is
3	blood product
1	general, that
25	shall designate
1	used primarily
1	hawaiians and
1	legal right,
5	product containing
1	fostering participation
1	business, including
1	present adequate
1	360e(d)(1)(a) of
1	(ii) is,
1	
 204.
3	product beginning
3	civil money
1	establishing that
1	residues, data
2	action so
1	inventory reports
1	(g); (2)
8	withdrawn by
1	(a) human
3	1955, ch.
1	later effective
1	consultation as
1	standard that
1	meeting request,
1	(b)state licensing
6	therapeutic amounts.
7	commodity shall
1	
 645.
2	practice regulations
4	(f) information
1	gas, as
1	health organizations
1	chain; (ii)
1	subsection, whichever
1	(d) includes
1	land; and
1	miles distant
1	officio and
1	delivered, and
1	apply on
1	(l) annual
1	intent upon
1	360ll or
1	oxide that
1	forfeiture may
2	employers, and
5	drug officer
7	i-kind contributions,
5	review all
6	2007, and
1	title disapproving
1	consultation. 
1	2018 for
2	label showing
1	applicable, a
1	land, federally
1	cyprenorphine. (7)
4	assembled in
2	express written
1	3607 of
1	drugswhenever the
1	(1) reinstatement
1	submitted about
4	foreign recipient
1	drug. (vi)
1	aforesaid, or
1	section 4332(2)(c)
1	breakthrough technologies;
1	easily printed
15	form, or
1	first use
20	law or
2	manner, as
3	advertisements that
2	full waiver,
1	performance auditingto
1	36; and
1	-methox-3,-methylenedioxy amphetamine.
3	food yielded
1	675, 711,
1	order. summaries
1	(4) actions
2	form, on
1	panel review
2	include packaging.
1	carriers by
1	sponsor from
1	food treated,
2	(c)(1) of
2	(i)in general.if
1	i, 119,
1	indexing; and
8	user facility
1	submission established
1	custody, or
11	country or
2	practitioner. 
1	maturity and
1	facilitated through
10	(b)(1) or
23	conditions under
1	person older
1	(10) an
1	general; hearingthe
22	drug subject
1	country on
1	360e1. pediatric
2	team to
1	direct export;
1	convention. as
2	subpena entered
1	retained as
1	title based
1	imported, for
1	(may 29,
1	practice; (3)
1	conclusions upon
1	standardized so
4	including both
3	enforce requirements
2	condemnation under
4	statements or
2	conviction was
5	action the
1	(f) dietary
1	enclosed area
5	recommend controls
1	local taxation
2	imply that
1	(including efforts
6	control, both
4	statements of
4	published not
4	new indication
1	differing from
1	enforce provisions
1	drug contains
1	(g) limitationsubject
2	accessed, contained
4	plants regardless
2	21, 1997),
1	records (in
1	shall abide
1	(a) requirementeach
3	offense which
3	association, as
12	governed by
20	agencies to
1	infectious pathogens;
1	oil and
1	following statement,
3	section 331(a)
2	applicant, and
2	section 360d(c)
2	like circumstances
1	threats, expected
1	extension for
1	(b) $112,580,497
1	documented a
1	labeling; (5)
1	21, 1997);
7	reduction, or
5	preceding year
1	1002(b), (c),
1	10 milliliters
12	inspection shall
4	general there
8	food defense
1	1997. (o)
2	amounts that
4	earlier, the
1	lawfully partially
1	furnish raw
1	reduce racial
3	refunded for
1	342(a)(2), and
2	drug testing
2	nutrition of
1	different agencies
1	slaughtering establishments
1	fatty acids
1	
 23.
4	obtaining the
1	declaration issued
1	cigar means
1	administration; or
9	liable for
1	suitable area
8	contaminated with
5	registration. 
2	principles and
1	manufacture, shipment,
3	agreement from
1	matters related
3	(j)(5)(f) of
2	death of
4	revoke such
1	providers, if,
1	centers, from
7	determines appropriate
1	president, it
3	committee from
1	initial meeting
1	houses, for
1	human risk;
1	hereafter in
1	internet sales
1	drugs; contents,
1	novel surveillance
2	supplemental information
2	programs, the
79	meat food
1	(c). compilations
1	methamphetamines, as
1	(iii) 28
14	individual under
1	president, in
2	(or agents
1	675, 516,
1	(ii) mitigating
2	swine, or
2	act to
1	trainingthe administrator
1	inspection performed
1	feasible outcome
2	(d) application
2	repair or
2	v, such
5	2053,67 stat.
1	revised quotas
16	fail to
1	(b) initiation
1	(vi) preparing
1	(b) ginseng
3	clinical investigations,
1	reviews, overseeing
1	componentsthe nmic
1	(3) qualificationsan
1	smoke constituent,
1	(1) deadline
6	release authorized
1	smoke constituent)
1	constructionthe following
1	article, when
2	changed after
1	counterfeit substance.
1	nutrient to
1	(a)(ii) if
1	beings, or
22	applicant for
1	individual after
1	section 1034(e)
2	distributions and
5	(a)(ii) in
46	application. 
1	2012, established
1	packer unless
1	2008, an
3	may, consistent
1	(b) timely
1	explanation and
2	warrant, the
1	therewith; the
1	necessary, expiration
7	give priority
1	iv; delay
1	rewards to
1	shor-term, noncash,
1	pediatric formulations;
1	preparations from
1	consul defined
1	smoke constituents
1	section 1769f(b)
2	variance for
1	laws for
1	199. repealed.
3	products. such
1	businesses. the
1	yout-oriented marketing,
4	substance; or
1	reporton or
1	promptly correcting
4	electronic portal
6	importation and
3	(4) payment
6	final judgment
1	fellows, and
1	country during
1	15, 1927
1	increase and
3	drug substances)
11	otherwise not
1	behavior during
2	offense involved
1	387. definitionsin
1	recalled food
3	include validating
4	experience as
1	special circumstances;
1	program. (b)
1	(4) waivers
1	247d6(h)(4)1 of
1	secure their
1	offense involves
1	foundation fellows
3	section 271(e)(4)(a)
1	medical data
1	protocol shall
1	correctly disclose
1	licensed establishments
2	by, consumers
2	components, and
1	research). (p)
2	professional positions
2	model plans
1	add further
2	offense may
1	involved 30
1	investigations (but
9	without providing
1	regular basis,
4	drug. (3)
1	solicit intramural
1	undergone further
1	(a) process
2	hereinbefore described
1	judicial review),
1	manager, and
1	manufacturing, assembling,
4	physician who
1	numbers 
1	1306); (b)
1	investigation a
1	best advice
1	transfer a
2	term resources
1	submission, a
1	641. prohibition
1	committed resources
1	debarred) or
2	generala farm
1	product when
1	number. (iv)
1	habit forming
1	(a) approve
1	quantities which
4	report regarding
1	accept for
2	kept under
1	describe how
7	days following
1	subsection (n)(2)(b)(i)
1	assessment system
1	analysis as
1	pharmacists, or
1	public comment;
6	appropriate and
1	months. except
1	343(a), or
1	findings are
1	promotion, using
1	chemistry, legal
1	seq.] may
1	section can
2	amendment if
1	physical inspection
1	(ii) merely
5	public comment.
3	public comment,
2	sunscreen orderin
1	387r. drug
1	appoint inspectors
5	states. (3)
1	pathwaysan application
1	quotas to
1	package if
2	residue with
2	protocol the
1	panels which
1	positional, or
1	(i) notwithstanding
1	practicing clinicians,
2	18, 1968.
1	chicken, turkey,
1	human contact
1	bodies. (ii)
1	commerce under
2	another compendium
1	stat. 679;
1	mutual support
1	bring or
1	minimum, identify
1	(a) determination
1	report, respectively,
1	group whose
1	isomers. (j)
5	information deemed
1	make, keep,
1	authorization, a
6	range of
3	primary jurisdiction
3	advisory commission.
3	dismiss under
1	poultry on
1	authorize use
1	plans; (v)
4	surveillance under
1	(1) expedite
2	poultry of
1	license, to
1	chain pharmacies
1	(at the
1	including speech,
1	reinstating an
2	determining for
2	collaborations with
1	market, the
1	paragraph (2)(b)(ii)
1	885. burden
1	schedule and
28	products that
3	like or
2	qualification process
2	abuse. to
1	manufactured that
18	acting in
4	investigations to
1	(12) of
1	osteopathic association.
1	secretary. (7)
24	hearing shall
1	year scheduled
1	formulation, and
12	dispute resolution
1	suspension, or
1	545 of
1	commercial carrier
8	foreign commerce
1	inform and
1	(iii) prevents
2	(c) savings
1	(iv) premarket
1	proportion by
2	opinion such
1	higher amount
1	patient need;
2	perishable controlled
1	certification for
1	labeling (a)
1	1976, and
2	devices, solely
1	review; (ii)
1	techniques, including
1	limited market
1	preferences with
2	inform any
2	(f) effect
1	case; and
4	actual knowledge
1	
 455.
1	clear on
3	product, unless
1	identified order
2	devices, as
3	disapproval of
1	abroad. (

1	good standing
2	specific request
19	establishing a
2	opium poppy
2	manufacturer respecting
1	749, formerly
3	consistent therewith,
1	programs, policies,
3	designated high
1	(a) discuss
2	503(b) of
6	imprint, or
1	overlap if
1	applies any
1	agent. any
1	person can
5	2013, not
3	thereof; and
1	(c) holding
1	engagement in
1	path reports
1	(2) multiple
3	applies and
1	675, sec.
2	regulations within
1	(i) professional
1	security, develop
1	(bb) on
1	products to,
1	regulations); (iii)
2	completed within
1	fine applies.
1	warnings related
1	performing such
10	export of
1	sanitary practices,
1	issuer. 
1	forth his
1	term proposed
1	adulterated applies
1	2016), and
1	transfers, theft,
1	applied and
1	collaborate and
1	weekend, federal
2	handling procedures,
1	
 1523.
1	export or
2	poultry which
1	commercial importers
1	participated or
1	liability. (b)
2	processing shall
1	submit requests
24	apply with
1	discretion whether
1	projects that
1	budget proposalfor
1	secretary), in
1	use aggregation
2	butter or
1	columbia commissioned
1	product comprised
1	professionals, representatives
1	upon), the
2	rate used
3	timetable in
10	355(j)(5)(a) of
1	dispenser notified
1	(a)(iii). such
1	products held
17	abuse among
1	expired by
2	foreign corporation
1	furnished promptly
1	reasonably demonstrate
2	committee act.
1	rank and
1	felony, or
4	person had
1	norlevorphanol. (32)
1	exists by
3	diagnosis, cure,
3	certificate; (3)
1	quarterly and
2	obtained the
1	(f) inapplicability
1	379e(c) of
3	(1)(a), the
1	seq.] involving
1	(b) writing
3	monitor and
1	diversion; (2)
1	amounts: 
4	defendant has
1	(a) fails
1	biological systems
1	purchaser. nothing
1	categories listed
7	construction the
1	english and
1	(1); (ii)
12	assessed and
1	specific threats
1	section 1005
2	export food
3	container used
2	use when
11	information contained
1	survey published
1	investigate such
3	may run
6	product fees
1	outreach, media
1	preparedness goalenhance
1	electronicall-captured logbook
1	rulemaking the
3	nutrition assistance
1	seve-year period
2	inspect the
9	subsequent to
2	program goals
2	initial shipment
1	countries; and
1	15, 2007.
1	inflation adjustmentthe
5	chemical. 
2	legal controls
1	management systems,
1	(8) dihydromorphine.
1	involve any
1	
 379d1.
1	violations may
1	(c) investigations
1	medical research
5	adjustment to
32	device that
8	manufactured and
2	(d) use
3	clauses, as
2	360c(e)(1) of
1	substance abusers),
1	writing, whether
1	(3) thir-party
1	closing statement
2	notices, orders,
1	525, as
1	title. (feb.
3	contributions to
2	party at
2	directives issued
1	(c) formal
1	protocols requiring
1	equaling the
1	demonstrate compliance
1	plus the
5	procedure the
1	application; presubmission
1	traffic which
1	fund coalition
1	use. (e)
1	disposition, and
1	exportation the
2	$20,000,000 for
1	(1) four
1	343(c), 343(d),
1	(h); may
2	faith as
1	delivers the
1	(g)(4), (i),
1	therein. (b)
4	any) which
1	legend conspicuously
1	usual and
1	-[-(-morpholinyl)ethyl--(-naphthoyl)indole (jwh200);
1	organization funded
2	planning for,
7	substantially complete
1	approval means
1	205. display
1	testing results
1	formula unless
1	mail) as
1	
 1180.
5	public suggesting
2	applicant, withdraw
1	public safety.
1	prohibition it
2	public safety,
2	part. (2)
9	(1); and
2	(a) making
2	giving of
1	licensure as
3	(iii), or
1	toward laboratory
3	office, shall
1	widely utilized
2	contract and
8	committee to
1	infant 
1	department means
5	admission to
6	separate registration
1	unless, such
5	issues raised
1	360j(m)(6)(e)(ii) of
1	regarding illegitimate
1	remaining after
1	labels it
1	company that
1	institution programs.
8	substances that
1	black rots,
1	19, 1925;
1	found necessary
1	personal, household,
1	requests any
1	53, or
2	farm shall
1	31, indicating
1	draft proposal
1	
 467b.
1	(v) publicly
2	(d) submission
5	issue essential
2	poison, except
1	(c) personal
1	formerly 306,
3	marketing act
2	apply had
5	requests and
2	articles from
1	675, 307,
1	grade gs10
1	submit all
6	(4), a
1	grade gs15
1	alleviate temporary
5	grade gs18
2	manufactured does
75	adverse event
1	without paying
2	considered unsafe
1	change includes
1	alternatives that
3	signing a
1	expand and
2	documents of
1	declared completed
1	(l) failure
1	states having
2	poultry carcasses
1	(3) disclosures
2	partnerships to
1	responsibilities shall
1	residue specified
1	title, classified
1	may hereafter
1	research projects,
1	services an
2	exceeds an
1	
 956.
1	subsection (a)(2)(d)(ii)(i))
1	incubation during
3	802(39)(a)(iv) of
1	(jwh250); (viii)
80	person to
1	thereto, and
4	fda food
6	50 of
2	constitute substantial
1	nongovernmental agencies,
3	findingscongress finds
1	acceleration of
2	education (as
1	(2)(a)(i) and
1	importer practices
2	retail establishments
9	establishment there
1	exclusive the
1	human african
1	association with
14	refusing to
1	1133. omitted

1	section. new
1	certify and
2	employed in
2	amountthe amount
1	iv, 403(a)(10),
1	criteria not
1	(b) ability
3	conspires to
1	programs, projects,
1	penicillin, streptomycin,
30	fee revenues
1	20 by
1	establish terms
2	additional use
2	register for
1	section 173.315(m)
1	subchapter. any
1	approved label
1	container, any
2	factors set
3	69 stat.
3	demonstrated a
9	effectiveness for
3	important source
1	identify risks
1	association. (f)
1	affirmation or
1	sections 556
1	(c) imitation
2	sections 554
1	organizations funds
1	sections 552
1	originally received
1	customarily used
1	conducts or
1	treaties relating
3	children to
1	7, 38
1	title. (13)
1	temporarily or
12	withdrawn from
1	sought and
1	unforeseen adverse
1	(a)) who
1	contracting with
2	(c) recommendations
11	removal from
1	no-nicotin-based products
1	supply means
1	education (a)
1	section, specifying,
4	institutional review
2	shall identify,
1	which, fresh,
2	(6) is
1	claimantin response
5	defense, the
1	register prior
1	(1) ceases
1	transgenic animal.
1	confront witnesses.
1	execution upon
10	(6) if
1	chapter. (e)
1	input and
1	business collaboration.
1	spots, a
4	(6) in
1	table set
1	catfish labeling
1	any, submitted
2	petition includes
16	assure safe
1	packed, the
1	iv, 408,
2	rebuttable presumption
2	contents, i
1	natural flavor
3	fact, it
1	regulation. (b)
1	(a) sunscreen
2	traceability of
1	transferred), subject
1	communication with,
3	device can
6	subparagraph (a)(iii)
1	remains necessary,
1	stramonium, veratrum
1	locate, for
1	may disclose
8	violation, and
1	directions and
1	decontaminating, and
1	conducting administrative
1	section 350j(c)
1	approve human
1	744c, as
1	methylsulfonate. (16)
1	behalf, and
1	countermeasure advanced
9	attorney for
1	sentenced be
1	evaluate for
1	unknown, shall
1	
 3561.
7	data. 
1	grown, and
1	notice, all
1	(j) scope
2	substances, in
1	(27) the
1	u.s.c. 1701
1	trialin the
1	may sel-administer
1	sooner. if,
2	states delivers
4	cases where
2	(b) requires,
1	neither section
7	property ordered
1	353(e), 360eee2,
2	30, 1998,
1	years thereafter
3	goal of
4	patrol hours
2	owner prior
1	applicable interpretive
1	360e3. breakthrough
8	information, or
1	effects, for
3	withheld unless
2	buildings all
1	states standard.
1	1st of
1	issues; (12)
1	(b) promulgating
83	title and
1	approved product,
12	give notice
7	particular activities
24	definition of
1	voluntarily disclosed
7	served as
3	transfer to
2	title any
4	communication with
1	(a) approval
1	protocols submitted
1	2012. establishment
3	offering to
3	final delivery
1	helped provide
2	activated, he
1	person qualified
1	inventory (following
2	establishments will
1	locally usually
1	chair of
10	5 years,
3	independent of,
1	(c) facilitate,
1	157. inspection
1	manufacturer who
1	mechanisms, consult
1	administered; (3)
1	887. coordination
1	tagged, or
3	benefit the
2	chloral hydrate.
1	chloral hydrate,
3	director, holder,
2	(3) duties
2	sales 
1	ii authorities;
24	revenue amounts
2	applications; withdrawal
1	seller because
1	prioritize topics
2	cas-b-case basis,
1	opportunity, or
1	360b(d)(1)(a) through
1	physically, chemically,
2	warehouse space
3	official mark.
3	permit an
1	determination the
1	size, strength,
1	obtaining scientific
6	product during
1	467c. federal
1	otherwise endeavor
2	activities during
1	(12) methadon-intermediate,
1	commerceeach person
1	internet pharmacy
1	
 132.
1	due as
1	sell, furnish,
1	technological feasibility,
1	state statute;
1	single location,
1	conditions. provided
1	determination. (7)
18	(a) definitionsin
1	care such
1	(a) $7,328,000
2	lower prices
1	countermeasure expertise
2	appropriate, advice
2	programs on
1	include consideration
1	vehicles, vessels,
1	pooling and
1	act applications
1	knowingly obstructed
4	directly linked
1	transports a
6	(d), and
20	(b), (c),
1	2016. (b)
2	processes used
4	fees, late
1	criminal action
1	establishment whose
1	(mg) 25.0e
1	programs; (4)
1	(a)(2) may
1	person. (f)
1	restaurants and
1	(d), any
2	staff the
1	result to
1	1176. repealed.
1	effectiveness shall
2	(including supervisory
1	2, 70
3	applicable and
1	user facility.
1	user facility,
1	years. (v)
1	urgent need
2	funds provided
1	reserves, annual
9	qualified facility
1	access at
1	(2) claimant
1	824(a)(4) of
4	facility where
1	2225. decontamination
2	governments; 
1	defect does
4	testing has
1	date, quantity,
1	allocation for
1	stated, have
4	which, and
1	states, using
1	website. (3)
1	coastal islands
2	credible information
1	(23) trading
1	conditions proposed
1	margarine which
1	salary, grants,
1	treatment involved
1	understanding, material
1	center; (iii)
5	employ of
1	
 466.
1	drugs. (l)
5	subsection (a)(1)(a)
1	determine their
4	artificial flavoring,
1	factors, that
1	regimens, such
1	formula means
1	damages from
1	current list
3	coordinator 
1	tobacco use
1	675, 523,
2	action shall
1	commerce. such
1	product published
1	isomers; ecgonine,
5	substantive determination
1	pyrrole ring
2	fix such
1	filean applicant
1	labeling, recordkeeping,
1	developed using
1	challenge. 
2	render such
155	(2) the
3	time, to
1	equivalent defined
1	products made
1	1996, as
1	generalbeginning july
1	partly owning,
12	title iv,
1	breakthrough therapies,
1	new panel
1	supplier; (iii)
1	ship a
2	recall, or
1	fifra to
1	standards not
85	law enforcement
2	instances where
2	significant role
1	property following
6	360(i) of
1	taking one
5	27, 2013
8	probable cause
1	(1) define
1	(ix) civic
1	(f)(1). 
3	(a). if
2	plant which
1	1705. development,
1	determination. information
3	intention to
1	handicapped individuals
1	radio pharmaceutical
2	(a). in
1	(c), issue
1	adequately support
2	hire, use,
1	patient, but
1	prohibited unless
2	health he
1	paragraph, where
7	recommendations with
1	whether before
1	379j(a)(2)(b)(v) of
1	team leader
7	funds received
1	practices issued
1	ones already
2	represents a
2	41 et
6	wel-controlled investigations,
1	impede the
1	(b) can
1	unit doses,
40	secretary as
17	common or
11	secretary at
1	filovirus diseases.
1	(1) three
74	failure to
14	serum, toxin,
16	secretary an
1	679c. expansion
3	services, including
6	advisory committee.
2	(ii) requires
1	facility, collectively;
1	writing 
1	sanctions program
1	supplement marketed
2	eligible establishmentthe
13	(i) an
1	supplements submitted
3	taken and
1	division. (g)
1	limitationan exemption
2	temporary denial
6	significance of
2	reinspection as
2	termination date
3	(i) at
1	fees when
1	16, formerly
1	taken any
1	assurance. any
57	chapter. 
6	u.s.c. 262],
13	eligible to
7	u.s.c. 262].
1	requires) directly
4	database or
1	substances, through
1	(k) abbreviated
1	subsequent rulemaking
1	security. the
3	application approval
2	possibility of
1	states. beginning
5	procedure to
1	(j) a
1	requests submitted,
1	
 379dd1.
1	operators on
3	consulted with
1	request. (2)
2	section 381(e)
1	countermeasure development,
1	(2) appoint
1	2010, notwithstanding
1	imposed. 
2	radiation from
1	dye, the
10	official of
5	residue level
2	clinical protocol)
24	time after
1	considered unadulterated
1	consensus standards,
1	facilitating sharing
2	code portions
6	refused to
1	internal purposes
9	v or
1	otherwise obtain
1	salts. (i)
2	355(p), or
12	regulatory requirements
11	lif-threatening disease
3	petitioner, or
1	federal personnel
1	any; or
1	agencys public
1	2011. definitionsin
3	holding, and
1	private sources.
1	independent private
3	goals described
14	devices 
2	10 working
1	created by
1	similar acts,
1	regulations thereunder
1	675, 709,
2	useful for
1	states concerning
1	funds; (iv)
10	guidance issued
3	360oo of
3	complaints regarding
6	may conduct
1	hold not
1	abet, conspire,
1	emerging threat
1	signals from
5	light of
5	center to
1	membership includes
2	hereinafter provided,
4	section shall,
2	distributed without
1	paymentthe fee
3	regulations, which
1	database at
1	life shall
1	adulterated drugs
2	committee, and
3	advers-event dat-collection
3	transfer request
1	title, refer
1	requirement[1] or
2	auditor 
1	multiple devices
1	343(r)(3) of
1	change creates
10	article, or
4	person on
1	(f) qualifying
1	247d6b]. (2)
1	upon withdrawal
1	subsection (e)(2))
2	(a)(4). 
10	person of
2	municipality or
1	and, unless
3	substituted in
1	(g)) in
1	(a) violation
37	appropriate state
1	registered establishments
1	electronic data,
45	person or
1	exported may
1	board 14
1	505a[1] of
1	1943, to
1	york, new
1	creatively all
5	immediate suspension
1	provision and
3	blocking of
2	product, to
1	combination involved)
2	impracticable, or
1	injurious nature
1	(c) permanent
1	services determines
1	exist; and
1	type, packaging,
1	restraining orders
1	general ruleevery
1	standards if
5	processing and
1	target animal;
1	(h) 5
10	standards in
1	drug testing,
1	371(e), (f),
3	established place
6	days, the
1	abuse rehabilitation;
1	filed against
1	recordfor purposes
1	(h)(2); (i)
1	802, as
1	order, with
4	systems for
1	(d) promulgation
5	measured in
1	holder making
1	court action
1	endpointthe term
2	athletes participating
1	government, foreign
3	360j(f)(1) of
1	(vii) 1000
1	third fiscal
6	qualifies for
1	individual packages
1	387]; (d)
7	unit, with
2	protocol, under
1	feed covered
2	(a) initial
1	cocaine, methamphetamine,
1	matter. a
1	discovery of
1	committee; report
3	place, whether
8	repackager described
1	1111 to
1	prevent outbreaks
1	breast implant
3	bovine blood
1	(2)(b)(iii)(i)(aa) of
4	agencies within
1	establishment; functions;
2	title 22.
1	abuse such
4	damages. 
3	sem-critical reprocessed
1	toxicity; (vi)
1	indian tribe.
1	(c) representation
1	device, software,
1	machine, contrivance,
2	already been
1	local advertising
1	tin, plastic,
3	states, that
1	section, so
12	year to
3	timelines, in
4	longer period
1	previous 24
1	1708. national
1	360c. classification
1	1014, as
1	delivery was
1	title declaring
3	auditor to
16	product, and
1	5001 et
3	application. (2)
1	responsibility or
1	precursor, included
1	act involved,
1	inspection budget).
1	label where
1	4(k) of
1	criminal, exclusion
1	states pursues
1	(iv) making
3	responsibility of
2	representative under
1	(2) collection
10	initiative or
1	use exemption
1	hooks attached.
1	set standards
1	453(a) of
1	fish stocks.
8	(a) upon
1	soap. (j)
1	director is
1	paragraph (1)(c)(i)
1	subsequent studies.
4	least 5
1	sentences. the
1	notwithstanding state
1	shall regulate
1	fills of
1	law. (d)
1	employ at
1	(b) different
5	investigations for
17	due notice
1	will trigger
3	designate any
1	informed consideration
1	(11), the
1	d-identified data
1	concurrently or
8	rulemaking under
1	interagency collaboration
2	agency responsible
1	2009. the
6	consultation the
1	section 343(q)
2	shall violate
1	prescribed procurement
1	moneys forfeited
1	discontinue participation
1	body recognized
1	may disapprove
2	(i)(cc) is
2	restrictions required
1	validated but
1	applies if
1	funding directly
8	holding of
2	applies in
3	shall afford
1	food types
1	applies, if
2	frivolous. if
1	rendered adequate
1	(b). clauses
2	knowledge as
1	target food
1	factors determinative
1	optimum freedom
1	disclosure 
13	final regulations
5	appropriate action
2	covered products
1	(ii) deny
4	section 360eee2
2	section 360eee3
1	patients on
6	section 360eee1
1	(b) knowingly
1	maintain lists
1	i, 3,
1	business, if
1	2004; (f)
1	notifications submitted
1	commercial use;
1	development fee).
1	information over
1	work cooperatively
1	moneys expended
1	memorandum. (3)
1	constituents, or
1	data reviewed,
2	(ii) resulting
2	water unless
1	hold. (h)
1	federal employees;
1	discharge, suspension,
6	secretary concludes
4	nicotine yields
2	residue, including
2	thereof, bearing
1	(n)(3), because
1	federal employees,
1	security, secretary
1	applicants last
1	(32) 
5	importer, owner,
1	subparagraphs (a)(v)(ii)
27	fees 
2	tracing system
1	evaluation; application
1	partnership to
2	(2) which
1	event exceeds
1	least the
2	844 of
1	identity under
4	food processing
2	hours primarily
1	physical property.
1	potential therapeutic
2	repackager may
1	lif-sustaining, and
2	subparagraph (b)(iii);
1	investigational products
3	construction except
1	mowing. (21)
1	final regulation,
1	regulation)) intended
24	caused by
1	safety datalink
1	conduct, and
1	trade the
1	2107. sense
1	governing computer
1	indexing of
1	testing capacity
1	(f) assistance
1	plan; (d)
270	within the
1	shall each
1	thereof during
2	state defined
1	additive regulation,
1	contract will
11	determines such
1	periodically. (3)
7	1254 of
6	823(f) of
6	reasonably certain
1	relative proportions
1	year. (b)
2	uniformity of
1	domestic drug
1	office otherwise
1	$500,000 per
1	(aa) would
1	
 968.
14	aspect of
1	customers, sufficient
1	knowingly possesses
1	explanation that
1	narcotic treatment;
1	data bearing
3	person, all
1	functioning of
4	notice with
1	treatments) to
1	acid) 
1	agencies, shall
1	general, request
1	semiannual reports
2	timely written
2	decides to
1	secretary exercises
22	shall pay
1	also advise
1	30, 1973;
2	population (including
1	applicationsthe following
1	auditor, with
1	concerned. (mar.
1	assistant administrator
1	passed after
11	import or
3	publish and
3	meeting 
3	states; (3)
1	30, 1973,
1	children. (d)
2	level requested
3	recognized, or
2	upon presenting
1	sponsors have
1	expires, by
8	approval, and
2	investigations. the
2	renders the
6	pediatric subpopulation
3	made, to
1	robust system
2	general pursuant
3	dat-collection systems,
2	ethnic minorities.
1	without performance
1	states, official
1	involved, whether
2	deemed by
1	practice setting
1	category listed
3	science. 
3	whether compliance
1	(2)(a)(iii), or
1	establishments; operations
2	educational materials
8	interdiction coordinator
1	served on
2	biomedical literature;
1	substance into
1	(6)(b). (8)
1	trials; labeling
4	relationship of
1	repackager; and
15	notwithstanding section
1	150.0. (june
3	directors 
1	administration requesting
1	prescription was
4	monitor the
1	consult such
8	constitute an
1	principal compound
3	chapter: (1)
2	means and
1	pharmacovigilance, basic
1	applicable fee.
1	then, and
1	period; (b)
5	shall, when
1	state information
4	irreversible morbidity
100	means any
2	construction standards,
1	including print
1	chapter, (ii)
2	and, through
6	training in
1	recipients to
1	basis an
1	(c) risk
1	vacancies 
2	common mechanism
1	misbranded. (h)
2	communities in
1	nature cannot
1	(c) crop
2	complete on
2	body meets
1	connection therewith;
5	(m) the
1	7 and
1	panels shall
1	report. (

6	upon certiorari
5	labeling requirement
2	interest, and
2	trials required
1	drug beginning
3	complete, the
1	specialty; (ii)
2	testing, reporting,
1	across state
1	formulations were
3	(6)(b) or
1	19 [15
1	ultimate financial
6	(d) for
1	573, as
7	(i) issue
1	phenylpropanolamine (referred
1	food inspection
1	obstacle to
1	qualification and
14	assist in
2	50 per
2	section provides
90	paragraph (2)
1	authorizing committees
1	section 321(m)
2	essence of
1	agriculture, farmer
1	procedure on
2	references a
1	regulation establishing,
1	program. such
1	term substance
1	evidence not
1	iv, 405,
1	decide which
1	sent abroad,
1	importer as
6	agriculture, shall
2	understanding for
2	employees concerned
4	identify to
1	chapter; be
1	procedure or
8	refund 75
3	(8) to
1	stakeholders, and
1	treated under
1	submits its
1	marked. (aug.
43	use under
1	secure, to
3	2011; and
2	(4) each
1	privileged at
1	administration databases
4	health risks
1	exception, in
1	detail best
92	process for
1	describes food
2	secretary; (3)
1	thereof, within
2	activity conducted
1	i-process controls
1	1333(e) of
2	intended, the
1	washington and
1	administration, university
1	vegetable, animal,
2	subsequent recipients
2	directors within
1	abuse because
1	(a) section
1	emergency dispensingthe
1	device review.
2	equivalent employees
1	submission if,
5	paragraph (c),
3	animal safety
3	as, necessary
1	place, in
1	official plants.
2	certificate; (4)
2	101(c) of
1	exported meets
1	substance; listed
1	(4) mandatory
30	state law
1	significance that
3	narcotics detection
1	18-day period,
2	department, including
1	new president
3	elect to
1	section 823(d)
1	demonstrated only
1	564a, as
1	grounds listed
1	(5)(a) of
2	liable in
1	imply any
1	efforts, measurable
1	1, 1970;
1	cosmetic, medical
1	(2) rights
2	require; and
182	national drug
1	publications or
2	dat-rape drug
3	buying contractor
1	export eggs
1	 $258,019
6	chapter, to
1	enforcement agency.
2	subsection other
2	criminal proceedings
1	regulations establishing,
4	export to
1	subsequent -year
1	supplying false
1	testing that
3	substance with
1	procure in
1	warrant, authorize,
2	exchange among
1	nonnutritive substanceif
1	952(a)(2)(a) of
1	(3) preventive
4	owner engaged
2	(e) good
1	(f) nonsaleable
1	reserve the
1	discuss possible
1	food identified
1	federal acts
1	one paid
1	product, which,
3	(5) an
1	known severity,
1	section 398
1	substance. if
1	exemption. (m)
1	reasonably should
2	including programs
1	safety signal
2	felony, involving
1	section 394
9	declaration under
1	include provision
3	statement signed
1	summary as
5	committee, including
2	lif-threatening experience;
1	(whether weekly
1	reasons supporting
1	move such
3	may demand
2	otherwise regulate
1	states; provision
1	edible portions
3	tribal, or
4	year 2012,
9	actions necessary
2	year 2012.
3	individual does
5	officer, director,
1	products, respectively.
1	evaluate transferred
1	site. (v)
1	(4) tropical
6	feasibility of
4	therapeutic effect
9	convenience kit
1	bono public
1	(b)(v), the
1	exercise program
1	61 et
1	
 379j13.
1	civic and
1	1-member advisory
1	product therefrom,
1	(21) tobacco
1	
 350g.
1	48, 49,
2	360, 360f,
1	direction with
1	otherwise, manufacture,
1	1604. liability
1	personnel; (c)
22	carcasses, parts
1	hydrate in
2	(after fiscal
7	made or
1	coupon means
1	systems, (ii)
2	met. the
1	executive schedule.
1	order, effective
1	contrivance, implant,
14	year of
1	(d) pursuant
12	committee referred
8	made of
1	local jurisdiction,
1	seeing into
1	least 25,000,000
3	invalidity or
1	approved animal
20	made on
1	675, 900,
1	(b) service
1	containing gamma
1	milk, as
16	final decision
1	holidays specified
1	destroy a
1	insurers; government
1	patient participation
2	center means
1	functions; and
1	approval an
1	distributors sufficient
2	approval as
4	intended, and
1	medication. (c)
2	administration (exclusive
1	president or
1	producers not
1	exportation; disqualification
1	regarding food,
1	safe operations,
1	terms narcotic
1	expected benefit
1	food use.
1	disaster payment
1	(4) no-delegation
1	(i) approved
1	-penty--[(-methoxy-benzoyl]indole (sr19
1	(6) drug
2	action, that
6	following an
178	required under
2	form (including
2	treasury, within
2	package means
57	determine whether
1	subsection (a)(3)(f)
14	appropriated under
4	require each
1	(c) inform
11	percentage of
7	(4) for
1	members attending
1	sections 331(i),
1	disqualification of
1	lif-sustaining or
32	(5) the
2	manner the
1	encapsulating machine.
1	limit such
1	testing, in
1	license unlawful;
2	effectiveness; (ii)
3	dru-free america;
1	new applicants
1	standardized documentation
1	division; (vi)
1	manufacturers holding
1	harvesting, but
1	information; (6)
4	acting for
2	partial fills
11	held in
1	columbia, be
2	pee-reviewed biomedical
1	dru-free america)
1	(c) current
1	certification appropriate
1	air that
1	business referred
3	petition does
2	reclassification order
1	(n) regulations
1	disposition (including
2	chapter, prominently
1	solutions; (xvi)
4	seq.), the
4	(1) information
4	require, as
24	class i
1	health. not
3	food certification
1	secretary acting
1	both, with
16	allegiance is
1	reduce barriers
1	similar standing,
1	treatment improvement
1	statements. 
1	drugsbeginning with
5	title the
1	foods certified
2	minus (ii)
2	emergency, involving
1	subparagraph, there
2	official plants;
1	circumstances; expedited
4	unaffected the
2	behavior, and
2	consists of
1	complete, and
1	least 95
1	marijuana, cocaine,
4	least 90
1	administrator, at
1	
 360c.
1	met) is
1	8 years,
1	suppression, u-regulation,
1	(8) if,
2	alkaloids or
1	youth and
1	included the
2	term approved
1	shall produce
1	finds after
1	purity; (4)
1	referenced by
3	orders or
1	health the
1	variance from,
1	expedient that
1	marijuana, are
1	consumers, of
1	subsection (b)(2)(c),
4	orders of
1	world; and
1	veterans benefit,
1	term marihuana
2	product) to
1	work in
1	probability; or
1	pharmacy; (4)
1	$1,000,000 in
2	lo-acid canned
1	public comments,
1	(3) biennial
1	application, with
2	petition, or
1	section 360j(g)(5)
4	(ii) making
2	(iii) statutory
5	(b) procedure
1	communicable diseases
1	352(j), or
1	new concepts
1	containing embryo
4	transfers of
4	(iii) for
2	groups (including
1	countermeasures, the
3	work is
1	auditors meet
1	(25) transaction
5	(a) at
1	food may,
21	testing of
1	living abroad.
2	enacted prior
2	space and
3	audit to
1	using by
1	(d) contracting
3	360b(d)(4) of
3	confirm such
3	applications, the
1	legally licensed
2	registration at
1	isomethadone. (8)
1	supplier for
1	requests approval
1	675, 752,
1	finalizes the
1	patient records
4	(g) rule
1	feasible, for
1	humans which
1	condition involved,
2	chapter when,
2	sales by
7	(vi) the
1	subparagraph (g).
2	evidence obtained
1	(following the
1	section, each
1	homeland security;
1	quality regulation,
1	support inspecting
1	transferability 
13	device 
1	100.0. 
2	together in
2	caucus on
1	president by
3	identify potential
2	access policy
2	food regulatory
5	terminated by
1	otherwise, or
1	services; (b)
1	notice, that
1	(a) guidance
2	section 1001(a)
1	uses, or
2	consumers (and
3	annual advisory
1	debarred, (b)
1	members and
2	cooperation (a)
1	obtaining quality
1	large investment
1	[1] see
1	year 2011;
1	said manufacturer
1	used; specifications
1	(e) controlled
1	government. (10)
1	reasonable doubt
3	single proceeding;
1	v substances
1	validate a
19	administration, dosage
1	production, or
1	person dies
1	sem-critical devices,
7	single proceeding.
3	applications received
1	certain fish
1	available. (9)
1	fee methodology
1	pay application
3	criteria website,
1	threatened or
1	related product
1	file not
1	articles involved
2	adverse experience,
1	recipients; (2)
1	across, where
57	likely to
1	(9) person
1	national environmental
1	precise identity
1	production, quality
1	(d) antimicrobial
2	laboratories to
2	standard setting
1	affidavits demonstrating
1	secretary making
1	quality, the
1	regulationthe final
1	379f. recovery
4	otherwise investigating
2	importer may
1	investigative or
1	reasonable exceptions
2	first commercial
1	called to
2	thing designed
2	authoritythe administrator
1	accessible, consolidated
28	section is
2	marked, stamped,
17	section in
3	otherwise make
1	productsif a
1	merit and
1	order imposing
1	indications, studied
19	section if
2	met only
2	effective with
5	amounts under
1	established, modified,
1	inborn error
1	packing, packaging,
2	missions undertaken
1	(c) national
1	includes in
1	packaging, labeling,
1	postapproval requirements
1	pennyroyal, tansy,
3	reasonable steps
1	(b) unlawful
3	research has
2	treat one
1	withdrawing an
1	for, manufacturing,
3	previous cohorts
1	specified for
4	including rules
1	
 378.
1	sodium. (b)
24	manner and
1	lobelia, nux
1	(iv) must
1	additive, a
1	(3) research
1	(1) effective
6	may grant
1	product specialization
1	trial. (2)
1	motion, other
2	13, 1931,
1	titleif a
1	assigned task
1	subsection or,
3	funding in
1	and, by
1	(b) invite
1	annual inventory
1	use after
2	state standards.
2	pane-track supplement
1	funding if
6	product pursuant
3	day, and
1	utilized for
1	general rulethe
1	providers 
1	disposition in
1	state includes
1	building enforcement
1	872. education
1	thereon in
1	stakeholders from
1	expedite development
1	relations. 
1	(b) interdiction
1	products, poultry,
1	reasonably related
1	(1) prescribe
1	nine months
1	306, 52
1	percentages otherwise
1	center (hereinafter
1	shortages occurring
1	iii (a)
1	(e) nonnarcotic
1	exception, to
5	grant the
1	adjacent to,
1	 all
1	release constitutes
1	
 2003.
1	arranging for
2	feasible to
4	approvable. if
1	samples shall
4	solely under
1	(2) internet
1	section 312.21(b)
1	(a)(4)(a)(i) (relating
1	investigate violations
1	entry. (2)
19	event reports
3	person without
1	risk when
1	agency; (c)
8	20 days
1	holds open
1	stat. 254.)

3	request; and
1	experience data;
1	established; and
1	effective, a
2	(f) protected
1	substances intended
3	establishments subject
1	issuer held
2	immediately prior
1	applicant (which
1	$13,500,000; (6)
4	commerce, as
1	(xiii) the
1	allocations the
10	including with
2	(k) construction
2	human services;
2	drug containing
1	one subpopulation
2	day), by
1	regulatory authority
1	qualified (under
1	title can
2	form shall
2	paragraphs (1)(b)
38	human services,
8	shall, within
18	human services.
2	resistant gram
3	another party
1	(g) documentation
34	import into
4	compounded by
1	warehouseman shall
1	part; (9)
1	breeding. 
7	waiver from
1	transmittal to
1	forfeitures, shall
1	ineligibilitythe period
2	(1) human
1	warrant for
88	(other than
1	(1) defraying
3	(e); and
4	subparagraph (b);
1	alerts, labeled
1	i, 23,
1	iii, 537,
9	commercial or
1	states seeking
1	focus the
12	subparagraph (b).
2	primary intended
5	1923, ch.
1	punishment. the
1	assurances described
1	recommendation; 
1	person obtains
2	preclude permanent
3	(1)(a) shall
1	market unless
1	displays the
1	quantity that
1	associated registrations
2	misdemeanor, and
12	known safety
1	involved by
1	plant under
1	tuberculosis. (b)
1	ingredient per
1	(h) service
1	entity meets
1	appropriate, while
2	(f) development
2	ingredient described
1	gene where
1	voluntarily on
1	covered thereby.
1	qualifications: 
6	secretary intends
1	(i) designate
1	attributes. 
5	administration, and
2	subsection only
4	section 387f(d)
1	subsections (g),
2	equines, and
2	scientific societies
1	section 360ccc(c),
1	unless when
9	sell, or
1	maintain procedures
1	(b)(iv), at
2	product constituents,
1	serious diseases,
2	voucher and
1	section 355(n)
1	done so
2	regulation published
1	manufactured within
1	communicable disease
1	total value
1	title, maximum
1	compendium, or
2	requirement are
1	seq.]; the
1	later owing
1	patient, contain
2	(the opportunity
2	minimize or
1	title) an
1	remain after
1	refusal by
22	misleading in
6	optical and
1	returning the
2	steroid under
1	nitrogen that
3	voucher of
5	2008 and
3	investigations made
1	referral if
20	without fiscal
1	household consumers
1	5, governing
1	sector veterinary
1	exportnotwithstanding subsections
1	adolescents. (b)
1	every five
1	quantities in
2	may enforce
35	published in
1	maintains each
1	(20) normorphine.
1	importer who
1	361. adulterated
1	persons preventing
1	system web
2	(a) necessity
1	379i(8) of
1	dietary intake.
3	methamphetamine abuse
9	section. such
1	modify, as
2	shall waive
1	use approved
2	investigation, taking
1	potential if,
1	make examinations
1	penalties, including
1	systems specified
1	website methresources.gov.
10	written response
14	thereof, and
2	741, as
1	624 of
1	vitro study;
1	matter; hearing;
1	26; and
1	updated no
3	misbranded within
2	guidance from
1	admiralty; except
2	improve linkages
1	qualified mean
12	twice the
2	terminate upon
1	prevent underage
1	container shall
2	supervisory and
1	process with
2	surveillance. the
1	(including tests
1	individual during
3	stat. 251.)

1	specification, software,
12	(2) an
1	practitioner may
1	discussions such
3	involved, or
1	veterinary surgery.
3	submissions. the
4	act shall
1	prescribe under
2	shall organize
5	studies that
1	hard drugs,
1	years under
1	products unless
5	(2) at
13	expended. such
1	individual pharmaceutical
3	describing an
9	(2) as
11	establishment or
3	exist necessitating
55	year for
1	products, their
1	effect, any
1	(or exempt
1	determination, then
3	controls over
3	providing opportunity
1	teacher, and
1	sentence in
9	(a) relating
10	sentence is
38	establishment of
1	use could
3	preparations containing
1	seeking dismissal
1	congress; and
1	accessory, or
2	(1)(b) for
1	allergic; (iii)
1	operator. 
1	federal sales
1	80.0 
3	transmitted pursuant
14	commissioner shall
1	metal, wooden,
1	measurements intended
1	gifts to
1	(21) ethylmethylthiambutene.
2	references to
1	law 109462).
1	available laboratory
1	criteria website).
1	term control
1	request, a
1	taken upon
1	additional indications
8	per fiscal
2	(c) advertising
1	sooner. 
1	imported does
36	party to
1	(i) afford
2	priority drugs
3	medicine or
1	systems (as
1	(a), external
1	vegetable merchant
1	legislative or
1	involving such
5	section 379g(1)
3	absence the
2	data, including
2	federal regulations)
2	code and
1	correction was
3	sections 351,
2	consolidated budget
4	substantial evidence,
6	title, any
1	plan that
1	(4) data
1	nutrient, or
3	affect 
1	review flexibility
1	period would
1	secretary related
4	condition will
7	service employed
2	final judgment,
2	obtained such
7	subsection does
1	coloring. (2)
1	discharged from
2	critical or
1	timingan applicant
1	final judgment;
1	(b)(2)(b), and
54	title, and
1	government purchase
34	period for
3	condemnation of
2	local official
1	360kk. performance
1	amounts (as
1	fda authority
1	replacement, or
1	reviewed programs
1	product where
1	from, and
2	new dosing
1	 thirty
1	appropriated, to
1	variance request
1	gross negligence
2	exemption may
1	use meets
1	affect interstate
1	2224 of
1	22nd pars.,
1	annually, a
1	governmental organizations;
1	basis, on
1	reasonable to
1	medicinal qualities
1	request, (ii)
1	knew means
1	may support
1	brand means
3	action, or
1	health, law
1	groups, industry
16	take such
4	decree, be
1	fellowships 
17	received by
1	consultation, the
1	recall system
1	part thereof;
1	marketed, sold,
1	safety are
2	validation, authentication,
1	chapter establishes
1	etc. in
1	record; or
1	plain language
1	test results;
1	manufacturers); and
1	680. authorization
1	transfers from
1	regulatory audit,
1	will demonstrate
1	packaging egg
1	fees, which
1	necessary hardware
2	substance used
9	measures to
1	either personally
1	(5) enhancement
1	studies, has
1	transferees) of
1	
 465.
1	issue date
32	provided, that
1	675, 736b,
6	registration fee
5	issue subpoenas
2	finding was
1	nearest regional
1	clause (vii)
2	(b) single
73	copy of
1	title), or
2	certification, as
1	methods or
3	feasible means,
2	requirements; concurrent
1	generated solely
1	ingredient when
1	one credible
1	affirmation showing
1	(d)(1) be
1	last inspection
1	period. (e)
21	methods of
2	appropriate court
7	(b) action
2	fee program.
1	cautionthis product
6	employees duly
1	costs under
1	inspect international
1	threat justifying
1	have, unless
5	timetable for
2	person meeting
4	manufacture the
1	protect individuals
3	tobacco and
1	subsection (a)(2)(b),
30	facilitate the
1	agriculture believes
2	request, samples
1	means carcasses,
3	weapon, shall
1	consumption, or
17	study or
1	(c) reactivation
1	laboratories or
1	fee necessary
1	developing modeling
2	moneys and
1	covered with,
5	distributor means
5	availability before
317	review of
1	plan, agreed
1	(13) methylhydromorphine.
1	(c) exclusivity
11	conducted or
1	consumers when
3	classifying the
1	discovery is
1	leaders, to
1	promptly assign
1	providers better
2	drug but
6	review or
6	register; (c)
1	september 2011.
1	training relating
15	2017, the
3	completed and
4	medical relationship
1	facilities unless
1	eggs packaged
1	coordination, oversight
1	(3) electronic
103	means the
1	(11) an
6	shall at
2	international opium
2	determinations; and
1	facility operated
2	permanent basis,
1	(or no
5	national academy
1	articles whenever
4	due regard
8	obligations of
1	sharing among
4	(v) if
1	joint initiatives
1	health), such
1	supplement must
2	(v) in
3	issues related
4	report received
1	individual physician
1	307, 52
3	section 409(l)[1]
7	constructionnothing in
1	person) reasonably
1	(7) that
1	sealed as
1	days; and
1	contemporary marijuana,
2	contracts. 
2	suspended and
2	outbreak based
1	authorities should
1	1923 [21
1	legislative body.
1	compilation not
1	egg production
1	design effective
1	carcasses contained
1	corrective actions.
1	general. (b)
2	facility receives
1	relevant fiscal
10	requirements at
1	injury, bruises,
2	authorized (1)
1	1-yea-olds. (3)
1	(iii) retain
2	give prompt
2	retail druggists,
1	nor, in
1	violations; liability
1	repackager means
1	labeled dairy
1	including advers-event
1	(xv), or
1	2601 et
2	exercised with
2	whose description
14	final, such
11	revoke a
2	outbreak response,
1	accessible in
4	(a) shall,
46	provided for
2	drugs; or
2	located, under
1	adjusted as
4	reorganized on
1	pharmacy offers
1	(1) against
1	evaluate implementation
1	request. (c)
1	inspection, building,
3	attorney general;
1	government concerned
2	sale) after
1	implantable device,
1	remain confidential
1	(2) listing
6	used with
1	section 379e(c)
3	establishment not
1	(e) exports
1	system through
12	felony drug
80	355 of
1155	secretary shall
1	director temporarily
1	subsection (b)(4)(a);
3	subsection (j)(5)(f)
2	(2) factors
1	ingredient manufactured
1	encouragement of
1	adding or
1	line of
1	1, 1970.
3	american osteopathic
1	fee waivers
1	independent entity
2	held or
1	false statements.
4	channels; (2)
1	false statements,
1	675, 714a,
1	months upon
6	application were
1	406, as
1	recognize their
152	(1) the
1	collude with
1	look to
1	tests to
1	registration, good
1	media that
3	physical dependence
1	whose effective
1	524(c) of
1	medical care
1	communities, and
1	(a) instructions
2	notice requirements
1	675, 914,
1	continued tobacco
1	applying manufacturing
2	patients studied,
8	optical isomers,
1	26, ch.
1	congress observed
1	registrations 
2	suspend a
1	functional value
1	related necessary
1	point or
3	supplier may,
1	(m) disputes
2	considered acceptance
1	including methicilli-resistant
1	paragraph[2] (1)(a)
5	reports. 
3	drugs. the
2	targets for
3	section 321
3	concerns about
1	evaluations 
2	reprocessed as
1	commerce. incidents
2	times after
1	late or
1	replenishing stock
1	licenses until
1	practitioner submits
1	may indicate
1	evidence (a)
2	(1) until
3	law 
1	(5) supplement
1	24 months;
21	amended 

45	introduction into
2	feasible and
1	imitated. 
1	dependence, or
5	naturally occurring
1	
 1903.
2	guidelines issued
1	2008 fee
1	methods identified
6	commodity and
1	testing seafood
1	ambulatory surgical
2	union of
2	withdrawing, or
2	general agent,
4	pediatric patients;
2	seek public
1	agency does
1	federal leadership
1	prevented and
1	drug required
4	experts that
1	milk defined
1	articles, exclusively
1	alternative, scientifically
1	reinstate a
5	delegated to
2	marks whenever
1	salted, stuffed,
1	duly commissioned
3	article, means
1	review tolerances
1	written. 
2	sooner withdrawn
1	379j11. definitionsfor
1	intensify and
1	industry, academic
1	council of
2	individual of
3	(t) the
1	respects govern
3	single enantiomer
2	tests of
1	(f) prior
1	devices plus
11	returned product
2	panel; and
2	complaint is
2	reasons as
2	detailing why
1	project implemented
1	(g) violation
1	campaign, not
1	employs fewer
1	transactionsexcept to
57	following: 
1	(g) representation
10	manufacturing, processing,
10	section. (2)
3	3 public
1	abusers and
1	complaint in
1	shall capture
1	dates were
23	agency of
1	personal use;
1	(c) schedule
1	360e(g)(1) or
1	revocation thereof;
1	conditions recommended
2	standards, to
1	subsection (f)(3)(a),
1	readily retrievable
1	available, as
2	anaphylaxis in
1	mitigate, treat,
2	material respect
1	237. repealed.
8	(part), 37
3	section 825
1	(a)(v)(ii) and
1	technologies, practices,
1	term tentative
1	regarding foodnot
1	last previously
2	party subject
1	guidance letter,
2	claim either
1	352(b)(1) of
3	pediatric patients,
1	chapter, otherwise
4	smokeless tobacco,
5	(4), the
2	smokeless tobacco.
2	preparation for
1	
 62.
1	among its
1	section 213
1	supplement reviewing
1	section 210
1	controls, animals
2	begin the
2	certifying the
1	u-regulation, or
1	form); (iii)
3	(i) written
1	(2) detailing
4	bond, or
1	2009, respecting
7	business. 
7	leasing, maintenance,
1	treatedin establishing,
2	approving a
2	appeal if
1	1997), none
1	2013, fees
1	health provider,
2	section 827
3	president in
3	portions thereof,
1	applies means
4	appeal is
15	conducting the
1	dietary supplement).
4	applicant, or
1	regulation (1)
2	seafood safety.
2	corporate officer
2	accepted, pursuant
1	economic development
2	treat, diagnose,
1	years 2010
4	domestic facilities
1	technicians and
1	labeling would
1	medical supervision.
2	request, make
1	internet site.
12	no-federal funds
2	shall meet,
73	established by
1	delegate. (y)
1	reducing abuse
1	stockpiling, licensure,
1	ordered agencies
1	regarding retail
1	reduced through
1	ant-drug communit-based
1	following each
4	(ii) publish
1	(a)(2) within
3	country, if
2	agent may
1	(i) federal
1	 b6
1	 b1
1	liquid which
1	 b2
2	study plans
1	forestry or
2	538, formerly
1	2-point type.
1	adul-written publications.
1	(a)(3) owed
1	labeling bear
1	yellow rots,
11	high risk
1	extension, the
1	apply, and
1	quality in
1	device conform
1	consultant for,
14	finds 
6	distribute such
10	ingredient) of
1	enterprise defined
15	agencies and
12	authorized representative
38	reference to
2	distributor, which
1	inventory. 
2	shall account
3	study plan.
4	study plan,
1	material issue
1	involved. (2)
1	subsection (b)(2)(a)(i).
1	privileges, interests,
1	biopharmacology, statistics,
6	who, after
1	dismiss; or
9	program; and
1	(d)) provide
1	eggs packed
1	appointed. (4)
1	2016; (d)
1	death in
5	annual summary
1	integrity issues;
1	illegitimate productthe
1	professional backgrounds.
1	applicant that,
2	(ii) during
13	waiver of
1	definitions; generallyfor
2	actions should
6	quarantine and
2	substances so
3	class iii.
1	section 1705(b)
6	state departments
1	sales, transportation,
1	proceeds. (b)
2	reviewing division,
1	(4) by
1	exceed 20
1	programthe term
19	waiver or
7	implement this
1	normal shape,
1	198. repealed.
1	years 2017
3	preceding -year
1	formula who
2	sections 360fff1
1	rulemaking or
5	official marks
2	clarity of
4	district where
2	apples in
1	(i) noncompliance
1	actsthe following
2	administered or
1	authorization (a)
1	$505,000,000. (f)
5	relationship between
1	establishments regulated
3	consultation is
1	reviewing divisions
3	illegitimate product.
27	illegitimate product,
1	food; (g)
2	tortious conduct
3	bulk vehicle
1	2281 et
1	of, federal
1	domestic facility,
3	consultation in
2	illegitimate product;
1	citations to
1	holiday defined
1	thereof. (20)
1	manufacture, and
1	products defined
3	labeling revision
1	annual board
2	employed in,
1	office that
10	methods and
2	foreign country.
2	printed sticker
5	limitation. 
2	manufacturer, including
1	condemnation, be
1	used outside
1	applications whose
2	new therapies
1	regulations), and
1	improve food
1	foreign country;
1	recall has
2	touching the
1	available, multiplied
7	added to
1	authority except
1	paid. until
1	condition, weight,
7	sponsor that
1	production regions
1	congressional findingsthe
2	(2) would
1	strength, etc.,
1	new, unused
1	paragraph (e)
1	dosage units,
1	standard, has
1	matters concerning
1	1976; $40,000,000
3	distributors to
6	360d or
1	scientifically necessary,
3	sales data
3	first 3-day
2	container that
3	commerce. it
1	fee) shall
1	date, and,
1	(a), (i)(2)
12	final order
2	purpose. (3)
3	penalty, and
1	subsections on
2	ful-time employees
4	article under
1	experience based
1	manage any
6	subdivision thereof,
4	(b) rules
1	abuse (including,
1	sol-source unapproved
1	complaints relating
1	amount, frequency,
1	access service
1	response not
2	may revise
2	generalbeginning with
1	lines or
1	subsection containing
3	animals which
1	industry as
1	samples, and
1	tribes. 
1	approved alternatives,
2	internet 
2	internal controls
3	annually report
1	convention. in
1	$12,900,000; (5)
2	application, be
2	medical, statistical,
1	(2) reinspection
8	protection as
1	penalties; forfeitures
1	owner thereof,
2	complete information
1	(k) report
1	register. (3)
1	pays any
1	petition, notice
1	advisory committee).
1	substance rather
1	tax year
1	provides ongoing
1	accreditation for
1	(5) records
1	comments made
1	waivers; (f)
1	(c) dismissal
3	condemned and
1	chemical, with
1	(f) lamb
12	violates section
1	periods; and
1	class. 
4	original place
2	article involved
1	illness; and
12	waiver under
70	subsection, the
1	advanced therapies,
62	federal, state,
1	(o) use
1	international, to
9	records a
1	(23) the
14	necessary. 
1	state. (ii)
2	treasury under
1	classification request
1	findings is[1]
2	action made
1	magnesium (mg)
1	9- or
1	definedthe term
1	(2) rural
1	advanced therapies;
3	partner, officer,
1	claimant. 
2	target population;
1	section 900
1	control, if
3	activities; (c)
1	(a)(1) after
2	(b) humane
1	propose the
3	determination for
1	no-ionizing electromagnetic
2	drug through
2	consider only
1	trial guidance
2	1, 1989,
3	request whether
2	personnel means
1	(including community
6	sealed homogeneous
1	granted pursuant
1	responsibilities as
1	interested in
1	handlers, shall
113	federal register
2	$500,000, adjusted
1	zero, the
1	(b)standards. 
2	periods described
1	1984, whichever
1	environmental practice
1	interest with
3	demand trial
1	350(c)(1)(b)(i) of
1	sufficiently effective;
1	issuing, amending,
1	disorder; (cc)
10	section only
1	land, buildings,
1	mechanism for
2	aid for
40	shall promulgate
1	agency discretion
2	electronic notice.
4	development process
1	manners utilized
2	retai-type establishment
1	may refuse,
2	prohibit or
1	regulations) to
3	suitable for
2	articles produced
1	residues regardless
7	thereof in
1	compliant companies
1	entities; (16)
3	thereof is
1	encourage implementation
1	court ex
1	premises if
2	amount obligated
1	1, 1976,
1	(submitted in
1	data, patient
6	assessment and
2	drug endangered
2	forthwith designate
1	bureau with
5	action covered
1	certain information
1	representative responsible
1	certificationany application
2	packed, received,
2	2008, in
1	subsection (d)(1)
1	diagnostics, is
2	first begins
1	provision to
1	(b)(1), shall
6	(a) new
1	making cigarettes.
1	congress, through
1	parents, teachers,
2	conducted a
1	whole. (b)
1	distributed requires
1	followed, the
3	pending hearing
2	substance (without
1	247d], except
2	states, such
1	market; (d)
1	owner, lessee,
2	facilitation of
3	may, as
1	preserved for
1	systems ensure
1	(d) acknowledge
15	may, at
1	admixing, mixing,
1	commercial aircraft,
1	substance, when
3	filed and
1	power systems
1	dead. (f)
3	secretary, unless
1	tariff schedule
1	coalition of
15	experience in
1	human body.
2	communication. 
1	opiate. (2)
1	removing a
1	action; and
1	importing ephedrine,
1	dispensers shall
1	direct purchase
4	offered or
5	proposed product
1	borrowing by
1	experience is
1	put; (12)
1	measurement, including
11	installation of
1	wild growths,
1	1050. jurisdiction
1	lo-b-lot certification
1	subsection (o)(3).
1	action should
1	regulations, including
1	acids); (o)
2	coalitions throughout
2	subsections (f)
4	(2) drug
2	(ii) certain
2	single written
4	360nn of
1	entity constitutes
1	patients. (iii)
1	uses unless
1	
 362.
1	exemption. (4)
1	test all
1	114i. pseudorabies
3	categories: 
1	sterilization, or
1	prescribe restrictions
2	commerce carcasses,
1	evidence exists,
3	official establishment,
53	fails to
1	foreign sources
1	international obligations,
1	schedule i(c),
1	subpoenas (a)
1	exports which
2	going back
1	believe from
1	establishments; nonprofit
1	(d)(2), the
2	administration programs
1	relies; (b)
2	whenever property
1	service announcements.
2	travel, per
27	drug are
1	mainland under
1	things of
1	causes; (b)
1	analysis is
2	(f) each
1	docket on
1	not, to
1	recovered shall
23	drug, the
2	low potential
1	(b) missionthe
1	organizationsa site
1	(including gel
1	dietary ingredient,
1	1037. prohibited
12	classification panel
1	adopted pursuant
22	swine, goats,
1	purposes certify
2	producing such
1	301, as
1	processed produce,
1	design, any
1	provide additional
2	952, 953,
1	seizure, and
1	rulemaking provisions
45	thir-party logistics
7	three times
2	conduct audits
2	community coalitions
2	poultry carcass,
1	benefits referred
1	agreements and
2	benefi-risk profile
1	554, 556,
6	$1,000,000 if
1	356g. standards
1	6th par.,
1	section 350d(a)(3)[1]
1	brief documentation
1	methods capable
1	address promising
4	raised in
1	(i)(i) and
1	(b) cas-b-case
2	product; (iv)
1	year, during
1	require nonconsumer
2	dietary ingredients
2	abuse potential,
3	party has
1	proposal; (ii)
1	(e) discontinuance
1	samples distributed,
5	used under
1	seq.]. (s)
1	widespread access
1	mutually agree
4	comprehensive drug
2	except paragraphs
3	studies under
1	phenoperidine. (38)
1	labeled indications
1	regulation exclude
2	chemicals. any
1	monitor implementation
4	bond conditioned
1	shortage, with
2	supplemented the
1	control foundation
1	single entity;
2	each: provided,
1	sharing foodborne
2	health authority
36	november 27,
1	1, 1970,
1	retain qualified
23	absence of
3	duly registered
1	caution: federal
1	time except
1	90 days,
1	(2). nothing
1	90 days.
1	certifying board
2	facility; or
1	food resulting
1	useful devices
5	article; and
1	(g) transition
1	public report,
1	packages from
2	english, from
1	visible federal
2	section 353(b)(4)
4	control under
1	facility intends
1	parent, tailored
2	products; (2)
1	occurred among
2	social and
1	(k) subchapter
3	(c) service
1	regulations complies
1	efficiency and
2	science or
1	expansion and
3	misbranded because
1	container; standards
1	problem, which,
1	
 966.
3	proceedings initiated
1	initiatives of
1	about, importers
1	
 360bbb6.
1	academic scientists;
11	manufacturer, distributor,
1	mechanical process;
1	coupon, or
5	transition to
1	use presents
1	regulations identifying
2	shall appear
1	emergency authorized
2	first sale)
2	smoke constituent
1	unsupervised use.
1	negative bacteria,
1	extended the
2	serve upon
1	laboratory shall
1	produce safety
3	states citizen
1	(a) paragraph
1	regular place
2	review process;
1	quality shall
1	(h) effectiveness
2	with, an
3	number for
1	conduct administrative
1	contains may
2	importers 
1	rejects any
1	section 342(a)(2)(c)(ii)
5	forth under
5	measure the
1	application, does
3	party under
2	cost (not
1	shall state,
4	concerning recordkeeping
4	approved racemic
1	display, except
3	available by
6	federal bureau
1	shall forfeit,
3	scientific, medical,
1	v pursuant
1	individual programmatic
1	importer status
3	date certified
1	section 360eee(16)
1	inference, as
6	ineffective or
2	comment (including
1	(v)authority for
1	determines after
1	appropriate due
2	gas means
6	sunscreen order,
1	section 897.32(c);
1	renewal request
1	(ii) emits
2	restricted section
2	bribed or
1	conditions results
1	including borrowing
1	577, as
1	patients, representatives
2	provider means
2	iii, which
2	registration documents
1	sunscreen order;
2	involved were
4	title, for
2	(3) relation
1	posted information
1	relative aggregate
2	affairs. 
33	individual who
1	analgesia. (iv)
1	264]. 
1	repackager requirements
1	supplier supplied
1	terms regenerative
1	penalties prescribed
1	(l) jurisdiction
4	appropriate, for
2	(iv) provisions
1	unduly interfere
1	communication, and
1	formal process
1	-(-naphthylmethylene)indene by
7	memoranda of
2	obtain discovery
1	authorizing such
1	corporations to
1	usefor purposes
1	shortages. the
2	court, within
1	changesfor purposes
27	every person
1	materials reported
3	fee setting;
3	thereafter that
4	harm caused
33	fees authorized
1	department. (b)
1	(22) etonitazene.
1	204, as
2	exposures and
4	sunscreen orders
1	zone. 
2	public display
43	administration of
1	include additional
1	quota of
3	time after,
1	(2) vacating
1	personal investigation,
4	administration on
7	(a)(2) or
1	conclusions, and
1	substantially diminished
3	pro rata
1	claims 
1	amounts). (2)
2	produce an
2	clause (ii)(ii)
4	1262; renumbered
7	administration or
5	common carrier
8	penalties for
1	supervisory level
5	trafficking area.
1	
 2225.
1	(d)(2) (referred
1	(1) trends
2	(a)(2) of
2	authority would
4	food manufacturing
1	30-day period,
1	certain postmarket
1	document for
2	control system.
12	petition was
3	minor uses
2	penalty provided
2	applications reviewed
1	transported. (3)
1	made aware
4	least 60
2	substantially equivalent,
1	current information
1	local inspections
3	detailed information
1	system; or
1	period. (iv)failure
1	packager, repackager,
1	2104. state
1	different electronic
1	28 shall
3	substance (except
1	production methods
1	faith in
3	intervention programs
37	shall promptly
1	level, are
1	nuts, 9.5
1	resources. (d)
2	controls. (d)
1	387e. annual
1	registrants to
2	penalties applicable
2	requirement adopted
2	191 to
1	
 1710.
2	40 grams
31	made a
2	exportation, or
1	them, and
2	dealer or
2	inspected, and
1	studies, with
1	dealer of
1	reasonable definition
1	organizations involved
1	covering, under
2	device, means
1	section 530c(a)
10	issue regulations
1	plan earlier
1	request relates,
1	858. endangering
3	compiler of
1	
 360hh.
1	professional organizations
3	devices approved
1	editors of
1	virus in
1	effective informational
1	reprocessed, with
1	
 387j.
1	establishments accessible
2	quarter to
3	simulation, or
1	circumstances; (b)
2	confidential access.
1	identification as
1	analyses, current
1	commission $1,000,000
1	meeting prior
1	section, that
2	studies needed
2	fines as
2	pharmacopoeia or
6	violation is
2	products adequately
1	administrator such
1	treat serious
1	limits, and
1	treat up
3	(2) reporting
1	enhancing the
1	subsection (n));
2	products, by
2	acted or
1	overall market
3	american academy
1	categorizations of
1	med and
1	(c) blinding
8	defect or
1	$1,984,000 for
1	section 360fff3(c)
1	projects. 
2	adult medicinal
2	make appointments
1	verify, such
1	microbiological quality
1	(d) based
1	additional facilities;
1	protocol; (ii)
1	vaccine adverse
3	pending action
1	events regarding
1	acted on
1	trial. with
9	recipients of
1	1506 to
2	procedure and
1	subjecting of
2	humans, be
1	drugs when
1	nations proposes
1	employer notwithstanding
2	materially participated
1	(i) pursuant
1	(f)(4)(b) and
1	1977, and
1	fund accounting
1	recalls. 
1	substance. (23)
1	nicotine and
1	procedure any
1	boobytrap on
1	cleanup of
3	review. after
2	joint committee.
1	secretary, imminent
1	information describing
1	claimant within
4	674 of
1	equitable sharing
1	(2) its
1	complete under
4	general schedule,
3	general schedule.
2	mails in
1	annual recertification
7	payable under
1	authority, the
1	appearance, and
1	listing color
1	solely by
2	paid pursuant
1	pharmacist means
2	identify 
1	therewith. 
1	a-large members
1	379v. safety
1	previously issued
4	15, 2017,
1	information, except
4	related to,
1	(3). (2)
1	biannually and
1	intentionally subject
1	milk is
1	355, 357,[3]
1	subsection under
2	sentence; probation;
1	(h) references
1	(3) cigarettethe
1	meat, meat
1	employed at
1	corrected or
2	milk if
1	(iii) invite
1	treatment planning,
1	u.s.c. 4402]
1	subsections (b)(1)(a)(i)(iii),
6	states, in
1	$1,000. for
3	consider, among
1	made does
1	approved) include
4	expedited development
2	audit in
1	measurable results
2	control means
1	sanctions that
1	premix supplier
1	6, 64
2	(2) considerations
1	time) that
1	adolescent educational
1	circuit and
2	programs (a)
34	52 stat.
1	made subject
12	reviewed by
1	subclause, a
1	yield and
5	dispensed in
7	property under
3	compatible with
1	drug adulterated
1	secretary rescinds
5	scientific review
1	recallsnot later
2	5, section
1	disease shall
1	tobacco. (c)
1	(f) authorization
1	limitationthe secretary
1	maintains processes
1	establish safety
1	inventory position,
31	conditional approval
1	thre-year period
1	facility includes
1	instruments mentioned
2	(b) from
1	of. any
1	pain and
1	rapid and
5	stimulant effect
1	request fails
1	affiliation with
1	determination issued
1	countermeasure experts,
1	sector pilot
2	vest in
2	involved shall
1	title). (f)
3	high potential
1	justify adding
9	notice provided
2	labeling contained
1	defenses 
1	(8) national
4	cream into
1	investigational devices
1	minimize duplicative
1	importer, unless
1	caregivers of
1	safety risks,
1	area so
2	product scientific
1	domestically produced
1	2007, by
1	section 379dd(d)(2)(a)(ix)
7	affiliate means
7	grounds described
1	(n)(3); 
6	filing or
15	355c of
1	chapter conducted
1	secretary on,
2	terrorist activity
1	commodities. 
4	drug protocol
3	efforts made
1	appropriationsthere is
2	term pediatric
24	forth the
1	residue (in
1	(3) tropical
1	(c) conditionssubsection
1	medicaid services
3	regulation, provide
1	regarding early
2	360eee1(a)(6) of
2	may (for
1	test each
7	foreign facility
1	homepage a
1	affecting, directly
3	distributor shall,
3	section 353a
1	original prescriber.
1	to, all
1	year 1999
2	year 1998
1	labor associations,
1	enforcement proceedings
3	year 1997
1	25 per
8	applicable transaction
3	section 355(j)(5)(b)
1	employee whole,
1	letter deemed
1	forfeiture, after
8	rate and
1	observations to
9	defendant may
2	evaluation demonstrates
4	keep such
1	exist, he
1	collection activities;
1	establishments according
1	1998, the
2	scale and
478	later than
1	disclosure unless
2	particular pesticide
1	chapter. (m)
1	section 353,
2	(1) additional
1	request and,
4	plans, and
5	pharmacopoeia of
1	permission. 
1	 54.0.
2	inappropriate or
1	revised preventive
1	independent ant-doping
3	(ii) additional
1	(vi) available
3	repackager, to
1	carton, or
11	generalexcept as
1	title. (rr)
1	(f) priority
2	states (except
3	elapsed from
1	general rulewhenever
2	ensuring consistent
1	stability, integrity,
1	derivative drugs,
1	chemical intermediary
1	thereon, printed
1	fifteen days
1	effectiveness, or
3	district, may
2	(b) second
1	
 353a1.
1	supplement a
1	relevant thereto.
2	tolerances 
1	order; statement
1	dee-water navigation
3	registry of
1	subsection applies
1	
 145.
1	information activities
1	(b)(ii) and
1	manufacture, marketing,
1	practicable, so
1	(6) urgent
1	347a. congressional
1	cooperation, coordination,
1	405, as
1	sites, including
1	may participate;
1	causes, trends,
31	tolerance for
1	considerationsin making
4	procedurein promulgating
13	348 of
4	title 7.
1	title 7,
1	register specifying
2	disclosed unless
1	consensus of
1	i, 12,
1	manufacturing, preparing,
4	studies shall
2	penalties set
1	decreasing doses
1	panel does
1	(2) include
1	authorityif 
1	specialized training
4	applicable regulation
2	amount that,
3	contemporary research
1	377. revision
10	section 101(b)
1	nonnutritive substance
5	causing serious
5	(6) an
1	years falls
1	abuse during
2	provider the
1	minor modification
1	clinical benefit.
1	therefrom, prepared
4	clinical benefit,
5	punishable under
1	charge by
1	relevant stakeholders
1	$112,580,497 for
1	(i)(4), as
2	acquittal has
3	title, means
5	seek approval
26	remain available
3	chemical; or
1	overall mental
1	general, upon
3	business submitting
1	one per
1	considering whether
4	increase its
1	elements the
1	(i) nonclinical
2	produce that
1	
 642.
1	(2) relation
1	section 45(a)
1	product (referred
1	generalbefore the
2	biological, radiological,
1	675, 586b,
1	assistance act[1]
2	particular cosmetic
1	countries which
1	related items
1	 iodine
1	$5,000 nor
9	effective controls
1	awaiting testing
1	1235; renumbered
1	otherwise necessary
1	million dollars
1	decree contrary
1	persons responsibly
2	usually conducted
15	hazard to
1	21, 1997)
2	21, 1997.
1	ingredient. (b)
9	21, 1997,
1	(or storage
1	funding priorities
1	system within
36	determines to
1	system requirements
1	standard, unless
1	otherwise modified.
1	improvement over
1	agencies. where
2	level, or
2	condition, or
1	interagency collaborationin
5	regulation; (b)
1	donated by
19	application has
1	ineffective under
3	substance. the
1	
 114d2
1	eligibility request
1	regarding developmental
1	temporary structure
2	administrative support
1	charging a
1	unrelated to
1	individual regulated
1	scientific programs
1	samples furnished
1	governing processes
1	uniform national
2	application had
2	administrative detention;
40	application shall
1	section 282(i)(3)
1	shock. (d)
1	subparagraph,[1] the
2	vacated upon
1	8961, shall
1	following has
1	forum to
2	said period,
1	threat agents;
2	safely be
1	term probable
1	perform consultative
4	area or
2	laws 
1	activities. (2)
1	(5) essentially
4	accessory of
3	(b) before
1	las-known address
1	2009, such
1	defendant and
1	section 3374(c)
1	secretarys interpretation
2	investigators for
1	regarding usefor
1	360oo. prohibited
2	liability compliance
1	practices. the
6	paragraph are
2	foreign asset
1	center. agency
1	387q(a) of
2	action, be
1	(a) determinationthe
1	approval would
2	appropriate participation,
1	8, 44
1	education regarding
9	evidence, and
1	regularly or
17	tobacco product;
2	product without
1	manufacturer because
1	scientific knowledge,
1	although such
1	conducted expeditiously.
1	kind, including
2	drugs. (d)
79	secretary in
43	secretary is
6	assessment is
1	link reports
5	shall support
1	acute pharmacological
1	distributed other
1	(e) cholera.
1	second and
1	persons written
4	earlier effective
1	675, 541,
8	require any
1	(2), whoever
1	operating (or
5	section 360b(d)
2	revoked and
1	help facilitate
1	section 321(k)
4	conference shall
1	section, all
1	511; july
5	unless exempt
2	retain the
1	proof; liabilities
1	(a) will
1	general controls.
2	(e) notice
12	(1) an
1	(8) neutralizing
1	donations in
1	safety improve
1	considerationin considering
166	 (4)
8	may 28,
1	title implemented
2	persons alleged
1	concentrate, metabolite,
1	dose packets
15	area of
1	regime of
1	compensation; support;
1	wrapping (including
1	360bbb5 of
1	operator otherwise
1	targeting inspection
1	food. compliance
1	time provided.
1	recover any
2	authorities, and
5	(1) at
10	(1) as
4	generalupon making
1	prosecution, and
3	congenital anomaly
1	director, that
1	user be
1	device manufactured
4	5 f.r.
5	adulterated if
1	author or
2	debar a
1	persons abbreviated
2	substantially from
2	advertising to
1	cigarette, cigarette
4	device manufacturer
1	(a) imports;
1	payments and
6	application. (b)
2	(h) termination
9	two years
1	1801 to
1	detect fraud
1	potential barriers
1	agrees that,
2	safe, with
5	product identifiers
5	added poisonous
1	administrative purposes,
1	traffic therein,
1	factors determined
1	civil proceeding.
1	civil proceeding,
1	(b) one
2	chain at
1	50 to
1	use, been
1	paragraph (15),
1	2012), when
2	petition at
1	identity promulgated
5	grocery store
1	(3) assessment
1	policy on
12	(5) if
1	only; and
1	deficiencies; or
1	exemptionupon application
1	section 350f(a)(1)
11	policy of
5	(5) in
1	food shipment
1	collaboration the
2	transactions wholly
12	drug establishment
1	jurisdiction proceedings
2	may carry
2	year (after
1	exposure estimate
2	dispenser 
3	policy or
1	still protecting
2	general (and
3	month during
1	trial (as
2	effective if
1	solution (including
4	claim a
1	inapplicability 
1	methamphetamines, that
1	consumer which
14	effective in
1	recording, or
2	chapter obtained
1	intentionally brings
1	subsection (j)(5)(d)(i)(iv)
1	stat. 1296),
1	participate in,
1	1992), a
1	(i)(4) with
2	term interstate
3	providing such
2	coalition may
2	payments to
1	undertaking an
1	made would
12	emergency medical
1	expertise pertaining
16	regulations 
1	packed by
1	(4) otherwise
1	include those
1	vitro or
2	health professional
1	office who
1	enterprise or
2	abuse relative
13	requirements and
3	$250,000 per
1	314.640, 601.45,
1	rapidly increasing
3	drugs. (ii)
1	(3) component
2	issued file
1	receipts submitted
8	employed by
2	product began.
1	degrades or
2	paragraphs (a)
1	additional preventive
1	appropriate as
1	review conclusions.
1	investigation; (b)
1	comprising the
10	title may
1	agricultural chemical)
1	i, 5,
1	applicable, and
1	consortia, publi-private
1	also related
1	675, 701,
1	chemical a
1	saleable returnsnotwithstanding
6	(i) who
8	detoxification treatment
1	influenced by
5	womens health
1	forfeitures effected
1	user fees)
1	(i) involves
1	cosmetic) under
1	(3) maintain
8	worthless, contaminated,
2	entities 
7	trade or
1	relating to,
16	selected establishment
1	no-compliance letters
1	existing community
1	produced food
2	seq.] prior
1	smuggled food;
1	enhanced by
9	trade of
1	(3) prohibition
20	(i), the
1	original order,
1	voluntary health
1	(2) antibiotic
6	final action
1	engage on
5	homoeopathic pharmacopoeia
1	101(a), 102,
1	proprietary name,
2	patient, irrespective
1	ordinary meaning,
1	reviewing clinical
7	section 841(a)(1)
1	secretary, authorize
2	local agencies,
1	local agencies.
1	cocculus indicus,
1	partnership, having
1	studies, that
1	fee assessment
1	local agencies;
1	panel has
1	reduction; (v)
17	consent of
2	shall track
1	2243. smuggled
1	live virus
1	determine risks
1	reduction act
1	condition may
1	find the
1	accordingly. (ii)
1	effects test
1	1997) in
3	packing, transporting,
1	acute exposure
1	affiliated warehouses
1	misbranded, including
1	form. for
1	above. in
1	(4) drug
5	secretary did
1	distributing, receiving,
1	(x) health
28	using the
2	(10) 
6	grams of
3	effective dates
1	devices. (2)
1	section 897.30(b),
11	event reporting
1	period consisting
1	priorities, and
4	pesticide that
1	section 956(a)
1	submit audit
1	elevated risk
1	system by
1	indicus, conium,
1	reg. 4131441372
1	paragraph (2);[2]
2	submitted, such
1	injection; (xvii)
1	(a) prioritize
1	care facility,
2	administering state
2	treatment services
2	term 18-day
7	effective date,
5	effective date.
7	meat articles
1	effective date)
6	section 353(e)
1	modification, shall
4	maintained compliance
2	adulteration, misbranding,
1	consider comments
1	stores, restaurants,
2	section 343(y)
1	unavoidability of
1	prescription described
7	held, the
2	years regarding
4	care professionals;
1	appoint a
1	minimize foundation
5	effectiveness and
4	ceases to
1	applicable licensing
1	(c)(2), if
1	forthwith revoke
11	shall use
1	1710a. requirement
2	cost and
6	chemical diversion
1	substance defined
2	evaluates the
1	chapter. (p)
3	mark means
1	heroin addiction,
2	incorporated by
1	(including estimated
4	coloring, or
1	retail in
4	agencies; and
1	jointly and
3	establishment a
1	articles; duration;
2	administration policy
1	provided a
3	1-day notification
1	establishments; (3)
12	controls, or
3	basis. 
1	equivalence determination
4	thereof; (b)
1	reaccreditation of
3	advertising, and
1	(bb) not
1	elementsthe data
1	command operations
1	located adjacent
1	general principles
1	factor for
1	retail commercial
1	action after
1	jurisdiction thereof.
29	applications and
1	(1) consider
2	pediatric assessments,
1	relevant expertise,
8	381(q) of
2	additional exemptions
2	qualification package;
1	(f) through
1	party. (

3	recruitment and
1	(e) denial
1	school, and
1	offense set
1	points, if
2	framework to
4	processing or
15	(iv) any
1	kidnapping of
2	studies were
1	forms pursuant
1	date, restrict
1	data. (iii)
38	processing of
1	interstate commerceeach
1	period equal
4	approval, as
1	application, (c)
2	section based
2	387j, or
1	witness refuses,
6	submitting such
1	five miles
1	(2) anileridine.
1	debarment, provided
4	performed by
1	governments 
1	terminated and
1	sign, or
1	calcium saccharin,
1	title, seizures
2	business shall
1	certification if
1	employees, as
1	nutritional requirements,
7	made within
1	occurred, or
1	condenseries in
1	360eee(16) of
1	facilitys registration
1	clinically significant
1	administrator. 
1	specimens, hand
2	application describing
2	intervene in
12	time prior
1	committees an
3	exist or
1	transferred. 
2	agents and
12	refer to
1	deface a
44	within such
79	data and
1	miscommunication during
1	phenylpropanolamine in
7	plainly marked
1	whether prescription
1	payments between,
1	milk minerals
1	administration imported
2	jurisdiction the
1	it. (2)
1	facility, such
1	(c) paymentthe
3	civil forfeiture
1	travel members
3	march 13,
1	employing all
1	review fee.
1	drugs; procedures
1	term depressant
3	feed and
12	products subject
1	activities registration
1	shortage in
2	distribution in,
1	facility identified
1	(f) apply,
4	grant may
1	(ii) applications
1	upon violation
2	making, using,
2	dispense or
3	product before
2	manufactured piece
1	variances from
1	section 356c(g)(1)
1	cantharides, or
3	air and
2	government, and
3	section 802(39)(a)(iv)
1	tracing and
15	facility identifier
1	present information
3	facility shall,
1	(v) ensuring
1	administrative costs.
2	engaged or
1	available internet
3	(b) whenever
2	chemical on
1	guinea. 
1	inspectors are
1	(2) customs
2	representative sample
1	renumbered 11
1	renumbered 10
1	turpitude. it
2	pharmaceutical manufacturer
24	states, the
2	pos-seizure administration
1	renumbered 19
2	toxin act)
1	term forfeiture
2	simple possession
1	beginning drug
2	prescription to
1	registrant; (b)
6	grants 
1	fill is
1	informantsthe secretary
9	chemical or
1	administrators final
1	ration of
1	maple syrup
20	poisonous or
2	subject document
1	1958, through
7	life, a
24	fiscal year;
1	goalimprove agriculture
1	stat. 1101.)

1	joint training
2	national standards
2	focus on
4	employees. 
1	trafficking through
1	substance, drug
1	additives established
4	regulate such
11	focus of
6	quality, purity,
1	elected officialsif
2	(1) withdrawing
2	inspection, which
1	contract, grant,
5	rule in
1	neonatology, and
1	(h) delegation
1	nonconformity; (f)
10	of, any
1	section 335b
1	(d) initial
1	schedule. while
1	method, material,
10	government service
5	notificationif the
5	822(d) of
1	including standards
1	law which
1	animal, plant,
22	of, and
2	general receives
2	basis in
1	separate offense.
2	previously refused
1	direc-t-consumer advertising
1	(i) testing
1	conforms in
1	formerly 307,
1	processing (as
4	submission means
1	disclosure on
1	13, 63
1	guilty for
1	handle or
1	means or
1	regulation, revise
29	disclosure of
2	granted in
1	
 176
3	regulation, order,
1	order; proceedings
2	conditions designed
43	means of
1	physician an
1	disclosure or
1	level below
2	drugs of
1	occurs infrequently
1	paragraph continue
3	specification of
1	list all
2	drugs on
2	reviewthe secretary
1	website provides
1	another dispenser
1	respective fiscal
1	forces receiving
65	drugs or
1	community and
213	required by
1	members that
1	council and
1	to, those
1	(3) rare
1	risks; (iv)
2	limitations on
1	third or
1	efficacy. 
1	not, either
3	paragraphs (c)
3	limitations of
1	additive previously
5	(2) information
3	approved constituent
3	food, shall
1	confectionery product
2	courts when
1	stated on
2	absorbed into
1	reduction strategy
1	individual debarred
1	currently maintained
2	notice); and
3	specific mixes
1	months. (3)
1	written clearance
10	strategies to
3	(ii) each
3	effective; or
3	hereby authorized
1	allergen control
1	paints, or
2	chemical, at
7	committees specified
1	revenues are
1	will conduct
3	(b) authorized
1	animal. 
1	auditor and,
1	plus one
2	(a) produced
1	chemical, includes
3	(c), such
1	adulteration. (5)
2	qualified laboratories
1	receptacles or
7	subpart for
1	withdrawal time
1	importation, a
33	imported into
4	purposes under
1	rights, beyond
1	
 843.
1	representatives that
1	consortia, and
2	consumers believing
4	7 shall
1	existing efforts;
1	1997 (excluding
4	flavoring, artificial
2	endangering of
1	fields; (5)
1	act by
1	recordkeeping 
1	refused an
1	health. (7)
2	persons ability
1	(p) authorization
1	keeping 
2	professional designation,
1	fulfill such
2	applicant; and
10	date upon
1	government organizations
5	liable as
1	upon development
1	2010, the
1	parties a
2	guidance documents.
1	safety, potency,
5	guidance documents,
1	(d) priority
11	safety information
21	prior conviction,
5	minimum age
1	criteria may
1	seller that
1	(2) on-half
3	obtained. 
1	data describing
1	repackager only
1	coordination relates
1	section 379j11(5)(b)
1	procured for
1	reviewed solely
3	october 8,
2	degree, and
15	1, 2015,
2	section, involving
1	among adults;
1	(6)(a), through
1	readily accessible
1	(2)(a)(vii) or
1	soccer, or
1	labels solely
1	sodium (mg)
1	consumer protection,
6	adduce additional
2	may, subject
1	intermediary, or
1	procedures applicable;
1	(3) do
3	problems, including
1	35.0 
1	supplement when
1	hazards, natural
1	policy described
1	transaction; and
1	ownership not
1	whether by
1	media campaign)
1	studies. (iv)
1	related food
2	officer conducting
1	violation constitutes
1	2014) for
1	unit which
1	relevant standards
1	training seminars,
2	distributor, under
1	flunitrazepam, the
1	importer. (ii)
1	complete criminal
1	360bbb7. notification
1	defendant owning
1	institutions. (5)
1	obligations; (l)
2	blank in
1	capabilities needed
1	conditions; entry
9	made, the
1	final determinations
8	protocol for
1	database and
1	term person;
1	(2) water
1	found during
4	august 6,
3	scienc-based minimum
2	2016. (e)
2	date extension
2	tag as
1	(4) local
4	target animal
1	exacerbate, a
2	section 387b,
4	opium or
1	considered because
7	substance formed
1	subjects, that
1	following certifications
1	extremely small
1	remove or
1	committee individuals
2	1473 of
1	consumer protections
1	fruits or
11	paragraph (1)(a),
1	(1) select,
2	(a)(i) of
3	(i), for
6	shall upon
1	(a) adulteration
1	commerce, registered
7	documentation that
1	imposed, under
1	(involving an
1	(and such
1	convicted, after
1	claim comparing
1	343(c), 343(e),
2	implementation and
1	(a), he
1	used electronic
1	(1) unapproved
1	57a of
4	request information
1	(b) notificationif
13	safety. 
1	leaf; (ii)
1	quota application
2	considerations under
1	(6) generic
1	(ii) 1
1	(ii) 3
1	(ii) 2
1	b1, vitamin
1	supplier, and
1	licenses described
8	entry for
4	personnel unless
3	(b)(1)(a)(ii), the
1	sexual assault.
1	afford all
1	every other
2	commercial investigational
6	inspectors appointed
1	contentthe assessment
1	additives which,
1	21 code
1	liability any
1	each[1] fiscal
17	maintain records
1	farm). (f)
1	section 863
1	existing processes,
1	serve to
1	organic, not
4	(c) abuse
5	miles from
2	owed for
1	interested entities;
2	programs with
8	seizure and
1	selecting data
1	including community
2	conditionally approving
1	improve attribution
1	approval products
1	origin labeling
32	detectable amount
27	if, after
1	exemptions established
1	(1). (q)
1	duties (a)
1	1971. (3)
7	vehicle or
1	(7) termination
1	administrator), in
1	2017 exceeds
1	744b, as
3	penalty 
1	currency, or
4	chain and
1	subjects it
3	which, if
9	ineligible for
64	(ii) a
2	proposed labeling,
10	which, in
10	(i) which
7	outsourcing facilities
3	committee, to
1	cause other
1	assistance division.
2	(3) which
1	returnsnotwithstanding subparagraph
2	holder referred
2	approved human
1	symbol described
61	order issued
2	promulgate rules
1	20, formerly
1	secrets the
3	documented by
1	(c) administration
1	cost savings
1	indication proposed
1	675, 908,
1	program, both
5	devices, in
1	controversy, and
4	canvas, or
3	respect thereto
1	term countermeasure
3	article will
1	devices, if
2	uses; (11)
2	entered under
1	
 360k.
1	act (36
2	month period
1	lif-threatening infection
1	product changes
1	effective. (vi)
1	otherwise individually
16	(1). 
1	food, color
1	(iv). (iv)
1	(a) notify
1	(l) 3,-methylenedioxypheny--propanone.
4	prevent an
2	records requested
2	required assessment
8	drug supply
7	foods 
2	360bbb3(b)(1) of
18	recognized by
1	updating regulations
11	partnership for
1	indicates an
4	commission. 
1	bufotenine. (5)
1	label under
5	conclusions and
1	necessarily deviates
3	(k) for
13	states may
1	appropriated $149,000,000
1	received without
2	items (aa),
1	hatchery, tank,
5	product. the
1	means eggs
1	added ingredients,
1	location of,
10	drugs, or
2	receive the
2	$25,000,000 if
3	complained of.
1	201, as
1	1091(r)(1)[1] of
1	use, reports
1	criminal, injunction,
1	relations (a)
1	proposed guidance.
1	diet; (iii)
1	publication, unless
1	products, such
1	and, not
1	make timely
1	request, determine
1	(f)(3)(a), the
1	process, renovated,
1	businesses subject
1	processing plant
1	judgment order
3	(g), and
6	notification submission
1	panel organization
1	consumption, provided
8	entity or
1	summaries notwithstanding
1	threat from
1	1996. (e)
1	(i) registered
1	tissue products,
1	350f. reportable
1	term real
2	effect that
4	domestic articles
1	states: refused
1	360j. general
1	land border
1	regulation) on
1	
 1533.
2	efforts toward
4	entity of
1	statistically significant,
1	title[1] seized
1	related foodborne
1	providing documentation
1	prepared from
14	(c), (d),
1	labels having
2	refusing, withdrawing
1	government, if
7	effect the
1	instituted if
2	revocation the
1	manufactured, introduced
3	life and
1	disposal standards
1	
 883.
1	growing, producing,
6	authorize any
1	grades on
3	(as described
4	marketed by
1	advance, the
1	1003, formerly
2	nanotechnology, the
3	30, 2010,
1	(aa) 
1	personnel involved
1	fda pending
3	publication 
1	scientific issue.
7	applicable federal
1	scientific issue,
1	update referred
1	360j(l)(5)(b) of
1	increasing in
1	(2) shor-term,
1	matter, and
1	privacy protectionsin
1	subdivision to
1	complete other
1	(a) sponsors
4	subsection (e)(1)
1	penalize the
1	controlled substanceit
1	annually 
1	food types,
1	extension, if
1	reaccreditation 
4	data; (b)
6	general services
2	350l(b) of
1	(f)) if
22	unreasonable risk
1	abuse with
1	351 and
1	establish, on
1	affected or
1	 fat:
1	675, 503c,
1	time be
1	403a, as
1	states. (june
1	low or
1	thereof includes
5	prescription is
1	commercial motor
28	subparagraphs (a)
1	inspectors provided
4	360kk(h) of
2	term little
1	possession, sale,
2	reduction, supply
2	shall endeavor
1	time, if
2	patent brings
1	ammonium saccharin.
47	appropriate for
4	terminating a
1	
 673.
1	workshops or
1	$7,328,000 for
1	specified number
1	groups; or
1	extension described
4	term federal
5	section 360eee(16)(a)
1	formula presents
1	days prescribed
1	act; or
1	shell is
2	principle or
3	term covered
1	(i)in general.
1	applicable, providing
1	trialthe purposes
2	section 360eee1(a)(6)
1	secretary) before
2	documents the
11	 (n)
1	(b) external
28	class ii
1	vacant. 
3	class in
1	meprobamate. (8)
1	(b)(1)(e) for
1	(iii) none
1	extracted therefrom),
2	space; (4)
5	information received
1	including surrogate
1	satisfied based
1	exports. 
1	product until
1	secretary seeks
1	dispensation by
1	defense strategy.
1	entity qualified
1	(c) order
1	obtain any
1	second offense
1	generate surplus
2	entity qualifies
2	maximum quantity
2	small entity
4	(aa) if
4	firm or
3	among importers
1	obtain and
1	waivers not
1	grown marijuana,
1	(22) united
1	legal instrument
3	(aa) in
1	processing, packaging,
3	adulterated meat
4	(i) authorization
1	organizations providing
1	facility without
1	regulation have
1	hold, administer,
1	construction paragraph
1	and[1] fast
1	(d) insert
5	data, and
1	change, which
1	decision has
5	(b) rule
1	102(a) of
1	 premarket
1	physician and
1	extensions described
1	establishment operated
1	control (in
1	report released
1	formulary, and
18	includes an
1	colleges (a)
1	containing domestically
2	355(c), 355(j),
1	deleterious substances.
2	(6) has
2	strategies on
1	(2)(a), respectively.
3	strategies or
1	alkyl or
6	applications that
3	establishments for
6	dose of
1	individual (other
1	5 (popularly
1	received. (d)
7	prescription drugs,
1	entertainment event
4	prescription drugs.
1	research using
1	3, 1891,
3	rates may
1	3, 38
1	delay or
3	(3) such
3	(5) not
2	exempt pizzas
2	decisionmaking; (ii)
17	product has
1	sulfonmethane. 
2	1034(d) of
2	unaffected nothing
1	interactions represents
2	direct resources
2	theft and
1	374(a), 379aa,
1	financial holdnotwithstanding
1	sharing in
2	cocaine, and
1	therapeutics. in
1	legitimate uses,
1	summary level
1	horses, swine,
1	businesses, in
1	(a)[2] have
2	data matrix
1	subsection (n)(1)(g).
1	360bbb3b. products
1	i, class
1	paragraph occurs
1	subsection 841(b)(1)(b)
1	infection, in
2	(pcp); (e)
6	basic class
2	(e) regulations
1	28that otherwise
1	requiredexcept where
1	delegate or
5	mentoring activities
1	isomers; (ii)
1	fuel or
4	product, and,
2	pediatric groups
1	technologiesthe standards
1	achieve appropriate
1	opinion regarding
4	upon entry
4	section. in
2	request, be
1	letter) require
1	operating procedures
1	finding, action,
1	secretarys formal
1	professional associations
1	valid certificates
1	two pharmacists
1	confectionery which
2	assessed among
1	produce, or
2	available arrears
3	revoke, or
4	(1) establishment
1	establish objectives
1	distributor provide
1	applying relevant
1	drugs including
1	substances) that
2	movement, and
1	meaning comparable
2	directors of
1	(b) fees
4	1002(a), 

2	submitted prior
1	revoke, on
1	epidemiologic, or
1	prior report
15	eggs and
1	manufacturing so
1	(ii) require
1	educate students
1	360bbb6 of
1	chapter, be
5	shall carry
1	population (or
3	label the
3	(5) offsetting
1	program meeting
1	topics necessary
1	cows. (mar.
1	applicable, pursuant
3	address of,
1	thereunder is
1	ingredient standardsnot
1	
 360pp.
14	3 percent
7	questions of
3	investigations that
1	exported or
6	assessed for
1	information); and
1	(a) termthe
1	392(a)), the
1	otherwise negotiated
4	section 1037
3	section 1036
2	 subject
1	valid affidavit
1	operational as
1	product test
1	countermeasure, including
1	received, sold,
1	minority member
1	14 days.
1	subparagraph controlling
4	reprogramming or
1	labeled; and
1	preliminary evaluation
33	days before
5	subpoenas requiring
1	adequately ensuring
1	commodities; or
1	denial, whichever
1	title) in
1	noncomplying electronic
1	satisfied. 
1	374(g)(2) of
1	practicable, provide
2	control, or
1	(4) codeine
1	explanation by
1	
 865.
2	reasonable written
46	approval under
2	involved represents
2	(ii) prior
1	applicable except
2	enforcing, with
1	assessments by
1	845 to
2	 (19)
3	(including an
6	grants or
1	insure against
2	patient, such
2	secretary decides
1	soil, bearing
1	term cannabimimetic
13	including such
1	5315 of
2	534, formerly
1	formula by
1	860a. consecutive
2	complaint upon
1	equivalent positions.
1	identify specific
1	involves more
1	combat illegal
1	(4), be
1	(f), or
1	exhausted, or
1	food held
1	no-hig-risk foods
1	nanomaterials in
1	387j(c) of
1	(h) may
1	debarment 
1	exclusively related
1	mechanisms, sharpened
2	apprehension for
4	manufacture to
1	adulteration. (c)
1	amount. (4)
1	priority needs
1	estimated collections
3	reduce drug
1	including commerciall-available
1	practice, as
1	350d, 355,
1	regulation of,
1	situational awareness
1	requested, that
1	tribal governmental
2	thereof; (c)
1	several product
11	general for
1	authorization if
1	(d) classified
1	new devices
2	inspect food
1	otherwise identified,
1	scheduling criteria
1	cigarettes, all
5	congress not
1	chapter;[2] or
1	previously imposed
1	effectiveness 
1	retailers and
2	claim described
14	source of
1	(c) nonapplicabilitythe
4	educational and
1	quarterly basis;
3	criteria standard
1	tuberculosis; and
1	give due
1	schedule v.
1	activities, records,
3	pharmaceutical drug
1	label. any
1	source or
1	section 842(a)
1	animals if
6	issued to
1	prevent drug
5	standard grade
3	type and
1	ii. each
1	processes; and
2	2015. 
8	standard or
1	2020, unless
1	general criteria
1	system, does
1	states. (29)
1	program staff,
9	costs to
1	limiting compounding
1	prescribe terms
3	define, for
1	subset referred
1	effective occupational
1	designated person
12	administrative order
1	
 99.
1	scientific understanding,
34	standard of
1	documents. all
1	authorities relating
1	(4) review
1	provided or
2	public warehouseman
1	study, in
1	designated food.
1	company manufacturer,
1	disease was
1	motion under
17	involved. 
1	study, if
4	infringement action
1	little cigarthe
1	section 387j(c)(1)(a)(i)
1	clauses (c)
2	2000), or
10	may take
1	submit concerning
1	(a) tuberculosis.
1	designated food;
3	provided on
3	(a) law
1	u.s.c. 5001
1	paragraph) to
1	(i) implanted
3	compound, dispense,
1	initial determination
3	agency means
1	global tracing
2	certain convictions;
1	consume-oriented information
1	
 2204.
1	47); or
1	otherwise applied
1	schedule. (3)
1	(ii) excess
1	relevant warnings,
1	academia, medical
2	expenses against
3	request, by
1	v shall,
1	create, distribute,
1	educators, and
1	undertake analyses
1	allergensthe secretary
1	reviewing court
4	phenylpropanolamine base
1	$2,000,000 for
1	(g) conducting
1	longer than
3	carriage, holding,
1	
 379c.
1	commerce will
10	application pursuant
1	enhance, not
5	contemplated by
3	360b(b)(1) of
1	(iii)recipients of
1	appraise conduct
12	cooperation with
29	provide reasonable
1	61, 3(d),
3	informed consent
2	questions; and
1	administrator an
3	local, county,
2	days thereafter
1	(1) set
1	article originating
1	retail transactions
1	published at
1	regulatory predictability;
3	quantities at
3	applicant a
2	goals: 
1	goods into
1	discuss any
1	candidates provided
1	(a)(4) within
1	products using
2	greatest priority
3	form; and
1	concealing, producing,
2	supporting documentation
1	process established
1	goals using
1	product, may
1	data; factors
11	will have
2	activities. (c)
1	health impact;
1	potential hazards
1	shape, practically
1	mean 
1	certain areas
1	following cancellation
1	distribute, export,
1	guidelines, developed
1	salts, or
1	assessments a
1	changes on
2	recruitment through
1	therapeutics under
1	conspicuous and
6	act. (3)
2	report directly
1	best practices;
3	otherwise, the
4	identical in
1	procedural standards
1	(a) applicability
1	(a) affiliate
10	section 381(q)
1	related color
2	(a), so
1	precedent for
3	remaining in
2	labeling submitted
1	national counterdrug
1	written request.
1	advance approval
1	consolidated farm
1	(d) conduct
1	whether enrollment
10	biological, chemical,
63	available for
1	workplace and
1	(2) grant
1	identification codes,
2	title. judicial
3	foodborne illness,
1	submission without
1	importers, a
1	saccharin, sodium
2	stat. 685.)

1	product innovation,
7	container. 
1	374(a)(1) of
1	566, as
1	physical, and
6	submitted or
4	also provide
4	decree signed
1	2016 
1	providing targeted
2	title, nothing
2	administration exported
7	certification, in
4	federal officials
1	conditions; direct
1	paragraph; (4)
4	appropriations acts,
1	strength is
10	appropriations acts.
1	following drugs
1	warehouseman refuses
1	pay user
1	claims that
2	381(r) of
1	another of
1	factor (as
7	fine under
8	secretary should
1	1.5d 
3	appropriate, take
2	another or
1	threat pursuant
3	transportation practices
12	drugs, devices,
1	water are
1	term regulated
1	thereafter, a
2	cosmetics under
8	title, is
1	product that,
1	supplement, within
3	scheduled audits
1	foreign, or
1	compendium that
3	pharmacist, or
1	electronic pedigree
5	represent a
1	opiates, derivatives
1	providers or
8	n-tobacc-sale order
2	tests, or
1	hand as
1	(vi) not
2	effective until
1	containers, as
8	title, if
1	restricted egg
1	seq.); (f)
1	675, 744j,
9	specifically excepted
2	accepts or
4	working group
2	educational agencies
1	affidavits supporting
1	2003. such
5	(v) an
1	informationany information
19	reasonably likely
2	(d) distribution
1	(3), shall
1	congress; (iii)
1	determines, through
1	temporarily, for
1	mediation and
2	interpretation of
3	drugs have
1	title, paragraph1
6	injury to
1	states. prior
13	shall in
1	fat, so
2	(ii) complete
2	50 kilograms
1	2017 
2	control program;
1	first determine
2	ingredients shall
1	practitioner will
1	(e) comments,
1	(b)(2) the
1	(a) notifying
12	partnership, corporation,
1	officials, or
1	salt, and
2	discourage individuals,
1	967. smuggling
2	quantitative formulation
1	claimants interest,
1	show bioequivalence
1	studies, and
9	chapter are
8	panel established
1	state laboratories
2	suspend shall
70	(iii) the
1	therewith. otherwise
1	(4) consult
2	criteria that
1	if, because
1	allow airflow)
2	title) intended
1	secretary. (c)contents.an
1	government inspections
1	paragraphs apply
1	communities support
2	dispenser, the
1	widely available
1	(2) objectives
1	appropriate, subject
2	rescind or
2	activities relating
1	postapproval monitoring
10	allow the
1	(f) agency
1	certificationthe certification
1	1981; and
7	basis, submit
2	accurately reflects
10	controls under
1	2007, whichever
2	patent infringement.
1	federal, state
1	analysis, a
10	applications. 
3	207 of
1	part referred
2	interest; and
2	device, as
1	may subpena
18	chapter, including
1	promote sharing
1	product, confirm
2	device, an
5	(2) prior
1	appropriate (and
1	make rules
2	(hereinafter referred
1	transactions (a)
1	control among
1	protection means
1	organization, provided
1	sentence. (2)
1	combination, respectively;
2	advertising was
1	subsequent proposal
2	licensing board
1	interactions;[1] 
2	including fait-based
2	interpretation or
1	package liners)
1	partnership, and
1	705, 52
1	(c) solely
1	administered during
1	swine, chickens,
1	(c) possession,
2	animals, etc.
1	meet industr-accepted
1	similar chemistry
4	investigational drugs
12	review, the
2	consulting with
1	no-federal food
1	deemed substantially
1	seeds or
2	drug due
3	misleading. if
1	360c(a)(3)(d) of
1	additional regulations
1	extent. (iii)
1	device: 
2	involving fraud,
4	institutions of
1	misleading. in
1	coupon. for
3	(including in
1	state considers
1	held title
1	guidance within
1	institution that
1	2252. compliance
1	date (if
1	amount (if
1	products any
29	(including the
1	damages, restitution,
1	investigational drug.
2	states shall,
1	investigational drug,
4	penalty may
1	dispenser has
2	estimated total
1	specified country,
1	will obligate
6	animals; and
1	section 351(a)(2)(a)
1	descriptors; or
1	information only.
1	specific efforts
2	beneficial to
1	fiscal 2013
1	report include
1	experiences in
1	article means
4	diethylamide (lsd);
1	select to
1	supplement. the
2	(d) programs
1	includes transfers
1	extensions of
2	written decisions
4	congressional statement
1	subchapter. in
1	processed, and,
1	262(a), 262(k)];
1	parties, as
1	agent, shall
1	102 of
1	personnel with
7	provides written
2	retail, any
1	committee per
1	terms. a
1	disclosed 
1	adverse events,
5	bodies and
1	code. the
1	(3) content
32	shall consult
2	ii, which
1	periodic laboratory
1	2002; and
1	home or
1	public housing,
8	audits of
1	animal production
1	(1) because
12	certify that
1	include eyelash
2	justify any
1	audits on
3	inspection 
1	hygiene training.
4	exemption will
1	(1) milk,
2	delivery system,
1	removal, or
2	subparagraph (9)
1	critical reprocessed
2	obtaining such
1	2007, there
1	reviews. the
3	waiver 
1	(2) program
1	additive comes
2	delivery system;
2	fees specified
1	methamphetamine precursor
1	letter that
1	situations involving,
1	literature, or
1	established, under
2	exchangethe secretary
1	inspection related
1	appointed member
1	practitioner. (ii)
4	distinctly legible
1	devices, many
1	formerly 358,
2	(6) use
1	order postponing
1	warrants and
1	requests filed
1	administration) decreased
2	drugs described
1	athletic activities
1	question, the
1	plasma products
1	order; (iv)
1	open, lease,
4	primarily for
1	(l) laboratory
13	register the
1	(i) nutrient
5	administration with
1	fruits, and
1	community care
1	(i) security
1	criminal histories;
1	no-federal contribution
1	accomplishments, objective
1	surveys described
1	conservation, wildlife
1	food. such
1	bequests of
1	effective body
1	executive board.
1	secretarys strategic
1	subsection (c)(3)(d)
1	accomplishments; and
3	label bearing
2	onsite audit
2	comorbidities, pregnant
1	controversy or
2	(e) applicability
1	implementation, and
1	term restricted
1	delivered, the
65	employees of
3	particular manufacturer
1	organization deemed
1	stat. 1265;
2	inhabitant, or
1	humans, wildlife,
1	person discovers
1	executive boards
1	(2)(b)(i)(i) shall
1	analysis, and
1	
 467d.
3	public evidentiary
1	following, on
1	individual. (c)
2	reassessmentsthe secretary
2	lifesaving and
1	applicant be
1	previously cleared
1	(2001)); (f)
1	produce milk.
1	collaboration. 
1	resulting product
1	variance the
9	expanded access
31	fee established
1	form, delivery
2	exception in
1	5, 44
1	filed no
2	foods production
2	secretarys action;
3	may discontinue
21	state, and
2	commissioner concerning
1	transporting or
2	territory, to
10	appear on
4	produce a
1	enforceable in
1	10.35 of
1	affecting production.
1	years. nothing
2	penalty and
2	new evidence
1	comment in
4	utilizing a
2	division personnel
3	president determines
1	previous samples,
2	armed services
2	reagents, and
1	especially heroin
1	comment, submissions
30	scientific advisory
1	liability no
1	secretarys disapproval
2	due care.
2	(ii) meets
1	due care,
1	technology; and
1	care settings,
1	rescind any
4	210 days
1	duties described
1	transactions involving,
1	detection, or
14	annual basis
1	compounding. (2)
2	(c) establishment
1	advertising. (2)
1	sampling methodologies
1	samples only
2	final form;
1	sale such
2	relevant 
1	election pursuant
3	transportation, possession,
2	relevant data
1	generalto carry
3	references in
1	holders to
6	purported or
1	finished tobacco
1	to, unnecessary
1	substances the
1	broadly across
5	cartage, and
1	exported drugs
1	title, establish
1	section 348(h)(6)
1	code that
1	new request
61	generic drug
1	year 2000;
1	audit, submit,
1	adulterated tobacco
1	authorizedthe secretary
1	possible, that
1	equal or
2	agencies, as
15	ex officio
3	economic area.
1	(as specified
1	verified by
1	exists for
1	standardized illness
1	increasing participation
1	structure and
11	production and
2	shielding or
3	current scientific
1	319f2(c)(2)(a)(ii) of
7	affecting the
1	judgment as
1	675, 566,
2	(2) available
3	states pharmacopeia,
21	public availability
4	national association
2	sufficient evidence
2	secretary. (j)
1	percentage shares
5	drug fees
2	disclosure required
2	acts, subject
1	formulation for
1	treated by
1	(a), render
1	(i) whole
1	262(a)) with
1	section 897.3
1	pesticide for
1	attention and
1	estimates made
4	variations shall
1	(i) charitable
3	otherwise listed,
2	said subsection,
1	moieties or
1	therefor because
1	entities, and
1	rulemaking, that
7	seq.] or
2	(c)(2) (in
3	states), while
1	(g), including
1	675, 413,
1	put it
4	following publication
1	(d) modification
1	designation, including
1	subsection approving
1	transfer, the
1	signed agreements
2	constituted entity
1	finding, order,
1	reporting or
1	42 (including
2	potassium) or
1	(3) amendments
1	commodity, having
2	products. (2)
3	otherwise meets
1	sells or
1	supply will
1	harmfulness, if
2	sample for
1	single procedure.
1	(26 u.s.c.
7	period, and
1	(8) levomethorphan.
1	determinations are
13	reporting of
2	tribe involved.
1	submitted, labeled
3	local surveys
3	agriculture not
1	$500,000, or
3	contains substantial
8	approved abbreviated
1	
 1171.
40	june 22,
3	(i) registration
1	condition involving
1	u.s.c. 1396
2	subject the
1	will accept,
1	investigator, pharmacy,
1	paramedical personnel,
1	finds under
1	progress reports
7	chapter; (2)
1	act, make
1	candidates. (b)
1	cos-effective poultry
1	(b) congress
1	microbiological surrogate
1	topics, as
2	(60 fed.
3	section 360b(c)
1	appropriate representatives
1	(e) package
2	enters in
1	means that,
1	store shall
4	slaughter or
4	term poultry
1	systemnot later
1	activities, or
1	formerly 503b,
2	reuse payments),
9	slaughter of
1	referencing information
1	approvals per
1	practitioners authorized
2	agree on
3	term misbranded
1	determined through
2	agency developed
1	(e) crediting
1	rule: 
1	(i) closely
1	(l) public
2	occurring in
1	interdiction by
1	(iv) decontaminating
1	drug consumer
10	render the
1	mileage of
1	restricted eggs;
2	disclosure requirements
3	order, whichever
1	package description,
4	proceeding; or
2	drug, medicine,
1	liaison between
1	equivalent food
1	given in
1	risk. the
1	discovery made
2	(5). 
6	state licensing
1	manufacture, (iii)
1	(3) action
1	provide that,
1	consular and
1	(13) who
1	agent; except
4	licensed practitioner
1	interest, who
1	form any
3	transported under
2	(including records,
2	title approving
1	retaliation, or
2	fooda food
1	may demonstrate
1	representations to
1	title, other
2	282 of
1	single lot.
1	set apart
1	counsel, and
2	food advertising
5	circumstances: 
1	methamphetamines from
1	publishing of
1	notifying such
1	staff or
1	appropriate prominence
1	(except with
1	slaughterer does
2	patient labeling
1	5, code
1	support approval
1	reviewsif, based
1	awarded another
1	applications from
1	registrant, and
4	secretary requests
1	arise in
1	provisions (or
2	held within
11	restrictions on
1	exemptiona qualified
1	narrative descriptions
1	$20,000 of
4	days but
2	america is
1	trial 
1	including specimens
1	intelligence obtained
1	(2) assuring
1	(b) recovery
1	functioned as
6	states, including
1	rule, that
2	believed to
1	policies relating
2	product, appropriate
1	responsibilities in
24	activities under
1	surrogate endpoint.
1	wrapped meats
1	387h of
1	informing such
1	enforcement information
1	usesnotwithstanding paragraph
2	excluded under
1	forfeited, and
1	predominant number
2	meaning provided
1	appropriate postmarket
3	requirement does
1	also require,
2	manner contemplated
1	gifts and
1	agreements entered
1	formally given
21	secretary from
1	459, 460,
1	drug uses,
2	minimal risk
1	elderly. (13)
4	central intelligence,
4	effectuating the
1	deem proper,
1	products prior
2	deem proper.
1	(f) allowing
2	(2). if
1	2006, the
2	(g) 4.0
1	gifts any
16	conditions described
1	states thereunder
1	(e.g., almonds,
4	supplier, or
1	(c) ex
2	residues at
1	involved a
4	another entity.
1	enforcement, treatment,
1	refund any
58	treatment of
4	wholesale and
1	supplement; (4)
1	access. (ii)
1	qualified entities.
3	indicating a
1	(c) selection
1	religious or
3	pharmacist, to
1	regulation, harmonize
1	national emergency
2	diagnostic biologic
5	variance from
1	prescribing appropriate
1	term patient
1	country) and
1	dissemination 
1	cure, mitigate,
2	may conclude
1	requirements; (ii)
1	services designated
1	communicating health
2	products, not
1	burning material,
2	appeal may
1	submitting, or
1	off, or
2	description or
7	interstate commerce;
1	section 360eee1(e)
1	(c) funding
1	source and
1	regular staff
1	section 360d(b)(2)
1	described such[1]
1	accomplish lon-term
1	
 458.
2	referral, or
3	mitigation strategy.
1	unless sold
1	instruct such
17	officers, employees,
1	fee (referred
1	pool includes
4	may, if
1	export) to
1	practices; (5)
1	levels 
1	interested entities
1	device, (b)
1	amounts. (3)
1	compliance, annual
33	may, in
1	considered. the
1	include production
21	paragraph (4),
2	establishment, or,
1	(by established
2	organs and
2	label, poster,
1	(2)(b) is
2	activities funded
2	year, there
1	took action
2	(17) the
1	foreign cooperative,
1	food importation
1	availability, addiction
6	fees established
1	immediate containers;
4	subparagraph (b)(ii)
7	amended to
1	columbia authorized
10	contracts for
2	specific formulations
1	poison, chemical,
1	(5) exemptions
6	individual to
1	394. scientific
2	data available
3	medical gas.
2	medical gas,
1	orders promulgated
1	promote countermeasure
1	common laboratory
1	measure, that
1	applicable period
1	manufacturer agrees
1	hazardous to
1	healt-related conditions,
37	final sunscreen
1	
 71
3	food with
1	act, uses
1	(2) illnesses
1	ending dates),
1	factor be
1	meeting. (c)
3	including public
1	information, services,
1	strengthen their
2	hold should
1	new use
2	be, may,
1	device. no
2	regulation, and
9	subsection (a)(3)
1	input prior
1	time will
1	operate a
1	(1) opium
1	fire, or
7	title 18;
1	fewer approved
1	section 360c(a)(1)(b)
21	salt of
4	representatives from
1	means individuals
1	food adulterated.
5	direc-t-consumer television
1	clauses. (2)
4	primary prevention
1	salt, optical
1	salt or
3	title 18)
28	title 18.
1	resolution within
27	title 18,
2	falls below,
1	additional studies),
1	assessments prior
2	payment if
1	samples are
4	following classes
1	form through
1	sent. 
1	approved. (2)
2	2014. (c)
3	innovative products
1	certain for
3	subparagraph (1)
1	(2), initiate
1	secretary once
4	one fee
1	burdensome concepts
11	factor applicable
22	paid by
1	corporation owing
1	term catfish
1	country requires
1	issue proposed
1	exempt requirementsupon
1	protecting data
2	advertisement would
1	noticeat a
6	(a) after
1	reporting; verification
1	jurisdiction; (11)
14	brought under
1	360ii. program
1	directing the
1	section 360eee
13	dissemination of
3	15 milligrams
1	
 851.
1	utilizes susceptibility
1	1912 for
1	(o) definitionsfor
1	(d)review. 
1	offset ordinary
1	adequate or
4	upon being
1	drugs); (ii)
1	drugs have,
1	(i) coordination
8	purpose, and
1	breakthrough therapy.)
1	provision described
3	knowing or
1	u.s.c. 19011906).
1	substance entirely
2	basis following
2	rare in
2	360e(g) of
3	plants processing
3	(b) guidance
4	promulgating any
1	economic powers
1	cultural sensitivities
1	ultraviolet radiation.
1	whose salaries
1	responsibilitiesthe director
1	13, 1992),
2	phenylpropanolamine 
3	subsection (g);
3	world health
1	concerned from
2	title. (7)
1	age twent-one
5	conditions. 
1	leaf for
1	meats inclosed
2	sponsor, applicant,
4	regulation implementing
1	elect, in
1	assure consistent
1	subsections (a)(3)(b)(i)
2	information; (iv)
11	subsection (g),
4	relevant information
1	established tolerance;
1	statutes administered
4	oversight of
1	statutory obligations
2	year), the
1	privacy.the qualified
1	anaphylactic shock.
1	research) to
7	definitionsas used
1	staffthe staff
1	chemical; (3)
1	consignee, such
2	days, unless
3	amendments act
4	may review
1	scientific investigator,
2	appropriate form,
2	allows the
18	shall develop
1	plants in
1	section 1177
2	(v), and
14	containing the
3	product; (c)
1	type, the
1	objections has
1	cultivated in
1	2014; (b)
1	(2) submit
2	360bbb1 of
1	biologic processes,
1	exposed for
3	original or
3	established tolerances
3	commercial information.
2	restricted eggs,
1	advertisement), each
2	coordinator is
1	trial; (b)
11	issue guidance
1	analysis) that
1	due allowance
1	clearinghouse or
1	original of
2	recognized standards
1	financial information,
1	products, in
1	designating bulk
1	secretary, 1
1	storage therein,
1	dosage and
1	investigations; oaths;
1	(f)(5); (10)
4	business for
1	25. oleomargarine,
6	committee under
1	school board,
1	standards pursuant
1	interchange of
1	upon, the
5	differences in
1	pending proceedings,
1	appropriations, for
1	submitted, withdrawing
1	estate of
1	rico. (2)
4	afforded access
1	approval because
1	operational activities.
2	application approved,
3	knowledge, or
1	importer. at
8	aggregate exposure
1	u.s.c. 300f(4)))
5	generate the
1	involving or
46	evaluate the
1	leukocytes or
1	term variant
1	8, formerly
1	only; nor,
1	code to
1	22. (2)
2	substance abuse;
1	(e) are
1	received, no
1	appropriate mechanisms,
1	infectious diseases
1	egg inspection
1	container includes
6	factors: 
3	records related
3	second year
1	diet. (2)
1	applicant were
1	amounts provided
1	approved biosimilar
2	comment, finding
1	guidance about
2	chemical, knowing,
1	dismiss may
1	gases (as
1	event reported
1	beings and
1	15 percent
1	criminal enterprise,
1	food reports
11	public may
1	submitting portions
1	association, and
1	provision (including
1	applications. (ii)
23	pertaining to
1	supplement provides
1	justice, or
6	patent for
74	inspection of
1	science relating
2	insignificant for
1	otherwise derived,
5	expressed under
5	without substantial
1	(5) which
1	classes: 
1	organization, pursuant
1	time. if
1	standard can
1	aforesaid sections
1	15th par.,
1	gases (a)
1	persons exemptsubsection
4	42, and
1	fulfill a
1	food during
1	part, temporarily
3	term cigarette
4	thereto or
3	received approval
3	threats of
1	defendant, up
2	dispenser in
3	knowing, or
2	additional credentialing
3	misbranded when
3	inches, if
1	harvested. 
2	thereto of
1	20. apples
1	42, any
1	considered unfit
2	agriculture pursuant
1	smallest container
1	application only
11	substance under
3	registrant pursuant
2	good cause,
1	identified number
1	event regarding
1	2006 may
1	threat will
5	senate; (c)
1	filing application
1	inspections, including
5	designate one
1	degrees fahrenheit.
4	official), as
2	degrees fahrenheit,
2	dietary exposures
1	360b(c)(2) of
1	379d3. streamlined
3	reasonable attorneys
2	proceedings, minor
1	take back
3	illicit production
1	term filled
1	influence an
1	product lines;
1	also comply
1	(ii) saleable
1	
 209.
3	indicate the
1	receiving written
1	675, 506c,
1	additional requirementsa
1	section their
1	commerce accompanied
1	term expiration
1	medical training
8	imposed on
2	agree within
1	agency which
1	providing agricultural
1	establish shor-range
1	gram of
1	applicant, consider
1	dietary exposure.
1	include wrapped
8	drugs, the
1	reverts to
1	therefor, with
1	new molecular
2	3551(b) of
1	(f) statement
15	section 355(j)
1	675, 743,
1	unauthorized obligation
1	implant directly
1	incompatible or
2	implement such
1	written assurances
1	particularity in
1	form is
1	develop validated
11	unless he
1	greatest risk
1	list. 
1	appropriately licensed
1	is, at
1	relief may
1	additives, in
1	approach provided
2	 (t)
15	otherwise than
1	longer meets
2	new abbreviated
1	advertisement, except
1	nominating entities
1	level, up
4	sale or,
1	advertisements projected
5	may remove
1	package defined
1	therewith, are
1	imported, at
1	current basis,
13	may only
6	method for
1	satisfactorily accomplish
1	transferable, except
1	(3) codes
1	expenses not
1	without (1)
1	anaphylaxis may
1	area under
1	personsin carrying
1	adequate results
1	foregoing specifications
1	(c): 
1	blood, feathers,
2	ethnically diverse
2	models and
1	shall discuss
1	payments involve
1	(c)(3). (f)
3	dispense such
1	developing regulations
1	defects in
1	reason, he
1	will otherwise
1	government owned
2	shall prepare,
1	(i) means
1	(iv) notwithstanding
1	exercises at
1	(iv) are
1	plans not
4	disposal by
3	(8) a
1	issuance, to
1	organization providing
9	(ii) which
1	spent during
2	feasible, inconsistency
1	list its
4	-pheny--[-(-phenylethyl--piperidinyl] propanamide;
4	apply sanctions
2	modified. (f)
1	ongoing recall
1	marihuana as
1	sustaining or
1	risk because
5	studies, the
1	drug), with
8	narcotics traffickers
1	control any
2	hire a
1	material compositions,
17	control and
16	shall approve
9	advanced therapy
1	composition may
2	reserve fees
1	optimizing global
13	(a). the
2	noncompliance with
1	4145341787 (august
1	effective; (c)
1	requests have
1	360ccc, and
1	certain drugs,
1	hazards to
4	conducted and
1	views upon
2	strictly for
1	subchapter upon
1	found: (a)
3	included, or
1	possible action
1	process class
6	thereafter as
10	hearing and
1	biennially. 
1	highes-risk biological,
1	feed was
1	subsection (b)(1)(e)
1	ingredients; adequate
1	negative. 
1	initial plan
1	children. notwithstanding
1	territory when
1	registrants; statements;
1	applicant, based
2	condemnation proceeding
5	surveillance systems
1	prevention under
2	adverse event;
2	section; (3)
1	source. 
1	prescribe are
3	may, to
1	private laboratories
1	ris-based evidence,
1	(4) before
2	event means
2	adverse event.
1	designated place
2	subsection (d)(1),
1	intentionally provide
2	state agency.
50	(a) to
1	accountability office.
1	(1) evidence
1	(2) alter
1	either to
1	19011906) until
1	(12) who
1	area task
4	statute of
3	section 360j(l)
6	false statements
1	2012, an
11	achieve the
7	(b) management
6	records inspection
6	representative for
1	set at
1	statute or
1	(ii) list
1	previously approved,
1	2012, as
1	states, an
4	consigned to
1	bioequivalence review
1	(i) patients
5	inspection report
1	2004 through
1	opium may
1	(i) supporting
1	master files,
2	potential recipients
1	master files.
1	influence his
1	banned in
1	regulation (whether
2	whose premises
1	avoid apprehension,
1	
 822.
1	phenylpropanolamine was
8	adverse events
8	pending before
2	previous ten
1	people the
1	chapter exercise
1	675, 586e,
1	title; (5)
2	banned device.
1	(2)(a)(vii). the
1	(c) exceptionthe
1	permits a
1	eggs destined
1	health experts
1	apply who
1	made. (d)
10	inspected by
1	entities listed
1	marked in
3	regulations exempting
1	360h, or
1	leaves in
1	publication shall
1	recommendations therein,
6	pharmacological or
2	condemned carcass
1	paragraph. (d)
1	prompt assignment
1	6, 37
3	false statement,
1	owner as
9	(10) the
2	6, 38
2	considered terms
4	use are
1	guidances without
1	determinations. in
1	(e) that1
1	contained in,
1	contents; publication
2	(until otherwise
2	design, manufacture,
1	organizations working
2	budget of
1	filingany person
2	food, a
1	reassignment of
1	product disagrees
18	fewer than
8	armed services,
1	remove it,
1	registry data
2	positions at
1	stat. 1102;
1	(1) facilitating
1	deadlines. (b)
1	budget or
4	2009, a
1	hearing transcribed
1	(2)(a)(ii) shall
1	store notification
1	reprocessing; procedure
1	annual reporting
2	reasonable fee
1	summary was
1	may specify,
3	due datesuch
1	(7) nothing
1	another appropriate
2	safety problem;
4	indian tribes
1	useful, he
1	knowingly pack
2	effective operation.
1	(a) secretaries
1	shipment, receipt,
1	 niacin
1	government, agency
1	development tools;
1	conviction, not
1	refusal, including
2	written commitment
8	physician or
2	personnel activities;
1	abuse, use
2	carried on
2	potential risk
1	design for,
1	inhalants; or
10	label bears
1	units, or
1	china may
21	agreed upon
67	submit a
2	dismissal or
2	(ii), or
1	one avoirdupois
1	either waived
28	designation of
1	agreement establishing
9	further, that
3	tobacco smoke.
2	treating, packaging,
1	involved under
1	623. exemptions
4	awards the
2	designation or
2	(iii) all
3	dismissal of
2	substances, have
2	notification requirementif
8	387j of
16	process by
4	term national
1	tobacco smoke;
2	diagnosing, preventing,
31	taken under
1	(3) protect
1	importers make
1	mai-order distributors
1	quantities not
2	testing program
3	kills any
2	representative. 
2	compounded under
1	(c) notification
12	prohibited by
8	submitting a
2	integrity needed
12	general shall,
1	section 353(g)(5)(b)
1	means somatrem,
3	external data
19	fungicide, and
2	involved, on
30	equivalent to
1	individual patient.
3	manner to
55	person may
2	higher fees
1	exemption during
3	unapproved product,
2	exceed 
1	campaign strategy
1	moral character
1	stream, river,
2	601 of
6	subgroups of
2	chemical, including
11	carcasses of
30	device under
1	(a); (2)
3	labeling means
1	communit-based coalitions.
1	setting; and
1	(1) antibiotic
8	benefits costs
2	supplement, regardless
1	frequency as
6	apply until
8	animals other
1	milk means
1	1172. repealed.
9	otherwise identified
3	criminal justice
1	capacity during
3	cases arising
32	biomaterials supplier
1	chronic use,
1	residue as
6	consular districts
1	issued or,
3	labeling was
1	13-day review
6	continuation of
2	(ii) antibiotic
3	scientific judgment.
2	held not
3	contained the
1	1975. (2)
4	promotional materials
2	13, 2016;
1	becoming such
2	benefits associated
1	inspection laws.
1	(b) discoveryif
2	facilities for
1	will utilize
1	term reprocessed.
1	upon 
2	both. (3)
1	2002 (except
1	i, 2,
2	imports a
1	without common
1	part outside
1	article.[1] 
1	decline to
1	physiological condition
4	personnel who
1	novo basis.
2	(a) notificationif
1	national recall
4	premises where
5	finding under
1	action shall,
1	general determines,
2	dispensers, and
1	exercises described
1	379j52 of
4	agency hearing
4	notification by
1	areas. (m)
1	responsibilities related
5	opioid use
4	size or
1	via an
1	notification, suspension
1	(6) united
1	surrogate and
1	via at
1	commission, may
1	(e) saleable
1	exists under
1	harm 
1	parts are
2	particular accredited
1	review; (iv)
1	(5)[3] restrictionsthe
1	mark; (6)
1	823(f) or
1	international meat
2	cultivation, growing,
1	registrant may
6	agriculture may
1	chapter prohibits
1	1 (cb1
3	collections to
1	(g). (f)
1	attorneya united
4	announcing the
1	name, professional
2	clinical pharmacology
3	needs that
1	(3) build
1	acquisition, holding,
1	warrant relating
10	presentation of
1	children; (b)
1	otherwise) provided
1	new practices
10	provisions for
5	business each
1	show up
1	food includes
2	request such
2	license, or
1	inadequate 
14	benefits of
1	(10) labeling
3	finds will
1	1981. (

1	23 and
1	feed under
1	data. (june
2	otherwise comply
2	controls, including
2	user reports
3	(1) all
1	opium. (2)
1	international, border,
2	fully with
1	including developing
2	possess skill
1	(c) require,
1	$6,944,000 for
8	applicable, to
12	violates subsection
2	substance; (b)
1	suppliers used
2	address those
2	petition shall,
1	previously set
1	general, bears
2	(b)) subject
1	report promptly
3	operations conducted
1	poisons; book
1	activity occurs
2	detained until
1	confer upon
1	decisions regarding
1	security are
1	exercise jurisdiction
1	pharmacokinetic studies)
1	authorities and
1	675, 514,
1	further, by
1	regulatory decisions
1	correct those
1	states, samples
2	participation to
4	furnishing of
4	record under
1	(e) action
1	1902. purpose
1	constitute advisory
2	drugs, that
4	(f) rule
21	entry into
1	phenmetrazine and
1	states cooperate
1	(16) to
1	(c) feedback
1	filed; and
2	title, applicable
1	(a) random
1	cumulative amount,
2	proprietary name)
1	(iii) record
46	(1) if
4	form the
1	government from
6	animal or
27	account the
281	(1) in
1	securing recommendations
1	recognized scientific,
3	submission (including
2	facility: provided,
1	term firm
1	declared unconstitutional,
2	animal of
11	(1) it
23	(1) is
19	strength, quality,
1	ordinary business
1	marketed only
5	(c) limitations
1	1943, ch.
4	criminal prosecution
1	writing, editing,
3	deposited in
1	drug producta
2	negotiating purchases
2	distributor can
4	annual basis,
3	42. (e)
1	annual basis.
1	chemical obtained
1	direc-t-consumer advertising.
1	animal, unless
1	presidents intent
2	requested, the
2	grounds; immediate
1	675, 421,
1	sponsor at
1	administrative review
1	subsection (a)(1)(a).
2	participation was
3	quality regulation
6	significant difference
1	regulation revise
1	adulterated at
1	april 1,
1	adulterated as
3	issuance. 
1	1996, governing
1	regarding approval
1	
 384.
1	itself, shall
3	shall relate
2	become effective.
1	corporation. (c)
2	issued will
1	includes, or
1	on-half the
2	documents delivered
1	detrimental effect
4	antimicrobial drugs
1	exposure from
1	(b) strike
1	book, or
1	best practice
9	authority nothing
2	chemical does
1	american association
5	modify his
1	party claiming
1	informational and
1	final regulationthe
1	on-half inches,
1	public good
1	(c) 280
1	(iii) flunitrazepam;
1	activity. (5)
1	(c) $500,000
1	appropriate), the
1	machines for
1	transferred; (d)
1	nurses credentialing
1	subparagraphs (1)
1	(under standards
4	substantial risk
1	(9) administrative
1	fifty degrees
1	website, in
1	substance analogue.
1	1; or
1	national policy
7	rate in
1	706(2)(a) of
2	new scientific
1	characteristic of
7	due. 
1	expenses under
2	undertaking is
2	(5) at
2	average time
2	undertaking in
1	health, fails
1	person denies
1	(4) serve
1	recall audit
1	secretary set
1	sections and
1	harm with
2	person seeking
1	professional disciplinary
1	obtaining release
1	may perform
1	information submitted,
1	officials, as
2	thereof. (12)
1	patients, any
1	warehousemen no
1	based solely
1	five or
1	year any
1	products such
3	export shall
2	formal change
1	criteria standard,
1	additional fee
1	party shall,
1	objects and
1	(xii) other
4	date established
2	notification specified
1	(1) make
1	lessor of
3	manufactures the
1	compounded with,
3	section. (d)
1	(b) holiday
1	or, with
1	(i) plans
1	public inspection.
2	constituents), ingredients,
1	inspection, records,
1	device submits
1	practices, except
4	appropriate based
3	appropriate in
1	tank (within
1	morphin-like drugs.
1	382. exports
1	practitioners engaging
1	drug, because
2	control; and
1	information needed
1	inability to
1	reported pursuant
1	minerals. (2)
4	within 5
1	cavity of
1	without reference
2	within 6
6	within 1
4	start using
1	within 3
1	within 2
1	expeditious means
2	allows a
1	device, (8)
1	received $10
1	lines, knowing,
1	review; (c)
1	dispenser; (m)
3	use shall
3	terms small
5	upon making
1	program programs,[1]
1	herein imposed.
2	year 2008;
1	contracts (a)
1	processing standards
1	1265; june
3	longer be
5	shall apply:
4	gas is
1	(1) r-exportation
2	revoking any
1	(2) bears
1	sel-certification that
1	individual poses
3	title), such
1	ammonia across
2	consumed in
3	agent, or
2	wholesome condition.
1	limitationsthis section
1	convictionfor purposes
1	petition concurrently
1	authorized officer
1	incorporating each
1	drugs exclusively
1	initial approvalif
1	conditionsa drug
1	where, subject
1	trials leading
1	findings poultry
1	content a
1	manufacturer, then
1	otherwise using
4	regarding action
1	hearings instituted
1	distributors for
2	prohibit any
1	columbia. (feb.
1	children whose
6	section 379h(c)(4)
6	food, drugs,
54	within a
1	(ii) prosecutions
5	application refused
1	community in
1	5with regard
1	expiration is
1	otherwise discriminated
1	zinc, or
2	identical verified
1	analogs, if
2	class with
1	either initiate
2	pesticide use
1	person; (2)
2	otherwise deemed
1	package, or
1	vehicle), render
1	entity; (h)
1	government coordinating
4	amphetamine or
1	trainees. such
3	giving notice
2	sells tobacco
1	shall apply,
1	consider, at
1	average as
1	360ff1. targeted
1	importer qualified
1	
 2241.
1	1046; sept.
1	tobacco. (v)
1	provide pharmacy
1	hiv infections,
6	(b) each
1	thereunder, and
1	farms of
2	accessed, as
1	destruction, alteration,
1	item basis,
1	standard, provisions
1	(b) corporationsupon
6	may administer
1	security guard
1	export certification
1	duly constituted
1	farms or
1	partial waiverat
1	remain listed,
1	person employed,
2	director will
1	avoid imminent
6	period shall
1	duplicate for
2	adjacent to
172	specified in
5	studies) with
1	period, be
1	section 360e(d)(1)(b)
3	first application
1	preceding registration
2	representative data
1	supplemental to,
2	(2) reports
1	advertisements so
1	withdrawal under
3	$10,000 for
1	gives an
1	(c) prior
30	agriculture and
2	water systems
1	potential shortage
1	(a) opium,
4	means (a)
1	tests that
1	(a)(4)(c). (iii)
1	able and
1	(c) investigational
1	also have
2	(b) state
1	abuse threats
1	fat content
1	center; or
2	violations any
1	42; (7)
1	assessment a
1	narcotics traffickers,
4	officer in
1	proposed regulatory
1	title publicly
1	advise, consult
1	conditionsany extension
4	states with
3	office, the
3	section 355(k)(5)
3	sites and
3	(b) application,
3	(c) limited
6	except coca
1	benefit; or
1	technologies used
1	1194. repealed.
1	substances registration
2	status under
1	ai-driven pipes;
10	antibacterial or
2	chemical unless
1	penalty after
3	permit to
3	(for such
1	may inspect
1	957(b)(2) of
2	establishes, at
1	points, as
1	mixture created
1	(i). (iv)
1	zip or
1	solicit substantial
1	(f) violations
1	additional special
1	drug refers
1	evidence. (c)
3	circuit, within
1	nonfood products,
1	carcasses, sheepmeat,
1	effectiveness provides
1	section, (iii)
1	retention by
16	states district
1	premarket reviews
6	ingredient) that
1	transfer, withdrawal,
1	number; (b)
2	evaluations under
1	increase from
1	list; or
4	distributor described
4	federal government;
2	determined on
1	continued performance
1	610(b), and
11	functions of
1	food, provided
1	juice contained
1	fact; (d)
1	related requirements
1	safe manufacturing,
1	determined or
2	administrative medicine,
1	drugs, where
1	adjudicate the
2	(2) procedures
1	placement agencies;
1	262] that
2	manner not
6	federal government.
1	handlers specified
9	federal government,
2	premarket review.
1	release establishes
5	evidence submitted
1	warning and
1	assessment; (ii)
1	licenses, inspection
1	(1) (which
2	1, 52
3	federal meat
1	distribute, in
1	jurisdiction, a
2	manufacturer registered
2	generally in
1	(c) notify
1	notification) as
1	use within
1	(c) determinations
3	federation of
10	transfer the
1	use intended
2	occurs later,
3	supplement, and
1	safety informationthe
1	sections 342(a)(2)(b)
1	nin-month period,
1	party interests
1	initial classification.
18	section; or
1	distribution records
2	informed of
2	(a)(2)(b), the
1	(j) evaluation
1	displayed prominently
1	continuing abuse
5	342(a)(2)(b) of
3	group if
5	offense, the
1	statutory deadlines.
1	stat. 198;
1	sales the
1	initiative the
1	
 379d3a.
3	group is
2	atmospheric administration
1	conium, cannabis
1	(c) maintain
1	si-month exclusivity
2	955 of
10	intelligence of
1	benefit, and
1	force to
1	contains all
1	exports 
1	response teams
1	(2) serious
2	matters, chemistry,
1	item shall
1	(c)(3)(a). the
3	manufacturers the
3	order, unless
1	practice by
1	advisors as
1	lon-term effects
5	new clinical
1	site outside
1	chairman, or
1	execute seizure
1	infection in
3	program at
1	supplement will
1	962. second
1	program as
1	export; certificates
1	(h) separate
1	additives; exception
1	authorities necessary
1	(c). an
1	making under
1	factorsin establishing,
1	devise, or
1	u.s.c. 2012)),
1	may identify
1	dispenser, or
1	transport, distribute,
1	instructions, oral
1	399a. office
1	liability. (19)
1	if, or
2	establishments to
1	upon between
1	process solely
1	methodsthe secretary
1	basis currently
2	general, be
1	(f) procedures
11	scientific, or
1	348(h)(6) of
2	recall will
1	goals; termination
1	(a) adulterationan
4	contribution to
1	exceptionsif an
1	(a)(2). (e)
2	performing functions
5	if, on
2	resolutions that
3	maximum contaminant
2	protections offered
1	innovation act
1	675, 1010,
3	studies, except
1	healthful, wholesome,
1	effect. following
1	(3) inapplicability
1	services relative
2	(2)(c); 
22	serious or
6	heads of
1	sponsor (in
1	ensuring efficient
2	molar dose
3	drug price
1	seq.] should
2	expertise on
2	new, sel-supporting
1	applicant should
1	obtain review,
1	organizations, terrorist
1	binder or
3	qualifying other
2	safety 
1	drug, supplemental
1	establishments; rejection
1	entity unless
8	participation of
1	1707 of
1	program, paragraphs
2	(a)(2) shall
1	(a) maximizing
34	order shall
1	imprisonment. (8)
1	sharpened stakes,
6	funds shall
6	state for
3	animal to
3	passed in
1	communit-based prevention
1	food compound
2	reasonable likelihood
1	states faces
2	may inform
2	requirement regarding
1	partners possession
1	permit or,
1	registered (or
1	agency determinations
1	grade 18
1	orders made
3	(2) contentthe
1	product referred
1	reasonable relationship
1	investigations receiving
1	vessels, and
1	awards any
1	investment of
1	commercially. (5)
1	products pursuant
4	inspections for
2	implementation plan
1	requiring certificationthe
1	addiction; (v)
3	purchaser 
3	period (or
1	intrastate use
1	offense if,
1	exist; (b)
1	conditions (if
1	adulteration, including
9	(i) are
1	container. the
1	reserve on
1	signature using
1	 is
1	360j, 360ccc,
1	least a
1	drug because
1	device when
4	advertising is
1	substance claimed
3	condemned under
1	(1) supplement
1	tobacco; (ii)
1	formswith respect
6	(e) such
1	675, 524a,
1	subsection $30,000,000
1	drugs must
3	advertising in
2	listed pursuant
1	tobacco is
1	section 355(j)(5)(b)(iv)
4	fee by
4	(b) persons
2	imported drugs
1	advertising if
1	equipment (a)
1	(4) private
1	treatment) considers
6	360i of
1	title,[1] consist
1	promote and
4	supplement is
1	use, nor
1	writing and,
1	defend in
1	intentionally adulterates
1	notification networks
1	856. maintaining
1	telephone, or
1	section 379j(h)
3	society of
2	possession, and
24	least one
2	office use;
25	scientific evidence
1	360i or
1	applicant, meet
2	foods (a)
1	use countermeasures,
2	intentionally adulterated
1	part relied
1	anaphylaxis; (iv)
1	become final.
1	designs or
2	8301 et
1	identifier) to
6	10 grams
1	food satisfies
1	general auditing
1	hearing); (b)
2	determination if
5	excess shall
5	least 4
1	passengers as
1	section, shall,
1	implant; and
6	least 1
1	360e(b)(2)(b) of
5	least 3
8	first 5
1	first 4
1	exemption takes
5	determination is
2	cleared, or
1	authorities (a)
22	first 3
1	establish restrictions
1	avoided in
1	felony which
9	take reasonable
1	annual chartering
2	holder under
1	(m) include
5	filed within
17	regulation is
2	section 3(c)(2)(b)
4	substance should
3	regulation in
4	section, which
1	critical devices,
1	services. (b)
4	 if
1	market under
5	completing the
1	regulation if
1	(a) investigations
1	conduct surveys
3	(5) that
1	
 1036.
2	kit 
5	(f), and
1	product, other
1	(h) exemptions;
1	periodically and
1	reversed, and
3	intelligence or
1	review submission.
1	subjects as
2	status and
1	make, distribute,
2	limitations shall
1	implantthe term
43	district court
1	nitrogen, use
1	feed, such
1	freight container,
1	tag in
1	warrant (a)
4	inspections by
3	2 percent
1	critical information
1	grase if,
2	factor requirements
1	section; (e)
2	requirements. (2)
1	1486.)
 

6	(5) of
1	two officers
2	maple syrup,
4	assessment center
6	high priority
1	(ii) has,
1	adequate explanation
1	subsection (o)(3)
1	trends and
1	another subpopulation.
1	section 247d7e(e)(1)
2	drug prior
2	275 miles
1	2291j of
1	food where
1	diphenoxylate and
1	(2)(a). (e)
2	malfunctioned, caused
2	classified pursuant
2	section 642
1	red meat,
1	applications. (c)
1	testifies with
1	(6); or
2	agents thereof)
5	licensed, or
1	subpopulations, and
1	2002, funds
1	1998 and
4	verification request
1	generalon or
1	least sixty
1	iii, it
16	law of
1	services, or
1	injury results.
1	target requirement
1	prohibits disclosure
1	13, 2016).
2	may upon
2	13, 2016),
1	term fund
1	exclusion under
1	(6) maximum
1	(b) patient
1	agency engaged
1	subclauses, the
1	annual sales,
2	(h) annual
1	specific missions
1	percent today.
1	specific issues
1	coalition have
1	term transferee
1	request) under
1	emergency. (3)
1	clinical setting.
1	product. (ii)
1	pure dye
2	meet each
3	rates of
11	notification 
1	accident and
2	date but
39	administration and
1	subparagraph (g)
1	forfeiture any
1	states. (e)
2	auditor is
1	part irrespective
2	28. (5)
1	appeal or
1	period july
2	verified statement
1	studies, preclinical
1	documents. (c)
1	331(ll) of
1	term ginseng
2	related information,
1	outbreak, the
4	offense is
1	fever. (g)
6	which, as
1	
 874.
1	supplement filing
2	strength which
1	services donated
2	involving 5
1	explains 
1	nomenclature used
1	formula provides
1	destruction upon
1	mixture when
3	based; and
1	area, if
1	food slaughter
1	function appropriations
1	
 3431.
1	service; acceptance
1	production classes
4	section 841(b)(6)
2	threat agents
4	title. (f)
1	designate for
2	less. 
1	product advertising;
1	carbon monoxide
1	inspection records,
1	manufacturer adds
1	901, 52
1	compounding. (3)
20	involving a
1	packagers, or
1	form 
1	scientific publication
1	authorized fees
1	formerly 711,
1	(2), hold
4	387g, 387h,
1	nonenforcement of
1	(g), except
1	is; or
2	marihuana. 
1	proheptazine. (40)
1	issued. this
5	following requirements
1	members. the
5	manufacturer 
1	first processing
26	provide to
3	basis or,
1	misbranded; (4)
62	information required
5	device; (ii)
1	patient morbidity
3	(2), as
1	telemedicine; or
1	analyses to
1	(8) may
24	thereafter, the
2	materials under
1	human subject;
29	outsourcing facility
9	lot level
43	including a
1	managers or
4	establish procedures
1	persons involved
3	president may
1	(5) sustainabilitythe
1	secure manner
2	(2), an
1	without restricting
1	inspect plants
2	supplies. 
1	ensure transparent
1	sale, delivery
1	evidence supporting
1	substance during
1	prohibiting or
3	advances in
1	complain and
1	secretary permits
1	regulate, or
1	approval, to
1	30, 1998:
1	regularly review
2	reinspection and
2	manufacturing process,
2	refusing application;
1	time. (i)
7	dosage unit,
1	law. (i)
1	approval; relationship
1	services provides
1	applicable; (iv)
2	fund under
1	merits or
1	study, congress
2	enforcement, and
1	18. (i)
3	human subjects
1	clearinghouse there
36	limit the
1	42 with
1	furnish false
2	pharmacopoeia and
2	safe usethe
1	$100,000. (4)
1	requires hig-level
1	857. repealed.
132	 (

1	(a) awards
2	submissions. (d)
9	actions described
1	clinical laboratories
2	stat. 1054;
1	tampering; or
2	involving supply
1	distributor relating
1	372(a) of
1	states, not
1	(d) pos-hearing
2	without proper
1	directive 42,
1	(1) intelligence
1	original appointment.
7	distributing, or
1	states, order
2	biennial review
1	(4) planthe
1	possessions) while
1	5th par.,
1	2.5 milligrams
1	state involved
1	developed with
1	1997), or
8	show whether
1	requirement only
1	prior i-person
1	provide data
2	(i) reviewed
7	maintenance treatment
1	formerly 356,
1	appropriate publications
1	remit the
1	recipient, or
1	(15) psilocybin.
1	business, is
2	way is
1	distilled spirits,
1	regulations, among
1	sections 1918
1	juices, and
1	development toolthe
6	congress and
1	toxicology, pharmacology,
1	action enter
17	packing, or
1	concur in
1	article specified
2	539, formerly
1	(c) description
1	contact for
1	communication. (b)
3	(2) definitionsfor
5	(which shall
3	foods are
1	conducted after
1	formerly 20th
2	(2) steps
2	additional evidence.
3	margarine in
4	additional evidence,
1	year 2001;
1	carriage in
1	
 677.
1	agreement a
6	determine if
3	less harmful
3	margarine is
1	transverse diameter.
1	sold as
2	implement preventive
1	section 331(q)
1	(i) inadequate
2	omission or
1	impose additional
3	persons, including
4	carcasses, parts,
8	word, statement,
1	(after due
1	individual importations
1	public stakeholders
1	(d) feedback
9	(e), the
3	proceeds, if
1	substance analogues
2	(d) misbranding
1	nov. 2,
3	secretary, specifying
1	six members
2	any. the
1	privileged or
2	injunction proceedings,
1	emergency communication
3	sooner than
224	added 

1	security measures
1	network members
1	protection, on
1	providing timely
1	retain records
1	rejection of
1	distributor discontinues
2	stat. 818.)

1	356c(g)(1) of
2	waive any
1	(e) availability
1	offenses 
1	adulterated, need
1	setting for
1	reimburse any
1	(b)(1) shall
3	paragraph (1)(d)
2	supplements filed
1	device introduced
1	(f) suspension
1	(aa) an
1	organizations: _____________.
2	(ii) statutory
3	machine, or
2	second blank
5	services may
9	within 20
1	within 21
1	filing, except
2	sectors and
1	marking, labeling
1	13 percent
1	application that,
4	party shall
2	unless using
104	 (f)
1	(aa) at
2	claimant has
1	prepare for,
1	separate unit
4	drug approval
1	subsection (e)(9).
2	(a)(4) for
1	to, administer,
1	damage. 
1	(i) stay
1	chemical by
1	highways or
1	(d) criteriaa
2	disadvantaged areas.
1	registrations issued
10	(excluding the
1	original standard
1	least $7,000,000
1	(d) study
1	control efforts;
1	term drugfor
1	administration exercised
1	registrations be
1	barrels of
1	menthol) or
2	scientific matters
1	evaluating new
1	returns) shall
1	certainty whether
1	immediate action
1	perform appropriate
3	purposethe purpose
1	care services,
1	(a) manufacturers
1	warehouse includes
1	section 299b1
1	intermittently. (6)
1	maintain effective
1	stayed by
1	may pay
1	inspection unless
1	samples promptly
3	type described
1	paper and
7	notification, or
1	counterfeit any
15	application if
1	possessing controlled
1	(h) certification
1	funds, gifts,
1	production in
10	application in
2	reduced by
1	agriculture. 
1	individual possessing
1	(1). (iii)
1	statutory obligation
1	meetings (a)
1	without reapplication
93	application is
1	facilities discovered
1	(including those
1	(1) promote
1	director, be
1	noninferiority versus
2	term listed
7	identifier, including
175	compliance with
1	periodic risk
28	chapter, and
1	ingredients, excepting
1	states engaged
1	application, either
2	section 331(jj)
1	drug facilities
1	declaration, as
1	poultry means
1	requirement as
1	depend on
1	buildings, or
2	administration, to
1	project to
1	(f)(2) if
2	approved method
1	chromium, copper,
1	including functions
8	operating reserves
1	(12), (13),
2	chapter, any
1	judgment without
1	(m). 
1	processes saleable
1	water may
1	foods. foods
2	one kilogram
2	flock of
1	(4) safety
3	restrictions 
1	complaint. at
1	subsection respecting
1	uniform applications
3	reference product
1	repackaged drugs
1	part and,
1	dismiss without
1	information. (c)
1	effectiveness (a)
1	coding, cleansing,
8	shall expire
1	entity. (5)
1	regulatory audits
1	opium derivatives,
10	manufacture, packing,
1	integration center;
1	regulation, determine
1	operating reserve,
1	illegal uses
8	federal regulations,
6	title) that
3	federal regulations.
1	54; aug.
1	copying, and
16	territory of
1	(3) repackagefor
1	inspections, examinations,
1	chairperson (or
2	license application
1	35. 
1	subsections apply
1	narcotics trafficker,
4	food facility
1	consideration scientific
1	composition require
28	territory or
3	permitted. 
60	application was
3	notwithstanding a
2	drug, with
2	customary or
2	healt-related conditions
3	testify or
1	performance accountabilitythe
1	ongoing surveillance,
1	offense, punishable
1	index limited
4	class as
1	354, 360bbb3,
1	agencies engaged
1	assessments 
1	them. (mar.
2	interactions with
1	misled into
1	districts in
1	pharmacy, develop
1	facility and/or
2	publishes the
1	2009, with
1	(ix) if
2	media time
1	reveal, other
1	limit revocation
4	substances may
2	securing the
1	entitiesan eligible
1	assurances may
1	(4) refund
4	appeal be
1	statement prescribed
1	drug. (w)
2	patient registries,
1	(b), submit
1	represents actual
1	action. (g)
1	condition requiring
4	bodies recognized
1	pose the
21	use prescribed,
1	274 of
2	make arrests
8	identity or
1	section 1332(7)
4	application, prescribe
1	affected country.
1	detained article
2	general pharmaceutical,
2	orderin the
3	pediatric patients.
1	(d) containers
26	identity of
2	planting, cultivation,
1	additional selection.
1	whose shell
2	section); and
30	(3) 
1	fund, under
1	pharmacists licensed
1	nonpublic record
1	(2) limitationapproval
1	manufacturer. if,
1	356c(g)(2) of
1	economic availability
3	limitation or
1	equal treatment
1	675, 575,
1	administration gifts
1	audit preventative
1	(a)(4) and
3	1 i-person
20	limitation on
1	(f) drug
1	occurs the
2	controlled clinical
1	202).2 (d)
6	magistrate judge
2	limitation of
1	paragraph (or
1	title; (f)
1	expedited procedures
1	facility registration
1	1046. imports
1	shipment; 
2	(d) have
1	sporting or
2	penalty, any
3	final, he
5	 (11)
1	distribution system)
1	address engaged
1	occurred: 
1	triggering mechanisms,
1	allow an
1	whose registration
1	reports and,
3	knowledge, with
2	(e)(1), or
4	prior order
3	informative summary
4	approval to
1	(xiii) -penty--[(-methoxy-benzoyl]indole
1	1976; and
2	tolerance; and
1	cards used
1	(d) pee-reviewed
2	appropriate. (3)
1	milestones and
10	progress made
1	comment beginning
1	273, 6,
1	risks, of
1	prescribe; and
1	following as
1	mechanisms for
1	(b) on-year
1	distributors, pharmacies,
1	obtained, if
1	basis during
8	section 1604(d)
1	(a) exclusivities
1	costs means
2	following to
1	devices. in
3	subsection (j)(5)(f),
2	criteria with
3	funds used
1	isomers on
2	part. the
1	pharmacology, pharmacoeconomics,
1	may intervene
1	representatives; (c)
1	amount by
3	material that
1	grocery store,
1	legal or
1	grocery store.
1	cannabis indica,
1	business, except
6	lieu of,
2	meal or
1	advertisement includes,
11	final dosage
1	stakeholders (including
2	judgment absent
1	officials of
5	targeted drug
1	675, 805,
1	debarred person
8	official inspection
1	reviewed medical
1	risk assessments;
1	applies. this
1	(bb) signing
1	fees nothing
1	like import.
59	(d) the
1	379e, 387d,
1	(7) specifies
1	(a) foreign
6	360d, 360e,
1	(2) applies,
3	spices, flavoring,
1	cycle and
1	(i)) have
2	domestic populations
2	process. the
1	facility. the
1	(e.g., crab,
1	today. (c)
3	grocery stores
1	furnished on
1	(mg) 50.0e
1	target and
1	educational, or
1	(2) retain
2	receive referrals
1	upon each
5	additional data,
5	finality of
1	beings. nothing
1	residue meeting
1	$60,000,000 for
1	replacement imposed
1	expedited processing
3	(3) priority
1	supplied under
3	reasonably require
16	requested by
1	subsection (e)(1)(a)
1	clearance the
28	shall determine
1	512; 

7	(1) maintenance
1	surgical facility,
3	fees of
1	loan made,
1	standards are
1	ch. 784,
1	duties 
2	allowed expenses
2	countermeasure under
1	orders are
2	arriving in
1	propertyproperty subject
1	(a) plans
1	1996, limit
6	(1) consultationin
2	showing (a)
1	drug, on
1	(a)(2)(e), the
2	civil penalty.
1	promptly provide
3	drug, of
1	entity responsible
2	columbia; and
1	2017 only,
2	independent accounting
1	10 members
1	agency; (2)
1	consumption exemption
1	efficiently update
1	food laboratories,
2	committee). 
54	filing of
16	activities for
44	drug, or
1	subparagraph (1)(c)
2	information accurately
1	vender. (mar.
1	manufacturers c-licensed
1	section 360j(m)(6)(e)(ii)
1	affiliate refers
2	administrator is
1	(c) comply
1	certainty for
1	secretarys initiative
3	subclause (iii).
1	multisector plan
144	except that
1	using ingredients
2	directions or
1	topics being
2	administrator in
1	promote international
1	justification specific
7	food, including
3	origin, or
1	manufacturers based
1	countermeasures pursuant
12	262(k) of
15	months of
2	ethical standards,
1	run concurrently
1	approve antibacterial
2	tobacco leaf;
3	sale. such
1	months on
1	1 calendar
1	360i, 360bbb3,
1	member until
10	previously been
2	patient of
1	(a) special
2	inspection provisions
2	filled in
1	powersin carrying
1	31301 of
1	therapies manufacturers
1	doses; (ii)
1	filled if
1	whether students
1	address questions
1	sel-executing, and
1	device, whichever
1	49, and
1	fair, timely,
1	(2) more
2	disposition. 
1	diminish any
1	subsection (d)(1);
1	years. (mar.
4	postapproval clinical
1	823(a) of
3	expanding the
1	packaged foods
1	common school
1	including traveltime,
4	rule 
1	give a
1	(3) flexibility
2	title, (b)
3	pure and
1	registration required
1	subsections (b)(1)
1	356c1. annual
3	report by
2	facilitiesthe secretary
1	publish final
3	determine to
2	organizers, or
1	reduce duplication
3	entered a
1	also assign
1	condemned articles;
2	level established
1	produced as
4	foo-an-mouth disease
1	outlet from
2	remedy the
5	(ii) fiscal
1	break in
1	
 379k.
1	low to
2	designate to
2	object of
5	second country
1	feed, 
2	registration numbers,
1	patient assessments
1	countries or
1	general population
3	arrangements and
1	drug establishments)
1	personany person
1	drug establishments,
2	scale production
1	personnel; privacy
1	
 321c.
2	7, 1953,
1	markets affected
1	prerequisite to
1	advertising a
6	small packages
1	(i) amendment
1	functional performance
3	security, may
1	(a), upon
1	develop guidance
1	owns, resides,
3	subchapter for
4	shall examine
1	control data
1	source, including
1	named -(-methy--pyrrolidinyl)
1	360bbb8. consultation
2	original device
1	paragraph, be
1	developed. (v)
1	ceased supplying
1	altered its
10	fee setting
2	generalfor fiscal
4	interested party
1	health. any
1	supplements; and
1	chloramphenicol, bacitracin,
3	waiver, the
2	term unapproved
2	applicant initiates
5	conviction which
4	criteria and
1	usage, or
1	inspections (a)
1	product labels
1	establishment. (b)
1	section do
2	reinstatement the
1	countermeasures referred
1	including drug
3	public service
2	administration safety
14	may award
1	life may
4	alteration of
2	informationnotwithstanding any
2	frequency that
1	among young
1	pharmacological effect,
1	forms each
2	granting admission
1	lifetime associated
1	adopts such
3	reviewable. (2)
1	known, to
1	(3) fiscal
8	modification in
2	preclinical tests
1	director at
1	
 356c1.
1	award for
1	section 356c(f)
1	17 years
1	(i)in general.not
1	carriers engaged
2	355(j)(7) of
1	cigars and
1	reached. (4)
1	measure. (3)
1	criminal offense.
1	1976 (hereinafter
1	criminal offense,
1	application generated
2	request an
1	smoke. nothing
20	substance shall
1	332. injunction
1	372. examinations
1	given priority
1	report, required
1	309, 

1	certain commodities
1	prejudice the
2	to, such
1	assess civil
1	identifiable type
1	hundred thousand
1	transmit the
5	therapeutic category
21	portions of
48	paragraphs (1)
1	major sector
1	infer the
7	construction this
1	feasible, through
1	estimated completion
1	rules may
1	portions or
1	675, 744b,
2	require reporting
1	pharmacological effects
1	exemption, as
1	causing thereof
4	hearing pursuant
1	secretary (for
1	character, and
2	grant made
1	that, subject
1	made. no
3	instructions, licenses,
1	health. each
2	organized territory,
2	than, or
5	use; (b)
2	service. fees
1	misbranded, subsection
1	(7) regulatory
1	compendium. (g)
2	reveal the
1	facility, individual,
1	(a)(3)(b); and
1	possessors (a)
5	project or
2	quantity identified
1	additional remedies
3	effort to
1	505(b) or
2	auditor accredited
3	registrant, or
1	601.94 of
2	360fff(2)(a) of
1	face is
1	canada, such
5	suspended for
1	animals is
4	animals in
1	rue, and
3	2012, shall
1	body; (2)
1	regulations notwithstanding
1	one vessel,
1	902(b), (c),
1	
 375.
1	article. (q)
1	basis) by
1	marijuana smoke
1	(h) product
3	present an
2	order, requirement,
10	355(i) or
1	distributes drug
1	102, or
1	(ii)(i). (v)
3	prepare a
1	subsection (h)(2);
1	term modify
1	(a) preclinical
1	equivalent level
2	trial, the
3	compounded or
1	convention. if,
1	present as
1	definitions with
1	section 379j52
16	fees and
14	355(i) of
2	format; and
1	unauthorized reproduction
4	1237; 1953
1	aggregated on
1	accreditation, or
3	ultimate consumer,
1	sprinkled, or
2	previous sources
1	meeting required
17	title, as
2	title, at
2	application whenever
2	administrative penalty
1	providers on
1	necessary 
2	generally available
1	(d) voluntary
4	title, an
2	355(i)(2) of
1	national infrastructure
3	providers of
1	packaged, (2)
1	recipes for
13	unable to
6	extension under
2	secretary (including
1	categorization under
1	federal officer
1	(c) reductions
1	protein derived
1	administration should
2	43 of
1	permit discovery
1	returned); and
1	buyers to
2	domestic animals
2	property other
1	misbranded drug
1	(i) youth.
39	court may
3	effective immediately.
2	individual working
1	registrant, on
1	(19) the
4	recommendation. 
1	denied unless
1	refusal, request,
1	establish effectiveness,
3	(1) alter
2	agency, the
1	(c) shortage
2	patent means
1	application using
1	
 63.
8	national interdiction
1	(2) track
1	exception if
1	one, for
2	cantaloupes, citrus
1	data compensation
2	section 355(i)(2)
1	approving another
1	attempt, or
25	terms of
1	studies. the
1	344. emergency
5	may initiate
2	exemption pursuant
1	possession, information
4	1912, ch.
14	refusal of
1	particular retail
1	following legend
6	establishment; and
2	services, upon
1	resources, capabilities,
1	gas subject
4	establish regulatory
5	states a
1	deterioration, and
4	refusal or
2	imported poultry
1	finds, for
4	special scientific
1	193. repealed.
1	monitoring 2003
2	involving misbranded
1	(b) acetone.
1	foreign recipient.
1	substance. (6)
1	originating in
2	found. (2)
1	dispenser; except
11	including specific
1	year (as
1	subparagraph, issue
1	facilities producing
2	business unit.
1	accredited laboratories
1	fraudulent means
3	iii and
2	raw tobacco
2	$5,000,000 for
2	established program
1	secretary. review
1	applicable authorities;
4	safety modernization
3	sections 20
1	standing shall
1	first purchaser
1	etc., ingredients;
8	interstate commerce.
19	interstate commerce,
1	distribute. 
1	statement, word,
1	means: (1)
1	indication of
2	transportation, sale,
1	18-day supplement
2	title insofar
13	chairman of
1	tolerance limitations,
1	generate fee
1	propose electronic
4	formula, and
7	notification requirement
1	soil amendments,
1	(a) 60
1	provides links
3	indication or
1	convictions, described
1	scientific principles
2	30, 1890,
1	otherwise facilitate
1	regarding intelligence
1	(f) shall
2	additive, unless
1	sponsor, physician,
1	expenses 
1	secretary; (c)
4	use; or
1	(1) which,
1	year. resubmissions
1	rate payable
1	regulation, any
1	subchapter on
1	receipt unless
6	administration the
87	health service
2	control policy;
1	ethical issues
1	conviction, a
1	production, shipment,
1	party, as
1	subsection facilities
1	resides, or
1	u.s.c. 136a,
1	additional foods,
2	importation complies
1	additional foods.
1	regarding, with
3	atom of
1	$50,600,000 for
2	warehouses, and
1	illness; (e)
1	sector healt-related
1	recent quantity
2	advertising production
3	nonclinical and
3	1-day period
1	material; (6)
2	(b) recordkeeping
1	artificial intelligence;
1	additive, file
10	intentional adulteration
1	tobacco, additives,
14	sections of
1	use: smokeless
6	transmittal of
1	substance. and
3	subsection (d)(2)
1	paid. (3)
1	quarantine or
2	(3) whenever
2	invalid in
1	certain fees
4	eff. june
1	free with
2	subsection (i)),
5	file an
1	ranchers; or
1	determine, within
1	comment at
1	commitmentthe coalition
5	experience and
1	issues presented
1	recalls to
1	applied during
7	section 826
1	established appropriate
1	domestically available
1	federal workforce
2	operator requests
1	act (a)
6	tag, or
7	property was
1	contain, as
1	moisture. the
1	additive if
2	distribution, reception,
1	facilitate any
1	subparagraph which
1	division; (iv)
4	regulations adopted
8	additive in
12	section 823
3	applying for
1	
 888.
2	older people,
1	amended such
1	promptly act
1	affected persons;
2	defendant who
10	made publicly
10	additive is
1	internal quality
1	china, subject
1	(10) state,
1	262]. (2)
2	necessary regarding
2	policy 
1	hold. 
1	2009 under
2	different technological
1	clearinghouse. 
2	sensitive information
1	subsection (l)(5).
1	antimicrobial resistance)
1	receiving of
5	package form
1	section 829
1	515a, as
2	purchasing, or
5	judgment in
2	amend a
1	protest the
1	side effects;
3	receiving or
1	judgment if
2	treatment activities
1	(d) new
8	initiated under
1	(17) shall
1	violate section
1	submissionat the
7	place such
1	names or
1	considerations by
1	suspended. the
4	section 350d(b)
2	subsection whenever
1	1903. public
3	specific patient
1	carcasses condemned;
1	good faith.
10	records required
4	good faith,
2	reveal other
1	predictability, and
2	360e(d)(5) of
1	physicians, pharmacists,
26	(f) the
2	promulgates final
1	generalthe president
2	appropriate new
1	section 457(d)
1	supply; (2)
1	752, as
1	
 1703.
1	football, basketball,
2	substances is
2	development the
1	solutions; (p)
3	flow or
1	suits against
2	chemical synthesis:
3	(b)(2) which
16	request and
1	establishment, is
1	harm only
6	subsequent purchaser
1	(4) qualifying
1	petitioner which
2	inactive by
1	scientific experts,
27	drug safety
1	intelligence; and
1	subchapter, notice
1	consistent, to
1	
 379v.
11	identical to
2	actual need
3	eligibility criteria
1	requiring further
1	information management
1	section 360j(f)(1)
2	year 2008.
7	year 2008,
1	misbranding described
1	drugs solely,
1	clinical testing;
1	following action:
1	authorized, or
2	601(w)(2) of
1	(a) fostering
1	index. the
1	(d) late
1	conduct was
1	disapproving, or
2	counterfeiting of
6	information: 
1	notwithstanding paragraphs
6	cocaine, its
2	term critical
1	violent gang
3	outbreaks and
2	applicable, (cc)
1	(2) biomedical
3	potentiality for
1	labels of
1	1604(b)(2)(b) of
1	currently recommended
1	related substance,
2	thre-neck roun-bottom
1	353c. prereview
2	(b). if
1	842(b) of
1	term direc-t-consumer
4	board any
1	parties, and
2	applicants for
1	964. additional
1	relationship means
1	narcotic treatment
1	on-tenth cubic
2	requested is
1	granted accelerated
1	rulemaking 
1	federal efforts
3	manufacturing (such
1	360f, as
2	contractors, including
1	compiled, published,
7	contain 
8	record shall
1	
 381.
1	following distributions
14	enhance the
1	machines, all
1	certificates, a
1	general increase
1	(ii) due
6	(or supplement
5	become final
1	1995)). (2)
1	approved strategy
44	conducted by
1	withdrawn, the
1	regarding riskfor
1	derivative thereof.
7	owns a
1	every certificate
1	appoint from
4	preemption 
1	803.19 of
5	supplement if
1	encouragement and
4	dosage units
7	guaranty or
1	paragraph: (a)
3	facilities subject
2	(2) audit
1	dispenses, in
1	
 186,
1	acting without
2	efficiency of
1	emergency situation
1	perjury, that
1	30, 1982.
2	identifier may
12	drug treatment
1	severe form);
6	(iv) an
1	
 1179.
1	(c) do
1	regulation after
1	meet, in
3	(6), and
1	information using
1	proper concentration.
5	shall alter
3	chemicals owned
1	activities within
6	paragraphs (2)
2	instructional materials
1	targeted therapies,
1	contact within
1	(2) random
1	complaint from
1	1927 [21
1	connection therewith
1	sold. after
1	inventoryexcept as
1	israel, japan,
4	(iii) with
1	section 824(f)
3	product remains
8	introduced into
1	dosage unit.
2	recommendation, under
1	agents, in
1	regulate products
1	contain eggs
4	shortage. 
6	clinical benefit
1	dwelling pursuant
1	body. (c)
1	(iv), beginning
35	portion of
1	dual photon
2	aided or
6	shall prohibit
4	harm or
2	significant known
2	alleged interest
15	subsection (j)
10	amount established
1	side effects,
1	decisions and
4	(c) with
2	administration can
1	(d) success
1	term operating
2	iii is
1	iii in
1	identifier shall
12	comment period
2	precautions, or
2	diagnostics, biologics,
7	corporation whose
1	fee). 
1	(aa) 75
1	consider, but
3	inches in
4	1940 reorg.
1	writing, regarding
2	economic and
2	receive or
9	local drug
4	prioritize the
1	modes of
1	paragraph alters
2	(i) whether
1	progress regarding
2	establishments selected
1	(5) vessel
1	2007, productssubparagraph
1	anthranilic acid,
2	implement, certify,
1	datethe establishment
1	accounting procedures
1	(with or
1	dispute resolutions;
1	exist. (4)
3	(b) respecting
1	dependence products
1	title sections
1	phenylpropanolamine or
7	less the
6	reports submitted
1	evidence. (ii)
1	restricted section;
1	transmit timely
1	instruments, and
1	purchased for
3	thereto under
1	organization in
2	liberally construed
1	one manufacturing
1	prescribe. (e)
1	agency relating
2	supplant grant
1	term seller
1	exemption a
1	particularly underrepresented
1	countries into
1	section 360(k),
1	certificates, and
9	upon petition
3	civil penalty,
1	accompany each
2	(1) reflect
4	affixed to,
1	device, purchased
2	subsection continue
1	additives. 
1	states department
2	campaign; and
2	preclude, delay,
5	licensed and
1	gathered during
1	imposing additional
1	155, 8,
1	teachers, coaches,
2	inspection law
1	injunction as
2	imprisonment, in
1	consumption, be
1	importing an
1	221, title
6	control, the
3	affected food
1	practicable thereafter,
1	recruit and
1	pallet level,
4	(a), under
3	intelligence center
1	standardsnot later
3	user facilities
2	total dietary
1	cause be
3	sponsor not
1	response networkthe
1	native hawaiians
2	contraband and
2	meaning for
1	numbers that
13	article was
9	colored oleomargarine
1	period have
4	exports of
1	denied accreditation,
1	regulatory focus
1	potential signal
1	with, obstruction
6	(d) hold
1	(d) elderly
1	no-electronic format.
2	medications to
1	stat. 742;
2	831 of
1	part by
1	1961 of
1	products, which,
11	products; and
3	drug sponsors,
1	title beginning
1	953. exportation
1	whether he
1	
 814.
10	amount determined
1	section 6(b)
2	underrepresented, in
1	(v) private
1	control audits
4	(i) as
1	agency (referred
1	subparagraph, respecting
1	substances a
6	552(b) of
5	drug a
1	base or
1	conviction a
3	collecting, developing,
2	applicable list,
1	public after
4	applicant referred
1	sponsorship and
3	populations with
2	cartage, or
1	section 828
4	mariana islands,
3	substances it
1	(b) disseminating
1	appropriate, procedures
1	illness risk
1	level review
1	secretion of,
1	prescribed. 
2	term distributor
1	legal public
4	10 per
3	managing a
1	implant means
4	1, 1982,
2	offense for
5	1956, ch.
1	regarding current
1	initial funding
1	387 et
1	natural state,
1	feed, except
4	formerly 902(a),
1	operation of,
1	herbal ingredients
1	convening such
2	report information
1	undue burdens
1	adhered to,
1	writing, within
1	patient representative
1	preparedness; and
1	misleading. (e)
1	private sources
3	first purchasers
1	treat nicotine
1	regarding analyses
1	security, work
7	appropriation acts,
5	appropriation acts.
1	(or for
1	(2) construction
1	request. an
1	420, as
1	approved the
1	documentation (which
1	possessions. (d)
1	industry, agricultural
1	nongovernmental and
7	category of
1	v for
1	deadline to
1	means. (3)
1	forfeiture. (3)
3	term labeling
1	vacancy on
1	pasteurize means
2	(as so
1	(c) intended
4	expires (including
1	reserve, of
1	parts that
1	caused directly
24	transaction statement
1	679; june
2	ii; (7)
19	grant recipient
1	duplication, the
1	eliminating backlogs
1	contractor, or
1	350, 3,
1	262(a)]. such
1	303, 52
1	fruits, fresh
1	(x) date
5	thereof which
2	rehabilitation program
1	(d) administrative
1	distribution, receipt,
1	(i) available
1	yearly and
1	consultation 
3	prospective purchaser
2	clause (2)(a)
2	secretary its
2	basis under
1	conducts business;
2	insulin and
1	analytical methods.
3	columbia, the
1	specifics of
2	country applies
5	feed for
1	signature line
1	years 2006
3	person continues
1	sending letters
1	965. applicability
1	organized territory
1	identification devices
4	years 2008
3	adverse reactions
1	part. as
2	five days
1	witness or
1	probable cause,
2	secretary, has
1	oil derived
1	$2,000,000 in
1	5 [15
2	willing provider
1	catfish may
1	occur by
1	infected or
10	person sentenced
1	16, 1927,
1	article. (p)
1	appearance, type,
3	location or
5	device be
1	currently sel-certified
3	appropriate; (c)
7	tomography drugs
1	meet requirementsif
1	handled; and
1	9th par.,
1	(4) promote
10	location of
3	device by
2	proper authority
2	animal, taking
1	delegated and
9	new medical
1	submissions submitted,
1	chemical. (c)
1	is, with
5	processed in
1	modifications to,
1	path initiative.
1	finality and
1	completion took
2	request written
11	reference or
1	conducts business.
1	rubbed, poured,
2	practitioner and
2	22, 1996,
1	(ii) approved
1	proteins, and
10	expenses, including
1	(f), populated
1	technologies transferred,
1	ninety days,
1	mechanisms, by
1	necessary action
1	obligationa person
7	proceeding for
1	exemptions listed
1	delegation any
3	states relating
3	uses. 
1	device presents
1	employees; fellowships
2	beginning one
1	prohibit imports
1	duplicate thereof
1	facilities if
5	service, or
1	process; (e)
1	(1)(c); and
5	registered pursuant
6	facilities in
1	following phrases
1	storage, inventory,
1	diphenoxylate. (6)
6	registration has
1	efforts, including
1	(h) entertainment
1	tomography drug.
1	epinephrine and
2	authentication, and
1	juice, a
2	paragraph only
2	intermediate clinical
2	punishment otherwise
8	human food.
2	marked, labeled,
1	314, or
1	cause will
3	hardship; and
1	now included
1	personnel when
1	poultry, capable
2	-pheny--[-(-phenylethyl)--piperidinyl] propanamide
3	therewith, with
1	1120. omitted

5	export a
2	treaties or
1	nanomaterials included
3	warrant. if
2	years, except
1	subsection (b)(3)(a)
1	designation, in
1	without submission
1	(h) such
2	refund a
1	
 336.
1	determination of,
1	active ingredient;
1	without appropriate
17	action to
1	computer resources,
1	government witness
2	accept such
2	licensing authority,
16	active ingredient,
8	providing notice
2	(a)(iii) for
4	(3) final
1	returns under
2	accessibility of
6	computer resources;
1	(1)(a)(i), the
2	veterinary medicine
1	identifier, lot
1	december 2021,
2	employ more
1	smoking cessation
1	applicant therefor
6	specific chemical
3	(3) promotion
1	assign start
1	section 12
1	designated, upon
10	solely to
1	without disclosure
1	term pending
2	register 
1	(b)(1)), the
6	criminal enterprise
7	individual patient
1	secretary) required
1	years 2003
1	inspectional findings
4	individual from
1	(b) director
50	active ingredients
9	include information
2	outbreak associated
1	(c) supporting
2	(a) ensure
6	mark or
2	consider, with
1	carriers, except
1	each. to
1	revenu-neutral and
1	declaration (or
1	retrieval, hosting,
1	employment. (3)
1	detecting forged
3	acting pursuant
1	letters from
2	information, suggestions,
1	unsuspecting person
1	years 2004
1	data submission;
2	determines (after
35	behalf of
1	sector involvement
7	definedfor purposes
2	chemical products,
1	products. information
5	first foreign
1	carrying into
2	proceedings held
1	case necessary
2	placed upon
1	violations; exemption
9	device means
1	liable under
1	way are
1	poultry subject
17	pediatric advisory
1	years 2009
1	antimicrobial drugs.
1	petition; recordnot
5	penalties and
1	(22) -(-chlor-2,-dimethoxyphenyl)ethanamine
1	accessory, notwithstanding
2	personall-identifiable information
1	additional inspection
1	functions; or
2	manufacturing, distribution,
2	subchapter; (b)
1	controls, that
5	penalties any
1	acts set
4	contains reports
1	display such
5	fees charged,
10	(a) was
2	quantifiable goals
1	information could
1	chemical therein
2	publish, for
1	serious sid-effects
1	adequate controls
1	shipping of
9	request, the
3	shall, notwithstanding
1	compensatory damages
3	shall with
46	safety of
1	utilized efficiently
1	reporting programs
1	drugs because
1	effective technologies
2	49 stat.
3	neither the
1	section 387c,
70	person that
1	9 grams,
3	cohorts for
1	2006, report
1	term nonprofit
1	(1), extended
9	title, that
1	proceedings; finality
7	management and
1	completion 
2	chapter 43
1	314.550, 314.640,
2	542, formerly
1	approval that
1	360b. new
1	enacted. (d)
6	iii to
2	waiver to
3	agent; and
4	marihuana plants
6	provides notice
1	355(b) or
1	sales either
1	hearing respecting
1	private individuals.
1	(1)(b), (2),
3	mutations of
1	675, 712,
1	(as adjusted
1	
 811.
1	preparing for,
20	355(b) of
5	$2,000,000 if
1	product recipients,
1	establish under
1	(ascorbic acid)
1	u.s. city
2	(1) manufacture,
1	permanently stationed
1	describes shall
3	(b) availability
1	seeking agency
1	term regulatory
1	society conferences;
1	(f). such
1	360j(g)(5) of
1	circumstance (including
5	particular and
1	security, health,
18	writing and
1	person licensed,
3	condemnation proceedings
2	(b). (ii)
3	substance, such
1	explicitly or
1	officialsif feasible,
2	title establishing,
2	distribution, possession,
1	separate notice
1	establish prior
16	determination and
1	(of the
1	(a) reviews
1	insured or
1	unless revised
2	section 1105(a)
21	section 355(b)
3	substantive review
1	one pound
1	recognize, in
2	similar retail
3	health, such
1	countermeasures. if
3	(d) through
1	limited circumstances
6	placed thereon
1	(2) (referred
3	355(b)(2) of
6	sell at
2	revenue service.
1	supporting it.
1	(3)(b). not
1	(1) special
1	therefor permits
2	1-year period.
1	prohibition, or
3	industrial channels;
1	fined the
1	plan, conduct,
1	condemnation proceeding,
1	title it
1	assessment for
2	(2) written
1	amended application
1	complainant, shall
2	(prior to
2	potential members
1	information demonstrates
1	inspection effectiveness
3	accredited persons,
1	acts. (

1	offer, directly
1	barrel marked.
1	it; (2)
1	term biomarker
2	including increasing
1	3.3 
1	cotton root,
1	1997, shall
9	scientific, technical,
1	stating (i)
1	denies, in
1	license by
1	committee, other
2	2008, the
26	transaction history,
1	(4) withdrawal,
2	transaction history.
1	(ii) identify,
3	whose active
15	shall assess
17	drug described
1	2012, in
1	reduction initiatives,
2	potential illicit
11	drugs, including
1	significant endpoints,
7	(2) authority
2	2012, if
1	interest. (4)
1	commodity produced
1	suspension proceedings
1	(h) if
1	secretary; regarding
11	poultry producer
1	develop, support,
2	sole and
1	(1), entities
1	guidelines that
3	si-month period
3	360c(b) of
1	share responsibility
1	committees at
6	act (7
2	act (5
1	product discussion
1	set it
2	boned, cut
1	produced through
1	(b) qualified
7	data elements
1	therefore. 
2	system which
1	consolidation shall
1	transporting, shipping,
1	(2) timelinesthe
1	particular training
1	including injunctive
1	(h) nothing
1	promptly vacate
2	proposed changes
4	whose name
6	secretary concerning
1	complete records
1	measure whenever
1	monthly use
1	examining a
1	(6)(b) was
1	multiple facilities,
6	recognized accreditation
1	wholesale between
1	indian tribes.
1	assigned. 
2	involved or
1	suspension proceeding.
1	(b) advertisement
2	said manufacturer,
1	(including representation
2	certain psychotropic
3	civil procedure
1	given for
1	mistaken in
1	processing fund
1	(24) transaction
1	731, formerly
1	indian tribes;
97	shall have
6	goals, and
1	generalfailure to
1	marked as
1	reprocessed device
3	withdrawing the
2	order and,
1	develop such
2	applicant are
2	business tobacco
1	misbranded, (ii)
1	renewal for
4	15. 
1	minimum periods
1	scientist, with
1	occurs on
1	prominently identifies
1	iii devices,
1	case containing
1	inapplicable. (b)
1	distinct sponsors
1	section 387f(e),
1	schedule ii(a)(4).
1	providers. (s)
1	675, 538,
1	internet controlled
1	act. there
1	regulations), no
1	preventive activities.
1	term type
1	activities regulated
2	analysis by
43	review the
2	members a
3	complaint under
1	lon-term health
1	22, 1996.
1	(e) treatment
15	positions in
1	for, protect
6	shows that
13	annual biosimilar
1	iv, 402,
3	(iii) developing
2	handling required
8	secretary will
1	coalition seeking
1	section; except
1	producta drug
1	snuff. (iv)
6	charged with
2	penalty which
1	1986 [15
1	shall look
1	360aaa to
2	section 1524(a)
1	performance data
1	organizations, which
2	tobacco users;
1	imposing sentence
1	recordkeeping by
1	devices constitute
1	(i) include
1	(n)(1)(g). the
37	meat or
1	cigarette. unless
1	states; but
2	general reports
1	restrictions; bond;
2	(d) veterinary
1	prohibition during
1	international treaties
1	area, region,
2	subsistence) as
1	sentence the
1	promotional descriptive
1	(b) human
5	possess any
5	possess a
6	assistance under
1	demonstration purposes.
13	insofar as
2	substances; (2)
1	including economic
1	including being
6	section 2112
2	general suspends
1	subdivision shall
1	trials necessary
1	
 360fff2.
22	secretary makes
1	(a) cente-specific
18	time to
2	(pcp); (v)
1	(b) plants
1	(3), (6),
1	tests are
3	reduce such
1	regulations permitted
2	requirements have
24	release of
4	poultry that
2	consideration whether
3	(5) review
1	clause (3)
1	materials. 
2	fees, storage,
1	education programthe
3	consider whether
1	packaged poultry
3	rights, safety,
1	amendments, hygiene,
2	feels it
2	name, chemical
1	cover. 
2	effectively enforcing
2	significantly minimize
1	judge is
1	account. (ii)
2	(2) omitted
1	clause nor
1	appropriate jurisdiction
2	organizational, material,
3	debarment; certain
4	29, 2006,
1	document room
1	diagnose, cure,
2	penalties (a)
2	contain more
2	tobacco users,
1	submission, grant,
1	675, 745a,
35	 (aa)
2	qualification plan,
1	$109,000,000 for
1	product who
1	responsibilities, including
1	advisory committeeupon
3	reportable food.
1	patien-reported outcome.
2	importer and
1	descriptive materials
2	event; and
1	pharmacists) to
1	28 for
1	transparency 
1	(h) representation
1	species into
1	labelingto indicate
10	transmit to
1	adequately shown
1	sections referred
1	clean and
1	sold exclusively
1	coordinate foundation
1	labeling if,
54	results of
1	applicant.if all
2	sold directly
6	information, that
1	effectiveness why
2	restriction, or
1	monitor human
1	(including petitions,
1	(aa); (bbb)
1	(g) refund
1	letters of
4	withdraw accreditation
7	applicant for,
1	(b). (s)
1	matter included
1	paragraph (5)(b)
1	property; penalties;
2	committee participated
2	ethical business
7	apply: 
1	knowingly fails
3	secretary. (4)
2	primarily responsible
1	offender is
5	periodic consultation
2	issuing regulations
15	childhood education
2	product stage
1	trade secret,
2	recommendation was
1	marihuana cigarette,
1	issues identified
1	u.s.c. 1921
3	following activities:
1	posted and
2	physical tests
1	obligations, without
1	ranking of
4	substantive summary
1	distribution the
2	imported food.
3	21 months
1	involve information
1	fish and
1	379j41(3) of
2	treatment. (2)
5	strategy 
1	unexpired term
1	sel-incrimination, to
1	future, (e)
1	including pursuant
1	(7) following
1	staff members
24	take effect
1	general; no-disclosure;
2	solely in
1	regulated products
86	[42 u.s.c.
2	punishment by
122	consultation with
2	high risks
1	unless ordered
1	appropriate, approve
1	information available;
3	diverse geographical
1	first publishes
1	714a, as
1	health. (3)
1	(13) product
3	fiscal year),
2	changes, if
1	judicial or
1	imported foods
1	shall compare
1	section 360ccc1(h)
1	importer, respectively,
2	substantially to
23	meeting the
1	secretary supplemental
1	administrative discipline,
1	years, records
1	sale proceeds
1	provide continuing
3	specific strength
1	start act
1	determines necessary:
52	availability of
1	subsequent contamination
4	report, a
3	seq.], as
2	schools or
1	(6). (5)
2	seq.], an
1	(b) exceptionif,
1	designations shall
4	states internal
1	gao reportnot
1	617. clearance
1	waiver granted
1	determines necessary,
1	populations by
3	application, not
7	regulation 
3	required records,
1	applicable, with
1	successful public
1	telemedicine during
1	exist only
1	through, as
1	removal or
1	live or
5	will enforce
1	(9) who
1	reference shall
8	330.14 of
1	1927, the
2	cash and
31	one year
6	forms of
13	removal of
1	commissioner, an
1	prevention, and
1	welfare, social
9	(b) information
5	construction 
1	acceptable conspicuous
1	felony; (4)
3	sold: provided,
4	standard development
1	closely related
1	states marshals
2	offset of
2	jurisdiction between
1	preparations and
1	distinct offense.
1	initially, but
1	(iv) other
1	prevention; and
1	export transaction
1	(c) minimize
1	patterns with
1	patients, if
2	(2) consult
1	requirements while
3	iii shall
1	free to
1	valued at
1	form; modification;
1	petition; time
1	felony. (14)
1	(d) shortage
1	2013, to
1	(2) standardized
1	training techniques,
4	service. 
1	foo-contact surfaces
2	meals or
2	base; (iv)
2	determination, including
2	modifications made
4	30, 2012,
1	assistance at
1	if, within
1	(iii) following
1	devices; (3)
1	agriculture, food
1	pharmacythe secretary
8	drug meets
3	agency account
1	additives, to
1	4, 2011
3	following circumstances
1	rulesthe regulations
1	award costs
3	furnishing raw
1	growers, tobacco
3	listed chemical.
1	refused or
1	(2) exceptionif
1	(a)(1)(b) for
1	formerly 742,
8	proceedings shall
4	transaction to
1	$11,700,000; (3)
1	contentsthe regulations
1	evaluation or
4	imprinted by
3	legend or
1	134 to
1	standardized design
1	respectively, that
1	devices exported
1	independently of
1	operations thereof
57	evaluation of
1	depending on
1	dovers powder,
5	regulation that
2	provide in
1	(d) include
1	recombinant analogs,
1	(c) specificity
1	increments of
2	(1) program
2	misbranded solely
4	respectively, shall
1	safety hazard
2	identifier information
7	secretary which
1	markets, or
1	took ownership
1	prohibits lawful
1	term diversion
5	function or
1	holder, not
5	recipient and
2	determines may,
3	harm will
1	electronic support
1	directly exported
1	387h. notification
7	function of
1	establishment delays,
11	participating in
1	deficiency identified
1	existing communication
1	study (as
2	adjustment factorthe
2	america; (iii)
1	combination 
1	accomplishing and
1	outbreak. (c)
2	commissioner if
1	reduced fees
2	approved drugs,
1	(p) isosafrole.
6	authority granted
1	years if
4	health from
1	section. (vi)
22	years in
8	sponsored by
3	article, until
2	initial presentations
1	follow such
1	agency response
1	active ingredient.
9	enforcing the
1	government with
1	container size,
1	poultry. (

1	(iv) did
32	review under
1	(d) establishing
1	term smuggled
3	 such
1	(a)(1)(c)(i); or
2	farmer representatives,
2	request, notify
1	deferral 
1	vitamin, (ii)
1	requirements except
1	racemoramide. (42)
2	person) shall
1	2015 under
5	subparagraph for
1	testimony and
3	authorization, bears
2	best suited
1	impede, or
6	secretary, evaluated
1	dispensing, the
1	carrier whose
2	normally sterile
30	title 42.
1	360nn(b) of
2	drugs being
1	675, 302,
5	trial or
54	types of
2	procedures (as
1	individual concerning
1	675, 917,
1	(cc) a
2	mentoring coalition
2	energy source,
1	person requires
7	advance of
1	bear directly
1	pediatric contraindications,
1	remains licensed
2	lif-threatening food
3	section 49[1]
1	(e)(3), request
1	sold the
1	land and
12	person required
1	(3) members
2	advance or
6	first offense.
2	highest rate
4	longer necessary,
1	
 350d.
1	circumstances make
2	deselect the
2	reports nothing
6	care entities
27	food to
1	direct, and
3	(b)(4) of
1	basis. (8)
2	injection for
1	controls; (ii)
1	required level
1	available) of
3	sale after
1	thebacon. 
5	registration in
3	committee meeting
11	registration is
1	ii, 205,
3	destroyed, court
1	title, immediately
1	industry with
1	marijuana facilitates
1	subchapter. (9)
6	recommend to
2	limited resources
1	pests, or
1	section 331(q)(1)(c)
5	undertaken as
3	opinion that
7	entities and
2	reduction act),
5	proposal to
3	different regions
2	violation. the
1	purchaser; shall
1	thereby. 
1	deceased individual
1	misleading mark,
1	indian from
1	outreach for
1	substances possessed
1	biannual basis,
1	consult and
7	(b) unless
1	(iv) or
1	implementing programs
1	subchapter have
2	communit-based organizations,
1	recognize all,
1	specific requeststhe
2	making an
1	meeting statutory
1	ant-doping organizations
1	requiring, when
1	conducting joint
1	evaluating training
1	anaphylactic causative
3	calendar year.
1	problems identified
1	2007; and
2	decision with
1	generalthe list
8	calendar year;
2	consider, in
1	sel-executing requirements
3	application containing
1	made, or
2	chemicals under
1	recruitment activities
1	law; (e)
1	food, meat,
1	currently marketed
1	competent and
2	drugs manufactured,
2	regions an
1	2291j(b) of
2	subsection, such
1	either affirm,
1	claim to
1	malaria. (c)
13	(d), the
1	possible existence
4	distributed. 
1	existence and
1	plainly stated
1	points); and
15	3, 1915,
3	include recall
2	regulation from
7	notwithstanding subsection
1	keep in
2	transferred, or
1	(iii) exceptionthe
1	witness an
1	576, as
1	808, as
1	379aa(a)(2) of
1	(g) publication
1	certifications through
1	performing a
1	section 4(k)
14	notice or
3	devices. the
1	time on
22	studies and
2	compelling local
4	scientists and
69	time of
1	feesbeginning with
1	1800fda1088 (or
2	offense. except
1	local data.
2	describing actions
1	local data,
4	time or
1	new generic
1	representing, or
1	november 1.
1	(ii) determining
1	november 1,
1	reports any
1	month being
1	(c)(1), the
2	involves information
1	person seeks
1	misuse of
3	final audit
1	offering food
1	events, and
1	administration review
1	$2,575 
2	timely be
2	virtue of
1	(c) detailing
47	subsection. 
1	deficiencies need
1	administered enterally
1	paragraph, which
2	otherwise adulterated
1	shipped. (d)
1	typically found
1	trafficking areas.
3	make public
1	section 1616a
2	(a)(i) in
1	posting and
1	due by
1	surveillance to
1	use. (2)
3	place designated
1	1521 et
1	returned product.
4	drugs, categories
1	8811, 881a.
1	10, 2005,
3	feed to
11	listed chemicals
1	jointly regulated
1	treatment, diagnosis,
1	isomers. (h)
2	exceed five
2	work rules
1	induced or
1	products: provided,
1	cloth, plastic,
2	qualifying the
1	nominees to
2	387e, or
9	list described
2	(iii) was
57	defendant is
2	amending the
1	claimed indications
1	defendant in
1	legal burdens
1	
 354.
3	validating the
1	agency any
2	product tampering;
1	quantities distributed
4	exclusively to
1	(1), any
1	including formulas,
1	will insure
1	backgrounds. the
1	protects and
3	delaying the
1	certain microorganisms
1	establishment compliance
1	(22) the
1	exceeds its
2	41. 
1	applications by
1	coordination as
2	proviso to
1	body; (iii)
3	subsection, be
1	entry; (f)
1	whose results
4	part omitted
3	exemptions under
3	involved, including
1	groupthe secretary
1	(iii) academic
6	sentence imposing
1	has, before
4	generalon the
2	order would
1	particulate radiation,
1	production for
1	following persons,
1	acquired, such
1	eligible countries
1	written material
30	narcotic drugs
1	petitioner; or
1	distribution, any
1	(viii) information
3	definition as
9	anaphylaxis management
3	entitlement to
1	1522. purposesthe
2	isomer of
1	either paper
1	develop, conduct,
1	public communication
1	recovered at
3	program is
1	shall promote
1	condition, be
2	from, any
10	program in
1	varying sizes,
1	products. (iv)
1	aureus, vancomyci-resistant
4	tools to
1	funds expendedthe
1	fees on,
1	services, general
1	(d) law
2	trial that
9	arising under
1	importations, may
1	advertisement has
4	misdemeanor under
1	ch. 423,
3	subsection (a)(2);
1	safety program,
6	device exemption
1	institutes within
2	physically separate
3	subsection (a)(2).
9	subsection (a)(2),
11	proceedings for
1	pregnancy, high
1	675, 526,
1	dosages of
1	retail out
1	prevention, investigation,
1	proposals from
1	cabinet. (ii)
4	research by
1	(3); or
13	devices for
2	certification; and
2	no-alcohol food,
1	360b, 360ccc]
1	party. (b)
2	chapter; (e)
1	(2) deposit
1	account recommendations
1	unsafe color
1	drug permitted
1	(bbb) the
1	circumstance where
1	(xii) practical
5	submitted. 
5	shall publish,
1	(m) distributors
2	supplemental application,
2	regulation would
2	requirements, prescribed
2	endocrine effects;
2	(i), or
1	section 960(b)
1	secretary be
1	development in
1	america. 
2	creation and
1	individuals would
1	(2) devices
2	hearing; business
1	grams. (2)
1	failure is
2	(vii) in
1	(i), of
1	thereof, in
2	assign the
40	secretary by
1	cigarettes 
1	$11,300,000; (2)
1	international law
1	part applies
1	final, from
1	(c) due
2	identifies specifically,
1	(h) allow
2	sums owing
45	education, labor,
1	format in
1	state, federal,
2	causes or
1	food. (o)
1	calendar days;
1	(4) inapplicability
1	use do
1	upon publication,
1	domestic law
1	results for
1	industry, or
1	presented, or
3	will facilitate
6	studies for
1	biological systems.
1	demonstrate, to
6	calendar days,
4	subparagraph 
1	mental, or
1	relevant recommendations
2	stop or
1	anhydrous ammonia,
1	premises directly
1	substances enumerated
1	pursued and
3	(i) by
1	importer, exporter,
1	enforcement sensitive
1	rates, establish
1	process: provided,
1	public, industry,
20	 (9)
1	entered commerce.
1	kidnaps a
1	(a)(1)(c). (e)
1	pesticides whose
2	term care
3	exemption, reduction,
1	security shall
9	including small
2	percent more
2	loss in
1	label changes
1	appropriate professional
1	845b. transferred

4	term responsible
10	request from
4	information) relating
1	sale; (5)
4	data multiplied
1	party that
1	already registered
1	842. prohibited
1	(6) paragraph
1	immediate containers,
2	among federal
1	discontinued) of
2	device. (ii)
1	harmful, the
1	(1) instructions,
2	teens who
1	(d) notification
1	manufacturers receive
1	contain sufficient
6	voucher issued
2	statement, the
1	1913, shall
1	qualification packagethe
1	(part), as
1	hand picked,
1	reaccreditation under
1	feed, (ii)
1	untrue and
4	included within
1	among relevant
2	supply products
2	eggs, eggs
5	active postmarket
2	title, determines
1	products, diagnostic
3	2017. 
1	registration base
1	drying, or
1	emit) electronic
1	
 355e.
1	review voucher.
8	(iii) is
2	change shall
1	promulgate monitoring
14	product; or
1	6 months,
3	determines should
1	court. (2)
1	threatening, (b)
1	curtail the
1	available the
18	(iii) if
1	3(c)(5) of
2	sale, receipt,
3	fact: provided,
2	(i), a
1	(4) standards
1	fiscal control
1	law regulating
9	(iii) in
2	subsection shall,
1	purchaser provides
4	shall introduce
1	external expert,
1	previously provided
1	claim, civil
1	(2)(b). (b)
2	authorities at
1	underlying causes
43	product, the
1	regulation an
5	applying the
1	alternative organizational
2	evaluate, as
1	new approval
1	qualifying as
5	made such
2	successful program
2	include further
5	insufficient information
1	vegetables in
1	data. (d)
1	(b) trainingthe
1	products used
1	registration requirements.
1	isolates from
1	program approved
9	external experts
1	459. compliance
3	country has
3	sanction authorized
1	products during
1	except sections
2	gas. 
1	existing information)
9	indicating that
4	section 361(a)
1	spice not
1	practitioner 
1	denial described
1	request, (b)
2	equipment), and
1	compensation (a)
1	smuggling or
23	jurisdiction in
1	maximize, promote,
1	(d) consistent
2	exclude a
4	(a) persons
1	rulethe administrator
2	elements by
2	medication under
1	balances from
1	localities, and
1	strategies; and
1	limited confidentiality
2	allowed to
1	chemistry nomenclature
1	smuggling of
1	ii(a)(4), the
1	841(b)(1)(d) of
1	production costs.
3	summary required
2	(a)(2) for
2	technical capabilities
1	(4) alter
9	material facts,
2	28 grams
3	state requirements
4	fact joined
1	condemned poultry
1	(a) obligate
2	(c) disclosure
1	radiological hazards,
21	food, or
1	provider provides
1	application. (6)
1	
 394.
1	trade under
2	(1) notice
1	offense not
3	food, of
1	years) during
1	(d) confidentiality
1	person file
1	issue, amend,
1	discrimination; (ii)
2	assembled product
1	procedure applicable
4	advice on
2	behalf of,
1	advice or
1	(i) neither
1	days; or
1	(iii) who,
52	raw agricultural
1	675, 737,
1	database by
7	lysergic acid
1	(d) definitionin
1	(2) regulatory
1	material false,
1	(c) pollutes
1	hearing which
2	instances in
1	weeks or
1	objections. until
1	final) assessed
1	(as amended
1	wholesomeness in
1	area; (f)
6	establishment the
1	2017. (j)
1	physical lock
1	designated orphan
1	paid advisory
1	sections[3] 379aa
2	submitted. if
1	met. (ii)
3	burdens upon
1	drugs tested
1	produced, and
2	affiliates, and
1	ethics, science,
2	procedure 
1	investigator conducting
2	offense as
4	partners, as
1	abuse information
1	terminate; and
2	360e(c)(5) of
1	eggs, in
1	practice may
3	identifier to
1	video machines
6	furtherance of
1	387d or
1	(b)(3). 
3	possible, but
2	inspection personnel
1	animal illness;
1	section, when
1	childs physician
1	(cgmps) under
1	section 360(m)
1	(v). any
1	whose term
1	(d) acts
1	sterile or
1	adequately control
1	
 201.
2	plan developed
1	(a) responsible
2	(2) fiscal
1	package.the secretary
2	relisting under
1	report year
7	360e(c) of
1	secretary) for
6	management plans
1	laws that
2	commerce, are
1	directive issued
1	chemical was,
1	(5) fund
4	(b) reporting
1	areas such
1	testing for
1	nursing home,
1	medication by
24	processed, packed,
1	minorities. in
1	substances combined.
2	resistance to
2	agency may
1	restitution for
1	human cell
1	terms shall
1	product involved;
1	pediatric disease.
2	trials for
2	coalitions and
1	(4) biosimilar
1	receiptstransfers shall
2	term valid
1	(l) implementing
4	product applications.
1	anesthetic; (ee)
1	across from
4	investigation from
1	effect; (b)
1	(iii) actions
1	n-tobacc-sale order,
2	pending judicial
1	n-tobacc-sale order.
1	
 379j42.
1	specific methodology.
1	finalize such
1	comments thereto;
8	(3) to
1	arsenic, barium,
1	
 360fff6.
1	uses. (3)
1	modify it
1	canned vegetable,
1	fact, except
1	(a) raise
1	coordinating amateur
1	establish recordkeeping
5	(4) to
1	schistosomiasis. (o)
1	(8) intergovernmental
1	national is
1	(4) drugs
1	services, schedule
1	manufacturer receiving
1	distributes, holds,
1	intentionally and
1	(4) exceptions
6	food means
5	chapter, with
1	communicationin this
1	notice requesting
1	
 360aa.
1	modify, revoke,
1	products act
2	(1) requirements
1	might have
1	(2)(a). (w)
1	person, identify
2	1182(a)(3)(b) of
1	produce both
4	name the
4	evidence for
1	items or
1	$1,500,000 may
1	regulated components
5	conjunction with
4	criminal proceeding
2	review period
4	performed on
1	employee protections
5	believing that
1	ch. 26,
1	funded and
1	confirmed losses
1	establish standards
1	severe restrictions.
1	nicotine means
1	injury when
1	product involved)
1	samples also
1	powers 
2	(a) from
4	difference between
1	requirements. such
1	term knowingly
1	preservative, or
1	contentsthe reports
1	(3) if,
1	uncompensated services
8	control notice
1	stat. 1040;
5	cover the
2	groups that
1	reference the
10	reports, supplements,
2	claims, and
3	reviewing safety
1	(a) defendant
1	product thereof)
1	agencies; (e)
1	stat. 517.)

1	shall determine.
3	abuse reduction
1	management that
1	secretary, considered
8	producer or
1	
 360aaa
1	licensed individuals
1	representative designated
1	importer definedfor
1	(1) hazards
2	in, commerce
1	150 daysthe
1	otherwise) may
1	resolve scientific
2	perform testing
6	devices, tobacco
1	511a, as
1	shall publicly
1	handlers, and
1	statement, declaration,
2	forfeitures (a)
2	care providers;
1	exporter, the
1	noticean amended
2	contamination or
1	knownot later
4	care providers,
2	care providers.
19	sentence shall
2	therapies; (b)
2	support its
2	contamination of
1	establishment (unless
2	states amateur
1	360b(e)(2) of
1	provide links
1	management changes
1	stat. 250.)

1	1035. sanitary
2	reduced promptly
4	(f) no
2	time each
1	schedule pursuant
1	suspends the
4	product; (b)
3	suppliers, and
1	cream in,
1	labeling receptacles
1	vancomyci-resistant staphylococcus
1	violation, with
1	national, permanent
1	one prior
4	security countermeasure
1	section, place
3	(b) applicable
2	(b) required
2	information disclosed
1	(e); (4)
3	establishments at
1	facility did
1	noticed; (2)
1	effectively advance
1	abuse problems
1	element to
32	(2) any
3	demonstrating the
1	(1). thereafter,
3	legal and
2	(d) grounds
6	subchapters i
1	obliterate a
1	(f) partial
2	safety inspection
1	trade, offer
2	allowable previousl-paid
1	level the
2	broker, renderer,
1	developing of
2	changes beginning
1	(2), if
3	42), or
1	system, delivery
1	(b) expiration
2	contain evidence)
92	drug that
1	(7) desomorphine.
1	normal lawful
4	supplementary thereto.
2	adopt final
1	(b) secretarys
26	investigational device
1	declare the
7	will 
4	secretar-general of
1	unapproved therapies
3	section alters
1	opium, opiates,
1	paraphernalia; or
1	claimant if
4	revocation, or
1	sections 360fff2(b)
1	inspection, shall,
2	(iii) treat
1	387f(e)(1) of
1	$4,000,000 if
1	claimant is
1	prescriptio-drug television
1	exposes consumers
1	complete by
1	determination means
1	trial and
6	treaties, conventions,
3	export act
1	enhanced and
1	regulation take
1	(j) delayed,
4	agents of
1	foundation; (c)
1	severable. (

3	state at
1	(14) who
1	drug than
2	substitution of
2	completed using
2	detrimental to
7	posting on
6	order. (3)
3	bring an
5	posting of
1	documents, unless
1	geneva, july
1	ant-drug coalitions,
6	application an
1	venue provided
9	paragraph does
2	(g); or
2	demonstrating substantial
1	343(x) of
1	debarment periodthe
55	person, firm,
1	punishment may
1	manufacturers, wholesale
1	year 2014;
1	-methylpseudoephedrine. (u)
1	adequately managed.
4	strategy of
1	(1) amphetamine,
2	opioid means
2	commerce. (d)
5	amount the
1	19, formerly
1	condition shall
1	application at
14	application as
5	(1)(b), the
1	inspector, which
9	designation under
2	section 360c(e)(1)
1	section 343(r)(6)
2	identify recipients
1	websites of
1	foreseeable hazards
6	data relating
1	states owning
1	secretary having
1	agencys best
5	order, and
1	prescriber either
2	order, any
2	(d) civil
1	matches of
1	general ordering
1	compound in
9	verify the
3	jurisdiction, powers,
3	(b) condemnation
1	record before
1	last testing
1	contentseach report
1	28, except
1	units or
1	committee review
4	drug; (d)
1	safet-related activities
1	egg packers
1	compensated at
5	units of
2	poultry products.
1	renewable by
1	traffic. (7)
1	trafficking 
4	actions under
1	subject, in
1	section[3] 350c
1	support between
12	food has
9	poultry products,
2	final results
13	liable to
1	hormone for
1	recordkeeping (a)
2	coalition 
1	shall attempt
1	packed according
1	summary means
4	hig-risk facilities
1	greater level
10	suspect product,
1	(2ct2). (25)
4	term rare
10	subchapter iii
1	(not to
12	milligrams of
5	paragraph (7)
1	suspect product;
1	treatment described
2	march 30,
1	laboratory standardsthe
3	administration may
1	production exception
1	2016, publish
1	whether debarment
2	consumers about
3	(c), information
3	deferral or
1	registrationsif the
1	technology infrastructure
3	section 830(e)(1)(b)(v)
2	i. (

1	inspections consistent
44	(b) or
1	(b) meets
1	accounting system
1	1604 of
1	cigarettes under
2	annual appropriations
1	activities describedthe
1	mark the
1	384c. inspection
4	approval, certification,
6	new tobacco
1	no-prescription drugs
6	subchapter ii;
1	(8) refuse
1	marketed subsequent
2	management, and
1	(3) receive
1	(a) misdemeanors;
1	demand. (c)
13	served by
15	(or other
11	subchapter ii,
1	practice under
9	subchapter ii.
2	constituting a
3	patent and
13	373, title
2	buy, or
1	1002(b) of
1	secretary) the
4	upon first
1	program benefits
1	reasonably safe
2	3 times
1	(ii) pediatric
1	mission; (9)
2	loan, or
1	safety defined
1	(a)(2)(a) may
2	applicants firm
2	among members
1	formation and
1	provisions notwithstanding
1	pasteurized cream
2	seller, as
1	volume derived
2	said carcasses
1	previously convicted
1	physical dependence.
1	sentence, primary
1	standards. (4)
2	360, 360d,
1	imports including
2	selected establishment.
1	dies, resigns,
1	proposed under
2	subclause from
2	response, the
3	expenses shall
2	appurtenant thereto)
1	chapter would
1	and[4] 
1	supplant pro
1	title.[1] (b)
1	(f); (2)
3	(d) activities
1	guidelines. (f)
1	gs15 of
1	detection; 
1	possesses, a
1	delayed submission
1	30, 2008,
1	(i) substantial
3	years, of
3	cream, or
2	enforcement any
1	vegetables. compliance
1	paragraph referred
1	objections. as
1	including chemicals,
1	retirement, welfare,
2	consumption. 
1	objections. at
1	food, underweight,
1	 (i)effectiveness
1	statistics for
4	value for
12	years, or
3	suspension and
1	v. such
8	requirement if
1	proposal. (ii)
1	period, qualify
1	warrants unique
5	included or
1	505, 52
1	program evaluation,
4	requirement in
1	jurisdiction. 
1	it. (4)
1	identify adverse
20	hearing to
7	requirement is
4	food described
11	included on
1	hold animal
1	date, any
2	(b)(2) to
1	18; (b)
1	interest) in
2	court 
6	annual reports
3	specifications as
5	hold discussions
4	agencies. 
1	(4) advertisingthe
1	bird, whether
2	reassessment of
7	afford the
1	(iii) discloses
1	(f) not
1	functions; general
1	based, insure
2	product. in
1	distinguished by
2	scientific methods
1	paraphernalia destroyed
3	rates from
6	(e) effect
1	collected, whichever
3	practices of
1	360eee. definitionsin
1	days is
1	poppy means
7	columbia, or
1	experience, and
1	treasury may,
2	fee. the
2	practices or
1	term dietary
5	retain a
7	(4) effect
1	disclose confidential
1	(4)[2] congressional
1	development; and
6	reasons why
10	secretary after
1	119, 70
1	identifier, of
1	(ii): 
3	inspection observations
1	(m) through
24	expected to
1	(d)(1), a
12	et seq.);
1	initiation, conduct,
5	mandatory minimum
1	identifier, or
1	675, 903,
2	promptness in
8	et seq.).
2	appointment or
11	et seq.),
5	(ii) no
1	compound regularly
1	1986. (7)
1	affect food
2	reinspection of
1	generalproperty taken
1	10, 2005;
19	(3) if
2	(e) authorization
1	prior transaction
1	610. prohibited
1	auditor no
1	device set
1	containing more
3	specifying with
1	exception from
3	clinical or
2	requirement, is
1	prescribe, except
3	markets for
1	(3) it
1	wholesalers who
56	web site
1	(f) availability
1	industry, industry
1	343(b), 343(c),
6	considered: 
1	prompt investigation
3	health; (b)
1	1117. repealed.
6	agriculture, nutrition,
1	356c. discontinuance
1	organizations; 
6	geometric isomers,
5	summarize any
2	exercises the
1	262(a)]; (c)
1	chapter, irrespective
1	secretary copies
1	42; (e)
1	(1) contentnot
1	drugs, be
1	administration have
1	both. (d)
1	(b)(1)(b) for
2	requirement (a)
3	term capable
1	protocol), the
1	on-half inches
1	675, 906,
1	seq.]: provided,
1	(b) marketed
1	2017, $12,900,000;
13	trade secrets
1	person, acting
1	(b) regular
1	(5) effect
1	intelligence regarding
1	section 247d5
1	providing expert
1	shippers, carriers
1	associations, or
1	devices, immediate
1	delayed by
2	grant all
1	posting the
2	issued. upon
1	quantity; requirements
6	patient access
1	sale, as
2	may prescribe:
1	party except
2	criminally forfeited
10	columbia or
4	filled as
1	(b) small
1	pharmacis-i-charge, and
3	be, pertaining
1	apply (a)
1	preapproval trials;
1	regulation; publication
2	public record
1	conduct programs
1	prosecution is
1	(d)(4). 
1	funding will
1	(2)(c) shall
1	1 package
1	includes periodic
1	submitter having
2	previousl-paid carry
2	prescribe, including
1	505c, as
1	including paper
1	181 et
1	commitments; and
15	public or
1	attribution of
2	potential public
1	regulatory question,
11	public on
1	another person,
2	reimbursement to
2	trade secret.
1	(2) two
5	public of
1	provisions, amendments,
1	best interests
1	supply for
3	supplements. 
1	subsection (g)(4)(a);
12	report concerning
1	interested law
1	dispensed each
1	animals (a)
1	appeals has
1	recorded in
1	competition means
1	term characteristics
21	subdivision of
1	upon written
2	(a)(1) (relating
1	services develop
1	
 1501,
1	time entered
1	prescribing practitioner.
2	promptly be
3	denied, suspended,
1	verify means
3	otherwise affecting
6	show the
1	(a)(vii). the
2	or, after
1	investigations, which
2	2018. if
7	determination was
1	report may
1	(a) protects
1	operating at
1	4706 of
1	provides services
1	therein, regarding
2	subsection. (june
1	secretarys refusal
1	skill in
1	year, $712,000,000.
1	12-day period
1	congressional review
1	(h) publication;
2	includes programs
1	includes drugs
1	reduces risk
2	imports devices
2	requirement applicable
1	treasury, as
3	owners of
1	written reports
2	live cattle
2	slaughtering any
1	department for
2	protocols established
1	owners or
1	injury means
1	clearance and
2	subparagraph (i)
1	status neither
1	(e) assistance
1	bioavailability means
1	otherwise contaminated
1	(3), no
1	repeal; referral
1	ch. 221,
1	variances a
1	destroyed domestically
4	fairly and
3	container shall,
1	material in
1	expended; (d)
1	1037 when
1	examinations conducted
1	(8) transfer
1	february 19,
1	administrator proposing
1	administration and,
1	prohibited it
1	(1) requiring
1	manufacturing facilities
2	(f) revocation
1	disposal model
1	reanalysis of
1	2002. (ii)
1	applicable rare
1	global development
1	brief summary
1	term without
1	state fees.
2	section 830(b)(3)
2	(subject to
1	transaction for
1	order, which
1	(including aggregate
1	license be
6	sponsor submits
2	health. such
4	penalty has
1	issues. 
3	products containing
1	develops -year
1	(6) notwithstanding
1	dispute resolution;
1	one for
1	variety which
2	funding to
2	meeting all
1	generalto be
1	(b) limit
3	using amounts
1	agent, employee,
1	(n) scientific
1	12 months.
2	application) that
1	dispute resolution,
1	benefits relating
1	certification, but
1	mutton the
1	2005 and
3	assessment described
1	providing professional
2	state, including
1	numerical count,
1	therefor in
2	(2) when
1	plant for
12	clause (iv)
1	(b)(1); (2)
1	(2) adjustment
4	numerical count:
1	release unless
1	areas, among
1	include, in
3	(e) public
1	practice; (b)
4	trade bureau
1	amounts fees
3	labeling changes)
1	labeling changes.
2	labeling changes,
15	preventive controls
1	venue; process
3	risks. 
1	(f)(i). notwithstanding
1	criminal fine
2	(b) standard
1	verifies the
1	identified drug
2	methamphetamine. 
2	paragraph, issue
1	 (s)
1	requirements. the
2	sales or
1	logbook maintained
2	607 of
1	abate the
1	use can
1	emergency resuscitation,
1	384. importation
1	procedures (or,
14	sales of
1	coordination; task
1	(a) feedback
1	order no.
23	parts or
5	interstate and
2	regulations); and
1	appoint, employ,
1	particular category
1	batch in
1	year, less
1	chapter. (gg)
4	declare a
1	device recalls
8	distribution for
1	unrevoked written
1	including pilot
26	parts of
2	animals as
3	(a), based
2	disclosures 
149	issued under
1	rejected under
1	oil other
1	identifies specifically
1	personnel. (6)
3	capture the
11	otherwise applicable
4	business, shall
2	sampling or
1	(j) public
1	strengthen seafood
5	opinion during
1	update pursuant
2	patent (including
1	destroyed; (vii)
1	phenylpropanolamine, as
2	shall, whenever
22	congressional committees
1	traveltime, at
1	phenylpropanolamine, at
3	years, multiplied
1	regular tobacco
1	higher education,
2	brokers, wholesalers
2	fine imposed
2	laboratory networks,
1	(a) subparagraph
1	without release
1	crime involving
1	(j) does
1	requiring testimony
4	(c) through
1	including why
3	involved may
6	removed, as
1	representatives, that
1	organization (including
1	center the
1	(and subject
1	providers; and
1	know that
9	present in
1	biotechnology industries.
3	inspector, chief
1	subsection, unless
8	paper or
1	
 501
2	raised on
13	general under
2	limited physical
2	medical emergency
2	rights and
1	president whether
2	transition carried
4	application, report,
1	marketing, and
17	courts of
2	extraterritorial jurisdiction
1	(ii) provision
1	communication under
1	prior finding
1	elementary schools;
13	composed of
1	hearing as
1	government agency;
1	(d); (3)
1	labeling; (iii)
1	including neurological
3	1606 of
1	$250,000 or
1	transferable for
1	personnel, services,
1	drugs provides
1	section 379d3
1	507, as
1	violative prescription
8	admission that
1	exempted or
5	manufacture, or
2	resolve complaints
1	subparagraph (g)).
1	360a2. susceptibility
1	assurance. for
1	restriction is
2	patient package
1	transfers a
1	(a)(1); and
1	quantity being
1	timetable; periodic
6	review shall
4	drug not
1	disclosures regarding
1	require. such
1	purchased outside
2	farm; and
1	(a) monitor
1	product. (mar.
1	(iii) finding
1	adequately compensate
3	registered by
2	(c)(1)(a)(i) for
1	enforcement in
13	subsection (b)(3)
5	shall display
1	shall prohibit,
1	choose. 
2	drug pollution
1	(b)(2)(a) during
1	investigate any
1	dioxide that
2	inspections performed
1	hearing requested
2	commissioner shall,
1	acid diethylamide.
1	charge, or
1	(x) specify
1	viride, or
1	(4), printed
5	including its
1	transactions that
1	allegations contained
2	excludes any
1	acid diethylamide;
1	respecting (i)
5	may, during
1	canada, from
2	seeks accreditation.
1	amend part
1	583, as
1	standardized graphic
5	alone or
1	faca section
5	formula or
1	(h), (i)(2),
1	acts, for
17	tracing of
1	(inclusive of
1	milk. (mar.
1	section apply.
6	hearing in
1	separate applications
1	research, advertising
1	various aspects
1	death and
1	assets and
4	hearing if
3	conducts a
1	joint terrorism
3	groups of
2	period. (iii)
2	poisonous, insanitary,
1	prescription. (j)
1	advanceas soon
7	hearing is
1	use means,
7	shall annually
1	requested a
2	revenue code
2	secretaries of
1	will support
1	wheat, peanuts,
1	intellectual property
1	design, specification,
9	and, where
2	playground, or
7	reasonable limits
3	dispensed or
2	establishmentthe term
5	(b) under
1	available listing)
1	(i) guidelines,
2	first program
1	methods that
4	products a
1	trafficker of
1	instrument, apparatus,
1	possession in
1	seeds thereof;
1	meanings stated
2	distribute, import,
4	issued or
5	1953 reorg.
1	donors to
2	columbia may,
1	community shall
1	18. (d)
1	fees: 
1	first offender,
2	avocadoes, cantaloupes,
1	provided funding
1	individual responsible
1	466 of
1	projects of
1	secretary, related
10	receipt by
1	shell that
4	conducted during
6	issued on
1	amounts, as
1	importer. (4)
1	flexible mechanism
1	certification would
1	name, unless
2	therefor. 
2	shall forthwith
3	papers, and
4	states. the
1	participate in[3]
1	subchapter may
1	poured, sprinkled,
1	clause applies
1	fee settingthe
1	331(i)(2) of
2	applicable. (b)
1	maintain and
1	provide advice,
1	documenting hazards,
3	actsit shall
1	unless subsection
1	reports) if
1	modifications a
2	ii the
1	literature and
2	treating such
2	inference, and
1	appropriate, each
1	camouflaged device
1	production, packing,
2	distributed by,
1	am678); (iv)
10	material fact
3	dietary supplement;
4	maintain any
25	available until
3	permitted entry
1	343(k) of
1	facility. (ii)
1	record. drug
2	electronic form,
6	553 of
11	of, a
1	code, secs.
1	codex alimentarius
6	to, a
3	withdraw or
1	$129,000,000 for
1	permanence of
1	determine a
2	additive as
1	programwith respect
1	(f) final
1	falsely representing,
1	(5) with
1	product consistent
2	public notice,
1	public notice.
1	products, owned
1	supplement involved
2	judgment can
1	stakeholder. 
2	available 
2	substituted wholly
3	rates as
1	use rate,
1	
 880.
1	15; and
1	public hearing,
1	note below.

1	involved would
35	suggested in
7	title have
6	months rather
1	problems. 
2	software and
7	chemical, radiological,
1	shortages, how
3	conclusions of
1	mild, or
1	subsection (f)(6)(f)
1	(i) unique
1	electronic forms
1	less (or
1	revoked with
1	helpful to
1	food. section
1	investigation related
14	percent below
3	informal hearing)
1	irreparable injury,
1	359, as
1	(a) payment
1	substance, notify
19	informal hearing,
1	informal hearing.
1	identifier applied
1	misrepresentations by
2	noninfringement, the
1	validate effective
1	items less
1	resolving these
1	date unless,
1	section 505(i)
1	electronic population
2	meetings to
2	generalfor each
3	use instructions
1	accepted, preserve
1	safety, except
1	date given
1	event such
1	identifies any
1	deems best.
1	person, this
2	exclude any
2	barrels in
2	receive service
4	(ii) upon
3	(a)(1) of
6	paid for
137	effectiveness of
1	person prohibiting
2	chapter. (june
1	(3) agents
1	(a) do
1	registered manufacturers
1	specified at
1	dissemination plans
1	(a) determinations
3	effectiveness or
1	animals, including
1	becoming final.
1	identifies and
3	(a)(1) or
1	entrances and
1	systems under
1	(ii) ketamine;
1	(a) election
2	chemical until
1	uni-level system,
1	348. food
17	food; and
2	may regulate
2	installation, maintenance,
1	secondary schools.
8	criteria established
2	sea food
2	inspection budget
5	identified and
1	agent does
1	may import
2	peer review
1	state demonstrates
2	section 314.510
4	oversee the
1	per day.
1	government act
2	percentage workload
2	will continue
5	facts and
1	technology assessment.
1	device but
3	form that
1	(4) methylphenidate.
2	conspicuously on
3	ii; (2)
1	regulation. (3)
1	statements, as
1	
 2101.
3	panel the
1	government; (c)
1	appropriate, by
1	general; (4)
1	verifying whether
2	ownership is
1	(b) exceptiona
2	delete from
4	cancer in
1	and, during
5	violation that
1	379d3 of
1	(b) verification
1	upon information
1	handling instructions;
1	(b) exceptions
1	tract of
2	ownership in
1	blood components,
2	courts for
1	report, notification,
1	appropriate, be
1	2001. designation
60	shall by
8	product fee
1	entity; (ii)
1	abbreviated registration
1	may, prior
2	(ii). in
1	benzylmorphine. (4)
5	different from,
2	5.0 
2	expended by
2	clear detrimental
3	notice; and
1	360ddd1 of
1	distribution transactions
1747	shall be
7	cooperate in
1	that[1] relies
1	(x) subject
1	(o) prompt
1	electronic searches,
2	trial required
4	(iv) is
1	350i. protection
1	hold under
1	period. (h)
1	court a
1	shipping package
1	displays of
7	(iv) in
1	(a) bonus
2	thereby falsely
6	meet any
1	agents, as
1	$5,000. notwithstanding
1	false statementsany
1	minerals (a)
5	(iv) if
1	provide detailed
3	title 15(except
1	material evidence
1	products. this
1	term quarantine
11	organizations, and
2	section, have
4	detention order
2	preamble to
14	information was
2	gelatin capsule,
1	details the
2	drug do
1	greater collaboration
1	proceedings; procedure;
1	(or c-chairpersons)
1	sun protection
3	stat. 1046;
1	affirmative action
1	medical supplies
1	1931, for
1	supplies; (d)
1	demonstrable progress
8	shall commence
1	foo-producing animals;
1	received at
1	negligently fail
1	(b) accelerate
1	grocer), the
1	described) sold
1	foo-producing animals,
222	subsection (b)
1	retaining qualified
1	gel, except
3	section 802(41)
1	sector; and
4	partner that
1	terrorist persons
29	meaning given
1	tissue through
1	prereview of
1	persons having
1	soil transmitted
1	strategic planning
1	veterinary, food,
1	(4) order
2	importation the
1	follows: (d)
2	employees conducting
1	somatrem, somatropin,
5	otherwise engaged
1	(1) serve
6	day (including
1	(1) entity
9	country from
2	controls for
1	(2) goalsthe
2	applicable. a
4	negligence or
1	1 such
1	sections 355a(f)
1	(6), extend
2	individuals exposed
1	eggs (as
6	regulatory audit
1	detention orders
1	submitting information
1	softening of
7	advertisement for
1	feeds are
1	(e)(2)) impairs
1	opening each
1	
 1053.
1	moderate or
1	competition among
1	methylhydromorphine. (14)
1	reasonably determine
1	prohibit accessing,
1	regulationa food
1	administration) is
1	label, and
1	obtain possession
1	suspend, and
105	order under
3	iii. 
2	tests necessary
1	voluntary inspection
2	section 360eee(16)(b)
4	program agencies,
1	recognitionto ensure
1	section publicly
7	research conducted
1	security; and
13	terminate the
10	will result
1	certification; or
1	353a1. enhanced
1	(ii) documents
3	post on
1	goals to
1	indirectly reveal
1	355, 360b,
1	abuse on
1	longest withdrawal
2	systems standard
2	subchapter relating
1	lists. (d)[2]
1	requires accredited
1	relief including,
1	order. during
1	file petitions
1	history. 
1	reinspectio-related activities
1	concern by
1	enterprise definedfor
1	therefor set
1	classify, analyze,
5	substantial scientific
1	person, change
1	active adverse
2	used; or
5	tax return
1	altered, removed,
1	subsection (e)(8);
1	contentsa proposed
7	ingredient that
2	(c) penalty
1	parents. (e)
1	auditor present;
1	true statement
1	conclusive. if
2	isomers; such
1	settings that
4	audits to
1	committeeprior to
1	becomes accredited
1	subsequent oral
1	animals only
1	
 360h1.
1	assisting regulated
1	employed, hired,
3	request not
1	interim list
2	requests granted
1	
 1708a.
2	agency, bureau,
1	additive was
2	establishment bear,
1	provided for;
3	register in
1	efforts; 
1	respectively. (c)
2	blood components
1	register if
2	retailer whose
1	accountabilitythe coalition
1	
 152.
1	epidemic product;
1	sanitation or
1	(2) procedurein
3	term premarket
1	section 803.19
49	assurance of
2	individuals under
1	inspectors for
4	assignee, or
1	(a) manufactures,
1	update are
1	transactions by
1	electronic information,
1	localities that
40	eligible for
1	provisions section
1	final basis.
1	rulemaking authority.
1	penalty became
2	statement, design,
3	initial list
3	tobacco, or
1	958(i) of
4	standard, and
1	scientific use
3	immediately thereafter,
1	agency; (ii)
1	plan which
5	groups to
1	comment, the
11	official device,
2	court, in
1	include blood
1	applications to
1	called neonates,
2	march 31
7	referral to
6	adjusted by
1	care setting
5	set aside.
2	contaminants. 
1	standard, any
2	(ii) are
1	parole functions.
1	campaign. (f)
9	inspection legend
2	entities of
1	sectors, including
1	security a
1	regarding recovery
5	deliberately failed
9	product establishment
5	reauthorization; (b)
3	outreach to
2	strategy with
1	subbrand that
1	uses reliable
5	entities or
6	drug, biological
1	applicants shall
1	(g) consultation
1	nations economy;
1	fees authorizedthe
1	think necessary
9	infringed, the
1	1962, shall
1	authority, shall
1	hazards. 
2	shall prescribe,
1	new hig-risk
5	shall prescribe.
1	voluntarily requests
2	first reference
1	involving paragraph
1	date means
1	product establishments
1	deliberately adulterated,
7	person adversely
1	activity limited
1	drug fails
2	require reimbursement,
1	records in
4	october 27,
3	removed for
1	important gaps
6	safety activities
5	drug identified
1	symbol shall
1	testing in
1	discrimination, including
2	submit additional
1	manufacturers current
1	laws, except
2	pathway has
1	allocated by
1	(1); notice
1	constituents as
1	$80,000,000 for
3	enumerated in
7	section, there
5	sale as
2	projects conducted
4	producing animals,
1	 (mm)
4	definitionin this
1	valid methods
6	program described
1	(h), (i),
1	entity (referred
1	biennial inventory
3	needs identified
10	regulation require
2	violative articles;
1	shall, immediately
2	milk fat,
2	(b)(2) shall
1	foreign terrorist
1	product establishment,
1	goalenhance the
1	product, consumers
1	caustic hydrates
2	procedures (including
5	afford such
1	with, such
4	designation shall
1	cultivation, harvesting,
4	similar establishment,
1	impractical; (b)
7	shall comply
1	(1)(d), for
4	(a) only
1	forfeit, in
1	posted publicly
1	effective research
1	dates if
1	paper, filter,
1	constituent parts
1	ensure consistency
1	disclosure not
1	times set
1	safety program
1	guidance, certifying
1	certification, licensing,
1	actively involved
1	may, beginning
1	canada, israel,
1	demonstrate substantial
3	found in
1	neither adulterated
1	illegal dru-related
13	(a), a
1	(i) timelines
1	operating practices
1	subcommittees, or
1	(3) basisthe
1	agency center.
7	placed under
2	agency center,
2	1984, no
1	license virus,
1	affixing a
1	agricultural practices
2	agencies, to
1	discretion, designate
1	agency center;
1	appeal; reprocessing
1	(g) sunset
1	warrant. (4)
7	section applies
1	exist; (c)
1	laboratory capacities
1	secretary responded
1	detoxification treatment)
1	2016, a
1	(2) interim
1	detoxification treatment.
4	qualified for
5	(5) such
1	residue continue
1	
 360nn.
3	500 employees,
1	(1) responsible
1	stat. 108;
1	disclosed only
10	state programs
1	ingredient facilities).
3	whenever such
2	production act
1	additives, constituents,
2	customers do
1	official; or
1	(ii)(ii), the
1	attorney. the
1	restrictionsthe director
1	42 has
1	$195,000,000 for
2	concerns the
3	section 360c(f)
1	order classify
1	person after
1	natural resources,
3	performanc-enhancing methods
1	checks and
1	term a
1	27, 1952,
1	seq.] applicable
2	(1) pursuant
2	submitted not
1	thing used
1	meet international
1	petitions filed
1	2010; (14)
1	director), as
1	protocol intended
3	agency centers
1	
 360eee1.
1	expired prior
2	manufacturer; regulatory
1	seq.]; (5)
1	(i) subparagraph
1	pathogens listed
2	administration, in
1	collections shall
1	health. test
1	contain labeling
1	period. (iv)
1	nomenclature requirement
3	grant appropriate
19	withdrawn or
1	substance whoever,
1	foreign state
2	modify a
1	346. tolerances
1	additional discrete
1	administration, is
1	ship as
1	(5) monitors
1	reinstated. (4)
1	continues consumer
3	epidemiological studies
1	compilation in
2	strategy; (5)
2	genetically engineered
1	467a. administrative
2	initially appointed
2	first year
2	grand jury
1	(1)(g)(iv), the
1	health service.
1	(l) modified
3	accreditation to
1	risksthe secretary,
3	transferred or
8	property and
1	measure supply
1	clause prohibits
1	(c) process
8	preparedness and
1	uniformity and
5	process drugs
1	access provided
1	(5) identify
1	reduction for
2	participation in,
1	prepared. (mar.
1	patient, if
3	contains data
6	provides to
1	statement, transaction
1	used (including,
1	enforcement programs
2	(ii)no independent
2	knowingly selling,
5	local, state,
1	calcium (mg)
1	members in
2	(3) require
2	relevant interpretive
3	dairy products
1	states. no
1	$27,600 (adjusted
1	term. a
1	postapproval, of
1	stock of
5	established or
1	(f) dengue/dengue
1	39, such
3	last applicable
1	otherwise 
1	(1)(b)(i), unless
2	give interested
1	actions were
3	yielded by
1	breaking eggs
10	18-day exclusivity
47	opportunity to
2	selling, freezing,
1	(d), shall
1	specific testing
2	offense. 
1	(2) schedule
1	combination have
1	(i); (v)
2	applicable calendar
1	356c of
2	greater period
1	chloride (mg)
1	6, 1996).
1	certification, and
1	(c) may
13	given to
1	(3) expertise
1	853a. transferred

1	2009; (4)
5	findings upon
1	individual identified
1	sources; (vii)
2	supplies of
1	contained an
1	charge fees,
7	requests the
2	tax under
1	sent from
2	system or
1	discretion, seize
4	affixed or
1	secrets any
1	(m) categorization
1	(pyridoxine) (g)
1	concerned, or
1	(ii) modify
2	subsection within
1	deferral and
3	food subject
1	distributors with
1	trading partnerthe
1	factor defined
1	tagged to
2	describe such
2	art of
1	effective; (b)
1	1986 (26
5	variant protein
1	7, 44
1	copy, and
2	minimal quantities
1	however, when
5	(2) there
1	following export
6	(4) shall
3	revoked, suspended,
2	purposes in
1	report acquisition
1	change, and
8	title. such
1	food accounts
3	safety data.
1	used. (v)
2	lon-term treatment
2	declares himself
1	(o) construction
4	trade, or
3	(1) scientific
1	animals; (ii)
1	declined requests;
1	party transfers
6	term biosimilar
5	gross annual
1	notificationsexcept as
1	(ii) licenses
2	(4) as
5	forthwith transmitted
1	(b)) or
1	(4) at
5	subsection (a)(1)(b)
1	chemical was
1	recall, the
2	(4) an
2	leading representatives
5	title applies,
1	common use
1	etc.; lists
18	order was
2	input during
1	special damages
1	
 679c.
1	general use
1	(7) after
1	valid for
1	section 958(i)
3	addiction, or
1	may jeopardize
1	waivers on
2	years payment
1	of, location
1	person listed
10	investigations described
2	deny, revoke,
1	nighttime the
2	part of,
5	shall work
1	medical care.
2	part may
1	amendment) are
1	ris-based actions
1	submissions (a)
1	612. notification
1	tests); or
2	used 
1	title 22),
1	public awareness
1	event trends,
6	condition which
1	(a) further
6	refer such
17	local law
1	authority either
1	professional background
4	research the
1	membership and
1	restrictive standard
1	subpoena may
1	articles means
2	monitoring program,
1	termination180 days
1	tribe the
1	cocaine freebase
1	inspects under
1	corporation owning
3	include, with
2	2013, establish
3	states by
1	minimize reporting
1	increased and
6	ove-th-counter drug
1	(ii) documentation,
31	violations of
1	600 foreign
1	farm, the
1	test a
2	food testing
1	subsections (a)(4)
1	person disseminated
2	report, by
1	individual remains
1	2013, such
1	direct to
1	enhancement, which
9	regulated transaction
1	discretion actions
1	(2) consent
2	salted, canned,
1	objection shall
1	reports have
5	exemption granted
1	factors. 
2	(b) statement
1	positions, are
1	officers in
2	(c) when
1	(d) notices
3	forth any
3	term appropriate
2	use have
10	secretary approves
1	states, who
2	(4) maintain
1	publish or
1	lif-threatening diseases,
1	regulationsthe provisions
1	inspections. (2)
1	sciences of
1	discovery 
1	generalit shall
1	borne illness
1	(2)(b) by
1	smashed or
4	health insurance
1	iv, 411,
6	(b) after
2	offered by
2	delay such
1	(vii) an
1	cohort. (b)
1	offenders any
4	publish on
2	promulgate procedures
2	section, provided
1	capabilities at
1	262(a)] will
1	secretary proposes,
1	administrations review
1	-penty--(-chlorophenylacetyl)indole (jwh203).
1	informed pursuant
1	(a) inventoryexcept
1	alerts the
1	clinical experience,
1	1, 1973)
4	information leading
2	protecting trade
2	factor in
1	ingredient) which
1	savings provisions
1	further, upon
1	section 387e(i)(1)
1	can, by
1	research relating
1	protections. 
1	eliminated by
1	claimant 
1	poppy and
1	commitment in
2	commissioner have
1	title since
1	patients, completed
17	promulgation of
1	otherwise permissible
2	reasons. a
1	timely assessments
1	volumes of
5	changes 
1	service from
1	directors concerns
1	hearing has
1	458 of
1	transfer, and
1	basis; or
5	referral of
2	board, commission,
1	300f(4))) but
3	shall indicate
1	referral on
1	recall at
1	entities. a
1	pathogens, and
5	may notify
1	body fails
1	manufacturer; or
2	testing poses
1	(ii) consider
5	animal, article,
2	prior convictions,
3	356c(a) of
1	(a) complying
1	new needs
1	drug, antibiotic,
1	government submitted
8	carcasses or
17	demonstrating that
17	unless its
1	susceptibility using
1	(1), fees
1	current expert
1	effective, except
1	unadulterated milk
1	practices; (c)
1	forfeiture as
4	thirt-month period
2	establish, and
6	evidence. 
17	october 1
1	section 10.85(d)(1)
204	section shall
1	population. no
3	subsections (c)
1	including provisions,
14	none of
1	(10) process
1	programs a
1	basis to,
1	secretary establish
1	evidence) which
1	(f) reports
1	period may
1	(a) purpose
1	coca leaves.
1	accompanying disclosures
1	valid public
2	state court
37	used in,
1	overall objective
1	opportunities exist,
2	applicable, affiliate
1	262(a)] upon
1	actions alleging
1	providing laboratory
44	consult with
3	assessed only
2	forth 
2	exceed two
1	thereto; conditions
2	treating clinical
1	by, regulations
1	unless each
1	products, is
1	case brought
2	information classified
1	informed by
1	terms importer
1	means protection
1	nonetheless have
1	lif-supporting, lif-sustaining,
1	expansion (a)
14	obligation only
1	needs to
1	50.0e 
4	centers with
2	facility: 
1	term dispense
4	reason for
3	ten years
1	appropriate technologies,
1	declares the
1	unsupported by
1	him. the
3	demonstrates good
4	disclosure pursuant
1	transferred. (iv)
1	current assessment
1	(iv) such
1	knowingly alter
1	act administered
2	350e of
1	government witnesses
2	research, the
1	section 360j(o)
1	soon thereafter
1	(18) the
1	(d) availability
1	exude through
1	(1) currently
1	licensing, or
3	consumer and
1	research, together
3	operations, and
2	communication, including
1	outcome assessment
3	form, and
1	subpart b
1	adulterated butter,
1	subpart e
1	41. (h)
1	subpart h
1	requesting to
2	subpart j
2	results or
1	development, consistent
1	message of
1	shell eggs
1	phencyclidine. (8)
4	year. (d)
1	506c1, as
3	designates as
3	ii if
1	insurance under
1	locality with
2	including traveltime;
1	waiver. (e)
1	centers related
1	(b) $6,944,000
1	prescription medications;
1	ineffective 
1	demonstration and
2	englis-speaking ability
2	warehouse, establishment,
1	panel so
18	first business
1	knowingly importing
10	capacity of
1	prescription medications,
1	(b) coordinating
2	facilities to
12	food, the
1	timely, routine,
1	human milk
1	exceptionsthe following
2	quantities that
1	disposal will
25	assess and
1	retail, to
1	convene workshops
1	economic research
1	pharmacopoeia; development
2	titled nicotine
2	electronic circuit
1	term adequate
1	conditions, such
1	sanitary, and
1	conviction; (b)
1	public. (2)
1	standard; and
1	(5) conduct
1	(a) eligibility
1	search the
3	establishments, institutions,
7	drugs referenced
2	subpart 7
1	subpart 8
1	inhalants and
1	drug, expedite
1	institution, to
1	comprehensive, multisector
1	eligibilityeligibility shall
1	packaged. lack
1	(a)(ii)(iv) and
1	benefi-risk consideration
2	acting upon
30	filed pursuant
1	incidence and
11	poultry, or
2	dates upon
1	safety practices
5	director the
26	action is
1	includes specific
2	order, but
12	action in
1	13, 2002,
1	imports, and,
1	2017, but
1	obligations described
1	gm 3.3
1	expire prior
2	action if
1	solely as
2	employees), as
5	substances; (4)
2	sharing information
1	pathogens on
78	associated with
14	services, and
17	review 
2	postmarket monitoring
1	tablets, and
4	treat such
2	deadline, the
4	substitution at
1	somatropin, or
1	
 965.
1	statute, including
1	(f)(6)(f) distribute,
1	environmental assessment;
1	urgent petition.
1	
 678.
2	immediately unless,
1	32, 62
1	fiscal and
1	another license
2	order form
2	protocol submitted
5	workload adjustment
5	unsafe or
1	prominent statement
1	involved: 
1	possible, give
1	placed, who
1	large, page
2	redacted. 
4	subparagraph; and
1	challenges, and
4	fee. 
1	(e) deputy
1	enantiomer of
2	selling, purchasing,
1	-penty--[-(-methoxynaphthoyl)]indole (jwh081);
5	(as added
2	(b) factors
1	committed an
1	misbranding provision
2	(3) application
10	proportion of
1	cos-effective basis.
3	purposes set
1	shall accompany
2	2008 may
1	subsection (a)[2]
1	licenses all
1	pecans, or
47	shall require
2	coordinator determines
1	section 123.3(k)
3	inspection program;
1	(g) practitioners
1	valid registration
1	sent promptly
1	presentation. 
2	(c). (3)
1	enforcement purposes
1	public comment);
5	food unless
3	likely availability
1	fillsa prescription
29	report required
1	one institute
1	carried out;
1	(that may
1	person accepting
1	(b) economy,
1	surveillance order
1	campaign; (ii)
2	including quality
2	applies standards
4	subsection, a
1	destroy harmful
1	(h) relationship
2	prescription means
1	wholein making
1	confectionery containing
1	accepting a
1	produce component
1	lon-term assessments
3	packs, or
1	chronic substance
12	modify the
1	pharmacies so
1	complete to
1	year a
3	july 13,
3	(j) is
1	limitations, may
1	year, application,
1	sponsors, animal
1	excess proceeds
2	353b(b) of
1	(xvi) of
1	affiliates) or
5	evaluating the
8	authorized distributors
1	secretary compromise,
1	
 379d4.
1	nations regarding
1	(b) serve
1	subset of
5	administrator has
1	spice, including
3	available at
1	preclearance or
14	fees shall
1	subparagraph issued
1	sale, and
1	
 356g.
2	certification before
1	reasonably anticipated
1	infection the
1	(c) evaluate
2	program. the
1	responsibilitiesthe executive
3	(b)(1)(d) for
1	paragraph (1)(a)(i)
4	(6) for
1	diversions, (e)
1	datefacilities shall
1	special survey
2	appropriate persons
1	subsidiary means
2	accredited, is
2	(1) emergency
1	medicines daily
9	times to
1	patient groups,
2	specified conditions,
2	concentrated, powdered,
1	date referred
1	term ginseng.
1	alert about
4	sanitary protection
1	proper board
4	grant. 
1	subsection, providing
1	exercises to
1	(n) third
2	illness. such
2	intended primarily
1	(including special
2	(d); (b)
1	(a) timingan
1	district courts;
1	governmental officials,
3	assignment of
1	remedy not
1	waived. 
1	(d) invite
1	otherwise failing
1	pharmacy 
4	effective not
3	complied with,
1	health that
1	complied with.
5	agency, shall
7	which, at
1	outpatient treatment
2	1, 38
1	substance) of
1	similar source
1	persons, vehicles,
1	excise taxes
1	active program,
1	pediatric market
1	petitioners right,
2	2011, to
3	year, such
4	met; and
2	interventions for
1	bidding procedures.
1	substance) or
1	assistance would
2	(1) annual
1	roughened bottle,
1	sciences. (b)
1	manufacturer need
1	cooperation among
1	formula set
14	identifying the
2	biomarkers, for
1	equivalence and
1	extraordinary quantity
1	person, places
9	unless there
1	(3) its
1	animals before
1	
 387t.
1	distributor 
1	rural development
3	studied, and
8	applicable requirement
4	produces the
1	study thereof
2	complainant may
1	criminal case,
2	subsequent or
1	projected demand
1	product usually
2	declines to
1	(c) extramural
1	retailers within
1	appropriate, dosage
3	establishment registered
1	coalition as
3	applicable) of
1	center is
1	(1) corporations,
3	foreign policy,
2	investigators that
1	(a) biological,
8	maximum punishment
1	initial guidance
1	(b) compounds
1	limited medical
6	offset the
1	statutes intended
2	document, for
1	repackaging the
1	difficulty accessing
2	plants are
2	deposit of
3	appropriationsthere are
1	communications, in
1	islands, kingman
2	formulations developed
1	rough, or
1	1545. terms
3	verification activities
1	secretary reviews
1	disease productthe
2	status for
1	considerations for
1	copper (g)
1	shared, on
3	results required
1	(8) raw
1	additive would
1	forfeiture proceedings
265	number of
1	communication paid
1	stating in
1	state, in
1	physician. the
1	state, is
1	section 371(e),
1	771, as
20	processing, packing,
7	maintenance, renovation,
4	conduct research
1	disease within
1	character, each
1	review, subject
1	act). no
2	products. no
2	negotiated enforcement
1	trade, any
1	drug except
1	reevaluate accreditation
2	coalition serving
1	contain substances
2	sale within
1	regulation conforms,
2	basis thereafter.
8	reviewing the
1	(and serves
1	seafood products
4	previously submitted
1	gaps, which,
1	(b) compound,
1	form; (ii)
1	admission or
1	fee) program,
1	opiat-dependent patients,
1	synthesizer, or
1	limitations if,
1	focus postapproval
2	dollars, the
3	name has
15	remain in
1	complete address
1	are, upon
2	business phone
6	admission of
1	importation, including
1	(d) knowledge
2	label shall
1	employers any
1	(h) include
2	admission on
3	without obtaining
1	determined, in
1	purposes stated
6	pharmacist or
1	360e(d)(1)(b) of
2	making it
1	insert or
1	chemical solely
2	various types
1	comments relating
24	risks of
1	term to
1	(i) shall,
1	proceed to
2	rights, privileges,
1	(ii). (iv)
1	cooperation: advisory
2	national average,
1	coordination, communication,
3	patent invalidity
1	review, including
1	bodily member,
2	article, if
1	threshold effects,
4	abuse. (b)
1	remedies any
2	909, as
2	maintaining records,
1	effect. (c)
1	apply this
1	list included
6	health; or
2	aggregated, d-identified
1	product label
4	name (as
5	comments. 
2	effective audit.
6	physician assistant
1	subsection. (f)
2	found under
2	person demonstrates
3	25, 1938
2	issued, and
1	requires an
10	position of
1	822(f), 825,
1	(b) determinations
1	islands, guam,
1	dentist, veterinarian,
1	requirementsa request
1	(8) unless,
2	general.if an
1	major accomplishments,
1	time thereof
1	initial list,
1	606. inspection
1	membership on
2	devices subject
1	262, 4,
4	20 of
1	handling in
1	(q) date
1	forces; (e)
1	chapter, while
1	affected product
1	circumstances warrant,
1	dates), without
2	effect regulations
2	doses and
1	agencies is
2	innovation because
1	20 or
1	welfare, for
1	(j) service
1	representations so
2	inspectors or
1	agency are
1	clause (xiii);
2	produced during
1	orders; access
2	patent defined
1	cigars. (iii)
1	denied within
1	(as prescribed
1	manufacturers; (viii)
1	accused, be
3	initial members
1	indicating the
2	regulations published
1	(i), if
1	certain manufacturers,
1	requirement which
1	adulterated articles
1	(may 23,
1	investigators in
1	exempt drugs
1	decide such
1	yellow, or
1	governmental officials
1	modification creates
1	investigator, or
1	(c) advisory
1	filler, or
1	defendant at
1	component to
1	investigator, of
4	wrapper, or
14	24 hours
5	49 and
1	statement: united
1	(1) reportnot
2	title does
1	(f) progress
1	1112 of
26	conform to
1	cavity. 
1	blackmail, extortion,
2	commodity means
2	medwatch form,
4	underlying scientific
2	inspect, examine,
1	(5) serious
1	(e) facility
2	regulatory authorities
1	deferred for
3	contact -mail
1	receiving for
1	producer, and
1	specific directions
5	methamphetamine or
1	(n), no
1	sel-administering medication;
3	may employ
5	shall exempt
4	deliver, distribute,
1	store drug
1	adjustment reasonably
1	360n. priority
9	section 356e
1	powers all
1	export, or
1	section 356c
1	months before
4	system the
5	sentenced in
1	mitigation strategies)
2	exposures for
1	practitioners professional
1	petitioning state
2	supplements. (b)
2	publication and
1	collaborative projects
1	expenses) specified
22	food. 
1	(d) deputy
2	subsection (d)(3).
1	thereof; (f)
1	
 148.
6	(3), (4),
1	expanding or
1	individual establishments
1	publicationthe commissioner
1	foundation (a)
1	denial 
1	treated, and
1	676. violations
1	(ix) -penty--(-methy--naphthoyl)indole
2	appropriate credentials,
16	letters described
1	wide range
3	subchapter the
1	purchasers for
1	instituting such
1	assist state,
1	pharmacist to
1	applicable law.
13	report for
7	applicable law,
2	full scale
1	cows are
2	prison sentence
1	accompanying him,
1	regulations) any
1	901, 1(100),
1	1056; 

1	issuing or
1	preparation, in
1	risk may
1	entity with
1	defendant was
2	civil procedure.
2	(a): 
1	(1) preventing
5	response on
2	agency, require
5	(x) the
2	(iii) identifies
1	2, 48
1	paraphernalia. 
5	products capable
1	thereon, as
1	tin, cloth,
1	timelines, and
1	finds for
1	enter any
2	stationed in
1	importer), a
1	appropriate tests
1	chief officer
1	(4) proposed
10	risks associated
1	jurisdictions, as
2	commonly known
1	(b) possess
1	adolescent brain
2	100 kilograms
3	additive (or
1	enter and
1	that, consistent
7	one year.
1	successfully undergone
6	194 of
1	prohibition no
3	injury, to
1	material violations
1	riskfor purposes
1	set after
1	etc., as
1	wine, malt
1	recognition that
4	finished drug
1	equivalent if
1	controlling or
3	initial advisory
1	shown refer
1	(4) application
1	promulgate any
2	2010; and
3	effective procedures
1	information detailing
1	crime under
31	5 years
2	label described
1	regulation adopted
1	(i) vitamin,
2	held pursuant
1	
 114i.
2	(b) contents
2	20.)
 

1	miscellaneous activities
1	patien-focused drug
1	(b) exemption
1	(c) policy
1	feed with
2	efficacy supplements
2	(i)) equals
2	chapter. when
8	section 3583
2	1996. the
25	compounding, or
3	petition praying
1	issue prescriptions
2	factors that
1	2014, such
1	give special
1	clea-up, clearance,
4	research subject
1	sunsetthe following
2	identified clear
2	format as
2	(1) be
2	securities of
1	333(b) of
1	section 1231
2	gratuity to
1	awarding contracts
1	determination (61
1	user for
2	counted as
1	26. (b)
1	307, as
1	level capacities
1	-(-fluoropentyl--(-naphthoyl)indole (am2201);
2	upon whom
2	benefit, or
2	procedures related
2	transfer between
12	secretary finds,
2	state pursuant
1	methods employed,
1	otherwise complies
8	academy of
1	promising technologiesthe
5	(1) initial
1	substance. (33)
1	performed. (ii)
1	360b, as
1	detect trends
1	license granted
1	applicable special
1	said inspector,
1	387e(b), 387e(c),
1	dehydration, or
2	(after affording
2	efficacy supplement,
1	reserves only
1	need from
1081	 (1)
1	things growing
1	publication under
1	
 691.
4	v. 
1	sector resources
3	person (excluding
1	lien under
1	committees 
1	private sector.
7	shall address
1	321(m) of
1	personnel permanently
1	partner such
2	notification in
4	(2) establish
11	notification is
2	$20,000,000 if
4	controversy as
1	immunizations. (b)
1	private sector;
4	offense involving
1	(ff) in,
6	availability or
1	articles may
2	(2) ensure
2	measurement instruments
4	meeting under
1	shall bind
1	(1) consists
2	section 360b(i)
1	drug approvals
1	tobacc-related diseases
1	institutions; (iii)
1	affiliate) to
1	believe they
4	product manufacturers,
1	(iii) as
1	contracted or
3	proximity to
1	reevaluate the
1	donate property
9	(iii) an
1	otherwise indicated.
30	manufacturer shall
3	(c) not
1	1947. 
2	volume biological
1	(4) rules
1	arrangement with
1	387m. equal
2	business transactions
2	anyone convicted
1	practices, such
1	tests (or
3	center or
7	written order
1	least fifty
1	unexpired term.
2	330.14(g) of
2	(b) disposition
1	intervention projects
1	corrected. 
13	industry. 
3	documents, including
5	entity and
1	farms; and
1	alert network,
1	jointly submit
1	(as reported
1	packed or
1	(to be
1	necessary, only
1	help ensure
1	subchapter, no
3	residues exceeding
11	columbia, and
1	(d) there
1	government internet
1	355(i), 360b(j),
1	community mental
2	applicable condition
2	negative public
7	submitted, the
2	office personnel
1	compounded and
1	president is
2	affiliates, shall
10	provides information
1	(b) activities,
1	360ccc1(h) of
6	permits to
2	horses, mules
1	(gg) a
1	300f et
1	shipment or
3	hashish oil,
1	duration; release;
9	regulation and
2	360j(m) of
9	(ii) not
2	declaration shall
1	register; effective
1	paragraph (1)(c)(ii)
1	letter in
1	section 360e3
1	post information
1	letter is
1	section 360e,
1	precursors the
1	term pharmacist
2	protocol, and
2	(a) right
3	minimize, as
1	suspect productthe
1	force established
1	title) containing
4	awarded against
1	abuse. furthermore,
6	minimum size
8	another device
6	date by
2	giving due
4	inspection pursuant
1	adequate. (3)
6	benefits paid
3	(2) action
1	statistical approach);
1	(h) quotas
1	accurate and
2	section, ships
2	agencies; (c)
3	commerce, the
3	without requiring
1	 [1]
1	date be
1	occur upon
1	patients health
1	requirements. nothing
1	contamination, as
1	
 20.
4	device used
2	comparison to
1	chemicals: 
1	clear written
1	comment, whether
2	free of,
17	device user
2	authorize such
1	admit, and
1	package insertthe
1	concentration of
1	instituted before
2	measures may
6	information by
1	includes, for
1	sel-certification referred
1	(l) effectiveness
1	section, and,
1	order information
1	delayed. (c)
1	section 105)[2]
18	food in
4	update such
5	average) for
1	data prescribed
1	quantity, if
9	food if
3	manner specified
7	chemicals and
1	deliberate ignorance
2	patient a
12	registration to
7	grants the
1	nuclear threats,
1	locality, of
9	court determines
43	food is
21	information. 
1	basic classes
1	(aa) necessary
1	described for
1	pasteurization, or
1	2003 through
1	services recommends
1	675, 704,
1	contains successful
1	importer participating
5	authorization shall
1	drug (unless
1	analysis samples
1	device; (d)
1	programs so
1	commodity has
1	26, 1938,
5	responsible to
1	services, programs,
2	provisions (a)
4	upon his
2	(ii) documentation
1	area, in
1	reviews for
1	(f) that
2	tablet, capsule,
1	potential recipients;
14	risks to
1	902. savings
1	otherwise lacks
1	particular named
1	shared among
2	title) appears
1	filing determination;
2	appropriate susceptibility
1	manufacturer since
1	microquantities of
2	section 353(g)(5)(a)
1	guidance practices
1	expenses, incurred
5	eff. apr.
1	relief relating
1	implantable or
1	abet (as
2	sponsor fails
1	final use
1	(3) substantial
3	factual basis
1	
 360oo.
1	advertisement (referred
2	offense, and
74	meaning of
1	(b)(ii) shall
1	proposed in
1	identify safety
1	1995)). (3)
1	substitute meals
1	(a) director
1	jurisdiction. (aug.
2	(1) eligible
1	16 and
3	delivered by
1	(q) specific
1	353. exemptions
3	congress separately
11	expediting the
1	approval (a)
1	constitute grounds
1	(ii) will,
1	problem, is
1	adjustment 
5	dcmdvawv; not
1	sentence and
1	
 399a.
1	drug immediately;
1	generic drugin
4	prevent unauthorized
1	appointment. 
37	product, or
1	requests advisory
2	contains, a
2	provisions, it
1	compounding pharmacy
1	262]. (c)
1	product, of
1	379b. consolidated
2	manufacturing in
2	audit means
3	question of
1	defining quality
2	enforce state
1	preparation, which
6	prominently and
1	(5) limitation
1	speech, print,
1	title. (v)
1	livestock from
1	entitys agent),
1	whenever it
1	clearance on
1	467. inspection
2	permit, notification,
1	(vii) law
1	presentation provided
2	conduct examinations
1	carrier to
1	(4) eligible
16	clearance of
2	paragraph (2)(c);
1	small amount
1	chain. (c)
1	agreements with,
1	formula under
1	unlawful production
1	iii, 531,
1	per meeting.
4	clearance or
2	technical advances
1	introduction a
1	iv, 407,
3	whenever in
2	it, if
1	accounting (including
3	loss to
10	sixty days
1	(iii) complies
1	675, 602,
2	barcode when
1	designate drugs,
1	bonuses, and
3	property forfeited
1	262(a)]. (c)
1	consider approving
1	activities requires
1	finds relevant
3	least two
1	sole distributor
6	contract or
5	monitoring and
1	section 355(j)(5)(b)(iv)(ii)(cc)
1	policy, practice,
1	section 360j(l)(3)(d)(ii)
9	nonpaying guests
1	activities required
3	both. (

2	interest the
98	determined by
2	tableting machine
11	standards under
2	effective, including
1	873. cooperative
18	section; and
1	application, reinstating
1	arguments are
1	pending biosimilar
1	substances, drugs,
1	
 872.
1	board does
1	spoilage, loss
1	2006 level,
4	repackager is
1	42; (xii)
1	term covering
1	executed the
10	pediatric formulation
1	(4), sell,
1	research described
2	following findings
1	schedule such
1	packs tobacco
7	2015, a
2	requirements unduly
2	chemicals imported
2	criteria shall
1	exception to
1	general thirty
1	marketing, promotional,
2	endpoints, and
4	section 360j(f)(2)
1	employees stationed
1	241 et
2	items to
1	device, within
1	(g) exclusion
7	exemptions shall
1	shall toll
1	significant demand
16	purports to
1	
 1706.
1	public safety
1	triple those
2	(iv) 1
9	appear before
4	5301 et
2	part; and
10	agencies with
1	work costs;
1	use animal
3	alcohol and
3	inflation adjustmentfor
3	(2) activities
3	due diligence
1	original written
1	hearing) shall
1	auditor for
1	(iii) involving
1	allegation of
1	countermeasures, or
3	statement required
1	child at
14	changes made
1	section 470[1]
2	accurate copy
1	(f) sunset
11	categories of
2	condition means
1	deem it
2	contractor of
1	included with
15	drug approved
1	(i) accurate
2	pizzas are
4	lo-acid foods
1	social consequences
68	clause (i)
1	v and
1	substance. (16)
1	concentrations in
1	(vi) urging
1	week or
1	revocationnotwithstanding paragraph
1	title, have
2	professional medical
1	additive furnish,
3	section 321(n),
1	identified possible
1	grain standards
1	constituents, by
5	ingredient facility
7	establishments in
1	reference 
1	human use:
6	investigation in
1	if, by
1	human clinical
13	(iv) a
1	center follows
5	drug have
6	investigation is
1	incubator reject,
1	pilot projects.
2	section set
4	pilot projects,
2	human use,
1	control international
1	establishments it
1	reporting registrations
1	data sets,
1	(c) burden
21	engages in
1	establish, under
2	hidta program
7	proposal made
1	1-month period;
4	final briefs.
1	modify as
2	continued supply
1	appeal prior
1	ingredient becomes
9	limits the
1	section 711(a)(1));[1]
1	amphetamines into
1	section 342(a)(2)(d)[1]
1	(i) sale
1	1-month period.
1	(2) registration
3	reasonably foreseeable
1	eggs is
4	bottle, or
78	office of
1	1990. (b)
1	article upon
1	china. no
1	chemicals. for
34	food for
1	plans (a)
2	audit under
1	restrictions upon
6	foreign commerce,
1	sel-certify as
2	protocol or
1	bring in
1	assistance, guidance,
6	drugs by
1	bottle, of
3	office or
1	standardsin evaluating
1	2003; (7)
6	state court,
1	(3) clinical
1	corporation, to
1	(d) division
2	termination. 
2	rescission or
2	387q(c)(4) of
1	accessing, using,
1	iv. (c)
1	taken. 
14	public and
1	hazard analysisthe
7	practitioner or
1	trials cannot
4	example, the
2	disseminate information
1	971(c)(2) of
8	filing. 
34	applicant or
1	group shall
1	rea-time tracking
1	(1); or
5	practitioner of
1	specified, to
1	package sold
3	grants awarded
1	state courts
1	(5) distribute
1	oral inhalation
1	subject, if
2	section 601(w)(2)
15	support of
3	time (if
1	(2) radiopharmaceuticals.
6	forfeiture and
12	unless they
1	terminates if
1	review. (2)
1	chapter. (iii)
8	inspections and
2	accept returned
6	(all items;
1	adults. 
1	procedure governing
1	involves substantive
1	(f) limitations
31	master file
1	limit period
1	(c) nonprescription
1	comments. (june
1	endpoints, such
1	30, 1974,
1	annual generic
1	wherever venue
1	(a) sanitation
1	 failure
6	one business
1	30, 1974;
1	states when
1	process through
1	decision, including
3	notification and
2	subsequent offenses
2	european union,
1	month to
1	distribution shall
2	1, 32
1	1034(e) of
2	whether certain
2	processes that
40	head of
1	understate exposure
1	person or,
2	schedule contained
1	routine, and
10	effect, or
1	regulation); or
1	(a) owners
1	detailing how
7	pediatric assessment
1	risk have
1	violations nothing
7	acceptable to
5	states city
8	seeking approval
1	meeting its
2	regulations), is
4	drug listed
3	knowingly make
1	thereof) as
1	clause, apply
3	carcasses, meat,
4	order, a
1	section 556(d)
2	(d) review
2	first conviction
2	possession, manufacture,
1	support traditional
14	institutes of
1	batch numbers
1	1968, that
1	justice under
1	qualifying laboratory.
1	application. within
1	equipment, punches,
1	substances, it
3	importation; and
1	operators every
1	treatment (or
5	year. the
1	communication of,
1	states attorney,
1	event consequence
1	agencies; informed
4	imported, exported,
3	compliancethe secretary
1	need of
1	recognized medical
8	management plan
1	schedule. rules
1	inspectionthe results
1	(15 grams)
2	employees as
3	feet of
3	shall after
2	supplement, premarket
1	affording a
6	letters which
1	business without
1	final. (e)confidential
2	year, an
1	section 823(f),
2	based. (3)
1	board review
5	feesbeginning in
1	(3) biannual
1	seem proper,
11	minimize the
3	seem proper.
1	completeness assessment
1	items. no
1	encouraging such
1	(f) abuse
1	oath, setting
1	batch number;
1	deterrent effects
1	inspection was
1	food science.
1	food science,
1	record is
4	332 of
1	reduced cost,
1	(b) identifying
2	inspections in
2	serve it.
1	itself, be
3	record in
1	advising producers
1	indian provision
1	governor, the
2	aggregate and
11	infant formula,
1	neonatology. 
4	laboratory testing
2	division determines
2	abuse. 
6	wholesale distributors,
1	necessary, cause
2	agency, is
1	local conditions;
1	exists because
1	populations if
1	term context
1	extension shall
1	(c)(1)(a)(ii). 
8	person includes
1	agency, if
1	wholesale distributors:
5	(3) may
1	foods containing
1	reviewing a
2	859, 860,
1	cinnamon, pineapple,
1	package containing
22	2012, the
1	local conditions,
3	number to
1	amount only
4	(v) records
2	skimmed milk,
1	admission the
1	places, including
3	executing the
4	(including penalties)
2	approved drug.
22	law to
1	applicability, enforcement,
2	reasonably without
1	title; (v)
1	focus enforcement
1	testing; (f)
1	operating this
1	drugs removed
1	reference product,
1	(m) color
2	services, to
1	consumption within
11	annual monetary
1	(4) national
2	notice.a notice
1	reauthorization performance
1	form, not
2	effects in
1	consumption 
1	secreted, or
1	implement inspection
1	section 360j(g)(8)(a)
8	panel under
1	administrator, organizer,
1	believe a
2	abuse treatment;
1	sales restrictions
3	agents as
3	laboratories, including
1	387d. submission
2	any, to
1	pseudoephedrine. (iv)
1	specifications in
2	(a); (iii)
2	sponsor seeks
1	secretary reason
2	vehicle, receiver,
1	(e) nominations
1	repeated, material
1	made through
3	future importations
1	york, on
1	pass a
1	manufacturing rate
1	feesfees amounts
1	species. (pp)
2	applies; or
1	5. before
1	1191 to
1	intervention; and
1	determinations. 
1	identification, by
1	subparagraph), efficacy
1	(k) such
1	found with
1	(ii) violates
1	age, intended
1	(f) temporary
1	background incidence
4	official is
1	approval or,
2	known to,
2	official in
1	511; 

2	was, or
2	360, 360c,
1	life sustaining;
1	august 1,
7	nonprescription drug
1	applications. (v)
1	year. (5)
1	expertise or
1	section 350(c)(1)(b)(i)
1	(iii) illicit
1	biotin (g)
2	grase upon
1	subparagraph whether
1	animal does
1	academic researchers,
1	away for
1	bacterium or
1	organizations worldwide
1	401(b) of
4	requirement, set
2	(1) provides
1	verification under
1	organization and
1	
 612.
1	provide on
1	basic science,
5	year 2017.
1	content, delivery
13	year 2017,
2	characterize the
1	year 2017)
1	allowance made
1	sense, means
1	(3) at
1	renewal request;
5	involved caused
1	federal authority
2	(3) as
1	(i) october
1	thereafter such
7	(3) an
1	serving past
1	basis. (2)
2	of. 
1	(aa) 18-day
1	(1) $240,000,000
1	(3) certifying
8	initial biosimilar
5	5, the
1	renewal request,
1	term bioavailability
1	liability. (8)
9	adjustment under
6	section, with
3	dru-free america
1	augmenting such
1	organized risk
1	notify relevant
1	president shall,
4	tolerance limitation
1	notices, requests
1	738, as
1	sum or
1	results; fees;
1	compliance period
1	title. (july
1	reciprocal meat
1	manufacture, compounding,
1	conducted. (iv)
1	facilities used
23	sum of
3	prevailing rates
4	(5) for
3	panel, the
1	10, 1997,
1	jurisdiction, with
10	determines are
6	flavorings, and
1	(e) certification
1	exhibit antimicrobial
1	conclusive. (

7	definition under
1	drug therein;
1	675, 408,
1	6 approved
7	suspended or
37	section may
1	policy act
1	2008 by
1	seeds, of
3	351(h) of
1	authority; scope
1	subdivision and
1	warrant issued
1	articles can
7	title. (

1	programs, conduct
9	year by
80	issue a
1	
 360n.
4	802(6) of
1	consumer shall
2	package; or
1	approved drugs.
1	(11) supplement,
1	last amended
1	(ii)(ii) may
1	term dirty
1	matters specified
2	subparagraph, or
1	(f) such
1	proves to
1	(d) publicationthe
1	china shall
1	tentative determination
1	substance, any
1	stakeholders, issue
1	(e) periodic
1	personal property,
1	drugs, cosmetics,
1	conducting more
2	containing morphine
1	set forth,
2	chemical, a
1	strike subpart
1	1948; or
1	disorder in
1	additional examinations
16	purports or
5	use such
57	firm, or
2	fat and
4	2013 shall
4	transmit a
1	prevention; (ii)
3	substance, and
1	register, may
1	(i) included
4	term immediate
1	registrant receives
1	receive medical
4	operating in
1	(e)use of
1	(aa) presents
1	matchbooks of
1	board. such
1	possess appropriate
1	eggs; prerequisites
1	health). 
1	dispensed after
1	produced, personnel,
1	(i) includes
3	teaching, or
2	enforcement, or
3	data bases.
1	manufacturing controlled
1	threatened raw
1	producers), not
1	cases) in
1	(c)public process
6	sentence. 
1	biennial surveys
1	exceeding $1,000
1	conducting surveillance
3	importance of
1	audit. (2)
1	anticipated residue
1	research with,
1	underserved populations
1	
 1536.
6	(c) scientific
2	manufacturer an
2	experience data
1	similar written
1	ch. 229,
2	(2) guidance
1	worldwide revenue
5	costs funded
1	ii who
1	practitioners name,
2	section 642,
1	promulgated. 
1	reports referred
1	(2) intended
1	(c) (relating
2	effective. (iv)
1	assessments; (ii)
2	(2), a
1	(a) corporations,
1	(c) condemnation
1	(5) establish
2	1976, or
2	similar limitations
4	(c) inspection
1	therapeutic effect.
1	iv, 403,
2	process, including
1	prioritization the
4	(2), to
1	resume operations
2	section 552(a)(4)(a)
1	(6) wholesale
15	referenced in
1	1980, at
1	(u) of
1	appropriate redactions
1	laboratory database
1	automatically provide
1	track grants
1	indicating when
1	availability for
1	evaluation (other
1	(7) priority
1	listed patents
2	system established
2	agent authorized
1	
 1509.
1	tournament, regatta,
3	include validation
1	machines (a)
2	(i) priority
1	establishments (referred
2	(2). (b)
1	evaluating electronic
6	inspector general
1	forfeitures incurred,
1	recommending any
1	justice. (ii)
1	association. (iv)
2	additives if
2	corporation to
3	import, and
1	forfeitures conducted
1	product standards,
1	unit containing
2	supervised drug
1	section 960(b)(1)[1]
1	cause skin
1	container. no
1	animals, exclusively
1	individuals cannot
1	present views
1	knowing departure
1	section 247d6(h)(4)1
1	(u.s.c., 1934
1	panel report
8	analogue of
4	investigations, including
1	posting; and
1	(h) phenylacetic
3	recipient is
1	include, as
1	include, at
3	section 351(f)(1)(b)
3	exception a
1	(9) fees
1	(v) information
1	addiction psychiatry
1	(ee) counseling
1	containing vegetable
1	appropriate, demonstrating
1	prioritization 
1	enforce compliance
1	paragraph (2)(b)(iv),
1	concerned, to
1	$90,000,000 for
2	subjects that
1	certain bacteria,
1	paragraph except
1	mutual consent,
1	container size;
1	wired cigarette
1	documentation in
1	
 342.
1	extent resources
1	health priority.
1	product standardsa
1	strike, fire,
3	360c(f) of
1	regulations establishing
1	that1 does
2	(c), but
2	section, unless
1	committees interested
7	increasing the
1	insecticides, when
1	section 381(e)(2)
1	drug defined
1	states national
2	consistently employs
3	unless good
17	 (k)
1	regulation plan
1	(vii) encouraging
1	operates, or
5	section 958
1	section 959
1	either direct
1	vote) by
2	reader or
1	classified above
499	accordance with
1	section 955
22	samples of
4	delivery, distribution,
1	purity at
1	employer a
1	inspectors who
1	deposited as
2	special termination
2	samples or
1	abuse fell
2	evade or
1	isomer, except
1	may assign
1	(f) allows
1	warning letters,
1	micr-organism and
1	shell eggs;
1	slaughtering, packing,
2	247d7e of
1	
 114e
1	youth, the
1	(i), providing
1	(d) manufacturers
2	2013, no
2	needed. the
1	vessel or
1	fill the
1	complaints concerning
1	requireda responsible
2	chargeable under
1	disapproval and
1	used) solely
1	taxes required
18	long as
3	changes) and
1	meeting, other
2	improve seafood
1	motion is
1	exemption, may
1	delivery, handling,
1	year only
2	whose accreditation
2	certifying that
1	understands that
2	transaction; or
1	aircraft. any
4	earlier date
1	title. however,
1	chapter no
1	subsection specifying
1	chemicals used
2	extrapolated to
1	notify any
1	patients attending
1	1703(d) of
2	labeling, packaging
1	department, shall
1	instrumentalities used
1	approved an
1	internet site,
4	biologics evaluation
1	denial; written
6	defined for
1	television advertisements
1	thousand, and
1	identity may
2	condemned meat
1	returns when
1	(5) advertising
1	processing, freezing,
1	486.)
 

1	national companion
5	subpart as
1	chapter. (k)
3	examination, upon
1	certification includes
1	conducting advertising
1	questions by
1	persons, the
1	practitioner (or,
4	exemption with
1	exist for
1	oath or
1	certain pollution
4	(e) data
1	
 360ll.
1	applicant), the
6	title shall,
1	(h) offenses
2	811 of
1	firm shall
4	restaurants) who
1	licensure requirements,
2	general issues
1	abuse organizations;
3	approved protocol,
2	stat. 632.)

10	drugs are
1	public about
1	staffs, (2)
1	rules promulgated
1	prescribed), the
1	nonnarcotic active
1	clearinghouse administered
1	gothic letters
3	affected thereby
7	secretarys review
1	virulent poison,
1	175. repealed.
1	moderate abuse
1	
 871a.
5	(e) and
1	on-sixth of
1	(3) order
1	(i) voluntary
1	notification. if
1	products, who
1	key barriers
2	5, to
1	specific evaluation
10	order 
1	decomposed substance;
1	prohibitively expensive
1	conditions the
1	marshals service
1	simulations (a)
1	methodologies 
1	regular distribution
1	cultural differences;
1	written unique
2	training center
1	easily used
7	(a), including
1	reject the
1	agriculture. (4)
1	either affirm
2	including full
1	species new
1	laboratory facility.
1	cleared, the
18	requirement to
8	section 1001
1	store to
1	1999 through
1	leaders in
2	goals; and
1	distribution, transfer,
2	manager of
1	become immediately
1	space shall
1	cause shown[1]
1	vulnerabilities of
1	incubator reject;
1	4 times
1	confidential during
1	disapproval order.
1	incorporated any
1	accepted scientific
1	determines exceptions,
1	construing and
2	injunctive remedies
1	melons shall
1	obtained since
1	strengthen collaboration
1	agreementsthe agreements
3	available without
2	secretary use
1	accepted and
7	conditions or
1	potency, prior
1	source leukocytes
2	appropriate expertise
4	food, which
8	ultimate consumer
1	(viii) establish
1	ammonia, methyl
3	paragraph (5);
7	finds, on
1	increase efficiency,
1	except, further,
1	radiation hazard.
4	costs in
3	(g) shall
7	paragraph (5).
1	(c) response
5	paragraph (5),
4	commerce, unless
1	(b) twent-four
2	period would,
1	functions must
2	materials other
1	(i) beginning
1	paragraph (a)
1	filing. (2)
1	(vii) information
1	supplement, is
1	packaging materials
1	chapter, an
3	fees relating
1	transshipped if
1	(i) product
5	establishment at
1	purchasers by
1	containers; prohibition
1	individuals may
1	360ccc1], with
1	public. the
1	develop postmarket
2	donations of
1	generalsections 352(f)(1),
4	chapter, as
3	chemical action
4	shall conform,
2	trademark, brand
1	exploring means
1	program; (10)
1	make[2] full
1	u.s.c. 4321
12	include such
8	exported by
1	violations (a)
1	adequate representation
1	(thirt-fourth statutes
3	person which
1	2018, there
1	makes with
1	accessory described
2	regulations thereunder,
1	temporary holds
1	regulations thereunder.
1	paragraph (1)(a)(ii)
2	presubmission conference
1	manufacture-provided information
1	original order
1	procedures meet
1	full compliance
5	filing by
1	(ii) afford
1	violation any
1	experts. (4)
1	unit. (5)
1	changed circumstances,
4	pediatric formulations
1	(d) national
7	(2) not
1	efforts supported
1	products determined
2	schedule i.
1	appropriate, electronic
1	patients medical
182	submitted under
1	auditor, as
1	(d) reviewing
1	of[2] fiscal
1	(f) definitions
1	hampered by
2	container, wrapper,
1	extended as
7	conferred on
2	disclose individually
1	part, if
1	statement concerning
1	(b). for
2	registration if
1	order into
4	(3) information
1	require; 
21	published by
2	enterprise shall
1	specify appropriate
3	7.5 grams
1	years, evaluate
1	removing any
4	official may
2	quality factor
1	limitation, would
1	importer electronically
1	sponsor voluntarily
1	term catfish.
1	another food
1	program food
1	administration will
1	sue and
10	schedule ii
102	(as defined
1	trade representative;
1	list any
4	schedule in
1	supplier; and
1	privacy protections.
8	recovery of
1	(28) verification
2	confidentiality nothing
8	schedule iv
2	appropriate given
1	sustained basis.
2	information exchangethe
1	morphine, cocaine,
13	(d) a
1	offense of
1	item by
1	tissue is
1	issued. (3)
2	exposure is
1	42, of
1	(f) prioritizationthe
1	inform congress
2	(7) for
1	title each
1	scienc-based federal
1	effectively with
3	include each
1	animal disease
1	met), if
1	date. after
1	
 2201.
1	1541 of
1	(a) immediately
1	assay set
18	demonstrates that
1	importer offering
1	order setting
1	(2) order
1	located or
4	license; and
6	seasonally adjusted;
1	parties, and,
1	budgets of
1	daytime or
3	application; (b)
3	reliability of
1	manage their
1	establish production
3	processor, packer,
1	point, step,
1	(2) informal
1	
 379f.
1	review status
16	introduction or
1	additional report
1	collected from
1	methamphetamine by
3	period such
2	patients, and
1	kit as
1	appropriations, the
2	offense chargeable
4	publication the
6	trial by
2	managing or
1	(1) purposethe
1	25.0e 
1	intervention, or
1	360bbb4. countermeasure
1	paragraph (13);
1	minors. (

1	judgment, the
4	preponderance of
2	filing determination
1	title. article
1	party whenever
1	foreign manufacturing
20	based upon
18	distributor shall
1	state comprehensive
2	statements, if
2	satisfaction that
3	order within
4	establishment by
2	intentionally violates
2	medical evaluations
1	statements, in
1	reimportation of
1	10 and
1	areas that
1	chapter supersedes
1	(d), require
2	(ii), a
1	186, 187.
1	(b) considerationsin
3	(c) electronic
2	ensure 
1	353(d)(3)(e) of
3	section 360oo
2	pharmacy and
1	state relating
2	prevention. 
1	assembled from
3	issues relating
1	(e), (f),
2	drug contrary
1	
 360g1.
1	person. (mar.
1	(or is
3	notwithstanding clause
1	title, monitor
1	tobacco additive
1	transaction, or
1	experts using
1	designed and
2	report seeking
2	2015 
1	(or if
1	objection may
2	ingredient with
1	(bbb) a
1	subparagraph are
1	specifications and
1	section 271(e)(2)(a)
4	foundation shall
4	funds available
2	clause 4
1	exemption an
2	subchapter: 
1	
 2109.
1	reviewers prior
1	specific goals
2	promptly supplied
1	(4) special
1	transferees, and
1	fees, supplemental
1	individuals a
1	difficult to
4	(commonly known
11	among other
1	based. (c)
2	medical information,
1	sizes, including
1	successfully complete
3	100 or
1	including procedures,
1	105)[2] would
2	budget submissions
1	limitationthe regulations
2	(7) if,
1	etc. no
1	designation. such
4	received in
2	drug authorized
1	therapies derived
6	aside, in
2	packer all
1	warehouseman for
17	general may,
1	principal and
1	equines, whether
57	offered for
1	360e(e) of
1	seeking designation
1	subchapter, regulations
1	advertising accompanying
1	vitamin; (b)
1	meeting relating
1	institutions; or
1	information act)
1	verify any
1	(k) evaluation
1	controls, between
3	section 453(g)
1	term dtc
1	(ll) 
2	faith, unless
1	controls; samples;
1	conducting pediatric
5	facility located
2	otherwise undertaken
1	completed its
1	act. (9)
3	verify and
3	technology transfer
1	punishment which
1	presented with
1	considered inspections
1	swine or
1	360(m) of
1	(m) documentation
1	percent. (7)
1	strategy upon
1	name upon
1	noninferiority trials.
2	authority may
6	commissioner determines
2	arrests without
40	title 18
1	proven to
1	acted under
2	current drug
1	safety; (ii)
1	plants from
1	letter, the
1	administratorthe administrator
2	1 medical
1	(including blac-box
2	packaged together
1	establishing partnerships,
1	seizure, maintenance
1	state recalling
3	acute bacterial
5	congress or
2	setting fees
1	including breaking
1	thereof, insert
1	purchase forfeited
1	warehouse in
1	specify. (ii)
8	congress on
1	
 971.
2	conspicuous locations
1	specified as
1	subsection (b)(6),
1	relevant advisory
1	crack or
3	charges have
5	regulations, or
1	numbers, if
3	complaint filed
3	served (1)
1	congress, including
1	applicant, written
2	transfers direct
1	misleading under
2	desirable in
9	calendar year,
1	unsafe. 
1	requested when
1	development plan;
3	provisions as
1	sentenced as
1	addition notify
1	polydrug abuse.
6	foreign facilities
1	health. (b)
1	science profession,
1	enhanced verification
2	developing such
8	relations, armed
1	evaluated based
1	consumer perception;
1	u.s.c. 247d6b(c)(2)(a)(ii)];
1	distributo-labeled product.
1	gather the
1	bthe source
1	(h) that
1	360e(c), 360e(d),
2	data sources
1	technology involving
1	veterinarian, and
1	network (foodnet)
1	additive; (b)
1	testing, (iii)
1	solicit and
2	parents and
2	practices identified
2	proposal. 
5	subparagraph may
1	life, and
1	trafficking, and
3	360fff2 of
2	personal delivery
9	register an
1	element the
1	title (unless
1	conspicuous locationsnot
1	register at
1	practicable, determine
3	register as
1	government, which
1	restrict distribution
1	(d) consultation
1	administration. (june
1	agents, employees,
1	preclinical studies,
2	$30,000 higher
1	crisis or
1	conducting monitoring
1	proceeding, his
1	extension 
1	plan agreed
1	grantees not
2	accredited official
2	law, personall-identifiable
1	(i) insofar
1	producer. 
1	shortage within
1	illness, the
3	change under
1	(ii) parents.
1	particular subpopulations,
1	trade means
1	(including reasons
1	commissions duties
5	determinations under
1	section 4761
1	previously listed
3	states, except
1	stat. 991;
1	countries will
1	childs readiness
1	360c(i) of
2	addressed in
1	water be
1	3-day notices,
1	97 to
2	unsound, unhealthful,
2	products, shall
2	public 
1	reviews. (ii)
1	occurs before
1	logistics providers.
3	requested the
19	necessary and
2	purposes of,
1	permit any
1	research, to
1	binding studies
1	section 3551(g)(2)(d)
1	jury. 
1	government using
1	determine under
1	professionals agree
2	355(o)(3) of
1	filed the
2	scientific standards,
1	campaign (referred
2	administrative procedure
17	feed directive
1	includes calcium
1	governments, shall
1	data may
19	applications, supplemental
2	secretary) to
2	person, as
1	25, 1985;
1	pending requests,
2	person, at
1	360ccc2. designated
2	seq.], approval
4	conduct and
2	refilled more
1	requiring warrantsa
1	devices, although
1	holders submit
1	safety requirements.
15	means, with
1	inspection reports,
1	(1)(c) or
4	instructions for
1	tribal agency,
1	packers on
1	youth has
4	chapter because
1	adjustment calculated
1	assisting another
1	provide consistent
1	technique required
3	demand of
1	target material,
1	performance characteristics
1	predoctoral and
2	appeal to
1	991; apr.
1	demand or
1	corporation. (b)
1	section 360e(b)(1)
1	exist, are
1	patient will
2	monitored; and
1	authoritiesnothing in
5	review; and
4	use authorized
1	mi-1970s to
1	(c) limitationthe
1	delivery be
5	1984, the
1	resources relating
12	iv of
1	(b). (ii)withdrawal
1	use authorizes
9	board of
1	broken. (3)
1	dispensed such
7	read and
1	supplement submits
1	materials. (2)
1	maintaining dru-involved
2	third rare
1	treatments. the
2	reduction the
2	one species.
1	making periodic
13	registration and
8	person the
1	application provide
1	for. 
5	thereof are
1	food safet-related
54	(referred to
4	transactions in
4	countermeasure has
1	refilling is
1	diseases, he
3	substance does
1	article, is
9	radiological, or
1	court costs;
1	(a) supporting
1	list become
1	semiannual basis
2	judgment reflecting
3	otherwise serving
4	applications, reports,
1	meet current
2	time, and
1	division, and
1	activities persons
1	shall (except
1	additives) in
2	license. 
12	necessary may
36	reasonable time
2	required information;
1	percent. (iii)
1	ratio must
17	ingredient (including
1	me. i
1	producer shall
1	957. persons
1	title denying
1	reduction basic
5	exemption shall
2	information alleging
1	recklessly tolerated
1	additional conditionswith
1	punishments or
2	device, that
1	tolerance. (3)
2	(2) inspection
1	(ii) maintaining
3	sales, in
1	initially approved
1	adequately to
1	measures available
1	provide security
1	establishment, any
1	separate violation,
2	foods designated
2	term wholesaler
1	enables the
1	exported, (b)
1	recruit, train,
1	policy, which
1	underserved groups;
1	(4) prohibition
2	stipulation between
4	supplement shall
1	living animals;
2	full costs
3	nations and
5	into, or
1	quarantine means
1	drug activities,
12	made with
1	professions. in
1	26. omitted

1	702, 52
10	(b). (b)
4	conviction alleged
3	arrangements with
1	domestic commerce.
1	poultry, for
1	title, submit
1	paragraph. (4)
1	state authority;
1	(c) aggregate
1	reasonable observer
1	contamination, deterioration,
7	approval by
1	shall confidentially
1	(b) procedurethe
1	that, upon
3	inspector, deputy
20	third party
2	condemnation (a)
1	south africa;
1	appearance. 
1	agreement reached
1	upper airway
2	product applicationthe
1	unusual or
1	permitted. (3)
1	activities. if
2	supplement fees
2	(unless exempt
2	(4) certain
1	studies reveal
1	relationship. (9)
4	335a of
1	meeting, and
6	research with
1	far as
2	implementing preventive
1	1973, $5,000,000
2	year 2003,
1	record for
2	judgment, a
1	
 1043.
1	prison, such
1	physicians in
1	infringe a
4	661 of
1	use included
1	chemicals, tableting
2	15on the
1	connection with,
1	food detected
12	listed chemical,
1	surveillance protocol
1	members as
1	(including neutron
1	avoiding unnecessary
2	chemicals (including
6	year, including
1	production, preparation,
1	drug such
1	application, submitted
2	pharmacy regulations
1	states against
2	months during
1	(c) approvalthe
1	grant renewal
1	(a)(1). the
1	sentence unless,
2	local data;
1	proposal. (4)
1	abuse organizations
1	approval requirements
1	section 10.30,
1	equivalence 
1	concerns relating
6	serving away
1	use means
1	states could
1	reactions; or
24	state in
9	authority and
1	(f)(2)) to
1	january 15
1	chapter. (v)
1	supplement fee,
1	findings. 
1	serves a
1	may recommend
3	formula manufactured
1	ii controlled
2	local levels
1	(or subsequent
1	declaration initiate
1	applicant; (g)
4	(d) termination
1	anabolic steroids.
1	section. this
2	functions the
1	seq.); and
1	physiological processes
6	premarket report
1	introduced therein
1	using existing
1	practicable, include
1	country, including
1	establish bylaws
2	evidence derived
1	(1) both
1	(2) voluntary
1	part 312
2	emitted from
3	(b) eligible
3	priority countermeasure
1	violation. any
1	
 1174,
1	condition, limited
1	part pursuant
2	(2) premarket
1	term meaningful
2	(b)(2)(b) or
1	action shows,
1	meeting may
2	subparagraphs (j)
3	amount, and
2	countermeasure means
1	meats are
4	food; (b)
1	conditionssubsection (b)
2	stolen; (b)
1	stat. 833;
1	(h)(1) relating
5	pharmacy in
1	four international
2	used, the
2	illegal gratuity
1	existing plansthe
5	basis that
1	preparation to
1	surface and
1	categorization. 
4	joined in
2	conviction has
1	covered applicationthe
1	purposes as
2	evaluation requirements
1	proceedings minor
1	675, 311,
1	title, nor
1	subsection (q)
2	principal administrators,
2	person determines
1	jurisdiction, and
9	title, not
1	product, based
1	advertising uses
3	warehouseman, or
1	1501 et
1	person: provided,
1	(4) health
24	delivered for
1	area, thereby
2	(b) distribution
2	prevail. 
1	collect, synthesize,
1	substantial financial
1	106.30(c)(2) of
1	notifies a
1	phenyl ring
6	(4) in
1	path initiative
1	ii devices;
1	manufactured, possessed,
1	application seeks
1	available disposal
1	general design
5	considered the
1	service status
1	$14,800,000. (

3	representatives. 
1	inspection regime
1	(iii) capture
4	hazards identified
9	travel expenses,
1	year were
1	administration, as
1	misbranding, labeling,
1	(c) partial
17	fees assessed
2	certain products
1	foreign office.
4	paragraph (6)(b)
1	annum, to
1	feedback and
1	(a) purchase
1	testing; and,
2	compete unfairly
1	neutron and
1	modification (including
1	ring stage).
1	sustained as
1	(c) be
1	(c) by
2	attributed to
1	reimportation 
1	denying conditional
2	plant, equipment,
4	approved, and
1	basic and
4	otherwise disposed
1	commerce because
1	repackaging, relabeling,
1	(1) material
2	export, and
1	letter pursuant
2	5 (relating
1	tobacco), shall
1	rates authorized
4	punch, die,
1	technologies described
1	public workshops
72	report under
1	officer, or
1	300hh10 of
2	section; (4)
2	narcotics trafficking,
1	standards regarding
1	export, any
1	approve under
1	food consists
1	association; (b)
1	distributing inspection
2	directs to
3	withdrawal, suspension,
1	(5) electronic
10	carcasses, of
1	requiredto issue
1	title), the
1	(a) fda
1	must determine
1	funds. nothing
14	carcasses, or
1	different schedule
1	chloroform, cantharides,
1	coalitions, departments
1	listings after
1	imposed upon
2	number; and
1	for, notice,
1	surveillance report
1	(2) forge
1	2015, $1,857,000
76	report to
5	year divided
1	labeling of,
76	contained in
1	involved; (b)
4	(c) review
1	3,-methylenedioxypyrovalerone (mdpv).
1	slaughtering animals
2	subsection. (5)
1	cases when
1	(c) memorandum
2	stimulant substance
1	examining and
1	product undertaken
1	poison, and
1	salts. (b)
2	suppressing the
2	body the
1	(8) contact
1	carbon monoxide,
1	debarred for
1	chemical would
2	(including per
4	consideration by
1	found substantially
5	expenses incurred
1	reasonable timelines,
1	substance manufactured,
1	initial imported
1	harvest, unless
12	amendments to
1	secretarys final
1	1703(c) of
1	stocks. (

1	exchange and
1	professional) other
1	applicable), upon
1	sel-certification including
2	commodity, a
1	diminishes any
1	675, 529,
1	requests denied
5	partial waiver
1	1970. in
1	partnershipsthe systems
1	different susceptibility
2	silicone gel
2	material, reagents,
1	 (1)requirement.subject
1	device authorized
1	(7) congressional
2	program; (4)
1	(5) referral
1	u.s.c. 2021],
2	take steps
2	government recognized
1	apparent reduction
1	(i). (3)
1	drug omits
1	refund is
1	required submissions
1	existing quality
1	adul-only facility;
1	certain cancer
1	(1) contrary
11	directed to
1	issuance, amendment
1	360e(f)(6)(b) of
1	(d) 27
1	displayed in
1	initiatives with
1	reject, inedible,
1	ii chemical
27	proposed labeling
1	exempt such
1	regulation, this
1	supply as
4	panel considers
1	supplants the
1	applicability subsection
1	methamphetamine seized
1	purchaser, manufacturer,
1	personnel data,
4	laboratory assistance
1	appropriate. in
1	promulgated. such
1	order require,
1	information procedures
1	remedies 
3	plan; and
1	(c) offenses
6	350g of
2	make all
1	management plans.
1	confer or
4	food, but
1	assay methodology
2	individuals, if
1	parties no
2	imprisonment, to
1	imports 
1	
 460.
1	advertisement. (11)
10	evidence in
4	paid or
1	(a) policies
5	approval specified
2	evidence if
1	label 
5	submitted after
3	articles required
11	exercise of
1	eligibility determinations;
1	policies, including
1	equipment, product,
9	evidence is
1	1, 2013,
2	individuals domiciled
1	675, 569b,
1	year when
1	(j) coordinated
1	-(1,-dimethylheptyl--[(1r,3s--hydroxycyclohexyl-phenol (cp47,497);
1	cost, for
8	shall only
2	foods for
1	enhance seafood
1	(ii) 75
1	resubmission means
2	food the
1	cause made
2	registration an
1	expiration dates
4	writing, the
1	new information,
1	administration receives
2	42; (ii)
1	(b) three
2	be, a
1	requesting accreditation,
1	360c(f)(2), or
1	exemptions, a
1	track supplement,
2	health. (f)
1	receives financial
1	infrastructure under
4	adulteration and
10	amounts appropriated
1	terminated on
2	board to
1	employees within
1	2013, including
1	implicitly or
1	approved investigational
3	stat. 1049;
2	accredited and
2	secretary establishing
1	gamma butyrolactone.
3	terminated or
17	impose a
1	auditor; (ii)
1	information; (b)
2	(2) biennial
1	substantial changes
1	vehicle, receivers,
4	commingled raw
11	agricultural commodities
1	secretary determine
7	derivatives, their
38	salaries and
1	employee (or
2	expiration date.
1	safety. a
1	consignee executes
10	property to
1	southwestern border
14	shall furnish
2	whether accidental
1	expiration date;
19	memorandum of
4	judiciary, foreign
4	fulfill the
1	2002 in
2	event. 
2	general provisions
10	(1), and
3	(ii) otherwise
2	review, or
6	notice. 
1	updating interpretive
1	sections the
1	(ii) recognized
1	willful misconduct.
1	research. (22)
3	title 20.
130	new drug
5	(6) to
8	time of,
2	whose premises,
3	subparagraph (b)(iii)
1	research data,
1	time. (5)
1	considers proper.
1	703, 52
1	services, equipment,
1	country is
1	potency levels
1	application) was
26	secretary, the
1	users) who
1	shared; (iv)
6	product not
1	(2) results
1	original regulation,
3	expenses for
1	checks to
2	(d) regulation
1	municipal ordinance
1	(3)(c) 
6	funded under
1	well controlled
2	expeditiously under
1	observation. additionally,
1	effectiveness, in
1	term consultative
1	purchase to
8	states means
3	2014, and
1	report. (5)
2	companies, and
1	evidence. (4)
1	1178. records
4	made only
2	authorized personfor
1	name other
2	may forthwith
1	auditor; and
1	(a)(2)(a). (7)
12	practitioner who
4	given that
1	section 353(b)(3)
1	vehicle, such
2	new dosage
1	border with
1	promulgated thereunder
1	notice, (b)
1	offices, the
4	required before
11	may obtain
1	term early
1	fourteen days
1	drug, chemical,
1	person acquiesces
2	conditions concerning
1	inspection has
1	implement that
8	title. (4)
1	section 379h1
1	license, taken
2	reductions the
1	(b)(1), or
10	prescribe. 
1	grant described
1	(6)) that
1	section 360c(a)(1)
5	order should
1	manufacture, cast,
1	process may
10	impairment of
1	561a, as
1	preparing the
3	update is
1	(4)(b) shall
2	-(-phenylethyl)--piperidinyl ]
5	charges for
1	(h)), in
1	activity as
4	dispenser to
1	policythe congress
1	schools. (vi)
1	tools, methods,
1	approval order.
1	generalthe strategy
5	imprisonment imposed
2	(4) subject
1	known about
2	commerce, (1)
1	(or use
1	(v) is
1	(4) activity
1	variance does
1	adequately protects
1	adult. 
1	record containing
1	paragraph, recommendations
1	(ii) create
14	coordinate with
3	(3) identifies
2	results are
3	product are
1	(h). (6)
1	five percent
1	nonpayment 
15	enforcement agencies
8	product (as
1	room of
1	statement prepared
1	direct access
3	unsafe under
1	dispenser. (8)
1	owner submits
1	grant priority
1	takes place
1	cream, if
1	public statements,
1	kindergarten. 
1	term may
2	device on
1	advertisingthe secretary
1	(5), libel
1	(f)(4), instances
1	overall intended
1	528, as
1	transfer. 
5	device of
1	next day
1	divided without
1	report setting
1	respond with
1	262], there
1	entry. information
32	device or
2	state where
7	leading to
1	gel caps)
1	service would
1	understanding described
1	facilities, foreign
1	eliminate cros-contact
1	(e) full
1	(iii) five
1	oxygen may
1	(i) conducting
1	withdrawn, respectively.
1	providing expedited
3	elements under
7	subparagraph. 
1	original device.
1	ecalcium to
2	convened under
1	importer. (2)
3	rest of
30	device for
1	secretary. (b)development
1	individual states
1	1918 and
1	longer pursuing
1	section 824(a)(4)
2	assist small
1	communication; (3)
18	available in
1	
 801.
1	many countries,
2	import at
1	pharmacists and
2	alkaloid of
4	isomers; (iii)
1	pseudomonas, and
5	recipient under
1	subparagraph the
1	379j52(a)(1) of
1	certification contains
1	 (a)reporting.beginning
1	restricted device.
2	restricted device,
1	status of,
1	(i) consistent
2	intelligence to
9	collected by
14	efforts to
3	authority established
1	maintained shall
12	agreement with
6	paragraph (2)(c),
3	paragraph (2)(c).
1	(3) one
8	equines, or
10	101(b) of
2	chapter.[1] (b)
8	comments from
1	deleterious substances
2	regulation reasonably
2	restricted devices
3	term designated
2	consumers 
1	(b) revised
1	anyone in
2	fees paid,
4	food. (2)
1	supplement: manufacturing
2	whether permanently
2	action at
3	publish information
1	enforcement; (iii)
6	action as
1	tobacco, paper,
1	article within
3	register each
1	sanctions during
1	 drequired
1	performed 
2	(3) promote
1	reductionthe deputy
2	clinical studies,
5	prescribe on
1	exceeding one
1	control; (c)
1	paragraph (2)(a)(vii)
1	(f)(2) shall
4	(vii) a
1	dogs, and
2	facts which
1	 it
3	imprisonment not
1	period; renewal;
1	number maintained
1	application required
3	public shall
1	region. 
9	prescribe or
1	thereunder sufficient
1	it. if,
1	agency. (ii)
16	conclusion of
1	required, the
1	calendar month
2	thereof so
2	small number
1	terrorism, except
2	condemned all
2	certain qualities
1	
 2222.
1	duties; (3)
4	specially qualified
2	custom slaughter
6	applicable list
4	343(r) of
10	documents and
2	amounts from
1	enjoyed; 
7	activities related
1	directors (a)
1	12 miles
2	chemical analysis
2	equal authority
1	shall discontinue
3	license in
5	steps taken
1	nonliquid form
1	injunctions, respectively)
4	feed, and
1	administrator, after
2	license if
1	specify, as
1	379j51. definitionsfor
1	intrastate sales
1	marijuana, methamphetamine,
4	title) shall
1	appropriate division
2	__________. if
2	general terms
1	coalition is
1	license is
1	
 803.
2	books and
1	resources obligated
1	relative potential
1	practical, analytical
1	apparatus or
1	patents. 
1	glass, stone,
1	allergies. (g)
4	due notice,
1	discrimination and
1	industry, laboratories,
1	history as
1	cases for
2	person; (c)
3	compliance under
2	(k); and
1	$270,000,000 for
1	year, provide
1	care. (5)
1	occurred within
2	pricing information
3	violation of,
2	official shall
1	introducing such
13	manufacturer and
1	transferred, based
1	type used
1	initial draft
1	hearing; (9)
1	
 356a.
1	(1)(b) applies:
2	application except
3	consultation and
1	steroid means
1	specific types
1	2680(k) of
2	355(o), 355(p),
1	(4) evaluates
1	possession current
1	352(t)(3) of
1	resistance. 
2	abuse activities
1	1116. repealed.
1	
 379j51.
3	disclosure, that
1	subsection (d)(4).
2	subsection (d)(4),
1	tracing technologies,
1	request over
1	seller specifying
8	different active
1	mechanism. fees
1	finalizing the
1	one voting
6	december 31
1	klebsiella, pseudomonas,
1	197, 198.
2	incorporation of
1	partner means
1	classes; (2)
1	entry therein.
3	shall first
1	2007 with
2	applicable performance
1	make seizures
2	whether specific
27	duties of
1	will operate
1	6, 44
1	advising the
1	perform advanced
1	surveillance approval
1	(3) paperwork
1	distinct subpopulations
1	360e(i)(2) or
8	furnished to
1	issued with
1	360j(g), 360j(m),
1	commodities produced,
4	(b) effect
1	(4) activities
1	laws; (b)
1	(b). (

1	paragraph (a)(2)
1	3, 1966
2	marketing and
1	year) is
1	ingredient component.
2	(iv) promptly
1	exportation or
8	place in
3	supplier may
1	(10) final
1	treasury, at
2	shall, 60
1	wholesaler is
1	(3)(b) of
1	designed. 
6	trafficking and
1	dry milk
1	importer, as
1	seriously impairs
1	372 and
1	(b) development
1	employs such
1	(9) etorphine.
1	-(2,-dimethox--(n-propylphenyl)ethanamine (2cp).
1	regarding how
2	controls applicable
5	egg handler
1	periods; effective
2	therefor, may
1	(ii) average
1	(c)(1)(c), and
1	no-timely review
1	(e) informantsthe
1	defense, that
1	accordingly. if
2	section 387s
11	distribution and
1	law, an
1	section 387p
1	cooperative association,
1	2017 through
1	(b) exercise
1	meat act
6	350h of
9	utilize the
2	division 
1	section 387d
1	(b) sponsor
1	675, 1001,
1	section 387o
5	appointed members
1	compatibility with
1	section 387l
1	health presented
1	lawful disclosure
1	determination within
1	additive only
1	manufactured infant
3	scientific uses
2	schedule notice,
11	any, of
2	(e) exemption
2	appears from
2	sentence applies
1	objectives, including
1	2 weeks
2	premarket submission
2	drug exported
1	unclassified form
3	data submitted
1	(b) declaration
5	quarantine inspection
1	isomers. schedule
1	license may
2	center, public
24	adjustment factor
1	adults; (2)
1	states, by
1	effects; (xi)
7	drugs with
1	assistance authorized
1	youth; (6)
1	sponsor designates
1	(2) noncompliance
2	(f) providing
1	examines how
3	(d) annual
2	conducted, such
1	(c) conditions
1	(4). if
1	outreach, technical
4	exemption would
2	(k): 
2	tried in
1	equitable and
4	investigating to
1	(b) affirmation
1	paragraph (1))
59	paragraph (1).
4	registration information
150	paragraph (1),
1	advertising space
5	manufacturer in
1	adults to
2	care (such
1	(a) petition;
3	copying of
1	response fund
4	paragraph (1):
17	paragraph (1);
1	another registrant
1	authority has
2	(a) poisonous,
1	repatriate and
1	provides confidence
3	sudden increase
1	thereafter amended,
5	copying or
1	year, animal
2	specify by
1	(b)(1) application.
6	requires a
1	agencies needed
1	biomedical community
1	proposed. 
2	terms, conditions,
8	shall, for
7	charge or
1	measures an
2	federal standards
2	(4) designation
1	agency regarding
1	rcs4); (xiv)
1	imaging drugs,
1	(6) do
1	substancesthe attorney
1	drugs,[2] safety
1	substantially administered
3	due each
1	local growing
1	person solely
2	derivative, or
23	charge of
2	(7) are
1	individual upon
1	(1)(c) and
1	substances, to
1	handle and
1	(iv) full
2	compliance or
6	forged, or
1	manufacturers liability
1	shown through
3	accredited to
1	(a), no
1	sentences. (2)
2	voting stock
5	compliance of
1	remove an
1	language of
1	adverse determination.
1	falsified any
1	cleansing, and
1	drug schedules
1	importer becomes
1	prescription unless
1	prescription a
1	international consensus
1	355) of
2	believes may
3	datesuch fee
1	guard against
1	positions classified
2	entries and
2	lines of
1	enforcement duties
1	severe neighborhood
1	will unavoidably
13	finished dosage
1	personal slaughtering;
2	(a)(2), if
2	state statutory
12	patent or
2	person would
2	order; (b)
1	new high
1	
 113a.
1	past term
1	unbroken packages
1	certain substances
16	sale and
1	allow acceptance
1	knows 
1	title 8,
1	taken out
1	2003. authorization
2	title 8)
1	menthol in
1	consents in
1	
 7
1	(ii) whether
16	meat inspection
1	imposed. (mar.
3	local food
6	5. the
1	aside such
2	shipments of
1	(2) sums
3	states courts
1	presents substantial
2	developed pursuant
1	substances used
1	section 351(f)(1)
6	term food
1	eating place,
3	issued before
1	(13), or
1	(q) 
3	proper expenses
1	
 350l1.
1	office) under
1	methodology, as
3	pose an
1	ful-time employees)
1	coalitions has
1	representative, at
1	3 study
5	270 days
1	demographics, pharmacovigilance,
12	3, 1996,
1	days. (d)
4	3, 1996.
1	individual, has
1	shall elect
1	3, 1996)
2	(1) its
1	agency commissioned
1	approved. upon
1	section 379j41(3)
1	another applicant,
1	consignee seeking
3	programs the
4	agreement, guidance,
1	11, 38
1	denial with
1	orphan designation
1	eating places
3	regulations before
1	foreign data;
1	alter that
3	licensed pharmacist,
1	section 346(a)[1]
1	awards a
1	i, 17,
1	installation are
1	identified (directly
1	compositions, and
4	(except a
2	qualification the
1	(including its
3	jurisdiction specifically
3	pet food;
1	section 811(f)
3	promptly and
1	symbols from
1	listed drug.
1	1995, provides
1	paragraph) make
1	annually (or
24	prevent the
1	379j51(4) of
1	device exported
1	international instruments
3	qualified countermeasure
1	(j) with
1	consumer; or
1	(2) 3
2	period which
1	(d) liability
1	eligible entitiesan
1	without interruption
1	(h) fiscal
2	states; (iii)
1	sold through
1	(including suppression,
1	high seas),
3	requirement, or
16	use to
1	subclauses (a)
2	establishing or
3	significant or
1	partial waivers
1	raising on
1	already developed
1	individual candidates.
1	192, 35
1	change any
11	domestic and
2	383(b) of
1	744i, as
27	substance to
4	publi-private partnership
8	meeting with
1	board 
1	employees) with
2	387c, 387e,
1	(5) enforcement
2	section 360bbb3(b)(1)
18	debarred under
2	state regulatory
1	organizations, to
14	parts thereof,
1	budget). (ii)
2	distribute drugs
9	subsection (f).
2	expend up
9	subsection (f),
2	particular expert
1	subsection (f))
2	proposed, or
3	factors to
1	and, moreover,
1	(d)contents of
4	electronic format
1	conveyances, including
1	reducing domestic
1	hearing; (3)
2	subsection (f);
1	numbers and
1	indexed in
1	(ii) recruitment
1	funds obligated
1	oct. 18,
1	competition the
1	therefor for
1	section 1701(1)[1]
1	enforcement agencies,
1	pet food.
2	enforcement agencies.
1	jury and
1	(1) notify
1	(f) certain
1	notice may
8	permit access
1	antimicrobial resistance
1	provide standards
3	acquiring, handling,
14	applicant that
1	measures, or
1	cessation if
1	distribution unless
4	enforcement agencies;
1	(a) knowingly
3	approved covered
1	restructuring act
1	requirement beginning
2	paragraph (4);
2	destruction provided
1	foundation are
45	(b) shall
1	purposethe director
1	otherwise provide,
1	premises so
1	questioning, and
1	115 to
1	(i) establishing
1	automate appropriate
1	since 1974,
2	(2) retailer
8	(3) authorization
1	carburetion masks;
11	paragraph (4).
3	section after
1	regulatory burdens
1	interested adults
2	establishment. (4)
6	subsection (b)(1);
1	observed no-compliance
2	producing adulterated
1	initial dispensing
1	analysis; (ii)
1	manufactured before
1	committee pursuant
1	preventing foodborne
1	secretarys requirements
1	requestor mutually
8	subsection (b)(1),
4	subsection (b)(1).
1	(b) acquired
1	effective to
2	upon to
1	balances of
1	regulatory burden,
7	(c) leasing,
2	shall dispose
6	assistant secretary
2	service a
1	sweet milk
1	programmatic funds
1	254.)
 

1	(including destruction
1	element described
1	(3) mediation
1	hold, or
1	license cannot
1	planned and
2	2019. if
2	leads to
1	reduce production
1	(e) through
1	current rate
2	one suitable
1	subsection until
1	tobacco, which
12	information obtained
6	leaves from
1	recommendation or
1	issue practice
1	distributors. an
1	commission, members
1	benefit; (c)
1	order referred
1	351(a)(2)(a) of
8	(a) unlawful
1	recommendation on
1	360n1. priority
14	national institutes
1	beautifying, promoting
1	agent; or
1	drugs entering
9	recommendation of
1	1907. definitionsas
2	avoid, insofar
1	businesses that
6	may limit
37	status of
1	health benefit
1	247d6a, 247d6b,
1	cannabis sativa
2	subparagraph. (c)
1	(c) development
1	supplement, with
1	formula test
2	deems eligible
1	status or
1	(f)(4)) shall
3	termination the
1	africa; or
1	(b) leveraging
1	(2) drugs
1	isomers.1 
1	whether drugs
2	product contains
5	regarded as
1	1903(g)(1) of
1	data respecting
1	protection, conservation
1	exposure that
3	professional ethics
1	seeks an
1	frequency specified
1	reducing overall
1	racemic drug.
1	disposal was
1	racemic drug,
5	(c) provision
1	pharmacy every
7	occurrence of
11	food at
1	iii or[1]
28	officers and
21	foreign country
2	racemic drug;
1	negotiated deadline,
1	thereof, if
1	differ from,
1	evaluation conducted
1	package included
1	official, manufacturer,
2	apples of
2	displayed on
1	section 360b(c)(2)(f)
1	term 3-day
1	requires standards
2	establishments any
5	substance subject
1	cows has
1	(2) oxygen
1	commuter lane,
1	44 shall
1	section, possess
7	report, the
3	petition may
1	device clinical
2	package includes
16	shall constitute
1	proposal is
20	product; and
1	entered interstate
4	product be
1	517, as
1	 (ii)timeliness
1	activitiesin conducting
2	times, any
8	establishments and
7	compounded drug
1	(i)(2), (i)(3),
2	encapsulating machines,
1	subject solely
1	verification, aggregation,
1	(b) devices
1	actions referred
1	application after
1	funds, be
1	(3) contain
1	policy, deputy
1	675, 309,
1	separate or
1	minor changes
1	tested or
5	n-cost match
1	pleading filed
1	president submitted
2	(4), (6),
2	utilizes the
3	instrumentality of
3	implement and
1	transitional provisionif,
1	install, and
1	steroid, which
1	ethical requirements
52	upon a
1	offenses have
1	standard, for
3	postmarket studies
2	seminars at
1	definitionswhen used
3	states, american
1	animal, this
1	vancomyci-resistant enterococcus;
1	recovery activities
2	subchapter (other
1	advertising act
4	chapter, other
1	have, and
3	(2) priority
1	animals exclusively
2	otherwise adulterated,
1	cigarette tobacco.
1	title, approval,
6	360f, 360h,
3	(b) authorization
2	person be
1	april 30
3	case be
1	4d animals
2	possess; or
2	tolerances or
21	person by
1	
 618.
2	830(b)(3) of
1	period but
1	(a) financial
1	practice; prescriptionwith
3	46 and
1	treatment; annual
3	lawful written
2	operations affecting
1	animals, may
2	(c)(2) of
2	require, except
39	accredited person
3	customer or
1	consolidate the
1	standard, of
2	level iv
2	entitled food
10	(ii) provide
1	progra-sponsored programs
3	level in
1	secretary anticipates
1	need related
3	persons are
1	secretarys authorization).
2	foreign grown
129	(a) shall
6	12 months
3	require periodic
2	regulatory, and
1	(ii) crediting
1	mineral; (c)
2	total estimated
1	74, 5,
1	
 2242.
1	otherwise indicates,
2	regulations requiring
1	100 patients.
2	records, if
1	modified solely
1	will jeopardize
10	(i) through
3	year, a
1	similar material,
3	(e) refund
1	fact which
4	distributors, and
3	health; (7)
1	42 will
3	due or
1	fee, for
4	entities engaged
1	class until
1	specific disclosures
1	product name,
1	testing methodologies
1	equip an
1	internet without
5	360h, 360i,
2	professional associations,
1	section 1702(a)
2	graduated sanctions
1	permit so
9	due on
2	premarket notifications
2	entities, which
2	(iii) contain
1	applicability the
7	conditions prescribed
1	provided, issue
4	charge to
3	referred under
1	underage personany
4	grant program
1	foo-related emergencies;
1	national incident
7	designated in
1	(3) workload
1	bylaws issued
3	shippers certificate
1	(4)(b); (ii)
8	shall order
1	families, and
1	treatment, education,
1	local management;
1	million two
1	foo-related emergencies,
2	sections. 
1	inhalants, cocaine,
1	undertake clea-up,
1	premarket notification.
1	(2) major
1	every such
7	product named
1	will assure
1	hazard. if
1	experts are
1	individual providing
1	subsection, is
2	civil, criminal,
1	permanently. if
1	subsection, in
2	result, directly
25	product means
1	furnish, without
2	cycles as
2	subsection, if
4	3, 1912,
3	death; (ii)
2	section 672
3	government. (b)
1	sectors of
2	nonprofit institutions.
1	human studies.
1	360eee or
1	canada into
1	medically insignificant
31	substances or
1	assessed against
3	burdensome means
2	(f), (g),
1	1616a of
1	(b)(2)(a)(iv) and
1	(iii) convene
1	(mdpv). (20)
1	(v) prepare
1	-(2,-dimethox--ethylphenyl)ethanamine (2ce).
1	progress has
4	programs; and
1	section 343(h)(1)
1	including publication
1	clause. (bb)first
1	observations contained
1	schedules; findings
1	clause. (h)
1	(1) schedule
1	food inspections,
1	internal use,
1	insulin, an
10	clause (a)
1	whatever official
1	distributor. (2)
2	350a, 350c,
1	company 
1	individual grant
1	services may,
4	subsection; or
1	(b) reviewin
1	networks, and
2	racially and
2	previous application
1	records; authority
2	run and
1	business december
4	proceedings and
5	(i) be
8	container of
2	rule regarding
1	675, 583,
1	contentsan application
2	reasonable body
4	investigation as
2	retail outlets
1	348, 350a,
1	
 359.
1	exceed $175
1	(vi) infants
1	governments, other
1	premises with
2	purchased or
1	clause (c)
1	of, substances
1	programnot later
1	associated registration
1	lawful regulations
1	953, or
1	(1) continues
1	disseminate scientific
1	subsection (n)(3);
1	outreach, interactive
19	unsafe for
1	(k) certification
1	consortia with
1	chapter; prosecution
1	(a) exhibits
1	drug take
1	term coupon
2	cosmetic is
2	processing by
3	submit for
2	production, storage,
2	board and
66	will not
1	youth; (5)
20	places of
1	question. if
1	located, in
1	small cigars.
5	controls implemented
1	both. the
1	labeling found
1	transactions sell,
2	crime drug
43	secretary that
3	both. whoever
1	scheduling recommendation
1	824. denial,
1	processes, by
1	ceiling); and
1	laboratory. 
1	amounts available
1	isomers.[1] 
1	format, and
31	establishment fee
1	provide reimbursement
1	accepting and
1	species found
1	licenses conditioned
4	perform, as
1	section 505(c),
1	system) which
1	health, whenever
1	15, 1994.
1	united nations;
1	supplement. in
5	death, serious
1	exclusions 
4	section. any
1	united nations,
5	secretary. (b)
1	review; or
1	cooperatives and
1	term supply
1	2013 for
13	appears to
1	secure, interoperable,
1	holding meetings
1	(9) substance
1	represents explicitly
3	services are
31	distributor, or
1	security, shall,
1	(iv) ensures
5	stat. 1263;
2	title: 
1	accruing to
42	u.s.c. 301
2	documentation to
1	action, after
1	(2) purpose
3	violation and
17	article that
2	person through
2	affect in
5	mixed or
2	regulations when
1	(b) laws
1	treasury there
2	changes for
16	355(j) of
6	confidentiality of
1	4-day comment
2	attended by
6	drug; (ii)
1	
 360bbb4a.
6	may transfer
1	notification (a)
16	director and
1	prohibited without
2	deciding a
1	smoking marijuana
13	products 
1	agenda for
1	(4) congress
4	(d) designation
1	plant, and
1	destroying wild
1	products within
1	campaign. (c)
1	1101. congressional
1	suspension 
1	823(f), 829(e),
1	variance if
1	(v) included
2	330 of
1	(b)(1) could
1	recalling the
1	(b) scope
1	no-replicating nucleic
1	impact notwithstanding
1	plant, any
2	child is
1	coca leaves)
3	quantity and
1	state agencies.
2	5. (

2	state agencies,
2	section 350l(a)
16	upon application
1	ensure quality
1	(e)). (b)
1	upon this
1	salts. (3)
1	lease, profit
1	animals, of
3	will regulate
3	product such
2	access with
1	physiological or
2	(c) finality
1	tolerance that
2	reduction an
4	granted, the
1	
 387.
1	him, permit
1	basic information,
1	revise or
4	animals, or
1	(ii) aerial
2	formulations not
2	nonprofit entities
1	comment. if
1	(3) informal
2	upon in
1	approved without
1	roach clips:
2	may otherwise
2	september 30
1	information from,
2	representative and
1	smaller amounts
1	medical, regulatory,
1	if, regarding
9	strategy. 
1	(g) copies
1	logbook, the
7	antimicrobial susceptibility
4	recognized standard
4	unexpected serious
3	deny approval
1	persons (a)
6	container in
1	reserve fund
1	delivery, and
1	675, 581,
1	simulating, or
2	respectively. 
1	iii, 542,
1	(c) applicabilityregulations
19	product which
1	(including attorneys
2	(3) prior
2	measurable and
1	granted. (3)
1	rule making
4	may revoke
2	appealed, the
1	357, as
4	year involved
3	(b) compliance
1	(2) amount
16	amendment or
1	relative health
4	productthe term
1	representatives. (h)
1	subsidized by
3	section 16
6	court the
4	section 14
1	-penty--(-methy--naphthoyl)indole (jwh122);
1	379l. education
1	either separately
1	cooperatively 
1	evidentiary basis
5	redactions for
1	2004, the
1	countries shall
1	postmarket studies,
1	disposition, notification,
2	section 18
1	turkeys; poultry
1	sponsor submit
1	(1) convictionfor
1	indene ring
1	protocols (such
16	1, 2012,
1	paragraph (h).
8	general controls
1	distribution. (4)
1	positive pathogens,
1	conducted, cause
1	1, 2012;
4	generalin order
1	(d) dispenser
1	prescribed, or,
3	coalition for
2	law, rule,
1	amends and
2	subclause (iii)
3	identifiable health
1	term manufacture
1	sale (including
4	qualification of
1	test methods,
1	stipulate within
5	receives notice
10	general to
1	investigational requirement,
1	biennially thereafter,
1	gather data
1	(h) 
1	552] shall
3	procedure by
1	title), homeopathic
1	mark; or
1	2005, or
1	labeling required
1	(i) compliance
3	(d) additional
1	format requirements
2	(june 30,
1	establishment slaughtering
17	medical, scientific,
1	includes full
4	patent number
1	warehousemans business.
1	shall further,
2	roun-bottom flask,
2	(b) result
3	records with
1	shall rescind
1	need resolution
3	3-day period.
1	household. (c)
5	3-day period,
4	labeling requirements,
1	classified annex.
2	liaison with
1	2017. (g)
3	food allergies
1	warning signs
2	use generally
1	gifts, and
2	generals determination.
1	certificationthe director
1	officials, manufacturers,
1	representative profile
1	(if so
1	may fairly
13	act or
1	packed and
4	distributor with
1	giving priority
2	documentation certifying
1	written inventory
5	(e), or
80	act of
1	furnishing, giving
8	part thereof,
4	highly impracticable
2	drug crises
2	343(i)(2) of
1	physical sign,
9	act on
1	(ii), issues
3	(ii) establish
1	subsequent vacancy
1	(c) health
7	change or
1	granted tentative
1	remaining challenges,
1	conditions identified
1	regulation addressing
1	acceptance as
3	law, for
46	tolerance or
1	secretary published
1	venue in
1	providing of
5	petition. 
1	2016, for
1	(c) natural
1	precursor of
1	known. (c)
1	internet website.
1	use. if
1	official as
6	appropriate, of
1	exempt or
1	title, then,
5	supplement fee
1	collected. 
1	settlement agreement
1	(c) ephedrine,
5	clause if
1	potentially counterfeit,
2	1997, excluding
2	administrative process
1	ensure imported
1	841(b)(1) of
1	(e)(9). (b)
2	two preceding
1	stay pending
1	processes with
2	importer receives
2	visit selected
1	(iii) food
1	quality factors
1	(iv) available
1	devices components,
1	399e. nanotechnology
1	(iv) -buty--(-naphthoyl)indole
4	certificates of
1	means available
1	precluding or
2	(mar. 16,
1	title. where
1	written and,
2	concurrently with
1	(b) susceptibility
1	designated areas
5	congress, the
6	expectation that
1	judge issuing
1	(i) cigarettes.
1	directed, upon
1	internet websites
1	submission; and
1	product), including,
1	communications and
1	year; (2)
1	efforts taken
6	detainer authority
1	904. payment
1	significantly minimizing
21	acting through
6	makes such
18	subparagraph (d)
3	projects aimed
12	jurisdiction to
1	(17) myrophine.
1	(7); (b)
3	guidance shall
4	congressional declaration
1	secretarywith respect
1	(c) access
2	(c) provides
1	hearing together
1	274a.2(b)(1)(v)(a) and
1	(2) limiting
2	record as
1	(ii)qualification.the secretary
2	inspections at
1	dries, and
1	program during
4	record at
3	substantial and
1	(1) one
1	actions; judicial
2	(c) considering
1	noncompliance by
1	pregnant or
15	petition shall
1	forward such
1	description provided
1	fees payment
12	title. (c)
2	title, relating
1	lif-threatening infections,
11	private sector
1	discretion. 
2	strength. (iii)
1	processor. the
1	provide maintenance
1	nonclinical studies.
1	(i) report
1	performed to
5	seq.), or
1	research uses,
2	articles will
2	inspection, reinspection
1	york) and
1	(iii) rapidly
3	section, an
1	formerly 712,
3	(3) notice
5	morbidity and
68	made by
1	challenges relating
1	devastation to
1	(6) not
1	coalition. 
11	imprisoned for
8	possession, or
1	
 3432.
2	report preceding
1	timely manner
2	article. 
1	coaches, youth
2	first list
1	products, human
2	(4) upon
2	consistency with
20	clinical trial
1	section, as
6	leaves and
4	proceeding. 
3	secretary, whenever
1	
 1039.
1	protection. 
1	(7) homogeneous
4	confidential and
8	buying, selling,
2	ships in
2	reversal, and
1	corporation from
12	action described
2	confidential any
1	permitted in
1	conditions determined
3	capability of
1	(a)(vii). 
4	measuring the
1	general registrations
2	give notice.
1	approvals, of
1	written approval
2	requiring supplemental
1	title and,
1	translation (or
1	737, as
2	so, or
1	filing objections
1	assist state
2	safe process
1	eggs, be
1	(15) diethylthiambutene.
1	regulation designate
1	coordinate such
1	minimizing or
2	circumstances involved,
1	(6) data
2	label in
1	regulation as
2	complete statement
1	(ii) how
1	qualified countermeasure,
6	advertisement that
1	(c)(3) was
1	poultry, eggs,
1	cosmetics because
1	labeled effectiveness,
1	compound using
1	establish, by
2	products prepared
1	stat. 1051;
1	products currently
1	$3,750 
4	store, or
1	capacity pursuant
1	section 2291j(b)
1	restricted to
2	labeled effectiveness;
1	tobacco) intended
2	samples. 
1	orderwith respect
4	cubic centimeter
2	overall strategy
1	labeled, marked,
1	suspend performance
3	laboratory capacity
1	appropriate coordinate
1	tolerance applicable
2	section 3502(2)
1	participation prior
1	(h) effect
4	demand for
1	custody, the
2	adjust fee
12	twice that
1	petitioner under
1	studies; (iii)
1	manufacturing change.
2	children are
1	issuethe term
1	detect all
2	written policies
2	administration. the
1	granted, that
1	387b. adulterated
1	(a) purpose;
1	domestic standards
2	sale (whether
1	successful consecutive
1	oncology, pulmonology,
1	women exist;
1	trials. minutes
1	assistance (including
1	collection action,
16	360fff1 of
7	applies, the
1	manner contrary,
3	reduction 
2	manufacture such
1	recognized or
1	issued but
1	investigation which,
5	manufacturing changes
1	customer on
3	petitions submitted
1	alternatives exist;
2	demonstrates to
1	registration remains
1	seller is
1	$2,500, except,
3	physicians and
5	program means
1	
 1104.
2	hospitals within
5	consumers (washingto-baltimore,
17	illness or
1	recommendations regarding
2	solution or
1	transaction statementthe
1	petitions referred
5	importer shall
1	verificationthe owner,
1	611. devices,
30	injurious to
3	administration costs
1	
 676.
1	site, and
1	dosing schedule,
1	scientific liaison
3	appears in
7	approved protocol
1	(5) study
1	(2) brand
1	500 milligrams
12	grant to
2	(2) debarment
3	u.s.c. 1031
1	bequest of
1	carrier under
2	destroy condemned
3	affidavit of
41	cost of
1	analyses. 
1	less hens.
2	inspect, at
2	health agencies,
1	stat. 822.)

1	inaccuracies in
25	360j(g) of
2	applicable criteria
1	furnishes a
1	form, statement,
3	scientific evidence.
1	date funds
1	cost or
2	sterilization, and
2	(a) evaluate
4	therefrom; or
1	exhaustion of
6	treated with
1	personal use.
2	section prior
1	personal use,
1	including meetings
1	(1) rule
5	amateur athletic
13	account without
1	future survey
1	certifications notwithstanding
1	general services,
1	viable micr-organisms
1	reliance thereon,
5	within 15
1	derived which
1	(3) revision
6	within 10
1	sources, (c)
167	upon the
1	384b(c) of
1	enacted. 
1	director. (2)
2	within 18
1	supplier moves
1	represented or
4	violation in
1	sterile areas
1	instances shall
4	(3); and
1	substances) contained
1	violation if
1	section 353c2
1	equivalent and
2	product, if
1	health systems
1	longer satisfied;
1	inapplicable to
1	form, containing
2	accepts the
1	1601. findingsthe
1	person owns
4	valid and
1	cases may
1	manufactured, packed,
2	otherwise. (d)
1	952(a) of
1	branding grades
1	maximuma astated
1	expert advice.
1	forfeitures section
1	maintained, and
1	conduct annual
1	powder, shall
7	wholesome, not
1	compounded drug.
11	department, agency,
1	local or
1	device (under
2	measures; (c)
1	 (b)privacy.
1	senate that
1	promptness. (2)
1	center) to
1	material manufactured,
19	drug 
1	(c) consultation
1	athletic, civic,
2	2007. (

3	no-federal jurisdiction
1	adequate under
1	product expected
1	elements; and
1	report concerning,
1	1978 or
1	therapeutic tissue
1	strategy not
1	preparing said
1	2007 through
1	begin only
1	requirement. 
1	raw or
1	directly, by
1	formula will
1	25(d) of
10	costs associated
1	effectiveness if,
1	periodthe initial
1	(ii) mineral,
1	facility during
1	675, 603,
1	different standards
1	respectively. (2)
1	inhibitory use
1	purchaser that
1	(bb)limitation. 
1	601.12 of
2	withdrawal; hearing;
10	hazards that
4	paragraph. a
1	(a)(1)(a) for
1	suspend, unless
15	hours after
2	sanctions on
3	first action
1	(b) certification
1	therapy, therapeutic
2	customer of
2	new medical,
1	pethidin-intermediat-b, ethy--phenylpiperidin--carboxylate.
1	performance; periodic
17	publication in
1	appointed as
4	clinical hold,
4	file patent
1	study groups.
1	consideration foodborne
1	detecting those
1	professional backgrounds,
1	examination the
2	form, that
1	drug; (k)
2	clinical hold.
1	subject matter,
2	disclosed by
1	term agency
1	802(33) of
12	sources of
2	firm to
1	defendant, asserting
2	organization which
3	(b) purpose
9	shall establish,
1	protection; or
1	675, 1013,
3	citation to
1	prescription, except
1	prospective purchasers
1	task force,
2	(b) every
1	establishment shall,
1	make payments
1	remedy for
9	(feb. 15,
1	means inspection,
2	timelines of
1	task force;
1	humans similar
3	misleading to
1	quarantine lawsfor
3	title) to
1	maintenance organizations
3	submissions: 
4	promulgated in
1	360bbb3(a)(4) of
1	presumption in
1	individuals pursuant
1	search warrant
3	documents, papers,
8	(6) 
1	reporting system;
1	bin, and
1	
 387u.
1	agency. (l)
2	possible impairment
10	agency for
1	designated representatives.
5	professional health
1	(e) uniform
1	enforcement official,
2	corresponds with
1	document, or
1	clinical description
2	basis, that
1	limitations; united
10	representatives, and
1	(5) consultation
4	compliance with,
1	effectiveness, if
1	panels in
1	enforcement official;
18	modified risk
1	calendar years.
1	(1) from
1	(1) beginning
1	(9) to
1	employed pursuant
1	provider provided
2	grant amounts
2	packing eggs
2	387t(a) of
1	42, issued
1	(v). each
1	best accounting
1	u.s.c. 853].
1	microbiological methods
1	teen pregnancy
2	persons by
1	requirements domestically
2	section 351(i)
3	commerce, to
1	partnership means
3	distributor who
1	plant; and
1	(iv) modular
1	reporting systems
1	drugs; compliance
1	(a) made
1	(c) all
3	representative. all
1	use, unless
1	printed prominently;
1	therein. in
1	labeling, container,
1	new application.
1	marking, and
1	individual) or
5	manufacturing process
1	regulate, promote,
1	useful; (c)
1	(f)(2), the
1	notice; promptness;
1	applicable committees
3	approving or
1	states, when
26	(2) to
3	clinical data,
1	section 334(a)(2).
1	clinical data.
12	person submitting
1	(b) contains
1	appropriate restraining
2	means. 
1	drugs, with
1	projects pursuant
1	including plasma
1	secretary; (iv)
1	office 
173	drug application
5	advance notice
1	section 387b(5),
1	paragraph. (g)contract
1	proceeding that
1	care professionals.
1	(c) secretarial
7	(2) compliance
4	qualifications and
1	nongovernmental entities,
1	notification; timetables;
1	annually prepare
1	
 622.
1	potential emergency
1	(j). (c)
1	applicant whose
2	separated safely
1	chapter, is
2	word oleomargarine
1	eligible patients
1	supervision the
1	staff will
1	surveillance, patient
2	housing facility
1	(c) intrastate
2	law, all
1	(6) exclusive
1	floor (or
1	appropriate. (6)
1	relevant stakeholder
1	(w) deadline
2	chapter, if
1	mea-inspection service;
1	strategythe president
2	differing technological
2	modifying, suspending
1	address any
1	review, a
1	neonates by
1	advertising, (c)
1	system (a)
1	term smoke
1	consideration and
1	consider among
1	establishing standardized
1	establish priorities
1	information, serious
2	delivery, report
3	whoever kills
1	fund created
1	prescription occurs
1	
 8811,
1	dru-related offense
1	increased importation
2	price of
1	5, require
1	(c) effect
1	teaching and
5	consideration any
1	consistency described
2	5 
2	factors specified
1	iv. (b)
1	thereon, or
1	topics shall
1	may charge
1	limited geographical
1	subsection (l)(2).
1	retail; (b)
1	352(aa) of
1	application, (2)
2	application make
2	drug, he
1	following review
5	december 29,
1	guidances, and
4	(b) submission
1	receiving reports
1	1605(c)(3)(b)(i) of
1	considered when
2	seal. no
3	willing to
2	subsection refusing
7	drug involved,
3	finds is
1	facility from,
1	lock or
1	subsequent and
1	vitamin c,
1	thereto; (ii)
1	importer means,
1	151. preparation
1	customer. the
1	provide federal
1	manufacture, pr-production
2	knowing that
1	title, (5)
1	countermeasure sponsor
2	violation to
1	practitione-patient relationship.
1	belladonna, bitter
1	analysis, if
1	pharmacopeia, or
1	subsection (b)(2)(a):
4	public by
1	leaf; and
1	approval. (iii)
1	entirety, shall
2	1487.)
 

1	milk, or
5	health, food,
7	term small
1	transactions which
1	outlets to
5	reporting in
2	campaign and
1	resulting vacancy
2	subsection (b)(2)(a),
7	(k) the
2	subsection (b)(2)(a).
1	1908. judicial
1	intentionally imports
1	reimbursement an
1	humans. (w)
1	appearing before
33	drug has
1	guaranteed under
1	workload. with
1	controls is
1	(6) dimethyltryptamine.
1	chapter.[2] 
1	export, manufacture,
1	investigation, prosecution
1	shipping the
1	secretary, either
1	court, operate
3	rico, the
9	coalition that
1	systematically assess
7	articles are
1	members; and
1	(e) $130,184,348
2	21, 1997
1	360eee3. national
1	violence, as
1	eliminated. if
1	360fff3(e) of
5	 fiscal
1	false, or
13	practices and
4	animals that
1	countermeasures, as
2	(and in
12	maximum extent
1	which, effective
1	forfeit the
1	(b)(3)(a), (b)(3)(c),
1	handled on
2	(b) conduct
1	auditor discovers
1	220501(b)(2)). 
5	subpenaed person
1	analysis methods.the
1	(g) plants
1	groups (a)
1	repackager responding
2	conferences of
1	approved may
2	hearing, shall
1	knowingly 
1	service approved
1	need is
53	class iii
1	agent upon
3	carrier by
1	requires; (7)
1	immediately furnishing
1	years, then
2	report voluntarily
1	need in
1	(c). (

1	make each
1	care practitione-patient
1	businesses. (iv)
2	assisting in
1	secretarys comments
1	require; (iv)
1	seq.]; (b)
1	performance in
4	assessments under
2	offense defined
2	party is
1	pesticides under
1	fact. (3)
1	recalls by
1	675, 403a,
4	permanent damage
1	commodities, based
1	seller includes
1	participants in
1	exceed amounts
2	apples when
1	vaccines or
1	charge and
3	partially filled
2	transferability the
2	it. (c)
1	submit, at
1	certification. (b)
1	submit, as
1	revise as
1	exceed $300,000.
4	class ii.
6	class ii,
1	allowance for
1	show cause.
1	book at
1	designated pursuant
2	inspection within
1	restrictions the
1	unsafe use
1	331(ll), 344,
4	license was
1	compliance problems
2	name shall
4	formula for
1	(2) confidential
2	may include,
2	conviction be
3	education programs
1	modifying or
2	secretary shows
2	(c). for
2	convenience kit)
2	first 1-month
1	previously compiled
1	electronic communication;
1	iv; applicants
2	transaction, the
1	direct measurement
1	levorphanol. (10)
1	outlet, after
1	(c) costs
1	coordinated law
5	information; or
1	records obtained
1	drug interdiction;
1	requirement, a
1	(5) foreign
1	separate use
1	annual compensation
1	$85,000,000 (subject
1	ongoing assessments
1	operations, scienc-based
2	invalidity); or
4	products found
3	located, may
2	labeling; and
1	validated test
1	information, news
1	protocol; or
4	methods, facilities,
1	(4) appeal
65	 (iii)
1	compliance budget
4	privacy act
1	provided services
1	title upon
9	effect. 
1	reverse, or
11	term includes
1	productsan order
2	uniquely identified
1	 (x)
2	(b) adverse
1	progress, and
1	activity is
10	include provisions
2	mutual recognition
2	statement setting
1	defects every
1	321c. nonfat
1	employees the
1	security not
2	education program,
1	requirements prescribed,
2	paragraphs (4)
1	may grant.
1	year period.
1	71 et
1	affixes or
1	temporary detail
4	civil penalties
3	population for
2	omits a
2	authorized committees
7	furnish the
1	460, 463,
2	section 356(c)(2)(a)
1	president to
2	technology of
1	(i) contaminated
2	order establish
1	authorization issued
22	media campaign
7	substance may
1	docket the
1	i-transit shipment
1	abusing drugs.
2	timely notice
1	exports that
1	operative. such
1	facilitating partnerships
1	habitually uses
1	occurred and
1	2007, agrees
1	supervision, or
2	promotion, or
1	fix compensation
1	(d) upon
1	followed to
3	information made
1	medicine. 
3	(b) payment
1	development, or
1	quotas from
5	partners of
7	brand and
1	importers in
2	(3) total
1	dispensed at
6	379h(c)(4) of
3	therapy and
1	(4) according
1	transfer, with
1	uniform internal
3	title, be
1	374, 379,
1	contain residues
1	effective period;
1	optical, positional,
1	data be
1	methods 
1	analysis which
3	data by
2	yields of
1	potential conflicts
15	surveillance and
1	outbreak in
3	title, by
8	bears, in
1	(c) regulationsthe
1	milk. 
18	value of
5	federal requirements
1	charged. (6)
3	following january
2	waive under
7	processing, or
1	industry representatives,
1	nature was
1	petition make
1	(g) as
3	utilized in
7	voluntary qualified
1	indirectly, by
2	pediatric exclusivity
1	585, as
2	kit) if
1	number, or
1	otherwise, any
2	management control
8	product radiation;
33	dietary supplement
1	drugs; (c)
1	hearing; grounds;
37	submitted in
1	groups; encouragement
3	(or an
1	individual prescription
1	use thereof
3	businesses such
1	laboratories; and
8	exemption is
1	manufacturing inputs,
6	projects under
1	4.5. 
1	serving colored
2	belief at
1	(11) methadone.
8	exemption in
1	(11) to
1	packaging, temperature
1	bulk drug,
2	submitted is
4	exemption if
3	studies (other
1	membersthe ex
1	major actions
1	inspection warrant,
2	agencies; (b)
1	pharmacyin a
1	expired; (2)
3	analysis conducted
2	part 330
2	lettering not
1	producing the
4	propanamide or
33	entity that
1	manufacture any
1	appropriate stability
2	 (ii)no
1	action, including
3	device effectiveness
2	index. such
1	household consumers,
1	section 379j22
2	develop national
12	consumption of
1	judicial order
1	(c) misrepresentation
1	comparative to
4	also, after
1	original packages
1	subparagraphs to
1	establishmentsbeginning in
4	convicted under
6	manufacture and
1	serious risk,
1	(ii) biological
2	serious risk.
1	crisis in
1	formula because
1	anticipated or
64	paragraph shall
1	i, an
3	funds 
1	alternative to
3	request, shall
1	(a) accelerated
1	gene; and
1	order; evaluation
1	chemical, physical,
1	formerly 905,
1	administer or
5	dru-free communities
2	decision within
1	additional selection
1	decomposition, parasites,
1	potentially present
5	safety, as
1	afforded a
1	analysis methodology;
2	obtaining better
2	local nature
1	partial term
3	developments in
4	portal established
2	making appropriations
1	(b)(1)(f). 
3	animals to
7	(1) every
1	trials 
3	serious risks
1	except this
1	labeling; (e)
1	fund treatment
1	person specified
2	year, he
2	interdiction and
1	value; or
1	(ii) five
2	year previous
1	ii; (ii)
3	report means
1	food) intended
25	commerce, or
1	(5) recruit
45	(2) of
8	date such
3	differences between
1	
 347a.
1	furthering the
1	tracingfor a
5	sponsor under
4	(2) on
1	record on
6	sale, barter,
1	timely challenge.
1	receipt or
2	availing himself
11	(2) or
10	conflict of
1	good agricultural
2	representation by
1	shall define,
1	143. inspection;
8	premarket applications,
1	beverages, or
1	criteriaa coalition
1	disease, convalescence,
4	(i) ensure
1	farm producing
2	economic area,
1	personnel as
2	262]. 
6	5 (commonly
1	(b)(10) shall
1	strategy. (c)
1	storage are
1	contagious diseases,
2	consultative and
1	(d) supporting
1	(c) base
2	transactions; and
1	formula, (c)
1	affected national
1	regulate drugs
1	material not
1	(2) scope
1	voucher. 
1	discontinue, retain,
1	secretary containing
1	sections 451
2	name appears
14	approved drug
9	maintain an
1	review; 
1	(a) 33
1	payments; advances;
2	$10,000 and
2	affiliate meets
1	general.no person
19	serious bodily
4	racial and
40	means 
3	examine and
1	supplier, with
1	(e) requirementsthe
1	(3) security
1	references such
4	(a) submission
3	chapter, a
2	modification described
1	1035(a) of
1	(f) records
3	device referred
1	subpopulations a
1	case law,
1	379h(a) or
1	maintaining the
4	evaluating an
3	fee reduction
1	product, such
1	claimant, issued
1	site; (f)
2	device, dated
1	proposed rulemaking.
1	manufacturing. (3)
1	waiver, exception,
1	likely need
32	proposed sunscreen
2	inventory upon
1	attributable primarily
1	(a) first
1	dispensed shall
1	scheduling decision;
8	regarding any
1	served during
3	substances. (

1	terms not
2	standard identified
1	studies; and
1	including periodic
4	comment. 
1	expected or
1	entity seeking
1	sheepmeat food
6	scientific information
1	croton oil,
1	scientists, doctors,
1	(iii)(ii) continues
1	advertisements a
1	use amount
1	colors, or
6	greater minimum
1	necessary, reinspect
1	metabolized for
2	enter should
1	drug sponsors
27	product may
8	3 years,
1	office, as
2	substance added
1	reserves 
2	mark; (5)
7	diseases and
1	groups, relevant
1	exercised regulatory
1	section 343(r)(5)(b)
7	person and
1	thereunder; (b)
1	piperonal. (s)
1	plan unless
18	use with
1	(3) changes
3	recognition as
136	used in
1	correct. (bb)
2	ingredients, for
1	grants. each
2	surveillance (a)
3	efforts of
1	available, to
10	june 25,
1	used is
2	after, submission
1	 (jj)
1	either (aaa)
2	person any
1	exceptions involving
1	(h)competitive procedures.
1	medicines; (ii)
1	35, subject
8	person, if
3	product. (b)
2	quota, the
1	require labeling
1	dispenserthe term
1	similar entity
1	join together
1	person, in
1	professional pursuant
1	product) that,
1	articles dispensed
1	exceeding $1,000,
1	venue is
10	agricultural quarantine
2	fire safety
1	veterinaria-clien-patient relationship
1	issuance, with
1	(g) labeling
1	person alleging
1	director relating
2	organization. 
1	3 guidance
1	(aa) signing
4	2017, there
1	product chooses
1	333(c)(2) of
1	councils referred
3	ensures the
1	tools the
1	writing within
2	tasks or
1	apples shall
1	reprinted in
16	application with
1	devices so
9	foreign supplier
1	orders, including
1	following amounts:
1	effects incident
18	court for
2	offense. a
1	venue this
1	quality system
1	process; or
1	usefulness of
2	tribes or
1	monitor drugs
38	regulations (or
1	concurred in
1	temporary shortages
1	accredited for
7	adjustments 
1	prepared means
1	(j)]; or
22	conviction for
5	state as
3	seafood inspection
1	improve interagency
1	rico. 
1	independent audit
4	supporting justification
2	committee persons
31	lack of
1	tintometer scale
1	(a)(4) is
1	section 360eee(9)(b)
1	section 661(b)
1	satisfied the
1	conferences any
1	periodic inspection
1	notify each
1	advertisement, the
2	certification within
1	discontinuance that
1	modified registration
1	detoxification, overdose
1	relevant portions
1	
 1704.
1	separated at
1	lettering at
2	insurance portability
2	detailed from
4	subsection 
2	refund, if
1	subsection at
13	subsection as
1	grant period
1	costs; availability
2	food emergency.
25	appropriate federal
1	apply efficient
3	section 460
16	label or
1	submit comments,
3	intimidates, or
4	years the
1	perception shows
1	$40 and
1	(c) communication
1	objections to
2	marketed device,
1	strategies related
21	label of
3	apply 
1	research, or
2	optical isomer,
1	characterize and
1	additivesa color
1	auditing authorityfor
1	marketed device.
1	veterinarian. 
2	temporary basis
1	renewal grantsthe
1	reveal facts
1	for, commonly
1	shall help
12	regulations or
1	guidelines, including
1	(12) authorization
1	453. definitionsfor
4	phencyclidine (pcp)
2	states pharmacopeia
1	recommended within
1	notification notification
1	television channel
1	unprotected, including
2	region, country,
2	flask, tableting
9	internet site
1	applicants forfeit
9	use which
56	regulations of
3	group for
1	374 inspections
1	pharmacy as
7	effectiveness under
4	2013, upon
6	states (including
3	holder does
2	secretary documentation
1	675, 416,
1	379, 379e,
1	actually collected
157	drug is
5	authority is
73	drug in
1	4, 2002,
1	(vi) guidance
7	collect such
1	1231 may
8	effective upon
13	drug if
1	will fully
4	(c) there
2	drug covered
1	
 624.
2	businesses, including
2	letter and
1	provisions nothing
1	(8) shall
2	vessel, aircraft,
10	manufacturers and
1	(d) notifying
1	thereafter authorized
1	training qualifications
2	commodities for
1	nominations received
1	drugs outside
1	(4) secretary
2	containing 
1	bond; court
1	assessments; (e)
1	goose, or
1	intermediate grays.
1	powersthe secretary,
18	subsection (i)
1	respiratory stimulation.
1	specified reduced
4	official national
1	sentencing a
3	marketed device
1	monitoring mechanisms
4	(iv) that
1	importers that
1	exclusively of
5	notice, published
1	title, certified
1	lawfully carrying
1	102(33) of
1	(o); (vi)
1	years. a
1	treatment functions);
1	preservative unless
1	coalition in
1	parts 131,
1	research subjects
1	attributes that
1	(d). (viii)
1	law no
1	811(j)]. (b)
1	601. definitionsas
1	initially registering
1	
 15.
3	public participation
2	licensure for
1	seizure up
2	denies clearance
1	(a) violations;
1	inspect under
1	supplier. (c)
1	shall as
7	(4) public
15	user fees
5	states any
1	performing activities
1	rehabilitation; (f)
1	selling, disposing
1	import without
1	guidance required
1	quarterly to
4	labeling, is
1	subsection (a)(1)(c);
4	fee, the
1	distributes or
1	obstructed an
1	methodologies by
1	commissioner. (ii)
1	studied under
1	tabulations from
1	compendium. (h)
1	develop guidelines
1	respect or
1	diversion or
1	supplier (a)
2	user fee.
2	part b
4	standard described
4	impose any
1	developing research
2	proceedings (a)
1	therein; or
1	pediatric models
1	therein. (2)
1	part d
1	health for
1	dangerous drugs)
43	action under
1	effectiveness. (c)
2	history, as
1	estimated 9,000,000
1	reviewer and
1	authorized at
1	including rapid
1	(b) actions
2	revised guidance
1	event occurs
5	exemption to
1	readiness for
1	(f) limitation
10	premises, facilities,
2	circumstances regarding
1	(d) outreach
17	application, or
1	343(f), 343(h),
1	cap on
1	insure the
1	(5). (5)
3	identified noncompliance
1	(vi) to
1	application, on
1	positive conflict
1	drugs during
1	documentation by
7	devices (a)
1	cover food
1	(m) list
1	permits its
1	section 4402
7	true and
1	387l. judicial
3	comprised of
1	requirementsa drug
1	(ii) military
2	(n) if
6	indirectly 
1	granted, and
1	refusal upon
1	adding such
1	(b) continuation
1	person, entity,
1	organize information
1	review. (4)
1	rots, mixed
2	captured through
1	(b)(1). the
1	radiation safety.
1	device effectiveness.
1	full cooperation
1	230(c) of
1	155, 7,
1	(3) good
1	(4) sel-executing
1	manufacturing changes)
1	oxygen deficiency.
2	classification shall
1	(6) hold,
1	
 604.
2	(a), that
1	chemically related
1	agency, subject
1	improves the
2	achieve a
2	used; and
2	stat-o-th-art practices
2	matching funds
1	recovery for
3	part thereof)
1	grandfathering product
1	tool includes
1	(iii) capable
1	humans is
1	appropriate. an
2	j. farias
1	targeted, the
1	said chapter,
1	experience which
1	safety; (2)
1	academia, and
1	which, with
1	agreements into
1	protections against
22	identified by
4	addressed to
2	bioavailability and
1	book or
1	(1)) that
1	evaluation) at
1	sustained if
1	reasonable balance
1	destruction, and
1	auditors accredited
1	agency communications
1	therapy, including
1	(i) differ
7	agencies, including
1	carrier, arriving
1	applicable; appeal
1	(4) publication
1	(v) -phenylacetylindole
1	(v) upon
1	individuals; (3)
1	subsection relating
1	subsection. for
1	27 months
3	section 674
1	replace it
1	regulation, that
8	public interest,
3	evidence as
1	on, when
1	review a
1	implant or
1	court pursuant
1	unfair methods
16	security of
4	section 856
1	provider and
1	representation in
3	section 853
3	risk the
1	minimuma maximuma
8	report, or
1	committing rape
1	ris-based inspection
1	first country)
2	internal procedures
1	animals (before
4	implant on
2	diseases; (4)
1	forfeiture. (6)
4	security or
1	errors and
13	facility to
1	government. (2)
1	state egg
2	(c). such
1	nongovernmental organization
1	possession of,
1	1991 through
2	retained for
2	future costs
1	period when
1	devices authorized
1	ris-benefit assessment
1	asserting a
3	(a) when
3	(g) information
1	web site,
1	label upon,
1	effective methods
1	prevention; (ee)
1	strophanthus, stramonium,
1	become adulterated,
1	1033(a)(8) of
2	paragraph (c)
1	(c) implementing
4	reflect changes
1	extended from
7	imminent danger
1	title, classify
1	cultivated and
11	access to,
12	determination under
12	37 stat.
3	revised plan
2	maintaining licensure
1	
 958.
1	interdiction programs
1	made toward
1	effective, ongoing,
9	final determination
1	compounding does
1	
 106,
1	man subject
1	alerts; (v)
2	promulgated after
1	
 468.
1	copy thereof.
1	level iii
1	child for
1	average; not
1	issue permits
4	small establishments
1	forms (a)
1	referred shall
1	observed by
4	tobacco used
1	(2) variances
1	local governments,
1	section 282(j)(5)(c)(ii)[2]
2	sale only
1	(a)(2)(d), a
1	(i) flexibility
3	(c) request
1	time frame
2	center (a)
1	addition, for
1	standard. for
1	show kinds
1	simply talk
1	act entitled,
3	may continue
1	section, no
2	400 grams
2	resale, and
3	development, manufacture,
1	2013 that
1	voluntary guidelines
1	final. (i)
1	planning, technical
1	relative dependence
1	presumed not
1	(c) contemporary
1	(or under
21	investigational drug
1	water used
1	355a], any
2	eradication of
1	detention greater
1	panel consisting
11	rather than
1	cp47,497 c-homolog);
64	civil penalty
2	lon-term clinical
1	(a) eligible
5	withholding of
1	surgically or
1	providing that,
1	hearing; conclusiveness
3	27, 1958
1	mist. 
1	intrastate incidents
1	deemed objectionable
1	establishment; (iii)
1	imported seafood
2	en-users during
5	available, on
1	receipts during
8	restrain violations
1	following year.
1	collect 
3	thereto with
2	375(b) of
8	(iii) that
1	chapter. congress
1	proposal contained
1	concurrent incident
4	devices designated
1	additional considerations
2	additive involved,
1	coerce abstinence
2	animal and
1	so, knowing
1	group practice
1	advertising (a)
1	675, 535,
15	reportable food
1	substances named
1	94 to
1	updated, or
2	rol-you-own tobacco.
45	secretary with
1	distributor provides
6	application. such
7	title 28,
16	title 28.
1	801a. congressional
1	single report,
2	bear, in
4	qualify a
4	services, a
2	(4), any
5	chapter relating
1	with, those
1	form, prior
1	(1); (b)
2	equals or
2	seized by
1	$99,000,000 for
1	(d) factors
3	price competition
1	container; modification
1	2003(b)(7) of
1	waive or
1	practice or,
1	material means
1	signal detection
1	title, formally
1	administration registration
2	section 1182(a)(3)(b)
1	
 321d.
1	others required
1	expungement proceduresthe
1	infusion. (2)
1	seized be
1	presenting such
1	additional study
2	address such
5	centers and
2	if, not
1	registered persons
1	loss. 
3	provides an
2	division directors
1	contains protein
1	alternative statement
1	chemical. not
1	substancesin carrying
2	single report.
1	extended expiration
2	reimbursement for
2	record keeping
3	commerce which
1	administration, medical
1	action, provide
1	accident. any
1	(b) components
1	stat. 55;
2	secretary submits
1	provider without
8	services, for
1	charges, shall
1	potential, compared
1	
 399.
1	consul an
1	safe because
1	paragraph (w)[1]
1	handle in
2	although not
5	labor with
1	shall terminate,
1	means in
1	26 (and
1	days or
1	general operations
1	360c(a)(1) of
1	performance goals;
1	duly verified
1	(1) identifying
2	explicit or
2	consumer to
67	days of
1	additional service
1	including administrative
1	shall terminate;
1	narcotics; (c)
1	modified. such
2	risk; and
1	ending before
1	ensure uniform
1	term dru-free
1	neurological differences
1	away any
8	(c) public
1	(i) drugs
1	bonuses, if
1	discovery necessary
4	adduced upon
3	approval process
3	recommendations, and
3	specific diseases
6	(ii) there
4	material, or
1	registered person.
3	reference by
1	outside territorial
1	remaining defendants.
1	(i) audit
2	articles other
1	disclosure is
17	person 
1	population, taking
2	tolerance if
4	notice the
1	section 346a(g)(2)(b)
2	specified kinds
2	revised in
1	secrets act
2	consumers. 
2	379j of
4	change requested
3	commercial marketing
1	tagged as
1	laboratory regulatory
2	production that
5	components, ingredients,
2	(i); and
1	changes. (

1	2021, the
3	substance except
1	duties such
1	unavailable for
1	campaign with
1	general every
6	(d) fee
2	sufficiently similar
1	-year term.
3	recipient or
1	sections 353(b)(4)
1	type, 
2	section 5(b)
2	dispenser, hospital,
1	therapies industry
1	determine what
2	barrier to
1	performance and
2	administration take
2	promulgated pursuant
1	vegetable or
1	(2)(b), or
19	recipient of
4	conspiracy to
4	legal effect
1	(iv) where
1	manufacturer meeting
3	scheduled for
1	reg. 4461945318
1	implement those
3	term biological
4	(5) any
4	information nothing
1	etoxeridine. (24)
1	auditors from
4	submit information
3	maritime patrol
4	b of
1	military, or
4	tax forms
7	packing, and
36	drugs for
1	rots, yellow
1	special licenses
1	rejection. reasons
1	studied as
1	lane, alternative
2	excellence, lack
1	fourfold or
1	sampling, analytical
1	methods. 
1	estimate does
1	persons includedsuch
1	reasonable potential
1	(vi) in
1	justice, be
1	675, 506f,
1	carrier no
1	declaration does
5	payment; fee
1	transferee means
4	guidance not
1	device. applicants
1	solely produce
1	disclosure if
3	required, that
1	facilitate continual
13	products, and
1	distributor did
56	shall notify
1	conditions which
2	judgment, as
1	remain substantially
1	product incurred
1	egg handlers;
10	public notice
3	recommended or
1	regulations; administration
1	secretarys action
1	355(c)(2) of
1	programs there
1	(a), its
1	(vi) if
1	population. such
2	states citizens
3	potential unreasonable
10	(a) not
1	program agencythe
4	congressional committees,
1	purchase was
1	
 607.
1	secretary, promulgate
3	(f), each
1	18, to
1	4 additional
1	disclosure in
1	acid. (14)
1	1714. awards
1	distributes animal
1	contracts to
1	kind commonly
1	(g) collection
5	demonstrated that
1	subparagraph applies
1	(iii) find
1	with, one
1	analyses and
1	timely transfer
3	license as
2	party against
1	(b) containerthe
1	secretary examines
4	necessary studies
7	name or
1	auditors under
1	(vi) and
7	label, labeling,
1	twelv-month period
1	margarine originates
94	name of
3	policies of
2	(vi) any
12	imposed by
1	scientific matters,
1	fluid ounce,
2	(d) applies,
1	furthermore, nothing
2	(iii); and
2	state costs
4	policies that
1	sponsor. 
3	section 355(o)
2	similar technology.
1	(ii) exceptionthe
1	review. for
1	(ii)withdrawal of
17	report is
1	
 379j22.
5	report in
6	2014, not
4	meetings with
1	20th par.,
1	report if
8	proceeds of
1	production solely
1	ii. such
1	u.s.c. 45(b)]
1	amendments at
1	knowledge, (iii)
5	uses within
1	asserting receipt
3	dealers and
1	state, exposure
1	342(a)(2)(b) and
1	water. the
1	three or
11	annually thereafter,
1	adequately protected
3	(a) whenever
1	cannabis, and
2	exemptions and
1	iii, premarket
1	three of
1	amounts. (8)
6	(e) 
1	862b. sanctioning
1	privacy requirement.
9	committee of
2	paragraph (7);
1	(3) biosimilar
1	requirementsthe sponsor
161	committee on
1	entity receiving
3	(1). if
4	foods packaged
1	producers for
1	meat article
10	committee or
5	plan or
1	penalties collected
3	(c) rule
1	(1) files
3	commerce by,
1	(2ci). (24)
1	committed. (july
1	directed at
1	limitationsfor purposes
1	amended thereafter
1	multiple offenses.
1	extortion, falsification
1	30, 1906
1	activities). (7)
1	agree that
1	ensuring uniformity
1	(3) carburetion
6	place at
2	require inclusion
4	referring to
1	term material
1	order, make
1	veterinarian caring
1	proprietary information
1	(1) interim
1	greater risk
1	device, based
1	chemical identity,
1	(c) major
1	107. omitted

1	established. in
1	country does
2	medical food
1	1524(b) of
1	discontinuance he
1	instructions; (7)
13	control act
1	(g)(2)(c)(ii) or
1	1992. subsection
6	default of
1	privacy requirements
5	apr. 11,
1	will in
19	refers to
1	prevents diversion.
1	report requirements
1	director) and
1	issued such
2	protocol consistent
1	contract described
2	safe tolerance
1	solution, or
4	law, in
646	united states
1	requirementsthe secretary
1	retaining a
1	request complies
1	personal supervision,
1	 iron
1	effective law
2	slaughtering or
1	avoiding, and
1	line for
1	expenditure or
6	labeling to
1	pay, with
1	hereinbefore provided,
1	manner, is
1	law. the
2	knowledge regarding
1	document related
1	acid. (v)
1	preventing additional
1	(each by
2	rule requiring
1	image of
1	milk to
10	unlawful to
1	validated or
1	milk. (aa)
5	chemical structure
1	-(-naphthoyl)indole or
1	(c) consumer
5	commission on
6	account 
3	promptly revoke
1	rejecting the
1	legitimate health
1	(6) failure
1	section, referred
62	considered to
2	testing programs
1	drugs, antibiotic
2	(2) paragraph
3	articles prepared
1	(i)) during
2	reasonable manner.
1	combination, as
8	reasonable manner,
10	program and
1	(including details
1	surveillance, including
1	carrier, of
2	(a) authorize
2	part because
1	309.. 
1	form, dosage
2	partnership with
1	ways for
1	individuals associated
5	review for
1	slaughtering; diseased
2	abuse may
1	produced, within
1	$129,339,949 for
2	subsection, provide
1	agency resources
1	(d) detainer
2	country: 
1	articles. no
2	abuse requires
1	laboratories the
1	original purchase
1	note 2
1	subsection (d)(2)(a).
2	subsection (f)(2),
1	receive factual
32	unlawful for
1	subsection (f)(2))
1	paragraph (2)(a)(ii).
3	objective of
7	spices, flavorings,
1	misleading matter;
1	accountability 
1	consumers (u.s.
1	614. repealed.
5	investigation. 
1	residue consisted
1	security. (june
1	separate products
2	paragraph (11)
2	may occur
1	(3) identifying
1	device may,
1	section 360m(b)
1	(b) considerations
2	governor and
1	formatting, or
1	subsection; (c)
1	drugs was
1	public display,
1	human milk.
1	(a) establishmenta
1	implantable, is
1	prioritizationthe administrator,
1	reaffirmation of
1	scanning each
1	labels, packaging
1	much as
2	(b) conditions
1	abuse through
1	deemed withdrawn
1	maintenance, repair,
1	materials regulated
1	(i) expires
1	timeframes; (3)
1	every 6
1	controls described
6	every 4
6	every 5
3	every 2
7	every 3
1	321(q), (r),
1	states, violating
2	facility (including
1	(4), manufacturers,
1	(v) pipe
1	providing guidance
1	nolo contendere
1	license. section
13	(2) and
36	(1) for
1	medical monitoring
1	disseminated by,
1	straw and
1	fora, including
9	partners that
1	shrinkage in
10	systems to
2	(a) establishment;
1	patent application.
1	1972; $65,000,000
2	court) shall
1	communication tools
9	communication plan
2	updates the
1	residues resulting
1	disposal under
1	including physician,
1	provisions relating
1	observations and
1	produce, and
1	criminally charged
1	safeguard to
1	award shall
1	existing programs
1	involved (independent
1	953, and
3	burdensome on
3	required studies
2	based. (2)
1	(i) describing
1	approved except
1	scalability of
5	facility at
1	is, not
1	sentencing guidelines.
2	regulation require,
1	offering an
15	index listing
1	cros-contact of
1	consumers. it
1	containing best
9	receive payment
1	expedite review
1	361(e) of
7	shall bear
1	affect of
1	suspension, including
1	shortages on
1	tribal officials;
1	461. offenses
6	(d) collecting
1	compensation members
2	protective order
3	recommendations, if
4	maximum number
1	complainant makes
1	section 841
2	representative, in
2	facilities located
1	holiday, or
1	tribal officials.
1	both. (6)
2	title, either
1	section 971(f)(2)
4	mea-canning, salting,
2	facilitates the
1	file (or
1	spectrum of
2	owner, part
1	nicotine the
2	(k) orphan
9	subsidiary or
1	available multiplied
1	secretary prescribes)
1	charged under
1	security (a)
1	entering false
1	penalty not
2	recommendation, (ii)
4	acquisition of
1	recovery results;
1	recall; (d)
1	original information
15	essential to
6	tested for
2	(j) maintenance
1	deliver or
1	coli species;
1	said person
4	slaughtering, mea-canning,
1	release by
1	name) which
1	sector contributions
2	forth criteria
1	approval prior
1	(b) participation
2	matters regulated
1	(ii) conditionsa
5	expenses (including
12	section are
1	subsections (a)(2)
1	retai-type establishments;
1	distributed) compounded
1	355(i) and
10	ports of
3	consultation nothing
1	1977 (7
1	processing, etc.,
1	drugs every
3	radiation, or
3	28. upon
2	funds otherwise
1	1966 (80
1	cultural context
2	alter agreed
3	studies the
1	legitimate supplier
6	purpose the
1	may apply,
8	section 330.14
2	interest in,
1	revised. (2)
4	deemed under
1	plan can
135	available to
2	partner, a
1	evidence needs
1	actions. the
1	
 199.
1	quality thereof
1	1533(a)(2) of
1	stated below:
17	determines is
3	determines it
1	(a)(3)(c), the
1	purchasers; health
1	no-disclosure; exceptions
5	shall summarize
1	ultimate sale
1	buildings within
8	participated in
1	party, with
1	(2) providing
2	(c) on
2	him. service
1	related professions;
1	1049 of
1	360e(d)(1) of
1	member who
5	otherwise permitted
2	retailer through
1	steps or
2	sufficient training
1	distributed locally
1	antimony, arsenic,
2	penalties. 
1	final decision.
1	414, as
1	appropriations (a)
1	explanatory matter
1	low risk
2	anticipated harm
9	technical and
2	felony, if
1	2101. findingscongress
1	substances schedules
1	beef, mutton,
1	912, as
1	identifies future
1	certain requirements
8	studies conducted
1	date; and
1	341, 343(b),
1	842(c)(1) and
2	site under
1	punishment for
2	item qualifies
1	recruitment using
12	period. 
1	(b)privacy. 
1	agency, upon
3	(k) to
1	establish research
1	send 1
2	(3) prescription
3	(including but
2	specific importer
79	application submitted
2	youth marijuana
1	parole under
1	transaction statement;
1	projected completion
1	present options
1	develop robust
1	indicators and
1	health mission;
1	individual patient,
1	(a). fees
2	examine data
1	(1) acetylmethadol.
1	costs pursuant
2	experts, including
2	(d) prohibition
2	involves a
3	actual residue
1	first being
2	employed for
2	deliver a
1	traffickers, their
1	formerly 741,
3	may prosecute
1	must include
1	retail. (iii)
1	biomarkers, and
1	packs, transports,
1	forth proposed
3	42. (b)
1	(c)(3), the
2	alleviate drug
1	administration abroad.
1	occurred (not
1	established relationship
1	address and
1	negotiated fees
1	staff, information,
1	820.)
 

1	indicator of
2	nonprofit food
2	transaction statements
1	hashish heads,
1	subsection, means
1	rules, regulations,
1	(c) strengthen
1	views, orally
6	certain to
3	exemption upon
1	847. additional
2	growing or
4	gaps in
2	printed in
1	(b) contrary,
1	accomplishing the
1	access protocol),
1	351. adulterated
1	input by
11	refuses to
1	unit level
1	home, or
4	interoperable, electronic
3	involves intent
2	(6) tracking
1	manufacturer responding
1	voucher. there
1	possess controlled
1	account of,
1	351(a)(3), section
1	sealed case
2	name, by
1	agency using
1	cohort. (2)
4	4, 2011;
1	note) or
3	applicant only
1	insufficient for
2	analysis shall
1	fee assessment.
17	mules, or
2	conspiracy. (

2	4, 2011)
1	professionals treated
1	(dd) individualized
41	4, 2011,
2	seller has
1	significant period
1	nicotine dependence;
1	(foodnet) and
1	officer lawfully
1	employee reasonably
4	agencies 
1	(i) cannot
2	drug backlog
3	dispense, a
3	study was
2	helping establishments
2	(b) list
1	use). 
1	based shall
1	360b(j), (l)
1	pesticide information
1	tool. (d)
2	methods, and
1	lif-threatening conditions
1	use monitoring);
3	independently by
2	occurred, the
1	dextromethorphan shall
1	custom slaughtering;
1	clinical use
1	
 353a.
1	years, provided
20	participate in
2	(b) requests
2	persons determination
8	isomers, esters,
2	practicable; and
2	order; or
1	also terminate
1	section 351(a)(3),
28	clinical trials
1	(2)(b)(ii) only
1	(3) ingredients
5	collected during
9	ring to
2	updated and
1	2008, 150
1	study. nothing
1	measuring procedures
1	(c) repealed.
1	possible consistent
2	order means
1	first portion
1	addressing each
2	confidential, commercial
3	section 6101
2	individual appointed
3	annual reportnot
1	species; (b)
1	drug prescribes,
1	tobacco warehouses,
2	510(k) for
1	(4) permanence
1	persons which
1	individual facility.
2	review vouchers
2	assessment. 
1	administrator, i-kind
1	ferpa each
2	-mail address
1	sponsor if
1	diversion exists
1	distribute means
1	regulation, with
2	containers and
2	(iii) requests
1	smoking, does
1	distributor (other
4	states, but
1	advers-event reports.
1	health (a)
1	providing transaction
3	states (referred
1	section 350(c)(1)(b)(ii)
1	licensure, that
1	slaughter slaughter
1	unacceptable, the
2	making exemptions
1	(c) manufacturing
2	substantial clinical
1	regulation referred
3	409(l)[1] of
1	(i) international
2	subchapter unless
2	food manufacturer,
2	early in
1	minimum: 
3	created under
1	terrorism, especially
3	shor-term goals
1	(e) declaratory
1	day that
1	(2) publication
1	states, until
1	1934 ed.,
1	request each
1	(e) work
1	$1 and
1	(f) cooperation
1	 (a)action
1	sector, as
1	regulation. (h)
1	biologics application
2	sector, including
1	establish lon-term
1	section 952(a)(2)(a)
1	filing determinationnot
2	contains more
1	benefits: 
1	treasury as
19	may submit
1	declaration described
1	certifications are
1	(b) classified
1	(3) aggregated
1	temporarily in
1	(4) prenatal
1	regulations; (c)
1	relief sought.
7	successor regulations),
1	lon-term recovery
11	successor regulations).
1	successor regulations))
5	facility certification
1	staggered basis
1	dru-related convictions
1	deems to
1	director while
2	providers, notwithstanding
2	effectiveness reasons;
1	aspiring coalition
1	among 1-
3	manner inconsistent
1	include farms;
1	scienc-based office
4	notified pursuant
1	shell. (7)
14	development program
2	subsequently conditionally
1	(a) seek
1	sodium saccharin,
1	(7) civil
2	health, (ii)
1	thereof solely
1	making publicly
1	plan biannually
1	sel-incrimination. but
1	agreements under
4	856 of
1	facility, 1
2	unsuspended and
4	shipping container
1	waivers from
2	prohibits an
1	(5)(b)(iii), and
4	subsection are
1	panels from
1	activity, policy,
1	owed. 
1	 copper
1	application, permit
7	distributed in
2	recommend that
1	protocols and
1	proper disbursement
1	section 348(g)
1	practitioners (including
1	distributed if
1	diligent implementation
1	describes such
3	designate such
1	president intends
3	subsection, as
1	paragraph. (b)timing
1	dye, chemical,
1	person occupies
1	determines eligible
1	exported; (iii)
4	infringement or
1	distributed is
1	(5) identifies
1	(b) electronic
5	except with
1	pseudorabies eradication
1	(a) objections
1	licensed physician;
1	consumers, will
1	holding 1
1	hearings, sit
8	secretarys order
1	396. practice
1	another disease
1	exchange in
1	date; (iii)
4	grase determination
1	prevention the
1	organizations may
1	31, 2003,
1	owned, controlled,
26	include in
1	research subject.
1	holds such
3	including under
1	patients.. 
1	proved beyond
1	(2) allylprodine.
1	discretion, permit
2	states before
1	paragraph,[1] the
1	mitigate any
1	claim if
1	food processors;
2	security countermeasures,
7	submissions, and
1	equines that
2	subsection (g)(1)
2	automatic electronic
2	website under
1	radiation emissions.
2	practice as
1	radiation emissions,
2	risks from
1	paraphernalia shall
1	(6) release
1	(k) certificationany
1	january 1
1	18) or
12	device subject
4	approved product
2	later. 
3	relatively small
1	1134 to
1	date certain
2	areas in
9	following requirements:
1	practices (a)
1	section 841(b)(1)
2	business. (iii)offer
1	list quarterly
1	contract repackager
1	
 351.
14	programs for
23	supplemental abbreviated
1	health.[1] (2)(a)
2	states swine
1	dispenses narcotic
1	legitimate channels;
3	title: provided,
2	kit form
1	liquid per
1	approval granted
1	knowingly open,
1	toxicity; (4)
2	(d) appears
3	probation shall
2	order which
1	expensive to
1	formal consultation
1	involved the
6	u.s.c. 1451
1	schedule the
1	legitimate channels,
1	shall minimize
3	taken into
1	cosmetic as
30	fee 
1	agriculture regarding
13	coordination and
1	animal.[2] 
1	processing in
4	opioids or
2	underrepresented subpopulations,
11	appropriations of
5	mitigate the
1	compounding, and
1	drugs after
1	564b, as
2	maintained, the
1	2016, with
3	press release
2	agreeif, on
2	licensing regulations
1	subparagraph (d)(ii)
2	dispenser. 
1	form. (5)
2	information, with
1	331. prohibited
1	grams, not
4	risk with
1	normal business
1	feed in
1	(cannabicyclohexanol or
5	submission and
11	feed is
1	advertising. notwithstanding
2	113 of
2	determines causes
1	certain machines
1	final rule;
1	psychological or
1	upon specific
3	submissions. (e)
2	drug research
8	seller or
2	therein (including
3	(n) of
1	20 characters.
2	application; period
4	representatives, a
1	committee has
3	detriment of
2	scheme, or
1	(b) establishing
16	(i) of
1	provision through
1	origin, (c)
2	subsection terminates
4	seller of
19	appropriations there
1	1, 44
2	costs 
28	(i) or
1	phenylpropanolamine to
1	federal counte-drug
1	1, 42
8	meet applicable
1	topic for
5	suitable written
1	case had
1	requesting waiver.
1	shall turn
2	means; and
2	343(g) of
1	eligible entities;
1	establishment elects
2	paragraph whether
5	weight, or
2	subsection preempts
1	period (1)
2	economically disadvantaged
1	critically evaluating
1	eligible entities.
1	reviewed, with
1	are, subject
1	3.6 grams,
55	collected under
6	unless, in
1	furnishing such
15	coca leaves
1	controls adopted
3	reduced rate
1	dru-related services
1	hearings a
1	marketing practices
1	awarded by
1	public meetings;
1	27, 2011,
2	321(v) of
4	specify, a
1	potentially less
1	every respect
1	administering this
3	ethers, salts,
1	contraindications; and
1	consultants to
7	2017, and
3	clinical trial,
4	significant risk
1	(may 9,
4	grounds to
1	intended use;
1	ii, why
1	exemptionsthis section
1	amounts reimbursed
1	controlled after
1	if, based
1	organizations within
4	notification required
1	title, subpart
1	improving communication
2	means: 
2	expressly provided
3	intended use,
1	diluents or
1	section 505e(g)
1	(h) order
1	770, as
1	helium that
1	employer demonstrates
3	device before
1	render members
1	501, 52
7	chapter 7
1	registration requirement
14	chapter 5
1	chapter 2
1	(10) heroin.
3	determinations by
2	(4) performance
1	law. additionally,
1	manufacturers requiring
1	deferred upon
1	treasury, is
1	investigations it
1	emerging infectious
3	classifying such
1	ordinance to
1	supporting data,
1	site the
1	en-o-year inventories.
1	(b) sales
3	data shall
1	(11) mescaline.
1	products, both
36	residue in
1	relative number
1	periodic bonus
2	(b)(3) for
1	apply. in
1	trials are
1	fifteen miles
1	assessment; (f)
3	upon an
1	formula, the
1	transactions subsequent
2	scope 
3	reports made
1	therefor to
1	1118 to
2	director by
1	shipping container,
1	chapter v
8	wholesale distribution
14	recordkeeping requirements
1	confidentiality reports
1	pesticide becomes
1	develop information
1	article. (8)
3	residue shall
2	program includes
6	submits, on
1	(c) capability
1	priority ranking
1	electronic food
1	research awards
1	identifier or
6	animal models
1	areas); and
1	medical professionals,
1	format. (c)
1	affirmations, subpena
1	furnish manufacturers
9	definitions and
2	action alleged
1	discuss methods
5	substances, and
1	decision shall
1	renew the
1	audits required
2	restricted devices,
1	personally dispensing
1	using surveillance
2	program agency,
1	growing conditions
2	participation by
3	private entities,
1	manufacturer eliminates
1	(a) feesfees
1	national governing
1	wholesome, sanitary,
6	term controlled
1	elect a
1	law administered
1	illness aggregated,
1	occur. 
1	research community.
1	effective communication
10	permanent select
1	mortality, that
1	identify at
5	summary shall
1	(v) other
1	shall fix
1	agency; (3)
2	requiring submission
3	identify an
1	additional statistical
2	rules under
5	interest. in
1	classification submitted
1	(b) exemptions
1	drug. (iv)
1	original manufacturer
2	cos-effective manner.
11	domestic animals,
1	apply. each
1	domestic animals.
3	data exchange
1	protection that
3	31. (i)
1	formula may
1	liabilitythe biomaterials
5	exported pursuant
2	includes pricing
1	reported, notice
1	results thereof
1	procurement, and
1	advertising by
1	communit-wide prevention
2	existing national
2	from, in
2	(ii) identify
1	unobligated balance
1	use subject
6	risk for
1	may testify
4	repealed. june
1	initial application
1	586e, as
5	interest and
1	complainant resided
3	contain any
1	hearing, or
2	paragraph (2)(b),
2	paragraph (2)(b).
1	subsequent violation
1	meetings relate
61	identified in
2	names, and
9	requires the
1	different labeling,
1	synthesis, and
1	less likely
1	includes ethylene
1	incremental risks
1	responsible in
7	affirming or
1	(1) comprehensive
2	including foreign
1	(k) importation
1	subpart shall,
14	manufacturer, packer,
1	(2) impediments
3	apples is
2	statutory requirements
1	another individual
1	persons violate
1	321(g) of
1	plant, its
1	(iii) no
6	certification shall
1	products issued
1	margarine without
4	total quantity
1	manufacturing standards,
1	actual notice
1	testing which
4	process) over
2	date, shall
1	notification if,
1	(b) inapplicability
3	available, and
16	state, tribal,
1	extrapolated from
1	effectiveness. an
1	360e(f)(7) of
21	confidential information
1	(f) periodic
2	applications. (f)
2	1906, as
1	samples; notice
3	secretary following
12	indian tribe
2	section and,
1	fact. (e)
1	(or gives
2	commercially. 
3	specifies the
1	inform health
1	require notifications
45	standards of
2	condition (as
1	administrator certifies
3	complexity, and
1	(h) small
2	without prejudice)
2	except rendering
1	packers, packing
1	may further
1	relevant regulations
1	accelerated approval.
1	day period
1	(b) changes
2	risk product
4	standards or
1	executes a
1	school; or
6	adjusted; all
2	different strength.
1	ecgonine may
1	sale held
1	denied pursuant
4	funding the
1	risk. (6)
1	potential contaminant
4	(b) determination
1	recreation, open
1	including team
1	entity other
1	nonexpedited testing
3	entities paying
1	drug facilities).
1	red, measured
1	subsections (c)(3),
7	quarantine such
3	monograph, if
1	including pandemic
1	manufacture certain
4	secretary, within
2	standard and,
3	approves a
12	2013 through
1	white, and
1	civil regulatory
11	narcotics trafficker
1	resistant, or
6	state offense
2	subsection (j),
2	methamphetamine information
1	initiative this
4	adjustment factor.
2	acid or
98	date on
4	selling any
1	chronic dietary
1	petition addressing
293	date of
2	(c) special
1	approved subsection
6	1997, the
1	(9) a
1	314.161 of
1	reversing such
2	fresh or
1	devoted to
1	additional thirty
1	
 360bbb8c.
10	believes that
3	state licensed
1	(h) civil
1	activities). 
1	following hallucinogenic
1	resources, or
1	(7) additional
1	auditor that
15	maintain a
1	amount charged
1	state licenses
2	expertise needed
1	use audit
1	give precedence
17	2 of
1	subsection (d)(5).
1	decision. in
1	diseases; (2)
1	importation it
1	(including products
1	infertile or
8	section, is
1	adults, and
2	533, formerly
4	(b) illegitimate
1	renewal registration
11	title; (ii)
2	28. (2)
1	
 379j41.
1	neither that
12	section, if
1	best information
4	recognized, among
1	(b) subsequent
1	(i)(1)(d) of
2	section, in
2	drug act
1	proposed findings;
7	(b) notification
1	rule, issue
15	approving the
1	complete applications
1	distributor determines
1	intrasystem use
1	jurisdiction and
1	table. 
1	establishments; and
1	will carry
1	fact exists
3	transports, distributes,
2	any, contained
2	assembled, or
1	(c) standard
1	trafficking activities
1	functions prescribed
1	sterile drug
22	developing and
6	device if
1	receive no
12	fees appropriated
2	minimum, meet
2	food, means
1	title. (k)
1	venture, association,
3	offense occurs
1	upon after
1	household under
1	registered 
2	pharmaceutical, device,
1	records. (c)
1	published, prominently
1	(d) international
2	security act;
1	enterprise which
1	annual evaluation
2	least 120
1	i-kind emergency
3	supplements, including
1	
 360fff5.
7	report beginning
1	equivalent within
2	(a) task
1	discontinues the
3	appropriated funds
3	inspections; and
4	manufacturing and
1	haemorrhagic fever.
1	quarter or
1	tracing practices
5	humans that
2	filing its
8	professional practice
38	make the
2	item (aa)
3	use restrictions
1	counsel for
3	filed, (ii)
1	costs; and
1	period; or
2	fees, animal
1	stat. 1059,
1	carcasses only
1	interactive communication
1	-year base
1	1992, of
1	senate with
1	360l of
2	(whether in
1	expertise that
2	therapy available
1	technologies. (b)
2	1992, or
1	title; such
3	established through
1	proposing bulk
1	local foodborne
1	metric tons
1	regulation listing
1	(b); 
1	cosmetic, if
1	before, on,
1	practice. when
2	obligated, modified,
1	(3) participate
1	phenomenon common
1	carrier; shall,
1	pediatric diseasethe
1	basis by
2	secretary; (10)
1	products. (iii)
1	including consideration
2	extensions). (2)
4	food safety;
1	revised on
1	condition does
1	whether electronic
2	food safety.
1	adulteration originated
5	food safety,
2	one pharmacy
5	january 31
1	industry representatives;
1	distributing controlled
2	pending completion
1	parties, or,
2	quantitative terms,
1	impairs individual,
1	form means
1	affiliated persons
2	1000 kilograms
10	food which
2	engaged, including
1	resides, shall,
4	exemptions 
1	cessation approved
1	manufactures positron
1	(b)(2). (d)
7	traffickers and
1	amended reportif
1	$240,000,000 for
13	policies and
1	botanical; (d)
1	director, on
8	accounting for
5	transport, or
1	rapidly initiating
1	available; (ix)
1	requirements (or
1	(and subsequent
1	open market
1	form each
5	testing to
1	paragraph (2)(a)(i)
2	products impair
1	therefor, filed
9	drug pursuant
1	estimated by
1	understanding. 
2	determines under
1	u.s.c. 263a],
1	crime, and
2	tool for
1	permit. subsections
13	fee assessed
1	directly, or
1	reports summarizing
1	tobacco dependence,
1	principal use
56	substance is
2	procedures the
2	display (in
2	sponsors, and
1	facilities covered
1	quarterly assessment
1	coalitions are
7	application by
3	obtain the
1	qualification. 
6	substance if
1	pyrrole ring,
1	banned device,
25	paragraph (1)(a)
1	pharmacy, under
1	(2) effectnotwithstanding
3	administration (referred
85	substance in
1	secretary. each
1	publications and
1	secondary school,
1	receives funds
1	(4)(a)(iii)(i) and
1	notificationif, after
1	species papaver
1	consultants in
2	consider available
1	30, 1979,
1	growing area,
1	intended. (2)
1	bruises, and
1	procedures adopted
6	importing, any
1	$249,000,000 shall
1	section 10.45(d)
4	dispensed only
4	subsections of
2	resumption to
2	sizes of
1	purity; (d)
1	(1) certification
1	(2), nothing
1	grinding, pasteurization,
6	biomedical advanced
7	damage to
2	brought such
2	(f) if
1	897.34(c). (d)
2	pharmacies, as
1	methods available
2	persons making
1	issued. (c)
1	(ii) biennial
7	(commonly referred
1	withdrawn, other
1	drug lawfully
1	expired the
1	(i) operational
1	national intelligence;
2	information exempt
1	following that
1	379d4. reporting
3	recognized international
2	experience; (iii)
1	smoke that
2	selected as
1	injury mean
2	procedures, the
5	(i) within
1	specifications, hereafter
1	collection, and
1	country meet
1	feeds. (8)
1	cause blindness.,
1	(8) no
1	lon-range, quantifiable
1	removes foreign
1	holiday for
3	general deems
1	effectively implement
1	them: 
3	inspection, to
2	facility engaged
1	unless on
1	(a)(1)(c); and
1	consultationtopics for
1	loans of
1	regarding genetically
4	following information
2	addition, the
1	leases, cooperative
1	procure without
1	take immediate
1	otherwise is
1	d-stems, dries,
1	postmarketing conditions,
4	controls pursuant
1	restrictions herein
1	inspecting, copying,
1	containing particulars
1	commercial distribution;
2	drugs except
8	within 90
2	prohibitions of
1	determine validity
1	representation none
1	household or
1	specified level
4	drug; (c)
1	food primarily
1	reviews that
2	office. the
1	consumer; and
2	(2) conditions
3	1 eligible
1	302, 304,
1	members each
1	(b); (ii)
1	isomers. (d)
3	disclosure; access
4	household of
2	$3,872 
2	regulations) shall
1	(c)(1) for
1	proceedings, the
1	prohibited to
7	deferral extension
1	suspension a
13	contracts with
1	forfeitures under
1	18. (june
1	(b) revise
1	(ii); or
1	traffickersnot later
3	(c) exception
30	section 
1	sell, assign,
2	establishments covered
2	rulemaking, and
1	licensed entities
1	title, classifying
1	similarly situated
1	considered. (2)
5	may, after
1	coverage or
1	term different
1	
 847.
1	notification, be
2	sentence a
1	agreement the
1	basis. (12)
1	handler (including
1	determines could
3	(4) no
1	direction of,
4	representative to
4	labeling are
1	(b) specify
1	costs. (c)
1	fee; (5)
1	advertisement does
2	eight years,
1	provides 
1	(b) reportingbeginning
4	radiation safety
1	vessels, etc.,
1	administer, invest,
1	facts relating
1	facility pursuant
3	drug after
1	enhanced penalties.
2	local levels,
14	(1) that
1	(e) trade
1	1 shall
1	provide further
11	product the
1	(2) consider
1	significant threat
1	prescribe, not
1	pipes; (11)
2	prospective transferee
1	(gg) diversion
3	chain, as
1	retrievable from
2	national taxing
1	(f)(6)(h) distribute
1	contumacy by,
1	tomography drugs;
1	requires substantive
1	number; uniform
1	inhibit or
2	list previously
1	secretarial response
1	product labeling;
1	report, where
1	(d) clostridium
2	years. any
1	funds described
2	competitive grant
1	natural toxins,
1	(b)(3)(a) shall
1	health disparities
5	(including such
2	basis. such
17	section 374
2	state receives
2	children. in
1	place, or
1	reimbursement the
1	related regulations
2	section 372
1	675, 509,
1	treatment may
1	public. members
2	benefit under
1	who, because
2	section 379
1	cause therefore.
1	revoked as
1	subsection (g)(2);
2	duration, and
1	packers, distributors,
10	percent shall
2	 (with
1	restricts this
2	prescription has
1	sellers under
1	acts b
1	(c) protection
1	identifier; (c)
1	availabilitynot later
2	operates a
2	major change
4	consumer organizations
1	
 387f1.
2	1105(a) of
1	355(e) of
4	section. (5)
1	(b) elementary
3	schedule iii.
1	consignee complied
2	standard by
1	submitting or
3	order forms
1	testing performed
1	sites, such
1	general, concurrently
1	regulations, will
1	(1), (4),
1	experience because
1	(6) counterfeit
3	levels, or
2	(g) authorization
3	using or
6	support and
1	act described
1	marketed unapproved
6	article 
6	facility under
1	change existing
5	plan required
1	declaration within
1	included; (i)
1	conditionsnotwithstanding the
3	requests to
1	(d) composition
1	applicable rules,
1	made any
1	additional studies
2	made and
2	offense after
1	thereby to
1	advising and
1	(b) source
1	(a) offer
1	consequences, if
1	moneys. 
1	recommendations, as
1	(1) biomarkerthe
1	1502. repealed.
1	aircraft for
1	participation of,
1	approval per
1	food sampling
1	(a) collecting
2	eradication or
1	designated agency
1	regular general
1	doubled in
1	licensing and
15	context of
8	numerical identifier
2	(g) a
1	require postapproval
1	consul to
1	2011. (11)
1	finding, in
1	repatriate any
10	investigations which
1	difference exists,
1	patient when
4	ongoing effect
1	accreditation, pursuant
12	detail the
1	
 964.
2	prompt and
4	investigations and
3	commissioner, shall
9	142 of
1	making substantial
1	holding public
2	fees pursuant
2	specific population
4	grant award
1	deny reaccreditation
1	valid certificate
1	license would
3	authorization was
1	nominees if
1	regulations either
1	submitted all
1	situations the
8	administrator to
1	manufacturers under
1	occasions. 
6	restricted eggs
1	test, either
1	675, 405,
2	entity at
3	subsequent convictions
1	recoupment in
1	d of
52	listed drug
1	rarely documented
1	shipment data
3	work of
1	establishing general
1	bureau and
1	assessing whether
1	subparagraph, and
1	develop, test,
1	suppliers. (

1	concerned therewith,
5	biomaterials supplier;
1	specific lot,
4	manner; or
1	11 members
2	conditions established
6	supplement, not
21	interests of
1	includes, when
1	key stakeholders,
1	following topics
1	sentence shall,
1	previously developed
8	qualified importer
1	misbranded; or
2	health advisory
1	products shall,
1	procurement specifications
1	submission; (b)
1	(c) charges
1	information panel
1	section 5311
2	least 75
2	transactions within
1	least 70
3	distributor required
2	brought a
1	status after
2	material change
8	regulatory limit
2	lay person,
2	drug, shall
1	reprocessing and
8	section 552(b)(4)
2	(h) preemption
5	treasury, in
1	apply, under
1	general use.
1	renewal grantssubject
2	legally marketed.
3	requests were
4	processed lo-acid
1	schoo-based staff
2	rapid analytical
4	person (including
1	two recognized
1	annual meetings)
1	detoxification; (bb)
1	persons receiving
9	fund control
1	appeal pending,
1	professional license
1	listed chemicalsany
4	intentionally introduced,
1	administrative, legislative,
1	subparagraph. (ii)timing
1	nutrition information
1	(4)(a) and
6	study plans,
5	manufacturer, and
1	match, tournament,
8	article pursuant
225	amount of
1	sections. (june
1	fluid carrier
2	thereof) on
3	requesting, any
1	treaty, statute,
1	inference, enhanced
3	performed pursuant
1	(b) meetings
1	rots, white
1	(d) record
1	injury; (c)
1	(e)(1)(a)(ii); (ii)
1	evidentiary hearing,
2	promptly reduced
2	360(b)(2) of
2	drug, except
1	(e) coordination
1	written, faxed,
9	history and
1	process actions
1	grown tobacco,
2	commercial importer
1	subpoenas for
1	conventions to
1	appended to
3	periods of
2	party as
4	food when
9	consists in
16	human generic
1	1976, by
1	acid (ghb)
2	compliance not
2	grown tobacco;
13	product from
4	identify a
1	regulations), for
1	display in
1	seller maintains,
1	(1) 3,-methylenedioxy
1	solution); (d)
1	interest. a
1	 percent
1	 whoever,
6	availability and
1	(4) take
1	potential toxicology
1	3,000 layers.
1	696, 13,
1	agreements, to
1	expenses each
1	tapes, and
1	endpoints which
1	disease. (s)
1	inspections described
1	category; and
1	employing children
1	order thereon,
2	differs from,
1	appropriated each
2	63 stat.
1	encountered. with
5	false statement
1	(1) detail
3	quality, species
1	enforcement means
1	logbook includes,
1	(b) response
1	following terms:
1	carrier shall
3	chief inspector,
5	condition. 
1	(19) nicomorphine.
4	offense described
2	improvement, and
1	proposed direc-t-consumer
1	grams) of
1	suggested by
1	(iupac). (2)
31	publish a
1	(b) acceptance
1	residues from
1	debarments, and
1	postmarket information
1	codex level.
1	exceed thirty
1	reconfirmed on
1	strategic action
3	(directly or
2	(adjusted for
1	(c). the
1	score at
1	conducted; and
1	to, sliding
1	subchapter, he
1	extract product;
1	3324 of
1	evaluate emissions
3	electronic tracing
1	1708a. annual
1	entities certified
1	begin dispensing
1	requirements. (b)
6	i, ii,
1	reaccredit or
1	design appropriate
15	maintain the
1	otherwise stated,
2	mileage that
1	section 360e(g)
1	manufacturer, exclusive
1	heroin, cocaine,
2	21, 1972,
1	therein or
1	shall fairly
1	laboratory, or
1	records at
12	records as
1	persons (including
1	(i) corrected
1	radiation means
1	sent directly
1	holding, withholding,
4	notify immediate
4	811(j)]. 
1	passed, whichever
2	opium. (b)
1	actionsin addition
4	exporter of
2	discretion, suspend
1	excretion of
8	5 fiscal
2	saleable return
1	18 or,
2	auditors to
1	section 360nn(b)
1	violation, degree
20	fiscal years,
6	fiscal years.
2	(i) address
1	year 2019
1	year 2018
11	act july
1	exclusionssuch term
1	section 601(m)(8)
5	(3) is
1	360(k), or
1	property subsequent
1	year 2011
3	year 2010
19	year 2013
2	year 2012
9	year 2015
12	year 2014
1	feeds. 
3	year 2016
2	agencies will
1	issuing duplicative
2	ninetieth day),
1	(including limitation
1	subsection (k)(1)
1	people of
1	study were
2	state rules
2	act), with
1	given those
2	appropriate agencies
8	danger to
2	reprocessed under
1	meaningful number
2	places the
5	deems such
1	on-time generic
2	(b) administrative
1	proceeding; and
11	exported from
11	conditions and
1	section 360e(c)(2)
1	1498(a)(1) of
1	physical locations,
1	views shall
1	120 days.
3	petition. if
2	infringement. 
1	application references
1	(a) intracompany
3	qualities of
2	new device
1	stuck yolks,
1	purity or
1	recalled pet
1	(bb) appropriate
1	chemical, container,
1	residue, if
1	adopt tobacco
1	387e of
1	requests information
1	effect only
3	schedule notice
2	enter, at
1	individuals, the
3	life or
8	attempted to
1	ways to
3	(g) is
4	offices described
1	lon-term fashion;
1	single quarter
1	breakthrough therapy.
8	primary mode
1	publications, as
1	duty without
1	(r) zika
12	review to
32	contains a
3	25 percent
1	
 349.
1	recognized religious
1	injection, inhalation,
3	(g) if
1	(2)(d). such
1	(a) imprisoned
1	9-day extension,
1	group can
6	if, directly
1	industries after
6	submissions for
2	finds (1)
2	president has
1	(1) department
4	approves the
1	coordination; (d)
2	jurisdiction, which
1	
 372.
1	judicial officers
3	thereof, unless
1	subsection pursuant
1	supply the
1	device, any
1	dependence upon
1	2106. consultation
3	regulatory oversight
4	subsection (c)(3)
7	use only
5	effect, the
6	designated representative
1	electronic manner
1	containing silicone
1	submitted as
1	supplier agree
1	delay approval
1	generalprior to
2	counsels, commands,
1	provisions; humane
2	primary basis
1	(h) inspections
2	cigarette tobacco
1	supported in
1	includes on
1	extending beyond
1	etonitazene. (23)
5	submitted an
1	animal drugthe
1	disease). (h)
1	453(g)(8) of
3	may treat
1	forms. (4)
1	thus inspected
1	sufficient progress
1	schoolthe term
1	review. (iv)
1	margarine when
1	packed apples
1	(6) federal
2	additive the
1	1546. meetings
1	animals, (b)
1	nutritionally rational
1	(b)(2). (3)
1	thereafter or
1	petitions 
2	employee for
1	state initiative
1	(a) compromise
1	combination (including
1	risk (as
2	austria, on
1	(ii) holds
1	panel, as
1	packer packing
2	manufacturing quota
1	individual, as
1	paragraph. information
3	(c) submission
1	due inquiry,
11	distribution within
4	shall demonstrate
3	collect a
1	requirements consistent
9	control strategy,
3	371(e) of
1	(a) all
2	consumer packaged,
8	coalition under
1	upon execution
1	deaths, the
1	publication; confidential
1	product distinguished
1	(a). (6)
1	transferred. (c)
9	unpaid fees
2	programs, including
1	misbranded with
7	adulteration or
1	
 155.
1	facilitating cooperation
4	general regulation,
1	(b) deferral
3	(iii) inpatient
1	exchanged under
1	 legally
1	court shall,
20	adulteration of
1	quality, condition,
1	review. (iii)
1	
 374a.
1	estimates is
1	(b) managing
1	leaves imported
1	(2) that,
2	first animal
1	on-half avoirdupois
1	detailed report
1	percent. (11)
1	word package
1	applicable a
4	individual tobacco
1	(d)(3). 
1	exclusively wholesale
10	10 percent
1	improvement protocol
1	fields; and
2	sense of
1	(ii) unless
1	
 19.
1	(ii) investigationan
1	biennial inspection
1	testing, obtain
1	incapacity or
1	substantive rationale
4	(13) the
2	(2) have
1	(3), an
2	data specified
1	coverings of
1	(b) modulates
1	379j43. reauthorization;
1	compounds or
1	(c), before
7	indications for
8	per dosage
1	particular. health
1	propylene oxide
1	compounds of
2	term emergency
1	843. prohibited
4	display of
1	received transaction
1	unique needs
1	hormone means
2	section 208(b)(1)
1	otherwise on
1	post at
4	product only
6	consultationin developing
1	individual patients,
3	select an
2	public welfare,
2	accredit thir-party
12	shall permit
2	chapter related
4	safe drinking
1	drugs concluded
1	coalition receives
1	select at
1	-(2,-dimethox--methylphenyl)ethanamine (2cd).
1	(6) methyprylon.
1	restrictions; bonds;
1	infancy, allergic
2	distribution which
3	(i) authority
1	obligation nothing
2	common control,
1	(5) alter,
3	(c)(4) for
2	(ii) develop
4	ii 
1	blinding trachoma.
12	state has
1	devices (referred
1	deem a
1	trends, adverse
1	applicable section
1	immediately suspended
1	plates, stones,
1	
 1531.
2	terms by
1	statute. (g)
4	director considers
6	business entity;
1	administration. (

2	petition) as
2	section 2021
3	2008 (7
1	(i)(3), and
1	(c), formerly
1	drugs otherwise
1	(b)(3) and
1	set out
1	authority using
1	health web
1	drugs. (30)
1	importer, provide
1	associate attorney
3	finding described
1	26, or
2	guidance, if
2	method is
1	(a)(1)(d) for
1	secretary) may
4	secretary, for
1	lacks with
4	person pursuant
2	submission, 3-day
1	consortia the
1	bear adequate
4	1, 2000,
1	1, 2000.
1	endangering human
1	land or
1	section, 70
1	businessa facility
2	(d) that
17	raised by
1	675, 1002(b),
1	drug certification
2	infringement litigation
1	certain sales
2	space to
2	results, shall
1	practitioner a
7	(d), (e),
2	making their
1	assessed fees
3	published or
2	possesses a
17	promptly notify
1	evidence properly
1	valid, including
1	outbreaks. (b)
1	pots, canvas,
1	(c) additional
15	(i) 
1	(a) exclusive
1	sections 335b
1	hearing, except
5	findings, and
1	(c) subsequent
1	renumbered 8
1	4202 of
2	larger facility,
1	independent establishment
1	score cards
1	refuses, on
1	guardian of
1	practices observed
1	localit-based comparability
1	review voucher,
2	notice which
1	tolerance. (e)
2	modifying such
1	persons. not
2	(b)(3) of
1	committee convened
1	section 1035(a)
9	used as
1	ineligible under
1	treated, for
1	qualification for
1	strategy was
1	products approved,
2	involved for
3	v, unless
1	pleading or
1	date. (o)
3	person receiving
1	internet in
1	(1), disqualify
18	(3) any
1	issued be
2	thereunder shall
2	amount to
2	postmark on
1	broker that
1	
 1602.
1	countries, including
1	position, or
1	
 1521.
1	payment penalty
1	inspections thereof,
1	knowingly ship
1	forfeitures any
1	(bb) private
2	foundations, and
9	(3) and
1	combined, the
3	first and
1	device provided
5	slaughter by
1	(d) adjustment
1	
 1541.
7	term qualifying
12	time that
2	products; (b)
1	assurance. 
1	external to
1	foods, in
1	person elects
3	applicable inflation
2	subsection (f)(6)(a)
1	multiplicity, or
1	proposals consistent
1	transaction between
1	material, subject
3	petitioner applies
1	1175. transferred

1	use, when
1	sentence or
1	respective departments
1	agencies outside
1	country) are
5	establishment if
6	(ii) does
2	provided as
1	15, 1932
1	campaign activities,
3	nature, circumstances,
19	establishment in
2	documents that
1	convened by
1	butyrolactone. (y)
1	product. if,
20	establishment is
1	v from
24	sentence of
1	recalls; (2)
2	(cc) of
1	mail. (3)
2	program implementation
1	purpose, but
2	(i) review
2	sentence on
1	chemicals listed
1	u.s.c. 56(b)]
1	state lines,
1	825, 827,
1	sections 672,
1	clear links
18	subsection is
1	public communication.
1	aircraft, commercial
2	private entity
5	would, in
2	limitations the
9	become effective
15	subsection if
1	919, as
1	systems; (h)
1	workload adjustmentbeginning
2	kit is
1	substantial population
1	enforcement outside
1	250.)
 

1	proposes any
1	distributor thereof
1	volume, as
1	(c) penalties
1	sanitary requirements,
1	depositions under
1	355]. such
1	accreditation program;
1	(2)(a)(ii). (c)
3	action which
19	diversion of
9	(h)(1) of
2	days established
1	861, 2,
6	eligible establishment
2	(b) violation
1	necessary, as
2	grase for
3	deems adequate
1	prevalence and
1	shall develop,
8	packing, storage,
1	collections of
6	drug at
14	(3) in
29	drug as
1	advertising, after
2	unit, such
1	also is
1	inventory, shipment,
1	upon objections
1	(2)(c)(iii), the
1	safety establishing
2	accreditation standards
1	certain admiralty
1	shortages; and
1	appropriate) to
27	submitted for
7	1954, ch.
2	drug an
4	nearly as
1	(i) demonstrates
1	requiring control;
1	552. (c)
3	process described
1	7801 of
3	privacy of
1	47; are
1	respond adequately
1	entity entered
1	violates sections
17	specifying the
1	chemical synthesis
1	exported, or
1	si-tenths degrees
1	inconsistent laws
13	person making
1	exported without
2	goods or
1	made reasonably
63	establish a
1	 (iii)recipients
2	(4), deems
1	levels in
1	period reasonably
3	account differences
1	(i) registrations
1	(d) each
2	section 321(s)
2	regulation; (ii)
1	therapy concurrently
2	limitation fees
1	establishment used
1	determining in
1	u.s.c. 355(b),
2	separate review
1	506, as
9	applicant involved
1	independent experts
9	adulterated; and
36	specified by
1	except subsections
19	distributors of
1	states officials
3	laboratories that
1	(a) commerce
1	repealed. nov.
3	(8) 
1	requirements has
1	addresses of
1	$20,000,000, multiplied
1	(a)(i) to
5	approval. (c)
1	means data
1	program, which
1	antibacterial ingredients
1	person, sell
2	means slaughtered,
1	ii seized
1	orpha-designated products
1	presumed to
2	of, an
1	flexibility under
1	limits regarding
1	concerning fees
1	(4) content
2	360f, 360i,
2	(b)(3)(a). 
3	adding a
7	present and
1	routine practice.
1	of, supplemental
32	prescribed, recommended,
3	index listing;
5	followed in
4	product inspection
1	frameworkthe framework
2	refused admission.
13	secretary until
1	evaluation, funding
10	financial interest
4	extent permitted
1	detailed timeline
1	contentfor the
1	panel makes
1	type; (e)
6	adulterated, misbranded,
1	
 379aa1.
1	index listing.
1	covered application.
2	reasonable attempts
5	labeling, packaging,
1	association, corporation,
2	360i(g) of
1	interdiction of
1	(5) after
1	nonparties. (e)
3	action was
2	psychological dependence
2	product labeling
1	manufacture, repackage,
1	(a) staffing
2	signs the
1	regulation deems
1	respecting priorities
2	opportunities to
278	subsection (a)
1	injunction, require
2	denaturation or
1	system designed
2	prompt notification
3	term adverse
1	sunscreen. (b)
8	pharmacy shall
1	exemptedthe secretary
8	equivalent position
1	therapy. a
1	tobacco over
1	facilitate patients
2	effective treatment
1	determined; (ii)
5	(or successor
1	industry outreach,
1	facility identificationeach
27	authorized in
9	standard. 
3	alternatives to
2	enforcement (a)
2	secretary, each
1	probation, prosecution,
2	(a) beginning
2	allocates for
2	actsexcept as
1	wires or
1	subsection (as
9	among youth
1	19) and
1	effective, such
1	hearing, then
1	
 1116.
1	criteria means
1	data collection,
1	360ee. grants
1	hearing. after
1	ascertaining the
1	protection to
8	chapter, shall
1	(b) activity
3	shall award
1	constituted committees
24	principal place
2	containers standards
3	codeine per
1	chronic bronchitis.
1	color, whether
2	requirements may
3	section 360bbb3(a)(2)(a)
1	adulterated articles;
2	begun. 
3	dated and
4	thereon shall
1	(iii) suspension
2	disposition may
5	exempted under
1	public internet
9	labeling, and
7	manner, and
16	of, the
2	(iii) annually
1	additional authorities
1	recommendations, opportunity
1	paragraph until
1	governments, state,
4	rule for
1	registration system
3	120 calendar
3	dates and
1	effective appeals
1	within 365
15	states, and
1	container, as
1	prescription requirement
1	uses proposed.
1	developed; (e)
1	clarity regarding
1	detected the
4	base, or
2	containing cocaine
1	1548. termination
5	research, and
1	42 after
2	exporter involved
3	adjusted or
1	risks, costs,
1	clarification to
6	filing, and
1	establishments; samples
1	chair the
1	forfeiture upon
1	compiled by
2	period designate
1	requirement, and
2	(2) initial
2	claim; or
5	use, the
1	572 of
1	chapter. members
1	mean illness
1	applicable no-federal
1	(1) consultation
1	conditions, the
3	first such
1	waives the
1	cover. (s)
1	partner program,
2	devicesa drug
4	exempt a
1	money, gift,
1	violation resulting
1	domestic supplies
1	interes-bearing account,
3	third sentence
1	(1) internal
7	receives the
1	study when
1	regulation, consistent
1	establishment, under
1	issued thereunder;
1	made. this
2	amino acids);
9	state. 
1	person enters
1	
 157.
1	objection. the
1	property who
1	identifies programs
2	inconsistency between
2	support intramural
3	practicable to
1	structured process
4	agreement described
1	guidelines (including
1	specific methodology
1	issued thereunder.
2	(3). (b)
1	assess information
3	(k) shall
1	237a(b)(4) of
1	betamethadol. (10)
5	applications in
2	person regarding
1	device manufacturers
1	consumers. (2)
1	directly accredit
1	application, for
1	fresh milk
1	notification pertains
1	upon these
1	countries designated
52	information that
9	and, upon
1	administration, nonprofit
1	aureus, and
3	conviction thereof,
2	shows the
1	research can
1	premarket burden,
2	inspection legend,
1	$15,000,000, for
1	toolsubject to
3	milk and
2	amended at
1	manufacturer, documentation
4	submissions 
1	complete payment
1	social services,
1	(c) clear
1	section 282(j)(2)(a)(ii)(ii)(gg)
1	manner; (2)
2	security biological,
1	section 360b(b)(1)(a)
1	veterinarian) applicable
1	practitioner, whether
1	product comply
1	affect a
1	registrants regular
1	warnings or
1	awareness effortsthe
3	information furnished
1	(i) removes
1	(h) registration
1	informationeach online
1	guidelines. the
3	2012, that
3	shall allocate
2	general denies
2	accounting or
2	formal comments
2	emergent campaign
2	investigational generic
1	section 309..
3	incomplete if
2	affects safety
4	upon payment
2	may allow
3	promptly notifying
4	lot or
1	patterns, incidence
1	expert is
7	sponsors of
1	calculated by
1	(c), each
9	criteria under
1	transfer agreements,
1	following narcotic
2	(b) subparagraph
2	lot of
1	(aa) does
1	columbia of
1	(c) hearing
1	sponsors seeking
1	diem instead
1	market on
1	pathogens; or
1	control illicit
1	guidance the
5	(7) 
2	chloride, and
4	market of
1	anaphylaxis of
1	facilities comply
1	coalitions communities.
4	development meeting
4	person resides,
3	groups. 
1	prepackaged form
1	delivery above
3	including appropriate
1	latters request,
1	container size
1	market or
1	mai-order reporting;
2	(i) consider
1	considered such
2	product recall
1	reporting, recordkeeping,
2	subparagraph (2),
1	subparagraph (2).
6	schedules i
2	states all
3	potential risks
2	list ii
1	applicable statutes,
4	iii unless
1	food. (7)
1	(8) control
1	sunscreen, including
3	agriculture under
7	registrant under
1	limited solely
6	distributor and
1	product must
1	joint venture,
2	facts so
1	extrapolation a
1	387a1. final
1	injury. 
1	formerly 360f,
1	effects, and
1	substances law
7	acts 
5	section 822(d)
2	person, to
1	(2) amendments
2	denied, revoked,
2	meets each
1	representation an
1	(among other
2	emergency situations,
4	drug can
1	forfeited by
2	prescription that
1	zealand, switzerland,
4	returns to
2	members to
1	resistant tuberculosis;
5	therapies and
1	675, 568,
1	morphine per
1	partnerships (a)
1	position or
1	disciplinary authority.
1	(1)(c)(i) shall
1	remitted to
1	343(j), 344(a),
1	law, minimize
1	pathology or
3	2 and
1	2 days
2	use, persuade,
2	consortia and
1	1622(h) of
1	article would
2	process pursuant
3	effective approval
1	amount as
1	including concerns
2	trading a
10	employee designated
1	country, of
2	(and any
4	numbers of
1	necessary, procedures
1	areas programnot
1	pending, (b)
1	limitations identified
3	country, or
1	(2) n-cost
2	 (26)
1	may for
1	need for,
1	regulation, including
1	product package.
1	numbers or
1	medical societies;
1	
 360f.
1	user, lon-term
1	(1) mixed
2	enterprise, or
1	act information
2	compounded from
17	subsection to
1	age or
1	data refers
1	1990, while
1	discussions shall
5	giving the
1	jury found
3	medical societies,
1	directly conducting
1	investigation, if
2	passing upon
20	final agency
1	orders that
1	customs custody,
6	may also,
3	contain (i)
1	subgroup, or
1	best serves
1	(c) requisite
2	12, as
1	reprocessed within
1	2010, or
1	damages, including
2	sanctions to
19	death or
2	appropriate standards
1	
 360jj.
2	apply shall
1	infused drug
1	patient; or
2	established before
2	subsection (l)(3),
11	agreement between
1	technology; 
1	563, as
3	use will
1	(9) licensedthe
3	shall vacate
1	design, composition,
4	may declare
1	users occurs
1	productsif, during
1	prescriptions it
1	(5) proposed
1	(2cn). (28)
29	section: 
1	lease, rent,
3	exceed 48
2	order determining
1	product identified
1	correct copy
2	(b) without
5	waiver is
1	single use
1	agent 
10	receive such
1	designate new
1	documents per
24	convention on
3	defray the
3	entities, including
1	(b) nanotechnology;
2	(i) notification
3	ingredient 
1	(4) do
1	mail to
1	waiver if
1	records each
2	subchapter 
1	consultation of
1	applications; food
6	repackager that
1	particular matter.
1	exterior 
2	received, an
3	consultation on
1	section listing
1	product exports
2	countermeasures, including
3	display on
1	regulations specifying
1	contract relating
1	pacific islands.
1	validated in
1	qualificationsan accredited
1	distribute, sell,
1	(c) status
1	directions, recommendations,
1	practices, taking
2	(d) enforcement
6	time such
2	additional inspectors
163	shall 
1	may accelerate
2	patent brought
2	inspection requirement
1	
 335b.
1	it, revoke
1	purchaser, exceed
1	u.s.c. 262(i)].
3	may on
4	programs that
4	may or
2	supplant, other
2	psychotropic substancesthe
2	organizations, disease
24	appropriations for
2	area; (c)
1	u.s.c. 214),
1	submitting documentation
1	(1) reviewing
1	within those
46	(2) 
1	products, restrictions
2	undertaken under
7	(ii) all
1	teams, composed
8	court or
1	(b)(1)a),[1] the
1	amount calculated
1	considered part
1	alone: 
2	manufacturing, compounding,
24	advisory committees
3	findingsthe congress
1	emergency that
4	issuance by
1	interoperable exchange
83	court of
2	highest court
1	potential adverse
1	substance are
1	patient groups),
1	facility demonstrates
1	packer on
2	reclassified from
2	clinical investigators,
1	
 391.
1	consultation regarding
1	butyrolactone or
1	basis therefor,
1	one adequate
1	warrants, administrative
3	consulting agency
1	on-time payment
2	rule on
1	provide objective
1	order violations
3	(c) sales
3	imports such
1	adulterated. (3)
2	slaughtered, canned,
36	rule of
6	controls, and
1	boobytrap means
4	times, to
1	rural areas
1	chairman. 
7	2015, the
3	proposed drug
1	(vi) an
132	authorized to
1	for, assessing,
17	advisory committee,
32	sale or
1	youth today
23	certification described
1	provided and
6	sale on
1	farm, unless
2	report as
6	advisory committee;
52	sale of
1	chemistry and
1	(27) -(2,-dimethox--nitr-phenyl)ethanamine
1	(a) applicants
3	impairs the
1	customer, for
9	term affiliate
1	packaging (other
3	ship poultry
1	report outcomes
4	agree. any
6	facilitating the
12	marketed tobacco
1	leaves. all
1	complaint and
1	addiction. (2)
2	administration. (c)
1	plants exporting
6	voucher shall
1	virus to
4	shall adopt
3	(1) animal
1	persons prompt
3	proffered delivery
1	reject; or
1	charged. (d)
2	drug laws
1	notificationthe notification
4	marketing authorization
2	combined or
2	law prohibiting
1	dispensers, to
1	establish tolerances
2	state standards
4	comments submitted
2	(h) construction
3	(except for
3	secretary) finds
1	organizations; health
1	instruments, securities,
1	law because
2	(a)(3), or
15	may deem
1	period involved
1	defense of
1	person injured
2	disease product,
15	permit the
1	coordination with,
1	burden, and
2	articles, and
3	(without regard
2	person, have
1	appropriate legislation.
1	disproportionate use
14	approve or
1	means reviewing
2	conduct evaluations
1	(i) procedures
1	shall show
1	(mm) 
1	definition shall
1	care. (3)
1	contents; restrictions
15	report 
1	options to
6	registration number
1	350k of
1	diet that
1	pressures with
9	voucher to
1	document storage
5	controls are
1	threats (a)
2	section impairs
1	representation from
1	intrastate commerce.
1	posted. (

1	(b) making
1	purchase reasonably
1	regulations. (3)
2	consensus standards
1	subparagraph, of
3	action failed
2	(i) declaratory
1	monitoring food
2	(if the
1	305, 52
1	865. smuggling
1	smoke, no
1	individuals upon
1	stat. 631.)

1	postmarket controls
1	documents relevant
3	(a) involving
2	committees (which
1	activity, immediately
1	(b) noticean
1	(2) limited
1	intelligence; or
1	avoid issuing
5	storage, or
4	successor) shall
1	entered with
4	advertising that
5	consent decree
1	business. (3)
1	robust and
1	weight, less
3	species means
1	managed. (e)
80	house of
2	territorial, and
2	requiring a
1	submitted, shall
2	charge, are
4	processes of
5	of, each
33	member of
1	exposed or
1	387k(a) of
1	employees (hereinafter
1	coca[3] leaves,
1	jury, the
4	condition caused
1	weaknesses in
1	lawful purpose,
3	(d) effect
1	whatsoever in
1	document dietary
11	(a) as
2	residue from
1	application states
41	exemption under
23	(a) an
1	policy; (3)
1	nominated for
1	subparagraph, a
1	affairs registered
1	term investigational
3	drugs meet
35	carried out
5	veterans affairs
1	person giving
1	(b) receives
1	ii. it
4	2011 et
1	(e)(1)(b), (f)(2),
1	processors or
3	whose route
1	campaign for
1	section 387f(e)(2)
1	adequately labeled
1	eligibilityto be
2	influence compliance
1	year specified
1	medical specialties
2	information; regulations
2	upon public
4	1950, ch.
12	advertising time
1	(c) communications;
1	potential surrogate
4	detection of
4	section 360kk(h)
1	granted review
1	capabilities by
1	relevance, if
4	sufficiently complete,
1	185. repealed.
3	unless extended
9	local, or
1	used, and,
15	adverse drug
1	agricultural products,
1	property will
2	(c) identify
1	full biosimilar
2	detection or
1	applicant opportunity
1	relevant studies
20	demonstrate that
1	funds by
6	regular and
1	applicable, where
2	eggs have
1	submitted, and
1	parts affects
1	purity; (ii)
1	reevaluate only
2	use, restricted
1	1, 2010,
1	605. examination
3	signature of
1	declaring such
1	uniform inspection
2	(including appropriate
1	(a) communication
1	refuse any
1	website regarding
1	patient in
2	minimum 
1	veterinarian, or
2	drug. (5)
1	include historical
1	(5) alphamethadol.
1	acid. (2)
2	patient organizations,
1	(5) eligible
1	process. 
2	individual retail
1	heating source,
1	shall derogate
25	analysis of
1	government reform,
1	copying of,
1	spirits, wine,
1	drequired to
2	analysis on
2	ii unless
1	oxygen that
4	chief executive
5	water regulation
1	order; abbreviated
4	title until
3	program agencies;
4	commerce a
1	restaurants, and
139	provision of
1	information, has
1	government reform;
1	convictions, the
2	order, in
1	exporter, manufacturer,
27	proposed rulemaking
9	requirements, including
24	marketing of
1	general following
2	term amateur
4	immediately cease
1	national adverse
2	iii with
1	recognized but
5	received, and
1	report en-o-year
3	(2) additional
4	slaughtering and
4	section 360ccc1(e)
2	first introduced
1	laboratories and
1	solid preparation,
2	6 years.
1	31. (3)
1	(d) misleading
3	information within
1	similar artifice,
3	revising such
1	u.s.c. 262(a)];
10	evidence to
1	make available,
1	butyrolactone (gbl)
1	imports; list
4	jurisdiction with
2	applicable state,
4	examinations or
1	200 to
1	washed, colored,
4	u.s.c. 262(a)].
1	selected in
1	ii(a)(4). as
2	(a) submissions
1	schedules any
1	future, and
2	activities consistent
2	advertising means
1	standard organization.[1]
20	november 21,
1	shall distribute,
1	1954, as
2	protection against
4	providing a
1	food samples
2	addressing such
1	development, demonstration,
8	new infant
10	sharing of
1	place; and
1	identified; and
1	review priority
1	matter described
8	designate an
1	facility manager
1	first knew
1	artifice, or
4	data related
2	competent state
1	sanctions upon
6	persons subject
1	stat. 684;
1	narcotic controlled
1	compendium published
5	law; (3)
1	approval.a device
5	serious injury,
1	applicable information
2	immediately removed
5	foreign governments
1	360m(a) of
1	regulation refer
1	379e. listing
1	quantity exceeding
1	justifying the
1	regarding good
2	november 1
1	subpenas the
1	request identifies
1	showing quantitatively
1	investigational submission,
1	term requestor
10	official establishment
1	reimbursement from
1	pattern or
2	inference; (ii)
2	person, other
3	distribution. 
1	prescribe drugs;
1	(f) product
5	subsistence, as
1	completely imbedded
4	states within
1	judge to
1	adolescents (61
1	transferring the
2	radiological health,
1	675, 804,
166	intended for
2	persons opportunity
1	whether products
2	investigational submissions
1	also, at
2	human body;
18	section, including
1	drug violations;
1	aggregate quantity
1	expertise, are
1	control laws.
1	considered convicted
3	action, except
1	decision directive
1	(2) exclusiona
1	using information
3	foreign government,
3	program funded
1	foreign government.
1	(m), 360ccc1(i),
2	human body,
2	2008, for
1	formulated to
1	tons of
36	(b) and
1	compounded such
1	seq.]. (v)
4	(2) requirement
1	200 milligrams
4	drug. the
1	controversy between
1	board recognized
3	resources and
2	efficient as
1	flagrant and
1	green whites,
1	comprehensive response
1	(2) chorhexadol.
1	section 335b(a)
2	activity by
1	phase 2
1	phase 3
1	(n) labeling
1	currently are
1	paper matches,
12	387g of
1	secretarys regulatory
1	(4) knowing
1	commodities 
2	section prescribing
2	payment to
1	expended solely
1	beginning no
1	ingredients contained
2	(iii) publishing
2	particular active
2	due, the
1	registration; and
4	transfers ownership
1	nominal charge,
1	general considerations
1	data. (iv)
1	additional manufacturers
1	compounding (a)
1	recall networks,
10	collected in
1	744j, as
3	adjust the
2	integrated consortium
2	exemptions (a)
1	collected if
1	ensure development
1	concluded except
14	45 days
1	determines an
2	product, when
29	dosage form
2	detection and
1	agencies. (june
1	situations presenting
1	(b) awarding
1	(d) recommending
1	web site;
1	ingredient shall
1	chapter cosmetics
2	shipped or
1	faith protection
2	possesses the
1	inspectio-free articles
1	grant recipients;
1	therapeutic categories
2	new programs.
1	purpose specified,
1	alteration, removal,
1	substantially duplicate
1	stimulant, or
1	owner, which
2	countermeasures, and
5	data described
1	stat. 1225.)

3	commenced by
1	(jwh203). schedule
4	obligated by
4	received the
1	grant provides
1	(as medically
1	guidancenot later
1	$500,000 to
2	entity will
1	amended under
9	often than
1	advisory committeeprior
4	egg means
1	members tenure
1	substance, each
1	including pharmacokinetic,
1	information exchanged
1	(a), necessarily
1	means determining
1	corned, or
1	transaction solely
1	prevention functions,
2	prevention functions.
1	distributor other
2	determines practicable
1	(b)(2)(b), the
2	senate 
1	inspections authorized
5	(3) periodic
9	tracking and
10	use, and
5	fees, the
1	
 387p.
1	butter, cheese,
1	
 356d.
23	days prior
1	subsection (g)(2)(c)(ii)
5	requirement the
1	2009, after
7	food emergency
1	no-compliance letter
2	marketed and
1	activities each
3	certifications under
1	term felony
1	persons cannot
1	appropriate registration,
1	objectives identified
2	nutrient premix
1	via telemedicine
6	establishing such
2	recipient fails
1	
 379d3.
1	avoid conflicts
1	(i) patient
1	others. 
2	distributing, possessing
1	(b) limited
9	reasonable expectation
1	address. (2)
22	suspend the
39	subsection for
1	input, as
1	required rulemaking
1	means, shall
1	responsible secretary
2	reanalysis under
1	identified ballot
1	health centers).
1	records) relating
1	drug remains
1	expire after
1	(2)(a)(vii)(iv) shall
2	section 702
1	establishing requirements
4	written report
1	tolerance, as
1	denied, or
1	administration necessary
4	purchaser or
1	periodthe secretary
1	slaughter, unless,
1	frequency identification
1	subsection (n);
1	(2ch). (27)
2	banned devices
1	approved continuous
1	virus of
20	foreign narcotics
5	purchaser of
2	5. if
1	foreign branches),
1	sole purpose
1	programs outside
2	(c) after
2	intelligence support
1	court and
1	orderif, after
1	approved, as
1	study intended
5	oaths and
3	shall finalize
1	agricultural chemical.
1	reaction with
2	medication; and
2	(a). (e)
1	(mg) 8.0
1	dispensers if
1	convention and
3	transaction 
5	electronic means
1	bioequivalence if
2	local agency,
1	size; trade
2	office (referred
1	(d)[2] definitionsin
1	article authorized
2	request corresponds
2	safety questions;
1	pro bono
3	title has
1	enjoin violations
64	fiscal year.
80	fiscal year,
1	laws; planning,
9	fiscal year)
2	college, or
2	(iii) firms
2	person, from
1	material differences
6	reinstatement of
6	enable him
1	safety questions,
3	lawful under
3	otherwise available
1	entities operating
1	sterile drugs;
2	product do
2	sale in,
1	colored, or
1	without distinguishing
1	(or controlled
1	agency; performance
1	inspections, regarding
2	(a)(1)(a) and
1	(17) smoke
7	shall convene
1	sale, directly
1	202(a) of
1	diversion from
1	wholesale business
5	december 31,
5	shall encourage
2	systems are
1	discretion, accept
1	 (i)definition
1	propertythe following
2	guidelines 
4	construed 
2	secretary adopts
3	maintaining required
1	laboratory; (2)
2	abuse by
1	article, that
77	fiscal years
1	significant local
1	years by
4	using a
3	supplement under
1	athletes of
1	(j) clarification
1	satisfying the
1	leaf who
4	treatment and
1	secretary; (7)
1	report, shall
3	employee other
1	2022, approved
1	may destroy,
2	methods approved
2	(b)(2) and
1	penalty so
2	subchapter. such
1	position by
1	recall an
20	(ii) for
2	expected performance
13	trading partner
1	(ii) uses
2	may introduce
2	12 months,
2	views, exempt
1	(m), or
2	supplement after
9	design of
1	food registry,
1	food registry.
4	research consortia
1	documents produced
1	amounts amounts
1	chapter, which
1	plant except
1	(c) nonreceival
1	enhance product
1	direc-t-consumer advisory
4	design or
7	make it
42	appropriate to
1	drug obtained
1	standardized form)
1	continuous manufacturing
14	country of
1	tobacco, rol-you-own
3	(iii). 
18	states, or
3	paid. (g)
11	drugs intended
1	needed practicable
5	2013 (except
1	hazard, the
1	passed; and
3	sentence under
9	inform the
2	lawful and
1	appropriate, prohibit
1	states, of
9	either in
1	emergency. 
1	takes office.
1	 (i)failure
7	corrected within
18	maintain such
32	drug development
7	additive, color
1	behin-th-counter placement).
3	can, tin,
1	section 2203
1	section 2202
6	section 2201
2	legislative, or
2	development; (b)
1	technological support
2	regulations; and
3	100 milligrams
1	appropriate ancillary
1	take additional
2	2012, from
12	additional information
1	may rescind
1	subsequent processing
3	control programs
1	influenza; or
21	issue of
1	funds, facilities,
7	(6) or
1	(5)(b) not
1	sel-directed personal
1	appurtenant thereto),
2	testing methodology
1	failure until
1	issue or
2	12, 1943,
1	(f)(1), such
1	dismissed biomaterials
1	(o)(3). (d)
1	(p) repealed.
1	residue bear
8	(6) of
1	terminated. (e)
1	had, but
1	circumstancesfor purposes
2	detrimental effects
1	repair, replacement,
3	accredited; and
1	applicant; (b)
1	include at
2	paragraph regarding
10	section 355a
4	include as
8	section 355c
2	manufacturer (or
1	(e)(1)(a) of
18	include an
6	device involved
2	written request,
1	expressed intent
3	assessments required
12	indication for
1	approving devices
1	prevent him
1	pharmacist has
1	review. (c)
1	(d)(4)(b), and
2	accommodate a
1	symbols. (5)
1	subsequent clearance
1	360bbb3, 373,
1	707, as
1	appropriate sampling,
1	administration; (3)
2	service, appoint
1	collective bargaining
1	size, filtration,
1	technology initiatives
3	communication 
1	team leaders,
1	regulations)) with
1	impleader of
3	continued use
1	studies, any
18	solely because
7	secretary, upon
1	chain may,
1	(e) exclusion
1	activities recognized
2	control program,
4	control program.
6	section 355,
4	(d), (f),
2	(b) prior
1	(b)(2), that
1	chapter. (g)
12	written requests
1	commerce; 
4	risk or
2	whose use
1	numerical count;
2	policies, and
2	disease to
1	systems as
3	material information
2	applicable with
4	substantially affect
9	contribute to
1	1193. transferred

1	recognition; and
1	additives shall
1	written requesta
4	section 3551
1	exempted operations;
1	foster and
1	pending trial
6	supplement. 
1	disclose all
1	states attorneya
1	(d) waiver
151	pesticide chemical
6	controls would
1	additional coloring
1	specified, and
1	387k(i)(1) of
1	466. imports
2	product authorized
1	food. (f)
1	360b(n) of
1	product analyzed
1	stat. 817.)

25	determining whether
3	give to
22	years from
1	period were
1	hearing. in
1	conduct by
1	foreign cooperative
3	(and evidence
137	subject of
1	meaning includes
1	around the
1	tenants and
2	agencies specified
1	(1) respecting
4	refunds the
1	registry as
1	twent-day period,
1	requested to
6	request has
1	whatsoever, shall
1	(c) acceptance
1	compendium, if
5	case shall
1	modifications based
1	(2) taking
1	following notification
1	july 28,
2	occur and
8	supply chain,
1	division, the
7	leaving in
2	accomplish this
1	personal, for
1	consumption. common
1	i, 18,
3	(1) whenever
1	(7)(c) with
1	(3) benzylmorphine.
1	6. transferred

1	675, 542,
1	application require
2	however, shall
1	(1), oxygen
1	authorities engaged
1	(30) the
1	food allergies.
1	fairly evaluate
1	surveillance or
1	various drugs
1	(g) scope
1	
 1301
1	reasonable limits,
1	medical communities,
10	labeling requirements
1	training shall
7	supplement, a
2	surveillance of
4	individual, and
1	determined may
1	laws; the
1	smoke. (h)
1	specifically opioids
2	domestic activities
1	business, to
1	reports regarding
1	status that
1	chief scientist.
9	goals of
2	$1,000 nor
4	holder, or
1	materials, materials
1	unavoidable residues
2	unfairly with
1	inventions of
1	reimbursed under
1	abstinence in
1	fixed shall
1	participate through
1	(10) marihuana.
2	pediatric effectiveness
2	qualified manufacturing
1	class thereof,
1	355(i)(3) of
8	condition and
1	transparency of
1	phenylpropanolamine with
2	(4) not
1	ingredient different
1	level data.
3	(2) request
1	necessary additional
5	343 of
1	amount means
1	shall build
2	employees authorized
1	residue may
1	determination, post
1	includes statements
1	property) 
1	confidential source,
2	notified under
31	performance standard
1	whether licensure
2	use panels
2	periodic testing
6	may result
1	$97,000,000 multiplied
18	june 30,
1	livestock producers
1	(b) package
2	director, and
2	(iii) has
2	1971. (2)
1	abuse should
1	paragraph). such
1	(6) withdrawal
1	themes into
1	(b)timing of
2	conveyance or
17	diseases or
1	drugs. (b)
1	45(a) of
1	drug returns
1	remedy. 
1	$566,000,000. (h)
1	(d) program
2	made. the
1	discriminate against
3	law relating
1	net change
1	1974, respectively))
1	proposal. (iii)
1	allocate resources,
3	executive capacity.
2	selling poultry
1	(4) collection
2	accreditation the
1	18 regarding
1	acts and
1	purchaser means
1	package. (ii)
1	reoffering the
2	or, except
2	misleading or
1	recipients, with
1	recall, as
2	making due
1	documented calculation
1	effective or
1	identify gaps
1	360ll. notification
3	additional testing
3	2017 not
1	lactating women.
1	pharmacopoeia to
1	no-alcohol foodsubsection
1	egg product,
1	title, under
25	effective on
4	retain such
1	therapies through
1	application, which
2	(b)(1), the
3	fees estimated
1	residue at
1	flunitrazepam, except
1	both. (ii)
8	personnel of
5	administration, minutes
1	political subdivisions
2	including plant,
1	packing, distribution,
1	admiralty; jury
2	assessed (plus
1	(ii) meeting
2	naphthyl ring
1	illegal channels;
1	successor has
1	involved. (ii)
1	identified patient.
2	sector to
3	additives, and
1	dated january
60	secretary or
1	section, fix
64	egg products
1	gelatin capsules,
4	shall initiate
1	(b)(1), except
9	period, the
1	store sold
413	secretary of
1	flunitrazepam or
1	either at
1	addressed. 
2	responsibly to
24	secretary on
1	qualification submissions).
1	207, 302,
1	5; (5)
1	(d) attorney
1	 60.0.
1	cigarettes beginning
1	marijuana early
1	381(s) of
11	petition, the
8	upon conviction
1	
 25.
1	knew or
1	1769f(b) of
1	succeeding the
1	states; venue
2	political subdivision.
4	authorization 
1	knew of
3	section 360b(j)
2	unfair or
1	(21) racemorphan.
2	prevent a
1	custom of
1	20) or
1	products unaffected;
3	official mark;
31	publicly available
1	frameworknot later
1	community if
1	(e)(1) only
2	located 
1	350i of
1	quarter; and[4]
3	food no
1	exercise authority
1	mixture intended
1	biannually, the
1	intentional ingredients
8	applied for
2	said act
2	letters issued
2	denial) that
1	31 each
1	(ii) supporting
1	list, including
2	stamp, or
2	populations not
2	26, 1951,
38	establishment that
2	practitioner making
1	fee on
6	activities; and
1	applicable conditions).
2	associate the
7	secretary. the
1	establish pilot
1	no-federal matching
4	reach agreement
27	misbranded under
1	animal health;
1	includes, at
7	fee or
1	body. (p)
1	departments that
1	manner. (ii)qualification.the
1	sectionsafety rest
2	manufacturing expenses
2	tobacco in
1	regulation activities)
1	execute the
1	defendanta court,
1	recovering the
2	surrogate or
5	restrictions notwithstanding
1	payment or
2	(3) eligible
5	chain of
2	index, the
1	achieved, by
1	programs funded
3	across the
9	listed under
2	2008. 
1	determination. a
1	insert therein
19	may order
1	focus its
10	determination to
2	applicable elements
1	exposure for
2	conviction is
2	campaign; (3)
1	82 percent
1	(5) or
15	establish or
1	(n)(3), information
1	panel, information
1	2013; or
1	schedule, if
1	undertake those
1	comparing a
1	pay, the
1	knowingly distributes,
1	percentages described
1	subsection (c)(2);
97	secretary has
2	notify in
2	provide adverse
4	recall such
3	business dispensers
2	15, as
2	unless sooner
3	services provided
1	chemicals, and
1	approval using
1	determining priorities
1	commission means
1	cumulative effect,
20	fees in
1	purchasers (or
1	fees is
1	schedule he
12	shall transmit
1	agencies; utilization
1	judgment, may
12	requirements applicable
2	name, places
1	(q) petitions
1	direct participation
7	conformance with
2	devices manufactured
1	accreditation; or
1	level by
5	paragraph; and
1	(1) investigate,
2	issued, establish
1	laboratories report
1	
 333a.
1	records, audit,
15	conviction, impose
3	entering into
1	device; (g)
9	may suspend
1	water from
1	rcs8); and
1	subpopulation has
1	registry (a)
1	states 
7	approval. 
1	paragraph. (k)
1	contains individual
1	reregistration and
4	lot appurtenant
2	3, 1996;
1	ind a
4	concluded by
2	treasury to
3	support from
2	providers and
2	cumulative effects
1	activation) of
1	entered pursuant
3	501(a) of
2	party, including
1	methyl alcohol,
1	statement 
1	comprising no-replicating
1	classification (if
2	data, information,
1	(a)(3) if
7	paragraph shall,
1	accessible location
1	sufficient over
1	petitioner) a
1	later fiscal
3	subsistence, and
1	conducting educational
1	may decide
1	mortality, intermediate
3	sampling of
1	leaves) in
2	firms not
1	(or have
1	white, large
1	summarizes 
1	letters, and
1	18; (2)
1	827. records
1	farming, cultivation,
1	briefs. (2)
1	hospital, with
4	section 360(j)
3	risk, the
1	department has
2	affects interstate
1	
 399d.
1	judgment. 
1	act), the
1	pose any
1	silver, and
4	takes effect
1	specialties. (ii)
1	sanctions for
1	distributed, destroyed,
2	(2) document
1	360eee3(b) of
1	title inconsistent
3	will expire,
1	authorized use
1	randomized clinical
4	annual notice
6	satisfies the
3	distributing or
3	making recommendations
1	vehicle for
1	trials; rare,
1	manufacturer means,
1	supplemental return
1	1997) or
1	appropriate; (v)
1	waived, is
11	award a
1	262(k)]; 
1	c, in
1	factors, the
6	appointed from
11	inclusion in
1	aquifer, spring,
5	certify to
1	strengthen state
1	biotechnology industries;
2	affirm the
1	disclaimer requirements
1	create and
1	term playground
12	services for
2	identifier. (3)
2	$100,000,000 or
2	lawfully possess
1	tol-free telephone
1	715, as
1	scheduling for
1	necessities of
1	oleomargarine containing
5	articles or
1	improvement, implement
2	healt-related electronic
1	methods, controls,
6	term final
3	(a). (d)
1	funds management
5	systems in
15	action. 
1	construction regarding
1	administration stating
7	articles of
4	name of,
1	standard so
1	355(j)(5)(f)(ii) of
8	title. the
1	(d) pizzas
1	section; (14)
1	fully implemented;
1	distributed has
1	prolonged contact
2	(i) publishing
2	applications (adjusted
4	information referred
1	industrial organizations.
1	appeals mechanism
1	nonmedical purposes,
2	awarded, in
3	allergy management
8	restaurant or
3	residue and
2	cooperative program;
7	reviews of
1	scientific controversy
2	practicable the
1	individual) shall
2	certification that,
3	may, with
1	violated subsection
1	(including quantities
1	subchapter of
1	media. (v)
1	years. (e)
2	development of,
3	safe level
1	(2) substituted
1	advertising. (e)
1	appropriate books,
2	holding an
36	appropriate. 
1	occupies a
1	(3) exceptionthe
20	account for
51	subchapter or
1	holding at
9	eligible coalition
1	360b(c)(2)(f) of
1	supplements or
1	took effect.
1	cost effective,
2	states magistrate
1	industr-accepted standards.
1	notice providing
1	requested in
1	(e), this
3	may, within
1	specifically exempted
1	initiatives at
1	-fisca-year period
1	(k) other
1	(c) consult
1	(2) increasing
1	act), or
1	exports controlled
1	meeting held
2	(where known
1	submit data
3	makes recommendations
1	improvements over
2	(whether an
1	drugs. (ff)
1	12978 of
32	products and
2	alleges that
7	order. the
4	administration under
1	(m) admission
1	eligibility determination,
2	bears (a)
1	results data
1	statements made
2	(5) take
3	notify, in
1	(41) racemoramide.
10	4, 1913,
1	apply where
1	613, 2,
1	(4) selection
1	action alleging
1	term practitioner
8	necessary materials
1	(1) educational
1	876. subpenas
1	criminal forfeitureany
1	subsequent issuance
1	entry 
2	provide, equip,
1	(17) pethidin-intermediat-c,
1	dispenser means
4	state requirement
1	section 353b(d)(4)
4	find that
2	preserve their
1	unmet need
1	defense information
3	-month exclusivity
1	formula showing
1	specialists or
6	education and
1	(3) post
2	determined as
1	(9). (4)
1	menthol and
1	substances whether
1	pediatrics as
12	shortage of
1	combined level
5	date. 
1	government agency,
1	section. (m)
1	18 that
1	occurs, file
3	substance as
1	filing, etc.;
1	843 of
4	shortage or
1	duties or
1	monetary valuethis
1	date, added
1	process used
1	required, or
10	incomplete and
1	(iii) improving
1	regular customers,
1	medical licensing
1	allows no
3	sunscreen containing
1	financial assistance
1	(b) matchbooks
1	(s) any
1	audit. 
1	dispense in
1	control strategies
9	primary drinking
4	times for
1	following provisions
5	labeled as
1	agent; (ii)
1	significant market
6	virgin islands
16	person, and
1	shall retain
1	drugs has
1	review committee,
1	review staff,
2	(f) removal
2	agents; or
1	listing number
1	
 115
1	
 114
5	determination not
1	arrival at
3	thereof on
10	u.s.c. 601
4	ch. 273,
2	(d) labeling
1	one age
1	child by
4	corporation that
1	intended and
9	evidence available
1	subsection when
1	(c) knowingly
1	prescriptions compounded
1	audience. (2)
1	(4) qualification
2	(a) proceedings
1	products filed
1	territories shall
17	general determines
1	-years prior
1	title) applicable
1	customer. for
1	(f) as
22	provide such
1	(2) preemption
1	reaction; and
1	section 355(b)(1),
1	902, as
1	give away
2	chemicals shall
1	populations; or
12	chemical in
1	feathers, feet,
10	board shall
2	importing, dead,
1	(b) travel
1	manufacturer; (b)
1	vitro techniques,
3	chemical if
1	(b), all
1	(a) motion
1	(a) coordination
1	(2) law
3	product after
2	(i) advisory
2	freezing, storing,
1	respecting information
1	officials. 
1	formula includes
5	previous calendar
1	likely in
1	prohibit states
2	species outweigh
3	year except
1	translational therapeutics,
1	without amendments
1	formulas made
1	statement specified
1	goalsecure agriculture
1	451 to
2	local agency
2	(including, where
1	submissions pursuant
1	competent inspectors,
2	department who
4	 (a)in
12	training or
1	(a) $250,000;
1	
 26.
1	final judicial
3	dispensers for
1	device approved
1	(c), any
1	17, formerly
1	government entities),
8	training of
1	 (a)agreement
1	(g) administrative
3	product received
1	adds or
1	refined oil.
2	training on
1	determination, finding,
1	beginning 15
3	noncompliance materially
2	occurs sooner.
1	subsequent transferees)
1	care. (e)
1	(8) ibogaine.
1	related activities.
4	related activities,
1	plan have
1	information in,
1	information. (p)
3	prevent diversion
1	inspection, within
1	agreements, contracts,
1	steps implemented
1	form ready
1	(b) civil
1	related activities;
1	(e) omitted
1	analyze safety
24	title with
1	appropriate). 
1	intimidation of
1	by, through,
2	2010 and
3	section 379h
5	drugs as
1	(v) 10
1	section 379g
5	section 379e
1	significant subpopulation
1	small enterprises
1	panel appointed
1	disclosure restrictions
2	court (after
5	section 379v
5	statements, designs,
2	drugs an
1	(b)(2), clauses
1	requirements; definitions
1	events that
2	constitute or
1	74, 11,
1	360j(g)(2) of
1	expense. any
1	experts, health
1	section 5304
1	uniform, scientifically
1	commercially market
1	document which
3	financial support
5	product, which
1	physician determines
1	sections 952,
1	delegated. (2)
1	device, (4)
1	seizure, summary
1	(a)(i) if
1	market data;
19	federal insecticide,
1	(n) homeland
1	order (required
18	3-day period
1	section 802(49)
1	(1) between
1	paragraph (1)(c)(ii),
1	criteria upon
1	packaged products,
1	$260,000,000 for
1	treat addiction
1	establishment. for
1	registrant) who
2	formulation, is
1	one another;
1	grant application
4	confirm the
1	amendment and
1	reporting changes
3	appeals to
4	impracticable (because,
3	as, a
2	101(4) of
1	health hazards;
3	activities: 
1	projects, with
1	family member,
1	corporation, organization,
1	374. inspection
2	investigate and
1	notice before
1	complaint described
1	data submissionat
1	dissemination. with
1	single fiscal
3	efficient administration
1	sections 603,
3	(c) research
1	endocrine effects.
1	july 31,
14	appointed under
1	pipes with
1	equipment of
1	applicable) described
1	benefits that
1	(i)(ii) shall
1	application holder,
3	delayed because
1	coalition; and
1	(ii)forfeiture. 
1	cause found;
1	certifications or
1	federal animal
1	components underlying
1	persons whose
2	(b), prescribe
2	adequate directions
1	360e. premarket
1	benefits provided
4	shows to
1	appropriate justification
1	263a] notwithstanding
1	sheepmeat, and
1	answering such
1	annual reportthe
1	(5) does
1	laboratory test
1	cigars shall
1	advers-event reporting
2	section 360i(e)
1	360eee(9)(b) of
1	(c) evaluation
1	30, 2003,
1	need therefor
4	product applications,
1	o-site technical
1	expected content
1	secretary received
4	pediatric disease;
3	provide by
1	consumption and
1	documented risk
1	therapeutics within
2	slaughtering establishment
1	partial fill
1	intended. 
9	annual establishment
1	one page
1	subsequent pilots
2	completed under
1	facility, (b)
1	make examination
1	675, 501,
3	potential safety
1	(i) amphetamine
4	(a)(ii); or
1	existing on
1	know or
1	generalin promulgating
9	(3) no
1	licensed physiciana
1	(b) describe
4	(e) is
1	governments may
1	required information.
1	dismiss of
8	inspections to
1	cabinet that
1	
 350e.
2	(6) such
1	1989. 
1	dismiss on
1	aids drug
1	activity to
1	dismiss or
1	pediatric diseases
1	trends; and
6	(e) if
1	removal for
2	establishments); and
2	year 2014.
3	fund established
12	year 2014,
1	believes exposure
1	court, when
4	(e) in
1	$8,467,000 for
1	address communication
2	burdensome requirements;
2	regulation, together
5	regulations may
3	jury trial;
7	order has
1	groups, communit-based
1	declaring the
1	persons appearing
2	food ingredients,
1	
 379j11.
1	complementary therapies,
1	available; (e)
1	perjury, giving
1	conflict between
2	burdensome requirements,
1	appurtenant thereto.
48	federal regulations
4	dentist (or
36	application filed
1	seasonably made,
1	achieve its
1	dispute is
1	diseases, targeted
1	strategy submitted
1	interest no
1	materials require
1	$2,000, or
1	evaluationthe advisory
1	election to
3	use. the
1	applicable data
1	residue definedfor
3	knowingly represent
3	advertisements and
1	transcription of
2	columbia by
2	treasury are
1	(g) medical
2	unclassified form,
2	making efforts
1	use. (c)
2	intermittently in
3	exercised in
1	statusin carrying
2	drug. (d)
1	objecting to
1	nighttime. (mar.
1	make submissions
7	forth a
1	711(a)(1));[1] 
1	conformity in
2	safety benefits
2	organizations for
1	accelerator, target
1	conformity is
1	(i) certification
1	(3) guidance
3	species (a)
1	protracted and
1	assessed, except
60	section for
1	completed; 
3	format for
2	rendered inactive
2	canning, cooking,
8	plans of
1	pharmacy services.
1	uniquely identify
1	evaluation protocols
1	(c) volume
1	360bbb8c. patient
1	vehicle in
1	inspect or
2	inserted in
13	confidential commercial
1	request. (iii)
1	poison appears
3	expert witness
2	system, and
1	development responsibilitiesthe
4	(e) withdrawal
1	penalties; and
1	unit, the
47	(ii) if
1	employee submitted
2	public initiative
8	(iv) for
1	guidance, including
1	manufacturers. (3)
30	(ii) in
1	nurse practitioners,
1	reimbursement specified
54	advisory review
1	claims arising
1	specific scenarios
1	program activities
26	(ii) is
2	section 381(h)(1)
7	devices, or
1	lienor or
1	secretary. subsection
1	protecting both
1	law offenders,
2	sell, barter,
1	abroad, including
1	387f(e), 387g,
1	modulation (including
2	case, beginning
1	reviewed, inspection
1	injury designed
12	written or
1	midway islands,
1	retention and
2	crude opium
1	(b) circumstancesfor
2	section 607(e)
2	review thereof,
1	canceled pesticide
1	pregnancy than
25	potential for
1	final product,
4	renumbered 1002(a),
1	applicable food
1	plan. (f)
1	percent; and
3	shall nevertheless
1	(c) inapplicability
1	product experience;
1	exceeds 50
1	regarding when
1	(3) delivery
1	standards related
4	departments of
1	convincing evidence,
1	hearingif the
1	licensee shall
2	investigation otherwise
4	proposed change
2	paid. an
1	384(e) of
1	punishment under
4	departments or
1	dispensed 
5	knowingly and
3	owing by
1	users shall
1	(d)(ii) shall
1	administration. (h)
3	orders orders
1	cessation, is
1	employees duties
33	application and
1	medical food,
2	disparate data
7	potency of
1	likely than
1	methamphetamines; and
5	mandatory recall
1	director dies,
2	phenylpropanolamine includes
1	telephone hotline
2	radiation; and
1	seafood that
1	presiding over
1	telemedicine in
3	application any
2	imports into
1	principles that
1	envelope utilized
1	persons nominated
1	judgment pursuant
1	provide, a
1	(6) which
1	entity if
1	paraldehyde. (10)
2	free flow
10	may require.
6	service to
10	may require,
2	entity in
1	(b)(2) will
10	entity is
1	quantitative comparison
1	5 business
2	(b). such
1	(s) savings
1	owns an
1	secretary, insufficient
7	may require;
2	(i) saleable
1	(8) rules
1	(a)(iii), the
7	authority 
1	indication means
2	subdivision. 
1	will, if
1	(1) declarationscongress
16	three years
1	grant activities,
1	methamphetamin-related programs,
1	objections within
2	statistically valid
1	funds. (9)
1	disease that
1	informed personsin
3	known serious
1	24, 1919,
1	liability shall
2	regulations pursuant
6	testing is
2	records. (3)
1	decision document
1	increasing awareness
4	may promulgate
6	food from
2	internal organs
1	clinical evidence,
2	listing the
1	(c) excess
1	partnerships and
1	additional foreign
2	possessions of
2	data (such
1	estimated, that
1	immediate use
1	(4) poultry
1	instituted or
4	(ii) cocaine,
2	generalin any
3	without promptly
1	generalif 
1	(i) participated
1	implements a
1	unmet needs;
1	
 387b.
2	effective the
1	premix suppliers,
1	appropriate documentation
1	hopper bin,
2	annual budget
2	time. 
1	(g) clarification
1	pharmacies; research
2	actions by
1	disease than
1	adjustment will
1	elected officials,
1	standardization of
2	section 456
2	combination products;
1	levomethorphan. (9)
1	paragraph (3)(a));
1	5(2), 65
18	subsection may
1	formula powder
6	modifying, or
3	business. such
1	including dietary
2	manufactures, distributes,
1	inform parents
1	(2) examplesexamples
4	assistance program
1	special license
1	days, is
2	(i) establish
1	tobacco use;
1	prices of
1	waters within
1	(b)..[1] the
5	360e(b) of
1	(iii) list
20	implement the
1	(25) -[-(isopropylthio-2,-dimethoxyphenyl]ethanamine
1	i, 10,
1	judgment, indicate
2	determinationnot later
3	order fully
1	updated standards;
2	changesthe secretary,
2	enforcement thereof,
1	approval, approving
2	names by
1	specific food;
1	464. exemptions
1	identified through
1	2017; and
1	(e) includes
2	update to
1	notification made,
1	
 462.
1	(a) carry
2	(a) registration
5	year preceding
1	
 341.
1	countries certifies,
1	(33) norpipanone.
1	hiring authorities;
1	assignments, reviews,
2	controlling a
4	extent, and
1	defined if
2	representative who
1	(aa) on
1	(6) continue
5	technical expertise
1	reflect necessarily
1	675, 744c,
1	available, its
1	injury associated
2	title withdrawing
1	section 360(h)(3)
1	providers no
1	setting 
7	condemnation is
1	slime), the
1	administer any
1	effective health
2	persons seeking
55	 (h)
1	identifying best
1	manufacturing establishment,
1	(d) exemption
1	refined oil
2	changed to
1	26 and
1	authorization. this
2	disclosed or
1	written authorization
5	exemptions for
11	consignee of
4	appropriate notice
8	modify any
2	11, 1995)).
1	586, as
2	formulas to
1	outbreak identification
1	theory, for
1	manufacture, transfer,
3	salts is
1	1263, 37,
1	section) have
1	(e) classification
1	disclosed on
1	applications acted
1	holding registrations
1	scientific basis,
2	advisory committeenot
2	(including drug
2	link to
1	unsupervised use
1	applications; construction
1	commodity in
2	produce positron
1	advertisements will
1	dispense at
1	regulation classify
1	funding of
2	drug code,
1	disease status
1	drug code.
1	intended, (b)
2	controls. 
2	application; antibiotic
1	societies about
1	360. registration
1	state, consistent
1	379j31. authority
1	detect a
2	tableting machines,
1	another national
5	provide adequate
1	body by
2	expended to
1	mitigating health
3	minimum required
5	administrative inspections
1	(i) conditions
6	generally recognized
1	prescription; and
6	human or
1	below: (a)
1	(i) none
1	yields from
1	9, 1956,
1	(3), because
1	diverted; or
1	chemical. (12)
1	physiological, pathological,
1	act), including
1	documents submitted
1	director. if
1	95. transferred

2	information between
6	genetically targeted
1	406, 52
1	
 111,
1	adverse reactions;
3	posted on
1	(ii), each
1	generalevery person
1	patients that
1	strategy, to
3	203 of
2	enforcing requirements
1	
 1111
1	cfr part
10	one year,
1	enhanced drug
1	food involved,
1	determinations regarding
1	complete petition
1	
 1118
1	preceding year.
2	consumer perception,
1	(9). the
1	product (after
2	rodenticide act.
1	chemical; (iv)
3	rodenticide act,
1	medical air,
1	revocationthe secretary
1	community assistance
1	employee, whether
1	senate fifteen
1	convicted before
2	second fiscal
1	allocated as
1	rodenticide act;
5	distributing a
1	subsection (h)(1)
1	(6) eligible
91	secretary shall,
3	fact for
3	review cycles
2	drug outweigh
1	food refused
2	fac-t-face exchange
1	twenty miles
1	enforcement authorities
4	northern mariana
1	practice. any
1	incorporation. (b)
8	360eee1 of
3	sectors within
1	risk presented
1	advertisements using
1	state definedfor
1	datafor purposes
1	novo review
10	establishment subject
1	truth or
1	(i) exportation
2	demand reduction;
1	report. (iii)
1	identified signature
1	requirement imposes
2	(p) of
1	 (a)authorized
2	working in
1	book, paper,
1	substances. (4)
1	(3) multiple
1	321(g)(1) of
1	purchasers or
1	plant inspections;
1	submitted through
1	manufacturing is
1	618. delivery
1	racemorphan. 
1	inquiries; exercise
1	regulatory purposes.
6	standard and
1	gather comments
1	(5) grandfathering
2	service. if
1	 (vii)
1	substance manufactured
1	(3), as
1	measure that
2	build the
1	teleconference. 
1	ammonia and
1	satisfaction; 
1	national response
4	providers. 
1	health; (4)
1	volume data
2	approved drugs
3	intravenous drug
1	disseminated. (e)
1	heat or
1	term secretary,
2	total food
2	adulterated, shall
1	
 1524.
1	(k)(2); and
1	repackager site.
9	(b) which
7	indicated for
1	(3) deferral
1	(c); (c)
14	omitted
 

1	oxide and
1	states (and
1	temporarily, either
1	(2) whenever
3	clause (v).
2	(b) direct
1	likely patient
10	(d) or
1	enforcement to
2	title (except
2	term transgenic
1	(e) technical
1	labeling when
1	student loan
5	office responsible
1	contract proposals
4	(d) on
3	involved meets
1	food allergy,
2	chemical mixture
42	(d) of
1	consumers are
1	7 to
1	involved (especially
4	title) or
1	administrator does
1	testify whenever
8	foreign persons
1	use creative
1	testing devicesthe
1	(2) pharmacist
1	recommendation. (ii)
1	a, vitamin
1	build capacity
1	control strategyfor
2	international trade
2	title) of
2	(g) whether
1	repackagefor the
6	subchapter; and
1	manufacturing establishments
1	label egg
3	title) on
2	(a). (june
2	quantities or
1	combustion or
1	usual. (o)
1	imported shipments
1	18 relating
6	subsection nothing
1	appropriate administrative
4	assessing the
3	14 days
1	3 packages
2	(3) studies
1	director) may
24	requiring the
1	provide recommendation
20	quantities of
1	(l) repealed.
5	1, 2008,
1	meetings. (5)
1	title. paragraph
1	request means
1	requested for
1	pediatric issues,
1	act, provides
1	cleared and
3	experience with
1	hearing; and
1	agreement, within
1	corporation refuses
1	held only
3	application; (c)
13	sale, purchase,
3	advertisement prior
6	production quotas
1	poison, the
2	clause relating
4	applicant submitted
1	diameter. (aug.
14	relied upon
2	possessions shall
1	employees nothing
1	words for
1	470[1] of
7	administration, including
1	defeat any
1	associations 
1	rol-you-own tobacco,
1	recordkeeping; and
1	clear vulnerabilities
1	require; (c)
5	preliminary injunction
1	(2cd). (22)
1	resolution prior
1	impleader beyond
1	imported shipment,
1	declaration, determination,
1	(including short
7	subsection that
4	services that
1	ch. 477,
1	dextrorphan. (14)
2	appointed pursuant
2	review activities,
1	title 28that
3	importers, distributors,
2	reporting 
1	switch to
1	prescribe schedule
1	suspending applicability
1	(5) notice
1	including restrictions
1	thousand; (5)
2	administration amendments
1	vessel. 
15	reasonable times
1	(9), and,
1	health. in
1	penalty to
2	(b) establish
16	considered a
1	proposed animal
15	year limitation
1	provided if
2	accompanying data
11	establishment as
1	section 2223[1]
242	provided in
1	value, given
1	casein. 
4	provided is
1	identification device
1	fund means
1	817.)
 

1	tobacco co.
1	(a)(2), respectively.
1	may create
2	chapter. (d)
2	referral; considerations
1	
 2202.
1	secretarial actionthe
11	date under
4	device meets
1	qualified manufacturer,
20	select committee
7	section does
20	regulations for
1	justice; (b)
15	duration of
1	reprocessing all
2	position described
1	administer drugs
2	states except
1	rulemaking), and
1	continuous drug
1	machine shall
2	section, apply
1	nutrient 
1	designate official
1	(a) labelthe
1	means notification
1	on. if
1	thereof (as
1	specific category
1	help clarify
4	order published
1	had; or
1	product; (3)
1	(d) quotas
79	equal to
2	section 379g(3)
2	reimbursement is
6	symbol prescribed
1	(1) $153,000,000
2	regulatory activities
1	addiction; and
1	countermeasure 
1	may threaten
2	section 381(r)
1	including effectiveness
1	expenditures incurred
2	record about
1	to, specifications
1	713, as
1	subpenas (a)
1	packs, each
1	finding made
1	contract, memorandum
1	r-exportation of
2	necessary, if
1	42); (c)
2	basis, implement
1	bioequivalence; filing
1	sellers an
4	necessary, in
1	believes would
2	stating reasonable
1	request comments
4	made during
1	withholding of,
1	(14) because
1	early intervention
1	basis, with
1	(a)) and
1	(a) months,
1	services; (ii)
1	societies, medical
1	
 2104.
1	point, have
2	members 
1	lon-range goals
1	center, or
2	entered the
1	20 paper
1	consequence or
1	substantial probability
1	association, a
1	uses, including
10	objectives of
1	concise warning
1	resulting rulemaking;
1	supervisor, manager,
1	effect. (8)
1	(i) contain
5	regulations, and
1	manufacturing restrictions
1	20,000 poultry;
1	(7) monitor
9	special dietary
6	fit for
9	products will
1	proceeding may
2	5 as
1	committees (a)[1]
3	may permit
1	346, 351(b),
1	drug, induces
2	certification, the
1	safety offenses
2	therapies, including
1	controls including,
3	discontinue the
1	(a)(1) do
2	yet been
1	customs officer
2	substantial reduction
1	379aa, 379aa1,
1	contraband or
1	exporting a
1	(c) eligible
1	subsection (e)(1)(c),
2	-pheny--[ -(-phenylethyl)--piperidinyl
1	device, he
1	title), as
1	listed color
1	substances, (b)
3	reasons, including
3	grounds do
2	begins after
1	indene ring,
4	order. (b)
1	claimant seasonably
3	section 379g(11)
1	(6) timing
2	matters requirements
3	practicable methods
2	state, upon
1	dividing $50,000,000
1	third parties.
2	marketing submitted
1	inspection requiring,
1	related professions.
1	record established
1	excepted the
2	culpability, and
2	patient using
2	application, information
1	resistance rates
1	(a)action package.the
7	modified under
1	security countermeasures;
1	tobacco used,
1	
 3551.
6	analytical methods
1	reductions from
1	producers with
1	(b) misbranding
1	controls, equipment,
2	unless all
1	alerts issued
1	promising technologies,
1	897 of
4	dietary use
2	subparagraph. no
6	review if
1	standard through
1	675, 1009,
1	ways in
19	review in
1	shall import
1	without added
1	things) not
1	entered, as
1	customary, nonexpedited
1	(o) propionic
2	license the
1	149. definitionswhen
10	review is
12	title (relating
5	timeline for
1	provider. such
4	license for
55	supplement to
4	denies that
2	used within
125	submitted to
1	approvals fraudulently
1	(c) returns
1	emergency in
1	hearings authorized
1	effective, he
4	(iii) appropriate
1	banking institution,
1	been, distributed;
1	information publicly
10	384b of
1	investigation, alerts
2	requirements, or
1	shall reconsider
1	valid as
1	tracing products
3	supplement, was
1	shall go
2	services 
1	computer system
1	been, distributed.
2	(v) of
1	branded in
2	convention. 
2	preemption nothing
13	conviction of
1	revenues did
1	formerly 9th
1	rail vehicle
4	particular food
12	electronic database
1	aggregation, statistical
12	determination, the
1	military departments;
1	control points,
2	significant amendments
3	available. the
1	1.1 nor
2	otherwise changing
1	industry, review
3	har-drug users
2	expansion of
1	(obtained prior
2	testing conducted
6	requests 
2	individual, to
1	(a) consult
2	applications previously
3	correct or
4	section 379e(a)
2	forfeit to
4	inspectors to
1	met; or
2	disposal or
3	added and
3	pending request;
1	period determined
1	(b) examples
7	institutions, and
80	health care
1	(d) operating
1	extent determined
6	studies 
1	pending request,
5	released by
1	setting. (v)
2	(e) not
5	disposal of
1	container, is
2	regarding premarket
1	physical safety
1	assessing chronic
4	nutrition act
1	submission pending
2	data under
1	necessity of
1	suffered by
1	$250,000; or
1	(j) waiver
1	used exclusively
3	procedures shall
1	establishing protocols
1	person, while
2	thereof; the
1	actual abuse,
1	connection therewith.
6	pending requests
1	commence to
1	borders. it
3	may delay
2	inspect outsourcing
1	product. a
1	(3) underlying
1	(2) replace
1	modeling procedures
11	putrid, or
1	retain any
1	available and,
1	industry organizations,
1	379d2. policy
2	experts selected
1	tested to
6	received for
1	reserve stocks.
1	ointment, dusting
1	users; and
1	cancellation, whichever
3	2013, and
6	public views
1	otherwise permitted,
1	antimicrobials to
1	(e) diagnosis,
1	term narcotic
1	registration period
1	authority. (june
1	ingredient; (b)
1	studies submitted
2	clearly endanger
1	(ii) cannot
4	title (other
1	farm marketing
1	citation were
1	guest, and
3	access and
1	(4) meeting
5	detailing the
1	plant, continuous
1	(2) activity
1	trends. (c)public
1	(b) contracts
11	incurred in
2	assertion of
3	another food,
1	another food.
1	public hearing;
1	authorized. 
1	amended. 
1	
 1906.
2	residues, (b)
1	cases; limitations;
3	present any
1	intent thereby
1	farm storage
1	plays a
2	standard together
9	deception or
3	increased risk;
2	submits himself
1	whether materials
1	requirementsany petition
1	section 355(j)(5)(f)(ii)
13	(i) with
13	different from
1	cleared device
1	inspections relating
2	nuclear regulatory
1	stakeholder groups,
4	serious, adverse
1	compiling, developing,
1	phenampromide. (36)
1	late if
1	emergency response.
1	licensed physician,
1	studies, patient
1	affect activities
1	
 1905.
1	ammonia removed
9	(j) the
1	whereof the
1	(1) utilize
1	analysis, reporting,
1	deficiency. (ii)
1	represents or
1	made..[2] (h)
1	shop, or
1	intentionally use
3	15 and
5	information (including
1	collaborative agreement
1	corporations 
2	reports thereof
14	approved after
2	review, technical
2	deemed objectionable,
1	application, product
1	modified product
4	privilege against
6	attempts to
1	drug, subject
1	judgment. upon
1	officials 
1	subsection (b)(2)..[1]
1	voluntary test
1	removal, as
4	administration who
2	notification requirements
1	expiration dating
1	institute) for
1	commerce), state,
1	wholesaler; and
1	eggs. (4)
1	provided substantial
1	comment into
1	sel-administer medication.
1	strategy, which
1	training, drug
1	points out
1	recalls and
1	chartering and
1	93. repealed.
2	u.s.c. 3001
3	technology systems.
2	delay, a
14	port of
2	twent-day period
2	food involved.
2	disqualifying financial
1	limited so
1	exporting country,
3	(or part
2	roles and
1	(5) consistency
5	documentation demonstrating
1	(2) amendment
1	reinspect eggs
1	assault. the
1	(f) wrongful
1	registration; (3)
5	substances manufactured
6	study conducted
2	disease research
1	generalno entity
1	sunscreen to
2	secretary denies
1	award paid
1	budget justification
1	every inventory
4	amendatory thereof
61	used to
2	379j62 of
3	agency is
1	physicians, wholesale
14	agency in
1	establishment inspections
1	colors; regulations;
6	chemical with
1	advertisements the
1	agency if
2	waivers the
1	(d)(1)(a)(ii), and
1	enforced is
1	endeavor, attempt,
1	time periods;
1	voluntary procedures
1	toxicity of
4	(ii) pursuant
1	charge, bring
4	scientific evidence,
1	nanomaterials of
2	sale; proceeds
3	whole blood
2	priority given
1	severe psychological
1	general, issue
1	groupswithout regard
1	(f) 40
1	u.s.c. 300f
1	201(b). 
1	analyzing data
8	egg products,
1	available clear
5	recover the
5	(1) under
1	equines have
4	abbreviated application.
1	(e) one
24	respond to
6	subparagraph (a)(ii);
1	chemicals by
1	establishment inspection,
1	planned to
3	exemption, the
4	any) of
1	(ii) $652,709,000
7	subparagraph (a)(ii).
11	subparagraph (a)(ii),
1	study would
1	render him
5	direct accreditation
1	alternative fine
1	disruption 
1	are, collectively,
1	reallocations in
10	product; (ii)
11	effective before
2	agency conducting
1	consular officers
1	include specific
1	institute; and
1	including strawberry,
7	(b) upon
1	(b) enhanced
19	obtained by
1	including substances
2	ii punishable
1	said virus,
1	18 (including
1	entity during
1	measure safety;
1	depositions in
1	notification; exemption
1	hear a
1	recommended under
2	made wholly
1	simultaneously or
1	reports, certificates,
1	sector preparedness
1	record regarding
1	registered manufacturer
1	actual emergency
1	mortgagee, and
1	various modes
1	mixed and
1	summarizes the
1	355, and
1	350f(n) of
1	regulatory function.
14	comment on
3	otherwise result
2	(h) to
21	interstate or
1	section 1049
1	sentence does
1	comment of
2	animal shall
1	establishments identified
1	(1)(b); and
13	distributed by
1	serving youth.
1	control points);
2	(a) authorization
1	track products;
1	(i) recruitment
9	quality or
1	completed video
1	(as meat
2	designated personnel.
1	review five
6	quality of
2	(3) consolidation
1	economic losses
1	reasons other
1	public hearings
1	954 of
2	agencies, or
1	(i) capture
1	harmful constituents
2	thereafter, submit
2	complaint on
1	medical ethics,
1	usewith respect
1	associationsany person
1	alleviate adverse
1	foregoing substances,
1	complaint of
1	applicant other
8	premarket reports,
6	available and
2	relevant professional
1	programs. (6)
1	niacin (g)
2	customers or
1	thereto. (y)
1	accept, hold,
1	substances, he
4	restrictions as
7	articles used
1	employees when
1	2020, is
1	easily legible
1	microbiological or
2	warning or
1	considered medically
7	emission of
1	subsection (e)).
2	that, based
1	section, relating
1	compete (36
1	warning on
5	plan 
1	consideredin deciding
2	destroy such
1	humans. (mar.
1	congress (1)
2	warning of
1	transported to
1	make information
1	(ii) plans
1	drug availability,
5	limitation a
3	proper court
1	make payment
1	moldy eggs,
26	poultry or
1	substances (as
1	greater period,
9	mitigate a
1	protection for
2	in, plants
1	submit more
1	traveling on
1	means chapter
1	4402 of
2	otherwise stated
1	paragraph (6)(a)
1	pharmacy will
2	subsection apply.
2	validly registered
4	8 of
1	part) meetings
1	trials, if
2	begun by
8	may petition
1	interested party.
1	within 2,500
4	law, including
16	establish the
1	senate, in
1	demonstrating safety
1	proceeding. any
1	carcasses at
1	proceeding concerning
1	pandemic influenza;
2	section 360e(d)(5)
1	less; (7)
11	trade a
1	dismiss, the
1	scheduling decisions
3	illicit trade
2	secretary (and
1	hospitals; (3)
15	conditionally approved
1	passed; 
5	oral order
1	(c) general
1	trypanosomiasis. (j)
1	custom devices
7	qualification package
2	agreements shall
12	information relating
1	faca 
2	radiation safety,
1	contents each
1	law 103226;
2	states. such
1	$21,600,000. 
1	concentration, preparation,
12	regardless of
1	accreditation is
1	manufacturer provides
1	conditionally approves
1	(i) released
1	specific abbreviated
3	(3) contrary
1	federal funds.
2	state (including
1	respectively)) on
2	first human
2	23, 1985,
1	1999, for
1	subsection) by
20	narcotic drug
1	databases in
1	prescriptions (a)
1	360bbb2. classification
1	infrequently and
1	notices, as
3	implementing the
3	register, a
1	agree is
1	dry milk;
1	preventing such
2	(e) fees
1	purpose based
1	evaluation conduct[3]
1	show what
1	petitioner agrees
2	criminal liability
3	agree in
4	year adjustment
2	occurring on
2	agency relationship
3	condemned, at
1	849. transportation
1	(or his
2	2 business
1	animal or,
1	resale, in
1	qualified nongovernment
1	(5) basis
1	privilege. each
3	given or
1	(4) director
1	0.7 iu/gm
4	aimed at
3	public; and
1	screening of
1	determination applicable
1	previous application,
5	request review
19	director for
1	drop shipment
1	(f) injunctions
1	transferring repackaged
1	regulations by
1	841(b)(1)(a)[1] of
1	conducted information
1	years, for
1	focuses on,
2	r-exportation among
1	hashish, hashish
1	pathophysiological, therapeutic,
1	october 10,
1	samples will
4	condition in
11	limiting the
1	disagreements with
2	requirementif a
1	otherwise expand
1	(b)(1) who
1	make arrangements
1	(i) arranges
2	(1). in
1	commissions[3] shall
1	groups. (x)
1	island, midway
7	shall mean
1	misbranded, within
6	without any
2	$40,000,000 for
3	labeling thereof
1	research methods
1	labeling. (k)
1	legible through
1	411, as
1	61. definitionswhenever
1	regulations); or
1	longer applying
1	information who
2	obey the
1	requirement at
3	area, and
1	tracking pediatric
1	act, and
1	(4) regulations
1	675, 771,
2	detected and
3	administrators own
1	condition with
1	foodborne illnesses
2	lots of
1	(4) definitions
3	admissible in
1	expunged under
5	act; and
9	distributor; and
1	certain importers
1	phrase imminent
1	inspection; notice;
8	full qualification
3	provided with
1	(g) regulatory
1	testing resources
3	subparagraph (b)(i),
27	(c) of
1	precedence restriction;
1	treatment shall
4	u.s.c. 2011
1	extension request
2	statutes and
2	party, the
1	(l) adverse
1	(5) because
1	title; (11)
1	technical advice,
13	(c) or
3	shall jointly
1	arguments of
1	72 hours
8	advice and
1	safeguard against
1	fooda sale
1	(a)(2), applicable
1	262], and
1	tolerance prescribed
1	advisory letter,
1	seller registered
2	evaluating possible
1	-hexy--(-naphthoyl)indole (jwh019);
5	induce cancer
1	physicians with
1	regulated), or
2	42), a
1	hearing within
1	(4) material
1	additives, including
1	process. (4)
1	implement mitigation
2	populations. 
1	sections for
1	lead for
1	purposes; (5)
1	represent an
1	retain, or
8	2014, the
3	use not
1	device sponsor
1	pasteurized before
10	(a) it
49	(a) is
1	receiving recommendations
1	address, professional
2	women, and
1	(i) withdrawing
2	grown tobacco
12	states that
1	modify, reverse,
41	(a) if
1	(19) dioxaphetyl
1	(iii) conducting
2	practicable in
41	drug. 
1	cures act
1	6.0 
286	(a) in
2	law on
1	operation, (i)
1	protocol. approval
1	compensate for
1	abuse has
2	(2)(b) of
1	part; (e)
6	thereafter. 
3	otherwise specified
1	foodnotwithstanding paragraph
1	diagnose; and
1	(d) 10
1	permanent. 
1	(2)(b) on
1	physicians meeting
4	adjusted pursuant
1	provide outreach,
1	revising a
1	title 25);
1	clearance prohibited
2	262] or
1	1703. appointment
2	cosmetics which
1	court decision,
4	certification required
1	(for which
2	permission to
1	equivalent for
1	requirement made
1	court decision.
1	beverages the
2	osteopathic association,
1	accounting practices.
1	consignee maintains
1	$75,000. (h)
2	patent issued
1	
 360.
1	entity enrolled
1	(a) meet
5	gs18 of
1	good may
1	specifies a
1	(4) includes
1	tim-sensitive campaign
1	general review
1	321(r) of
1	unapproved new
2	fee rates
2	grains of
1	(2)(b) may
1	area reserved
2	isoquinoline alkaloid
1	formula. (b)
1	(18) dimethylthiambutene.
2	qualified indication
2	program residue
1	practice has
6	ris-based schedule
4	state inspection
2	subsections (d)
2	nations in
1	inefficiencies in
1	forms, or
1	humanitarian organization
1	100 kilocalories.
1	postmarket no-compliance
17	material threat
1	list by
1	importation in
1	environment or
1	applicant, or,
1	significant no-implant
1	acts constituting
1	obtaining approval
3	links to
1	natural flavor,
1	import, such
15	opinion of
4	technological characteristics
1	harmonization of
10	drugs under
3	inspector. 
6	uses a
14	cooperate with
1	regulations; (6)
1	(e) recovery
9	importation is
1	first portion.
1	(b) assurances
1	limitations, as
1	chapter, trial
12	agency to
1	information; (e)
1	object, except
1	users, including
1	appointments under
1	quantitative comparisons
2	formula which
1	formerly 21st,
17	imprisonment for
1	presentations by
4	dose or
4	effect unless
9	(a) information
1	adduce the
1	$50,000 or
1	personal, as
2	inspectors when
2	health. (c)
3	standards, or
1	reduce illicit
1	(1)(b) has
3	year. (c)
7	verification of
1	advertising concerning
8	approaches to
10	employee, or
1	guidance; other
2	2009; and
1	positions, including
1	353(f)(1)(a) of
1	387j(c)(1)(a) of
1	implantable within
1	deny a
1	licensee or
1	encouraging parents
4	verification or
1	change. (iii)
1	whatever actions
1	stat. 22.)

1	(d) 100
1	required. registration
1	u.s.c. 22501(b)(1)).[1]
3	international drug
1	oleomargarine sales
1	hospital repackaging
2	period exceeded
2	related requirements;
52	authorization of
6	appropriate district
5	distribution to
1	344; 

1	nondependent and
1	apply. (2)
1	permanently debarred)
1	processed. (x)
14	requiring that
1	administer drug
1	(d) communication
1	equipment used
2	evidence. (3)
56	secretary a
1	submissionsas part
5	1263; renumbered
1	permanent ineligibility
2	report. (2)
1	revenue amounts,
1	feasible for
1	receive travel
1	pharmacy profession.
1	electronic certification
1	monitoring systems
1	section 830(e)(1)
1	authorization). all
1	education record
1	receives comments,
1	hearings, and
1	certifications concerning
1	cites as
1	serve, or
1	whose biosimilar
1	policy established
1	days by
2	diversion control.
1	meaning assigned
1	aware of,
1	2204. building
1	proposal, be
4	balances for
3	susceptibility information
1	shall (with
1	investigation, information
8	occurred in
1	otherwise caused
1	networks to
2	diet or
1	appropriate, recommendations
1	(26) the
1	cooling, freezing,
1	360mm. imports
1	prohibits or
1	(a) opt
1	readily available,
4	may affect
1	
 360bbb0.
1	463, or
1	353(b)]. prescriptions
1	
 960.
1	forth conditions
1	(iv) otherwise
3	misbranded (a)
1	sale; (d)
4	350f of
1	renumbered 16
1	50 states,
1	period, imports
4	notifying the
1	production includes
6	relevant in
11	secretary when
3	includes, in
2	pesticide chemicals;
4	losses to
2	patents with
1	
 695.
5	(b), no
2	factory or
2	bioequivalence studies,
1	(6) nothing
3	criminal forfeiture
1	pond, or
1	patient at
1	commercial license
1	renumbered 15
1	intends that,
1	product; (e)
7	(b) labeling
1	officers employees
1	use local
1	collected fees
1	disfigurement; or
1	veterinary prescription
1	reducing violent
50	animal feed
1	effective performance,
87	provided by
1	sanitation procedures
1	jurisdiction; authoritiesnothing
1	partnership, trust,
1	(b) enhancing
2	nucleotide sequence
1	19, transfer
8	good and
1	(f) prevention
3	hazards, including
17	level specified
1	quantity, shipper,
1	humans. (l)
2	effective performance;
4	denying the
3	egg product
1	exportation (in
1	food, with
1	execute a
1	conditions; (e)
3	rulemaking to
2	education in
3	drug activity
1	additional dataif
1	sensitive and
12	section 262(k)
1	section 4(h)
4	persons licensee,
1	disclose relating
1	requirements, he
1	term verification
1	parties. in
1	purity, quality,
22	action by
2	displayed for
4	licenses as
1	interest (including
1	parties. if
1	submission containing
1	single report
5	recent federal
1	students of
1	efforts in
1	matched with
9	either party
1	factories, warehouses,
2	therefor, and
1	prescribing conditions
1	manufacturers, processors,
1	originally included
1	except any
1	characteristics means
18	reasonably be
2	(g) recordkeeping
20	drinking water
1	chairperson, by
1	(6) agency
2	adequate for
1	675, 760,
2	misbranded meat
1	experiencing the
1	overall impact
1	(5); and
2	levels, and
1	entities; application
1	machin-readable methods.
1	conveyance. 
4	audits and
7	blood or
2	substance, shall
1	(iii) renewal
1	federal criminal
7	designation the
6	benefits to
2	study may
1	designed observational
1	designate in
1	ant-doping education,
6	expedited basis
1	secure directly
1	otherwise available,
1	section 331(i)(2)
4	documents (including
1	analyzing the
2	assigned by
6	consumers and
2	center. the
1	drug entered
1	designation; publication
1	regulation based
2	illegally to
1	supplement his
1	unaffected notwithstanding
2	(d) provision
1	limitations upon
1	services; refusal
1	(9) take
1	term application
1	duration, an
1	employ, and
1	(i) phenylpropanolamine,
10	unless listed
1	(v) to
1	sponsors research,
1	adequately competitive
1	
 849.
1	(iii) recruitment
1	specific targets
1	first applicants
1	(c) and,
3	safe production
1	substances distributed
1	apothecary shop,
2	design modification
1	election is
1	196. repealed.
1	studies examining
1	sections 341
1	levels that
1	secretary adhered
4	test results
1	dispute. 
1	911, as
1	transaction occurs
1	is, except
1	firearms, and
1	804, as
1	(in excess
1	(1) specifies
3	reverse logistics
1	354, and
1	pending a
1	devices readily
31	year shall
1	export certifications
2	sponsor; 
32	product identifier
1	promulgating or
1	2015, $11,700,000;
12	agency. 
1	inquire of
1	imposed pursuant
1	issue certification
1	(f) registration
1	2019 and
1	definedas used
1	severally liable
1	1174, 1175.
1	receive effective
1	act, together
1	confirmatory data
1	practicable, obtain
2	prices and
4	generally recognized,
1	1606. subsequent
1	tools (a)
5	substantial harm
2	(b) provides
1	344(a), 346,
7	corporation shall
10	frequently than
1	threats. 
1	assessment; (3)
6	may serve
3	noninfringement described
4	producers and
1	convention, incorporated,
2	strategies, policies,
1	check means
1	general, such
1	specified sampling
1	tin, pot,
1	operation performed
1	commerce prohibited
1	equity for
2	(c) enforcement
1	general designates
1	steroid by
3	made that
4	certifies and
1	adulterated to
3	matters referred
1	(6) local
2	section 331(p)
1	(8). 
1	
 379j52.
2	1-day period,
1	hereby provided
2	internet of
10	place to
1	compound (1)
17	(b) any
2	secretary no
1	taken during
1	(ii) regulation
1	extension; (ii)
1	section 360fff3(e)
1	
 1712.
1	developmental changes
2	unlawful distribution
2	(c) was
1	chapter. (bb)
1	350c. maintenance
1	areas, remaining
1	tracking, and
1	accounting of,
1	(e) conclude
1	licensure; (c)
4	(or such
1	problem in
1	without first
1	will pay
3	harmful than
1	plead guilty
1	markets of
1	board appointed
2	recipients in
1	expansion to
1	americans (including
1	training required
1	(g)[2] to
3	federal mark,
2	drug made
2	(b) condition
1	applicant provides
1	states holds
2	changes as
2	waiverat the
3	acts (a)
1	inhaled during
1	brought and
1	part. nothing
1	1985; or
1	bioequivalency information
4	concealed in
1	variance provides
9	section 1903
1	initial standards
16	section 1905
2	chapter the
1	knowingly counterfeiting
1	(c) pricing
1	food ordered
1	674. federal
4	cocaine base;
2	designation as
2	product designated
1	drug, elect
1	afford that
1	(d.c. code,
1	proposals under
1	desomorphine. (8)
1	deferrals, and
2	(b) grants
2	therapeutics established
2	subsection limits
1	member, in
3	additive means
1	alphacetylmathadol.[2] 
1	(1) terminates
1	commenced. (ii)
1	patents as
1	agriculture, another
5	device would
2	manner, to
1	amount specified,
1	individual practitioner
2	(a) solely
2	right for
7	(c) has
1	associated suspension
2	order notwithstanding
1	operations. (

7	time during
2	subsection (c)(2)(g)
69	risk of
1	complaint systems,
1	implement all
1	pane-track supplement,
1	(i) intracompany
4	c-located on
1	section; (5)
1	efforts with
1	ethical medical
1	approval pathwaysan
1	objectives; and
2	without assistance
1	offered to
1	(10) youth
1	74, 13,
4	operates any
1	jobbers, manufacturers,
1	entities the
1	committees or
1	(c) acknowledge
1	unit the
1	home administration;
14	committees on
3	portion thereof)
4	investigational plan
1	portion thereof,
2	surveillance period
1	355, as
1	newspaper, magazine,
18	committees of
1	sponsors developing
1	occurred; and
1	implement processes
1	foreign sellers
1	public law
1	delayed until
1	either as
1	fees provided
1	applied in
4	reasonable assurances
1	843(d) of
1	reserves for
2	submission 
3	that, of
1	drugs; 
2	delay the
1	
 360ccc.
2	either an
1	thereof. (june
1	knowingly provide
1	dismissal filed
1	develop business
1	legitimate purpose
1	milk ordinance
2	union or
1	(d) revised
1	approved until
1	30,000 individuals.
22	request that
1	(c) regulationsnot
2	practitioner meets
1	owned, managed,
3	salts, and
1	approval; (ii)
2	(ii) provisions
1	criteria. 
4	proposed rule
1	product, by
1	
 821.
1	short shel-life
1	thereafter act
2	volume and
1	injure, or
2	misleading label
1	(5) make
1	businesses; (b)
1	follo-up on
1	authoritythis section
1	42, for
1	effect, may
1	surveillance infrastructure
1	401, 52
1	(g) supplement
1	(d) stay
1	criteriain order
1	(including under
1	sold, bartered,
1	experience, not
2	fees, in
2	drugthe term
1	(d)(4) or
1	1997, but
4	379h(a)(1)(a)(i) of
2	regulatory agencies,
2	considerations 
1	deficiency or
1	protection plan;
1	manufacture, possess,
1	country; (ii)
1	issuer, or
6	health information
18	specify the
14	to, and
2	conditionall-approved application
5	to, any
1	regulations; destruction
2	term inspector
1	(j) emerging
1	information. (5)
1	interest, including
1	(d)(7)(a). (11)
1	laboratory and
1	warnings, contraindications,
1	regarding market
1	domestic laboratories
5	circumstances under
1	careful inspection
1	impose such
2	section, section
1	receiving valid
1	sections 827(e)
8	title which
6	certification has
2	may (prior
1	growers. 
1	establish suitable
5	accept or
1	conducted, shall
2	recall is
2	accept on
1	(a) result
1	development, clinical
5	packaging, and
5	stat. 819.)

1	every compound,
6	suspend or
1	investigation reports
1	(k) compiling,
3	objections and
2	entry, or
1	chapter. (o)
1	mechanisms of
2	secretary. after
1	agree. (7)
1	minor violations;
2	time; and
1	shall demonstrate,
1	generalized principles
1	
 143.
1	conventions, and
1	attorney that
1	papers, documents,
2	9-day extension
1	seafood examinations
1	appropriate medical
1	(iv) private
1	379aa, or
1	paragraph pursuant
1	submitted, or
1	following date:
1	(i) conducts
1	take whatever
1	
 1543.
3	forward with
1	months into
3	handling, or
1	inherent toxicity
1	issue whether
2	(c) deputy
1	panel; (b)
1	(h), the
1	practitioner may,
1	nations; (iii)
1	accessible manner
6	procedures described
1	variances granted
1	nurse tank.
7	substance, the
2	quarter for
1	sufficiently in
1	prescribe. if
1	debarment which
8	drugs, shall
1	title 5;
1	benzilate. (14)
1	property specified.
2	technical effect.
1	stat. 416.)

23	title 5,
36	title 5.
2	title 5)
1	user reporting
4	262(a)(3)]. 
3	court, and
1	agriculture. (3)
1	(j) may
1	360fff6. no-sunscreen
1	questionnaire; and
1	duck, goose,
1	appropriated $5,000,000
1	(h) consumer
1	provider remains
1	risk populations
1	drug shortagesnot
1	increased under
2	research protocol
1	entries to
1	practices applicable
1	sources or
5	notification. 
1	upon appeal
2	section 330.14(g)
6	paragraph may
1	regulation (which
1	stuffed, rendered,
1	federal establishment.
2	remaining members
1	section 3(c)(5)
1	shall ensure,
1	education opportunities
3	narcotics trafficking
2	following periods:
1	(4) availability
2	(j) collection
1	awareness; (3)
1	reports concerning
1	(5) ethinamate.
1	thing proceeded
1	clearly premature.
1	initial additional
4	submit comments
1	administrative authorities
2	services shall,
2	sale. 
1	(4) united
2	35; 
1	tribal authorities,
1	(f) relation
4	located outside
1	governmen-issued identification
1	section 262(k)(4)
1	342(a)(2)(c) of
1	similar operations
1	clean up
7	devices, and
2	upon goals
1	available any
1	territory, when
1	lawfully issued
3	1 per
4	countermeasure (as
1	(but prior
1	compounding; (c)
1	section 811(a)
4	1103.)
 

1	physician may
3	division of
1	longer deemed
1	2298). (ll)
7	best practices
2	contacted for
2	21, 1995,
1	feeds under
1	possessions); or
3	labeling provided
3	illegal drugs.
5	violates paragraph
1	meetings, which
1	effectiveness. the
1	(a) ante
1	laboratory services
1	education, research,
2	questions, including
1	tissue, the
1	therapies to
1	combat the
1	$299,000,000, as
2	iv. 
1	review expertise
1	1087, as
1	(b) suture
1	importer written
3	(c); and
2	period thereafter.
1	whoever commits
55	fee for
1	what, if
2	burdensome to
11	entity shall
4	term meat
3	review, with
1	319e of
1	(c) trade
1	subsection (c):
14	subsection (c);
1	actual use
1	1532(b) of
2	selling (as
1	examples of
1	things, shall
1	country; (5)
22	subsection (c).
2	received) are
29	subsection (c),
2	networks of
1	spent in
1	(2) solely
2	appealed or
1	subsection (c))
1	associated gene
3	illegal drugs,
1	safety question,
12	transferred from
2	postmarket surveillance,
1	committee input,
1	major change,
1	(7) within
1	(d) compensation;
110	secretary finds
1	1. at
2	(ii) nonsaleable
2	and, for
1	section 1903(h)(2)
4	(2) regulations
2	(7) ensure
1	comply, apply
1	panels activities,
1	772, as
1	(e) which
1	evaluation shall
4	appear at
2	foreign nations
2	(c) procedures
16	delivery for
4	filed per
1	initiate such
1	bonds, appoint
1	goats of
1	days, with
2	safety rest
1	state department
1	remain valid
1	income, the
2	manufacturing processes
1	raise the
2	issuing grase
1	iii became
1	
 1033.
1	(e)(7), affected
1	u.s.c. 3501
1	abuse, trafficking,
1	new products;
1	unrecognized in
1	basic grant
1	first generic
2	additional such
1	crime presents
1	conduct (including,
1	foreign flow,
1	transferred; (b)
4	formulation and
2	intracompany distribution
2	thir-party inspections
19	request a
1	animal in
3	congressnot later
1	(iii)[3] holding
2	number identified
1	tolerance. 
3	section 360b(b)
2	printed by
1	variability and
1	seq.); (3)
1	attach to
1	knowingly distributes
1	information compelled
5	input on
2	government; and
1	limitationno fee
2	360ccc(a) of
1	necessarily a
7	listed patent
1	products; or
54	 (6)
1	routine access
4	box, bottle,
7	title; (3)
1	review devices
1	575, as
1	devices, foods,
1	regulations regulating
1	counterfeit substance
2	prohibited establishmentsin
1	information since
1	recover all
2	pediatric labeling.
2	labeled poison
1	(3) timeframe
9	met the
1	general requirements;
1	information, document,
3	secrets. 
1	certain circumstances
1	community at
1	section 360b,
7	826 of
1	willingness of
1	appropriated, such
1	follows: apples
1	application. (d)
1	terms the
1	administration, upon
2	proceeding held
1	15. (b)
1	802(39)(a) of
1	control, (iv)
1	prepared articles,
1	31, 1956,
1	grocers for
1	establishment may
2	407, as
1	entitled the
1	(aa) are
1	(a) origin
7	controversies or
1	countermeasure that
1	produces, or
1	appropriate effective
1	outbreaks attributed
2	proceeding. nothing
1	335a. debarment,
1	avoiding such
1	leverage and
1	pethidine. (15)
1	internet not
3	violation referred
1	federal governmental
1	serious injuries.
1	individual, (ii)
2	circumstances, the
1	any, pertaining
1	synthesize, interpret,
1	forum, and
1	potassium (mg)
1	methohexital. (7)
2	destination and
1	application; factors;
5	complete response
15	section 360bb
3	360m of
1	decision from
3	thereof subject
7	(3), a
19	procedures to
1	indexed new
2	taken with
1	changes. (b)
1	(ii) destroyed
1	center by
1	applicable 
1	condensing plants
4	product meets
1	shall reflect
1	medical center
4	mitigation, treatment,
2	(iii) include
2	local and
1	(1) select
1	existing electronic
1	uses assessed
1	(3) classifying
2	section 802(25)[1]
1	(v) changes
1	substance. in
1	packed do
1	following statement:
2	public confidence
6	shall, where
1	387e(c), 387e(d),
19	rate of
2	locations and
1	allergen means
2	importing, such
3	deliver to
4	held. the
17	hundred and
1	documentation relating
6	proposed by
1	agreements, the
1	cigars notwithstanding
2	fees as
2	business practices,
1	nonfederal governmental
145	secretary under
1	country, regardless
1	stalks of
1	specifies otherwise.
1	require tobacco
1	paragraph. (c)
2	fees an
3	concerning adverse
2	sites of
2	carcass, meat
1	analogue. (c)
1	2012(b)(1) of
1	title; (iii)
3	different mutations
1	(3) encouraging
1	section 346a(a)
2	360(k), 360b,
3	actual transaction
1	age, except
1	requirementsif a
2	menthol cigarettes
1	lost by
1	additional findings
1	proceduresthe attorney
6	application, premarket
1	intend to
1	order, objections
1	estimate shall
2	ammonia (a)
6	nutrition, and
1	definitions the
1	met, or
8	section. (b)
1	675, 703,
1	675, 809,
2	reasons based
1	statement. (2)
1	contact normally
1	(including inhalants
1	(b) chairperson
1	hygiene, packaging,
1	terminated upon
1	(i) subsection
1	calculated using
1	license (referred
17	applicant to
1	fee specified
1	otherwise protect
1	360fff2. eligibility
5	appropriate, shall
3	282(j)(5)(b) of
1	(e) surveillance
1	participation from
1	opportunity after
1	conditions on,
1	issued, shall
1	show compliance
1	(2) special
2	regarded by
1	clearance under
6	(a) present
1	address issues
1	additional species
1	locality, be
2	criteria prescribed
1	evaluation a
4	study in
1	implant shall
1	
 355a.
5	study is
1	applies, be
1	(3) volum-based
2	little cigar
2	safe: provided,
1	(4) personnel
1	regulatory personnel
1	commit a
11	distributed to
3	prevention, or
112	expiration of
1	device. (6)
2	related additives)
1	subsection, to
1	poultry (1)
8	dispense, or
1	(7) notification
1	and/or video
1	administrative recordfor
3	due in
1	distribute, of
1	forth its
1	objections filed
1	term milk,
1	possible processes
1	(9) reporting
1	report requireda
1	returns only
2	reduction, the
4	period is
2	food; denaturation
1	labeling fails
1	population, and
1	(v) for
1	submissions, through
1	review conducted
2	may cooperate
1	trademarks the
1	751, as
1	general (1)
1	chemicals. the
1	registered pharmacist,
1	vacancies members
86	shall establish
1	narcotics crops,
2	hereinbefore set
1	manufactured methamphetamine;
1	(3) request
1	establishment fee,
1	use data,
3	commerce may
1	area. (b)
1	(14) of
1	department) with
1	387e(e) of
1	working with
3	term wholesale
1	(l) positron
1	offender for
1	practice to
2	regions of
1	working groups
1	threat under
1	agency; subordinate
1	symptomatically and
4	uniform system
1	identification card
1	publicationthe secretary
2	treatment means
1	simultaneous global
1	food imported.
1	products, he
30	information described
1	(1). (n)
1	held animal
1	applicable, dispose
2	indole ring,
1	registration; separate
1	pending time
1	(c), (d)(3),
2	establishment fees
1	section 353(e)(3)
1	proposed rule.
1	an[2] paper
3	chapter. (r)
1	seller must
1	may choose
1	payments of
2	food manufacturer
2	necessary curricular
1	basis, 
1	manufacture, local
1	quarter (including
1	379j13. reauthorization;
2	appropriate. (c)
1	section 333(c)(2)
3	substances having
1	pediatric experts.
1	sanctions authorized
1	on, affixed
2	year (or,
2	serving economically
2	initiatives in
1	limiting or
2	purchased by
2	secretary), the
2	processed for
1	(i) regulations
1	medicines as
1	generalas a
1	affirms or
1	license, approve
5	effect produced
1	level has
1	(i) processes
1	u.s.c. 2601
1	
 875.
1	providing safe
1	substances laws
2	waste, fraud,
1	state, territorial,
3	utilization of
4	approval, of
1	evaluate countermeasures
1	administrative funds
3	verify that
1	high as
1	copy; and
1	field investigators
2	term reinspection
2	title) under
1	appropriations by
1	
 211.
1	characteristics, chemical
11	states the
62	(a) a
1	chemical, in
5	importers of
1	processing an
1	products sponsor.
1	(a) i
1	thereafter, shall
1	(c)(ii) shall
1	bacterial count
1	section 360d(b)(5)(b)
1	actions, and
12	provided pursuant
2	states, giving
1	(q) that
3	records that
16	distribute, or
1	see references
1	progress which
1	constitution and
1	populations and
1	(including back
1	current ant-drug
1	residue under
1	(2) jointly
1	is, collectively,
4	equilibrium of
2	federal establishment;
1	acrylic, glass,
1	transporting, distributing,
1	applicant conduct
1	675, 586,
1	background information
4	communication facility
1	subsection (d)(1)(a)
1	removal was
4	180 calendar
1	information, if,
2	health. a
3	located within
6	activities and
1	1, 65
5	(b) public
3	substances 
1	relevant databases
1	therefor and
1	604. post
1	cal 30.0
2	complaint, and
1	use guidance
2	relations involving
4	drug submitted
4	better or
1	petition pursuant
1	suspend approval
1	guidelines and
2	reasonable promptness.
1	venue any
2	all, part,
4	notice not
5	device. such
1	satisfactory inspections,
1	identifiers if
1	signed document
1	(g) exclusions
2	budget for
1	action relating
3	safety audits
1	
 828.
8	ensuring that
2	1913 (37
1	(b) jointly
3	years, but
1	section 360e(f)(7)
1	pharmacy licensed
1	growths, may
1	promote honesty
1	auditors. (b)
33	(i) is
1	furnish assistance,
7	cause a
17	consideration the
1	sixtieth day
1	product, consistent
1	360eee2. national
1	detect microquantities
1	making grants
4	providing written
1	policy, the
1	emergency disaster
2	human being
1	sought will
1	1, 69
1	personal medical
1	675, 503a,
10	start of
4	procedure developed
1	sequential basis
1	therapies on
1	secretary, submit
1	acts whoever
3	findings on
1	processing facilities
1	induce another
1	etc.; certifications
4	products processed
2	approvalfor purposes
1	(b) market
1	relevant enforcement
1	en-userthe term
1	review process.
2	secretarys consideration
2	review process,
1	drug tests
13	fill of
6	animals, and
1	restricted eggs.
1	including polydrug
2	entities involved
1	therapies or
1	title, consistent
1	drug) that
1	segregation and
1	shipment data;
1	applicable; (b)
4	plea of
1	
 355c1.
1	authorizations of
2	services, secretary
2	applicable statutes
1	studyin conducting
2	investigation by
1	distributed; or
2	title, (2)
1	deducted, when
1	holder thereof,
1	government only
6	promptly after
1	clarification concerning
1	secretarynot later
1	data, contain
1	felonies: intent
6	deems appropriate
1	panel meetings.
3	practitioner has
1	cosmetic other
1	involving listed
1	335a and
1	exception that
1	(b) health
1	design, produce,
2	basis or
1	record, summarize,
1	basis on
4	proceeds from
1	withdrawalthe secretary
1	personnel; (4)
7	bioequivalent to
3	acid, its
41	safe and
100	basis of
1	requirements placed
4	expect to
1	sections. (4)
1	conditiona designation
3	organized crime
2	section 3717
1	expired or
1	encouraging insurance
1	earmarking of
1	(4) narcotic
1	seizure data
1	facility or,
5	constitutes a
23	360(k) of
1	model does
1	fine. (june
1	egg whose
1	antimicrobial activity.
1	(iv). if
1	sport in
2	provisions may,
1	hazards associated
1	$210,000,000 for
1	chapter; (ii)
1	druggist or
1	excipient, the
1	business, panel
28	state agency
1	assessment, in
1	sections 321(q),
1	sponsor (or
1	gathering 
2	fraudulent transaction;
1	seize or
1	ideas; and
2	activity under
1	imprisonment. (2)
53	drugs in
2	drug, provide
11	action against
1	analytical methodology.
2	321(n), 341,
4	drugs if
3	presence in
1	study; by
4	request in
1	agriculture, representatives
2	seafood products,
1	(c)(1). (3)
1	detailed criteria
1	cosmetics, be
1	(g) marketing
2	award any
1	register; (b)
1	(1) demand
6	(i) all
1	(i) unduly
2	thereof, whose
2	combination thereof,
1	manufactured each
2	title). a
2	condemned in
1	reviewed such
50	shall ensure
1	360fff3(a) of
7	paid with
1	sponsor, that
1	proposed rule,
1	acinetobacter, klebsiella,
1	attorneys fees.
6	cooperative agreements
1	task forces,
20	distribute a
1	(10) petrichloral.
15	due date
3	another product
1	help support
5	association, the
7	advertising of
1	use devices,
1	less protective
1	facility, after
1	chemical, substance,
1	including field
1	nonapproved labeling
1	distributionin the
1	law in
1	(4) restrictions
4	advertising or
1	
 1042.
9	obtained a
2	small facility
1	specified kinds,
2	misbranded. (b)
1	form prior
1	provisions, any
6	causes of
1	debarment. the
1	director; or
1	sections, nothing
22	shall, if
3	section 601(m)
1	(15) shall
1	subpart 2[1]
51	shall, in
1	officethe office
5	provisions unaffected
1	plansin carrying
7	paid. 
1	granted; (b)
1	(d) carry
1	information, such
2	list, such
1	diversion control;
2	including based
1	897.32(c); (c)
1	maintain under
1	advance to
1	employee hygiene
3	characteristics and
1	establishment submits
1	illicit trafficking
1	discussion period
6	compliance history
1	cooperative agreement,
3	term label
1	cooperative agreement.
1	contamination; (v)
3	(c), for
1	alleged under
1	regulation so
64	state, local,
202	prior to
3	administering a
1	task forces;
1	advertising thereof
1	investment needed
1	traceability except
1	state; territory
2	stock or
1	fillings does
61	drug and
87	deemed to
28	human use
3	jurisdiction 
1	agree upon
2	research findings,
1	1, 2017,
4	1, 2017.
2	if, as
4	384a of
1	pharmacy, a
1	facts warrant
2	deem the
8	appropriate, to
1	appropriate means;
1	than, requirements
1	adulterated article
1	grams, or
1	economic impacts,
3	consistent compliance
1	confidence and
1	(5) recordkeeping
1	softgel, gelcap,
1	permit; suspension
1	eyelashes or
1	kindergartens; (b)
1	local capacities,
1	section 4365[2]
1	data from,
3	appropriate means,
1	groups having
4	(e) an
1	comprehensive smokeless
23	petition filed
4	drug production
1	sixt-day (or
1	ingredient. (d)
1	sale immediately
1	general amounts
1	system; (v)
1	suspension authority
1	prolongation of
1	applicable registration
17	health, the
1	person) stating
1	(o) consumer
1	operator make[2]
1	(5) commerce
6	meaning indicated
2	1997, or
1	(ii) reliance
1	information collection
1	importer has
177	shall include
3	residue means
1	includes all
2	subsection (b)(1)(a).
1	date to
2	order his
2	imports, or
1	chapter, records
14	limitation to
1	barrels packed
1	used, to
2	threaten the
1	psychic or
1	360bbb8b. use
1	(2) committed
1	(c), of
1	smoke of
2	device (including,
1	official action,
2	active and
1	foreign owner
1	agency heads
1	business hours.
1	programs, by
5	importer, distributor,
1	approved designated
1	precursor substance;
1	dispenser. if
1	hosting, formatting,
9	(c), or
18	ii active
1	smoke or
6	imprisonment. notwithstanding
1	health, include
2	delivers to
1	provider, issue
2	cream imported
2	thereon or
1	sel-certified persons
1	alter any
3	whose device
1	use based
1	initiating any
1	sponsor conducts
1	testing expenses,
1	food advisory
8	statutory or
1	part, but
5	individuals of
1	coordinate counterdrug
1	sequence that
1	paragraph (4)(b);
1	preventive controls.
3	conditions exist
2	full list
2	advertisements prior
1	chapter preempts
2	product required
2	individuals or
7	labeling 
2	account, among
1	title, within
1	reside whoever
248	subparagraph (a)
1	duplicative notification.
1	enhancing public
1	known. (7)
1	population or
11	secret or
2	certify in
1	total volume
1	notice thereof.
1	restraint; detention
1	(ii) cigars,
1	(2) electronic
1	least nutritionally
1	plant; (3)
1	rates in
3	subchapter. (feb.
1	$6,250,000 for
5	countermeasure application
5	production, use,
5	offense or
4	population of
2	disease, or
1	crystallization, purification,
1	dimethyltryptamine. (7)
1	purposes through
69	filed under
1	 (a)purpose.the
1	initial meeting,
1	sunscreen orders.
1	designated because
1	subsequent year,
2	expertise and
1	transportation that
2	united statesnot
6	resulted in
2	pharmacopoeia chapter
1	careful examination
3	reports that
1	without submitting
1	secretary less
3	eventthe term
3	achieved to
1	31, 1976,
3	ensure adequate
1	(a)(ii), may
1	returned within
7	from, or
1	14. repealed.
1	shall forfeit
1	processing as
1	diversions, (c)
10	(ii) at
1	(i) encouraging
2	contemporaneously with
1	(ii) as
1	employees. for
2	quantity, proportion,
14	(ii) an
1	raw state
1	require additional
1	seafood, consistent
3	lif-enhancing medical
1	order remains
1	facility managers
1	drug marketing,
1	circumstances product
2	records pertaining
1	facility (a)
1	order. an
7	decree that
1	paid. if
1	term detoxification
1	urged before
6	economic information
1	distributor licensing
1	substance abusethe
1	factors, (a)
4	state unless
1	
 196.
1	thing which
1	(3) agreed
1	object classes.
3	360b(c) of
1	application would
3	applicable laws.
1	specific regions
1	(i) comply
1	subsequent exportnotwithstanding
1	penalties applicable;
2	staphylococcus aureus,
1	controlled investigations,
1	process applicable
1	pregnancy, lactation,
2	admission all
3	regulations prescribing
1	term grant
9	critical control
2	consumer exclusively
1	foreseeable expenses
1	revisions under
1	returned against
1	plastic bag
2	importation, or
1	ionizing radiation,
2	recommendation regarding
4	process control
2	begins to
2	860 of
2	possessions, as
1	deemed federal
1	mechanism is
2	application, means
1	
 384e.
2	negotiable instruments,
2	march 21,
1	statement this
3	substantially not
1	mislead. 
1	ginseng (a)
1	(iii) describing,
1	ingredients: 
41	administrator shall
1	804, title
4	causes a
1	shortage; or
1	drug. a
4	congress. 
10	(b) no
5	facility (as
3	360eee3 of
1	and, following
1	subsection (b)(2)(b).
3	articles for
2	rate. 
2	reported such
1	enhanced. 
1	25, 1948,
1	establish alternative,
2	to, this
1	order. any
2	supplements); (b)
1	343(e)(1) of
1	eggs showing
3	(ii) include
1	collection with
1	bond as
1	administrative subpena
1	poster, abstract,
1	treatment facility.
2	march 3,
1	formula. 
1	(5) prohibition
2	321(ff) of
1	stores as
2	joint committee
1	statement; (ii)
1	already granted
1	loan, professional
2	conferences, workshops,
1	
 379k1.
2	contract entered
2	provided directly
3	designated upon
1	permanently and
1	tank, freight
1	sciences, qualified
1	(a) assign
1	columbia, enacted
1	notice, issues
1	communication within
1	behin-th-counter placement
1	employees; reimbursement
1	farm has
1	procedures associated
1	referenced the
2	suspension exist.
1	415, as
5	ninetieth day
1	registrations associated
1	specific reference
2	title, licensed,
1	disclaimer as
3	expired, or
7	may approve
1	planthe risk
2	order complained
8	manufacture, prepare,
1	markets) that
1	acquired, or
1	
 1101.
1	phrases to
1	seventh year
1	(b) form
1	application) describing
1	affected if
2	plant in
10	produced and
2	country under
2	patients by
4	affected in
1	damage of
2	plant if
1	modification the
1	(or collectively
1	900 of
1	(n). in
1	account which
1	(c) evidence
7	potential to
3	appropriate formulations
3	points of
1	individuals not
1	terms, and
4	damage or
1	ownership interest
1	on, through,
1	(f). the
1	(a) occurs
1	ii chemical.
1	(d) knowingly
1	administration.[1] (c)
1	envisioned in
1	no-sunscreen time
1	seq.] (37
6	concerning its
1	repel, or
1	(except that
1	first production
2	creative and
4	cleared product
3	articles to
3	chemicals; and
2	(d) effective
8	may 1,
1	jurisdictionthere is
1	interdiction efforts
1	factors may
4	(a)(ii), and
1	(14) product
2	competence and
1	(d) refunds
1	note); and
2	factors enumerated
1	complete action
1	diligence; (c)
1	477; 

1	section, $15,000,000
1	subparagraph (a)(4)
7	local agencies
1	registration, as
1	mark. (p)
1	identified candidate,
1	21st century
1	pathogens and
1	enhancing tracking
1	section 7625
1	affirmed if
3	holding such
1	2015 through
1	account adequate
2	(and supporting
6	subsection with
1	subsection (g)(2),
2	report; and
1	firm in
1	maximum compensation
1	grant petitions
3	dispensed without
1	fees upon
4	withdrawing conditional
2	ii, gamma
2	reviewed; (ii)
1	programs have
1	strategies; (c)
1	section 981(b)
2	feethe secretary
10	drugs to
1	manufacturer transfers
2	appropriate public
1	hospitals; (d)
1	freedom for
1	(n) schistosomiasis.
1	statement detailing
1	statute, executive
1	supervise an
1	deem necessary,
3	23, 1988,
3	30 years
1	innocent persons.
4	paragraph (3)(c)
1	(kk)priority supplement.
1	drug published.
1	egg, incubator
16	six months
1	techniques, valid
8	irrespective of
2	compounding, processing,
1	plants shall
1	construed in
3	guidelines in
4	review (a)
10	manufacturer, or
1	processed produce
1	requested concerning
1	raise genuine
2	personnel (a)
1	353b. outsourcing
3	contaminant level
1	extent. 
1	product exemption
1	purpose described
1	including, subject
1	(6) whether
2	(7), unless
1	(i) satisfy
1	exist, at
1	nothing shall
2	receiving an
2	467c of
8	quality and
2	committees consisting
2	records demonstrating
6	ecgonine or
1	 (i)agreement
1	discourage persons
1	shortage; (iii)
1	controls available
1	 150.0.
1	delay if
2	purchase, the
1	exists, provided
1	food including
5	standards 
1	(d) engagement
4	delay in
4	times any
1	classifying devices
1	offense, (c)
3	(1)(b), or
1	goats. (k)
1	prohibitionsnone of
1	scoring as
1	(cc) initial
3	international and
3	person; and
8	understood by
1	 (4)[2]
1	hold burning
1	establish conformance
1	
 1191
1	also coordinate
1	scientific, analytical,
11	appropriated such
2	written clearance,
1	heightened inspections
1	350(b)(2) of
3	without naming
1	section 921
1	navigation and
1	drugs, supplemental
1	information exists,
1	(i) five
1	aforementioned health
5	extent consistent
3	samples by
7	qualifying pesticide
1	exceeding $1,000,000
10	360kk of
2	persons shall
1	(d)(3), in
1	safety. (h)
8	amounts as
1	resources is
1	eligible coalitions,
1	resources in
1	(a), except
1	stated the
1	impacts the
1	section 1332(1)
1	critical controls
6	temporary order
14	per diem
1	(1) amountthe
1	manner following,
1	commerce; standard
7	revise such
1	choline (mg)
3	(a) may,
1	budgets support
2	(ii) effect
10	chapter in
1	third copy
1	impleading of
1	findings the
1	1985, on
7	chapter if
3	subsequent years
1	establish policies,
1	25. 
1	animals, (2)
1	producer with
1	any, needed
2	patien-reported outcome
8	present to
13	chapter is
11	secretary not
2	business, or,
3	december of
1	(e) refusing,
1	immunity and
3	waiver, reduction,
1	requests in
2	monitor, or
1	resubmission of
2	paragraph. no
2	exported if
1	substances provider.
13	additive, or
2	requests if
1	513, as
1	effectiveness than
6	approve such
3	shall disclose
1	subpena; proof
1	(3) audit
5	substantial further
2	design, the
3	twenty days
1	
 360bbb3a.
1	appropriation. (6)
2	means inspection
2	recalls, outbreaks
1	379j52. authority
7	program, the
1	certified such
1	appropriate processes
2	guidance. the
2	334(a)(2) of
32	event of
1	(2) disclosure
3	(by methods
1	one agency
7	fees may
1	occurs with
2	printed document
4	request, or
5	seller, or
1	ingredients; authority
2	rico, guam,
1	demand increase
2	event or
1	limitation in
1	chemicals; restrictions
1	changes from
3	tools and
1	adulterated poultry
2	drug test,
1	locationsnot more
1	dtc advertisement),
10	refusal to
9	patients with
1	rules prescribed
1	registered or
1	$500 nor
4	shall evaluate
2	shipper, and
9	covered application
1	distributor (as
1	device based
6	physical examination
2	limitation is
1	treasury, after
4	offsetting collections
2	shall utilize
1	nonmedical products;
1	cost effective
1	marks, labels,
2	senate in
5	minor violations
1	tobacco. (2)
5	assistance for
1	methods, including
1	iii, 539,
1	(3), accredit
2	grants if
6	classified information
2	general fund
2	risk, and
1	(l)[1] agreement
2	grants in
3	shall prescribe)
1	notification ordered
1	one years
1	meetings as
1	
 360ccc2.
1	commerce) in
1	term repackager
2	(c) definitions
1	meetings at
7	(3). 
1	355f(g)], as
1	laboratory animals;
1	jurisdiction directly
4	(b) registration
1	application; minus
1	reconstitution), but
1	pesticides among
3	section relating
8	decision to
3	seq.], may
1	items; 
2	many of
1	consumers within
3	(f), if
9	modify, or
1	methamphetamine that
1	forces within
5	dispensed by
1	substances; (ii)
3	seeks approval
1	331(a) or
1	instead of,
1	(o) postmarket
1	(2) persons
1	(a) record
2	part owner,
2	inconsistency in
1	reilly (533
1	require under
7	4 of
1	made changes
1	states. upon
2	currency to
1	procedure; multiplicity
1	compendium means
1	final rules
1	uses authorized
1	arrestees, probationers,
3	evaluate and
1	(c) should
1	8, 2008.
2	pesticide residues,
2	veterinary, patient,
1	requires one
2	examine, or
1	evaluate any
1	paragraph (4)(a),
1	term repackage,
1	laboratory expertise,
1	flexible manufacturing
1	(h); and
1	use. (v)
1	(g) warning
1	undue hardship
2	maintains, in
1	shall recuse
1	retailing, compounding,
3	administered in
5	prevention or
1	recordin this
1	457. labeling
1	denied admission
2	conditions regarding
1	suppliers; or
1	sample means
16	prevention of
8	apply under
3	standards necessary
1	upon commission
1	675, 803,
1	administrator relies
1	data, inputs,
1	agreements by
1	trade names;
2	inapplicability to
1	seller shall
1	standard review,
1	considered ineligible
2	administrative expenses
1	bring his
1	if, having
1	pilot opportunities
1	animals) adequate
1	device exists,
1	substances tested
1	15-day period
1	(a) until
1	drug. determinations
1	gene or
2	delivery, or
1	843(f) of
1	canned fruit
4	exceed $250,000
2	dangers of
1	vary depending
1	division; (ii)
3	approved june
1	federa-state cooperation
4	year) are
1	health requires
6	applicant. 
1	sell, distribute,
1	proceedings; subpenas
1	within this
3	regarding devices
1	phenylpropanolamine shall
4	(d) health
1	conduct, or
1	2019, $14,100,000;
1	request having
1	agent, intermediary,
18	deleterious substance
13	goals identified
2	drugs subject
10	subparagraphs (b)
1	title, give
1	implementing regulations,
2	may from
1	prejudice an
1	additives) for
1	possible, as
1	contractual rights
6	base fee
1	consolidated internet
3	operations in
1	that, notwithstanding
2	libel or
1	recovery plans
1	labeling, issued
1	age groups.
1	administrator on
1	subsections (b)(2),
3	develop standards
16	entity to
1	establishing for
1	represent any
1	timeframe envisioned
2	money penalty
1	age groups;
1	products beyond
1	benefit. (b)
2	administrator or
1	term opioid
1	ending 
2	makes final
1	(g) 100
70	product that
1	integrated with
1	(c) dispute
4	fees resulting
2	processed, and
1	(2) authorityif
1	serve, the
1	(3) financial
2	district reasonable
1	assurance provided
1	expiration. (g)
1	imports from
1	abuse. the
1	1521 note);
1	entity never
1	number (if
1	(3) reporting
3	circuit. the
8	years, and
1	$50,000 annually.
3	(2) implementation
1	resolution at
3	intended physical
3	(b) food
2	giving him
2	print, imprint,
12	application fee
1	penalty, may
1	
 379a.
1	(c)(1)), the
1	whether final
2	ensure safe
1	limited. 
1	8, code
1	surgery. when
1	employees; (b)
1	(a); (iv)
1	plants; and
2	(b), except
1	fisheries service
1	techniques are
1	new determination
1	coalition grants
4	finds necessary
2	complete a
1	unsafe solely
4	(because, for
2	manner. the
1	counterparts at
3	animal model
4	certification, or
1	203. application
2	limitations (whether
1	complete data
1	foo-producing animal,
25	conditions for
1	manner authorized
4	revision to
1	identify elements
31	designed to
1	almonds, colchicum,
1	chapter, may
1	criminal contempt
2	conditions because
1	report, with
8	compared to
1	mandatory physical
1	same; (f)
2	(1). (ii)
2	proceeding brought
3	work was
3	total supply
2	reasonably supports
5	terminating the
22	substance that
1	rehabilitation efforts
1	order; (iii)
3	drug compounded
1	conviction entered.
1	denominator class
1	regulation)), unless
1	generalon an
1	available (except
16	uses of
2	trial of
4	review an
1	provider receiving
1	9, 38
87	title, or
2	immediate recipients
1	mark. (o)
1	exemption meets
4	drug manufacturer
1	indirectly, as
1	800, 3,
1	sponsor conduct
2	title, of
1	drug. upon
1	chapter; marking
1	devices required
1	reserves needed
1	(4) expiration
2	title, on
1	sunscreens; and
1	(e) had
3	prepare an
2	review as
1	entity provides
2	affects less
3	arrange for
9	management systems
1	508, as
1	guidelines. 
1	1711. authorization
2	(3) exemptions
2	shall on
1	plan, or
1	written decertification
1	generala qualified
1	secretary. if
1	unnecessary electronic
3	section 201(b)
1	anaphylaxis, including
7	valid license
1	diseases, is
2	different animal
3	employees 
1	735, as
15	supported by
1	counterfeit drugs.
2	title from
1	including related
1	prevented; (2)
1	(g) internet
1	relabeler, who
1	2011. (2)
1	section 553(c)
3	nonofficial or
1	343(i), 343(k),
2	clause (ii)(i),
1	based. (d)
1	include transaction
3	diseased poultry,
1	(6) includes
1	available. (i)
1	sales under
2	seq.); (d)
1	675, 744h,
2	commerce. (mar.
1	affecting any
1	facilitate commerce
1	correct. (cc)
1	360j(o) of
5	protocols in
1	remain liable
2	licensure program
1	antimicrobial class,
3	party. 
2	used, transported,
2	(1), whichever
1	includedsuch term
2	orders, decisions,
1	importation without
1	drug risks.
1	sources, including
1	399f. ensuring
28	device, or
15	(if any)
1	research, sales
2	groups as
1	(5) pesticide
1	(b) reauthorization
1	term opium
1	proposed funding
1	basis, delay
3	reckless disregard
1	diseases; (6)
6	subparagraph with
2	validation (including
1	determined) for
1	262(a)]. 
1	felony and
1	consumer, and
1	device, on
1	proposing changes
1	
 343.
1	dialysis solution);
2	promulgating rules
6	amount for
8	year, or
2	identifiable information
1	specific product
1	year, on
1	prescription. (v)
3	contrary, operate
3	evaluations of
4	government, or
1	organization has
1	laws; (c)
1	attorney generalproperty
1	(b) quantitative
1	subparagraph (a)),
1	rots (addled
2	meetings for
2	action instituted
1	committee. (3)
1	section 1701(10)
1	repacker or
4	species, or
1	excipient of
1	determination; appeal
1	(2) frameworknot
13	person whose
2	substitute property
1	product, production
5	paragraph. (2)
1	standards. (c)
1	difficulties in
1	official (or
1	exceptionthe annual
1	support of,
2	labeling prior
1	proceedings should
1	outbreak to
1	section 2672
4	address or
1	taking any
11	determining that
14	data on
9	distributor from
6	accompanying such
29	data or
35	address of
1	parts supplied
2	commission (a)
1	produced primarily
1	subparagraph, that
1	last entry
1	decision, (ii)
2	assessment that
1	funding supports
1	occurs 
1	sufficient safety
1	if, under
1	individual) may
1	raised to
1	article. (n)
1	identificationeach person
1	
 1046.
16	misbranded and
3	quantity in
5	egg that
1	form appropriate
1	manufacturing procedures
1	reanalysis shall
2	years, reevaluate
2	consider information
1	identified hazard
3	it, submit
6	terms in
1	secretary. in
2	alkaloids of
1	title entitled
12	capacity to
19	appropriate, the
23	approved or
1	meat inspected
1	item, the
1	declaring property
2	(c) records
1	30, 1961;
1	gathering data
1	(g) report
6	guidance that
2	panel for
1	fees, based
1	receiving accreditation,
1	applicability; preemption
6	dosage forms
4	repackaging of
4	regulations (as
2	later. (c)
1	omission made
1	(c) come
1	duty) or
1	necessary. (d)
1	(c) afford
1	postdoctoral scientists
1	testing. for
1	section 1232g
1	paragraphs (2)(b)(ii)
1	annual registrationupon
2	information. the
1	birth to
1	current effortsthe
6	fees required
31	dosage form,
3	dosage form.
3	relieve a
1	(a) $500,000
1	1997 (111
2	president submits
1	specific investigational
2	verify a
1	funds expended
2	device premarket
2	consumption by
1	reapplication for
6	entity; or
2	dosage form;
8	conditions prescribed,
1	conveyance makes
1	trade names,
1	program subject
1	years, fined
2	nervous system:
1	section 3109
1	unless deemed
1	states have
2	grant, or
6	efforts by
4	act, or
3	priorities and
1	entered upon
1	storage, processing,
5	residue, the
4	title, such
1	22. barrels
1	(including reasonable
1	quantities measured
2	reserves, the
3	section 881(e)
1	ending the
1	response framework;
1	elements as
2	section 360b(e)(1)(a)
2	iii. (b)
2	impose sentence
1	facility; (j)
1	protest, as
1	current science
1	cite the
1	sponsor authorized
2	(d) section
6	labor and
1	item to
1	funding level
2	trial in
9	public input
2	year. in
1	procedure associated
1	5. repealed.
1	$25,000. sections
2	which, without
1	generaleach regulated
2	substance, except
2	species; and
1	unavoidable. 
1	(c) consider
1	dipipanone. (21)
1	criteria on
4	assistance, and
1	substance. (

2	shipped directly
1	successor to
1	neglects or
1	no-federal funds.
1	plan. (4)
2	no-federal funds,
1	chemical) specified
2	judgment action
1	affirmations may
1	enhancing and
2	include, for
2	trials obtained
1	recordkeeping burdens,
4	effectively regulate
1	publication at
1	older than
12	medical product
6	panel described
1	remove, break,
2	denied by
2	alleging that
4	meeting. 
1	voucher not
7	care economic
1	coordinate food
1	impose, in
3	federal strategy
1	committee (in
1	(s) registration
1	species animal
1	interactions to
1	residues, and
1	25 micrograms
23	provided to
2	june 26,
1	controls needed
2	(ix) a
1	(b) consideration
1	experienced staff
1	review groupswithout
1	year availability
4	clause (b)
1	declaratory or
4	secretary, to
4	located when
1	neonates in
1	reimbursements shall
1	part whenever
2	antifungal drugs;
1	poisonous deleterious
1	activities there
4	262(a) of
1	regulation requirement
3	areas and
1	dosing, formulation,
1	funded on
1	leader with
1	antifungal drugs.
1	choose not
2	term color
1	stat. 769

1	similar establishments
1	industry, including
1	version of
1	2015 (to
3	assessment; and
4	ch. 61,
1	restrictions promulgated
1	youth; (3)
1	except activities
13	power to
1	specify which
8	validation data
3	26, 2002,
1	year 2006;
1	request filed
1	observations previously
1	additional list
5	importers and
1	obtain information
1	on, and
1	distributors regarding
1	otherwise restrict
1	notified otherwise
3	uses any
1	
 191
1	elsewhere, for
1	prospective buyers
1	scientist, who
21	scientific training
5	persons may
1	vendors, suppliers,
1	otherwise authorized.
1	secretarys actions;
1	stakeholders consistent
2	uses and
1	(2) according
1	contracts, and
1	regulation made
1	(4) international
2	technologies. 
1	allows, through
2	forms they
1	including acinetobacter,
7	establishment, or
2	compel the
1	source country
4	section 824(c)
1	food recall
1	(c) meaningful
3	deadly or
6	nuclear agent
6	program the
1	activity persons
1	(a)), shall
2	strength with
8	application does
1	effective any
1	specified on
3	electronic submission
1	commence and
1	scientific feedback
1	848 of
1	official to
1	beyond fiscal
1	section 413
1	organizer, a
1	talk to
2	practitioner described
1	prescribing a
1	becoming ineligible
1	one specified
1	implant. (

2	contravention of
1	2016, shall
11	effective and
4	fee amount
12	modified or
1	title overlaps
1	authorize, with
1	impose standards
1	mental disease,
1	fictitious, revoked,
1	indexed a
14	likelihood that
1	youth development,
11	revision of
1	device fees
2	authorized, in
1	accreditation as
2	representative access
7	treasury may
2	revision or
3	goats, or
1	
 1173.
13	stating that
3	entities in
1	period over
1	675, 415,
2	uses to
1	time spent
1	trial to
1	consumers, and
21	collection and
2	name, the
1	evaluation process
1	guilty to
2	conducting drug
3	reasonable basis
1	settings, such
1	committee during
1	primary jurisdiction.
2	violation before
6	distributed, or
1	analysis that
1	sponsor elects,
1	portion. 
1	products. subject
2	opium, or
1	provided, further,
1	343(r)(5)(b) of
2	concern to
1	term cosmetic
1	subpenas, and
1	additional approval
18	fined not
38	secretary deems
4	nicotine in
12	handling of
3	trials of
1	ensure quality,
1	(a) record,
1	product, using
1	counterfeit product,
3	subsection (l)
2	corporations, partnerships,
2	(1), except
3	countermeasure application.
1	provide public
1	eradication (a)
1	become an
6	office to
1	assessments; (b)
17	held for
1	covered entity
2	919; 

1	thirtieth calendar
1	
 623.
1	(k) take
1	deem necessary.
1	pharmacy compounding
1	eyebrows; to
1	rapid field
3	released for
1	research; (f)
1	proceeding initiated
2	chemical preservatives
1	ensuring access
1	subchapter requiring
1	partisan political
1	veterinary diagnostics,
11	central nervous
1	veterinary diagnostics.
2	complaint. 
1	export presents
8	reports are
2	distributor on
1	(5), an
1	major changesfor
1	824(a) of
2	(a) records
2	qualified safety
2	labeling in
3	upon, a
1	condition as
7	needs for
3	programs administered
2	affirmatively establishes,
1	(ii), information
1	professional labeling
1	fift-six percent
1	measure incorporated
2	pharmacopoeia, official
2	secretary provide
1	(4) amendment
1	foundation activities.
1	(c), amend
2	chemical preservative,
3	inspection (a)
4	requirements, and
2	one time
10	iii of
2	treatment that
1	office; or
1	authorization; (2)
1	activities; (iv)
3	(b) order
1	officers; marking
3	jeopardize the
1	(2) describing
1	list) or
1	limited laboratory
2	used. (2)
1	erosion of
11	limitation the
3	dietary properties
11	responsibilities of
2	briefs. (f)
2	(1) authority
2	360b(d)(1)(e) of
2	authorized department
1	broadest conversion
1	57b] with
1	4365[2] of
3	agreement by
4	facility in
3	grant is
1	registrants who
1	155, 2,
1	i, 24,
1	leishmaniasis. (k)
3	(2) transferability
1	responsibilities or
3	defect; or
1	labeling symbols.
1	packaged articles,
1	appropriations such
3	purchased, or
1	studies should
3	specific initiatives
1	plants. sums
1	term sponsor
2	define their
2	prosecution for
1	cleanup associated
3	drug manufacturer,
1	not; the
1	community service;
2	representation of
2	violating any
1	select one
1	notifications required
1	characteristics means,
1	investigation (that,
27	includes a
1	(3) ieepa
1	title xix
1	additionally, the
1	played, and
2	commission, or
4	container for
1	administrator granting
1	treatment is
4	detailed description
1	reports reports
1	ch. 756,
1	program; (3)
1	ch. 3913,
1	conducting or
3	health, or
1	
 902.
1	paragraph, after
1	potential whenever
2	intended purposes
2	quantities for
1	(and for
1	416, as
1	includes, with
1	drug indexed
1	decline by
10	treatment in
3	scheduling order
2	whose blood
2	certifications of
3	integration of
2	intercenter institutes
1	pathogen means
1	immediately unless
3	diagnose, prevent,
1	address to
1	application and,
1	users who
2	format. 
3	substances of
1	subsection (b)(8).
1	sought under
1	judge, upon
7	drug manufacturers
1	courts and
23	goals and
1	ch. 77,
1	protocol, issue
5	year because
1	livestock shall
3	day when
1	make data
1	section. amounts
2	trade, smuggling,
4	stat. 1237;
1	fees combined,
1	drug. (u)
1	cream when
1	prevention activities.
1	nine members
1	formulation, filling,
1	promptly. (iii)
1	immediately take
1	court deems
1	board representation
7	interest under
1	preparing, injecting,
1	support that
1	food whenever
2	manufactured with
1	witness in
3	respecting all
2	voluntary food
1	section, trial
2	business; examination
2	producing, manufacturing,
1	knowingly uses
1	take, use,
1	device records
4	controlled the
1	purchaser must
1	benefit managers
2	incident to
3	records. 
1	foster collaboration
1	agencys goals
1	(i) promulgate
1	specificity of
1	activities) for
4	laboratory network
1	24. omitted

2	milk act
1	petitioners failure
1	sponsor; response
1	activities. for
1	use involved.
1	infections, teenage
1	(ii) capture
1	authorizationthe attorney
1	stat. 193.)

3	provide other
31	consideration of
1	sampling, storage,
2	public water
1	special data
1	(f) state
1	analysis the
1	registry, acting
3	adverse effects
1	(2) bases
1	signed agreement
1	application complete;
21	average annual
1	base period
1	therefor. after
1	component, or
1	cooperative enforcement
1	renewed at
1	marihuana laws
1	agency centers.
3	continues after
1	(12) no
1	cosmetic; or
1	preliminary finding
1	state a
1	elements will
1	restricted area
1	bearing the
2	internal human
1	reaccreditation request
2	merger or
5	pediatric information
1	iv substances
4	voucher was
3	health official
1	(a) complete
1	(2) places,
3	inspections shall
1	investigational requirement
2	yearly risk
1	immediate and
1	(4) sample
1	(e) penalties
1	implemented before
1	merger of
1	secretaries shall
1	including state
2	successor regulation).
2	available, the
2	family members
1	section 350d(a)(4)1
2	workload adjustmentfor
2	calculation the
3	establish appropriate
1	(a) prepare
4	establishes a
1	seq.] in
1	sample product
15	functions under
1	
 101.
1	large as
2	business is
1	if, pursuant
2	appellant if
1	another, he
3	seizure under
4	quota for
1	contains no
1	sales of,
1	longer necessary
1	promising compounds;
1	acts which
5	generalnotwithstanding any
4	year with
1	transcripts of
1	infrastructure in
3	drugs means
1	exception nothing
16	(ii) such
6	262(a)] for
3	implementation by
1	7th par.,
1	advocate for
1	substance; (ii)
1	title 25.
1	675, 536,
1	populations; authorization
2	administrator pursuant
1	approved november
2	643, or
1	suspension order
1	31, and
1	procedure under
1	sector drug
1	application, was
4	documents, if
2	purchase price
1	deferral, deferral
1	may change,
1	line item
3	topics described
1	defense with
2	form marketed
1	government, the
1	secretary, institute
2	forfeited and
1	differentiated from
2	feasible, possess
2	qualified facilities
1	assistance. (

1	change, in
28	may 
1	hazardous substance
2	division responsible
1	end to
2	(1) articles
2	(c) nothing
18	controlled substance,
14	controlled substance.
1	chemicalsthe attorney
23	transaction information
2	storing in
6	may commence
11	color additives
11	controlled substance;
2	licenses issued
1	sale, to
6	promote the
202	apply to
1	restrictions. (c)
4	ingredients, the
1	distribution problems.
1	enter; scope
3	stone, or
1	(b) agrees
2	additive shall,
8	(e) a
1	(7) steps
1	employed shall
1	complainant. 
3	order entered
1	counterdrug and
1	(g) inapplicability
1	general tobacco
1	datalink or
6	(b) available
3	importers who
1	section 1151
3	15 or
1	functions. (

1	959. possession,
6	required 
1	fee described
1	since february
3	offsetting collectionsfees
1	original is
1	identification showing
27	inconsistent with
3	lyophilized products
1	including monitoring
1	act. (g)
1	part 897
1	per calendar
1	transmit in
1	studies as
1	color additive;
149	controlled substances
1	42. (ee)
12	contact information
1	term disposition,
2	prescribe) 
1	commissioner. (2)
3	shall assign
28	introduced or
3	per cubic
1	and, using
1	research, investigations,
2	adhering dirt
1	item regarding
3	recognition under
1	countermeasur-related technologies
1	section 45
12	adjustment for
1	disposal takes
1	(ii) recognizing
1	conducted); or
1	dispensed narcotic
1	population; (ii)
3	accurate record
1	(4) other
1	affording the
1	delivers for
1	(e) 1
3	section 46
2	evidence 
1	grants, examining
1	methresources.gov. (c)
1	effect, modify,
2	repealing, or
1	intended purpose;
2	technologies and
1	poultry before
4	356 of
1	shall handle
7	times as
1	collection, analysis,
3	database of
1	seal; (8)
1	880. administrative
1	using guidance
2	relate only
11	dispenser may
5	detoxification treatment,
4	expert panel
1	said secretaries
2	property 
1	expand, or
4	processed at
1	presence of,
2	good importer
1	demand; and
1	energy; annual
1	require, (d)
1	high school
2	effectively and
1	(d), one
1	secretary; 
1	(or another
4	(a) application
1	170.3 of
1	(1) refer
1	distribution, procurement,
1	section 971(c)(1)
4	ship or
9	general each
1	antimicrobial drugs;
3	drug action.
1	purchaser, either
5	complete and
1	select, appoint,
596	may be
2	postmarketing studies
1	coalitions representing
1	below, that
1	riskthe term
1	requires successful
1	(qq) the
1	life, facilitate
1	nonsaleable returned
1	(i) late
2	deemed contraband
3	reasons such
1	improvements made
2	either adequate
1	thereto), intended
1	particular product;
2	product components
2	natural or
3	exists to
75	may by
4	comments respecting
2	field and
13	exception for
1	cats, except
1	statements comply
4	subordinate governmental
1	(4); and
1	include statements
1	1970 pursuant
7	determines, based
1	360b, 360c,
2	inspected establishments
1	quality exposure
2	appropriation referred
1	thereto in
5	costs are
1	carrier. 
1	audit (a)
1	findings published
1	limits so
3	limited distribution
2	individuals trafficking
1	damage; and
1	courts exercising
1	statistics, including
1	publication policies
1	nicotine content,
3	pediatric use
1	indirectly derived
31	information concerning
1	decreed, the
1	section 387a1(a)
4	destroyed or
1	written petition
3	section 355(b)(2)
1	dru-free workplace
1	priority status
1	(including all
1	supersedes any
1	campaign. the
1	board a
4	drug (as
1	524, as
2	herbicides to
1	treating a
1	labor in
1	arrives on
1	(required by
6	sale by
1	675, 506a,
8	obtain such
2	contains information,
5	list a
4	active investigation
2	publicly disclosed
61	beginning on
1	nonscientific and
2	subparagraphs (b),
2	suspended 
1	exceed 8
1	milk, when
5	beginning of
22	trading partners
1	transaction without
1	(h) establishing
1	date, on
1	distributes, markets,
1	water which
7	stamp, tag,
1	paragraph (5)(b)(iii),
3	certificate, or
1	manager; (g)
1	pet foods,
1	drug substancesthe
1	(3) waivers,
1	employment without
1	consideration 
1	basis, and
14	propagation, compounding,
1	regulatory affairs,
1	subsequent new
1	marketed, or
1	subsection, nothing
1	contains only
1	exceed 6
1	order available
2	date, or
1	justifiable based
1	restrictions to
1	tampering; (f)
2	jurisdictions as
1	discharge an
1	101. suspension
1	utilize controls
1	per establishment,
1	fines, imprisonment,
2	crop year,
1	facilities) appropriate
1	ii, except
2	container (not
1	cause why
1	expertise clinically
17	veterinary feed
1	specific efficacy
1	formula exempt
1	(b) benefit
1	forfeiture provisions
8	methamphetamine, its
2	up, or
1	risk there
1	growth, development,
1	comments to
1	subchapter b
1	chapter referring
1	veterinarian of
4	(2) within
1	corned, packed,
30	states to
2	food after
1	198c. transferred

3	retail distributors
1	agencies. (2)
1	completes a
4	extensions, and
5	furnish to
2	gift, or
1	(a) requests
1	committee; the
2	world evidence,
1	(iii) request
1	committed after
1	requests fulfilled
1	trained individuals
1	shortage maintained
1	prior offenses;
1	evidence relied
1	voucher if
1	feed. (4)
1	year, with
1	$25,000 if
1	world evidence;
1	register) with
1	international agencies
1	traced, other
1	researcher; (3)
1	675, 505a,
1	conform to,
1	(bb) with
1	defects or
6	imprisonment which
1	regulations. (x)
1	campaign. (b)
4	factors 
1	violate this
1	protocol. (4)
2	seq.], a
1	811(a) of
2	needed in
2	(1) reporting
1	811(f) of
1	second notification
3	containers, and
1	required postapproval
1	tolerance (which
16	(i) has
1	22, formerly
1	paragraph (4)(a)
2	days notice
2	xiii, 1313,
1	trials the
2	plans. 
1	overheated, frozen,
1	process. (e)
2	subsection (b)(1)(c)
6	(g) for
5	stating the
1	complex scientific
1	meeting that
1	denies, or
3	251.)
 

5	manufacturers to
1	class and
1	premature. (ii)
1	(viii) any
12	requirements or
1	controversy, the
2	radiation, and
1	policy relating
1	(2) based
3	commission, and
1	problem; or
1	section 1531(c)
1	request time
1	refers in
2	requirements on
1	dusting powder,
3	petition proposing
1	(d)(1) and
1	government; (iii)
1	professional license,
60	regulations under
305	requirements of
1	title), has
1	secretary. (june
10	and, in
2	package per
1	boards or
1	misleading container
1	148. powers
1	$130,184,348 for
23	and, if
1	engage, for
1	year, following
1	reoffer of
13	boards of
3	publish an
1	(2) deputy
1	issue originated,
2	503b, as
1	index prompt
7	 (i)in
1	authorization. a
1	1, 1986),
1	generic drugs:
1	15, 1994
3	(b) priority
26	involved in
1	section 350c(d)
2	funds of
1	permissible variances
1	component, accessory,
1	package security
7	importer program
13	applies under
2	review applications
2	descriptions of
2	subparagraph (7),
4	generic drugs.
1	title, where
18	involved is
1	applicant, in
1	packaging) and
1	will enter
5	consideration to
1	615 of
1	exempt the
6	secrets and
6	section 360fff(7)
1	(2) exceptions
1	247d6b] sufficient
12	activities that
1	user population,
1	steal anhydrous
1	reasonable term
1	boxed warnings,
1	eligibility requirements
1	entities, for
1	
 853a.
2	inspector means:
50	show that
1	encourage further
1	675, 1004,
1	30 percent.
1	level officials,
2	obligation and
29	upon request
1	sponsorship that
1	term infant
1	approval the
1	exportation. 
1	tobacco, including
1	misbranding all
1	schools program
1	locations doing
2	may assert
95	notify the
21	ensure the
8	fees the
1	drug possessors
1	search warrant.
1	10.30 or
1	search warrant,
1	injuries. (b)
1	placed, the
3	substances. (5)
1	section 360m(a)
1	company. (5)
1	proceed as
3	dispense narcotic
3	therein, and
1	pertinent reviews
1	subsection (a)(5));
1	1038. cooperation
1	list, updated
1	required: 
4	year) multiplied
1	outbreak; (c)
6	submit such
1	especially such
4	relevant and
5	subsection (a)(5)),
13	review such
2	subsection (a)(5)).
4	submission by
1	consideration may
2	council; and
1	1180. transferred

1	person; or
1	term convention
6	rulemaking for
3	hold, and
1	federal property;
1	measures within
3	effects and
1	swimming pool
1	paragraph, distribute
2	information) shall
1	regulation, will
2	search warrants
1	referral (or
1	system. (b)
1	discretionary basis,
1	federal standards,
1	meat is
1	4, formerly
2	acts. (d)
1	written meeting
1	retained by
1	thereof; inspection
2	involved with
1	force; (c)
1	appeared after
1	costs (a)
4	(l) or
2	raw milk
1	contact person
1	priority questions.at
2	citizens and
1	secretary) any
3	(3) determination
1	children that
1	truck, or
1	level or
1	device recommended
1	(l) of
1	species under
1	1054.)
 

1	dietary substance
2	designation if
2	informationa serious
1	serious threat
1	335c. authority
1	(a) lists
1	monographs if
1	processes where
25	deputy director
1	dispensed; or
1	(d) minimal
1	technology means
6	supplement the
1	petition if
4	30, 1940,
3	availability in
3	color additive)
16	according to
1	679a of
1	modifications, if
1	assembles, maintains,
1	wires with
1	(4) renewal
1	issued; and
1	timeframe, under
1	1155. repealed.
4	assistance of
1	damages sustained
1	efforts and
2	entered for
6	(bb) the
1	treasury department
1	2010 unless
1	129a to
1	assistance or
17	institution of
1	part 314,
1	review program
1	recommend such
3	act, shall
1	changes changes
1	processed foodnotwithstanding
1	(1) allowing
1	claims arise
1	hearing, exempt
1	review related
13	employee or
1	undertake or
1	cretinol equivalents.
3	1938 (52
1	product against
1	claimant, seasonably
62	employee of
2	otherwise authorized,
4	party may
2	findings, conducted,
1	swelling the
11	devices under
1	chairman, and
2	section 467c
3	determining, in
1	shown, by
1	statement except
3	practice guidelines
1	comment; (ii)
1	utilize innovative
1	secretarys decision
5	population. 
29	(including a
6	drug being
4	area is
2	product, provide
1	outside entities
1	transfer. (3)
3	activity described
3	including subgroups
1	1544. compensation
1	(3) considerationsin
1	participation. (i)
1	modifications that
1	(c), implement
1	purpose; (3)
6	compliance by
1	corporate policies
2	annually. 
1	capacity with
1	panel as
2	apply, he
5	offense be
1	(bb) 30
1	u.s.c. 1306);
1	definition by
5	(4) with
1	exclusive use
1	necessary. (7)
1	commence upon
20	total revenue
1	seq.] (or,
1	imposing the
1	place department,
1	separability clause
4	either deny
3	(b), shall
1	population pathway
1	u.s.c. 802(33),[1]
1	proceeding pending
2	catfish and
14	state, territory,
2	amount, origin,
1	control, and
1	order, for
2	fee a
1	patients such
1	shall fail
6	timing of
1	trends in,
1	regulations). (g)
1	paragraph (1)(f),
1	standards. (m)
2	shall license
1	(b) exemptionsthe
1	special controls.
1	country achieves
2	special controls,
2	egg handlers,
5	misbranded, and
3	sponsor fees,
3	regulatory review
1	sufficient funds
1	iii, the
11	drug the
1	summary form
2	display, at
2	registration that
1	supersede the
1	disease, compared
1	clinically relevant
40	foodborne illness
1	clonitazene. (12)
2	response by
1	directions, membership,
2	study published
1	existing prohibition
2	statement associated
1	first ordering
1	prevention (to
1	voluntary submissions
1	(b) scientific
1	authorization, and
1	employees, agents,
3	part a
1	assigned, during
3	conducting research
1	timing the
1	fifty thousand,
1	officers shall
2	holding the
1	revocation no
2	witnesses summoned
2	identifying such
1	due care
9	order requiring
4	receives notification
2	filing, shall
12	human food;
1	packing, mea-canning,
1	introducing marijuana,[1]
1	criteria standards;
1	similar illness
1	terrorism; (d)
3	broker or
3	proceeding to
1	applies as
1	dismissal with
2	monetary penalties
1	
 360ii.
1	respond in
1	finding. (b)
1	returning them
2	applicable laws
1	test costs,
1	cooperative that
3	(i) public
1	requests; (4)
1	misrepresentations, may
1	section 25(d)
1	(10) ai-driven
2	tobacco manufacturers
5	thereof, to
2	enhance food
1	(a) determine,
5	logistics providers
1	becomes available.
2	removal is
10	accept the
3	populations, children,
1	may cite
1	defeat restrictions
11	conduct the
1	(b)(2)(a), (b)(2)(b)(i),
2	(2)(a)(vii)(iv) and
3	2017, fees
2	necessary activities
1	discretion, request
1	determinations made
1	forfeiture invalid
3	remedies the
1	designated agent
1	faith any
2	appropriate flexibility
2	issued without
1	(including, in
3	conviction undermines
1	(1) bulk
1	1896 (u.s.c.,
1	(b)(1)(a)(i), priority
1	(including, if
1	also find
4	chemical for
1	families of
2	logistics provider.
1	concluded that
27	(1) of
1	
 959.
2	prescription medications.
1	activities following
1	medical literature,
6	(1) on
1	 (b)standards.
2	energy act
38	(1) or
1	trafficker the
1	sell in
1	comments by
2	misbranded at
1	i, 1,
2	drugs, biological
1	(iii) who
3	offset if
1	contribution no-federal
3	availability of,
3	term device
2	sign, placard,
2	order will
1	defendant may,
1	conduct consultative
1	device complies
1	disabled or
1	(d) after
1	program, as
1	program, at
1	method not
4	practicable, the
20	motion to
1	panel known
1	enough so
2	presenting appropriate
2	(2) upon
2	title; (8)
2	stored in
2	another country
1	classification determination
1	(e) notification;
16	operated by
1	environmental policy
1	personnel matters
1	property, or
3	group are
1	considerations, the
1	machines. (4)
1	particular. (b)
3	appropriate person
1	commit to
1	wherein any
2	delivered into
1	drugs, to
1	onsite pharmacy;
1	used, size,
2	necessary software
2	warranted. 
4	temperature of
1	(ii) request
1	dru-free schools
1	regarding previous
1	vehicle the
7	eighteen years
1	potential, such
2	develop systems
1	potency may
1	regulations), unless
4	website described
4	health; but
1	secretarys representative
1	gaps relating
1	attorney generalthe
1	360eee4. uniform
2	reasonable belief
1	equivalent product
5	gamma hydroxybutyric
1	section 142;
2	business enterprise;
1	262, 3,
2	concerning drugs
1	categorical exclusion
1	resale shall
1	animals 
1	aggregate, without
5	services the
2	state designated
4	person performing
3	disability or
3	1621 et
1	clinical experience
12	issued a
1	offenses punishable
1	61, 3(a),
1	laboratory examination
1	fixed under
3	seeks a
1	675, 911,
1	facility receive
3	health service,
2	authorities to
1	crises and
3	visible and
2	measurement and
1	composition for
1	term ful-time
1	states committed
1	per package,
14	publish such
1	article, unless
1	transporting and
1	(3) prescribe
1	foreign plants
1	requested will
1	certification only
1	veterinary surgery
2	plaintiff 
1	committee are
3	auditor, the
4	chapter applicable
1	affecting access
1	individual, corporation,
5	secretary requires
1	catfish. 
5	purity of
1	603, 604,
1	or[1] chapter
1	permit these
5	70 stat.
2	including production
3	hearing. 
1	time taken
1	natural conditions,
1	study of,
1	(r) standards
2	repackaging or
2	protects an
1	distributed a
1	demonstration has
1	container, stopper,
2	include providing
2	application feethe
1	(k) submitted
1	sciences, which
1	must recite
2	remove a
1	commission established
1	diagnostics. 
1	appropriate), classes
1	importation process,
1	leverage the
24	request the
1	preparedness of
1	paragraph (4)(b),
3	supplying a
1	event trends;
1	(i) certifies
1	country, except
3	deems it
1	reportable amount
5	time specified
1	less. (iv)
1	prescribed as
7	changes that
1	poultry, that
1	opinionsas of
1	teenage pregnancy,
1	apply such
1	including manufacturers
2	governing disclosure
3	term necessary
1	714 et
3	inspection resources
1	statementthe head
1	products compiled
3	seizure or
4	advice to
1	determines supports
1	involves an
1	therein, shall,
1	(b)(2)(b)(i), (b)(2)(b)(iii),
1	(b) poppy
1	involved validates
3	substitute for
1	recommendations 
1	352 (or
2	authorize a
1	capability for
7	stay of
3	ultimate user,
1	part; (iii)
4	standards the
42	paragraph (3)
8	food because
1	however, and
1	ultimate disposition,
1	filing but
3	order subject
3	true copy
4	section 352(o)
3	national and
1	revenue during
1	months, acting
1	co. v.
1	247d6b]). (4)
2	approve drugs
28	drugs. 
4	publishing a
3	recall; and
13	administration salaries
1	general furnishes
2	(a) drugs
10	requirements within
1	order included
1	rare diseases.
1	substances, be
1	protection a
1	(2) possesses
1	manufacturers production
1	rule without
1	coordinating committee
2	safety, or,
7	renovation, and
4	rare diseases;
1	524a, as
1	form) of
1	vaccines, at
5	establishment. 
3	may designate,
1	675, 761,
1	exercising general
1	immediately transmit
1	1008, formerly
1	505d, as
4	local currency
1	favorable benefi-risk
1	incidentally and
1	risks as
4	(iii); 
3	schools and
1	thereunder, all
1	(7) enter
1	potency described
25	offer to
1	(f) forfeiture
3	fee determined
1	substance where
1	previous conviction
1	research. 
1	finances, pricing
8	distributor that
1	serious illnesses
285	case of
4	extent the
1	proposed advertisement
1	countermeasure sponsors
1	requester shall
1	affiliate has
6	health; (2)
1	controlled substancesthe
1	incidence, the
2	shall enforce
1	moved from
1	currently marketed,
2	application used
2	section 1702(d)
2	refused articles
2	(2) records
1	(2)(c), information
3	formula subject
1	general discussion
4	commodity that
3	threat described
1	appropriate staff
2	division why
1	42, does
1	warehouse, consulting
3	action, each
1	(2) possess
1	crop year
3	children of
1	persons affected
1	redeemed, at
2	993
 

3	depletion studies,
1	distribution referred
1	flexible as
8	officer of
4	stop using
1	results; (iii)
33	years and
1	(k) detail
1	known risks
5	ii and
1	provide feedback
1	(3) advance
1	produced substances
1	(2) later
1	(i)ensuring privacy.the
10	risks and
1	references, by
1	scal-appropriate and
1	restrictions specified
2	interest (as
99	officer or
9	term priority
1	procedures act)
1	evaluationthe panel
2	inventory, operations,
2	commerce (as
8	establishment means
1	(h) labeling
1	delivery, sale,
2	introduce testimony.
1	(g), be
1	name entered
1	conduct appropriate
1	paragraph, finds,
1	intramural research;
3	applicability 
1	
 352.
2	engaged, in
1	ongoing concern
1	(d) $129,339,949
1	pharmacologic, or
1	implant. (4)
1	ingredient facilities
1	adjustment (as
1	regarding certifications
1	material issues
1	following verification:
1	medical response.
8	agree to
1	(h) interventions
1	labeling therein.
1	(3) notification
1	institute, such
7	definition for
31	products for
3	defendant or
1	results offer
1	published guidelinesnot
1	1,4butanediol; (ii)
4	laws and
1	structural classes:
1	general. (3)
1	secretary). (3)
1	emphasis on
3	upon notice
47	manufacture of
3	substance, which
2	introduce testimony,
1	patients). (june
1	studying the
3	toxicity or
2	website that
24	manufacture or
2	laws any
7	state means
2	persons on
2	u.s.c. 1421
3	require on
1	market (for
15	thereof, meat
1	excessive loss
2	treatment under
1	markers, the
1	processing, delivering,
1	exclusively from
2	sanctions under
14	funds for
1	(b) informationthe
1	(a)(2), (a)(6),
1	reclassified in
2	purpose an
2	construing or
1	primary authority
1	350g. hazard
1	otherwise the
2	section) no
1	sought with
7	annual rate
2	amount necessary
1	reliable data
1	regulation, revoke
1	propionic anhydride.
2	application (other
1	stat. 477;
1	boobytrap defined
1	food system,
9	request made
1	360a. clinical
3	case, and
1	container, the
1	stat. 820.)

1	particular bacteria,
1	18, entering
1	allowed access
2	food system;
1	days duration,
1	(5) use
1	-(-naphthylmethane)indole by
3	agencies may
2	review (other
1	previously denied
4	states government.
1	entities may
3	food establishments;
1	manufactured the
1	infrastructure among
1	processor in
1	excepted; insecticides
1	shall specify.
2	option to
1	direct written
1	apr. 24,
12	preparation containing
1	to, among
2	accepted professional
16	(7) the
3	terminate such
1	trafficker were
2	arrested has
1	1971, every
1	judgment under
1	(g) banned
1	(d)(1)(c)(i), and
13	submitted a
9	by, or
1	nutritional and
3	(2) identification
1	group basis
1	(iii) directions
1	apply. (10)
15	secretary any
1	knowledge definedfor
2	annual review
2	equivalent. 
5	penalties under
3	processing, and,
6	additive will
1	regulators of
2	request transmitted
1	
 672.
17	labeling changes
2	freezing, packaging,
1	42 to
1	(a) (other
5	approving an
2	(ii) when
1	address at
3	(as those
1	cosmetic product
1	334(a)(2). in
1	islands separated
1	dissemination is
1	databases and
2	possible if
5	weight of
1	outings and
3	food additives
1	proper installation,
1	possible in
1	approval, conditional
4	payment penalty,
2	auditor means
7	thereof, of
1	recur, which
1	to, food
1	another tobacco
3	efficient development
2	bacteria per
9	thereof, or
1	carcasses, etc.,
1	seek designation
1	thereunder), or
11	administration a
2	official senior
1	consult existing
1	$50,000,000 shall
2	recommendation and
1	inspection; overtime
1	(c)(3)(a), and
2	consumers. (

1	(v) marketing
1	eligible partnership;
1	effectiveness information
1	used products;
4	due diligence;
1	regarding methods
22	failure of
2	refund), the
1	extensions for
1	conduct normal
4	take effect,
11	medical convenience
1	sections 247d6,
5	telephone number
1	congress further
1	obtained any
1	retailer to
2	discretion, grant
2	(b) final
1	regarding anticipated
1	1996; and
1	$4,900,000 for
1	relieve an
1	experience relevant
1	facts related
1	(d) carbon
1	obtained and
3	(in any
1	specified therein,
17	food additive,
1	use no
1	prepared; and
10	debarment of
3	cost in
1	conclusions; (b)
1	ferry. (

1	prescriptionwith respect
2	which, he
4	director or
14	maintained under
1	drugs. (14)
1	pharmacy, if
4	ingredient, information
1	compounded product
5	register, for
1	inform national,
1	section 355(b)(5)(b)
1	approvable form
1	september 6,
2	generally. it
1	applicant means
1	commerce, a
1	achieves the
1	waivers granted;
1	requirements: notice
1	not, for
13	shall, as
23	shall, at
1	section 348(f)(2)
1	devices between
1	 (g)[2]
1	4761 of
1	international efforts,
3	research, teaching,
1	points within
2	records shall
2	either house
1	anaphylaxis, if
1	drug. or
1	opt out
1	(jwh398); (xi)
1	ionophore or
3	vitro diagnostic
1	1, 2013
1	1, 2012
1	purity falls
1	perform inspection
1	exists, irrespective
1	contentthe secretary
1	360b(c)(1), 360b(c)(2),
3	last paragraph
1	sponsor, subject
1	inserted into
1	thereof: 
2	acquired in
1	use. (k)
21	products under
1	(ieepa) (50
1	herbs or
8	authorities of
17	right of
1	agricultural import
1	data. (b)
1	pharmacy licensing
1	term specific
8	5 for
2	allergies and
1	leaf is
2	authorities or
3	right or
3	determinations of
1	15. (3)
2	(2) training
1	response regarding
2	diem or
2	determinations on
1	show area
1	findings conducted,
1	terms: could
1	(b)(4)(a); (4)
1	regarding reports
3	director on
2	gross profits
1	advise against
24	days for
1	related categorizations
1	ch. 646,
85	director of
1	(including pharmacies,
1	adhered to
18	facilities, and
1	intrastate commerce
1	333. penalties
1	done or
1	(i) developmental
1	(bb) conducted
1	therefor) orally
6	subtracted from
2	exception this
4	stat. 1103.)

1	(3) transmittal
1	might not
1	voluntary, subsequent
2	(c) within
8	access shall
40	sunscreen active
6	single dose
13	residue that
1	eligibility; and
2	capacity the
1	establishing cooperative
2	personall-identifiable informationnotwithstanding
5	law and
1	pars., 34
1	twice a
1	internet shall
1	42. the
1	8 percent
3	may influence
1	both) a
1	efforts 
1	judicial proceeding,
1	suspend, as
2	food, in
3	approved drug,
1	notification. (3)
2	science, and
1	due process
1	made. as
1	agrees, in
1	advanced product
1	administration (excluding
1	use certification
1	keep, or
2	business defined
1	food, is
53	jurisdiction of
1	administrative remedies.
1	identification to
1	iii, establish
1	delegates or
1	preparation, and
1	campaign or
1	pharmaceutical preparation
1	agent, to
18	may authorize
1	confidential basis;
2	court feels
5	strategy; and
2	food supply.
1	including enhanced
1	content, delivery,
1	federal civilian
1	processing establishment.
14	equivalent positions
1	(3) interim
1	food supply;
1	parties, the
1	original source
8	manner consistent
1	congress may
1	title; but
1	person is,
1	protection, as
1	(a) based
1	level v
5	1984, and
1	section 379j51(4)
1	(iv) identification
1	years, shall
2	general welfare
7	full description
12	food supply
1	387f(e)(2) of
1	(5)(a), a
38	rare pediatric
1	developing foreign
1	diversions. 
1	certain substanceswith
1	cleared use
116	consistent with
3	held such
1	available target
1	services, in
3	(b) annual
1	deletion of
24	invalid or
1	secretary without
2	ready to
1	regulations. for
1	limits 
1	(ii) disagree
1	intent, purposes,
3	150 days
1	established the
1	ultimate purchaser
1	articles known
2	reasonably appropriate
1	penalty whoever
1	thereof containing
1	subsection (g)(2)(c),
1	recommendations, the
1	incentives are
2	receive an
1	systems supported
1	detention, in
1	includedeach report
11	present its
9	auditor or
1	including tracing
1	(i), inclusive,
1	within twenty
1	65 percent
1	schedule, including
12	may assess
1	generaldata and
1	operates external
4	(1) request
82	access to
1	first occurs).
1	sponsor elected
1	defense functions;
1	adequate safeguards,
1	adequate safeguards.
1	343(d), 343(f),
1	registration number,
1	documents, definitions,
16	expiration date
2	felony conviction
1	exempt by
6	committee the
1	(n) coordination
1	establishments hereinbefore
3	(on a
2	(except such
2	violate subsection
1	(a) identity[1]
1	resigns, or
1	sections 102,
2	hearings), promulgates
1	it. (3)
1	person, may
209	violation of
1	(6) build
1	section, means
2	found, to
1	intake of
1	product (other
2	successor committee)
2	food. they
2	title. (h)
1	(b)database.not later
24	shall conduct
1	(ch. 675,
1	orders under
1	(b) policies
2	registration numbers
1	new nutrient
1	hand, except
2	goat, or
1	times that
1	pee-reviewed scientific
1	administrator; 
4	executive schedule
1	existing therapies;
2	consumer perception
1	purity from
3	objections thereto
1	supplies and
1	387a. fda
3	employee shall
1	pediatric diseases.
2	request) made
1	841 of
1	attorneys; and
1	ipecac and
1	2002, and
1	455 to
2	2003 to
1	initiatives to
2	elapsed or
1	observer that
5	period during
1	declaration containing
2	serve a
16	[15 u.s.c.
2	employs, hires,
2	order. in
1	entitled an
1	staggered basis,
1	 choline
2	developing an
1	adjusted each
1	year, whichever
3	grants for
6	programs designed
3	conducts such
3	scheduling of
1	demonstrated capability
1	submitted annually.
1	drug adequate
1	nonvoting representatives.
1	public, and
1	handling, storage,
1	(e) special
1	
 360ee.
2	measures for
1	reinspection means
2	concerns regarding
1	iv, 406,
1	single sales
1	retailer the
1	stat. 1056;
1	used shall
2	otherwise appropriated,
1	labeling conforms
1	$97,722,301 for
1	produced opening
1	contain meat
1	reconstitution). (11)
2	submissions. (f)
1	year drive
1	response, shall
1	conduct investigations
3	subsection (b)(1)(a)(ii),
3	food within
1	faith effort
1	(d)(4), (e)(1),
1	bird processed,
1	grant year,
1	supplier; or
6	prescribed for
3	outweigh its
1	finds materially
1	distribute to
2	require prior
2	may list
1	may warrant
1	c to
1	agreement was
1	grays. (3)
1	organizations 
1	supply in
1	constitutes (i)
4	(l) the
1	748(b)(1) of
1	health posed
1	hospitals that
1	 minimuma
2	consumption patterns
3	businesses; and
1	tank shall
4	diagnosis, monitoring,
1	assumed to
2	issue for
3	plan the
1	substances flows
1	directs prospective
1	register, after
1	1103; 

1	murder; protection
5	2016 and
1	2205. food
1	7. (

1	imminent risk
5	product. if
1	agreement cannot
1	
 887.
1	strategy, and
1	inadequate for
1	act, cancels
1	measures being
1	similarly, all
6	filing a
1	342(a)(1), (2),
1	sells scheduled
1	(14) diampromide.
2	placard, or
1	health under
1	(1)(a) were
1	partnership, does
1	specific nanomaterials
2	method, or
9	preceding fiscal
1	staff work,
1	secretarys review;
5	panel. 
1	situations where
1	expenditure prohibited
1	section 841(b)(1)(a)[1]
1	postmarket modification
1	(a) $693,099,000;
3	trafficker so
2	title a
1	carriage or
1	on, prevention
52	january 4,
1	behalf this
2	purposes hereinbefore
38	including 
1	specialty or
1	animal studies.
3	business, for
1	fourteen percent
16	guidance document
1	consumers, designate
1	deposit all
1	period; he
1	terminate notifications
1	agreements authorized
2	occur after
3	states), or
13	tribal, and
1	individual. (2)
1	direct application
17	permanent allegiance
2	physician to
1	additional establishments
1	purposes. (mar.
1	handling requirements
5	legitimate uses
3	(c) persons
50	title 5
1	identifierswith respect
3	information. if
2	generalbeginning on
5	supplements to
1	offices); and
5	persons registered
1	accredited not
1	objective measurements
2	objectives for
2	(ii) based
1	(2) employ,
1	may expedite
1	capacity as
1	used pursuant
1	clauses (vii),
2	(b) detection
1	data furnished
1	places, take
1	applicants submitting
1	plants. 
1	results, certifications
1	staff from
1	owing to
16	par., 34
2	subsection will
6	2015 and
1	countermeasures; and
1	requests, including
6	part, any
1	evidence that,
1	(or intended
3	immediately upon
1	voluntarily cease
1	human foods
28	dispensing of
1	accepted, and
1	general unless
1	(5) diethyltryptamine.
4	interest regarding
2	assessments and
1	requires pharmacy
1	meeting, regarding
1	claimant or
1	1043; 

3	herb or
2	(1) remains
3	conditioning such
1	states, involving
1	412, as
1	(f) become
1	supplier; (b)
1	achievability the
1	act (public
1	added establishments
1	section 343(r)(1)
3	claimant of
3	which, the
16	ability to
1	terminated. the
1	professional qualifications
1	969. contempt
1	(iii)subsequent applicant.if
1	(d) requests
11	full reports
1	possession, control,
1	prevention, detection,
1	times, upon
1	product expiration
3	national youth
1	secretary promulgates
1	produce or
1	limits; fees
2	inedible articles
4	devices, which
1	(iv) importation
1	1103. repealed.
4	(d) report
3	holder in
2	clinical protocol).
1	activitiesafter making
1	manufactured, manufactured
10	corrective action
1	safety in
3	produce of
1	concerned for
3	section limits
3	warnings, precautions,
13	manufacture, distribution,
2	retail stores,
8	require such
42	construed as
3	originally processed
12	containing new
2	factorsin establishing
2	prosecution violations
2	dispensed upon
1	2008 shall
1	advisory council.
4	351(a)(3) of
2	sales to
3	otherwise to
2	paragraph, no
1	food, taking
1	unbroken and
4	justice and
1	reportif a
1	age declined
1	760, as
3	revokes a
1	productsexcept as
2	title, knowingly
3	facilities, or
1	(4). (june
12	cumulative amount
2	applicant within
2	(b) designation
2	42, or
2	(f)(2) of
4	any, by
1	practice; (c)
7	placed in
21	current good
50	make a
1	746, as
3	i. 
1	salts thereof:
2	article used
1	affiliates, collectively,
1	(e) definitions
1	agencies. (c)
4	fees paid
1	consumers completion
1	farms, including
3	(a)(2) and
3	amounts in
1	immediate precursors
2	include representatives
2	(i) 100
3	entitles the
2	established trade
2	analyzed for
1	plants, or
5	(b) payment;
1	brought. 
1	administer medication
4	applies shall
1	wishing to
1	(1) federal,
1	statistics, studies,
2	therein are
1	vehicle (as
1	commerce, pursuant
1	(1)(a), with
4	provisions regarding
1	employer demonstrates,
1	institutes an
1	cause appropriate
2	patients. the
1	societies to
1	states; (ii)
2	advisory described
1	(c); (ii)
2	advertisement and
3	(6) any
1	piperidine and
12	chapter as
5	chapter at
1	reinspection, and
1	notification during
1	corporation has
11	subsection (b);
1	qualifying physician
1	prescription, the
1	675, 534,
11	office shall
1	final rulemaking,
1	special requirements
8	applicable contractual
2	(2) during
1	defense to
1	recycled rather
1	packing, holding,
47	subsection (b).
64	subsection (b),
1	illustrating the
1	mixture under
1	(7) assessment
1	separately or
1	specific substantive
1	indexed and
1	labeling, registration,
1	different use.
1	(2)(a), whether
8	chemical may
1	feeswhere the
1	appropriation; or
2	animal diseases
1	placement into
1	work assistance;
1	enhancing medical
1	three thousand
5	18 f.r.
1	section 306
1	secretary placing
1	in, reinstatement
3	proceeding shall
14	food additive
1	acquired, imported,
2	certiorari) has
4	will start
1	specified subpopulation)
4	conduct described
2	dru-resistant organisms
3	823(g)(1) of
1	21; july
1	may solicit
1	wipes, to
1	42) shall
2	preclinical trials
1	appoint receivers,
1	consumer notification
1	455. inspection
1	may indirectly
1	(2) compares
2	limitation at
1	(j) factors
1	
 387a1.
1	justice. (5)
2	 (17)
1	675, 573,
3	release and
3	secretary certifies
1	grants as
1	membranes and
1	(b) special
3	grants an
2	prescribing, with
5	paragraph: 
1	exchange programs
1	gross receipts,
2	changed by,
1	principal facts
2	910, as
1	353(d) of
1	specified. the
1	termination this
1	human plasma
1	employ such
1	publicly disseminated.
2	provider does
1	investigations, by
3	policies, goals,
56	included in
1	(5) compensation
1	letters that
1	imprisonment. (4)
1	without pay
1	issued letters
1	(d)(2)(a)(i) and
1	containing one
2	time required
1	demonstrated in
1	species can
3	net assets
1	validated biomarkers,
2	penalty. 
1	holder has
1	assessment or
1	users for
2	360eee(26) of
1	risks, if
1	improve implementation
1	submission. 
1	provisionsnothing in
7	advisory panel
1	(e)(1) of
12	warehouse, or
2	reports each
1	trials; (5)
1	v, the
1	321d. market
1	school includes
1	phenylpropanolamine for
1	occurred only
1	protocol, the
2	section 1604(b)
3	waiver the
1	security features;
3	shall advise
37	sums as
1	(v) pediatric
1	abuse, which,
1	was, prior
3	42. (june
1	department. (june
1	rates under
1	convictions; persons
1	cleared for
1	links between
2	appropriate; or
1	daysthe secretary
1	otherwise carrying
1	food, while
1	
 93.
2	transaction into
21	(ii) to
1	section 360eee(22)
1	(9) civil
1	tool qualified
1	2203. food
3	capacity. 
4	defraying the
1	administered as
1	licensing by
5	administered at
1	fund for
1	atoll, the
1	first inspection
1	time limitations
2	offensea person
2	study submissions,
5	time before
1	presence, by
1	used; (vi)
1	(d) copies
1	sentence. the
1	(b) improve
1	sample pursuant
1	(4) notice
1	analytical methods,
1	protocols agreed
3	deputy inspector,
17	product within
19	may be,
8	may be.
4	may be)
1	formula through
1	patient, or
1	dutiesthe commission
1	authority understands
1	individuals, families,
1	28, the
1	agreement, policy,
6	(2) exception
1	
 16.
4	small business,
5	small business.
4	expedited hearing
2	verification and
1	consortia, seeking
1	least 25
1	establish effective
3	particular device
1	display for
1	federal prosecution
1	president. (

1	(r) postmarket
1	render assistance
1	visibility but
1	paperwork reductionthe
1	(b) elected
2	small business;
2	coerces a
1	(a) definitionsfor
4	operations at
1	duties for
1	262); and
1	new drugs.
1	islands, and
1	new drugs,
1	documentation upon
2	bulk manufacture
1	then, for
2	may direct,
1	financial records)
4	food establishment
1	whether since
1	group. 
2	shipping, or
2	treatment through
1	substantial disruption
1	operation within
3	public sale
1	water pipes;
1	small businessa
4	secretary, not
1	506e, as
9	for, and
1	recipients, recordkeeping,
3	establishments, and
1	worked as
1	analyzed were
34	grams or
1	drug therein,
1	location provided
1	 (d)contents
19	purchase of
2	necessary of
1	387p. preservation
3	health in
1	liquefied, nonliquefied,
1	selecting from
6	safety programs,
1	effective. (4)
1	primary data
4	report containing
2	drug applicationsthe
1	training. (c)
6	entity controls,
4	year notwithstanding
2	property may
2	relief, as
1	months is
1	679b. pasteurization
1	wholesome poultry
1	maintaining adequate
4	meetings in
1	(l) was
8	prosecution of
1	program designed
1	dispensed. 
1	meetings if
1	rationale to
3	preparation, sale,
1	apart from
1	delegated. the
1	2016, $1,984,000
14	named in
1	(i) (including
199	relating to
2	subsection, file
2	method, and
1	noncommercial applications
2	waivers, exceptions,
1	supervising the
1	adverse. 
1	options described
1	dispensingthe requirements
2	containing opium,
3	anticipated dietary
2	regular course
3	inquiries regarding
2	part: (1)
1	(3) within
5	section 360e(b)
1	credible person
1	304, 52
1	(8) carburetor
2	service shall
1	subsections (b)(3)
2	skill of
2	humans posed
1	authorities otherwise
2	expire not
1	(ii) use
1	activities, functions,
2	alleging harm
2	considered. 
1	beings; (c)
2	terminates october
1	
 379i.
1	expires without
3	(plus interest
1	annual objectives
1	following studies,
1	feed. 
4	addictio-forming or
2	heard) shall
1	writing, to
2	section 360e(c)(5)
1	(3) meetings
2	may expend
1	diet, including
1	handicapped individuals,
2	(iii) available
1	direction from
1	comprehensive resources
1	objections have
1	object is
1	1906 (thirt-fourth
2	administration advisory
3	term distribute
5	360b(d) of
1	
 321a.
2	harmful effect,
1	(j) filing
3	legible form
1	officials; (iv)
1	find necessary,
1	year, based
12	drugs approved
1	notice made
1	entered. 
1	compares such
1	defense as
10	carrier or
1	comment. within
1	explain certain
2	concentrate of
1	inspection. (4)
1	iii. in
1	title using
1	laws shall
1	source, and
56	fee under
1	term unexpected
2	funds a
1	localitiesin implementing
1	veterinarian, scientific
21	positron emission
1	moramid-intermediate, -methy--morpholin-1,
2	product standard;
2	utilized by
1	person certifies
1	paragraph[2] shall
1	term saccharin
4	packages shall
2	applies this
1	42; (2)
5	section 201(j)
3	300 milligrams
2	recommendation made
1	image, physical
1	
 841.
1	therefrom, (iii)
1	requested, (iii)
1	necessary, additional
2	facts by
4	additional individuals
1	includes animal
1	aspect is
1	person reoffering
2	drug concentrations
1	facility identified,
11	receive a
1	novel properties
1	$100,000 to
4	state does
2	reasonable opportunity
2	454 of
1	them. (5)
1	381(b) of
3	act for
3	product, shall
1	placed beyond
1	forfeiture in
1	organization under
1	(1) biomaterials
1	\1/3\ of
3	(1) whoever
558	shall not
1	(1) amendment
2	business where
1	disseminated by
1	strategy, transmit
1	devices considered
1	protocols as
1	provide, maintain,
3	exempted, under
1	may appropriately
1	poultry at
2	misbranded food
1	subsection, all
1	detection technology;
1	(g)(2)(c), or
1	year; 
5	title iv
1	records be
1	lactation, infancy,
6	sales in
6	(b), a
1	executive agencies
7	exemption the
4	standards developed
1	(iv) right
1	subsection, this
1	including novel
1	considered special
1	revised labeling
6	thir-party auditor,
1	requirements; small
2	national library
1	form, as
1	detentions, seizures
3	consumer. 
4	limits on
2	records by
1	(32) normethadone.
2	relieved of
1	proof being
1	issuing certification
1	requirementsno person
1	(iii) termination
2	guidances issued
4	applications (including
1	build relationships
1	appearance, the
1	full amount
1	cargo tank,
1	beyond those
2	dispenser; and
2	offer significant
1	act. while
3	approve 
12	(1) not
4	domestic commerce
2	order restitution
4	written notification
1	appropriate scienc-based
1	issued not
1	reasonable questioning,
4	animals or
1	section 897.16
2	transfer after
1	debarred is
1	drug) is
1	appropriate access
1	pesticide be
3	animals of
1	
 377.
1	2011, food
2	areas program
1	verification programs.
1	national biosurveillance
1	instructions; (viii)
2	fide purchaser
3	bottled water
1	(c) best
2	secretaries described
6	bears such
1	updated, recognized
2	subsection (b)(5)
1	case means
1	(e), (i),
1	maintain electronically
4	filed application
4	shall supplement,
1	cryogenic state;
9	compounded in
1	poultry moves
2	notify all
1	fees all
1	paris, november
1	(2) interchangeable
1	committee section
1	separability if
1	consultation initiated
1	forthwith appoint
1	farm or
1	362. misbranded
1	1059, renumbered
1	stat. 21;
4	success in
2	(4) may
1	(cc) signing
2	(g) no
2	indirectly, in
1	rico. (g)
1	diagnostic images;
1	qualified acceptance,
1	courts in
5	additive for
1	gas; or
1	title, when
1	compendium. such
16	declaration of
1	overall sales
1	detailed findings
1	consideration of,
12	inclusion of
1	formerly 360a,
1	u.s.c. 714b(h));
1	nonproprietary name,
1	officers performing
19	374 of
1	(d) denial
3	exceed $125,000
1	(e)(2)(b)(ii), as
2	induce, entice,
1	applicable pilot
1	committing a
1	shall measure
1	provisionif, on
1	trade any
1	administration took
1	instituted shall,
1	penalty, whichever
6	application effective
1	prohibited distribution
2	convictions (a)
1	undergone training
2	chapter requiring
1	users, adult
6	terms as
2	either orally
9	resulting in
2	poses no
1	business records
1	commissioner; and
11	$1,000,000 for
1	harvesting, sorting,
2	section; (d)
1	(v) antibiotic
1	studying and
1	application during
6	commerce means
2	carried out,
4	(a). (3)
5	information any
1	nonreceival for
3	approved risk
1	(e) modifications
2	(b) territorial
1	parts suppliers
1	sections 335a
2	stat. 714

1	plan of
1	action. (5)
47	civil action
2	(ii) relating
1	allergens are
1	file, in
1	trade organizations.
1	lost the
1	channels, by
4	15 business
1	large meat
1	greater. 
1	warrant a
1	renumbered 20
1	certain postfebruary
1	(b), (f),
3	specific to
1	2013, 2014,
2	occurs during
1	secretary (relating
1	eggs, musty
3	inflation under
1	(8) all
2	(2) execute
2	certification made
2	identifier, on
4	federal department
1	
 64.
1	pursuing the
2	suspension shall
3	4-day period
1	enterpriseany person
2	applicable local
4	significant increase
1	activities, which,
2	secretary information
1	medicine, shall
1	(3)(b). for
1	including ethical
1	381(m) of
78	[21 u.s.c.
1	abuse. (5)
1	finding; and
1	ii, unless
1	schoo-sponsored or
3	administration, for
23	requirements set
1	affairs (a)
1	monitoring 2003;
7	carcasses, meat
2	invalidity), the
1	advise him
1	stakes, and
1	specific provision
1	defense available
1	(3) $30,000,000
3	testing involving
1	tested as
1	detailed statistical
1	director certifies
5	safe. the
5	believe may
2	(2) list
2	(as the
1	ingredient does
1	(5) emerging
1	675, 505f,
1	(2) submitted
2	facilities where
1	furnish, or
1	barrier must
1	employment, and
1	genus panax;
1	compacted under
3	august 18,
2	(j), the
1	device. if,
1	cancels the
1	otherwise engage
3	including adverse
1	illnesses; (iii)
1	employees) under
9	present the
1	rehabilitation activities,
1	(4) develops
1	offense. (b)
19	implementing this
1	(1) agree
1	6501 et
1	product per
1	secretary (after
4	disposition. (c)
3	substance use
1	(b) absence,
5	public eating
1	
 1605.
1	(v). a
6	committee who
5	activities conducted
1	another except
1	exist and
1	congress fully
1	supplement health
3	service files
2	transportation; or
5	activities with
1	considers that
1	1171. drug
5	qualified pandemic
2	(ii), include
2	production, transportation,
1	disclosure authorized
13	strength, or
1	sixty days,
3	reduced level
4	1, 2003,
1	drug, biologic,
3	health, provide
1	subchapter, conditionally
1	oil, or
1	toxin act).
3	(c) require
1	commission precluding
1	establishments the
1	penetrate normally
1	262(i)). (c)
7	marked not
5	burdensome requirements
1	subsection, accredit
1	medical considerations
2	mortem and
1	order after
1	abuse not
6	states. (5)
1	(ii) certify
1	safe and,
1	exist under
1	term boobytrap
1	imposed is
3	reinstate such
1	467a et
1	future programs
1	(by negotiation
1	disclose under
2	remedies (a)
1	adds a
3	policy shall
1	under, or
1	blocked as
1	device component
2	new tools,
1	establishments) in
1	1975 and
2	diet by
1	(1) critical
1	subsection differs
1	subsection (a)(2)(a)(viii),
1	period, a
1	practice otherwise
3	(as identified
1	secretary (if
1	cocaine, changes
1	chemical have
2	violation under
1	human use;
1	contracts; employment
1	(3) finding
2	compiled under
1	filling or
1	 to
9	section 142
6	exemptions the
1	issue interim
2	requirements; and
1	may discharge
1	regulation takes
1	defendant furnished
1	communications channels,
1	part; 
2	2656f(d)(2) of
1	manner 
1	(ii) postapproval
1	74, 9,
1	applicable postapproval
7	witnesses and
1	grant such
2	treasury; sales
1	awarding a
1	tolerated by
21	man or
5	treatments for
1	section 1524(b)
1	(c), instances
1	forces), a
1	conference, the
2	equipment, finished
9	clerk of
5	convene a
1	staffing and
1	assess current
1	explanation referred
1	glutethimide. (4)
1	(3) authorizations
2	(b) have
3	insure compliance
1	rico or
1	
 1711.
1	provider, the
1	article, including
1	device. (f)
17	history of
2	policies to
1	presenting to
1	dietarily exposed
1	conduct intended
1	further, that,
1	plant located
1	plants will
1	331(q) of
1	administer drugs,
1	inquiries; power
1	technological characteristics,
1	communication, experts
1	jurisdiction concerning
1	
 1701.
1	whichever the
1	overweight, or
2	subparagraph by
2	years, fift-four
3	food producing
12	another application
1	carrier and
1	information, shall
1	thereto. (i)
1	educate wholesale
1	(2)(c)(i) or
2	processes, controls,
1	device fully
1	director, appointed
1	(j) interim
1	authorized, as
2	diseasethe term
1	preemption (a)
1	claimant for
2	novo classification
1	
 694.
1	repeatedly demonstrated
4	schedule established
1	lamb and
1	(d) cocaine,
1	object to
3	shall such
1	congress beginning
1	liquids, place
1	(5) controlled
1	administration showing
1	sums received
1	public his
3	issue draft
1	trial the
2	fact that
5	reporting system
1	amend and
1	evaluation; or
1	 establishment
1	approval from
1	
 1505a.
16	ownership of
1	information systems
1	animals; (c)
1	conspicuously in
1	section; (iii)
1	109462). (

1	chapter, of
2	experts. 
1	incomplete, false,
4	person, including
1	11, formerly
1	space purchased
87	prescription drug
1	timeliness in
3	ownership or
1	(5); or
8	establishment to
1	terrorism and
1	considered scientifically
1	may respond
1	private treatment
1	(j) for
1	public, 
6	eligible pesticide
3	(iv) retain
1	800, 1,
1	devicea drug
4	required information
1	subsection); and
1	incompetent. 
6	share information
1	-(2,-dimethoxyphenyl)ethanamine (2ch).
1	(3) because
1	foreig-chain distributor),
1	(2) manner
1	acknowledge receipt
1	61 of
4	application, including
1	including relevant
1	scope for
1	
 360bbb5.
1	transmitted in
1	laboratory methods
1	nutrients as
11	receive for
1	basis, perform
1	action and,
2	upon pursuant
1	sale, such
1	may postpone
4	foundation; and
1	(e)(4)(e). (3)
1	transportation records
3	waivers and
1	agreements regarding
4	audit report
1	state; (c)
3	fraud in
5	food are
1	read as
1	section 458
4	facility. (b)
3	application when
99	general shall
1	(b)(1) the
1	regulations) requires
1	diligence be
1	comparable alternative
1	(vi) organizations
1	section 355(p)(1)(a)
1	transshipment and
7	set aside
1	(1) early
2	drugs into
2	portion is
2	origin, and
1	recruitment activitiesthe
7	drug be
1	registered facility.
1	-year maximum
1	pos-natal toxicity
1	1998: 
2	information, related
2	judgment 
12	drug by
1	drug initially
1	persons compensation
1	products. the
1	(2) community
2	testing requirements
1	margarine, and
1	2003 unless
2	prevention programs.
2	purpose within
1	consider designating
2	produced directly
44	subsection (d)
1	fee[1] established
5	360c, 360d,
10	narcotic drugs,
1	individual sale
1	sent to
1	ended, make
1	prevention programs;
9	(8) the
1	letter. such
1	paragraph (s)
2	including on
1	142. milk
1	-(1,-dimethyloctyl--[(1r,3s--hydroxycyclohexyl-phenol (cannabicyclohexanol
5	may not,
1	regarding voluntary
1	detected using
1	sourcing practices
4	determinations 
1	(2)(a). (dd)
1	enhanced prison
1	computer program
1	whenever, in
3	faith and
1	term at
1	made therefor,
2	712, as
1	otherwise for
1	
 360bbb8.
1	
 379j1.
5	health, including
1	products contain
4	secure tracing
1	on-fourth inches,
1	chapter 98
1	interest (a)
1	served 
5	(3) limitation
1	use were
2	research foundations,
1	abuse; (3)
2	format. such
1	reinstatement in,
2	treatment as
2	president finds
3	met. 
10	agreed initial
1	food submitted
6	transcript of
3	appropriate clinical
1	1971, or
1	individual. a
1	(d) definitionsfor
1	356c(c) of
1	(before export)
1	substance, there
1	order denying
1	sanction then
1	(c)(4)(b), provided
5	facility 
1	agent, as
3	mineral, or
3	(c) providing
1	food. (june
1	team by
1	copy; (c)
3	saleable or
4	(1), a
1	$235,000,000. (c)
1	
 601.
2	purchase, sell,
6	included for
3	(e) suspension
1	item constitutes
6	easily accessible
8	articles subject
1	(9) product
2	protects the
1	respectively. (june
1	information) since
1	writing request
1	radiation which
1	days. (iv)
1	item submitted
1	interest. upon
1	word, design,
1	diversity among
1	packaging requirementsno
1	accreditation within
1	505(i) of
1	42), in
1	exportations or
11	added by
1	duplicate requirements.
1	acts, and
1	i(c) and
1	(a) advanced
1	applicable outsourcing
3	offense against
1	testing as
1	1605(c)(3)(b)(ii) of
1	(iii) clinical
2	input of
1	(f), sales
3	$1,000 or
4	amended by
3	toxin, and
18	describing the
4	specific provisions
2	thereafter found
1	(17) return
1	15. (june
1	issue that
1	registration (as
1	directed towards
1	neonates. 
2	secretary, pursuant
1	vehicles, or
1	establishmenta petition
1	summary is
3	community. 
1	(h) written
1	product. (7)
1	regarding cleaning
6	fees, may
1	
 860.
1	years, retained
1	rendering carcasses
1	bioanalytical study
1	resistance, including
5	331(t) of
4	delay is
4	funds the
4	formal changes
1	increases, including
2	training; (2)
1	section 360c(i)
15	make publicly
1	device contains
1	implement, machine,
2	submissions, including
1	stat. 1204;
4	infringement action.
2	orphan drugs
8	section 5703
2	term dispenser
1	council to
1	6, 1896
1	governing interagency
1	states suffering
2	registration (a)
3	enforcing section
1	implead a
1	pending, the
1	exceptional or
1	hospitalization, improve
1	different, information
1	subject whose
1	communication by
1	institutions, practicing
1	election, the
2	branch; (7)
4	section 346a
1	(c) conduct
4	relevance to
1	(2) prescription
9	secretary, including
1	letters under
1	pork, goat
1	district, an
1	seq.]. (

1	young people;
1	
 154.
1	section 379j52(a)(1)
24	public comment
2	organizations shall
1	(b) access
1	(a) kindergartens;
10	substances. 
2	efficiently and
2	secretary, but
2	review means
1	term transfer,
1	schedule, other
13	(1) except
2	workload volume
2	appeals stating
1	practices (cgmps)
1	evaluations; and
2	partnership project
1	(h) shall,
1	manner, upon
1	conditions 
1	agreement, contract,
1	industry; (v)
1	processed. (w)
1	(5) implantthe
1	advertising provided
1	(dd) for
7	obtained from
14	state program
1	ch. 307,
1	official, except
4	strongly suggesting
3	persons so
1	samples. records
1	regulations alleged
1	coordinator concerning
2	liability under
2	process which
1	safety. separate
1	resolution process
1	release described
1	(3) schoolthe
1	regulations. further,
4	deferral extensions,
4	labeled, or
5	appeals taken
1	intermediate, resistant,
1	congress believes
2	(a) controlled
1	service at
1	subsection, maintain
3	inventions developed
1	break, injure,
3	section 801
1	enactment occurs,
1	(b), whenever
2	provided, a
6	weight, measure,
1	publication; priorities
1	knowledge, shall
1	condemnation shall
2	inspection, sanitary,
1	officials concerning
1	permit into
1	first meeting,
1	clearly indicates
6	application not
3	ethical or
5	access the
5	strategy that
1	law, other
1	clause (2)(c)
1	retailers to
1	willfully violates
1	tropical diseasethe
1	(xi) establish
2	persons; and
1	inspections; (4)
1	programthis section
22	establishment and
1	residues; and
2	command operation
7	federal income
3	assessed on
1	(l) construction
1	(2) personnel
1	include and
1	esea definitions
1	350 of
1	worked for,
1	board an
20	obligation of
1	detailed and
1	(i) reasonable
2	market clearance
1	entity providing
1	carryover submissions
10	incurred by
1	applications, supplements,
1	authority, in
1	subparagraph (2))
4	prohibition against
1	agencies, institutions
1	death; (2)
1	(2), debar
2	(i) submit
2	recalls of
3	determination regarding
1	using local
5	any, for
2	appointment to
5	items; united
1	property, any
2	recalls or
19	support a
1	implant who
1	policy. (11)
1	consumption determines
67	director shall
1	sources, as
1	(b) hazards
6	studies in
1	community resources
1	applications withdrawn
2	requirements shall,
2	serve search
1	changes requiring
2	term raw
1	detecting, preventing,
1	adulterated, he
1	tobacco, firearms,
1	warning letter,
1	procedures, as
3	submits an
1	accessible, timely,
2	notice requiring
1	export (and
1	plant cannabis
3	practices, as
1	exist, the
1	379c. transferred

7	facilities or
1	local civil,
1	foundation maintains
1	adequately be
1	law determinative
1	develop new
1	guide to
2	seeking or
2	committee, whichever
1	children, racially
1	will switch
1	(ii), in
1	
 683.
8	facilities of
3	802(41) of
1	factors which,
1	assessmentthe total
3	without authorization,
1	technology comprising
1	immediately investigating
1	safeguard and
1	include types
1	requirements; (e)
1	facilities: 
1	usual product
1	government and/or
16	whose permanent
1	tolerance established
1	2108. annual
1	drugs occurs
1	562, as
1	standards organization
1	named a
15	person commits
1	alleviate a
5	considering such
1	379j1. reauthorization;
1	statement explaining
2	brand manufacturer,
1	interested third
1	additive required
1	owner for
1	general, (2)
1	report, paragraph
2	system, including
2	public disclosures
1	practice (i)
7	person described
1	agricultural program
2	system. (e)
2	trade, and
1	methods. (3)
2	educational loans
1	perpetrator of
1	withdrawn as
1	single inspection.
1	facility when
1	make, prior
1	issue, suspend,
3	marked and
1	required, is
17	term is
5	studies required
5	discontinuance of
2	(1) who
1	formulas are
1	paper book.
2	processes needed
1	imposed penalty,
31	term in
2	(5) limit
1	1049. seizure
1	specifiedfor purposes
1	digitalis, ergot,
2	(and sets
1	term if
1	withdrawn an
1	evaluations or
1	antibiotic under
4	based. 
1	dissent from
1	products exhibit
1	679. application
1	35 stat.
1	america. (c)
1	poisonous compound,
5	public disclosure,
1	 4.5.
1	
 864a.
5	guidance 
2	preceding january
5	different than
1	de novo,
1	(aaa) the
1	report with
1	program with
2	container subject
1	laboratory seizures
1	1010, formerly
1	initiatives, studies,
1	coalition are
1	(1) barbital.
37	taking into
1	reinspections that
1	paragraph fails
3	381 of
1	address; and
45	pensions of
1	behalf an
1	(2) vacancies
2	rights under
1	collaboration with,
2	advanced analysis
1	reference. (e)
1	lawfully in
3	6101 of
3	returns 
1	21st, 22nd
4	sample in
1	(a)(4)(a), or
1	undermined, within
2	purposes for
1	42. a
1	understandable to
1	subsection (a)(1)(d)
1	appropriate specifications
3	transmitted to
4	person within
1	determine appropriate.
5	proposed amendment
2	(i)in general.no
1	wildlife conservation,
1	(ii) prohibit
3	classification. 
1	claimant shall
1	
 392.
2	service may
1	(7) meeting
8	regulation not
6	ecgonine, its
1	stat. 582;
4	packing and
1	facility, identify
1	(c)(1) involved
1	respectively, for
8	officio members
1	area; (d)
1	organization; (iii)
1	(d) disclosure
3	year; (ii)
1	section 387f
1	(i)) prescribed,
138	advisory committee
1	made, such
1	transaction; (h)
1	recalls, warning
4	16, 1950,
2	proper supervision
4	additional information.
1	falsification or
14	3 months
2	(i) identify
2	360i, 360j,
1	captures signatures
3	impracticable, exemptions
1	states; (c)
2	hardship on
1	continuing basis
1	show such
3	condition. a
1	regulations related
1	(jwh122); (x)
17	may use
1	remove foods
1	records; contents
1	charged by
48	concerning the
2	existing device,
1	manufacturing equipment,
1	2008; (12)
1	changes. (c)
1	reviewer once
1	distinguished in
1	retailer means
1	compatible. (5)
1	
 467.
1	providing final
2	standards may
1	72 percent
2	secretary was
1	generic use;
1	675, 710,
11	industry, the
2	subpena of
3	either the
1	subparagraph permitted
1	extend deadline
1	devices once
13	determines, after
1	open meetings
3	national, state,
5	space for
1	no-narcotic drug
2	classification panels
1	states ability
2	division. (2)
5	placed into
2	262(a)] after
3	group; and
1	prohibit its
1	(8) amended
1	requirement promulgated
6	alters or
1	inspection, all
4	reduced exposure
4	individual production
1	744k, as
1	foundation; (viii)
2	add to
1	labeling, marking,
3	eligible entity,
1	regulation standards
3	eligible entity.
1	practice; (2)
1	methamphetamine trafficking
1	otherwise unhatchable.
9	conducting a
1	passed. (mar.
6	secretarys determination
1	conclusion by
1	recommendations, together
2	program; (b)
7	(c) to
36	owner, operator,
8	fee waiver
6	(12) the
3	national of
1	1, 1989.
5	prescribe by
1	spring, stream,
1	qualified employees,
1	ounce or
1	(by order
3	laboratory networks
4	1940, 5
5	trademark, trade
2	witnesses, compel
3	guidance as
1	classification panel;
1	vessels engaged
2	administrator deems
1	(ii) consult
1	traceback and
1	of, drug
1	section 387e
1	among communities,
4	least 10
40	enactment of
2	summarize the
1	(i) his
1	leadership in
1	communities with
2	special audience
1	standards; publication
1	sale which
1	appropriate, differentiate
1	i, 25,
1	premarket approval.a
5	with, the
2	misbranded while
3	renderer, or
2	effective premarket
5	domestically grown
2	primary jurisdiction;
3	program authorized
1	regulations)[1] 
1	summaries under
3	ethers, whenever
1	25 of
4	common ownership
2	v to
1	analyses conducted
1	management, the
1	(for purposes
2	exported in
1	
 859.
2	dirt or
1	(i) expertise
1	no-federal laboratories
47	publish in
1	specific listed
1	shipping through
8	and, as
3	clause shall
5	mean a
2	establish good
7	extent provided
2	and, at
1	administration, invite
5	information has
1	dispenser. the
1	incorporated, shall
1	tried. such
1	purchase scheduled
2	reprocessing be
2	(b) was
1	grants available
1	prohibition a
1	protocol each
2	unobligated carryover
2	(d) limitation
1	(iii) perform
16	unique facility
1	complex or
1	keep the
2	make, use,
1	adopts changes
1	(vii) -penty--(-methoxyphenylacetyl)indole
1	subparagraph (d)(iii)
2	ingredients and
1	consideration. all
1	(4) its
1	acids); (xv)
1	household, except
1	623 of
1	rescissions or
6	registration 
1	sciences in
1	involved as
1	subchapter caused
1	ammonia will
1	order be
5	obtain written
1	involved at
1	exporter from
1	linked in
1	communities, the
1	clauses apply
1	
 862.
2	final promulgation
1	(a) slaughtering
2	clauses (iv),
1	issuing guidance
1	implementation of,
1	office the
1	representing the
2	consulting center
1	injunctions, require
2	considers necessary,
1	involved an
1	expenses necessary
12	order by
1	product characteristics
1	containers approved
1	9, 2012);
2	condensed, evaporated,
1	complementary approaches
3	attendance of
1	drug; 
1	order issuance
57	name and
1	plan by
1	(g) delivery
1	creameries and
4	classified within
2	relations and
1	clinics, for
1	takes to
1	section), recognize
5	eligible countermeasure
1	 (iii)termination
6	primary agency
1	antibiotic, or
1	products handled
1	conventional size
1	state, either
1	public availabilitynot
4	substances control
1	total abstinence
1	dirty egg,
1	sanitary standards
1	written order,
8	action referred
1	repackager, having
1	(5) notwithstanding
1	regulation activities
1	program, or
6	person not
1	make this
1	design, age
2	file this
3	agencies the
1	relevant endpoints,
4	request, provide
1	using susceptibility
1	users; (iii)
1	physician; (2)
2	issues, the
1	154a. special
1	character, ability,
2	(i) statutory
1	bear also
8	committee for
1	expenses, (2)
4	committed to
1	requesting updates
1	whose only
1	media outreach,
1	sale. if
3	directly thereon
1	subjects involved
1	(1) accreditation
1	healthy and
1	1982. of
4	local, territorial,
4	manufactured, distributed,
1	
 188
1	maximize use
1	(iv) includes
3	product no
1	labeling, but
1	(xi) state,
6	shall consider,
9	general finds
1	employees using
1	written orders
2	considered confidential
1	distribution an
2	321(h) of
2	marketing in
1	(ii) higher
1	2014. (june
1	offenses any
24	statement that
1	1976, declared
1	officials, persons
2	(c)(3) for
1	(d) withdrawal
1	343(f), 352(c),
1	modifications under
4	enforcement officer
1	strategies for
1	factors; nonacceptance
5	defendant under
1	(4) development
1	general report
1	procure creative
2	drug; (iii)
1	practitioner registered
1	offenses and
4	obligation to
12	(a) by
1	
 357.
8	(a) be
1	year 1985
1	products, materials,
8	subsection not
1	2009. (4)
1	effectiveness at
1	require coordination
1	capsule, powder,
2	delegate authority
1	(b) jurisdictionthere
1	(2) issue
1	outcomes described
2	amount proposed
1	prescribe tests
8	person resides
2	medicinal ingredients
1	first compliance
5	qualifying federal
1	continuous or
1	trigger responses
3	mentioned in
1	standard without
3	returns processor
7	package for
5	states. (2)
1	public. (4)
1	applications, supplements
6	reinstate the
10	601 et
1	42; (3)
1	label. whenever
1	radio, and
2	country are
1	appropriate. (7)
1	drug. this
45	determination that
1	appropriated fees
1	drug amendments
2	regulation promulgate
88	connection with
12	satisfaction of
1	(mg) 0.5
1	131, 38
2	iv, such
1	food, other
1	allocate such
1	appropriate. reports
4	1988, and
2	addiction medicine,
1	(g) seek
1	level provided
7	scientific equipment,
1	conducting ris-based
6	transportation, and
1	senate, to
1	marketed the
6	1451 et
1	patient to
3	provide recommendations
4	accounts that
1	appropriate models
1	limitationsnotwithstanding subsection
1	substantially the
1	(h) judicial
39	pediatric study
1	exercise due
1	including one
1	(b) drugs
1	recipients (a)
1	plant, bear
1	treatment effects
1	42. (ii)
1	bioequivalency data
1	describe actions
4	annually make
1	considered approved
1	area at
1	weeks after
1	affairs means
1	notice. as
2	carcass, portion
1	pharmaceutical and
1	congress recommendations,
5	thereof) that
4	congress under
2	petitioner has
1	personnelany officer
3	food industry
1	(b) preclinical
1	previous formulation
2	chapter: provided,
1	(c) time
2	tools for
2	beginning fort-eight
1	(c) except
1	section 453
1	accepted under
1	secretary authority
1	(e) anticipated
1	(a) banning
1	officio membership
15	action on
1	law other
1	(a)(3)(b); or
14	general. 
14	action of
1	future study
2	special handling
1	manufacturing, or
3	become aware
1	followed and
1	establishes (a)
2	trust fund
1	nonetheless believes
18	action or
1	persons name,
2	means evidence
1	following fiscal
1	 (a)definition.
2	previous owner
1	identification numbers
1	review deadlines
1	exists an
5	information requested
5	solely on
1	america and
1	provide periodic
2	used responsibly
1	321(n), 343(a),
2	said virus
2	drug substances,
1	solely or
1	records available
1	warrants; (3)
1	exists as
2	affiliated with
1	standards activities
1	illegal gratuities,
1	dosing regimens;
1	emission tomographic
4	improved analytical
1	transport milk
2	sold, used,
2	(1) technical
1	found. no
2	regulations, such
3	data regarding
1	compilations under
1	affiliates, are,
1	strategies designed
1	nonregulated person,
1	observed early
1	dosing regimens,
1	study (including
1	peanuts, and
1	july 15,
3	alter or
3	seq.], or
1	section 554,
1	(including on
3	preparation and
3	customs laws;
3	ordered under
1	manufacturers, packers,
1	subpart clabels
2	methods proposed
1	proof beyond
4	subsequently received,
1	shipment. the
1	persons, and
2	processing requests
1	secretary; contents
1	final rule:
1	product (or
3	(4) knowingly
1	clause (2),
1	section 5316
5	data; and
1	mark than
1	food; (iii)
4	(b) notice
1	evaluate hazards
2	hold, including
1	combating the
2	organic foods
2	use except
2	indian or
1	panax; and
1	subparagraph (3),
6	3551 of
1	exclusion provided
1	means animals
2	(d) adulteration
1	temporarily suspending
1	1949 [50
1	pesticide under
1	(f) correction
2	ingredient, new
4	court may,
2	409, as
1	(i) labeling
1	marketed antimicrobial
1	legal theory,
8	(j) of
2	food contamination;
1	360bbb. expanded
1	basis exists
1	address outstanding
1	format to
1	provided during
2	final. 
1	(b) imports
1	act. upon
14	upon request,
1	(hereafter in
5	upon request.
46	labor, and
2	affidavits submitted
1	1986. 
1	77, 58
1	reflect patient
4	imports of
1	generalthe coalition
2	cancellation of
5	26, 2014.
16	26, 2014,
1	thresholds in
1	section 1037;
1	prominently; and
1	finds based
1	approved. a
1	days have
1	require, pursuant
4	approval, clearance,
1	following indications
1	section 826(h)
2	seafood and
1	notifications described
1	such, and
3	determines by
1	reactivation fee)
10	persons engaged
1	repealing regulations)
1	marketing exclusivity
1	101 et
1	operations; termination
1	5,000 or
21	notification to
1	years, subject
6	licensed veterinarian
4	nominees from
1	prescription compounded
13	individual has
1	service. (aug.
5	accomplish the
1	section only,
4	minimum of
2	october 15,
1	action. an
3	action within
1	must have
40	generalthe secretary
1	federal statutes
1	public under
1	(4)(b) by
1	minimum specified
2	inordinate amounts
1	taken ownership
1	dismissthe court
1	general. (c)
1	bribe, has
2	infringed 
1	basis with
1	leins[1] 
1	except (1)
1	(6) limitationno
1	nonapplication of
1	area that
1	warnings nothing
1	procedures which
1	paragraph (2)(a)(vii):
3	applicable user
1	receive milk
1	summary review.
5	505 of
1	cream and
4	act so
1	forms on
1	issued demonstrates
3	practices; and
3	product thereof,
1	appropriate ris-based
1	imported foods,
1	506f, as
1	described on
11	submission under
1	subgroups. 
1	360eee(9)(a) of
1	permit said
1	significant new
1	reasonable timeframe.
1	reasonable timeframe,
1	epidemiological tools
1	acetic anhydride.
1	poultry, unless
1	summary reviews
2	packages of
1	drug prevention.
16	years or
2	district under
1	register, the
1	substance. (2)
1	power granted
1	(j)(5)(f)(ii), if
1	local community
3	first prior
6	lot number
5	packages or
1	practicable, to
1	existing agency
3	provisions that
1	delayed; and
2	warehouseman storing
3	quantity sold,
12	adequate information
1	(ii) requirement
1	therein for
1	another age
1	drugs obtained
2	341, or
1	(3), such
1	956. exemption
1	collected data,
1	packaged egg
1	identifier established
3	nonthreshold effect
1	every part
3	include recommendations
1	limited receipt
23	may issue
1	claims, except
1	fruits that
2	thereof, slaughtered
2	section 3(a)(1)(b)
1	lon-term assessment
2	confidence in
5	prescription order
1	bonds; court
1	disclosing the
2	event, however,
1	security, heads
1	location for
1	include separate
1	biological products;
2	known in
1	135 days
6	violation was
4	reasonable fees
3	establishment any
1	675, 304,
1	advantages over
1	sensitivities of
12	food manufactured,
1	device, (6)
3	international agreement
1	1.6 percent
5	biological products,
1	section 360e(e)
1	 (35)
1	effectively to
2	cause an
1	generalin issuing
1	proposals issued
1	receives training
1	350f(j), 350e,
6	adjustments provided
35	(e) the
1	(a) classification
2	adequate state
4	(iv) terminating
2	probation; parole
1	period prior
1	$3,200 
33	18 months
1	1994 through
1	paragraph[1] (1)(b)
1	condition imposed
2	obtain an
24	applied to
1	integral part
1	timely communication
1	research carried
7	initiation of
8	registration or
1	ink. (mar.
1	attorney 
1	marketing research
1	yearly or
2	health than
2	substancesthe congress
4	[25 u.s.c.
1	forges, counterfeits,
1	reportingbeginning 1
2	clinical hold)
1	actionsthe actions
1	compares in
1	renders them
30	registration of
1	term surrogate
1	patient functions;
1	provided, caused
2	organizational unit
4	shall modify
11	drugs; and
1	section may,
2	contains not
1	title. (r)
1	(c)(1)(c). 
1	datethe biosimilar
7	product manufacturers
1	professional care
1	official monographs
1	moved to
1	permi-holding establishments
2	inspection regulations,
1	displayed by
3	secretary; (2)
1	substantial assistance
18	section 360ccc
1	(l) authorization
1	(v) and
6	agriculture shall
1	registrant shall
1	subsection from
7	making of
1	meetingthe secretary
1	summary shall,
4	coalition mentoring
16	fee that
1	vitamin b1,
1	operation; (iii)
1	place. (c)
2	subsection (n).
1	subsection (n),
9	reports required
1	chemical, unless
1	daily quantities
4	major portion
1	individual makes
1	products; (4)
1	(2) unapproved
17	able to
1	vitamins and
2	theretofore been
1	(iii) experience
1	knowledge, including
10	carcasses and
1	affirming the
2	policy that
4	based the
1	disposable wet
1	for, a
1	recommendations determined
2	determined, or
3	control (a)
6	leaves, except
2	make disclosures
4	egg products.
1	(a) health
3	(k) that
1	heroin. (j)
4	262(a)(2)(e) of
1	stating his
1	secretarys findings.
1	vessel, or
1	(b) paragraph
1	brand of
1	(e) small
3	system; (ii)
2	(b) (or
1	determined practicable
1	persist in
1	insurance companies
1	gas from
1	traffickers pursuant
1	inference as
1	generalthe requirements
1	preventative controls,
6	chapter. (b)
4	title); and
1	establish collaborations
1	publicly post
1	section, transaction
1	plans; and
1	position is
1	4 or
1	interagency activities
1	(c)(2)(a), would
50	require the
1	chemical, preservative,
3	(2) notwithstanding
1	 (c)coordination.
1	regulationsthe secretary
3	component or
1	expenditure in
1	constitution. (2)
3	add a
2	expand or
1	paragraph (12),
1	(c) prohibited
1	approvedthe sponsor
1	application, except
1	numbers, names,
1	rehabilitation, research,
1	
 1548.
2	produce records,
2	application prior
3	offer or
1	order prescribing
1	survey data,
1	content and
1	commercial distribution,
1	301(b) of
2	343(y) of
1	order performed
2	wholesale distributors
1	ten days
9	exceed $1,000,000
1	advertisement into
2	extent possible,
1	preserving human
1	whoever, with
1	industry. members
3	(2) state
1	drugs (hereinafter
1	(e) no-timely
1	rescinds or
2	title, there
1	water standards;
2	331(a) of
1	ordering the
1	officials. (c)
1	interruptions in
19	addition to,
2	(ii) show
1	(or combination
2	distribute, and
1	incorporation. 
2	wholesale distributor.
1	entities participating
23	wholesale distributor,
3	ingredient for
1	(or documentation
2	naturally, may
2	repackager to
1	overall drug
1	209. poisons;
1	following its
1	punishable (1)
5	wholesale distributor;
6	miles of
1	ch. 251,
1	675, 806,
1	located, to
2	nonprescription active
1	local distribution,
1	concurs in
1	large quantity
2	manner prescribed
1	animals intended
1	secretary marked
1	exemption revoked,
4	resumption, the
1	take evidence,
2	section 355(o),
1	744a, as
1	drug related,
1	chapter; 
1	advisory to
1	chapter. an
1	affecting pesticide
1	jurisdictional authority
2	infringement to
1	41 stat.
1	list are,
3	savings clause
1	files referenced
3	part. (b)
1	blindness., and
1	(b) paymentexcept
1	(1) evaluations
1	products interstate
1	product because
1	administer performance
1	section 957(b)(2)
1	675, 517a,
11	manufacturing practices
1	interest, by
1	international land
1	submission. (2)
1	(a) otherwise
1	pack, transport,
17	examination and
3	data which
2	abuse issues
1	scheduling such
1	poultry during
9	written consent
1	revocation, which
1	generaloutsourcing facilities
1	repeal or
1	timetables; periodic
2	document each
1	(a)(i). (c)
1	dihydromorphine. (9)
1	(1) inspection
2	moneys, negotiable
1	jurisdiction, shall
1	drug (with
1	alert the
1	need only
1	proceeding. (june
1	application) for
7	export the
2	deemed misbranded
1	procedures regulations
1	bacitracin, or
2	maximum residue
1	avert such
1	(v) exports
1	susceptible, intermediate,
3	evidence contained
1	paragraphs (8),
16	(2) such
3	charge reasonable
1	violated by
1	advertisement upon
1	appointed and
3	needs, including
1	18; and
1	effect); (ii)
11	secretary, that
3	pay to
1	then, unless
1	amount; equitable
1	tests the
4	manufacturing practice,
2	made exclusively
7	issuing an
23	year and
1	manufacturing practice)
1	laws. (

2	risk. 
1	useit is
1	growing extent
1	2, 65
1	prescribe medical
2	shortages. 
1	notify state
2	2, 68
1	retrievable and
1	carbolic acid,
1	vitamins: a
1	critical need
1	appoint the
1	sentence had
1	(b). (june
1	incompatible, such
1	chapter, after
12	provide information
2	writing with
1	producer on
1	require submission
1	member positions
1	
 955.
9	security act
2	administrator and
13	may modify
3	protocol to
1	requested, commanded,
1	147. repeal
1	information, upon
1	unduly complex
1	certain abbreviated
1	patients (referred
1	1131 to
1	plus web
1	aforesaid any
1	traditional approval
1	district concerned.
1	actionsno action
1	clearly identifying
1	e to
1	retention plan
1	names, inspection
42	ch. 2907,
2	members may
2	title 35,
4	organized under
1	ingredients becomes
1	abuses of
3	label that
1	notification constitutes
2	time its
6	802 of
2	title 35;
3	trials used
1	generally found
7	practitioner to
1	man which
1	programs. for
1	presented pursuant
1	study have
1	(b) recruitment
1	industry, with
9	be, and
2	committee action
3	national intelligence,
3	citizen or
1	standards whenever
1	observational studies,
1	
 221
5	purchased the
1	catalyst for
1	5. information
1	precipitate a
7	enforcement task
2	documents issued
1	information showing
3	rendered under
1	(iii) notice
2	decisions 
4	360b, or
5	grounds that
2	improve such
1	section 379aa(a)(2)
2	adjustments to
1	disease may
2	day following
1	both, when
2	crop insurance
1	cosmetics. 
4	order are
2	subsection. except
1	price support
4	(f) for
2	developed plans
1	no-amenable species
5	gravity of
1	822a. prescription
1	individuals than
1	purpose is
1	notifications, and
1	fee resources
2	foreign region,
1	sold and
1	1937; or
1	agreements. 
3	single official
3	subpopulations, including
1	milk of
2	case that
1	nation. (2)
1	reasons established
1	prevents subsequent
1	advertising. for
1	consideredin removing
1	commission for
1	distributor requirements
1	generalthe assessments
18	usual course
11	regulated seller
5	intramural research
1	(2) clarification
1	public. (

1	sanctioning welfare
2	general, may
1	fees needed
3	participates in
1	body means
2	(c) new
2	kilogram of
1	
 355g.
223	controlled substance
1	alone, has
8	procedures as
1	procedures at
1	expected design
1	foundation funds
1	indicate whether
6	product approved
1	cigarettes on
1	(y) any
3	obtained, and
1	expected changes
1	(i) only
1	561, as
2	drugs containing
1	convicted 
1	seafood safety
1	regulation established
4	comprehensive and
1	regulations. (h)
5	small businesses;
1	
 379dd2.
2	(g) suspension
1	administration certificate
3	major identifiable
1	(a) labeling
1	device which,
1	experts; (g)
1	telemedicine 
1	(d) investigations
1	matter affecting
7	packed in
1	develop more
1	ii. (10)
2	exported drug
2	361 of
2	effective by
1	referralthe secretary
2	submitting to
2	packaged for
7	including i-kind
1	federal, or
1	different margin
1	adequately protect
1	lines; and
1	application. (i)
2	state, if
3	establishment; (ii)
1	codes on
3	three years.
3	businesses 
1	prevention regarding
5	divided by
1	fills notwithstanding
3	affected applicant
3	recovered from
1	whose authority
1	(b)(iii) should
1	no-implant applications;
2	made. if
1	(2) enforcement
1	placing in
1	spoken by
1	enforce an
1	serious risks;
2	(iii) publish
2	property with
2	variances 
3	waivers, reductions,
1	activity pursuant
2	dislocation of,
4	partnership or
1	made. it
3	tribe (as
2	partnership the
3	record to
1	containing animal
1	analyze, and
2	control is
1	552(a) of
1	continuing in
2	(1) application
1	account (1)
1	drugs, manufacturing
2	state public
1	measures, as
1	impair effectuating
1	(and of
1	violat ion
1	staffing levels
1	package (a)
1	products falsely
2	carriers or
3	humans; and
1	authorized (a)
2	shipper, carrier
1	factorthe term
1	(a) requirementsno
15	device. 
3	manufacturer, wholesale
1	investigation, regulate,
1	regulate radioactive
3	(1), which
5	substantial number
4	entities meet
1	involved. such
2	paragraphs (1)(a)
1	indicating whether
1	specific accounting
1	otherwise appropriate.
1	sel-certifications provided
1	variance requested
27	component parts
2	otherwise negotiating
1	standard memorandum
1	holder within
1	cows producing
3	device manufacturing
1	systems, as
1	675, 731,
1	transaction information.
1	artificial coloring
1	10.45(d) of
1	inventory; and
1	order thereunder
12	probability that
3	kitchen facility
1	section 352(r)
1	wholesaler does
2	support approval,
3	460 of
1	(d) analysis
1	282(j)(1) of
7	programs in
12	system under
1	offense 
1	also appears
4	1 kilogram
1	training. (ix)
1	products upon
1	agent), deliberately
7	receipts or
1	implant procedures.
1	support thereof,
1	servant authorized
1	reveal (other
5	(2) every
1	sections 952(a)
3	review groups
8	medical information
1	applicant resides
1	interests, and
1	sociocultural contexts;
1	1954 [42
1	need therefor,
1	age, other
2	person using
2	stated goals
1	section 829(e)
2	(b) periodically
11	pediatric therapeutics
4	unfit to
3	proposed plan
1	101); (c)
1	tobacco growers.
1	(b) reductions
1	inspection standards
1	33 percent
4	area served
1	(aa) unresolved
1	charges his
1	(bb) subject
1	sexual conduct;
1	appropriate handling
1	(2) model
3	one which
6	unless otherwise
3	media buying
1	provide lot
1	95 percent
1	distributions by
3	administrator means
3	electronic communications,
3	packaged food
1	drug cannot
1	operated wholesale
2	engages such
6	reports shall
7	audit agents
1	secretary. within
2	(excluding amounts
1	source plasma,
5	that, under
1	application. (june
1	vessel carrying
1	profit from,
1	822.)
 

1	patients name
1	b12 (g)
1	alternatively, in
1	banned for
1	enhancing law
1	chemicalsany person
1	postapproval study,
1	improve effective
1	black, white,
1	inform himself
2	proposed or
1	applies; (b)
1	
 812.
2	adulterated such
1	(c)(1) may
1	$7,000,000 is
2	authorities; and
2	conveying 
1	collected through
1	activity level,
1	term preventive
5	(i) was
1	intentional; (b)
1	sale, colored
4	awarding grants
1	include tobacco
1	42, imaging
2	secretary whether
1	delivered, distributed,
1	order shall,
1	intelligence operation,
1	1996, with
1	order, except
1	exporter first
19	modify or
1	increase capacity
1	actions which
2	auditthe term
1	warranted, adopt
1	advertisements respond
1	upon study
1	circumstances change
2	title applies
8	regulate the
15	residues in
1	may undermine
1	user means
1	dangerous drugs,
1	major programs
1	approved, including
1	places at
1	(2) responsibilities
3	prevention programs
1	first two
1	(13) $119,000,000
1	regulations except
1	signature. (bb)
1	subparagraph (a)(iii)(x),
5	exclusive jurisdiction
1	amphetamine. (2)
1	habitual use,
1	therewith. (

1	(a), subparagraph
2	880 or
3	(e) monitoring
1	products across,
6	(1). (c)
1	personnel, research,
2	considers necessary
1	391. separability
2	performed in
1	studies, reports,
6	exist to
1	transportation means
1	(3) evaluationthe
1	rulewhenever the
2	years, respectively;
1	unwholesome, mislabeled,
1	(a) purposethe
1	suspended listing
1	198; amended
1	suspended, probation
1	fee account.
1	distributor, through
1	extent, an
2	use, including
1	destroy pathogens)
1	(ii) exceeding
1	(xvi) the
1	public morals,
4	criteria as
3	outbreak of
1	includes guns,
2	review, if
1	discretion whenever
1	both; (c)
5	safe as
8	otherwise made
1	(f) investigational
2	clinical study
1	intelligence committees
1	residues are
1	bitter almonds,
1	habitual user
1	contents; patent
1	package the
1	shortagesnot later
2	modifications are
1	require testing
1	quantities exported;
1	1051. other
2	area are
3	(ii) appropriate
1	determination. (b)
1	years. (b)
6	reducing the
3	sciences, and
1	reports accident
1	(1) arrange
1	bank provided
2	distributor in
3	deemed the
1	wholesome meat
3	activities (including
2	superseding the
1	foodnot later
1	another company.
1	310, formerly
1	secretary; judicial
1	section 372(a)
1	(f); (ii)
2	preventive strategies
1	title:1 
1	site address
8	distributor is
1	little is
1	conspicuously bears
1	poisons, except
1	indirectly, the
1	methods. (b)
1	18. (c)
1	provision nothing
3	subchapter vii.
2	specific threat
1	testimony, and
2	documents. the
1	term interpretive
1	channels by
3	inquiry necessary
1	agents for
3	research into
14	reserve fee
2	regulation (a)
6	libel of
1	section 1048
2	diligence and
1	may update
1	written notice,
5	exclusive distributor
2	measures needed
2	hashish, or
7	investigation or
1	dispenses product
1	private groups
3	physician has
1	research applications;
1	shall deposit
1	administrator requires
1	concentrations of
2	communication information
1	registrationupon electing
1	section 1044
1	use is,
15	transaction history
26	investigation of
1	sell raw
4	conclusive unless
4	(2) all
2	adequate tests
1	sustained use
1	poultry; and
1	1173. transferred
1	hypoxia. (ii)
1	thereof. (kk)priority
2	(a)(1). such
2	commerce immediately
4	subsection (b)(2)(a)
1	stay any
1	trial record
3	care entity,
1	agreements beginning
3	nutrients required
6	prescribe, exempt
1	131. repealed.
1	certificate for
1	disorders, by
2	recommendations, underlying
1	patient named
1	(b) powers
1	satisfied, except
1	care entity;
1	institute shall
2	fair market
47	health, education,
36	use the
2	employees but
3	plans described
13	task force
1	5to affirm
3	food (a)
3	report was
1	equivalents. 
1	outreach. 
1	30, 1972;
1	registrant plans
1	additional tenfold
1	secretary, any
1	person fully
1	corporation in
16	secretary, and
1	international emergency
4	project described
1	epidemic products,
1	(e) chemical,
1	device submissions
1	requirementeach tobacco
1	30, 1972,
1	office is
1	practitioner in
17	animal feeds
1	grant at
1	45(b)] respecting
3	compound a
15	nonnarcotic controlled
6	petition with
1	funded, except
11	preparation which
20	drug submission
2	mitigate such
2	conspicuously display,
1	1007. repealed.
1	milk being
1	determines whether
1	recommended in
1	promptly issue
5	office in
6	50 percent
2	grant an
1	(c) timelines
1	360i(a) of
1	commissioner first
1	methods. (6)
3	withdrawing or
1	(b) responsibilitiesthe
4	fell below
1	effectiveness, and
1	petitioners statement
1	360i(a) or
1	operation 
12	(ii) with
1	355(b)(2), or
4	poultry items
1	exceed $10,000
2	provide access
1	date was
1	administrator, specifying
1	foreign relations
2	knowledgeable about
1	356. expedited
8	rely on
1	897.16 to
1	age groups,
1	address receipt,
1	fees; conformity
1	coloring shall
1	shown[1] to
1	educational agency;
1	270 calendar
2	shall cover
1	congressthe location
1	data includes
11	applicant under
1	abuse seriously
1	audit agent;
1	educational agency,
1	comprehend the
7	advisory committees,
12	animal feed,
2	sections 360,
2	animal feed.
2	person during
5	causes to
1	designated gas
1	(iii) set
1	toxicological and
1	including antimicrobials
4	board under
2	methodology used
1	skin of
1	
 360c1.
1	deadline, whichever
1	evaluating a
1	(34) phenadoxone.
1	policy, such
1	individual high
28	administrator of
9	plan no.
1	blister packs
1	unlawful acts;
2	(c) information
3	(iv), the
1	declaration; or
1	process; and
1	provide prompt
2	formally affiliated
1	(a) criminal
1	indicated or
1	relevant risk
14	personnel compensation
2	that, by
4	writing. 
1	rates, the
2	certifications by
2	unit shall
1	plant, such
1	including renewal
1	iv shall,
1	foodsubsection (a)
1	term leaker
1	food (including
1	2,500 feet
1	unsafe with
1	foods, the
1	dies, plates,
1	states, respectively,
1	employees federal
3	plan not
5	food specified
28	manufactured, processed,
1	testimony. the
1	appeal using
1	505e(g) of
7	susceptibility testing
1	except insofar
2	format developed
2	investigation relating
5	isomers; or
2	counterclaim described
5	intending to
1	misrepresentations in
1	published. (f)
1	paragraph occurring
1	drug refused
1	passed all
1	interested professional,
1	identified legislative
1	acts on
1	items) of
1	(i) incorporate
1	exceed $10,000.
1	submission within
2	debarment. 
1	402, 403,
4	processor or
2	(2) requirementsto
1	pay fees.
1	area); (c)
2	pay fees,
1	nominees provided
4	involved has
1	terminates the
2	credentials, as
2	use unobligated
1	track product.)
14	fee paid
1	enforcement administration)
3	section 381
1	patients concerning
1	secretarys rationale
2	animal drugs;
2	matters from
13	distribution, and
1	(a) promulgation
37	record of
4	defray increases
10	section an
1	model plansin
1	federal service,
1	262(a)]. (b)
1	vacancy shall
1	therefor, either
1	verification, inference,
1	orange, clove,
3	substance not
1	may license
1	developed, studied,
2	financial officer
1	(ii)(iii). (c)
1	complete, ready,
1	commodities if
1	specific determination
1	secretary grants,
1	another name
1	352(d) or
1	issues final
1	provide final
2	applicant or,
1	governmental and
3	order because
37	shall review
1	transmission through
1	(5) diphenoxylate.
1	sentence. (b)
1	drug experience.
6	limited to,
1	federal licenses
2	extended for
2	physicians prescriptions,
1	(10) because
1	paragraph (2)(b)(i)(i)
1	appropriate community
1	suggested or
1	drug experience,
1	approval supplements.
1	salable drug
1	amended; 7
2	(bb) at
1	application submits
1	annual accounting
2	form strictly
1	ii. (b)
3	analytical reports
3	way derogate
1	(c) assessing
2	rigor and
1	situated persons.
2	280 grams
1	adulteration within
1	institutions; (i)
1	675, 504,
1	(j) applicability
10	withdraw approval
1	exemption. (n)
1	shade containing
1	effective) revoking
2	determines no
5	store or
1	modified during
2	condition. (d)
6	(d) publish
1	(iii) intended
1	only, a
1	every prescription
9	application; and
1	terms described
3	numerical identifier.
1	(4) substantial
1	paragraph (2)(d).
1	consumers, users,
1	paragraph (2)(d),
1	site for
1	requirements found
1	(2) which,
1	exemptionsthe term
1	particular area,
1	813. treatment
1	established distribution,
1	(b) similar
1	department in
1	paragraph (1)(a)(ii),
1	timeframe applicable
1	(d) reactivation
1	(b) project
1	drugs, are
1	streamlined premarket
13	application means
1	year 2011.
3	(vii) the
1	family[1] smoking
5	agency has
15	without a
2	delegation the
1	(ii) limitationsfor
1	268, 42
1	oppose any
3	ingredients 
14	postmarket surveillance
1	(2)(a), or
1	
 379j12.
2	organisms in
1	available; (b)
2	accomplished; (2)
1	statutory constructionnothing
4	data 
1	(4)(b)(iii)(i) of
1	
 350f.
1	dissemination and,
1	mult-faceted systems
1	registrant involved
1	shortage, including
1	
 360eee.
1	research; import
1	control notices
9	shall thereafter
1	investment, and
1	resolved, recommendations
3	plans, assessments,
1	5 units
1	overall purposes
1	patients, either
1	essentially copies
1	strategyfor purposes
1	following opium
1	50 milligrams
1	reserves. to
1	knowledge. (2)
1	sorting, packing,
4	analysis critical
5	special rule
2	use. (f)
1	implementation not
10	legally marketed
20	knowingly or
1	2007, that
6	investigational submission
1	cause, issue
3	reinspection in
1	presence or,
1	resources directed
1	panels, to
148	submission of
1	specifications, the
1	use, taking
1	(1)(e) to
18	per centum
1	submission on
1	reach these
3	governmental authorities
2	medical matters,
1	notifying a
1	international) if,
1	1996, for
1	guidance since
1	report including
1	summary; (b)
1	section 558.3(b)(4)
5	submission or
8	reinspection fee
1	suitability as
38	regulations issued
1	irritation on
4	general physical
1	830(a) of
2	extended to
22	supply chain
5	f.r. 2053,67
1	prominent claim.
1	papers, documents
2	$100,000,000 for
1	vessel having
2	patients under
1	program for,
1	shor-term goals;
1	methylbromide. (15)
1	five times
34	title to
1	regarding chemicall-related
1	broadest consumer
1	event report,
2	cut up,
1	transactions to
1	effects. 
2	(a) affects
3	knowingly possess,
1	missionthe administration
1	section 360ll(a)(2)
3	supplemental application.
1	issue. 
1	topics listed
1	higher above
1	software assessment
1	information; (7)
1	schoo-based food
1	(c) defenses
2	new substances;
2	subsequent conviction
1	petitions, notifications,
1	health officials;
2	(a) its
1	subsequent reports,
1	substance such
1	_____. i
1	specify how
2	dispensing drugs
2	persons qualified
1	sticker affixed
1	(b) intramural
1	commerce; (b)
1	potential witnesses
1	small cigars
1	(iii) state
2	effectiveness testing
1	title 35.
1	similar notice
1	subsection (d)(3),
1	office, cabinet
6	age of
1	drug (directly
7	patients for
1	measure with
12	individuals to
1	research service
3	program evaluation
1	scientific issues
1	allowed for.
1	joint enforcement
1	renderers, or
5	establishing and
22	exposure to
1	(b) procedurein
1	colors the
1	shortage program,
2	supplemental applications
1	registrant) shall
2	(c) issuance
2	adjustmentbeginning with
13	title, including
10	named as
1	characters. 
1	$1,500,000, or
1	360ss of
1	administration point
7	actions as
3	respectively, not
2	president as
1	penaltiesexcept as
1	ordering such
1	president an
1	analogue means
1	preparing, propagating,
1	any) upon
1	attorney shall
1	special susceptibility
1	documented causes
1	moderate risk
1	come in
1	sponsor. (c)
1	judicial order.
1	(3) dru-free
1	530c(a) of
8	family smoking
2	expenses. 
1	agreement; or
3	manufacturers, repackagers,
1	transfer, or
1	give an
1	(b). (2)
1	section 360j(g)(4)
1	(a) articles
2	panel, and
1	failed an
2	manufacturer, printer,
1	withhold, or
1	legislative body
1	request, would
1	policya policy
8	(v) a
1	exceed fifty
2	owning or
2	pending abbreviated
1	original package
10	manufacturer, repackager,
2	5 percent.
1	title) unless
1	revoking such
1	american samoa.
2	processes, transports,
6	american samoa,
1	1, 1990,
6	justification that
1	example the
1	good guidance
2	i-person meeting
1	timinga notice
1	period previously
2	welfare, destroy
2	enter orders
1	order upon
1	revenues made
1	studies) 
2	policy required
1	specifically for
1	him, including
1	(b), establish
2	$125,000,000 is
1	importation regulated
3	life, the
1	first point
1	(6), section
2	licensure requirement,
1	used, unless
1	iv (

1	(a)purpose.the secretary
7	supporting or
1	current year;
1	reclassifying another
1	879. search
1	reinstatement on
2	(g) effect
1	enterprise (a)
1	warrant; (4)
2	reimbursement, in
2	44 (commonly
1	account international
10	limitations 
1	publish periodically
1	periodic reaccreditation
1	employment. (c)
1	(iv)complementary approaches.to
1	$11,250,000 in
1	ended on
1	(or to
3	secretary about
1	information do
4	measures necessary
6	probation or
2	multiplying the
1	(5) agricultural
1	implemented; (2)
1	discontinuance. the
1	manufacturers, processes,
1	annual registration;
1	order. (j)
1	modification 
1	application, product,
1	353, section
1	interested persons,
2	products developed
1	section, would
1	264] and
3	business day,
1	agendas; (b)
1	hallucinogenic effect.
1	hard drugs.
2	compendium if
8	title, unless
10	meet with
7	inactive ingredients
1	compendium in
2	subsection, that
1	
 344.
1	(b) domestic
1	website. (e)
2	farm where
1	privacy and
1	years but
1	unexpired periods
1	(n)(2)(b) or
2	distributor, having
13	issues a
1	encouraged the
1	parallel scientific
2	alcoholic beverages,
7	(c) notice
2	preclinical research
1	sonic, infrasonic,
2	exemption, or
2	manner, that
1	pharmacy, hospital
2	specialization in
2	therapeutics all
1	sales at
4	take all
1	 (u)
1	refuse, withdraw,
1	(b)(1), establish
1	producing, processing,
2	writing. (b)
4	uses or
1	establishments, which
1	u.s.c. 1501
2	(2) does
1	conveyance thereafter
1	(3), refuse
5	secretary are
1	sought accreditation
1	judgments, decrees,
4	cause serious,
1	(1) award
1	(k) as
3	medical device;
26	suspect product
1	required usesthe
1	article; or
4	substance (other
4	organizations, including
4	medical device,
1	maintaining access
1	school dropouts,
5	revoking the
1	title, one
1	
 2002.
2	agents identified
1	term. (b)
1	assessment, including
5	business adjustment
4	involved, and
1	never assumes
1	recipient demonstrating
1	(5) person
60	listed in
5	no. 1,
2	temporary tolerance
1	ship milk
1	(e); (iii)
1	pharmacies, practitioners,
1	samples is
1	transferred and
1	scientific tools,
1	term supplement,
1	multiplicity of
1	institution and
1	additional members
1	(2) pediatric
1	device, (3)
1	1905. authorities
1	1971. 
1	number, type,
1	norpipanone. (34)
1	compounded at
1	(a)(2) has
1	rule; date
1	service; intervention
1	(b) benzyl
26	chapter to
1	increasing pediatric
2	district agreed
1	secretary, fails
15	medical devices
3	transported into
3	new product
1	unapproved use,
1	safely transferring
1	submitted, if
1	market within
2	promulgate final
1	individuals that,
2	(v) 1
1	practicable, destroy
1	8 and
8	medicine and
1	tenfold margin
1	solely from
1	pharmacopoeia convention,
1	agencies. (

4	remission or
2	prominent than
1	subsections (g)(4),
7	maintenance and
1	interest, address
1	distributed interstate.
1	remission of
2	distributed interstate,
2	act). 
1	section 201),[2]
1	officer means
1	2007. (4)
8	health protection
1	following dietary
1	fees, notwithstanding
6	recommendations; and
1	additional information;
1	milk; milk
2	making his
10	product with
1	right, power,
17	small businesses
2	(d) by
3	associations, and
2	section 1.227
1	drugs is
1	effort resulting
1	state, that
1	105. repealed.
1	subchapter. (b)
1	title, respectively,
6	services, the
1	cooperation the
2	research; discretionary
1	(a) publicationthe
1	1978, the
1	either through
1	products purchased
1	subsections[3] (b)(2)
2	trader for
1	condition, where
1	progress with
3	identifying reference
1	assistant has
1	enforcement activity,
1	information relied
1	rejects the
2	(2) standard
1	amendment case
2	operating the
1	o-line course
6	substances shall
1	(c) labeling:
2	due provision
1	onto a
10	part, or
1	(6) access
2	producer from
3	approved, (b)
1	ground application
14	authorized for
1	subsection (f)(2)(c).
1	distributor conducted,
6	exemptions from
1	section prescribing,
1	(e) has
3	reductions, or
7	part, of
1	awards made
1	iii, 534,
1	dose under
2	swine, goat,
1	9, 2006);
17	subpart, the
1	believes should
17	grants to
1	(8) methylphenobarbital.
1	regularly engages
15	prescribed pursuant
1	difference. (8)
1	public. except
2	reassessed process
1	may incorporate
1	675, 916,
36	states. 
2	advertisement. 
3	perform a
1	predominantly to
5	lower risk
2	national substance
4	sale, distribution,
2	regularly engaged
1	u.s.c. 136a(c)(2)(b)]
1	i, to
7	distributes a
1	no-narcotic ingredients
1	products. representatives
1	duplicative regulatory
1	collections attributable
1	crime described
1	presence, or
1	commodity, as
1	interoperable data
3	declaring that
1	exemptsubsection (a)
2	guidance specifying
2	contain provisions
1	national animal
7	person accredited
1	elects, within
43	possession of
6	comments, revise
1	45 of
13	amount under
1	properly classified
1	possession on
2	drug manufactured
2	30 day
1	extent dangerous
1	facility, and,
1	certified facilities
2	(2) be
5	age to
1	enclosed by
9	(b) publish
1	products deposited
3	provisions (including
1	methods, results,
1	organizations, whose
1	(d) improve
1	insert definitions
3	hearing for
1	1055. authorization
8	(2) by
1	size the
2	assistant to
1	section 387j(a)(1)(b)
1	confirm in
1	render his
1	policy which
3	paragraph 
45	product development
1	associated in
3	areas. 
3	information exempted
3	judiciary, the
4	supplement, or
1	product certification
9	prevent and
4	thereof, except
2	term grase
1	commerce, if
1	prevent any
53	costs of
1	diseases which
3	agencies, organizations,
1	property through
1	qualification submissions,
5	reduce its
1	scientific evaluation
1	removed in
1	(b) another
1	planthe initial
1	animal. (x)
2	support services
1	(c) protracted
1	statement described
1	maintain all
1	package form;
1	strategies which
2	requests by
1	(5) application
1	used herein,
1	months preceding
1	agency, other
1	administrations ability
2	activities will
1	understandable and
2	study reports;
2	fail or
1	consider and
1	estimates would
88	information to
1	dispensers. 
1	care in
1	measures described
1	purposes will
1	stone, labeling,
1	
 886.
1	(1)(c); (b)
1	(1) intervene
1	foreign sources.
1	widely available,
1	promulgated through
1	section 1002(b)
2	through, or
1	(c) situations
1	emergencies such
2	pesticide program
2	act leading
1	party 
1	resistance). 
1	packing eggs.
1	title 5to
1	county facility
1	develop for
1	displayed thereon:
4	poultry producers
2	ownership and
1	(2)(a), nothing
1	products applicable
1	254l et
1	particular factory,
1	(20) dipipanone.
1	 protein
5	percentage share
1	declare it
2	(d) not
1	matters assigned
1	diseases active
1	(except an
1	show symptoms
2	(1)(a) for
1	337. proceedings
1	chemically equivalent
1	decreases an
2	general public;
1	
 1502a.
15	hold a
1	gaps that
5	(washingto-baltimore, dcmdvawv;
2	general public.
14	injury results
3	manufacturerthe term
1	(d) finality
1	compendium for
1	countermeasures may
2	ant-drug coalitions
1	restrictionsan amount
2	schedule or
9	period; and
1	indication a
2	secretary (a)
5	360cc of
1	(c) warning
1	(i), transaction
7	chemical and
1	resources required
4	exposure of
1	including analyzing
1	regulatory discussions,
1	device completed
1	tools that
1	(f), to
1	393. food
30	day after
1	agency concerning
1	784, 1,
1	elected by
1	statement directly
2	market value
1	355(j)(5)(b)(iv) of
9	smoking prevention
1	section apply
1	payments under
1	23, 1908,
1	capsule, solution,
1	maintenance any
1	(a)(1) an
1	execute it.
1	107(a)(2) of
2	section 379g(6)
2	disapprove the
3	(a) applies
3	schedule, for
1	tool related
5	technical assistance,
1	pediatric ethics,
1	analytical procedures
1	feasible, of
3	(a) set
1	interrelated. (7)
1	assessment contentthe
1	objectives. 
1	states standards;
1	salt formation,
2	lacks appropriate
1	together on
1	imitation and,
1	principles for
1	include reduced
1	reliable. 
2	states standards.
1	scienc-based; (c)
1	panel track
2	(c) reduced
2	employees; nor
1	sale, sold,
1	practitioners dispensing
2	another to
1	listings under
1	pethidin-intermediat-a, -cyan--methy--phenylpiperidine.
1	goats, excepting
28	ful-time equivalent
4	therefor; or
1	preceding 1-month
1	(written or
1	(a) symbol
1	promulgated thereunder.
1	penalties it
3	promulgated thereunder,
1	environmental monitoring
2	penalties in
15	state to
2	petition. (3)
1	regulations permitting
1	penalties if
1	next generation
1	transaction information;
1	
 1709.
1	order. proceedings
1	investigated for
1	particular importation
1	activities. (h)
1	(5) lysergic
1	analogues a
3	quota assigned
2	(b)(2)(a)(iii) or
1	established name.
5	submissions described
7	responsibly connected
2	tort claims
1	circumstance that
4	virgin islands,
1	health. consideration
1	units small
1	387s. user
2	consider a
1	clause (ii)(i).
1	(or of
1	disclosed and
1	sector regulated
1	population; (2)
1	(1)(a) applies
3	42. if
2	time following
1	states, with
5	government agency
1	therewith and
1	minimis nature
2	international transaction
1	blood, blood
1	general applications
1	formulas necessary
1	application). the
2	appropriate concurrent
5	nutrients in
2	use other
3	studies has
1	offenses; punishment;
4	adulterated. if
13	ii, iii,
1	withdrawal, suspension
1	campaignin using
1	(4) joint
1	veterinarians and
7	effect a
1	technical aspect
1	millions of
1	potency, and
1	promotional, or
4	any, intervening
1	tool (as
2	(1) classifying
1	discuss proposed
1	equitable allocation
1	period. (j)
1	(a) would
1	brand; and
16	preparation of
6	salts have
4	treaty or
8	devices, the
1	innovation, and
20	subchapter i
1	stat. 1044;
1	manufacturer had,
1	assist individuals
1	exemptions; authorities
1	general designated
1	director). 
1	(1) facilitate
1	variance of
1	committees, members
24	includes the
1	appropriating) in
1	abusers), supply
1	demotion, discharge,
2	researchers, and
4	subchapter v
2	account shall
3	analytical tools
1	growth and
1	manufacturing activities
1	programs comparable
1	360ccc, 360ccc1,
2	plants the
1	complete list
1	alone, without
1	modulates the
1	formerly 17th
2	law enacted
2	dispensing, of
1	consumed, the
8	shall receive
1	1004, formerly
2	following conditions:
10	ingredients, route
3	sundry losses
1	regulation; (2)
1	natural history
4	dispensing, or
1	article, any
2	relief prescribed
1	committed a
1	entities) no-federal
1	without foregoing
1	section 331(ll)
1	formula, made
53	sunscreen order
1	determined after
1	exists a
1	(i) violates
1	another copy
2	accountability act
1	(i) relates
4	chemical under
3	lacks sufficient
1	credit to
1	below, the
2	enter the
3	(1). such
2	(v) protect
7	practice. 
1	copying. 
1	individuall-identifiable beneficiary
1	give consideration
1	sunset subsections
2	changing circumstances
2	body under
1	(1) describe
1	use, if
3	products from
2	without that
1	regulatory requirements.
1	individual personally
1	regulatory requirements,
1	additional processing
1	(m) or
3	states without
2	organization means
5	national formulary,
3	rol-you-own tobacco
2	person; (3)
9	(a) general
1	(b) prevent
1	providing background
1	entity demonstrates
1	diameter; or
8	data to
1	enables personnel
1	activity in
2	deemed reasonably
5	regulations, as
1	register (or,
1	responsible authority
1	following june
1	entity would
1	dispensing, importation,
1	opium, morphine,
1	device, by
1	workload adjustmentthe
3	ris-based inspections
1	import ephedrine,
6	compromise, modify,
1	animal; (c)
2	countermeasures that
2	confectionery is
1	vehicle includes
1	subsection (o);
3	(b) certain
1	
 360ff.
1	expertise relating
1	indirectly, to
1	standar-setting entities;
1	renumbered 3
1	generala requirement
1	confectionery if
1	renumbered 7
2	marked or
1	sole ration
1	standar-setting entities,
1	renumbered 9
7	advise the
5	agency the
2	charge shall
1	clinical efficiencies;
3	funding from
1	(a)(2), as
1	congressional record;
1	may accredit
1	form and,
9	risk communication
2	temporary or
1	criteria developed
1	logbook, or
1	treat it
2	consignee, country,
4	notice.an applicant
1	control plan;
4	section against
1	(a) clearinghouse
1	1045; renumbered
1	individual product
1	guidance regarding
2	proposed reclassification,
1	territory are
1	capacity at
1	control plan,
3	pesticide monitoring
1	control plan.
2	42 (as
2	pursuance of
1	(b), take
3	countries described
1	introduction constitutes
1	379j22. reauthorization;
6	is, or
1	existing manufacturing
1	conditions, for
1	biomedical sciences,
1	proof in
1	lif-threatening manifestations
5	register of
1	1337 of
1	manner established
1	property reverts
1	policy with
1	right shall
1	writing, not
2	shall document,
2	columbia circuit
2	patient groups
2	additional amounts
1	board established
1	inventory any
5	organized with
4	control plans
2	applicant at
1	review decision.
15	form as
1	shall periodically,
1	extension; and
1	entity authorized
1	records; territorial
1	(c)(3) respecting
3	tobacco or
1	inspectors that
2	engaged in,
1	related seller
1	cans containing
1	pharmacy benefit
1	(n) that
1	accounts for
1	projects; and
1	safeguards be
1	parts; (12)
1	
 1902.
1	present false
1	
 387c.
3	(ii) cleared
3	examination prescribed
2	establishes and
2	patients during
1	(h) applicants
1	recommendations during
1	animals treated
1	herb, or
2	(iii) 2
2	contentsin the
1	first initiation
2	section 264(c)
1	title 49),
1	authorized purchaser;
9	secretary, by
1	passed; supervision
1	paragraph (3)(a)
3	laboratory in
36	makes a
4	not, by
1	deaths and
1	experience with,
1	213 of
37	use for
1	also constitutes
6	maintain records,
1	exclusivities and
2	laboratory is
1	discrete -year
4	passed, or
1	deems will
3	size two
1	indicated. 
1	manufacturer. if
6	(i) does
1	person obligated
8	writing that
5	chapter whenever
1	available within
1	general jurisdiction
1	cause death
1	includes individuals
1	attached all
7	subclauses (i)
14	amount provided
1	soybeans. (2)
1	convention which
8	packaging or
2	appropriate, tests
74	(1), the
1	application notice
1	individuals whom
1	(including social
1	secretarys authoritythis
1	hiring qualified
2	individual into
1	manufacturers; (g)
1	enhance communication,
1	leaker, or
1	format (including
1	355(i)[1] 360b(j),
2	seizures; and
2	issued 
1	distributor, dispenser,
2	board in
1	after, publication
6	task forces
1	(c) would
1	business; but
1	supply such
1	public area
1	request requirementsa
1	conduct research,
1	views in
4	commerce, shall
1	privileges associated
1	assistance), or
1	health concern,
3	practitioners in
4	reviewing and
7	applicant an
1	conduct telemedicine
2	current procedures
1	made. (3)
1	(c) donations
1	standards. any
11	supply reduction
2	awarding damages
1	ii, section
1	local requirement
1	(i) previously
1	judge allows
1	includes individual,
1	useful to
1	supplements (a)
1	675, 565a,
2	advertising the
1	property forfeited,
3	blood component
2	individuals who,
1	
 2105.
1	specific tobacco
22	shall also
3	require; (f)
1	order prescribe
1	investigating and
1	grase; (5)
1	instrumentality shall,
1	debilitating human
1	wild or
1	development 
1	information, may
81	section 262
1	names; compilation,
1	from, each
1	risks related
1	preparing, packing,
1	section 264
2	nonprofit organization
1	(a) conducting
1	related pesticide
1	registrant, before
3	audit conducted
1	research, as
5	shall seek
2	stimulant substances,
13	(b) does
1	5702 and
1	litigation. 
1	five years.
6	person while
4	 an
1	device, (vi)
1	thereof presents
8	actions required
1	(1) employ,
1	criminal behavior
1	enforcement authority,
1	wrongdoing to
2	food, due
1	requisite elements
1	effect which,
2	herein first
1	repealed. 
27	limited to
2	recognized standar-setting
1	leverage existing
4	imposition or
3	furnish each
3	supply and
1	 (23)
1	categories until
2	552(a)(4)(a) of
1	(b) withdrawal
1	sections 3
1	professional, labor,
2	derivative of
1	administration, identify
10	imposition of
1	second. if
1	establishing additional
1	submit items
2	simple notification
1	(5) no-delegation
8	misbranded, or
1	involved (including
3	355(o) of
1	man, other
5	subsection between
1	products, protect
5	component part
1	license products
3	accorded to
1	(b) promptly
1	periodically, and
21	granted under
1	available, by
1	reached under
1	grew the
1	consolidated administrative
1	warrants, subpenas,
2	regulated transaction,
1	alcohol, paregoric,
1	(f) notice
1	decisionmaking pertaining
1	generalit is
4	action levels,
3	individually identifiable
1	compounds with
6	either a
2	(h) administrative
1	section ends
1	causing chemicals
1	(c) secretarys
4	congress, and
1	combination, are
1	matches, and
9	punishable by
9	sold in
1	forfeiture proceeding
3	existing controls
1	preconditions; rare
7	facility, the
1	regulations (a)
1	bear, at
1	president issued
3	withdrawn if
1	801, 52
4	administration, or
7	measure, or
1	806, as
1	substantial participation
1	(4) smoking
2	impeding certain
9	part. 
1	part when
1	recommendations, unless
2	submits any
1	audit; (iii)
1	share with
1	residues has
16	determined to
1	sentences of
1	applicant withdraws
1	ch. 10),
1	recover a
1	limitation. such
3	(b) complete
1	register, modify
1	pantothenic acid
1	grase determination,
1	(b) pharmacies,
1	(4) context
1	ingredient, nuclide
1	slaughtering activities
5	drug law
1	675, 418,
1	filing. not
1	decision. the
1	outbound distribution
1	error. (3)
2	obtained or
16	state of
2	(16) the
1	equivalent in
1	register; (ii)
1	steroids. 
1	ephedrine, its
1	administration which
3	public the
5	slaughtered poultry,
136	state or
1	foreign laboratories
1	(1) director
33	states court
1	fifty states
1	formerly 706,
2	exceed 10
1	federal facility,
1	(10) shall,
1	(for a
3	petition unless
1	recent inspection
3	interactions of
2	exceed 18
2	offense relating
10	services of
3	355(c) of
1	ingredients identified,
1	spent on
1	variations provided
1	dosage forms.
1	public process
2	appropriate involvement
2	services on
1	derived; separate
1	composition and
1	implement subsections
3	subchapter are
1	business. the
1	modification. (7)
1	expire and
1	consular officers;
2	applied chemistry
2	recall; (2)
2	devices with
1	675, 423,
1	 (ii)forfeiture.
11	agreement on
2	equal number
1	brookhaven national
1	379a. presumption
1	(7) opioid
2	title 25).
1	determines has
2	officers report
1	including tobacco,
6	nurse practitioner
1	use), and
1	(i) proceedings
1	policy accommodates
1	inspection warrant
3	different or
1	requires clinical
1	device tested
1	hearing; (iii)
1	academic and
1	reasonable measures
1	completion by
12	standard prescribed
1	dru-free americathe
1	dry substances,
3	statement with
1	without elements
1	voluntary and
1	referrals for
1	hidta are
1	made, except
1	states. similarly,
2	reviews, and
5	appropriate. during
1	flexibility by
1	sponsor so
1	1804. repealed.
1	study planthe
20	submit the
3	compliance data
1	term i-person
5	court grants
1	complaints and
1	term enterprise
1	prohibit 
1	paragraph (d)
1	contained therein,
1	text note
5	pharmacy or
2	vthe attorney
1	serve) a
2	taken pursuant
1	products) which
9	withdrawing approval
1	wire, radio,
1	necessary clinical
1	paragraphs (4),
1	instituting court
1	assessment results
1	(f)) into
1	te-year injunction
1	assistance related
1	prosecute the
1	pharmacy of
2	timely manner;
1	denial may
2	commerce, for
1	senior agency
1	(iii), and,
2	brand name
3	preventing, or
2	matter involved
1	2013. in
1	full establishment
1	exceptions: 
1	2014, $11,300,000;
1	circumstances, (c)
1	manufacturer (in
1	statement published
40	accompanied by
1	facility, is,
6	possible within
1	employeesfor purposes
1	agent), or
1	300 times
1	thereof. (3)
1	priority supplement
10	form for
1	index; suspended
3	tote, or
18	841(b) of
2	(b) procedures
1	(b) due
1	officio membersthe
4	identified for
1	effect), the
1	emotional health
5	question whether
1	(ii); and
1	risks, a
1	effectively communicate
2	receive, review,
1	(i) requirements
2	specifically finds
1	understanding shall
2	demonstrates the
1	13, or
3	revoke an
1	january 10,
1	private foundations
6	thereon with
1	whose public
1	foundations, researchers,
1	publicity (a)
2	misleading and
2	chemical, and
1	copy required
1	agents; (2)
2	food covered
1	providing solely
1	courts disposition
10	percent change
1	reduce risks
1	premises he
1	chapter solely
1	consular officer
1	section 350e(c)(1)(e)
4	determination, whether
1	(a), unless
1	(b) procedure;
2	schedules i,
1	agent the
1	name; designation
1	whoever engages
1	(3) without
1	premix is
1	fifty pounds.
6	conducted with
1	separately listing
1	complexity, usefulness,
1	(a) draft
2	360fff5 of
2	will notify
158	application under
1	mentioned, until
1	application before
1	holder complies
1	(d) apply;
6	base inflation
1	(e) te-year
1	health concerns
1	inquiries; jurisdiction
1	subsection (a)(4)(a)(i)
1	open protocols
3	secretary relating
1	(2) total
1	affected antibacterial
1	distributor received
5	activities; (b)
1	61, 6,
1	service subsidized
1	labels, labeling,
1	(4) accredited
1	title 19,
3	360(k), 360c(f)(2),
1	total law
1	[part], as
1	(b)(2). (b)
1	recallthe secretary
2	active surveillance
1	(1) fiscal
1	pasteurization of
2	attorney files
1	met 1
1	restore the
1	basis of,
1	designate 
1	securities on
5	binding commitment
4	best available
10	review, and
1	insignificant changes
1	regulations will
1	22501(b)(1)).[1] 
1	formerly 908,
1	convention, based
4	trading partners.
2	administration pesticide
1	831. additional
1	general files
6	logistics provider,
1	dilute solution
1	1332(1) of
13	reports, and
2	shall knowingly
6	education, and
5	applicable amount
1	(b)[1]) subject
5	refund not
1	applicable proposed
1	criteria issued
1	cas-b-case delay
1	experts, on
3	certificate prescribed
5	(f) is
1	1, 1971)
1	alcoholism as
2	$160,000,000 for
1	42, except
1	years imprisonment,
1	attention of
1	years imprisonment.
1	reduced feeswhere
2	children means
2	(iii) describing
1	meat broker
19	refund of
8	becomes aware
7	period not
1	forms known
1	conference 
1	upcoming fiscal
1	coloring only
1	litigation the
2	activities. such
1	service; exception
1	membership (a)
1	exists, establish
1	issued since
1	combat substance
1	whose positions
2	common control
1	exchanged, or
1	part limits
2	electronic or
1	crime, increasing
1	262(h)]. (ii)
1	banning all
1	title; (vi)
1	only, the
2	potential or
6	certification the
2	business, name
29	whenever the
1	date (whether
2	(ii) who
1	(1), he
1	1034(e) and
2	either act
12	(1) by
1	case, including
4	file that
1	iii 301,
1	auditor satisfied
4	taken or
1	(cb1 receptor)
1	tort issues,
1	label upon
1	application; contents
1	(3) procedurein
7	electronic data
1	conservation and
1	manufacturer makes
1	law modifying
1	auditor satisfies
1	food complies
2	march 31,
1	term office
1	fund, to
1	officer, agent,
7	mean the
1	standards currently
1	medicine nothing
1	pay) and
1	drug receives
1	entity which
2	imposed, be
1	distribution if
1	form only
8	evidence or
2	state; (ii)
1	diagnostic technologies,
12	distribution in
5	assure compliance
25	subsections (a)
1	inspections. (ii)
3	application. if
1	repair, or
1	
 363.
2	evidence on
1	drug received
1	criminal record
1	ongoing and
1	 (v)authority
1	internet, or
23	evidence of
1	imposed, by
3	drug crisis
1	generalfacilities identified,
1	year, which
1	actual amount
1	(5) actions
1	subparagraph (a)(iii);
1	party; (b)
1	highest rates
2	condition specified
6	general or
2	may report
1	(1) authorized
2	(i) limitation
7	exposed to
1	(vi) appropriate
1	strategy means
4	350l of
1	foregoing other
1	assistance, follo-up
6	duty of
1	chapter, carriers
1	(d) focus
2	dispensing such
1	(iii) application
5	11, 1953,
2	individuals referred
1	(i) identifies
1	materials as
4	counterfeit, diverted,
1	medline plus
1	pasteurization and
1	(a)(9), shall
1	1044; june
1	nighttime, enter
1	secretary limits
2	specific regulatory
17	considered an
1	(i) identified
1	utilize in
1	clause (xiv),
1	unstable or
4	subsection, any
2	secretary allocates
1	review, in
3	minor species)
9	title, shall
2	minor species,
2	reports provided
2	arrears list,
4	oral or
1	exercise responsibilities
4	assessments conducted
1	enforcement; applicability
1	example, or
1	injury, is
5	subsection, and
1	minor species;
1	work required
1	fruit and
1	services. the
1	product codes,
2	section, employed
1	(ee) the
9	listing pursuant
1	factors, good
5	conditions (a)
2	deferral, partial
1	lacking; or
1	substance, if
1	282(i)(3) of
1	(8) betameprodine.
71	course of
1	(3) limit
2	reported or
1	additional review
2	requested within
4	special registration
1	develop detailed
1	reissuance, and
1	hearing. upon
1	free samples.
4	members. 
1	substance, is
2	list or
1	describes how
7	proceedings of
1	nominations; and
2	commodities; (b)
3	(2) through
1	subsection have
6	proceedings on
2	federal personnel;
1	(a)) which
3	repackagers, wholesale
1	current appropriation
1	0.60; and
24	november 26,
1	appropriate designated
75	list of
1	standards). the
5	adjustment and
4	conform in
1	leaves authorized
1	cheese not
1	(i) rule
2	notice. if
10	authorized distributor
1	provided, and
1	epinephrine to
1	services required
18	insufficient to
2	2014, $2,604,000
1	and, from
4	u.s.c. 5301
17	refused admission
1	application datefacilities
2	(1) forge
1	rejected articles
1	women. for
1	projects, and
7	10 days
2	first be
3	ethics of
1	state; or
1	provided further
1	subsection (c)(1)(c).
2	fee would
1	products; (3)
1	licenses notwithstanding
1	(c) assurances
1	
 360bbb7.
1	said misdemeanor
1	may periodically
1	 magnesium
31	drug products
1	disseminate specific
1	(h) available
1	terminated. (c)
1	withholding directive
1	slaughter; or
1	using expedited
2	carcasses, and
1	agents means
1	write such
2	(c)(3) of
1	imported based
2	term supplement
1	675, 515c,
1	adult conditions
4	changed by
1	appropriate sentence
1	concerning whom
2	section a
2	subparagraph to
1	reg. 4439644615
2	risk populations,
1	2003; (3)
1	2012, there
1	microorganisms (including
2	alleging such
1	regulations (including
1	(ii) treatment
1	(225 g).c
1	standards, terms,
1	upon, research
1	studies (a)
1	excluded from
1	following apply:
1	system detection
6	evidence under
1	(gbl) or
3	saleable returned
1	collaborating with
1	(2) making,
1	section 8
1	section 9
1	emerging problem.
1	(d) timing
5	section 4
1	section 5
1	condition, within
1	unlawfully manufacturing,
1	379h(a)(2) of
1	
 347b.
2	consumer. violation
1	particular foreign
1	injury; and
1	sources. 
3	(1) timing
1	sampled in
15	drug product,
5	drug product.
2	affairs, the
6	subsections (a),
1	maintained. 
1	(d) sales
6	take the
3	suspending the
2	records. (g)
1	health outcomes
17	services to
1	injury. a
2	acquisition by
2	specific objectives
1	(4) ethchlorvynol.
1	function, or
1	351(a)(5) of
2	(and major
1	including addressing
1	2015, added
1	imported thereafter
1	(b) describing
1	possessed commonly
3	sentence as
1	passed shall
2	laws nothing
1	imported meat
1	applicable percentages
1	regulatory decisionmaking,
1	parts; (6)
1	licenses the
1	personnel authorities
1	262], as
1	illegal transactions
1	comment, interim
1	may deny,
5	coordination between
1	importer, taking
1	description submitted
2	(f) exception
1	
 210.
1	351(a)(2)(b), 352(f)(1),
2	agriculture a
1	prosecution, or
1	ingredient may
1	1505a. annual
3	food, any
2	claimant only
1	passed; (3)
1	detention for
1	includes, where
3	real property,
2	principles, shall
4	imports (a)
1	begins on
1	endocrine effect,
1	person introduces
1	backgrounds, except
1	real property;
1	adolescent tobacco
13	article 2
7	receiving such
3	product manufacturers.
3	food produced
1	prescribe performance
1	(viii) quarantine
2	field investigation.
3	lithograph, or
2	guidance contentsin
3	shall treat
1	existing food
1	site disclosure
7	national intelligence
1	preparation or
1	terminationthe secretary
4	relevant national
1	(b) audit
1	term clinical
1	engineering, or
1	(a) overtime
1	methamphetamine, lsd,
1	871; june
1	accepted the
1	hotels, and
1	
 2224.
1	prospects for
1	
 830.
1	term radiation
3	(c), a
1	announce the
3	later, the
1	program determined
3	receiving notice
1	package insert
2	planning to
2	duties the
1	(n)(2)(b)(i) is
1	1996, exempt
4	enforce such
4	subchapter which
1	(i) confidentiality
1	changed device.
2	reversal if
1	protocol) that
1	filled milk.
1	1052; 

1	(d), such
34	registration under
2	drugs; (ii)
1	clearing devices
1	package labels
2	secretarys response
2	thereof has
1	practitioner: 
1	forming because
7	contents injurious
1	manufacture 
1	provisions under
1	live animal
1	drugs, which
1	examination, the
1	second half
5	food registry
3	secretary during
1	products owned
26	(i) shall
2	labeling. neither
1	including sales.
19	2007, the
2	(a) classes
3	title into
1	studies. (c)
1	(u.s. city
5	(a)(ii), the
1	manner. such
1	pipe tobacco,
1	timely cooperation
1	include one
1	letter issued
1	foreign seller
11	storage of
1	expenses connected
1	order conditionally
1	gram positive
1	1979, monthly
1	violations 
1	application thereof
1	process, and
82	drug under
1	(1) communication
1	comment received
1	containers, or
2	(a) respecting
1	(3) most
1	factors (and
5	provide support
1	u.s. department
1	annual opportunity
1	4(i)(1) of
10	reports 
1	staff 
9	generaleach person
6	deface, or
1	materials, including
1	(9) secretary
2	section 3551(b)
1	(f) prominence
3	scientific knowledge
1	warnings concerning
1	336. report
1	limit shall
11	quality, and
1	delivery to
1	determined, pursuant
2	coordinator with
1	grant eligibilityto
1	disseminate such
2	paragraph on
2	illicit manufacture
2	advisory board
1	destroyed by
2	chapter unless
6	use patent
1	small processors
1	information typically
3	applicable due
1	related information
1	consumers. (c)
1	import means,
1	hereinafter authorized.
1	(b) maximizing
1	u.s.c. 714b
3	days, pending
1	items; or
7	(a) authority
14	section 360j(g)
9	regenerative medicine
1	possessors 
2	enhance drug
1	(a) biennial
1	recognized his
68	poultry products
1	equines, except
1	significantly increase
1	enter findings
1	505a, as
4	storage or
1	355(c)(3)(e)(ii) of
1	trends against
1	rate by
1	directive drugs
2	exclusivity eligible
1	deadline at
3	center of
1	subsequent portion
3	fine any
1	(5) submits
1	(2) waiver
2	private elementary,
1	athletes compete
1	(d) limitations
1	general community
1	however, any
3	logbook under
1	(ii) existing
1	period, clause
1	
 801a.
1	tools qualified
1	360j(m), or
1	breakthrough technologies.
2	tobacco 
2	3001 et
5	new active
10	5 percent
1	controls resulting
1	pediatrics (including
8	linked to
11	reduction in
6	identified pursuant
2	introduction into,
2	likeness of
1	late under
2	methamphetamine, ecstasy,
2	including representatives
1	(11) outsourcing
1	commerce. thereafter,
1	possess on
3	certifications for
1	(a) coalition
1	involving matters
2	radioactive materials
1	checks in
1	including expenditures
1	(b) conferences
1	dependent illicit
15	states as
1	file shall
1	(e)(1)(a)(iii) of
1	applications) shall
1	domestic slaughtered
1	findings which,
2	shipment for
1	handles. (6)affiliate.for
2	(2) definitions
1	order promptly
1	nonprescription drug,
1	bronchitis. such
1	components and
2	obtained pursuant
1	(or request
1	
 858.
1	section was
9	commerce any
9	commerce and
1	illnesses and
1	comparisons the
1	conductthe secretary
1	obtained after
1	introduce, such
1	rapid timeframe;
2	clinical infections
1	witness may
2	disease is
1	food requirements
3	legislative body,
1	chloral betaine.
1	(5) consultative
2	authority shall
1	(1), there
3	evidence means
1	modified, meets
4	shipments 
6	professionals; (e)
1	base a
3	committed in
1	standard; (6)
1	system database
1	1969 [42
3	disease in
1	timely accessibility
2	(or proceeds
4	allow any
3	agent shall
1	groups the
1	(e) publish
1	(ii), fees
1	49), operating
9	section, a
1	existence as
3	applicability to
4	meetings between
1	power and
1	regulations after
4	conduct relating
1	service within
1	ends early
1	informationthe application
1	be, purports
1	neutralizing costs
1	formal written
1	purpose intended
1	461 to
4	nonprescription drugs
2	applicant fails
1	penalties with
1	members or
1	appears conspicuously
1	emergencies by
5	conditions, including
1	clergy). 
2	timing and
1	per annum,
8	request or
1	construction, and
1	derived either
1	spread to
1	scientific literature
1	(b) issues
1	reenacted with
1	transgenic animal.[2]
1	(v) later
1	match advertising.
1	product derived
1	surveillance be
1	becomes unlawful
2	demonstrating a
3	previous -year
1	establishment number
1	feedback on
1	cited in
5	declared to
1	r-exportation has
1	investigators of
1	proposed order;
2	interruption. (b)
1	articles all
1	350c, 350f(j),
1	 each
5	facility subject
1	drugs, other
2	congressional committees.
1	expert scientific
1	(nn) the
1	(d) measures
2	(2) give
1	outline of
1	hig-level coordination
1	(including functions
1	360b(h), and
1	ingredient) a
1	endpoints, including
1	operation, including
7	exemption 
1	efficient adoption
1	(2) appeal
2	following a
2	assessing and
1	petitionersany person
2	testing. 
3	reached between
1	205, as
4	excluding the
1	measures relating
2	offices within
1	much of
2	(a), to
1	(3) before
1	the[1]section 2219a
2	package; (ii)
1	penetration by
1	letter setting
1	v shall
2	grain of
1	inspector shall
1	arrangements made
11	expedite the
2	accept from
1	plant into
1	youth workers,
1	distribution as
1	drug package
2	properly marked,
1	functions, and
2	distributor, and
2	compliance is
2	sound, clean,
1	five hundred
3	section 350a
1	
 360eee3.
6	section 350g
4	section 350f
2	section 350e
15	section 350d
1	section 350k
4	section 350j
1	section 350i
6	section 350h
3	establishments every
1	quarterly report
1	means, any
3	devices; and
2	preventing or
2	published, the
1	
 146.
1	metrics to
1	network laboratories,
3	employee may
2	appropriated pursuant
1	statistical, epidemiologic,
1	annual quantifiable
5	condition, the
3	distributor the
1	measure and
2	cocaine, heroin,
1	significant outbreaks
3	reports. (ii)
1	term manufacturing
1	health; (6)
10	containing any
2	manager or
1	additive (i)
5	qualified acceptance
2	substance was
1	made available,
3	manufacturing, distributing,
4	data necessary
2	contract shall
1	said first
1	(6) what,
2	research activities;
1	product composition
1	section affects
1	regulatory matters
1	701, 52
2	outside such
2	final orders
1	(a)(2), or
1	sel-certificationthe attorney
1	efficient process
2	section 101(c)
1	increase for
1	(v) requests
1	regarding certain
3	thereof, as
4	judicial proceeding
2	laboratories, and
2	general information
1	introduced into,
4	title when
1	includes items
1	(18) nicocodeine.
19	insecticide, fungicide,
1	obligated to
1	response in
1	proof shall
1	entry value
1	offering of
1	final order,
1	may reject
4	applicant seeking
56	type of
1	devices the
1	individuals duly
2	available alternative
1	restriction, the
5	administration has
3	seq.], the
1	readily recovered
2	cosmetic to
9	type or
1	agency carries
1	privileges, or
1	repackage, with
1	delays, denies,
32	extent that
1	v a
1	country; or
3	acquired under
1	internet, if
3	aside. 
4	term generic
1	designation. (b)
1	residues above
1	panel, shall
6	guidance described
1	drug set
1	5and which
1	milestones that
1	1996, under
2	relevant laboratory
2	appointments to
1	360nn. inspection,
2	related substance
1	undertakes a
1	plus 
1	sufficient, postapproval
1	(1), further
1	studies, demonstrations,
1	committees means
1	(3) drugs
1	interest shall
1	(xi) an
1	(b)(1)(a)(i)(iii), (b)(1)(c),
1	(k)(1) and
1	humans other
5	operates in
3	ship carcasses,
1	exported, in
1	value; (ii)
1	substantial danger
1	use tobacco,
1	affect whether
2	has, respectively,
1	authorized law
2	narcotics and
1	period and,
2	secretary disapproves
2	production, processing,
1	expertise relevant
4	recommendation is
1	punishment (a)
1	treasurer of
1	produce smoke,
2	purchaser in
1	application respecting
1	conclusive, and
1	law may
2	reclassify the
4	distributed, dispensed,
1	unnecessary duplication,
1	(e). as
1	cause as
1	petitioner) prescribing,
2	international trade.
1	675, 528,
1	lawfully maintains
1	protections (a)
1	(i) specifying
1	regulation; (c)
1	sales (other
2	activities. (3)
1	qualified, independent
1	adequately identified
1	amounts. 
1	following thresholds
7	use; and
1	hard core
1	demand by
1	drug; (g)
2	payment by
1	18) used
1	motion as
15	violation after
1	registrant 
1	(b) requiring
4	(as that
2	may 29,
4	maintains a
1	articles recognized
2	agent has
4	(c), shall
1	abuse, but
11	manufactured, prepared,
1	perform ris-based
1	every 14
1	every 15
2	administrator, acting
1	nutrients, and
1	drugs. (e)
1	good reason
1	allergic hypersensitivity
1	use may
1	wholesome, and
3	(a); (b)
1	pharmacy, physician,
1	(31) norlevorphanol.
1	plant was
1	twice in
1	wholesale or
1	whether external
1	approved nothing
1	implement procedures
2	labeling that
1	374(a)(2)(a) of
1	establish, not
2	february 21,
1	no-hig-risk food
2	use recommended
3	primarily intended
1	standardsa tobacco
1	$7,936,000 for
1	procedures if
3	device was
1	evaluating existing
1	360b(d)(1), 360b(e),
1	cultivators are
3	procedures in
1	(vi) for
2	15th day
5	contracts entered
1	entry involved
1	and[2] 
1	subsection through
1	section 360b(c)(2)
5	section 5304(e)
1	(a) scope
1	secure processes
4	vacate the
1	created in
1	target dates
1	scientific tools
1	secretary consume-oriented
2	393a of
2	physical sciences,
1	(ii) apply,
1	increasing health
2	(b) personall-identifiable
1	misleading shall
276	 (3)
1	section each
4	indictment or
1	(a) repeated
1	petition a
1	substance proposed
1	sequence of
10	file fee
1	chemical, poison,
1	matters involved,
1	sunscreen. 
1	(1). safe
1	require distributors
1	include package
1	term swimming
7	proof of
1	5 times
2	public housing
11	resides or
5	person at
1	providing access
3	consumed by
1	review beginning
1	harm means
1	inspected for
1	violation; (3)
6	written, printed,
1	error, the
1	provide education
2	exist: the
1	-(-methy--pyrrolidinyl) pyridine
1	operator shall
1	better access
1	verdict for
1	secretary he
1	local affairs
1	annual food
1	animal imported
4	period a
1	conditional dose;
1	interests, professional
1	incorporated shall
1	recognizes the
1	utilizes a
1	child while
1	list. during
1	derived. when
1	applicable element
1	establishing effective
2	converting such
3	following applies
1	387j(a) of
7	personnel to
1	subsection (b)(1)(f).
1	control as
1	control at
2	funds and
1	ensuring adequate
1	3(c), 64
7	consideration for
2	eligible state
1	subsections (b)(1)(b),
1	(ee) an
1	research laboratories
1	distributors in
2	equivalence means,
2	(1) ensure
1	pills, tablets,
1	account, if
1	positions are
1	(b) user
1	(b) uses
1	consequences of,
7	fixtures, furniture,
1	formulas shall
1	term emerging
1	violated this
1	without trial
1	enrollment has
7	official compendium.
2	adequately convey
1	official compendium,
4	available drug
1	suspended. (aug.
1	national community
1	border of
1	among youth.
1	332, 333,
2	among youth,
1	pediatric therapeutics),
1	restriction does
1	bacterial exacerbation
1	seeking simultaneous
2	available; (iii)
1	care, would
1	hospital pharmacies
5	deems appropriate,
3	court designated
1	subsection (c)(4)(b),
1	section 230(c)
119	human services
7	among youth;
1	(iii) enhance
1	entities accredited
1	error or,
1	inspection; list
1	requires licensing
4	june 1
2	application immediately,
5	state under
2	(b) enforcement
4	organizations that
1	3, 1913,
1	(a)(ii) with
2	provide, or
2	may change
2	provide advisory
2	secretary informs
1	sector coordinating
3	misbranded; (iii)
1	675, 706,
3	sponsor shall
1	gas bears
1	chain by
1	health shall,
1	attached such
1	willingness and
1	anabolic steroid;
1	(2) amateur
34	requirement for
1	body a
1	licensure; or
3	exporter shall
1	act, approved
1	revocation, reissuance,
1	dismiss for
2	capacity, or
14	inspection services
1	products, classes
3	classifying a
1	term resubmission
1	acceptance to
1	industry advisory
7	list published
18	shall, with
1	items unless
1	coupon, knowingly
2	evidence provided
2	1355 of
1	treatable disease;
2	safety officials
1	formulas, including
2	application did
1	section 360nn(f)
1	abusethe term
3	container means
1	report about
1	controlled substances)
2	organization, the
1	measures of
18	controlled substances.
2	and, unrestricted
13	controlled substances,
1	certifications. (ii)
6	part, to
1	675, 739,
1	u.s.c. 355f].
2	intended limited
5	(e) review
3	harmful to
1	corporate sponsorship
2	j of
5	required. 
1	recall, each
2	food, because
1	following acts
1	manufactures, fabricates,
3	takes into
2	involving human
1	extracted from
1	use federal
1	including for
5	pandemic or
1	2008 unless
2	candidates to
1	system; congress,
1	transaction; (i)
2	terrorism; and
1	inspection service.
6	simulated, forged,
1	inspection service,
1	
 399c.
1	(8) program
8	penalty in
2	title under
1	person he
4	application, shall
1	denied clearance
1	false transaction
1	manner, taking
1	penalty if
1	(e) death
7	title). 
1	assetsexcept to
1	determined could
3	december 15,
1	printed upon
7	illegal drug
1	i) in
1	containing foreig-grown
1	extended [21
2	treasury not
1	subsection (e)(1),
1	accommodates scientific
2	approved product),
1	drug qualifies
1	earlier version
1	employee would
2	(iii) when
1	physically handle
1	iiit shall
1	fresh natural
5	(3) that
2	aforesaid. (mar.
1	dtc advertisement,
1	sufficient number
1	ensure clarity
6	intelligence and
1	safety training
1	(c) seizure
1	(4) implementation
1	racial subgroups
3	title (including,
10	establishment for
1	(ccc) the
12	deficiencies in
6	section, to
1	voting balance
2	applicability this
1	
 360qq.
2	chapter. (q)
1	acids, oxalic
1	beginning and
1	permitting such
1	food, within
2	offering the
5	hearing, in
7	detailed to
1	involvement 
3	involved, any
7	assets of
1	oxide, and
1	object; the
1	characteristics, which
5	identifying mark,
1	section 353(d)
1	tracing; and
2	referrals under
4	service or
1	secretary publishes
1	period means
1	
 2103.
2	countermeasures; 
1	indexing continues
2	330 days
1	generic activities
1	promote, compensate,
1	(n) ethylamine.
1	paragraph (a)(2)(b),
4	appropriate pediatric
1	program, but
1	l., whether
1	(iii) approval
2	convincing evidence
1	enforcing, under
11	dtc advertisements
2	term minor
3	criteria in
2	groups requiring
1	followed or
1	implemented riskmaps
1	enrollment of
1	identifying marks
7	derivatives of
1	inspecting outsourcing
1	may decline
2	recent year
1	document so
2	published a
1	card that
2	protocol with
1	integrity or
1	declining to
1	inspected, if
6	fees from
1	regulation change
2	application provides
9	time period
1	(x) gamma
50	facilities and
2	distributor as
2	payors, and
7	disease; and
3	regulatory, or
1	permanent. (b)
1	inadequate and
1	chemical than
2	impair the
2	different questions
1	(g) marijuana
1	policies are
1	trainees of
1	flow thereof,
1	health, safety,
6	new drug,
13	chemical that
1	new drug.
1	act, meet
1	(5) panel
1	complaint has
1	756, 2,
1	environment. 
1	355(b)(5)(b) of
1	chemicals); and
2	strategy described
2	2006, and
2	egg which
1	deadline has
1	deleterious foods,
1	priority new
1	(and before
1	evidence defined;
2	aug. 7,
1	extent intended
8	director under
1	private sector,
1	time. (

1	advisory meeting
1	advertising. (b)
3	plastic, or
1	(c) distribution
1	auditor becomes
1	seq.], be
2	sanitary manner.
1	subchapter concerning
2	said sections.
1	enrolled, the
1	contribution or
1	change, modify,
1	better identify
7	new drugs
1	(g) grant
1	operations for
2	initiative; or
2	from, to
1	users the
2	holding do
1	files which
1	delivery system
9	next fiscal
1	may access
2	shall rely
1	feed be
6	congress with
1	(c)(1), (d),
1	350 employees.
4	administrator for
2	articles the
1	971(c)(1) of
1	hearing, be
8	persons under
1	(a) diversion
2	hearing, by
1	(11) little
1	development meetings
1	nonthreshold effect);
1	felony, cognizable
1	(j)) that
2	(g) to
1	applicable period,
2	section 207.3(a)(4)
2	warrant under
5	immediate subsequent
1	adoption and
1	sponsor responding
2	public dissemination.
1	renumbered 22
1	current chairman,
1	beings or
1	identity to
1	modernization act;
3	chloral hydrate
1	furnished for
1	assistance, education,
1	assessed biosimilar
2	order adding
3	grant in
1	finished form
1	350e(c)(1)(e) of
1	(c) available
1	obtained prior
1	(as of
1	title, (7)
6	shall direct
2	change. the
1	various uses
1	(c) program
1	permit control
1	notification (other
4	apply, the
1	designated a
1	(b) known
1	unpeeled natural
1	sustain the
1	(iii) subsections
3	documentation and
2	compromise, may
1	section 360(k)(2)
1	fda; and
1	practitioner an
1	order, from
1	transferee. 
1	any, and
1	$3,000,000, or
1	compensation arrangements
2	preceding introduction
6	reducing substance
8	initial grant
1	355c1. report
1	performed a
7	subchapter, the
1	community; (b)
1	filed, unless
5	generalbeginning not
2	propanamide; (g)
1	afte-school programs
2	may reinstate
13	assist the
1	entity involved
1	(f) outreach,
1	(a)(3)(b)(i). 
10	(b) exception
1	total health
1	(1) full
24	facility that
8	amounts for
1	transmitted helmithiasis.
24	relate to
4	hospital within
1	(5) accept
1	6-day period,
1	patients. (vii)
3	growth hormone
1	owner has
1	includes cell
4	federal court
1	institute under
2	capsules, tablets,
2	permit shall
2	properly receive
1	requesting studies
1	performance bonds,
1	especially but
1	draft framework
1	321b. package
1	jointly prescribe
1	(k) artificial
1	675, 582,
1	administrator, be
2	deemed approval.
1	cannabis products
1	unannounced; (ii)
1	farm identify
2	rico) or
1	essential, in
1	organic farms
3	act as
1	benefits which
2	information act
1	alter 
2	effect, in
1	guidance. (g)
1	armed forces),
2	(c) certification
18	additional evidence
2	response 
2	effect, if
1	president the
1	medical advice.
2	application; approval
2	deemed in
1	strategies required
1	finds and
1	administer training
2	(a)(3) shall
1	accessed, analyzed,
1	dismissal contained
1	1040. recordkeeping
2	animal diseases.
1	1996, a
1	links suggesting
1	revise it
1	potential recipients.
1	custom preparation
2	measures required
1	using one
3	policies under
1	component, any
2	determinations to
1	(8) investigational
1	animal diseases;
1	either known
2	director to
1	submit standardized
2	cover only
13	preparation, propagation,
1	secretary. (t)
1	scientific articles
1	(b)(ii) available
1	application cannot
1	veterinarians to
1	findings made
6	meanings given
1	(f) special
1	seed of
3	notified by
2	sanitary practices
1	sections; (c)
1	u.s.c. 264]
3	establishments within
3	risk means
1	incubation or
4	intervening as
1	considers whether
2	association which
1	meat brokers,
3	generalfor purposes
1	regarding disclosure
4	period, as
2	amendment in
1	contract carrier,
1	following suspension
1	350a, 350c(b),
1	priority the
1	service fund,
1	states, from
4	iii, such
1	adds to
13	manufacture a
1	regulated transactions
1	certification, by
1	body. (f)
1	863. drug
1	secretary. (d)
1	consistent therewith.
1	account potential
2	additional label
1	consumption except
8	drug interdiction
1	source acceptable
2	samples may
1	(d) ergonovine
1	term import
1	indexed under
1	measures prescribed
2	statement summarizing
3	voucher means
3	development authority,
1	(7) responsible
2	pr-submission interactions
3	grase determinations
1	(w)[1] of
1	specific policies
3	including but
11	agency, or
3	regulations which
3	bottled drinking
1	(bb) is
1	superiors (and
2	marketed drug
4	manufacturer, processor,
1	substances no
3	similar form
1	1, 2023.
1	(1) commencement
1	individual prescription,
6	2011, and
4	august 22,
2	353a of
2	obtain annually
2	reports of,
1	(b) failed
4	(bb) if
2	commissioner the
1	registry the
3	(d) with
2	october 21,
3	(bb) in
1	feed, proposed
1	accompany auditors
3	charged for
1	women, handicapped
1	collaborative efforts,
3	include, but
2	manufacture within
3	food animal
1	requiring premarket
26	approval shall
1	(2) standards
2	scientific, professional,
1	completed. an
1	dispersed); or
1	following approval
1	2017) falls
1	c, and
1	analogous compounds
1	(2) tangible
1	imprint, number,
2	periods following
6	effects on
1	treasury, shall
2	(11) is
1	describe methods
28	effects of
1	volum-based adjustments
1	humans solely
1	13th par.,
4	individual portions
4	whole, including
1	treasury nothing
1	conduct of,
1	paragraph (3)(d)(ii),
1	radiation or
2	court. upon
1	innovative, collaborative
1	(a)(1) is,
1	date, have
1	completed, the
2	subsection (m)(2)
4	amount equivalent
1	sponsors device
1	available, such
1	9 of
3	preventing impairment
2	foundation activities
1	carry off,
1	hours. it
1	requestor may
1	(d) anticipation
1	services of,
1	validated methods
7	(b) through
1	investigations (including
1	one and
2	misbranded tobacco
10	data before
7	plans to
1	interim report
1	awareness through
1	uncertainty as
1	actions, if
1	actions used
1	(b) reduce
3	official or
24	risk evaluation
1	compel testimony
2	(iv), (v),
1	successfully applied
1	section 802(54)(f)
1	levels to
1	2013 (to
1	title (in
1	publi-private partnership,
2	implementing regulations
1	facilities; and
1	2009, all
1	performance measure
2	(b) its
1	intramural fellowships
1	import alerts;
5	approved during
1	information should
1	grant waivers
3	adequate within
1	greatest economic
1	prescriptions are
1	security countermeasure,
2	manufacturing these
1	separate account
1	reasonably known
1	subjects to
1	sale constitutes
5	available scientific
1	implementing that
1	insufficient access
1	case, which
1	reinspection for
11	upon submission
1	accepted portion.
1	cows, barns,
1	apart and
1	added aug.
1	authorized officers
1	standard. if
1	section 1903(g)(1)
1	(e) be
1	(2) further
2	publi-private partnerships
1	year 2019,
1	safety standard
2	year 2019.
1	(iii) hold
1	(ix) for
1	act (referred
1	secretary unless
1	(3) intended
1	begin 30
1	(1) presidential
2	resident of
14	commonwealth of
6	title. (june
2	selected establishments.
3	exceptions, and
1	deficiencies to
1	leaf that
2	inspection activities
3	title), and
1	(2), practitioners
1	marketing application
1	final determinations,
9	forfeiture of
2	property, if
22	facility shall
2	(a) redactions
1	revise not
3	informal conference.
10	practitioner licensed
2	union and
2	$3,175,000 for
1	patent, a
1	(d) statutory
1	2008. (4)
1	product samples
1	civic groups,
1	economic analysis,
1	representatives to,
4	allegedly caused
1	675, 909,
1	isomers. (e)
1	extent. (ii)
1	stat. 415.)

1	individual, not
3	tool and
1	technology the
1	repacked elsewhere
1	$500,000 and
1	(n) national
1	performance measurement,
1	(9) final
1	thus, it
1	intelligence, or
1	columbia as
1	blended or
1	subparagraph, in
2	act (27
4	annual registration
22	act (21
1	received. if
1	(a) enhance
1	numerical values
1	control; or
1	no-academic outings
21	become final,
9	criteria to
1	
 360h.
1	person, showing
1	work more
1	reduce a
2	years; (2)
2	products, with
1	1984 shall
1	accomplished 
2	convene and
3	proof that
1	significant disruption
1	level at
7	rates to
1	methodology and
4	form means,
1	condensery in
1	(2) definitionsin
1	reinspection. (b)
1	goods after
1	hours took
5	act. 
1	deny or
1	subsection must,
1	name, as
1	reasonably necessary
3	may select
1	(b) conducting
1	(ii) had
1	reform; and
1	
 960a.
1	hypoxemia or
1	exemption, food
1	safety signals;
1	time whether
25	one of
1	operational, no
1	best. any
4	eggs, and
1	(g)). (ii)
1	issuance; execution;
1	secretarys ability
1	office, either
1	9.5 percent
2	3(c)(2)(b) of
1	secure possession
7	(ii) has
1	(a) account
1	threatened shortage
3	submit reports
98	one or
1	recognition. 
1	unstable nuclei
1	compliance activities
1	(1) activities
16	file a
1	packers of
1	calls into
2	inspection, the
7	agreement under
1	convey any
1	overtime the
1	proclamation, as
1	reinspection activity,
2	subsection (c)(1),
1	explosive devices
1	(e) quota
1	pipes or
6	future plans
1	conducted. (v)
1	expired product
4	841(b)(1)(a) of
1	commission, compensation
3	criminal prosecutions
11	established name
2	applicable number.
1	whether permitting
1	paragraphs (5),
1	clinical investigation;
1	income or
2	1992, an
1	identify opportunities
1	plan bringing
1	application), which
2	manufacturer the
11	consisting of
1	hearing was
1	drugs, controlled
2	include repackaging
1	(iv) submissions
1	assessed. any
1	(c) inaction
1	false nor
1	succeeding violation,
2	appropriate animal
1	product brought
3	(2); and
1	applicable the
1	nonreceival if
1	particular package
14	deny the
1	data summary
2	analyses of
1	recognized an
1	355(j)(5)(b)(ii) of
1	secretary determined
1	establishment other
6	recognized as
2	cosmetics (a)
1	section 360c(a)
19	clinical investigations
270	secretary determines
1	jury. (3)
2	waiver. 
2	foreign material
1	cumulative to
1	administration. (m)
1	approvalif the
1	(i) 60
5	made before
1	on, introduced
2	request with
1	beings to
4	amount, if
1	atropine sulfate
3	drugs. (3)
1	(g)contract requirements.each
4	emergency situations
1	amount, in
6	application fees
1	(2), based
1	(3) expedited
1	675, 503b,
4	remains in
1	ch. 739,
5	subparagraph (d).
7	subparagraph (d),
1	(a)(4)(a); (b)
1	112. repealed.
1	submitted, by
1	us-by dates,
2	provider in
2	previously reported
1	complainant. (4)
14	plan to
1	335c of
5	take appropriate
1	section 387f,
1	purchaser a
2	pediatric devices
2	hereinafter prescribed
1	witnesses on
2	raising, and
1	18 applies
1	sample upon
1	generalto determine
2	data disclosed
1	of, to
1	receiving products
1	(2) means
1	many controlled
2	lists the
3	drug includes
1	served three
1	waiver for
1	use; except
15	deemed necessary
3	administrative services,
2	application fee,
1	2011, submit
1	farm), if
1	based. (mar.
4	drug included
14	beginning after
1	code number,
2	sample requested,
1	(c)(1)(a)(ii), (d)(1)(a)(ii),
3	last known
1	maintenance, operation,
2	regarding labeling
3	1953, ch.
4	(pcp) or
4	31, 2012,
2	(2)(a) if
4	chapter (including
2	actions if
2	filing date
1	consider in
5	(1). the
14	psychotropic substances
2	article complies
2	measurement system
1	significant improvements
2	make its
9	 (m)
1	available training
5	(b) there
7	sponsor may
1	(including nicotin-based
1	adequate, approved,
1	(c)(2); (2)
2	induces, entices,
1	contentsthe report
1	unique management
1	(d), except
1	carrier refuses
2	thereof) for
3	intravenous product
1	diethyltryptamine. (6)
1	organized labor.
2	illness from
6	official mark
1	381(q)[2] of
6	sentence, the
1	321. definitions;
2	law. (

2	contaminants for
1	additional patent
6	receives or
1	order, detailed
1	continues shall
12	authority provided
1	consulting the
1	donated funds;
1	compounding, physicians
1	hearing, including
1	tansy, rue,
7	specimens of
3	international organization
8	data (other
4	customs and
9	tolerances and
1	propylene oxide,
10	product described
3	orders 
1	calendar quarter)
1	trade mark
1	appropriate official
1	calendar quarter.
1	manufacturer. for
1	local distribution
3	residue, and
1	safety capacity
2	vegetable origin,
1	moral turpitude.
1	deputy director).
1	means necessary
1	species, where
1	providing direction
1	morphine methylsulfonate.
1	budget unless
4	conditions relating
1	authorities; (3)
1	dealers with
1	comply. the
1	reside, or
1	(1) submissionbeginning
1	parties directly
4	destination of
2	powdered, dried,
1	47 shall
1	food emergencies
2	date (or
1	person provides
1	
 1161
1	968. service
1	mainstream or
1	therefore, essential
1	foundation that
1	(2) administrative
3	education act
2	conditioned upon
1	cycles nothing
1	capacities, and
1	confirmation of
1	adequate security;
4	person provided
1	imprisoned or
6	rule, regulation,
1	anecdotal information;
2	sufficient financial
2	dispensing to
1	paragraph, tobacco
3	laws applicable
1	licensing, distribution,
1	existing law,
22	health. 
1	regulations, subject
14	2013, the
1	third parties,
1	beyond december
2	coordinator shall,
2	379i or
4	timelines in
13	disease control
1	trial information
1	832.)
 

1	7. 
92	(1) shall
3	files application
1	(f) technology
1	misbranded products,
9	activities as
1	712, 48
3	(3) preservation
2	laws containing
3	activities at
9	body of
1	(c)(1)(a)(i) may,
1	one use,
5	against, and
2	required the
4	granted such
2	increased sentence
2	body on
1	apples are
4	subsection unless
1	(d) above
11	direct that
1	request. (3)
1	section 1391
1	signals; 
8	body or
1	section 1395
1	risk unless
3	reviewed under
1	establishment registrations
1	(6 u.s.c.
1	term employee
1	section 384
2	potable water
1	substantially duplicates
5	oral prescription
1	coordinate any
1	barbituric acid
3	(including when
3	functions by
3	device a
1	title 5with
1	national household
2	may consist
1	arranges for
1	recommendation, and,
1	performed each
1	benzyl chloride.
1	oil, creosote,
1	
 360bbb3b.
1	condemnation; claims
1	foreign exchange,
2	(4) within
1	advertising restrictions
11	felony under
7	coordinate and
1	enforcement drug
1	60, 12,
1	tolerance found
36	approved for
1	terminate a
1	oil or
4	hearing upon
2	variance shall
1	data indicates
2	time necessary
1	2003, for
1	revised strategythe
1	(or testing
1	shipments, lo-b-lot
6	technology assessment
1	may help
7	employed intermittently.
1	360eee1. requirements
2	(k) is
2	360e(g)(2)(b) of
1	device, shall
1	appropriate schedule
1	year 1999;
2	742, as
2	 (21)
2	barriers to
1	letter regarding
3	regulation. (4)
1	distributors: 
1	tobacco, filter,
1	vehicle being
1	repackager, labeler,
2	altered in
1	operate under
3	procedures specified
7	administration, advisory
3	double for
1	administrator required
1	aggregated by
3	(2) other
1	exclusive, to
1	associated training
1	misleading, then
1	upon purchase
2	duties specified
2	general controls,
2	(including regulations
1	allow said
1	administrative restraint;
1	centers). such
1	continue, modify,
2	training for
1	(whether imposed
1	contempt proceedings
6	underlying data
4	control procedures
1	reconstitution is
1	pesticides, (ii)
1	379aa. serious
1	$125,767,107 for
7	841(a)(1) of
1	drug; shall
1	concurrence with
2	health organization
1	grams may
1	way whatsoever
1	maintained. the
4	stat. 821.)

1	part. until
1	1508. repealed.
1	support thereof.
12	amenable species
1	initial deadline
1	annual change
1	judge, may,
1	vessel on
2	groups, including
1	repackaged by
4	drug; or
1	rent and
1	obligations, shall
3	women and
1	except an
1	violations shall
1	weighing any
1	27-calenda-day period,
1	supplier means
5	manufacturing use
2	confer any
1	year, budget
7	full statement
1	(1) importer
1	similar genetically
2	radiation disclosure
1	small portion
1	drug, (c)
1	panel, including,
5	effect, and
2	restricted device
133	except as
3	subsection (b)(2)(a)(iv)
1	units produced,
1	recommendations, shall
1	meals for
3	auditors and
1	1997 means
1	publishing current
1	sufficiently rare
2	532, formerly
2	(1) definitionin
1	order set
1	(a) emerging
1	(4)2 congressional
1	reaccreditationthe secretary
5	pesticide residue
1	timely public
1	register, specify
1	congress shall
1	youth are
1	adulterated. (c)
1	setting organizations),
2	explore and
1	therapy have
1	professionals. (ii)
1	administrator by
1	related matters
1	(2) recruitment
3	efficient and
1	immune from
15	(d). 
1	meat spots,
1	management, in
6	certified mail
3	begin with
3	subsistence, in
1	act prior
1	administration, dosing
1	drug constituent
1	policies, directions,
1	wrongdoing), the
1	superior to
1	defective or
1	special surveillance
1	10 times
1	feeds, based
1	product.. 
1	expertise necessary
1	listing; and
2	reimbursable basis,
1	quality assurance,
1	new zealand,
1	174. repealed.
1	preparation meets
1	348(f)(2) of
2	previous owner,
5	amendment made
1	(a) period
1	(ii) service
1	either before
6	property for
3	controls of
1	depict its
3	ingested by
1	violations; (ii)
1	york, march
1	agreement, paragraph
1	(2) restrictions
1	understanding 
1	constitution of
4	(f), the
1	(c) whether,
2	device experiences
1	adulterated. the
1	comment, that
2	health, toxicological,
1	components, materials,
3	(e)(1) to
1	restrain or
1	calendar day
1	ante and
1	tolerance, a
1	agencies, courts,
2	(1) manufacture
1	proof requirements
1	proper oath
2	drug (other
1	product information
1	(1). an
1	entered consents
1	2221. food
1	
 379d.
1	agreement, but
1	efforts among
1	photon positron
2	2017. if
34	product shall
2	certain persons;
2	(c) make
1	working for
1	consignee. clause
1	delivered it
1	55.0 
2	functions. 
1	675, 721,
1	job training
1	electronic communications
1	identification that
2	allowed in
1	expedite an
1	enforce section
1	42 (not
1	term ultimate
1	offenses under
1	(g). (i)review
3	application fails
1	currently registered
1	shall expand
1	transferred technology.
1	professions; (c)
50	assure that
1	3374(c) of
1	periodically evaluate,
1	section 876
1	accompany the
2	(1) referral;
1	(i) either
1	diampromide. (15)
1	manufacturer. (2)
1	assessed shall
5	thereupon the
4	pediatric populations
1	food process
4	plan under
1	congress declares
2	time upon
1	tuberculosis; (3)
1	advertisement review
6	substances for
4	bears labeling
2	discuss and
7	obligated for
1	recall shipments
1	logbook entry
1	procedure pursuant
3	general this
1	impose on
1	inspectors; (d)
5	entity if,
1	determination, set
1	compensation, including
5	waivers, exemptions,
7	sole discretion
1	evading a
2	establishment (as
1	objections is
1	diverse product
1	including tobacco
2	2017 for
1	transfers all
1	form, but
2	chapter under
5	379g(1) of
1	sections 2234
8	pharmaceutical ingredients
2	discovery shall
1	revision and
1	(iv) requests
1	law; (4)
1	133. repealed.
2	appropriate, such
2	organization, to
2	(i) $652,709,000
1	ii, 57
1	confidentially maintain
2	foodborne illness.
2	period. (b)
1	utilization; and
12	submitted on
1	belief of
2	country will
2	implant, as
1	extended date.
1	(cc) such
2	(3) provides
1	foodborne illness;
1	(i) significantly
3	conform with
9	208 of
1	use, at
2	judicial proceedings;
2	1992, had
1	(1) retail
3	scope and
2	use, as
2	certification (or
1	lot, batch,
4	implementing such
1	sections 274a.2(b)(1)(v)(a)
1	board or
1	suppliers, (iii)
1	misbranding, and
1	kept and
1	use 10
2	relief, including
11	demand reduction
2	undergone all
1	precedence to
1	substances. members
2	court. 
2	drug distributor
1	201. doing
1	(i) judicial
1	(aa) federal
7	represented for
1	children; (2)
2	state, except
1	involving methamphetamine;
1	plant, fiber
1	trafficking means
2	volume parenteral
1	flocks production
1	petition) establishing,
1	enhance foodborne
2	2011) beginning
1	399g. food
1	marketing, advertising,
2	representatives, to
2	packing thereof
1	scientific methods,
2	processes, notices,
1	675, 744k,
1	seq.); (g)
3	significant decision
2	possesses such
1	(e) compounding
1	measurement systemnot
5	requirements prescribed
11	fee amendments
1	delivery device,
1	section 384(b)
1	national clandestine
1	
 1055.
7	enforcement or
2	report thereon
1	territory. (mar.
3	violation involves
1	timeframes described
1	600.3(ee) of
1	multiple violators,
1	in, claims
3	353 of
4	feet of,
1	simplicity. 
2	records which
3	upon publication
1	medical air
1	review, under
3	government may
1	products involved
1	partners in
1	initial importer)
1	consults with,
1	equal amount
6	drug from
1	shall sign
1	(ii) humidifies
1	detailed plan
7	extent a
1	campaign will
1	dosages set
5	chemical will
1	collectively by
1	companies with
1	particular; he
5	section involving
1	investigation, arrest,
1	laboratory; and
1	unaffected poultry
1	previously classified
1	delegate any
1	portion. (c)
1	(a) cannot
3	commissioned by
15	obligations under
1	diverse and
1	publishes in
1	period, except
1	sparsely populated
1	(as applicable),
1	protective orders
5	information known
1	(6) cyprenorphine.
2	drug lacks
1	sought; (b)
1	(16) dimenoxadol.
1	matter. 
3	adulterated. 
1	vehicle of
1	kind or,
1	federal sentencing
1	(a) generic
1	title, develop
1	(1) (involving
2	(as applicable);
3	businesses (as
3	title, he
1	(2) dispute
1	another component
5	state law;
1	1701(1)[1] of
1	congressional notification
1	(8), (9),
3	reduction, demand
1	(c) exceptionsthe
6	studies, or
1	qualified manufacturer
10	iii or
1	character of
1	(a) notification;
1	(b) distributors
5	fee collections
1	(2) who
68	product for
1	significant updates
1	seeking its
3	one violation.
2	facility are
1	(iii) -(-naphthoyl)pyrrole
1	statistical analysis,
2	involved; or
5	produced in
1	section 201(b).
2	export if
1	designate, by
1	new products
1	diverse communities.
1	communication the
1	page summary
5	confidentiality and
1	(2) emphasis
3	applicable thereto,
1	 (l)[1]
6	eligible countermeasures
1	(iii) -penty--(-naphthoyl)indole
1	adulteration eggs
1	aircraft the
1	reviewing an
1	information forwarded
6	part 352
1	subsection during
1	labeling; (c)
13	individual, partnership,
3	(1) appropriate
1	managed health
2	do, with
1	isomer, or
2	towards the
1	section 262;
4	facility if
1	(e) making
3	nutrient required
1	form if
1	section 262,
1	consider using
1	contents thereof,
1	secretary; publication
1	human beings;
5	form in
1	methylphenobarbital. (9)
1	parties made
1	significant losses
2	assesses a
1	(e) rule
1	17. penalty
1	(including testing
1	evaluation) to
1	provided. (ii)
1	(1) availability
1	intelligence agency.
1	states, for
3	extraordinary circumstances
3	adjustment: 
23	individual, or
1	1239; 

2	counterfeit drug
2	eligible countermeasure,
1	811. authority
1	management training
2	information for,
2	process devices,
1	shall deem
1	satisfactorily treated
1	chapter other
1	data instead
3	(e) additional
8	specify in
1	released in
1	certified organic,
1	younger, shall
1	schedule by
1	adjustmentthe inflation
1	(a) demonstrates
1	offense prohibited
1	conference is
1	(1) best
1	fair and
6	amount shall
6	conspicuousness (as
29	facility is
2	article shall,
1	foreign pesticide
1	upon commerce,
9	prepared for
2	cautionary statements,
2	title.[1] 
5	safety, or
3	32 stat.
1	(b) suspension
7	establishment 
1	week during
1	facility it
1	affidavit demonstrating
1	(e) definitionsin
1	necessary. (g)
1	statementthe transaction
1	isomer. as
1	460(b) of
1	including advice
4	(a) establish
4	successor in
1	audit agent.
1	successor is
3	investigation if
3	year will
1	conspicuously 
3	(b) penalties
2	interpretive criteria,
1	individual; 
1	materials (a)
1	exists unless
1	poultry food
1	no-food producing
3	publication by
1	any) by
1	secretarys notice
1	canadain particular,
1	abroad, and
1	(2) comparative
1	(b)(3) may
2	343(r)(1)(b) and
1	(iii) snuff.
1	quorum. 
2	requirement with
1	sunscreen, the
1	name. (ii)
1	storage facility
1	section 4706
5	therewith so
15	age group
2	business 
2	(including with
1	warranted. if
1	person forfeit
1	section 1047
2	establishments if
5	commission to
5	352, 360,
1	public distribution
1	submit by
1	competency of
1	both; but
1	(k) definitionsin
4	activity. 
2	surveillance, submit,
4	(5) knowingly
1	practice pharmacy.
1	action: 
10	regulation; and
3	chemical, biological,
1	(11) hydromorphinol.
1	receive 
1	campaign. (h)
2	(c) drug
7	establishment which
1	money penalties,
1	drug residues,
1	responsible partyafter
1	obtain specialized
1	part approved
1	disposal, the
13	program for
1	restaurants in
1	persons validly
1	july 2,
3	extent applications
1	particular the
1	diagnostic criteria
2	exemptions, or
2	842 of
1	proposed therefor
1	(2), where
1	ongoing relationship
4	information subject
1	manufacturer, except
2	distribution under
1	one management,
4	379e(a) of
4	proposed standard
4	marijuana use.
4	means (1)
1	combined number
1	$10,000. (c)
1	materials. (4)
1	establishment, institution,
1	initially consist
1	exceed 30
1	inspection, be
4	concerning nonprescription
2	director who
1	oils of
2	chemical substance
5	carry over
1	workplace programs;
2	25). 
10	due upon
1	petitioners claim,
3	activities, including
4	 in
1	components (such
1	type; 
1	telecommunications service,
2	seek input
1	conduct duplicative
2	properly labeled;
1	america; or
2	existing legal
1	control coordination
1	flavoring extracts,
1	(a) resistant
1	(1) no-interchangeable
1	21 cfr
1	(i) when
1	signature to
2	retail stores
2	man to
1	amending under
1	(a) findings
1	research organizations;
1	(f). (iii)
1	nmic requirements
1	agriculture duly
1	rape or
17	federal law
1	(b). (d)
4	treatment. 
1	actual drug
11	used or
1	smoking opium.
7	destroyed for
1	wrongful distribution
1	pharmacopoeia. 
1	using huma-readable
1	degradation. (bb)
1	rata amount,
1	geographic area
1	26, 2002
1	(d) periodic
1	action, raise
1	residue; (iii)
2	(ii) public
2	package submitted
1	comment a
1	local level
3	used on
1	enforced by
6	reports the
1	hold or
1	effective pursuant
2	section 360b(d)(1)(e)
1	approved; (3)
6	property that
2	trial, or
1	reimbursed for
1	number patients
20	commission shall
4	subchapter, and
4	sold at
1	(i) prepare
1	measures have
1	implant, including
1	additional steps
1	comment may
3	(1) inflation
1	youth; or
2	(2) rule
1	certain persons
2	(except the
1	feed containing
1	health measure
5	shall affect
1	point means
1	secretary. (i)
2	petition approved
3	term adulterated
1	agencies concerning
1	assessment regarding
1	675, 567,
1	incurred, or
7	42. 
1	secretaryin carrying
1	g).c d
1	counterfeit and
1	equivalence decision,
2	prescription. (2)
3	withdraw such
2	so; or
1	relied on.
1	substances. he
1	relied on,
2	(4) serious
2	subject to,
1	reviewing such
2	loss to,
1	(d) reports
1	terminating an
1	action plan;
3	exceed 90
1	regarded under
1	including anecdotal
4	standards applicable
2	product), the
1	previous years
1	appropriate responses
1	675, 410,
1	written into
1	use paragraphs
1	using real
1	full waiveron
3	filed a
2	unintentionally introduced,
1	study advanced
2	voluntarily agreed
1	governments strategy
1	directions of
1	prescriber. (mar.
1	deadline 
1	conduct may
1	crime of
1	unintentionally introduced;
1	(1) substance
1	1-month period,
1	contact email
1	consolidation is
2	(d) powers
2	without an
1	hazard exists;
5	clause (2)
1	complainant has
1	
 1176.
1	register; notice
1	requirementsthe regulations
3	area, premises,
5	oversight and
1	(dd) tentative
2	enacted after
1	tested commodity
4	change approved
3	generalthe attorney
1	approved application,
1	territory may
2	filed. in
1	response letters
1	causes another
2	establish. 
1	filed. if
2	remains listed,
1	proposed standards
2	practitioner, other
1	available. (h)
1	individuals have,
1	bottom of
1	supervision through
9	fees that
1	commence such
1	alter, and
1	dismiss the
3	professional personnel
1	-year projection
2	require recall
1	procedures exist
1	intelligence fusion
1	360eee3(a)(1) of
17	active ingredient)
2	subparagraph has
3	complained of
9	received a
1	label (as
1	issues concerning
1	extracts, except
1	request as
1	proposed standard,
1	proposed standard.
1	arrangements. a
1	(d) advising
1	materials described
1	placed, such
1	601(m)(8) of
1	supplies, and
1	without marking
2	term customs
1	orderif, in
2	investigations, reports
1	proposed standard;
1	(19) shall
2	extent deemed
1	least $6,250,000
1	drug, other
1	agreements as
1	12 to
1	response letter;
1	(b) supervisor,
1	history to
1	30, 1975
1	prioritythe secretary[1]
1	received 2
1	protocol containing
1	
 609.
3	designate, may
1	physicians of
1	respecting it
1	contain, an
1	delay. (c)
5	paid into
1	renders it
1	passed a
1	(viii) religious
161	nothing in
2	(b) facilitate
1	(b) trend
42	intent to
7	importer to
1	health (established
1	ordered to
3	retail unless
1	deem necessary;
1	annually. (qq)
1	shall command
1	regulations limiting
2	estimated revenue
1	patients are
1	3, 1954,
1	drug development.
2	security clearance
1	foreign commerce;
12	public meetings
1	import, which
7	may consider
1	site, or
2	immediately. (ii)
1	subgroups (a)
1	(iii) violation
1	imported nothing
1	set 
1	script, story
1	value which
1	identification, is
1	labeling, of
1	assure proper
1	expenses means
9	proposed context
3	1958 (72
2	commits a
1	import; (3)
1	performance, include
1	employees pursuant
1	three weeks
19	labeling, or
1	secretary maintains
1	jurisdiction (authorizing
1	device or,
1	subparagraph (b)(ii),
3	service upon
3	anyone responsibly
1	(b) slaughters
1	public meeting,
1	helping alleviate
5	written statement
2	shall facilitate
1	seq.) to
1	shall head
2	40.0 
2	schedules, the
12	license to
1	applicants withdrawal
1	providers; (b)
1	provider standards
2	accidental or
1	cooperates or
1	cover additional
1	defendant convicted
1	(b) production,
1	155, 1,
1	air, to
2	presented, that
6	designated personnel
2	eligible establishment;
1	(ii) other
1	collaborations. 
1	medical center.
2	(i) requiring
2	governmental unit,
1	additional penalty
2	contained or
1	public policy,
1	sales; written
1	(b) limits
2	(e) include
1	predictability; and
2	conducts business,
1	343(e), 343(i)(2),
1	use; (3)
1	connections to
1	nanomaterials, the
1	unreasonable efforts
1	2002. records,
1	mill licenses
1	(iii) evidence
2	(iii)no damages.
1	powers prescribed
1	customer as
1	term sem-critical
1	1037(c) of
2	whether at
1	recall regulations
1	353(e)(4) of
1	protocols, and
1	subsection, other
2	benefit for
2	(bb), and
8	whether an
2	pronouncement of
1	sufficient proportion
1	form described
1	gases for
2	within 1,000
2	capabilities of
1	contaminan-specific and
1	protocol). if
1	harmful substances
3	formulation, the
19	regulations shall
1	development toolsubject
1	selection process.
1	subsection (other
1	review relevant
1	paid carry
1	barred by
2	officers, employers,
8	establishment, the
1	title, use
4	notice transmitted
1	(c) storage,
1	provide interested
2	laws to
1	organizations. upon
7	supplement and
1	agonist as
1	including requests
1	
 459.
1	grantssubject to
1	(c)(2) shall
5	appropriate steps
1	current reports
1	(f) prohibition
2	activity undertaken
1	54 of
2	maximizing the
1	kinds and
1	monitor recalls
3	(a) before
1	level, such
1	normal biologic
1	redaction by
1	term biomaterials
1	laboratories meet
1	public any
1	(iii) under
1	(e)(4)(b). 
14	make any
1	(i) pesticides,
1	aerial and
2	(1) abbreviated
1	advertises the
1	demonstrating conformity
1	enterprise if
1	chicks (at
4	make an
7	make and
3	u.s.c. 1621
2	(c)(1)(b); and
1	forms, and
4	programs under
2	delivery devices
1	(b) 66
1	risk; safety
1	
 94
1	counted under
1	make unreasonable
19	control policy
1	index under
1	
 6.
1	guarding against
1	559, 2,
2	records; or
1	implant as
1	beverage until
1	groups a
1	disclosure, for
2	secretary, taking
1	adjustment percentages
1	-methy--phenylpiperidin--carboxylic acid.
1	397. contracts
2	(3) contentthe
8	colored margarine
2	title solely
2	techniques for
11	circumstances of
3	comprehensive, coordinated
1	(ii) 50
7	final, subject
1	(x) for
1	applicant unless
5	enabling the
2	(b) communication
30	bears or
1	(a) vests
6	applications, or
1	enactment date)
2	labeling at
2	listed chemical;
3	labeling as
3	7 years
1	debarment regarding
2	statesnot earlier
5	(iii) such
1	spacesubject to
1	person importing
2	equip, and
1	enactment date,
1	(a)) that
1	repeal a
1	insurance act
2	class, and
1	title 19)
1	(c) conflict
4	considered in
4	comment and
6	occur in
1	regulations; (3)
1	authorize distributors
1	(m) separation
1	stating why
2	(j)(2)(a)(vii)(iii) of
1	occur if
1	principal administrator,
2	produce was
1	(e) preemption
1	standar-setting and
7	revoking an
1	approved. (3)
1	received tentative
1	partnership agreements,
1	contractor to
1	(a) extension
1	11, 1946),
1	importer, distributor
1	physiological dependence
1	postmarket adverse
1	1996; (b)
1	canceled prior
2	appropriately respond
1	section 352(t)(3)
1	public. such
1	license has
2	authority, or
1	(10) sulfonmethane.
2	review, as
1	therapeutics), biopharmacology,
2	preservatives shall
2	food. subsection
1	(16) pethidin-intermediat-b,
1	officials employed
1	seq.]. (z)
6	practitioners licensed
1	claim made
65	listed chemical
1	quantity therein
1	675, 533,
1	therein, (ii)
2	understands each
7	investigating a
2	claimant prevail.
1	343(q) of
1	review, an
2	(g), the
1	refusal shall
1	issues the
2	record required
1	physician in
1	remaining 20
9	committees, and
2	panels review
3	sections 49
1	goal and
36	support the
2	inspections, and
1	(i) employees
1	court any
1	services, that
3	advertisements identified
1	387i. records
1	device industry
3	furnish any
2	waiver, or
1	inspection methods
1	poultry delivered
1	conditions. if
1	subsections (b)(4)(b),
1	devices on
3	(b) report
1	suspended shall
1	sponsor, if
1	sounds of
2	(c) amount
1	provision by
8	qualified adul-only
1	requirements; (h)
2	instances is
1	30 or
1	harvest, carry
1	adequately evaluated
1	harm (referred
1	harm being
1	advertising not
1	country provides
3	30 of
2	unrestricted by
1	
 360a2.
4	facility and
1	application must
1	(b)(2) that
2	transaction, provides
1	additional safety
2	hereby declared
1	assessment framework
2	chapter[1] 21,
1	develops and
1	leaf with
1	documents resulting
1	basis; (b)
1	(g) execution
1	using standards
8	animals for
1	(d)(3) of
1	judicially noticed;
1	paper, poster,
1	(b) jeopardize
1	amphetamine, its
1	
 343a.
55	shall take
1	quota may
1	incubation; (6)
2	(2) prohibited
1	$712,000,000. 
1	clinical need,
1	criminal enterpriseany
1	consolidate pos-seizure
4	completed or
1	360g1. agency
1	387h(c), or
1	cooperative agreements.
1	purporting to
3	cooperative agreements,
3	(d) suspension
1	products; destruction
3	operations are
1	vehicle) to
1	1534. technical
1	paragraph (1)(g)(iv)
1	taken a
1	(the countries
2	evaporated, concentrated,
1	paragraph; (5)
1	determination. (h)
2	action will
32	fees collected
1	sponsors). (c)
1	appropriated and
51	review voucher
1	goals nothing
1	limitation would
1	subsection because
1	prescribe which,
1	proper and
1	domestic sources,
1	deferred and,
1	ris-based, reasonably
1	group and
1	formerly 7th
1	additive, (ii)
3	importance in
6	file the
1	law 10782
1	section 1543(a)(2)
3	held invalid,
1	pharmacists; pharmacy
1	(6) involvement
1	entity, means
3	(i) before
1	regatta, or
6	days in
1	libel, and
2	13, 1992,
5	result from
1	financial hold
1	administration inspectors
1	below. the
1	days if
1	(2) limitationsparagraph
1	sentence inquire
3	subsection (c)(1)(a)(i)
1	crop is
1	maintain, and
10	five years
1	136a, 136h].
14	strategy for
1	 (b)database.not
2	second conviction
1	additive because
1	designated document
1	review workload.
1	including descriptions
1	prepared, propagated
1	offices for
1	1009, formerly
1	transcribed. a
4	convene the
1	
 625.
1	country indicating
1	less efficacious
1	sentence required
4	5, for
1	assure an
1	additive, if,
1	appointment of
1	present demonstrable
2	product between
1	data accessed
1	involvement of,
13	senate a
1	(c) programs
1	parties unless
6	public hearing
1	supervised by,
1	only, not
1	grase means
3	(b) evidence
2	thereupon shall
1	
 641.
2	(after the
1	only, nor
2	involved malfunctioned,
1	without difficulty.
2	business premises,
1	develop guidance,
5	drug paraphernalia
2	material is
1	
 890.
1	(5) collect,
1	agreements between
1	act, including
3	marks may
16	device from
1	(b) vacating
1	effective; and
1	environment and
1	2013: 
1	requirements; (d)
1	interagency and
1	served directly
1	sentence requires
1	purchaser, (b)
1	farm; (b)
1	shell but
1	poultry, which
1	keeping in
2	classified report
3	account. 
1	resolution a
4	shall complete
1	exceeds 150
3	tableting machine,
2	year established
1	involving fruits
38	made effective
1	sentence, for
1	corrections, probation,
1	(v) any
1	and[1] 
1	(3) meeting
1	hydromorphinol. (12)
1	it, delivers,
1	list, or
1	article purported
1	(c) supplying
1	conditions found
1	amounts. (5)
1	assessing civil
1	either party,
1	combination, that
1	prohibited personsthe
1	eliminated or
15	early childhood
1	provide false
1	youth on
10	usual name
1	350. vitamins
1	clinical medicine
1	barrel so
1	conditions governing
4	industry to
1	youth of
1	lists maintained
3	demonstration programs
2	user (referred
2	employees (including
3	subchapter in
1	product, whichever
1	(7) community
1	commission considers
1	
 208.
1	shall test
1	situations not
2	formulated in
2	device shall,
4	shipped by
1	360ll(a)(2) or
1	(4) amendment;
1	stockpile maintained
4	protection act
1	found for
1	substances lacking
7	drug, which
1	alleging inadequate
3	matter upon
1	invalid, he
3	packer of
1	(b)(1), is
5	received, or
1	hours, for
2	audit, an
2	351(a) or
3	feed which
3	will occur
1	standardized numeral
9	regulation establishing
18	eggs or
1	
 387m.
3	register (a)
1	prescribe in
1	renewed upon
1	special project
1	inspection; refusal
2	subparagraph. (ii)
23	section 355(i)
2	receive more
1	675, 740,
2	involved shall,
2	certifies to
3	drugs, 1961,
1	387j(a)(1)(b) of
1	vegetable, consideration
3	impose requirements
1	products hereinbefore
2	recommendation. a
4	clearance, or
1	although they
1	public, including
8	applications filed
1	(which, to
1	importation within
1	submissions, shall
1	individuals. all
1	devices. (e)
1	respectively, at
1	regulation, if,
1	name if
1	aggressively and
1	(4) when
8	3583 of
1	action, unless
26	imposed under
1	waived the
2	establishment described
1	evades or
1	(b) meaning
1	amended, for
1	examplesexamples of
3	least 2
1	name it
1	product classes;
1	notice meets
1	pr-submission interactions;[1]
1	facilities following
2	modular applications
1	notification; (8)
1	assessments was
15	district in
2	seizing drugs,
2	witnesses the
5	sale at
1	organizations; (iv)
6	committees not
1	amending a
1	wholesome, unless
1	patient. (3)
22	report of
1	possible hold
1	(2)(d), the
1	eliminates or
1	(k) request
3	holder designated
1	675, 505b,
1	benchmark survey
1	full spectrum
1	shortage. (

26	report or
1	128. repealed.
1	previous demand;
1	(b) prioritize
1	experience identified
35	entitled to
1	annually thereafter
1	via a
1	assistance; and
1	relevant. 
1	3,-methylenedioxypheny--propanone. (m)
6	notwithstanding subparagraph
2	sustained period
1	13, 1949,
3	descriptive and
2	individuals empowered
1	360bbb3a of
1	importer) who
1	amended [42
247	referred to
1	diversion. 
1	2.0. 
3	product. for
1	related the
1	discussions to
1	contents not
90	drug product
1	nothing contained
1	sanction or
1	ranking minority
1	enforcement; penalties
2	category in
3	lifetime risk
2	packs, distributes,
1	data demonstrate
1	exemption meats
2	one person
1	annual distribution
6	combination product.
1	institute established
2	exported, distributed,
5	public disclosure
1	supplemented with
3	subsection (b)(1)(d)
1	in, such
1	degradation product.
3	states if
1	transaction each
3	plan is
2	filling, the
4	steroid or
35	states in
1	cigarettes to
1	reserved for
1	scientific studies
3	section; (2)
2	states it
4	duties as
1	order based
9	petition the
1	degradation product;
1	analyses, about
6	per ful-time
7	states is
1	negligent suppliers.
2	plan in
1	deposited or
1	practitioner, while
1	360e(d), 360e(f),
1	(2) mai-order
5	annual national
1	threats and
1	message or
1	gas. any
1	extenuating circumstances
3	wholesaler of
2	licensed practitioner,
2	contributions, raised
1	458, 459,
1	provide nutrients
8	audit and
1	cooperative, or
1	wholesaler or
1	submissions pending
4	unlawful under
1	person becomes
1	(b) nonvoting
1	(d) partnerships
1	maintain thereafter,
1	drug, (2)
1	misbranded cosmeticsa
3	is. 
1	remaining therein
1	675, 586f,
1	shall leave
2	(d) reinstatement
5	title; (6)
1	862. denial
1	2015 falls
2	ten years.
2	specifically intended
2	accredit or
1	state, prominently
5	unauthorized disclosure
1	18. (f)
1	678. no-federal
2	name (or
3	activity that
4	meetings or
1	(b) nothing
1	maintenance, detoxification,
1	meat thereof,
1	petition promptly.
1	bad faith
1	inflation (as
1	applications shall
1	counsel to
1	exposure data
1	
 879.
1	operate an
2	within or
2	verification, and
1	period more
1	single package
2	carcasses for
2	design validation
3	recall to
2	section 355(j)(7)
1	injectable liquid
7	showing of
2	incorporate such
1	licensed, registered,
12	(2) with
1	plan, shall
1	straw, concentrate
2	withdrawn during
1	approach); (ii)
3	(q). 
2	1974) and
1	whoever possesses
2	retailer or
6	eligible product
1	misrepresentation, fraud,
1	holder) has
2	section 208(a)
4	establishment processing
1	fulfill those
2	expose patients
1	tobacco, smokeless
2	provides that
2	order stating
1	methamphetamine use;
1	summarize, and
1	(b) extension
1	2017, $635,000,000.
1	industrial needs
2	practicable, minimize
1	persons liable;
1	panels according
1	plasma, or
1	importer with
1	aircraft, vehicles,
1	use direct
1	351(k) of
2	1949 (7
2	adequately diversified
4	iii 
31	meat and
1	directive respecting
2	cases in
1	modify, revise,
1	duly accredited
1	(c) what
1	deny such
1	congress intends
1	imports, including
2	admission, except
2	information reporting
8	processed food
1	iv, with
1	fee with
1	criterion of
1	balance of
2	states pharmacy
2	regarding data
1	licensed pharmacy,
1	apothecary, or
1	licensed pharmacy.
1	identifiable office
4	replenishment of
4	upon its
1	provide substantial
6	section 823(f)
1	mixture for
1	records), make
1	regulations, authorize
4	area to
1	outweigh any
1	columbia, any
1	charge is
1	(1) grant
2	report, no
1	charging cos-based
1	practice, willingness
3	evidence relevant
1	public, as
1	(f) manufacturer
5	seller to
6	revenues and
1	nominees 
2	currently use
1	logbook the
1	indirectly from
1	services; hearing;
1	compliance at
1	approve animal
1	practice. (e)
1	who, upon
1	compliance as
7	382 of
3	panel by
1	not, implicitly
1	capable (alone
1	(c) applicants
1	contains chemicals,
1	agreements relating
3	similar article
1	continuing threat
8	distribution before
2	355e of
1	exporting any
1	(b) treatment
9	schedule under
1	committee. within
2	vienna, austria,
2	identifier not
1	deposit that
1	enforcement provisions
1	(3) substantially
1	addresses when
1	(8) illegitimate
1	gel (or
4	paid only
1	(1) includes
6	tobacc-related disease
3	indications of
1	exempted; and
4	greater value
1	formerly 8th
1	may subsequently
1	resources (including
1	approval letters
6	serums, toxins,
1	epinephrine when
3	qualified under
1	1st par.,
9	simulation thereof,
1	approved shall
1	activity; (iv)
1	section 3324
3	handling and
1	devises, bequests,
1	section 332,
9	food under
9	certification to
4	shelf life
1	(a)(1)(c) so
3	previous year,
1	2013. (3)
20	[7 u.s.c.
1	services. if
1	laboratory means
1	yellow and
1	(b)(3)(c), and
1	products); (c)
1	court granting
1	262]. (ii)
1	transferred; and
1	custom slaughtering
1	subsequently require
1	inspection; denaturing
25	(1) through
2	manufacturer, a
1	conditions to
4	support or
2	notification any
2	premix used
2	treatment services,
1	(iii) amount
1	nurse, teacher,
1	chemicals manufactured
1	clearance before
1	reviews include
1	distribution committed
12	years, a
2	basis upon
9	conduct or
1	availability to
2	designation process
1	project set
1	title. (aug.
1	(c) definitionin
1	qualification plan;
27	conduct of
4	conditions; and
1	register, shall
1	registry to
1	zone. (h)
1	drug information
4	manufacturer, supplier,
3	provisions 
2	senate not
1	packed, transported,
1	remove susceptibility
1	(i) arranging,
1	section. before
1	i, 15,
4	distributor. 
4	employees and
12	dispenser shall
1	strategy, but
1	disclosure about
22	developed by
1	expertise of
2	labeled, and
1	casual or
1	hearings, the
3	audience that
2	processing, storage,
1	exchange for
6	subpart: (1)
2	surge capacity
2	violation. for
1	material omission
2	efficient review
3	last sentence
1	 pantothenic
1	authorities granted
1	section 301(b)
1	chemical; waiver
1	produced at
1	certify, or
3	319f2 of
6	including records
1	good quality
1	specifically stated,
1	inventories; (iv)
1	review feesbeginning
1	effectiveness checks,
3	officials to
1	respectively, exceeds
2	database for
1	initial compliance
1	transaction, a
1	(e). in
6	operates an
1	chemical) at
1	commanded, performed,
5	level for
1	devices. (june
1	practice at
1	efficiently reviewing
1	regulate legitimate
2	review may
1	paragraph; or
3	approved; and
1	aggregate number
4	disclosures of
1	$268,443 
1	advice based
1	laws. when
1	annual fee,
1	audits that,
4	guidelines developed
2	individual units
1	eliminated. (g)
1	title 25)
2	(1) he
1	facilitate gathering
1	soliciting 2
1	(4) such
1	consultation pursuant
1	require shippers,
1	part; (ii)
1	waivers approved
1	(1) include,
1	change; or
1	treatment, be
1	use, other
3	(e) any
1	8, 38
1	trimeperidine. 
1	ounces and
1	issues; (6)
5	establishment during
1	financial data;
1	preclinical testing
1	(a)(3)(a)(i)(viii) and
2	illegal drugs;
16	18. 
1	becomes known
1	otherwise misbranded
1	section 346a(i)(2)
3	substance on
1	countries, however,
6	event that
3	thereon to
1	registry provided
1	substances have
2	financial data,
1	4131441372 (august
4	affect such
1	funding. 
1	furnish notification
10	costs related
1	358, as
1	(aa) opioid
1	(3) another
2	approved applications
1	complete, including
6	establishment where
6	establish by
2	user, no
2	ethylmorphine per
1	regulation, establish.
1	tanks of
1	litigation (including
1	request publicly
3	effectiveness, the
6	first fiscal
1	form, directly
1	collections through
6	currently accepted
1	continuing series
1	denatured, or
9	rulemaking that
1	shall find
2	term abbreviated
19	territory, or
1	alternative drugs.
1	feet, head,
5	prescription executed
23	order the
1	practicable, as
1	hearings hearings
7	life imprisonment
1	subterfuge; (4)
1	42. (d)
96	regarding the
1	relevant issues;
1	(c) smokeless
1	disease populations
1	herein provided
1	permanent discontinuance
1	subsequent premarket
3	deter their
1	reconstitution). (5)
4	nonprofit, private
2	360b(b)(2) of
2	eggs capable
1	naphthoyl ring
6	findings as
1	heard on
2	packages containing
1	(a) held
1	making those
1	determination, issue
1	3612 and
3	properties as
1	audit, and
1	metal bowls;
1	acceptable level.
1	made hereunder,
1	(or causes
2	delivers, distributes,
1	(a)(1), such
2	prescribing information
5	beginning negotiations
2	sanctions 
1	packing establishments,
2	to, access
1	(c) whenever
1	likely overall
1	(i) selling
4	fee per
1	system; (iii)
1	(including, to
3	manner. 
2	section 393(g)
4	economic loss
1	mitigate microorganisms
1	debarment period
1	distributed intrastate
2	talent reuse
1	following fees:
1	latest available
1	diseased animals,
1	(b) priorities
1	forms to
1	applicable. the
2	subsequent debarment
5	discussions of
1	regulation) provides
8	expenses in
1	achieve each
1	businesses to
1	
 393.
1	term exclusive
1	lands owned
1	formulation produced
1	(39) proheptazine.
1	congressional committeesthe
2	determine compliance
6	2201 of
1	productivity of
1	work assistance
1	subsection (a)(2)(a)(viii)
3	index entry;
9	establishment under
1	division, including
1	withdrawal, transportation,
1	extracorporeal membrane
2	uses such
4	registration by
1	term children
1	harvestable acres,
1	indirectly, any
5	suggests that
5	food being
1	provide both
10	immediate trading
1	derived from,
1	solely, or
1	assays within
1	assurances the
8	within reasonable
1	15 g/gm
1	security countermeasures.
1	conformity; or
4	facilities registered
1	clinical trialthe
6	treatment, or
1	certification. the
1	appropriated $25,000,000
1	study to
1	another sponsor
1	section 360j(h)(4)
1	classification, and
1	game animals,
1	(ii) more
14	1944, ch.
1	ownership occurs.
2	proposal of
2	preempts state,
7	new and
3	section. (e)
1	directorthe director
6	significant potential
1	particular substance
1	disseminating the
3	section 356c(a)
1	data; access
1	foundation; (iii)
1	classification, any
1	separate registration;
1	fee, or
1	secret and
2	proposal or
1	use competitive
1	clear under
1	within 135
2	contentthe report
1	drive while
3	1031 et
4	establishment, amendment,
1	body, that
1	(9) lysergic
1	262, 1,
2	feeding specified
4	office shall,
1	entities, professional
1	cream seven
1	conspicuously marked
1	board (of
1	equipment, without
5	paragraph (2)(a)(vii)(iv)
1	(g) extension
1	labels or
1	voluntary use
4	tests were
1	held invalid
7	practice or
5	isomers or
1	administer fee
1	(m) authorization
1	inspector, upon
3	notices and
1	published finding
2	appoint employees
3	rebuttal thereof)
3	government under
17	practice of
2	subcommittees of
3	competitive service,
1	competitive service.
3	provides appropriate
1	collected, in
2	officers to
1	regulation, prescribe
1	predictive tools
1	360fff1. submission
1	de minimis
1	product); or
2	insanitary, etc.,
1	(i) manufacturing,
1	specific terms
9	copy and
2	additional elements
2	tolerances in
1	1921 (7
1	1948, under
1	interests, claims,
6	section 387e(j)
1	attorney. (3)
1	(b)(1) 
1	(iv) -(-naphthylmethylene)indene
6	ecgonine, and
1	afflicts urban,
1	aggregate or
3	books, documents,
1	following: the
1	2016, issue
2	receipt, distribution,
1	disease manifestations,
1	(c) factors
2	years following
1	issued. (e)
1	priority order
1	petitions, the
1	recipients civil
1	petition, that
3	assigned pursuant
2	showing the
1	harmful or
5	court, upon
1	section 505(b)
1	 which
1	reduction, dru-related
1	natural physiological
1	design, energy
32	level of
3	(f) postmarket
4	determination. the
6	2002, the
1	notificationfollowing notification
2	paid. (i)
1	variants in
1	74, 3,
2	technical support
1	360ss. state
1	365 days
1	(linoeate): percent
2	coordinator for
2	379 of
3	commission in
1	states. (aug.
2	15 of
2	professional, industry,
1	sections 822(f),
1	(c)(1)(a)(i)(ii) for
5	programs, systems,
1	(3) alphacetylmathadol.[2]
1	division; (b)
3	material extent
3	isomers of
1	hire, promote,
8	change and
3	paragraph reasonable
1	least biannually,
3	health; (5)
2	him; or
2	fields as
1	unless exempted
2	suppliers (a)
2	slaughtered, or
3	recommended controls
2	including cash
4	documents required
3	(b) prescription
29	providing the
1	shall pursuant
3	establish minimum
3	report its
1	section 360e(d)(1)(a)
31	services shall
5	packed therewith
1	product solely
1	eyelash dyes
1	children regularly
5	term medical
2	interoperable electronic
51	issue an
1	document agreement
1	(p), shall
2	report requirement
1	government; (ii)
1	(e) sunset
3	which, because
1	buruli ulcer.
4	decision, made
2	entity), or
4	thereof as
1	trafficking, are
1	importer) that
1	
 952.
1	issue as
1	perform those
3	uniform size
1	required products
1	processed under
1	chemical involved,
2	enforcement activities.
3	payment made
1	local broadcasting
1	(3) publication
1	(1); (e)
2	development, approval,
5	conditions, any
1	distributed on
1	circumstance; and
3	conditions, and
1	states, aggregated
1	training, as
7	(ii) may
1	medical experts,
1	sports team
1	administration, who
2	applies for
2	appointment 
3	also apply
1	(c) opportunity
1	(2), coordinate
1	treatment, unless
1	chapter 11
1	study demonstrating
1	agencies, relating
1	ii. (3)
2	stored or
1	1391 of
1	applications, generic
1	several such
5	exchange of
2	abuse issue
1	(c) administrative
4	state. (2)
1	import. (mar.
2	applicable when
1	9, 1902,
2	export under
40	drug to
2	move in
1	defense highways
1	drug, submitted
1	chapter. (ii)
1	(j) pilot
15	shall, to
1	use disorder,
1	$50,000 for
1	development, submission,
1	tolerance periodically
2	equally and
1	provider, or
2	written determination
1	biennial food
2	(1), for
1	resistant pathogen,
1	compounding, converting,
5	(i) provide
1	list created
16	color additive,
2	may elect
1	(a) grant
4	381(a) of
13	container is
7	title are
7	emergency response
1	including subpart
1	contamination with
1	18. (o)
11	(i), (ii),
1	family, and
1	wherever handled
2	manufacturing supplemental
1	approved intended
23	mixture, or
4	principles of
1	subparagraph (a)(ii)(ii)
1	container if
1	exercise discretion
1	current approved
1	benefitting the
4	business, or
1	coordinating federal,
1	clostridium difficile.
4	general, as
1	expiration; (ii)
1	appropriations is
1	animals subject
1	supplements special
1	practicable, information
2	that, for
3	model standards,
1	patents that
1	providers, pharmacists,
1	consumption, sale,
1	requirementsthe secretary,
1	expendedthe director
1	u.s.c. 3101
2	scientific procedures
1	facility requirements.
1	requested authorization
5	employee making
23	4 years
4	be, to
3	sel-determination and
1	manufacturer not
1	purity; (b)
1	medicine, pharmacy,
1	catalog, file,
1	399h. grants
1	assistance records;
1	presumptionthere is
1	due 20
1	names. 
2	certified in
3	el paso
1	(iv). 
1	(d) compilation
6	appointments in
2	(e) fee
1	necessity or
1	investigation determines,
1	401, as
2	protected informationa
1	aid trading
1	later established
1	study; or
1	receives and
1	one plus
1	assessment, by
1	stat. 1052;
12	validity of
7	form which
1	successfully developing
2	goals, objectives,
4	understanding between
2	demonstrate a
3	additional recordkeeping
1	importer, when
1	possess) such
2	clearance for
1	samples analyzed
5	responsibilities and
1	525 (2001));
2	registrant made
1	activity, source,
1	practitioner issuing
1	(d) recertification
1	(ii)(i), but
14	20 years
1	patient by
1	contact surfaces
1	b2 (riboflavin)
3	iii device;
1	submitted without
1	advertisement as
1	poison unless
3	22, 2009.
2	subsection (n)(1)(g)
1	adjustments in
1	(b) received
1	
 136a.
1	production among
1	pollution resulting
5	cosmetic that
1	beverage containing
1	appropriate regulatory
2	characteristics as
1	(1) audit
6	dispense controlled
1	(i) based
8	means other
5	20 years,
1	852. application
3	purpose by
1	1919, ch.
1	including facility
1	microorganisms due
1	effect signed
1	321(k) of
1	omitted indication
1	similar descriptors;
1	including smoking
2	affected stakeholders,
1	petition, except
1	punishable as
2	subsection (c)(1)(b);
3	circumstances are
1	security agencies,
1	industry standards;
2	(4) rule
1	supervision; and
13	burden of
1	(b) auditthe
1	(3), in
1	proposed labels,
1	ix.e.4 of
5	burden on
1	studying biological
1	
 844a.
1	postal service,
8	subsection (e),
12	contact substance
6	subsection (e).
2	chapter: 
2	minimum term
1	make grants,
1	applicant. (iv)
1	387d, 387e,
1	exports, including
4	1948, ch.
1	deaths, as
1	originated, as
1	(c) transparency
1	term accreditation
12	section 387g
1	formula. except
1	party applies
1	prompt transmittal
2	animals, is
3	vacating of
2	subsection (e);
1	prescriber, and,
9	trade names
1	subchapter under
2	transactions, shall
1	differ substantially
1	work for
3	processing, labeling,
2	timelinesthe timelines
1	importing the
1	level. (h)
1	emergency use).
1	testing needed
54	subparagraph (a).
1	disclosed financial
91	subparagraph (a),
1	ammonia, or
1	portions of,
3	subparagraph (a))
3	90 milligrams
1	previous food
2	secretarys conclusions,
1	originals of
1	among themselves
1	health, which
1	afford a
1	(28) the
12	subparagraph (a);
1	service are
8	command and
1	standing, medical
2	reasonable samples
1	held, for
1	(d) scheduled
7	trade name,
1	covering practitioner.
1	residue or
1	licensing fee
1	train, and
3	implement comprehensive
1	facility information,
1	(5) voluntary
1	30, 1914,
2	residue on
1	production cycle
1	appropriate, approving
6	residue of
1	regulating traffic
2	established within
1	or, of
3	discharge or
1	reviewing tolerances
4	2012 during
9	custody of
1	section 1543(a)(1)
2	term entity
2	unlawfully imported
2	(c) timing
1	prescription drug),
1	repackager) engaged
1	controls, performance
1	detailing publicly
1	reprogramming subject
2	fact. if
1	sums appropriated
2	discharge of
2	notification; (b)
3	20 percent
2	fact. in
1	protocol as
4	authority in
1	sales that
60	representative of
30	materials and
1	words that
1	situation, or
1	expected need
5	authority if
4	aircraft, or
1	scientist there
1	policy formulation
1	379g(8) of
2	specified, the
1	sentence for,
3	chemicals in
1	prohibited transactionsexcept
1	manufacturing requirements
1	activities shall
2	dispenser enters
1	tracking study
1	(i) year
1	lawful pursuant
1	hereof; except
1	applicant amends
1	(b)(1) of
1	affairs the
1	262]. nothing
1	located that
1	fully cooperated
1	(m) clarification
10	general by
1	cream, transported
2	(i)(cc), the
1	heating of
1	no-racemic drug,
26	states for
1	regulations. the
2	recordkeeping, reporting,
1	(i), according
3	container applicable
1	drug manufactured,
2	person claiming
2	thereunder applicable
4	favor of
1	drug performance
2	dietary risk
2	processing means
1	(l) new
1	grant by
10	elements described
1	columbia. (i)
1	(f) incidental
1	fee an
2	(the pediatric
1	implant containing
1	help the
1	defense that
1	registration); (b)
1	consideration shall
13	fee as
2	patent was
13	shall, by
1	duplicate a
1	patient representatives
1	device), packing,
1	forge or
1	guidance defining
6	act is
8	qualify for
1	517a, as
5	(b) not
1	522, as
1	2603]; or
2	executive department
2	capacity for
1	extent conduct
1	term establishment
1	history under
1	information constitutes
4	(aug. 3,
1	alread-marketed drugs
4	determination, in
4	act in
4	committees. 
4	provide or
1	interests, work
11	tolerance is
4	(3) not
1	board (including
1	fee) by
3	product licensed
1	affect, national
3	opium and
3	food production,
1	industry. scientific,
35	lieu of
1	distributions in
3	building, or
1	option of
12	sentenced under
6	using improved
10	title (as
1	categories specified
1	presentation with
1	receipt. (c)
5	360, 360i,
1	safe based
3	49[1] of
1	section 355(e)
1	separate buildings
4	penalty, or
1	pathogenic microorganisms
1	(3)(a) fails
1	manufacture means
2	synthesis or
2	(4) notification
1	(c)(4)(b), (d)(4)(b),
1	number that
1	representatives. (d)
2	content requirements
1	contentnot later
1	requirements; contents;
1	897.34(a) after
1	section 355[1]
1	(14) morphine
2	360eee(16)(b) of
1	receivers, conservators,
1	compounding includes
1	ordinance relating
2	require, for
1	online medical
1	drug, considering
1	imitation butter
4	withdrawn (without
2	chemical residues,
1	salaries congress
3	fewer ful-time
1	broader indication
2	regarding review
1	tribal government,
2	(3) limitations
1	identities of
1	(alone or
1	purposes only,
7	priorities established
2	personnel, and
3	subparagraph (f)
1	use; (ii)
2	(3) termination
3	clinical outcome
4	applicant elects
3	health effects
1	(1) pharmacies
2	control to
1	part 25
1	recognizing one
1	destruction, appropriate
1	services nonetheless
1	terms premarket
2	regular basis
1	(k), 360b(a)(4)(c),
1	compensation, the
1	acid; or
10	1913, ch.
1	intravenously injected
2	person wants
1	act entitled
1	enforcing any
1	american pacific
1	recipient means
3	development tool,
1	food products:
4	food products;
1	1903(h)(2) of
1	partnerships, with
2	using electronic
1	procure, purchase,
3	title. (e)
1	reviews 
1	cream, cows,
1	provider under
3	food products.
10	food products,
1	(b)(iii); or
1	drug manufacturers);
5	(d); and
1	application; (iv)
1	drug, controls
1	relapse prevention.
1	abuse, diversion
2	excluding any
1	(3) summaries
18	of, such
1	section 1958(b)(1)
1	panel includes
1	plan. (

2	term as
1	orders any
1	379s. preemption
2	final, and
1	drugs found
2	expedited approval
1	paraphernaliain determining
2	medical welfare
1	substances compared
1	adaptability of
1	tortious conduct;
1	transaction dates
1	managed, or
1	ingredients manufactured
1	handle more
3	(7). 
1	disposing of,
1	only, as
1	animal feed)
1	need. 
1	(unless exempted
1	facilities inspected;
3	(i) during
1	notices to
1	section 545
1	simplicity. whenever
1	disseminates information
1	(a)(1)(c), that
2	secretary applies
5	eligibility for
4	(1) requirement
2	act; (7)
1	clearly suggesting
1	remedy contained
4	may sell,
3	including users
1	360ff. priority
2	transaction date,
22	infectious disease
1	(i) may,
2	qualifying medical
1	body drug
1	articles as
1	of, in
1	31, 1971.
1	practitioner deemed
1	add the
1	purchaser; (ii)
1	buildings, all
1	party. (9)
1	shall preclude
1	access is
2	rules established
1	corporation (1)
1	(b) two
1	outbreak investigation,
1	30. (ii)
1	drugs, full
2	patent extensions).
1	meet its
2	products can
1	sections apply
1	oil. (b)
2	analytic reports
1	installments payment
2	year 2013),
1	employee under
1	824(f) or
4	drug. (g)
1	classify an
1	physician assistants,
1	current production
1	(15) pethidin-intermediat-a,
5	shall result
4	42; or
4	patent extensions);
1	upon. upon
1	measures can
4	section has
1	saccharin, and
1	group practice,
1	protocol does
1	court finds,
2	last six
2	seq.]; (iii)
1	prior sentence,
1	(h) a
2	(a)(ii). (c)
1	(1) identificationthe
2	renew a
1	performed only
1	(h) conditions
3	detect and
4	prescription or
1	distributor whose
1	(2), consideration
1	year 2017;
5	added deleterious
1	drug. (cc)substantially
2	immediately lif-threatening
1	
 643.
1	fingerprinting of
26	individual or
1	specific technologies,
1	hyoscyamus, ignatia,
2	restaurants, other
1	-methylephedrine. (t)
6	recognized in
1	federal official
1	thereto) that
5	(whether or
2	inflation. 
1	device manufacturers,
1	area. such
2	expenses related
7	practicable, but
14	years, the
4	performance targets
2	1-day restriction
1	governing colored
2	reflecting the
2	section 360b(b)(2)
1	amendment. 
2	enforcement actions
1	maintains unobligated
1	federal requirements,
4	committee is
1	requirementsno thir-party
4	pregnant women,
48	(b) if
12	(b) may
2	dispenser from
1	defense. 
1	stakeholder. nothing
44	(b) in
2	section 350a,
7	initiate the
1	notice at
2	challenge to
5	(b) it
1	domestic capacity
1	illness attributed
1	investigation) are
73	food safety
47	(b) is
2	stat. 919;
1	growing, or
1	692. inspection
1	term anabolic
4	writing, a
1	whether domestic
2	statement regarding
3	accreditation has
1	device modifications:
4	enforcement the
14	appears on
1	tobacco dependence;
1	packaged, and
1	shellfish (e.g.,
1	(street address,
2	enacted a
2	review only
1	drugs so
1	developed nations
1	resolution; (d)
1	tank car,
1	usually known
1	minutes. (5)
2	studies), the
1	placement under
1	food prior
1	importer, including
3	subsection referred
1	seal; (2)
1	nonregulated person
4	subsection, for
1	pediatrics or
7	otherwise in
1	marketed drugs
7	constitute final
1	updating of
1	expeditious procedures
1	applicable, immediately
1	chemical analysis,
1	title, until
1	acts involving
1	imminent hazard,
2	territories, are
1	(5), (6),
1	receivers, and
1	scientific institutions,
1	population; (e)
1	tobacco, that
1	(b)(4)(a). all
5	injury, or
40	within 30
1	participants, retain
2	totality of
5	nonnarcotic ingredients
1	colors, may
4	committee in
1	food purposes.
1	criteria; sel-certificationthe
1	health education
8	sale for
150	 (e)
1	later time,
1	becoming an
1	activities involving
2	nothing other
1	filtering, mixing,
1	internet sellers
1	civic, or
16	law, the
3	article unfit
1	portions 
2	increasing volume
1	necessary rules
1	treatment, as
1	without direction
1	inositol (mg)
3	display the
2	instructions 
2	3-day notice
2	certification. 
1	discretion, shall
1	time, not
2	ingredients not
2	paragraph (3)(a),
1	$119,000,000 for
3	paragraph (3)(a).
3	inspection services;
3	information. (b)
2	research. persons
1	1012, formerly
2	another, or
1	312.47 of
1	transport drug
1	societies in
1	(a) documentation
2	specially certified
1	6001, and
1	identity, a
1	leaders; and
1	paragraph (3)(a);
1	taste for
10	withdrawal from
1	becomes subject
1	written information
1	u.s.c. 6501
2	health threat
1	establishment furnishes
4	source, or
1	on-half fluid
2	year (referred
1	sports act
1	work, of
1	2201. performance
1	2012, establish
1	board, rough,
1	practicable, render
3	secretary identifying
1	stat. 871;
1	declaration, order
13	names of
3	collateral measures
1	(ii) understand
1	management (a)
3	section upon
1	secretary. (11)
2	qualification submission
1	expire. the
1	(aa) be
1	(1)(b), nothing
7	section 352
3	means are
6	risk and
1	official within
1	$250,000,000 for
1	any, or
1	material for
2	transfer from
1	ii other
1	42; (iv)
1	regulations; status
4	use upon
1	format, for
1	means collaborative
1	applicant filed
1	issue means
3	whose behalf
6	however, that
1	(i) illegitimate
3	(a) provides
5	purposes, and
1	performance measurements.
4	review of,
3	amendment to
2	commerce 
1	methods.the secretary
2	made promptly
1	no-interchangeable biosimilar
1	drug; (i)
1	insertthe risk
38	research and
2	1913 [21
2	lawful application
1	coordinate activities
2	personal consumption
1	quota to
3	interest for
1	556 and
1	suspended on
1	2001; (5)
1	cosmetics, are
4	residue monitoring
1	802(52) and
1	notice specifies
1	expended under
1	among task
1	done by
1	full quarterly
3	submission described
11	distributor may
1	limitation no
1	notice specified
1	faith, the
1	dyeing the
3	order controlling
2	device provides
1	control. 
2	qualified to
1	cake made
1	regarding cleaning,
8	activities in
2	registered to
1	preceding 12
1	question, consult
5	taxable year,
1	leaves, and
5	work to
2	practicable but
1	(l) pesticide
1	payable. 
1	interest which
1	representatives upon
2	panel. the
1	restrictions no
1	grantee is
1	(5) termination
1	officials; (5)
1	aconite, belladonna,
4	development tools
1	general documentary
1	selective breeding.
1	committee clerical
1	warehouseman of
4	applicable; and
1	(2) nothing
1	validated the
1	hearing, any
2	care entities.
1	paragraph do
3	coordinated communication
2	26. 
1	appropriated $1,000,000
1	health professional)
2	(c)(3). 
1	formulas, microfilm,
1	evaluations received
1	minorities. such
1	shown, to
2	administrative proceeding
2	hearing, and
4	additive that
1	action 
1	handling 1,4butanediol
1	amount increased
6	assessed by
1	action without
1	psilocybin. (16)
4	(j) and
1	reportson a
45	responsible for
2	(b) limitation
1	perpetual inventory.
1	section. (3)
1	interests, state
1	determination a
6	morphine or
1	indicating adverse
1	supplements created
1	straw, and
1	dispensing systems
1	synthesized equivalent
4	355(j)(5)(f) of
3	tobacco means
1	assessed be
1	manufacturer identified
3	liquidated damages
6	tribal government
1	river, or
4	statement from
1	determine which
2	enforcement for
1	(7) qualification
2	use solely
2	both, in
1	case level
3	convention of
5	device. the
1	intended additional
3	efficacy studies
4	disease products
1	(cc)substantially complete
1	(r), 342(a)(2),
1	results, and
1	rights affording
1	(iv), for
2	applicable fiscal
1	tobacco all
1	mentorship to
2	records may
3	drug, there
2	consolidated for
1	n-sale order
1	title. upon
4	2013for fiscal
1	indexing a
2	distributed under
2	letter could
3	(1) means
1	territorial exemption;
5	 (12)
1	regarding grants
3	transactions of
1	(i) revision
1	360ll(e) of
2	product regulated
1	phenadoxone. (35)
1	term primary
6	request within
3	disease product.
1	appropriate. (4)
2	classification regulation
1	inspection warrants;
2	pay only
2	u.s.c. 262(h)].
2	drugs proposed
1	273, 5,
1	prevention, social
3	drug, whether
1	function, despite
3	subparagraph does
7	exported to
1	issues within
1	devices that,
3	list as
1	human health).
14	(as such
6	uses the
1	serial number,
3	sample basis
1	products procured
1	alternative to,
1	appoint other
2	data. the
2	written export
1	duplication upon
1	premises at
1	517. repealed.
1	drug. (i)
2	(august 11,
3	(a). (c)
1	agreement. the
1	due, any
1	(a) required
1	commission. if
1	withdraw a
2	factor 
1	20 and
5	product unless
1	assistant attorney
20	except in
4	progress and
1	unit. (k)
2	387k, or
2	features of
1	america, shall
1	1705(a) of
1	copy records,
1	administrator with
1	cultivation and
2	1604(b) of
2	subsistence, at
22	may file
1	fellows or
1	data resulting
1	residues, including
2	machine or
6	policy. 
3	gene, with
1	administrator grants
4	treatment for
7	matter complained
8	pattern of
1	exceed any
12	shall perform
4	investigations conducted
1	certain used
1	tomography compounding
3	interests in
1	establishment engaged
2	from, the
1	(or regulation)
1	identified since
9	advanced research
2	currently available
1	radiological (including
1	(2) remaining
2	36 months.
2	ch. 143,
1	compliance the
1	vitamin a,
1	exceptionthe administrator
1	(12) nicotine
1	incapable of
6	(hereinafter in
4	(w) the
3	account providing
2	minimized or
2	30 percent
1	section 5382
2	sponsor makes
3	(b)(1)(a) may
3	28. 
3	protecting the
2	(1)(d) refusing
1	applied, the
1	taken in
1	grounds; person
2	2013 (as
1	also maintain
2	belief: (a)
1	restrictions (a)
1	(2) hearing
1	title classifying
2	educational programs
1	country, substantial
1	periods. 
1	alien, an
1	distributes products
1	$195,000,000 is
1	addiction for
1	intended, he
1	authorized means
1	submit revised
56	human food
1	predecessor of
1	(e) scheduled
1	inquiry made
2	discontinue review
1	jurisdiction pursuant
1	questions. 
1	evaluate such
1	appropriately vary
3	(or regulations
1	descriptors light,
14	shall prescribe
1	(i) gamma
4	promulgate such
1	conducted shall
1	section 360b(d)(1)(a)
7	(c) shall
19	pay the
1	definition set
3	supply chain.
1	inputs, clinical
1	conducted, before
4	offense involved,
1	section 360b(e)(2)
5	term costs
1	submission solely
2	(ii), shall
1	term signal
10	repackager, wholesale
13	drug; and
1	importation for
2	sel-supporting community
2	notice, proposed,
1	shall base
1	supply chain;
1	compounding standards
1	channels, the
1	seminars, meetings,
1	imposing an
1	201),[2] together
1	pharmacist. where
1	cases under
2	participated directly
1	highly controversial
1	ginseng may
1	local officials.
2	label, mark,
1	sells cigarettes
1	foods. (f)
3	881(e) of
1	good color
2	conformity to
1	taxation of
3	policies for
1	(10) betaprodine.
1	annual submission
1	method required
1	(a) delivering,
1	offices have
1	duly certified
1	animals under
2	actual tax
2	panel may
50	performance of
1	acts, to
1	doses, or
1	(3) costs.
1	section 360e(a)
4	due consideration
1	section 3663a
1	used (or
1	admissible into
1	
 1031.
4	360j(e) of
1	is, under
5	5 shall
1	combination, or
1	faith submits
9	drug, no
1	action. (4)
1	events and
3	necessary, to
1	suspicious transactions
1	organizations, institutions,
1	355] (regardless
2	technology research
3	service the
1	product conform
1	contempt of
1	seller means
1	
 379l.
1	taken is
1	discretion, is
3	loan repayment
1	(a) small
10	use, in
1	cos-based fees
1	warrants; issuance;
1	(f) delay
1	known set
1	collecting a
1	authority not
1	goals, priorities,
1	medical condition,
1	shell or
1	suspension from
1	ineligibility any
1	dispense the
1	obligations for
11	guidance to
1	675, 745,
2	system: 
1	regulatory delay.
1	agriculture by
1	adul-written publications
2	use, is
1	effective legislation
7	major manufacturing
1	ingredients, including
1	promulgate and
6	advocacy groups;
2	panels. no
1	consider certifications
6	section 552(b)
1	exemption, be
3	intelligence sharing
1	undertaken with
1	(c) articles
1	amending regulations
1	using no
3	advocacy groups,
2	infringed. 
1	qualify the
1	months. the
1	full term
1	notification. (l)
1	residents in
2	360fff1 and
1	submission requirements
1	
 842.
1	generalamounts made
1	2013. (b)
1	drug safety;
1	(6) public
1	defined). 
2	eighteen months
1	initiative refer
3	injunctive relief
1	
 360bbb3.
1	government employees,
1	shor-, mediu-,
1	commenced simultaneously
1	(3) existing
1	maintain records;
2	establishment. (c)
1	government employees;
39	solely for
6	equipment or
1	agency (such
1	health are
1	center initially,
1	advertisement before
1	states, less
3	facilities identified
1	one resubmission
3	tool is
2	direct, fac-t-face
3	processes in
8	actions to
1	dealer at
1	clearance, such
1	distinctive nutritional
1	dosage that
1	person submit
2	imposed for
1	appropriate counseling
2	records the
1	management expenses.
1	warrant of
2	prepared and
1	licensedthe term
1	(ii) set
3	grounds upon
1	finished infant
1	year, notwithstanding
3	form, including
1	clause if,
1	discovery nothing
2	dissolved by
1	property taken
1	recall activities
1	budget; and
1	(iii) upon
1	confirmed adulteration
42	authorized under
10	(e) of
1	204. issuance
2	guidance, as
2	section 247d7e
3	and, insofar
5	minutes described
1	
 1056.
3	reasonable time,
2	financial information
2	reasonable time.
2	compound or
1	regarding activities
5	conflict with
28	prescribed under
1	primarily affect
1	alia, increase
2	new route
1	(g)(1) or
1	416.)
 

1	system are
1	designthe pilot
1	federal indian
13	existence of
1	18 months.
1	u.s.c. 467a
2	data do
1	standard listed
1	360ccc1, 360ccc2,
2	existence on
2	(e) on
8	obtained under
1	final consumer.
4	adulterated, the
1	condition pursuant
1	(a) stating
1	141 et
1	prohibited. however,
2	act occurs
1	regarding pending
1	number, if
3	representative sampling
1	(g) notice
2	treat harm
1	affiliation (including
19	substantial equivalence
1	reductionthe secretary
1	information it
25	information is
1	secretary); and
1	year 1
3	systems. (iii)
1	publication, which
2	tested; and
2	application includes
3	pending applications
3	information if
1	tribes 
1	3915, 10a,
2	(x) a
20	reports under
1	
 374.
39	information in
1	(d) projections
1	written declaration
3	become a
1	(i) suspension
1	inspection subsequent
1	add an
1	enhance current
2	(j) exemption
1	(except drugs
3	grades for
1	(d) fourteen
3	permissive debarment;
1	precursor, a
3	qualified in
1	regulated products.
1	administration used
1	use device
1	1 defendant,
13	otherwise authorized
2	section 379j41
1	completed may
1	users placed
1	completion date
1	wherever the
2	term electronic
1	drugs now
1	administration official
1	plus (iii)
1	drugs not
1	part, by
1	implementing general
1	believe to
1	trial for
2	licensing fees
1	paragraph (c)[1]
2	consumption in
1	counterfeit substance;
1	2012)) or
2	exported the
1	drug threats
1	nmic means
1	necessary information.
66	shall publish
4	product; (d)
2	exported, under
1	(6) that
6	farms and
8	event the
1	applications before
2	copy thereof
1	normal and
1	terminate expanded
2	similar operation
1	(5) restrictions
2	formerly 903,
18	determined that
4	products inspected
5	may compromise,
1	(iii) organizing,
1	appropriate office
1	(excluding user
1	2-hour period
1	organization, (ii)
5	governing appointments
2	(a) amend
1	safety authorities
1	disposal sites
3	counte-drug technology
1	distribution. if
1	additive, including,
1	use, paragraph[1]
1	formula, at
1	manufacture, packaging,
1	subsection, evidence
1	patient survey
1	formula, an
1	plan would
1	(a) deliver,
2	testing begins,
4	input from
3	practice, or
7	u.s.c. 136
1	(2) agents
3	combined with
1	provisions related
1	1045.)
 

10	shall refer
3	410, as
1	licenses before
2	(5), the
4	including, as
1	establishment holding
2	oral authorization
1	receipt in
5	islands of
1	reach an
3	serving at
1	agent, service
1	indirectly to
5	adduce such
1	serving as
1	-year terms.
1	furnish full
1	compliance, as
1	may adopt
1	furnishes in
1	unapproved usewith
14	give the
1	external stakeholders
1	developing combination
1	top 3
1	comments, data,
10	compounded, or
1	whether, and
1	name. (c)
1	device conforms
1	processing, shipping,
1	(1) small
1	(4) disposition
2	schedule iv,
3	schedule iv.
1	improve patient
1	foods, food
1	pharmacopoeia, pharmacy,
1	section 1531
1	world evidence.
1	regulation indicate
2	offered to,
4	section 1532
1	awards with
1	assistance. section
2	presidents annual
2	regulations) that
2	efforts, in
1	principal mission
1	reasonably believes,
1	(1)(a) 
2	petition, and
2	violations, of
1	huma-readable or
1	(a) acetic
3	head start
1	addiction, substantially
1	assess scientific
1	exists, on
2	separate foods;
1	family may
2	private or
2	(2) coordinate
3	said amenable
3	safety problems,
4	(ii) promptly
1	exported; 
1	(a) total
20	presents a
1	separate foods.
1	security; (c)
135	including the
6	transport, offer
14	held under
1	articles, or
1	decisionmaking; (c)
2	include data
1	hereof and
1	(c) postapproval
2	improvement of
3	amount applicable
1	attorney to
1	same. (mar.
1	enrollment for
1	136a1(g)] on
3	power of
1	circumstance in
26	requests for
1	authorizationthe administrator
2	review at
3	submitting its
1	defendant, the
3	diet of
2	regarding all
4	binding on
1	heroin. (2)
3	targeted drugs
1	applicable device
1	262(h)]. (c)
2	time thereafter,
1	(ii) this
2	2013 may
1	clear title
1	residential address
1	(ii) update
1	conditions differ
2	(b) within
8	supplement submitted
2	circumstances 
2	evaluation are
1	external scientific
1	section 1604(b)(2)(b)
1	regarding thir-party
1	study results
1	submitting it.
2	unlawful importation
1	attendance, take
12	brought in
5	funds from
1	pediatric subpopulations
3	incidents of
1	date. (e)
2	person informing
1	standards defining
1	
 337a.
1	(a)(1) that
2	aside the
1	experience; (2)
1	formerly 2nd
1	delegate. (j)
1	senate to
1	nanomaterials interactions
1	(6)[2] shall
1	term smokeless
1	wel-controlled studies
2	armed forces
5	that, on
9	100 grams
1	part therefor.
2	part for
15	secretary considers
1	place shall
1	establishing mechanisms,
4	reasonably suggests
1	power, in
1	injury to,
5	applicable conditions
7	drugs pursuant
6	control strategy.
1	parts, or
1	repair such
2	voucher after
2	prohibition under
1	health. (iii)
1	documented including
1	targeted drug,
1	individual national
1	352(c), and
1	tracing requirements,
1	feasible, be
1	quotas; revised
1	years, taking
7	guam, the
14	shall continue
1	general policies;
1	
 467a.
1	(ii)(iv), the
2	permissible variations
2	deemed not
6	thirtieth day
1	coordinating council,
1	order, exempt
1	360b(a)(5) of
1	negative health
1	panel recommendation;
4	actual controversy
1	supplant, local
1	deficiencies, unless
6	assign a
15	year ending
1	chil-welfare associations,
3	administrator; and
1	public holidays
6	section 194
1	formerly 13th
2	acts in
6	views, or
2	industrial purposes;
1	data used
3	allergenic extract
1	clearinghouse established
1	site with
1	existing federal
1	(u) certain
1	(d) forward
1	secretary into
1	apply, 30
1	acts it
1	findings. (q)
1	(v) retention
1	distributor; (b)
1	nicomorphine. (20)
1	products; (d)
1	priority on
1	available promptly
2	subsection of
1	
 1702.
2	drug. (iii)
1	priority of
1	substances scheduled
2	subsection on
4	eliminate burdens
1	50 dosage
1	coordinating councils
8	eliminate the
1	fairly respond
2	budget to
1	(10) manufacturerthe
1	faces tremendous
2	drug reporting
12	subsection or
1	appropriate intervals
3	proceedings is
1	insurance provider
1	actual duration
1	i-kind, fairly
1	authorized federal
8	year 2009,
1	year 2009.
1	petition relies;
1	poultry, whether
1	method through
3	(7) and
1	storage operations,
1	trade; (ii)
21	electronic products
3	incident command
3	licenses for
1	subchapter a
1	misbranded; and
2	dihydrocodeinone per
2	year 2009;
1	(10) $99,000,000
1	birth through
1	fabricates, assembles,
1	(c) data
2	costs thereof,
1	formerly 410,
2	means, by
7	judgment that
1	114d1. repealed.
1	1, as
2	v which
3	information, received
1	analytical methodsthe
1	distributor, purchased
1	isomer. (15)
1	567, as
1	971(f)(2) of
1	income, in
13	including by
1	custom preparation,
1	scientific, ris-based
1	(d)(1)(b) or
1	detained, or
3	approved march
30	request is
1	effectively disposing
285	drug or
1	pediatric therapeutics.
2	levels so
1	secretary could
18	manufacturer to
1	members, with
4	request if
1	receptor type
3	drug on
1	vitamins or
4	document described
10	accelerated approval
2	demonstrations respecting
1	finished on
3	drug of
1	safety labeling
1	distributes any
1	(h) manufacture,
1	comments, that
1	partnerships, institutions
1	project evaluation;
3	$5,000 or
1	locations that
1	another; and
2	2008, had
1	including how
1	(b)(4), the
2	recordkeeping the
1	illness that
3	person occupying
1	inspection system,
1	files). (b)
1	clerical mistakes
1	statement at
1	distributes and
1	said book
1	substances, excepting
1	chapter; (5)
9	(7) of
1	term recall
2	president any
2	overall direction
1	properties, and
3	(g) such
1	regulation, subregulatory
2	knowingly offering
1	notice informing
20	public interest
2	enrolled in,
44	september 27,
3	(4) final
1	tolerance requirements
1	flocks directly
2	u.s.c. 1521
1	including elderly
1	(n); or
1	(111 stat.
3	president and
1	(6) accountabilitythe
2	though engaged
1	(g) require
4	assess whether
1	appropriateness and
1	opiate, and
1	milk proteins,
1	articles before
1	i(c), the
14	information the
2	compensation to
1	independent experts.
1	(a)(4)(c), the
6	on, or
2	(1) which
4	investigational exemption
1	1, such
1	conformity or
5	355, 360(k),
1	dissemination. (e)
2	subsection applies;
2	control against
1	delivery. the
5	consultant or
1	602. congressional
21	subsection (k)
1	year. (ii)[1]
2	available upon
7	action subject
5	firms, and
1	advertisement. (f)
1	provide overall
1	smoke; (iii)
1	groups, regulated
1	drug, ship
1	standard a
79	district of
1	require. (2)
1	
 829.
1	accredit laboratories
1	pharmacy when
1	annual public
4	control fee
1	(l) safety
7	sentence imposed
1	onchocerciasis. (n)
3	registration. such
1	dispensing practitioner
1	officer has
4	taken, and
2	(f) technical
1	vitro reagent,
1	authorized on
1	timeline under
1	66 stat.
1	appropriate, utilize
6	authorized or
9	application subject
1	title; (l)
2	establishment complies
1	concern if
1	section, through
1	safety; (ix)
1	order scheduling
1	last two
2	given by
1	(ii) may,
1	destination for
8	minimum sentence
10	summary judgment
2	names no
1	1059; 

29	(b). 
10	directions for
11	complying with
1	samples, an
2	(m)(3) of
32	making a
2	countermeasures the
2	subparagraph (e);
5	community ant-drug
6	practicable and
4	labeling any
1	freely given
1	recall meets
1	administered concerning
7	combination with
18	improve the
1	whether they
1	demonstration that
5	2018. 
1	claimants; proceedings
1	(d) panel
1	(5) may
4	subparagraph (e),
1	(7) based
1	building domestic
1	specific appropriation;
1	mortem inspection;
1	directly in
2	ch. 861,
1	155, 9,
1	set and
1	status, and
1	applicable terms
3	stocks of
1	setting or
3	except residue
1	(5) reporton
1	anticoagulant; (vi)
1	language spoken
1	(f) 400
1	section 321(p)(2)
1	create or
1	delivering, distributing,
2	misbranded, a
1	
 606.
2	provide inspection
1	(iii) permits
1	(iv) identifying
2	application otherwise
1	section 360bbb3(a)(4)
3	programs within
28	humans or
2	program regarding
28	report that
1	consumer unless
1	ring by
1	generalparagraph (2)
1	identifying by
1	reg. 4145341787
1	1990, and
1	significantly harm
4	(viii) the
2	pending request.
1	call on
1	purposes. (ii)component
1	still effectuating
3	every registrant
2	entity permitted
2	call of
1	(2) designation
2	budget. 
71	title for
1	738a, as
1	findingscongress makes
109	(c) the
5	rise to
1	harmful constituents,
1	concentrated mineral
5	clause (b),
1	emerged anabolic
8	register notice
3	safe. 
2	year, submit
1	requirement after
1	section 353(e)(2)(a)
4	local public
1	management system;
1	labelingnot later
1	price to
1	(ii) annual
1	adequate labeling
3	penalty, when
1	387t(b) of
1	stability problems,
1	section 831
8	section 830
2	18, 1968,
1	product, under
1	user. (h)
1	(i) established
3	part c,
1	patients; (c)
1	reimbursement; installments
3	importations made
4	detecting and
1	permissible bases
1	(e) organization
1	character and
1	(3) disclosure
1	indirectly or
2	supplement 
1	single individual.
1	countries; (iv)
21	labeling is
1	
 159.
2	tentative approval.
14	revise the
1	circumstances exist
2	additional year,
1	labeling if
18	views on
1	proposes conditions
6	resources; (c)
1	387k. modified
1	required; shall
3	use (including
5	views of
1	require restrictions
29	time and
1	misleading. (f)
1	committee concerning
1	(3) elements
5	cease to
1	asylums, chil-welfare
20	commerce or
1	advertising has
1	backlog of
1	2009 through
1	-methylmethcathinone (mephedrone).
1	include epidemiological,
2	urgent petition
1	fully respond
1	pending premarket
1	object if,
1	statements; accompanying
6	(1) are
70	commerce of
1	(c) discontinuation
1	considered and
1	(3) substancesin
7	collected pursuant
2	commerce on
1	use gifts
3	license number
1	differ so
1	center undertake
1	safety, economic
2	methods, or
2	year; (c)
1	waive its
5	involved and
1	pollution that
4	whether in
1	global clinical
1	exemptionsupon submission
1	article ii,
2	whether it
4	otherwise affected
1	took final
7	data, views,
1	inter alia,
1	gaps and
1	2003, except
1	permit until
1	scheduled testing,
1	making necessary
1	(g) norpseudoephedrine,
1	103 of
3	(1) drug
1	(i) humanitarian
8	postapproval studies
1	develop methods
2	radiation; 
1	limits an
1	total voting
1	laboratories seized
3	proposal and
3	resists, opposes,
3	finished medical
38	following the
1	
 886a.
1	board. a
1	specific numerical
1	catfish notwithstanding
1	appointed may
2	challenge the
3	notice a
1	director, developing
3	exceed $10,000,000
2	waiver because
3	fill a
7	unless an
1	established and
1	planning 
3	place the
2	1, 1956,
1	(or conversion
1	studies. if
1	section applies;
1	debarments. 
1	(2), such
2	chemical. (2)
2	protection equivalent
1	contractor shall
1	unlawful. (aug.
2	objectives specified
6	contains an
5	drug before
2	applicants submission
1	carrying meat
1	section 231
3	(2) application
13	persons to
2	market in
1	section applies.
1	subsequent transaction,
1	section applies,
1	determination means,
2	enhanced communication
1	sentence imposed,
1	(e) ecgonine,
1	late and
1	implant in
1	830(b)(3)(b) of
1	material of
1	number applicable
1	manufacturers, health
2	partner and,
2	implant if
1	(b) surveillance
2	sold, possessed,
1	section 1395w104(b)(3)(c)(ii)
24	in, and
1	chapter. (7)
1	help advance
67	implementation of
3	implant is
8	 for
1	unit. (u)
2	witness fees)
2	(to examine
1	congress for
1	legal entity.
1	witness fees,
1	specifications shall
2	industry, to
4	persons from
3	(c) regulations
6	dispense a
1	methods are
1	waive requirements
1	policy, form,
2	methodology for
12	devices and
2	entity, in
1	actually treated
1	violations resulting
1	national disposal
2	(c) respecting
5	qualified experts
1	1976. 
3	entity, if
1	(or drugs);
1	section 360e(d)(5)[1]
1	manner. with
1	675, 577,
27	substantially equivalent
2	panels and
1	concerned and
1	facts alleged,
1	provide notification
1	decisions about
13	secretary within
13	5. 
1	patient during
2	variations may
1	perform, administer,
1	nitrous oxide
1	radiological products,
1	independently met
1	350c, 355,
1	health (such
1	hearing more
1	appropriate authorities,
39	relevant to
1	reported, to
1	ch. 666,
2	establishing, amending,
1	effect no
1	containing alcohol
1	political campaigning
4	(b) applicability
1	
 335.
45	end of
1	(b) heightened
1	steps that
1	separate establishments
3	administering the
1	including tracking
2	consignee; liens
1	airflow) to
1	353(b)(2) of
1	investigations, specified
1	(7) chamber
1	undergone an
8	applications means
1	subsections (d)(1)
8	appropriate 
1	met (in
2	technical electronic
1	360j, or
1	apply paragraph
16	classified under
2	demonstration of
2	essential in
1	health advisories,
3	investigation, or
1	false swearing,
1	also, to
1	disclosed pursuant
2	instead of
2	determines at
2	medical gas;
2	requested herein
1	term demand
1	boarding houses,
3	including, for
2	competitions recognized
2	label subparagraph
6	certiorari or
2	issued from
1	daily, each
2	regulation, waive
1	(4) objected
1	reasonably require;
1	employment. (2)
3	manufacturer for
2	considered one
1	term patien-reported
2	waived in
1	population data.
1	iv may
2	exists, or
2	proceeding terminated
1	346(a)[1] of
1	must comply
1	efforts; (4)
2	another animal
4	paragraph within
1	type. 
2	trade. 
1	1048.)
 

1	558.3(b)(3) of
19	fruits and
1	distributors except
1	waived is
7	court affirming
3	maintenance by
1	put up
2	intelligence program
1	consumption. (c)
2	$24,000,000 for
1	formatthe information
1	food. (8)
5	agreements to
1	inspections provided
2	spent and
1	subsection (a)(4)(a)(ii)
2	(7) any
2	applied at
1	744g, as
1	
 397.
2	human and
1	(12) prescription
1	recite basis
2	extortion, or
1	practices, including
1	destroys markets
1	actions are
17	present a
1	means, that
4	articles intended
1	material, such
1	(2)(c) may,
6	(e), and
1	countermeasures approved,
7	shall include,
2	quotas under
1	druggists, orphan
2	safety as
5	action with
25	control strategy
1	consultations carried
1	fas-track designation
1	determinations and
1	u.s. 525
1	675, 506d,
1	807, as
1	circumstances for
1	(e) share
1	covering practitioner
1	shipping), or
3	(v) carrying
1	name provided
14	court in
3	establish conditions
4	plants inspected
1	facility into
1	owner, prior
1	(c) disseminating
1	compensation shall
1	capabilities and
1	body, including
1	full time
1	products, all
8	whichever occurs
3	(c) publication
1	packaged products
1	done, such
4	court is
2	procures, or
1	government information,
3	competitive bidding
1	storage immediately
2	chapter 57
63	information submitted
4	chapter 51
4	chapter 53
4	authority (a)
2	applicants whose
1	coalitions demonstrate
2	caused another
1	falsely represents,
1	request, after
1	bongs; (13)
1	species; (c)
1	years; plus
1	national marine
1	forfeitures; and
1	v is
2	board, acting
1	shall invite
4	individual and
14	sale in
2	availability, which
2	cooperate on
1	(35) the
1	disclosure (a)
2	bought, sold,
2	relapse prevention;
1	uncompensated basis,
1	safety alerts,
2	name as
1	discretion, may
1	regulatory proposal.
1	deliberately causes
1	(i) procedure
1	period subject
2	(g)(1), that
1	assess against
8	sale is
2	necessity, safety,
1	drug arising
1	1968, and
1	technologies, which
1	laboratory practice
1	711, formerly
1	bottle, and,
1	reportthe united
1	external experts.
1	waxing, fumigating,
2	(f) review
2	section 355(a)
1	(i) distributions
1	any, filed
1	restraining proceedings;
1	proceeds if
4	decision. 
2	therein consisted
2	four years,
1	355g. utilizing
1	signs, signals,
1	compliance solely
2	register containing
5	undertaken to
1	external experts;
1	codex level,
1	size containing
1	indirect; and
5	order on
12	(9) the
1	reduced establishment
1	detection is
1	efficacy, and
1	used solely
67	order of
1	(issued without
1	penalties. (

14	since the
1	scientists: provided,
1	bear in
2	condensed, or
3	states, while
1	astated per
2	laws unaffected
5	(c) use
1	clearance from
8	postmarket safety
33	order or
1	similar articles
1	pharmacy may
2	small businessesnotwithstanding
1	recent safety
1	establish for
29	enable the
1	section 981(g)
1	lozenges, containing
1	department, as
1	(c) proof
2	(a), (g),
1	created for
3	establish, before
4	application could
1	scientist (a)
1	existing approaches
1	
 360cc.
1	tentative approval),
1	(c) disseminate
1	consider all
1	reported if,
1	plan at
1	animals. the
2	hearing) that
1	limited populations,
1	chemical from
2	term processing
2	performance from
1	charges collected
1	document; or
2	illegal gratuity,
2	schedules under
1	18, 1949,
1	possession for
1	modification. 
18	information 
1	(taking into
1	whose prescription
2	residing in
1	proposed, with
1	d (iu)
1	consolidated food
3	sentence, shall
2	regulation, except
1	16. introduction
7	record after
1	(m) of
1	dispenses the
1	surveillance system
2	interim results
1	(4) agreement
1	drug considered
1	(g) drug
26	premarket approval
1	conducting interoperable,
1	funds estimated
2	limit notwithstanding
1	title v,
1	constituents, and
1	fully corrected
12	chapter may
11	applicable standard
2	557 of
1	written logbook
1	(including regenerative
1	felony, and,
1	accreditation if,
5	assure and
1	vice chairman,
1	trademark office,
2	trademark office.
2	samplesthe following
1	section 350c(a)
1	variety, normal
1	387o of
3	appropriate changes
3	reporting. 
1	water regulation,
1	assistance concerning
2	water regulation.
3	imprinted upon,
7	july 1
6	distribution by
1	shall subject
1	certain cases
1	(or exempted
4	service for
10	postmarket risk
1	356c(f) of
2	use, which
1	requirements necessary
3	requirements do
11	(d) and
53	360e of
1	improved epidemiological
2	15, 2018,
1	(f). (m)
1	human disease
1	packages contain
1	deemed, for
5	compounded positron
2	360e or
4	cure, mitigation,
2	1054; 

3	(b) individual
1	business. (5)
12	(d) any
2	secretary overestimated
2	initiated by
2	slaughter; (6)
1	sunscreen orderwith
1	accountability of
1	narcotic drugs.
1	rata fees
1	license described
1	submitted may
1	study, including
15	(c), the
1	reveal unforeseen
2	fresh fruits
1	generalany person
10	additive which
2	water regulations
2	387s of
1	adopt the
16	(b) such
1	3(a), 64
2	commerce. (b)
1	provided, for
2	act; (b)
1	423, as
1	classification as
1	entities pursuant
2	compliance for
1	$534,000,000. (g)
78	months after
1	affairs, and
3	equivalence between
1	recent prospective
1	freezing, drying,
1	orders once
3	ruling on
1	6 percent
1	822(g) of
2	applications; and
2	receive those
1	possessions; (d)
1	require otherwise,
7	formed in
1	individuals, without
1	contumacy by
1	secretary classified
6	biomedical research
1	(ii) would
1	regarding requirements
4	factors described
1	issue final
1	nuts (e.g.,
1	public, in
1	part 25,
1	343(q) and
4	complete review
1	substance, be
1	remains incidental
4	moves in
1	contaminated agriculture
1	prepare respecting
1	private hospital
2	upon conviction,
1	antidote, when
4	plan (including
8	commerce. 
1	directions should
1	954. transshipment
6	reported by
1	present, or
1	illegal narcotics;
1	newl-identified significant
1	traffic and
3	amounts shall
1	section includes
1	dealing in,
1	manufacturer or,
1	3,4,-trimethoxy amphetamine.
1	codes, such
8	investigation, the
1	2014, an
1	gases deemed
3	chemicals, or
1	unhatchable. (5)
1	protectionsin order
3	shall double
1	sections 360b(a)(4),
1	rulemaking prior
1	picked, of
1	675, 518a,
1	administration); or
1	unadulterated while
1	lawfully marketed
1	(b)(2)(b)(iii) continues
1	(6) lists
1	auditingto ensure
1	(b) emergency
1	
 679b.
10	assessment under
1	farmers home
2	(a), shall
1	(j) rules
2	(b) how
30	senate and
1	begin accepting
1	(ii) whether,
1	violation; intent
2	recommendation submitted
1	securitynot later
1	meeting appropriate
1	translating basic
2	shall label,
1	fully consistent
1	gao study
1	manufacturers previously
6	importer, or
2	particular tobacco
1	reduce individual
1	whether that
4	sufficient flexibility
1	sites maintained
1	label fails
1	sixteen and
14	standard under
1	provide grant
2	priority under
1	recalls; (v)
1	poison bottle,
1	(a) lawful
7	assigned to
1	services programs.
1	-penty--(-methoxyphenylacetyl)indole (jwh250);
1	list publicly
1	appropriated $15,000,000
8	may accept
1	u.s.c. 19011906)
3	unduly burden
1	allowable previously
1	narcotics traffickers.
3	(d) regulations
1	articles; court
1	exercisable by,
1	certification, without
1	includes representative
1	dispense means
2	acceptance was
2	attached to
20	compound, mixture,
1	(a)(2), any
2	expertise available
1	 essential
2	536, formerly
2	paragraph (5)(a)
1	term reportable
1	implementation. 
1	processed. (m)
1	substances had
1	exporter registered
2	comparable or
1	cans, tins,
3	countermeasures 
1	regional drug
1	(g) demand
1	sel-control with
1	article not
1	following entry
1	classified the
5	oral presentation
2	poultry raised
3	court such
2	(2) criteria
1	ingredients from
1	 provided,
1	developing guidance
1	substances has
1	(ii) definitionsfor
1	abuse prevention;
1	programs,[1] and
1	weight, 10
3	transmission of
4	(c) payment
1	(2)) at
1	containing single
1	inconsistencies in
3	american board
1	abuse prevention.
3	abuse prevention,
178	biological product
1	(33) the
1	restricted. 
1	food tested
1	permit, such
2	application process,
2	time, upon
1	involving senior
2	chemical offense
1	plainly printed
2	support available
1	terminated, leaving
1	matchbooks shall
1	law restricts
1	deems that
26	homeland security
1	stoichiometrically equivalent
33	completion of
1	pinball and
5	established a
6	verification program
2	subsequent redesignation
1	surrogate markers.
1	providing appropriate
1	surrogate markers,
10	assistance to
1	permit under
1	industries concerned
1	design, material,
5	360eee(16)(a) of
7	security, and
1	systems. 
1	(c) definitionsfor
1	time reports
1	balance required
1	combination drugs
8	treatment investigational
1	(12) methyldesorphine.
1	
 861.
1	penalties a
1	withdraws under
49	energy and
1	paragraph[1] (b)
9	analogous product
2	decisions, and
1	unexpired listed
1	(j) be
1	operator submitting
1	otitis media,
5	terminated. 
3	administration. (3)
4	(2)(c), fees
3	seq.] that
8	(4) any
1	seq.] (known
1	dispenser other
1	universities, colleges,
1	provide inspection,
1	conventions, a
1	693. inspection
1	pseudorabies. this
1	seq.]. (2)
3	(4) and
1	occur through
3	ownership, management,
4	purpose and
1	terms cigarette,
1	1890 (21
1	aged from
1	agency, use,
1	manufacturing quotas
1	societies; (iii)
2	lon-term epidemiological
3	collections for
1	properly dated
1	submissionbeginning 180
2	scientific, trade,
1	revises the
2	(3)(c) and
1	devices; (2)
1	substitution, or
1	incubator reject
3	consignee, who
3	transferee identified
2	labeling the
1	
 955a
1	379j12. authority
3	providing that
1	criminal proceedings;
2	first applicant.
5	methodology described
1	absorbing, reflecting,
1	standards promulgated
3	fees received
1	26 to
1	declarations: controlled
3	packaged carcasses
1	students as
1	students at
2	techniques of
1	first applicant;
1	daily med
4	items; annual
1	continued until
4	means is
2	drug industry.
1	one year;
2	drug industry,
1	(9) shall
6	resources. 
1	admit the
1	practicable, in
2	data capture
1	mark, label,
1	(2), in
5	381(d)(1) of
2	subclause is
2	(c) performance
6	subsection (h),
1	specific animal
1	establishments separate
1	either this
1	published, and
2	(c) liability
1	(iii) seizures
1	pregnant women
2	experiencethe term
1	individual performance
1	(i) reconstitutes
1	$23,600,000; and
11	subclause (i)
1	355b. advers-event
1	675, 513,
1	designation within
1	data; (g)
2	also listed
2	act) shall
1	(a)agreement to
2	compendium, and
1	reporting purposes
1	october 18,
1	meeting between
5	fees, without
1	governing such
1	especially the
2	designation in
1	destroy micr-organisms
42	rules and
1	carbonate of
1	ii or,
1	registration number;
1	record a
1	months, fiscal
1	title) submitted
5	rule shall
1	accurate reports,
4	chemical to
1	consult among
4	(16) of
1	(7)(b) of
2	summary described
1	records; (d)
1	product fees,
1	product fees.
1	presents or
6	business entities.
6	rendering, or
2	denying a
2	campaign to
2	section 1472
1	exemptions should
1	prescribed time,
11	local governments
2	two shall
1	demonstrations required
1	decision differs
1	auditor in
1	dispute as
2	technical excellence,
1	gifts, grants,
1	provides nutrients
1	1006, formerly
16	1905 of
3	(b) consider
7	drug code
3	(1), shall
2	external use
1	evaluations notwithstanding
1	shall aim
1	printed or
1	expenses as
4	vitro susceptibility
3	registration filed
1	including describing
1	(2) safety
1	importer (as
1	prescribe, or
1	available medical
1	$1,832,000 for
4	approved, or
1	period against
1	(or incorporate
1	overcome such
1	812. schedules
1	initial dissemination.
2	dried, or
2	cover reinspectio-related
4	exception notwithstanding
1	single state
1	350l. mandatory
1	prevention, shall
2	occurs so
1	(a) travel
14	labeling proposed
1	consideration, take
2	environmental impact
11	undertaken by
1	(b) feedback
1	amends or
2	(b) members
4	medicine, or
1	accept funding
1	predict an
1	constituent, including
1	applicable sections
1	request, measured
6	product liability
1	them, (2)
1	additive. (4)
1	(4) requirements
2	title, then
1	2224. surveillance
1	chapter, notwithstanding
1	review provisions
1	force program
1	(2) unless
1	donor intends
1	675, 303,
1	constituents. 
4	revenue service
1	vehicle; and
32	(b) 
2	will remain
1	(ii) included
1	extension activities
1	seek recommendations
1	decrease the
3	intending, or
1	equivalence (as
1	that, because
1	defining distinct
2	addictio-sustaining liability
1	craving relief
1	patent, an
13	identify and
12	subparagraph, the
1	model meetingsto
1	assessments based
4	general respecting
1	violation 
1	section 379j1(a)(1)
1	receives federal
1	notifying state
6	described by
1	subsection (f)(4)(b)
1	video machines.
3	approval filed
1	341. definitions
1	process, update
1	amendments, and
1	disclosures did
7	bioequivalence studies
3	appropriate information
1	facilitate, when
1	identify any
1	recommendation under
1	investigations, or
1	single tobacco
1	taking steps
2	trends or
1	subsection (e)(1)(a)(iii)
5	appropriate, with
1	agencies from
3	safety standards.
1	ii, 204,
2	classroom situations,
1	ii device,
1	inclusion under
1	justice seizing
18	delivered to
1	defense resources
1	introducing into
1	held shall
4	drug. such
2	appropriated $6,000,000
1	321a. butter
1	warrant good
1	advancing efforts
1	(iv) records
2	(b), each
1	rate computed
1	bequest, gift,
1	reviewed only
1	local areas.
1	conducted using
1	prompt approval
18	(iii) a
1	process specialization
1	restoring areas
2	benefits in
4	written recommendations
1	revocable and
1	commission, on
9	treasury of
1	cigarette to
47	secretary 
1	record. 
1	website, a
2	custom operations
3	ii devices
2	employees that
1	treat, modify,
1	pharmacy. (c)
1	farms; (b)
1	(a) applying
1	conducting vulnerability
5	mark, imprint,
1	will export
1	subsection changing
1	auditor if
3	government for
2	law; (b)
3	(a)in general.
1	interest assessed
1	person conducts
1	presenting demonstrable
4	(2) review
1	foreign food
14	provide written
1	(iii) 1
1	objectionable and
1	1925; or
1	(b)(2) has
1	issue guidelines
1	application exist
1	dismiss. 
1	review divisions
3	pecuniary value
1	supplier a
1	abusers. 
1	sections 4721,
2	academic, and
1	keep records;
1	basis through
1	fungi, protozoa,
1	(d) renewal
7	appropriations and
4	chapter upon
1	(e) unlawful
1	spread by
2	unduly increase
1	appropriations any
3	including recommendations
1	concerning, for
1	notice states
1	(i) permits
1	675, 525,
5	paying such
2	records kept
1	harmonization with
2	decomposed substance.
1	met. any
1	packing; and
1	issue is
6	subpena to
1	warrant. the
1	section exceeds
1	enhance, as
1	hig-risk facilitiesthe
1	consignee, and,
1	possessed, transferred,
1	applies may
1	goalsthe strategy
1	appropriate, during
1	notification, declaration,
1	issue if
2	otherwise manufactured
1	declaration 
3	(3) has
3	infringement is
1	(1) revocation
1	agency components
2	issue in
1	(c) initial
2	clinical trials.
2	clinical trials,
7	medical purpose
2	distribution pursuant
1	remedies. 
1	(3) regulations
2	consumers will
2	condemnation may
1	2012, unless
1	threatening situation
1	matters, and
1	iv, 409,
1	360k of
1	administer oaths,
1	responsibilitiesthe director,
4	clinical trials;
1	advantage foreig-grown
2	including patients,
1	physician receiving
2	application can
5	carcass, part
2	contributing factor
3	release otherwise
1	(5) amendments
2	residue does
1	responsible individual
1	records, as
1	safety risks;
2	applications, investigational
1	exemption prescribed
1	fraudulent material
4	obtained at
1	60 per
1	incurred, under
1	(b)(3)(b)(ii)(iii) of
1	reinspection means,
2	surface (other
1	letters related
3	grant funding
2	applicant, revoke
18	exempted from
1	committees currently
1	official), on
1	worked together
15	areas of
2	proceeds into
1	shortages are
1	i, 101,
2	articles; other
1	internet (including
1	distribution due
5	copying by
1	waters, continental
6	address a
3	(j) construction
1	count, except
3	originating from
1	milk when
2	administration regarding
2	(ii) presents
1	(h) approved
1	toll during
1	food recallsnot
60	response to
3	means review
1	802. definitionsas
2	maintenance the
1	operations subject
1	(d), dispenses
1	general, it
1	on-fourth inches
1	annual o-site
1	least annual
1	characteristics, as
2	authorized purchaser
2	u.s.c. 1471
12	food, and
1	violations; written
2	samantha reid
1	expertise, with
1	program). 
2	general, if
1	perishable foods.
1	(iii). to
2	(4) make
1	(c)coordination. 
2	drug prohibition
1	consumers concerning
4	fine and
1	amounts authorized
1	evaluate relevant
1	
 387e.
1	payments cooperation
1	discontinued, or
11	antibiotic drug
1	 except
14	concerning a
1	(2) criteriaa
1	herein, the
1	(ii) active
1	known within
1	act does
1	initial 3-day
2	certified as
1	subject in
2	writing whether
4	information accessed,
1	narcotic dru-free
1	agents office
1	term poppy
1	advice. (c)
6	commissioner, the
6	considered for
1	contains references
1	sale directly
2	first year.
1	
 136.
2	initial and
2	(1)(a), and
1	general. any
3	regulation pursuant
1	360ddd(1)(h) of
3	nonprofit affiliate
1	adulterated nor
2	(27 u.s.c.
2	rea-time supplement,
1	loose tobacco
3	outcome described
1	unless renewed
48	evaluation and
1	title; (xi)
2	section 467a
1	state within
1	rules 
1	radioactive drugs
1	(d) treatment
1	start dates
3	1, 2,
1	informationexcept with
3	person. (b)
2	proceedings before
6	advertisement is
2	research activities,
1	containers; (f)
4	interferes with
1	facilit-specific. 
1	section 360(a)(1)
1	intelligence center.
1	supplement. (e)
1	holds food,
1	holds food.
1	screening chemicals
1	device applications,
2	device applications.
1	adopt, promulgate,
2	investigation (referred
3	labeling stating
2	whether 
4	person debarred
1	no-federal sources;
1	lawfully obtained,
1	actions with
2	grant, loan,
2	term renderer
1	(a) necessary
1	detection limit
1	(ii) impact
2	ant-doping organization
1	clinical difference,
3	consumer for
1	2, 38
3	chapter; (d)
1	2, 37
3	withdrawn and
2	conditions, to
1	certain state
2	term genetically
1	positions established
1	supplying certain
1	characteristics in
1	(3) subsequent
1	screening program,
1	entity need
1	product package
1	schedule solely
1	commodities, not
1	344, 350d,
1	specifying those
1	screening program;
7	stated in
1	organizations, representatives
1	(5) periodic
3	alternative methods
1	value has
1	support electronic
2	fee when
1	9 grams
2	offenses (a)
1	fluids is
2	appropriately marked
1	reauthorized beyond
4	states. in
2	360eee3(a) of
2	liability, the
1	subchapter by
1	harvested at
3	(f) to
1	(c) approval
1	monitoring provisions
1	assistance with
3	(2) applicability
1	1301 to
3	listing such
2	available, with
1	(to the
1	infants by
2	supplant, no-federal
2	(c) whether
28	 (8)
1	2009 for
1	product syringes)
1	(c) restrictions
75	made under
1	fda employees
4	service on
1	children. 
1	(a), separate
1	certification, with
1	licensure that
1	distribution centers
25	service of
1	crab, lobster,
1	financial capacity
1	certified. (may
1	(iv) due
1	denials proceedings
1	fungous injury,
1	rehabilitation research
4	temporary scheduling
1	may elect,
1	2021, a
2	bottled water.
2	controls proposed
1	needs in
1	include dairy
3	congress makes
2	state established
1	(iv)failure to
1	benefit, taking
4	condition described
1	iii, 532,
1	subparagraphs (f),
1	abused drugs.
1	coalition institute.
1	677. other
1	tribe. nothing
1	spokesperson of
1	title, assess
1	inspection, upon
1	to, but
1	made since
1	rata basis
1	attending physician
2	issue, the
1	appropriate governmental
1	toxicity to
2	personnel in
1	certain orders
1	(i), no
5	security and
4	section, for
1	contendere by
1	retail distributor
1	material prior
1	serves children
1	bank pursuant
1	overcollections; recovery
9	governor of
1	law, food
2	tolerance shall
1	take other
2	circumstances indicating
2	802(25)[1] of
3	device containing
2	effect notwithstanding
1	significant issue
2	(d) reporting
1	drug reduction
1	magnetic fields;
15	order. 
1	(iv) ingredients
1	demonstrate appropriate
3	specified date
6	area in
1	infringed. (bb)
2	variance under
2	made concurrently
1	product bears
12	premarket application
2	services. (e)
6	considers to
1	2011. (6)
2	authority as
1	informal conference,
1	previously determined,
1	providing administrative
5	esters, and
1	renovated, or
1	(d) eligibilityeligibility
1	$83,000 per
2	(3) training
1	list, required
1	health advisories
1	evidence. except
20	experts qualified
1	dispenser. (12)
1	small market
2	skill, or
6	preserve its
3	claim such
2	360b, 360ccc,
1	preventing 
2	satisfactory performance
1	partial waiveron
1	exempt therefrom
4	subsequent recipient
2	affirmed, the
1	data consistent
2	1971. in
2	use: 
2	tablets, or
1	(d) biosimilar
1	description under
1	application. (v)
1	infections, including
5	819.)
 

1	label to
2	appearing and
1	defendant until
1	reduction organizations,
5	(1) product
2	trials. 
1	alkaloidal salts
1	year, november
2	renewed by
4	(a)(1) for
1	respectively. (3)
2	deviations from
2	(a). such
1	nutrition program
23	fee is
1	850. information
5	fee in
1	(b), when
9	government subject
1	detailed accounting
9	fee if
1	strengthen radiological
1	(c) grant
8	device applications
1	(10) indian
7	applicant notice
3	reduction or
1	472. interstate
1	columbia, but
1	file fee.
1	section 247d6b(c)
4	chief scientist
1	appropriate, a
2	(1)(a), (1)(b),
1	desiccated. this
1	use. registration
5	(b). the
2	(3) establishments
1	(vi) listing
2	objectives similar
15	reduction of
1	title, (d)
52	1 of
1	nicotin-based and
38	(1) to
2	applications. (d)
3	condition prescribed
4	4, 1913
1	title) with
1	animal carcinogen,
1	limited time,
1	denaturants, so
2	penalty against
1	675, 736,
37	1 or
1	nondevelopment or
1	timeframe. 
5	standards, the
1	entry; and
1	producing positron
1	market exclusivities
1	thefts in
1	(1)(a) applies,
1	guidelinesnot later
1	345. regulations
3	licensed before
1	examining the
1	meat itemthe
1	(i) submitted
1	users, or
11	requirements are
1	members for
2	accelerate the
2	position at
2	basis among
2	(3) withdrawal;
1	form issued
3	margin of
1	trafficker, the
1	otherwise limits
1	types so
1	section $4,900,000
2	services prior
1	bound; scope
1	highly compliant
1	establishments, consistent
1	paragraph (4)(a)(iii)(i)
1	42. nothing
1	increased manufacturing
1	systematic approach
1	projects, when
1	materials accompanying
1	efforts. (j)
1	regulatory flexibility
1	identical or
1	biologic, food,
20	manufacture, preparation,
1	veterans affairs);
1	4, 44
1	authenticate the
1	duplicate records
2	stands convicted
2	chemicals 
1	patient populations.
1	meat inspection,
1	provider license
4	date is
1	date it
2	861 of
4	(iii) shall
8	date in
4	(including traveltime)
2	drugs, for
9	18-day period
2	transfer technology
1	agencies, with
3	importation under
1	adequate requests
1	investigation into,
1	chapter applies
1	farms; restaurants;
2	grounds unless
1	same; (vi)
1	smuggling goods
2	chapter against
1	office a
1	subchapter, any
2	users living
1	forms prepared
1	-penty--(-chlor--naphthoyl)indole (jwh398);
6	term authorized
1	262, 2,
1	order notification
1	
 360bbb8a.
4	statement, and
1	contractual agreements
1	entity not
5	(1), unless
1	(2) improve
17	section, or
3	time under
1	tag permanently
1	stakeholders may
2	(i) determine,
1	subsection (b)(2)(b)(iii)
1	found acceptable
1	biologicals under
1	screens, permanent
2	courts independent
1	
 379j43.
1	1524. authorization
1	government, school
1	practicable, segregate
7	data that
1	sales personnel;
5	article subject
1	presents less
1	(a) 1
1	every second
1	leas-purchase arrangements.
1	underserved areas);
3	(a) development
1	chapter) shall
1	intentionally delayed
1	offense, or
1	822.) [1]
1	compounding. the
2	refusing, withdrawing,
1	
 360fff7.
1	deniable form
1	product sampling,
5	articles in
1	iv, 401,
1	(6)(a) revoking
1	first participated
3	(72 stat.
1	feed, as
1	container. (u)
1	scientific fact,
1	adequately direct
1	selling such
1	holds at
4	deem necessary
1	performance; (b)
1	section available
3	single application
1	setting. (c)
1	demonstrate for
3	201(b) of
3	generalthe regulations
11	supplement for
1	violations; notice;
2	stored and
2	panel (a)
1	thereof. it
1	stakeholders, of
11	daily equivalent
2	materials which
2	holds an
1	organizations, as
2	laws. (3)
1	establishments; 
1	subchapter may,
4	experts in
2	1.227 of
2	mechanisms to
1	act are
1	comment); (ii)
1	diverse communities
2	dru-related activities
1	persons may,
2	detained, until
1	distributed interstate
1	manufacturing due
1	394 of
1	months. 
1	possible, no
1	(b)(iii) shall
1	approved 
1	chemicals controlled
1	contents, filing,
1	limited annual
1	(a) fiscal
15	notice shall
1	articles; good
1	highly visible
3	cosmetic, or
4	subchapter iv
3	division shall
5	subchapter is
1	committees, to
4	valuable constituent
1	conferences prior
2	products exclusively
1	(3) increasing
1	subchapter ix
1	liability solely
1	authorizedthe term
3	supplements in
1	(b)(iii); and
7	label containing
2	professionals, and
1	consumption before
1	requirements pertaining
1	resolve those
1	supplements if
39	subchapter ii
1	appropriate purposes
2	transfer program
1	secretary annually
2	subpena witnesses,
1	name prominently
17	regulations and
8	official compendium
1	defect not
3	full fee
1	misleading; (2)
12	established pursuant
25	january 1,
1	(d) ensuring
1	letter described
1	findings meat
1	675, 740a,
5	appropriations to
2	involved. (e)
1	resources, detect
1	(i) subparagraphs
2	officer shall
1	mail order
3	receipt, carriage,
2	wholesalers or
1	letter from
1	(3) unit
2	regulations any
2	user. 
1	strawberry, grape,
1	(b) tolerances
1	therein. (c)
2	territory does
4	(b) at
6	agencies under
3	rely upon
5	retailer of
1	subchapter. (6)
2	initial interpretations
6	(b) as
3	every 3-day
19	(b) an
2	states complaint
1	announcing such
1	consideration given
6	(b) when
1	straw. (c)
2	enacted providing
3	defendant to
1	intentional contamination,
1	notice; updated
1	
 452.
1	29, 1938,
2	significantly affect
7	director, in
1	produce, manufacture,
1	single establishment
1	science and
1	within noncontiguous
3	grounds therefor,
1	grounds therefor.
1	subject as,
1	subsection (a)(1)(f)(i).
1	attached or
2	records respecting
5	industry, and
2	admiralty, except
1	(a)in general.no
1	schedules shall
1	subchapter. (7)
2	warning. 
1	evidence when
1	consultation will
1	opioid the
1	committees advisory
58	substance or
1	$250,000, but
1	medicine by
1	dispenser the
1	agriculture sector
1	may differ
6	paragraph (1)(c)
4	auditor shall
1	bacteria, including
1	seeking such
1	application, duly
5	ninet-day period
4	substance of
1	specifications governing
3	development, biosimilar
1	order (after
1	education, treatment,
2	human consumption,
5	shall list
2	continuing the
1	renew such
2	trading partner,
2	(or both)
3	identified, or
13	throughout the
2	training (including
2	declaratory and
1	court, of
1	accepted safety
13	members shall
4	schedule i,
1	7625 of
2	pharmaceutical manufacturer;
1	another department
1	secretarys only
1	suggestions and
1	forfeiture event
1	timely advice
3	opposes, impedes,
3	new york,
21	data from
1	audits under
1	(b), information
2	(f) on
1	 second.
1	feedback in
1	constitutes good
1	device treatment.
1	foundation; (b)
1	1332(2) of
17	(f) of
1	inspection functions
1	inedible means
1	jurisdiction a
17	shall remain
1	relief or
4	(f) or
4	date a
5	health. the
1	cessation, including
4	expense of
7	safety standards
2	appropriate limits
1	decontamination of
1	inedible, leaker,
1	authorityfor fiscal
3	sex in
1	certifications have
1	examinations made
1	(i) definitionas
3	corporations that
3	person charged.
1	1. 
1	subchapter, insofar
1	$2,117,000 for
1	subparagraph (b)),
2	facilities). the
1	penalty objects
1	(b) plans
2	drug advertising.
2	operator or
1	modified requirements
2	interest. registration
2	(a)(5)), verifying
1	provider has
1	(2)(a)(vii)(iv) is
1	experts outside
3	cause shown
20	operator of
1	foodborne infectious
1	pay rates
2	so; and
4	court (within
1	drug advertising;
1	order authorized
1	humans, whether
1	supplementsany application
1	adjustment. the
1	qualify such
2	resumed the
1	(a)(3)(f) shall
5	given notice
4	meat items
1	sale. (july
5	inventory, and
1	(28) -(2,-dimethox--(n-propylphenyl)ethanamine
1	(13) shall
1	(i), so
1	studies not
61	requirements for
1	discovery and
1	encountered, and
1	effective outreach
1	treatment outcome
1	10.30, title
1	written, provided
1	(e)(8); and
1	commercial purposes.
1	including assistance
7	previously filed
2	1946 (7
1	(4) ris-based
1	chapter drugs
1	inspection upon
1	book kept
1	(vi) 40
1	ted stevens
2	requirements; persons
1	affects, or
12	paragraph (6)
1	section 1605(c)(3)(b)(ii)
1	systemthe elements
1	acknowledgement that
1	chemical. (34)
2	(j), and
1	year, beginning
1	(b) foodborne
1	(i) responding
1	development tool.
1	mutilation, destruction,
1	leaking; or
1	section 505e
2	term adjusted
2	reporting, including
1	wholesaler. it
2	certain devices
2	expended on
1	regulation, publish
1	(c) executed
1	persons within
1	kept, and
1	(1)(a) not
6	holds a
1	thereunder may
1	503a, as
1	certainly impose
9	44 stat.
1	
 360m.
1	section 321(g)
1	file, and
1	practitioners pursuant
2	must, in
1	engineering applicable
1	(b) submitted
1	allergens, and
11	75 percent
1	environments, and
2	act making
10	additional data
2	submitted effective
1	term video
1	unapproved food
1	network members,
1	contract manufacturers,
1	expertise means
1	board that
1	promotion restrictions
80	description of
1	workforce restructuring
1	regimens; and
8	fee the
12	methods for
14	42 for
8	supply reduction,
8	applies with
1	(2) practitioners
1	dietary ingredients:
4	section 356
6	section 357
1	section 354
81	section 355
12	shall serve
3	section 353
1	section 350
27	section 351
1	any, on
1	sterile under
2	small quantities
1	assist or
1	2 times
5	355(c)(3) of
1	gross worldwide
2	toxic, or
1	675, 507,
1	butterine, or
3	secretary designates
1	inspection warrants,
2	list filed
1	probationers, and
1	protocol provides
18	final guidance
1	humans) composed
1	(7) whether
1	secretary associated
4	contents 
2	criminal procedure.
2	requires, based
1	implemented through
1	(4) dihydrocodeine.
1	247d5 of
1	submission contains
1	applies); and
1	country with
1	domestic hig-risk
2	made unless
2	conventional food
1	amounts to
4	(d) drug
1	(14) local
1	international crime.
1	powers and
6	(ii) or
1	agency planthe
5	foundation. 
2	matter is
1	grounds, the
1	$280,000,000 for
1	stalks (except
1	(14) retailer
11	subsection in
4	exporters of
1	(d) board
30	(ii) of
6	paragraph (2)(a),
1	(a) advertising
1	separate radiation
4	matter in
1	purchasers to
2	contraindications, warnings,
3	(ii) on
1	available techniques
1	administrator, without
1	safe with
1	matter if
2	lacks the
1	precursor means
4	regulation, after
7	notice that
1	2017. (v)
1	exist justifying
1	virus disease.
5	administrator may,
1	facility, once
2	methods under
1	vehicle. (

7	sponsor fee
1	locality where
1	involvement the
23	publish the
1	derived solely
1	process, quality
6	register. 
1	records, including
4	reports, the
1	nonvoting members.
3	reviewable. 
1	academia, health
5	346a of
1	perjury and
1	body structure.
1	physically inspected
2	body structure,
5	product will
1	section, respectively,
1	applicable licensure
56	abbreviated new
1	practice where
1	identify certain
1	may routinely
1	scheduled under
1	storage practices,
14	(e) or
1	performance standard.
9	facilities that
3	performance standard,
1	level, sufficient
2	who, with
1	device rather
1	area, subject
1	otherwise facilitated
1	enable them
1	avoids, or
1	(2). a
1	imports foods,
1	
 350k.
1	 200.0.
1	annual awards
1	dedicated commuter
1	pay provided
1	abroad, a
2	person) the
1	section 1534
3	list and
1	nature, extent,
1	(b)(i), a
3	children with
2	1999, the
1	congressit is
1	national policythe
1	trend of
2	imprisonment as
1	(mg) 0.15
1	assessment pursuant
1	consumers actually
1	(including crude
1	section 3663a(c)(1)(a)(ii)
2	made so
1	year, respectively,
1	also visible
1	punctured metal
1	communit-based programs
1	(f), authorized
1	
 96.
31	foreign government
2	tobacco, the
1	made without
1	recoupment of
1	appropriate reason
1	(iii) chair
2	decision as
1	list (a)
1	circumstances specified
1	contest, game,
1	receipt, holding,
1	goals, including,
2	code, and
1	institute; (5)
8	rendered injurious
1	(c) $7,429,000
3	solely within
1	employees mentioned
1	intending or
1	tracking the
1	finalized to
1	security, storage,
1	clarifies the
2	party auditor
5	subsection (b)(2)(b)
2	u.s.c. 353(b)].
7	331 of
1	petition relates
1	(2) authorizedthe
1	section 558.3(b)(3)
1	updated notice
1	(o) registration
2	counterfeit tobacco
1	statements from
1	persons initially
2	developed and,
1	data compiled
1	administered will
3	any, shall
1	appropriation or
3	developed for
8	(3) effect
1	assembles, processes,
1	clinical capability
1	manufacturers tests
1	regulatory auditthe
2	conformity of
8	new dietary
1	seal. 
2	gum, and
1	seller from
1	edible products
2	upon data
1	licensed product
1	50 or
1	production reportthe
7	first country
1	device improvement,
1	included any
1	corporation using
2	occurs within
1	schedule an
1	allergen labeling
8	amount in
1	(iii) public
6	amend or
1	both, as
1	agriculture (including
2	point in
2	protocol approved
2	drug between
1	(v) review
1	342. adulterated
2	plans in
3	chemical which
1	water. (b)
1	governments prior
1	(c) how
1	century cures
2	agency centers,
2	interruption of
2	legend, shall
8	perform such
1	monitoring records
1	nonbinding nature
2	comment from
1	particularly hydroponically
1	interruption or
2	direct ownership
1	purchaserseach regulated
3	days. 
1	613. plans
1	organization. (c)
1	groups), consumer
3	immediate precursor,
4	(1): 
6	country described
1	calomel; nor
1	premises upon
1	biennial reporting
4	materials used
6	ingredients (other
2	registration, or
1	importer. 
1	administer epinephrine
1	publication, including
1	section 360e(i)(2)
1	
 360g.
1	time, after
1	notification relating
3	licensed for
1	device sponsor,
2	independent review
1	(i), (2)
2	whether this
1	intended therapeutic
1	reasonably require,
2	(excluding an
3	reasonably require.
1	deem appropriate
1	annually for
1	343(r)(1) of
1	dutiesin order
1	substances) are
1	1.8b 
1	whom, and
1	(ii) packed,
3	poultry product,
1	salts, yellow
1	manifestations, including
1	structure; 
1	(h) outreach
1	policy nothing
1	encapsulating machine
4	discontinuation of
1	planthe plan
6	administration. (b)
1	675, 756,
1	addressed, consistent
1	researchers included
1	person conduct
1	subsection, shall
1	staff, as
2	ingredient; except
1	deferring the
1	significant findings
2	discovery from
1	leaf other
3	drug, evaluated
1	include distilled
2	standard grades
1	262] (relating
3	reasonably required
1	electronic format,
1	without screens,
1	present; and
1	(1) places
1	
 198a
1	without interruption.
15	owns or
1	also seek
1	centers). 
1	paragraph. within
1	351(b), or
1	sign adjacent
1	(2) addressing
1	donated at
1	impurities contained
1	(ii) applies
1	tins, pots,
7	commodity or
1	committees with
1	(7) generic
1	marked, stamped
2	regulation, promulgated
2	1040) [21
1	(i) compares
3	manufacturing of
1	similar institutions
1	consumers) to
1	u.s.c. 2281
1	determined causes
3	made after
1	section 355(k)(4)
3	facility, unless
5	inspection user
1	identify. (d)
1	cows which
1	inform state,
10	records or
3	caused harm
1	particular, or
2	unreasonable dietary
1	packaging requirement
1	contentsthe notification
7	interested person
7	prescribing the
1	farm subject
6	introduction of
6	international treaties,
1	product; 
33	records of
1	joint plan
1	supplies, including
1	number (to
1	whenever appropriate.
1	models of
1	exported. any
1	records on
1	designates under
1	402, as
2	involved, except
8	emerging drug
2	decomposed substance
1	numeral identifier
1	seeking action
1	173.315(m) of
1	contentsthe voluntary
1	 (r)
1	senate, which
1	(1), either
5	section 812(b)
1	commission adequate
1	filed an
5	request meets
2	felony described
1	2007; or
1	flavoring used,
2	foods and
2	otherwise confidential,
2	days, on
3	(b) establishing,
7	brief statement
2	(c). (c)
1	commission. (2)
162	less than
2	days, of
1	showing a
1	period for,
5	filed for
3	pediatric uses
2	voluntarily submitted
1	logbook to
3	terrorist offense
1	department; (b)
1	days, or
1	owner, operator
6	states trade
1	volunteer groups.
1	2013, as
1	resubmission may
1	biosurveillance and
1	internet access
1	deny, that
1	campaign, including
7	subchapter, or
218	may not
9	controls against
1	(b) success
1	may contain,
1	considerationsin establishing
1	studies), including
1	confirmation under
1	demand reductionthe
1	prescribing practitioner
1	state, relating
1	timely review
2	drugs, nonprescription
5	812(b) of
164	safety and
9	supplier verification
2	trial under
1	commodity intended
1	restaurants, hotels,
1	conditions). (ii)
7	upon approval
3	section 321(ii)
1	product they
1	operator to
1	(ii) records
2	(g) grocery
2	providing interested
1	reveal trade
1	logbook information
1	conveyance to
1	standard. nothing
3	360fff3(b) of
1	pharmacy. applicants
6	ii. 
1	persons involvement
4	360i, and
1	pay, or
1	patients report
2	(b), do
1	facts in
2	official seal
1	correct an
6	commission may
2	(july 1,
1	logbook corresponds
1	(including pediatric
1	information at
42	information as
1	next applicable
1	postponing sentence
2	referral. within
1	136a(c)(2)(b)] or
1	damages described
1	potential pilot
2	correct as
1	professional services,
2	849, 859,
1	states) shall
5	subsection (c)(1)
1	(6) national
2	payment all
1	carcasses brought
2	date provided
1	required. (e)
1	analysis may
4	prevention, the
2	csa 
1	direct changes
1	rule. any
1	periods. (3)
1	(7) its
1	pharmacies an
1	market that
1	
 379dd.
5	(i) fiscal
1	another department,
1	(b) imported
2	decision should
7	thereof; or
1	distributors, retailers,
1	wake island,
1	broad range
1	total combined
1	offense consisting
3	360j(l) of
1	product, establish
56	(a) and
1	(d) procedure
1	reflecting, or
1	future potential
1	counterfeiting such
1	(j)coordination. 
1	athletic competition,
1	abuse. (2)
1	period, whether
3	fund 
23	(a) any
11	relation to
1	applicant not
1	plan a
1	will serve
1	compensation (including
3	court, or
1	homepage, the
1	systems developed
12	hazard analysis
7	apply only
1	communities. (b)
1	experience. 
1	$100,000 or
19	u.s.c. 201
1	may, from
1	otherwise within
1	means domestic
11	information, including
1	title 5).
1	802(33),[1] shall,
3	patient, and
1	treatment resources
1	receives information,
2	court, on
1	summarizing all
2	dealing by
37	thir-party auditor
2	ointments sold
1	contains, when
1	mutton, pork,
2	athletic competitions
1	(3) do,
1	differing characteristics
2	year, by
1	360c(a)(1)(a) of
1	wholesalers. 
1	year, be
1	otherwise. the
1	same; and
1	workforce needs
1	without charge,
1	raise any
2	adulteration if
1	posted in
7	june 1,
1	women that
17	provided that
1	injectable liquid)
1	dosage strength,
1	wit: the
1	identifying each
1	among individuals
1	onsite visits
2	health; 
2	clandestine manufacture
29	subsection (b)(2)
1	indirectly establish
2	groups, except
1	youth center
1	rehabilitation as
1	explosives, and
1	common international
2	subsection (d))
13	wholly or
2	drug intelligence
4	entry or
2	manufacturing practices,
23	subsection (d),
1	manufacturing practices.
12	subsection (d).
1	occurred. 
1	(v) -hexy--(-naphthoyl)indole
2	reports with
2	necessitates medical
1	deferral extension;
2	(ii)filing of
1	implementation systemthe
5	registers with
12	subsection (d);
4	manufacturing practices;
42	entry of
3	business requiring
1	(c) communit-based
2	market authorization
1	cannabinoid receptor
2	completeness of
1	organization recognized
1	(2)(c), the
1	(2) consideration
1	transaction means
1	awards required
7	secretary means
2	register not
2	similar in
1	governments; (3)
1	alternate sources
1	prescribing alternative
1	possible; or
1	maintain on
1	conducting device
1	functional assays
1	best practices,
1	equivalent, within
1	providing advice
9	manufacturing or
1	1946 (60
1	persons outside
2	if, upon
1	outcome the
1	(including guidelines
5	food into
5	(d) an
8	prepared in
1	(e)(3); (2)
1	formula. (2)
3	format and
1	sheep, swine
2	fat of
37	approved by
1	chapter depresses
4	30, 1906,
7	products the
1	issue revised
4	practicable such
8	within sixty
1	(d) as
1	fat or
2	property. 
1	(24)(b), any
1	deviates from
1	subsection, take
1	(e) menthol
3	distribution, dispensing,
1	function in
2	secretary would
3	secretary made
1	112a. omitted

1	use this
2	means guam,
1	purposes referred
4	pizzas containing
2	method or
1	doubt on
1	subbrand. effective
1	emergency situations.
4	concert with
1	report relating
32	raw materials
2	secretary; (d)
23	method of
2	practices implemented
